<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
<head>

<meta charset="utf-8">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />
<meta name="author" content="Tim Woelfle" />

<meta name="date" content="2024-04-21" />


<title>PRISMA &amp; AMSTAR in Cullis 2017: LLM (Mixtral-8x22B) vs Human Consensus</title>

<meta property="og:title" content="PRISMA &amp; AMSTAR in Cullis 2017: LLM (Mixtral-8x22B) vs Human Consensus" />

<meta name='viewport' content='width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no' />

<link rel="icon" href="data:image/x-icon;" type="image/x-icon">


<script type="text/javascript">
window.FlexDashboardComponents = [];
</script>

<script id="flexdashboard-navbar" type="application/json">
[{"title":"Home","href":"../index.html"},{"title":"Source Code","icon":"fa-github","href":"https://github.com/timwoelfle/Research-Assessment-AI/","align":"right"}]
</script>
<script src="lib/header-attrs-2.21/header-attrs.js"></script>
<script src="lib/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="lib/bootstrap-3.3.5/css/cosmo.min.css" rel="stylesheet" />
<script src="lib/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="lib/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="lib/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="lib/stickytableheaders-0.1.19/jquery.stickytableheaders.min.js"></script>
<link href="lib/font-awesome-6.4.0/css/all.min.css" rel="stylesheet" />
<link href="lib/font-awesome-6.4.0/css/v4-shims.min.css" rel="stylesheet" />
<link href="lib/value-box-accent-static-0.6.1/theme-cosmo-value-box.css" rel="stylesheet" />
<link href="lib/flexdashboard-css-0.6.1/flexdashboard.min.css" rel="stylesheet" />
<link href="lib/flexdashboard-css-0.6.1/theme-cosmo.css" rel="stylesheet" />
<script src="lib/htmlwidgets-1.6.2/htmlwidgets.js"></script>
<link href="lib/datatables-css-0.0.0/datatables-crosstalk.css" rel="stylesheet" />
<script src="lib/datatables-binding-0.28/datatables.js"></script>
<link href="lib/dt-core-1.13.4/css/jquery.dataTables.min.css" rel="stylesheet" />
<link href="lib/dt-core-1.13.4/css/jquery.dataTables.extra.css" rel="stylesheet" />
<script src="lib/dt-core-1.13.4/js/jquery.dataTables.min.js"></script>
<link href="lib/crosstalk-1.2.0/css/crosstalk.min.css" rel="stylesheet" />
<script src="lib/crosstalk-1.2.0/js/crosstalk.min.js"></script>
<style type="text/css">
/*
  CSS for flexdashboard.js' use of Sly(). The sizing/position of this CSS needs to be
  applied _before_ flexdashboard.js initializes, which is why this CSS has been pulled
  out from flexdashboard.scss and inlined in the document's head.
*/

.storyboard-nav button {
  background: transparent;
  border: 0;
  opacity: .3;
  outline: none;
  padding: 0;
}

.storyboard-nav button:hover,
.storyboard-nav button:hover {
  opacity: .5;
}

.storyboard-nav button:disabled,
.storyboard-nav button:disabled {
  opacity: .1;
}

.storyboard-nav .sbnext,
.storyboard-nav .sbprev {
  float: left;
  width: 2%;
  height: 120px;
}

.storyboard-nav .sbprev {
  text-align: left;
  width: 2%;
}

.storyboard-nav .sbnext {
  float: right;
  text-align: right;
  margin-right: 8px;
}

.storyboard-nav .sbframelist {
  margin: 0 auto;
  width: 94%;
  height: 120px;
  overflow: hidden;
  text-shadow: none;
  margin-bottom: 8px;
}

.storyboard-nav .sbframelist ul {
  list-style: none;
  margin: 0;
  padding: 0;
  height: 100%;
}

.storyboard-nav .sbframelist ul li {
  float: left;
  width: 270px;
  height: 100%;
  padding: 10px 10px 10px 10px;
  margin-right: 8px;
  text-align: left;
  cursor: pointer;
}

.storyboard-nav .sbframelist ul li:last-child {
  margin-right: 0px;
}

.sbframe-commentary {
  width: 300px;
}

.sbframe-commentary ul {
  padding-left: 22px;
}

.sbframe.active {
  display: flex;
}

.sbframe:not(.active) {
  display: none;
}
@media only screen and (min-width: 768px) {
html, body {
  height: 100%;
}

#dashboard-container {
  height: 100%;
}
}
</style>



</head>

<body>

<div class="navbar navbar-inverse navbar-fixed-top" role="navigation">
<div class="container-fluid">
<div class="navbar-header">

<span class="navbar-logo pull-left">
  
</span>
<span class="navbar-brand">
  PRISMA &amp; AMSTAR in Cullis 2017: LLM (Mixtral-8x22B) vs Human Consensus
  <span class="navbar-author">
    Tim Woelfle &mdash; 2024-04-21
    </span>
</span>

<button id="navbar-button" type="button" class="navbar-toggle collapsed pull-right" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
<span class="icon-bar"></span>
<span class="icon-bar"></span>
<span class="icon-bar"></span>
</button>

</div>
<div id="navbar" class="navbar-collapse collapse">
<ul class="nav navbar-nav navbar-left">
</ul>
<ul class="nav navbar-nav navbar-right">
</ul>
</div><!--/.nav-collapse-->
</div><!--/.container-->
</div><!--/.navbar-->

<script type="text/javascript">


var FlexDashboard = (function () {

  // initialize options
  var _options = {};

  var FlexDashboard = function() {

    // default options
    _options = $.extend(_options, {
      theme: "cosmo",
      fillPage: false,
      orientation: 'columns',
      storyboard: false,
      defaultFigWidth: 576,
      defaultFigHeight: 461,
      defaultFigWidthMobile: 360,
      defaultFigHeightMobile: 461,
      isMobile: false,
      isPortrait: false,
      resize_reload: true
    });
  };

  function init(options) {

    // extend default options
    $.extend(true, _options, options);

    // add ids to sections that don't have them (pandoc won't assign ids
    // to e.g. sections with titles consisting of only chinese characters)
    var nextId = 1;
    $('.level1:not([id]),.level2:not([id]),.level3:not([id])').each(function() {
      $(this).attr('id', 'dashboard-' + nextId++);
    });

    // find navbar items
    var navbarItems = $('#flexdashboard-navbar');
    if (navbarItems.length)
      navbarItems = JSON.parse(navbarItems.html());
    addNavbarItems(navbarItems);

    // find the main dashboard container
    var dashboardContainer = $('#dashboard-container');

    // resolve mobile classes
    resolveMobileClasses(dashboardContainer);

    // one time global initialization for components
    componentsInit(dashboardContainer);

    // look for a global sidebar
    var globalSidebar = dashboardContainer.find(".section.level1.sidebar");
    if (globalSidebar.length > 0) {

      // global layout for fullscreen displays
      if (!isMobilePhone()) {

         // hoist it up to the top level
         globalSidebar.insertBefore(dashboardContainer);

         // lay it out (set width/positions)
         layoutSidebar(globalSidebar, dashboardContainer);

      // tuck sidebar into first page for mobile phones
      } else {

        // convert it into a level3 section
        globalSidebar.removeClass('sidebar');
        globalSidebar.removeClass('level1');
        globalSidebar.addClass('level3');
        var h1 = globalSidebar.children('h1');
        var h3 = $('<h3></h3>');
        h3.append(h1.contents());
        h3.insertBefore(h1);
        h1.detach();

        // move it into the first page
        var page = dashboardContainer.find('.section.level1').first();
        if (page.length > 0)
          page.prepend(globalSidebar);
      }
    }

    // look for pages to layout
    var pages = $('div.section.level1');
    if (pages.length > 0) {

        // find the navbar and collapse on clicked
        var navbar = $('#navbar');
        navbar.on("click", "a[data-toggle!=dropdown]", null, function () {
           navbar.collapse('hide');
        });

        // envelop the dashboard container in a tab content div
        dashboardContainer.wrapInner('<div class="tab-content"></div>');

        pages.each(function(index) {

          // lay it out
          layoutDashboardPage($(this));

          // add it to the navbar
          addToNavbar($(this), index === 0);

        });

    } else {

      // remove the navbar and navbar button if we don't
      // have any navbuttons
      if (navbarItems.length === 0) {
        $('#navbar').remove();
        $('#navbar-button').remove();
      }

      // add the storyboard class if requested
      if (_options.storyboard)
        dashboardContainer.addClass('storyboard');

      // layout the entire page
      layoutDashboardPage(dashboardContainer);
    }

    // if we are in shiny we need to trigger a window resize event to
    // force correct layout of shiny-bound-output elements
    if (isShinyDoc())
      $(window).trigger('resize');

    // make main components visible
    $('.section.sidebar').css('visibility', 'visible');
    dashboardContainer.css('visibility', 'visible');

    // handle location hash
    handleLocationHash();

    // intialize prism highlighting
    initPrismHighlighting();

    // record mobile and orientation state then register a handler
    // to refresh if resize_reload is set to true and it changes
    _options.isMobile = isMobilePhone();
    _options.isPortrait = isPortrait();
    if (_options.resize_reload) {
      $(window).on('resize', function() {
        if (_options.isMobile !== isMobilePhone() ||
            _options.isPortrait !== isPortrait()) {
          window.location.reload();
        }
      });
    } else {
      // if in desktop mode and resizing to mobile, make sure the heights are 100%
      // This enforces what `fillpage.css` does for "wider" pages.
      // Since we are not reloading once the page becomes small, we need to force the height to 100%
      // This is a new situation introduced when `_options.resize_reload` is `false`
      if (! _options.isMobile) {
        // only add if `fillpage.css` was added in the first place
        if (_options.fillPage) {
          // fillpage.css
          $("html,body,#dashboard").css("height", "100%");
        }
      }
    }
    // trigger layoutcomplete event
    dashboardContainer.trigger('flexdashboard:layoutcomplete');
  }

  function resolveMobileClasses(dashboardContainer) {
     // add top level layout class
    dashboardContainer.addClass(isMobilePhone() ? 'mobile-layout' :
                                                  'desktop-layout');

    // look for .mobile sections and add .no-mobile to their peers
    var mobileSections = $('.section.mobile');
    mobileSections.each(function() {
       var id = $(this).attr('id');
       var nomobileId = id.replace(/-\d+$/, '');
       $('#' + nomobileId).addClass('no-mobile');
    });
  }

  function addNavbarItems(navbarItems) {

    var navbarLeft = $('ul.navbar-left');
    var navbarRight = $('ul.navbar-right');

    for (var i = 0; i<navbarItems.length; i++) {

      // get the item
      var item = navbarItems[i];

      // determine the container
      var container = null;
      if (item.align === "left")
        container = navbarLeft;
      else
        container = navbarRight;

      // navbar menu if we have multiple items
      if (item.items) {
        var menu = navbarMenu(null, item.icon, item.title, container);
        for (var j = 0; j<item.items.length; j++) {
          var subItem = item.items[j];
          var li = $('<li></li>');
          var a = navbarLink(subItem.icon, subItem.title, subItem.href, subItem.target);
          a.removeClass("nav-link").addClass("dropdown-item");
          li.append(a);
          menu.append(li);
        }
      } else {
        var li = $('<li class="nav-item"></li>');
        li.append(navbarLink(item.icon, item.title, item.href, item.target));
        container.append(li);
      }
    }
  }

  // create or get a reference to an existing dropdown menu
  function navbarMenu(id, icon, title, container) {
    var existingMenu = [];
    if (id)
      existingMenu = container.children('#' + id);
    if (existingMenu.length > 0) {
      return existingMenu.children('ul');
    } else {
      var li = $('<li class="nav-item"></li>');
      if (id)
        li.attr('id', id);
      li.addClass('dropdown');
      // auto add "Share" title on mobile if necessary
      if (!title && icon && (icon === "fa-share-alt") && isMobilePhone())
        title = "Share";
      if (title) {
        title = title + ' <span class="caret"></span>';
      }
      var a = navbarLink(icon, title, "#");
      a.addClass('dropdown-toggle');
      a.attr('data-toggle', 'dropdown');
      a.attr('data-bs-toggle', 'dropdown');
      a.attr('role', 'button');
      a.attr('aria-expanded', 'false');
      li.append(a);
      var ul = $('<ul class="dropdown-menu"></ul>');
      ul.attr('role', 'menu');
      li.append(ul);
      container.append(li);
      return ul;
    }
  }

  function addToNavbar(page, active) {

    // capture the id and data-icon attribute (if any)
    var id = page.attr('id');
    var icon = page.attr('data-icon');
    var navmenu = page.attr('data-navmenu');

    // get hidden state (transfer this to navbar)
    var hidden = page.hasClass('hidden');
    page.removeClass('hidden');

    // sanitize the id for use with bootstrap tabs
    id = id.replace(/[.\/?&!#<>]/g, '').replace(/\s/g, '_');
    page.attr('id', id);

    // get the wrapper
    var wrapper = page.closest('.dashboard-page-wrapper');

    // move the id to the wrapper
    page.removeAttr('id');
    wrapper.attr('id', id);

    // add the tab-pane class to the wrapper
    wrapper.addClass('tab-pane');
    if (active)
      wrapper.addClass('active');

    // get a reference to the h1, discover its inner contens, then detach it
    var h1 = wrapper.find('h1').first();
    var title = h1.contents();
    h1.detach();

    // create a navbar item
    var li = $('<li></li>');
    var a = navbarLink(icon, title, '#' + id);
    a.attr('data-toggle', 'tab');
    li.append(a);

    // add it to the navbar (or navbar menu if specified)
    var container = $('ul.navbar-left');
    if (navmenu) {
      var menuId = navmenu.replace(/\s+/g, '');
      var menu = navbarMenu(menuId, null, navmenu, container);
      li.find("> a").removeClass("nav-link").addClass("dropdown-item");
      menu.append(li);
    } else {
      li.addClass("nav-item")
      container.append(li);
    }

    // hide it if requested
    if (hidden)
      li.addClass('hidden');
  }

  function navbarLink(icon, title, href, target) {

    var a = $('<a class="nav-link"></a>');
    if (icon) {

      // get the name of the icon set and icon
      var dashPos = icon.indexOf("-");
      var iconSet = null;
      var iconSplit = icon.split(" ");
      if (iconSplit.length > 1) {
        iconSet = iconSplit[0];
        icon = iconSplit.slice(1).join(" ");
      } else {
        iconSet = icon.substring(0, dashPos);
      }
      var iconName = icon.substring(dashPos + 1);

      // create the icon
      var iconElement = $('<span class="' + iconSet + ' ' + icon + '"></span>');
      if (title)
        iconElement.css('margin-right', '7px');
      a.append(iconElement);
      // if href is null see if we can auto-generate based on icon (e.g. social)
      if (!href)
        maybeGenerateLinkFromIcon(iconName, a);
    }
    if (title)
      a.append(title);

    // add the href.
    if (href) {
      if (href === "source_embed") {
        a.attr('href', '#');
        a.attr('data-featherlight', "#flexdashboard-source-code");
        a.featherlight({
            beforeOpen: function(event){
              $('body').addClass('unselectable');
            },
            afterClose: function(event){
              $('body').removeClass('unselectable');
            }
        });
      } else {
        a.attr('href', href);
      }
    }

    // add the arget
    if (target)
      a.attr('target', target);

    return a;
  }

  // auto generate a link from an icon name (e.g. twitter) when possible
  function maybeGenerateLinkFromIcon(iconName, a) {

     var serviceLinks = {
      "twitter": "https://twitter.com/share?text=" + encodeURIComponent(document.title) + "&url="+encodeURIComponent(location.href),
      "facebook": "https://www.facebook.com/sharer/sharer.php?s=100&p[url]="+encodeURIComponent(location.href),
      "linkedin": "https://www.linkedin.com/shareArticle?mini=true&url="+encodeURIComponent(location.href) + "&title=" + encodeURIComponent(document.title),
      "pinterest": "https://pinterest.com/pin/create/link/?url="+encodeURIComponent(location.href) + "&description=" + encodeURIComponent(document.title)
    };

    var makeSocialLink = function(a, href) {
      a.attr('href', '#');
      a.on('click', function(e) {
        e.preventDefault();
        window.open(href);
      });
    };

    $.each(serviceLinks, function(key, value) {
      if (iconName.indexOf(key) !== -1)
        makeSocialLink(a, value);
    });
  }

  // layout a dashboard page
  function layoutDashboardPage(page) {

    // use a page wrapper so that free form content above the
    // dashboard appears at the top rather than the side (as it
    // would without the wrapper in a column orientation)
    var wrapper = $('<div class="dashboard-page-wrapper"></div>');
    page.wrap(wrapper);

    // if there are no level2 or level3 headers synthesize a level3
    // header to contain the (e.g. frame it, scroll container, etc.)
    var headers = page.find('h2,h3');
    if (headers.length === 0)
      page.wrapInner('<div class="section level3"></div>');

    // hoist up any content before level 2 or level 3 headers
    var children = page.children();
    children.each(function(index) {
      if ($(this).hasClass('level2') || $(this).hasClass('level3'))
        return false;
      $(this).insertBefore(page);
    });

    // determine orientation and fillPage behavior for distinct media
    var orientation, fillPage, storyboard;

    // media: mobile phone
    if (isMobilePhone()) {

      // if there is a sidebar we need to ensure it's content
      // is properly framed as an h3
      var sidebar = page.find('.section.sidebar');
      sidebar.removeClass('sidebar');
      sidebar.wrapInner('<div class="section level3"></div>');
      var h2 = sidebar.find('h2');
      var h3 = $('<h3></h3>');
      h3.append(h2.contents());
      h3.insertBefore(h2);
      h2.detach();

      // wipeout h2 elements then enclose them in a single h2
      var level2 = page.find('div.section.level2');
      level2.each(function() {
        level2.children('h2').remove();
        level2.children().unwrap();
      });
      page.wrapInner('<div class="section level2"></div>');

      // substitute mobile images
      if (isPortrait()) {
        var mobileFigures = $('img.mobile-figure');
        mobileFigures.each(function() {
          // get the src (might be base64 encoded)
          var src = $(this).attr('src');

          // find it's peer
          var id = $(this).attr('data-mobile-figure-id');
          var img = $('img[data-figure-id=' + id + "]");
          img.attr('src', src)
             .attr('width', _options.defaultFigWidthMobile)
             .attr('height', _options.defaultFigHeightMobile);
        });
      }

      // hoist storyboard commentary into it's own section
      if (page.hasClass('storyboard')) {
        var commentaryHR = page.find('div.section.level3 hr');
        commentaryHR.each(function() {
          var commentary = $(this).nextAll().detach();
          var commentarySection = $('<div class="section level3"></div>');
          commentarySection.append(commentary);
          commentarySection.insertAfter($(this).closest('div.section.level3'));
          $(this).remove();
        });
      }

      // force a non full screen layout by columns
      orientation = _options.orientation = 'columns';
      fillPage = _options.fillPage = false;
      storyboard = _options.storyboard = false;

    // media: desktop
    } else {

      // determine orientation
      orientation = page.attr('data-orientation');
      if (orientation !== 'rows' && orientation != 'columns')
        orientation = _options.orientation;

      // determine storyboard mode
      storyboard = page.hasClass('storyboard');

      // fillPage based on options (force for storyboard)
      fillPage = _options.fillPage || storyboard;

      // handle sidebar
      var sidebar = page.find('.section.level2.sidebar');
      if (sidebar.length > 0)
        layoutSidebar(sidebar, page);
    }

    // give it and it's parent divs height: 100% if we are in fillPage mode
    if (fillPage) {
      page.addClass('vertical-layout-fill');
      page.css('height', '100%');
      page.parents('div').css('height', '100%');
    } else {
      page.addClass('vertical-layout-scroll');
    }

    // perform the layout
    if (storyboard)
      layoutPageAsStoryboard(page);
    else if (orientation === 'rows')
      layoutPageByRows(page, fillPage);
    else if (orientation === 'columns')
      layoutPageByColumns(page, fillPage);
  }

  function layoutSidebar(sidebar, content) {

    // get it out of the header hierarchy
    sidebar = sidebar.first();
    if (sidebar.hasClass('level1')) {
      sidebar.removeClass('level1');
      sidebar.children('h1').remove();
    } else if (sidebar.hasClass('level2')) {
      sidebar.removeClass('level2');
      sidebar.children('h2').remove();
    }

    // determine width
    var sidebarWidth = isTablet() ? 220 : 250;
    var dataWidth = parseInt(sidebar.attr('data-width'));
    if (dataWidth)
      sidebarWidth = dataWidth;

    // set the width and shift the page right to accomodate the sidebar
    sidebar.css('width', sidebarWidth + 'px');
    content.css('padding-left', sidebarWidth + 'px');

    // wrap it's contents in a form
    sidebar.wrapInner($('<form></form>'));
  }

  function layoutPageAsStoryboard(page) {

    // create storyboard navigation
    var nav = $('<div class="storyboard-nav"></div>');

    // add navigation buttons
    var prev = $('<button class="sbprev"><i class="fa fa-angle-left"></i></button>');
    nav.append(prev);
    var next= $('<button class="sbnext"><i class="fa fa-angle-right"></i></button>');
    nav.append(next);

    // add navigation frame
    var frameList = $('<div class="sbframelist"></div>');
    nav.append(frameList);
    var ul = $('<ul></ul>');
    frameList.append(ul);

     // find all the level3 sections (those are the storyboard frames)
    var frames = page.find('div.section.level3');
    frames.each(function() {

      // mark it
      $(this).addClass('sbframe');

      // divide it into chart content and (optional) commentary
      $(this).addClass('dashboard-column-orientation');

      // stuff the chart into it's own div w/ flex
      $(this).wrapInner('<div class="sbframe-component"></div>');
      setFlex($(this), 1);
      var frame = $(this).children('.sbframe-component');

      // extract the title from the h3
      var li = $('<li></li>');
      var h3 = frame.children('h3');
      li.append(h3.contents());
      h3.detach();
      ul.append(li);

      // extract commentary
      var hr = frame.children('hr');
      if (hr.length) {
        var commentary = hr.nextAll().detach();
        hr.remove();
        var commentaryFrame = $('<div class="sbframe-commentary"></div>');
        commentaryFrame.addClass('flowing-content-shim');
        commentaryFrame.addClass('flowing-content-container');
        commentaryFrame.append(commentary);
        $(this).append(commentaryFrame);

        // look for a data-commentary-width attribute
        var commentaryWidth = $(this).attr('data-commentary-width');
        if (commentaryWidth)
          commentaryFrame.css('width', commentaryWidth + 'px');
      }

      // layout the chart (force flex)
      var result = layoutChart(frame, true);

      // ice the notes if there are none
      if (!result.notes)
        frame.find('.chart-notes').remove();

      // set flex on chart
      setFlex(frame, 1);
    });

    // create a div to hold all the frames
    var frameContent = $('<div class="sbframe-content"></div>');
    frameContent.addClass('dashboard-row-orientation');
    frameContent.append(frames.detach());

    // row orientation to stack nav and frame content
    page.addClass('dashboard-row-orientation');
    page.append(nav);
    page.append(frameContent);
    setFlex(frameContent, 1);

    // initialize sly
    var sly = new Sly(frameList, {
    		horizontal: true,
    		itemNav: 'basic',
    		smart: true,
    		activateOn: 'click',
    		startAt: 0,
    		scrollBy: 1,
    		activatePageOn: 'click',
    		speed: 200,
    		moveBy: 600,
    		dragHandle: true,
    		dynamicHandle: true,
    		clickBar: true,
    		keyboardNavBy: 'items',
    		next: next,
    		prev: prev
    	}).init();

    // make first frame active
    frames.removeClass('active');
    frames.first().addClass('active');

    // subscribe to frame changed events
    sly.on('active', function (eventName, itemIndex) {
      frames.removeClass('active');
      frames.eq(itemIndex).addClass('active')
                          .trigger('shown');
    });
  }

  function layoutPageByRows(page, fillPage) {

    // row orientation
    page.addClass('dashboard-row-orientation');

    // find all the level2 sections (those are the rows)
    var rows = page.find('div.section.level2');

    // if there are no level2 sections then treat the
    // entire page as if it's a level 2 section
    if (rows.length === 0) {
      page.wrapInner('<div class="section level2"></div>');
      rows = page.find('div.section.level2');
    }

    rows.each(function () {

      // flags
      var haveNotes = false;
      var haveFlexHeight = true;

      // remove the h2
      $(this).children('h2').remove();

      // check for a tabset
      var isTabset = $(this).hasClass('tabset');
      if (isTabset)
        layoutTabset($(this));

      // give it row layout semantics if it's not a tabset
      if (!isTabset)
        $(this).addClass('dashboard-row');

      // find all of the level 3 subheads
      var columns = $(this).find('div.section.level3');

      // determine figureSizes sizes
      var figureSizes = chartFigureSizes(columns);

      // fixup the columns
      columns.each(function(index) {

        // layout the chart (force flex if we are in a tabset)
        var result = layoutChart($(this), isTabset);

        // update flexHeight state
        if (!result.flex)
          haveFlexHeight = false;

        // update state
        if (result.notes)
          haveNotes = true;

        // set the column flex based on the figure width
        // (value boxes will just get the default figure width)
        var chartWidth = figureSizes[index].width;
        setFlex($(this), chartWidth + ' ' + chartWidth + ' 0px');

      });

      // remove empty chart note divs
      if (isTabset)
        $(this).find('.chart-notes').filter(function() {
            return $(this).html() === "&nbsp;";
        }).remove();
      if (!haveNotes)
        $(this).find('.chart-notes').remove();

       // make it a flexbox row
      if (haveFlexHeight)
        $(this).addClass('dashboard-row-flex');

      // now we can set the height on all the wrappers (based on maximum
      // figure height + room for title and notes, or data-height on the
      // container if specified). However, don't do this if there is
      // no flex on any of the constituent columns
      var flexHeight = null;
      var dataHeight = parseInt($(this).attr('data-height'));
      if (dataHeight)
        flexHeight = adjustedHeight(dataHeight, columns.first());
      else if (haveFlexHeight)
        flexHeight = maxChartHeight(figureSizes, columns);
      if (flexHeight) {
        if (fillPage)
          setFlex($(this), flexHeight + ' ' + flexHeight + ' 0px');
        else {
          $(this).css('height', flexHeight + 'px');
          setFlex($(this), '0 0 ' + flexHeight + 'px');
        }
      }

    });
  }

  function layoutPageByColumns(page, fillPage) {

    // column orientation
    page.addClass('dashboard-column-orientation');

    // find all the level2 sections (those are the columns)
    var columns = page.find('div.section.level2');

    // if there are no level2 sections then treat the
    // entire page as if it's a level 2 section
    if (columns.length === 0) {
      page.wrapInner('<div class="section level2"></div>');
      columns = page.find('div.section.level2');
    }

    // layout each column
    columns.each(function (index) {

      // remove the h2
      $(this).children('h2').remove();

      // make it a flexbox column
      $(this).addClass('dashboard-column');

      // check for a tabset
      var isTabset = $(this).hasClass('tabset');
      if (isTabset)
        layoutTabset($(this));

      // find all the h3 elements
      var rows = $(this).find('div.section.level3');

      // get the figure sizes for the rows
      var figureSizes = chartFigureSizes(rows);

      // column flex is the max row width (or data-width if specified)
      var flexWidth;
      var dataWidth = parseInt($(this).attr('data-width'));
      if (dataWidth)
        flexWidth = dataWidth;
      else
        flexWidth = maxChartWidth(figureSizes);
      setFlex($(this), flexWidth + ' ' + flexWidth + ' 0px');

      // layout each chart
      rows.each(function(index) {

        // perform the layout
        var result = layoutChart($(this), false);

        // ice the notes if there are none
        if (!result.notes)
          $(this).find('.chart-notes').remove();

        // set flex height based on figHeight, then adjust
        if (result.flex) {
          var chartHeight = figureSizes[index].height;
          chartHeight = adjustedHeight(chartHeight, $(this));
          if (fillPage)
            setFlex($(this), chartHeight + ' ' + chartHeight + ' 0px');
          else {
            $(this).css('height', chartHeight + 'px');
            setFlex($(this), chartHeight + ' ' + chartHeight + ' ' + chartHeight + 'px');
          }
        }
      });
    });
  }

  function chartFigureSizes(charts) {

    // sizes
    var figureSizes = new Array(charts.length);

    // check each chart
    charts.each(function(index) {

      // start with default
      figureSizes[index] = {
        width: _options.defaultFigWidth,
        height: _options.defaultFigHeight
      };

      // look for data-height or data-width then knit options
      var dataWidth = parseInt($(this).attr('data-width'));
      var dataHeight = parseInt($(this).attr('data-height'));
      var knitrOptions = $(this).find('.knitr-options:first');
      var knitrWidth, knitrHeight;
      if (knitrOptions) {
        knitrWidth = parseInt(knitrOptions.attr('data-fig-width'));
        knitrHeight =  parseInt(knitrOptions.attr('data-fig-height'));
      }

      // width
      if (dataWidth)
        figureSizes[index].width = dataWidth;
      else if (knitrWidth)
        figureSizes[index].width = knitrWidth;

      // height
      if (dataHeight)
        figureSizes[index].height = dataHeight;
      else if (knitrHeight)
        figureSizes[index].height = knitrHeight;
    });

    // return sizes
    return figureSizes;
  }

  function maxChartHeight(figureSizes, charts) {

    // first compute the maximum height
    var maxHeight = _options.defaultFigHeight;
    for (var i = 0; i<figureSizes.length; i++)
      if (figureSizes[i].height > maxHeight)
        maxHeight = figureSizes[i].height;

    // now add offests for chart title and chart notes
    if (charts.length)
      maxHeight = adjustedHeight(maxHeight, charts.first());

    return maxHeight;
  }

  function adjustedHeight(height, chart) {
    if (chart.length > 0) {
      var chartTitle = chart.find('.chart-title');
      if (chartTitle.length)
        height += chartTitle.first().outerHeight();
      var chartNotes = chart.find('.chart-notes');
      if (chartNotes.length)
        height += chartNotes.first().outerHeight();
    }
    return height;
  }

  function maxChartWidth(figureSizes) {
    var maxWidth = _options.defaultFigWidth;
    for (var i = 0; i<figureSizes.length; i++)
      if (figureSizes[i].width > maxWidth)
        maxWidth = figureSizes[i].width;
    return maxWidth;
  }

  // layout a chart
  function layoutChart(chart, forceFlex) {

    // state to return
    var result = {
      notes: false,
      flex: false
    };

    // extract the title
    var title = extractTitle(chart);

    // find components that apply to this container
    var components = componentsFind(chart);

    // if it's a custom component then call it and return
    var customComponents = componentsCustom(components);
    if (customComponents.length) {
      componentsLayout(customComponents, title, chart);
      result.notes = false;
      result.flex = forceFlex || componentsFlex(customComponents);
      return result;
    }

    // put all the content in a chart wrapper div
    chart.addClass('chart-wrapper');
    chart.wrapInner('<div class="chart-stage"></div>');
    var chartContent = chart.children('.chart-stage');

    // flex the content if appropriate
    result.flex = forceFlex || componentsFlex(components);
    if (result.flex) {
      // add flex classes
      chart.addClass('chart-wrapper-flex');
      chartContent.addClass('chart-stage-flex');

      // additional shim to break out of flexbox sizing
      chartContent.wrapInner('<div class="chart-shim"></div>');
      chartContent = chartContent.children('.chart-shim');
    }

    // set custom data-padding attribute
    var pad = chart.attr('data-padding');
    if (pad) {
      if (pad === "0")
        chart.addClass('no-padding');
      else {
        pad = pad + 'px';
        chartContent.css('left', pad)
                    .css('top', pad)
                    .css('right', pad)
                    .css('bottom', pad)
      }
    }

    // call compoents
    componentsLayout(components, title, chartContent);

    // also activate components on shiny output
    findShinyOutput(chartContent).on('shiny:value',
      function(event) {
        var element = $(event.target);
        setTimeout(function() {

          // see if we opted out of flex based on our output (for shiny
          // we can't tell what type of output we have until after the
          // value is bound)
          var components = componentsFind(element);
          var flex = forceFlex || componentsFlex(components);
          if (!flex) {
            chart.css('height', "");
            setFlex(chart, "");
            chart.removeClass('chart-wrapper-flex');
            chartContent.removeClass('chart-stage-flex');
            chartContent.children().unwrap();
          }

          // perform layout
          componentsLayout(components, title, element.parent());
        }, 10);
      });

    // add the title
    var chartTitle = $('<div class="chart-title"></div>');
    chartTitle.append(title);
    chart.prepend(chartTitle);

    // add the notes section
    var chartNotes = $('<div class="chart-notes"></div>');
    chartNotes.html('&nbsp;');
    chart.append(chartNotes);

    // attempt to extract notes if we have a component
    if (components.length)
      result.notes = extractChartNotes(chartContent, chartNotes);

    // return result
    return result;
  }

  // build a tabset from a section div with the .tabset class
  function layoutTabset(tabset) {

    // check for fade option
    var fade = tabset.hasClass("tabset-fade");
    var pills = tabset.hasClass("tabset-pills");
    var navClass = pills ? "nav-pills" : "nav-tabs";

    // determine the heading level of the tabset and tabs
    var match = tabset.attr('class').match(/level(\d) /);
    if (match === null)
      return;
    var tabsetLevel = Number(match[1]);
    var tabLevel = tabsetLevel + 1;

    // find all subheadings immediately below
    var tabs = tabset.find("div.section.level" + tabLevel);
    if (!tabs.length)
      return;

    // create tablist and tab-content elements
    var tabList = $('<ul class="nav ' + navClass + '" role="tablist"></ul>');
    $(tabs[0]).before(tabList);
    var tabContent = $('<div class="tab-content"></div>');
    $(tabs[0]).before(tabContent);

    // build the tabset
    var activeTab = 0;
    tabs.each(function(i) {

      // get the tab div
      var tab = $(tabs[i]);

      // get the id then sanitize it for use with bootstrap tabs
      var id = tab.attr('id');

      // see if this is marked as the active tab
      if (tab.hasClass('active'))
        activeTab = i;

      // sanitize the id for use with bootstrap tabs
      id = id.replace(/[.\/?&!#<>]/g, '').replace(/\s/g, '_');
      tab.attr('id', id);

      // get the heading element within it and grab it's text
      var heading = tab.find('h' + tabLevel + ':first');
      var headingDom = heading.contents();

      // build and append the tab list item
      var a = $('<a role="tab" data-toggle="tab" class="nav-link"></a>');
      a.append(headingDom);
      a.attr('href', '#' + id);
      a.attr('aria-controls', id);
      var li = $('<li role="presentation" class="nav-item"></li>');
      li.append(a);
      tabList.append(li);

      // set it's attributes
      tab.attr('role', 'tabpanel');
      tab.addClass('tab-pane');
      tab.addClass('tabbed-pane');
      tab.addClass('no-title');
      if (fade)
        tab.addClass('fade');

      // move it into the tab content div
      tab.detach().appendTo(tabContent);
    });

    // set active tab
    $(tabList.children()[activeTab]).tab("show");
    var active = $(tabContent.children('div.section')[activeTab]);
    active.addClass('active');
    if (fade)
      active.addClass('in');

    // add nav-tabs-custom
    tabset.addClass('nav-tabs-custom');

    // internal layout is dashboard-column with tab-content flexing
    tabset.addClass('dashboard-column');
    setFlex(tabContent, 1);
  }

  // one time global initialization for components
  function componentsInit(dashboardContainer) {
    for (var i=0; i<window.FlexDashboardComponents.length; i++) {
      var component = window.FlexDashboardComponents[i];
      if (component.init)
        component.init(dashboardContainer);
    }
  }

  // find components that apply within a container
  function componentsFind(container) {

    // look for components
    var components = [];
    for (var i=0; i<window.FlexDashboardComponents.length; i++) {
      var component = window.FlexDashboardComponents[i];
      if (component.find(container).length)
        components.push(component);
    }

    // if there were none then use a special flowing content component
    // that just adds a scrollbar in fillPage mode
    if (components.length == 0) {
      components.push({
        find: function(container) {
          return container;
        },

        flex: function(fillPage) {
          return fillPage;
        },

        layout: function(title, container, element, fillPage) {
          if (fillPage) {
            container.addClass('flowing-content-shim');
            container.addClass('flowing-content-container');
          }
        }
      });
    }

    return components;
  }

  // if there is a custom component then pick it out
  function componentsCustom(components) {
    var customComponent = [];
    for (var i=0; i<components.length; i++)
      if (components[i].type === "custom") {
        customComponent.push(components[i]);
        break;
      }
    return customComponent;
  }

  // query all components for flex
  function componentsFlex(components) {

    // no components at all means no flex
    if (components.length === 0)
      return false;

    // otherwise query components (assume true unless we see false)
    var isMobile = isMobilePhone();
    for (var i=0; i<components.length; i++)
      if (components[i].flex && !components[i].flex(_options.fillPage))
        return false;
    return true;
  }

  // layout all components
  function componentsLayout(components, title, container) {
    var isMobile = isMobilePhone();
    for (var i=0; i<components.length; i++) {
      var element = components[i].find(container);
      if (components[i].layout) {
        // call layout (don't call other components if it returns false)
        var result = components[i].layout(title, container, element, _options.fillPage);
        if (result === false)
          return;
      }
    }
  }

  // get a reference to the h3, discover it's inner html, and remove it
  function extractTitle(container) {
    var h3 = container.children('h3').first();
    var title = '';
    if (!container.hasClass('no-title'))
      title = h3.contents();
    h3.detach();
    return title;
  }

  // extract chart notes
  function extractChartNotes(chartContent, chartNotes) {
    // look for a terminating blockquote or image caption
    var blockquote = chartContent.children('blockquote:last-child');
    var caption = chartContent.children('div.image-container')
                              .children('p.caption');
    if (blockquote.length) {
      chartNotes.empty().append(blockquote.children('p:first-child').contents());
      blockquote.remove();
      return true;
    } else if (caption.length) {
      chartNotes.empty().append(caption.contents());
      caption.remove();
      return true;
    } else {
      return false;
    }
  }

  function findShinyOutput(chartContent) {
    return chartContent.find('.shiny-text-output, .shiny-html-output');
  }

  // safely detect rendering on a mobile phone
  function isMobilePhone() {
    try
    {
      return ! window.matchMedia("only screen and (min-width: 768px)").matches;
    }
    catch(e) {
      return false;
    }
  }

  function isFillPage() {
    return _options.fillPage;
  }

  // detect portrait mode
  function isPortrait() {
    return ($(window).width() < $(window).height());
  }

  // safely detect rendering on a tablet
  function isTablet() {
    try
    {
      return window.matchMedia("only screen and (min-width: 769px) and (max-width: 992px)").matches;
    }
    catch(e) {
      return false;
    }
  }

  // test whether this is a shiny doc
  function isShinyDoc() {
    return (typeof(window.Shiny) !== "undefined" && !!window.Shiny.outputBindings);
  }

  // set flex using vendor specific prefixes
  function setFlex(el, flex) {
    el.css('-webkit-box-flex', flex)
      .css('-webkit-flex', flex)
      .css('-ms-flex', flex)
      .css('flex', flex);
  }

  // support bookmarking of pages
  function handleLocationHash() {

    // restore tab/page from bookmark
    var hash = window.decodeURIComponent(window.location.hash);
    if (hash.length > 0)
      $('ul.nav a[href="' + hash + '"]').tab('show');
    FlexDashboardUtils.manageActiveNavbarMenu();

    // navigate to a tab when the history changes
    window.addEventListener("popstate", function(e) {
      var hash = window.decodeURIComponent(window.location.hash);
      var activeTab = $('ul.nav a[href="' + hash + '"]');
      if (activeTab.length) {
        activeTab.tab('show');
      } else {
        $('ul.nav a:first').tab('show');
      }
      FlexDashboardUtils.manageActiveNavbarMenu();
    });

    // add a hash to the URL when the user clicks on a tab/page
    $('.navbar-nav a[data-toggle="tab"]').on('click', function(e) {
      var baseUrl = FlexDashboardUtils.urlWithoutHash(window.location.href);
      var hash = FlexDashboardUtils.urlHash($(this).attr('href'));
      var href = baseUrl + hash;
      FlexDashboardUtils.setLocation(href);
    });

    // handle clicks of other links that should activate pages
    var navPages = $('ul.navbar-nav li a[data-toggle=tab]');
    navPages.each(function() {
      var href =  $(this).attr('href');
      var links = $('a[href="' + href + '"][data-toggle!=tab]');
      links.each(function() {
        $(this).on('click', function(e) {
          window.FlexDashboardUtils.showPage(href);
        });
      });
    });
  }

  // tweak Prism highlighting
  function initPrismHighlighting() {

    if (window.Prism) {
      Prism.languages.insertBefore('r', 'comment', {
        'heading': [
          {
            // title 1
        	  // =======

        	  // title 2
        	  // -------
        	  pattern: /\w+.*(?:\r?\n|\r)(?:====+|----+)/,
            alias: 'operator'
          },
          {
            // ### title 3
            pattern: /(^\s*)###[^#].+/m,
            lookbehind: true,
            alias: 'operator'
          }
        ]
      });

      // prism highlight
      Prism.highlightAll();
    }
  }

  FlexDashboard.prototype = {
    constructor: FlexDashboard,
    init: init,
    isMobilePhone: isMobilePhone,
    isFillPage: isFillPage
  };

  return FlexDashboard;

})();

// utils
window.FlexDashboardUtils = {
  resizableImage: function(img) {
    var src = img.attr('src');
    var url = 'url("' + src + '")';
    img.parent().css('background', url)
                .css('background-size', 'contain')
                .css('background-repeat', 'no-repeat')
                .css('background-position', 'center')
                .addClass('image-container');
  },
  setLocation: function(href) {
    if (history && history.pushState) {
      history.pushState(null, null, href);
    } else {
      window.location.replace(href);
    }
    setTimeout(function() {
        window.scrollTo(0, 0);
    }, 10);
    this.manageActiveNavbarMenu();
  },
  showPage: function(href) {
    $('ul.navbar-nav li a[href="' + href + '"]').tab('show');
    var baseUrl = this.urlWithoutHash(window.location.href);
    var loc = baseUrl + href;
    this.setLocation(loc);
  },
  showLinkedValue: function(href) {
    // check for a page link
    if ($('ul.navbar-nav li a[data-toggle=tab][href="' + href + '"]').length > 0)
      this.showPage(href);
    else
      window.open(href);
  },
  urlWithoutHash: function(url) {
    var hashLoc = url.indexOf('#');
    if (hashLoc != -1)
      return url.substring(0, hashLoc);
    else
      return url;
  },
  urlHash: function(url) {
    var hashLoc = url.indexOf('#');
    if (hashLoc != -1)
      return url.substring(hashLoc);
    else
      return "";
  },
  manageActiveNavbarMenu: function () {
    // remove active from currently active tabs
    $('.navbar ul.nav .active').removeClass('active');
    // find the active tab
    var activeTab = $('.dashboard-page-wrapper.tab-pane.active');
    if (activeTab.length > 0) {
      var tabId = activeTab.attr('id');
      if (tabId)
        $(".navbar ul.nav a[href='#" + tabId + "']").tab("show");
    }
  }
};

window.FlexDashboard = new FlexDashboard();

// empty content
window.FlexDashboardComponents.push({
  find: function(container) {
    if (container.find('p').length == 0)
      return container;
    else
      return $();
  }
})

// plot image
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.children('p')
                    .children('img:only-child');
  },

  layout: function(title, container, element, fillPage) {
    FlexDashboardUtils.resizableImage(element);
  }
});

// plot image (figure style)
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.children('div.figure').children('img');
  },

  layout: function(title, container, element, fillPage) {
    FlexDashboardUtils.resizableImage(element);
  }
});

// htmlwidget
window.FlexDashboardComponents.push({

  init: function(dashboardContainer) {
    // trigger "shown" after initial layout to force static htmlwidgets
    // in runtime: shiny to be resized after the dom has been transformed
    dashboardContainer.on('flexdashboard:layoutcomplete', function(event) {
      setTimeout(function() {
        dashboardContainer.trigger('shown');
      }, 200);
    });
  },

  find: function(container) {
    return container.children('div[id^="htmlwidget-"],div.html-widget');
  }
});

// gauge
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.children('div.html-widget.gauge');
  },

  flex: function(fillPage) {
    return false;
  },

  layout: function(title, container, element, fillPage) {


  }

});

// shiny output
window.FlexDashboardComponents.push({
  find: function(container) {
    return container.children('div[class^="shiny-"]');
  }
});

// bootstrap table
window.FlexDashboardComponents.push({

  find: function(container) {
    var bsTable = container.find('table.table');
    if (bsTable.length !== 0)
      return bsTable;
    else
      return container.find('tr.header').parent('thead').parent('table');
  },

  flex: function(fillPage) {
    return fillPage;
  },

  layout: function(title, container, element, fillPage) {

    // alias variables
    var bsTable = element;

    // fixup xtable generated tables with a proper thead
    var headerRow = bsTable.find('tbody > tr:first-child > th').parent();
    if (headerRow.length > 0) {
      var thead = $('<thead></thead>');
      bsTable.prepend(thead);
      headerRow.detach().appendTo(thead);
    }

    // improve appearance
    container.addClass('bootstrap-table');

    // for fill page provide scrolling w/ sticky headers
    if (fillPage) {
      // force scrollbar on overflow
      container.addClass('flowing-content-shim');

      // stable table headers when scrolling
      bsTable.stickyTableHeaders({
        scrollableArea: container
      });
    }
  }
});

// embedded shiny app
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.find('iframe.shiny-frame');
  },

  flex: function(fillPage) {
    return fillPage;
  },

  layout: function(title, container, element, fillPage) {
    if (fillPage) {
      element.attr('height', '100%');
    } else {
      // provide default height if necessary
      var height = element.get(0).style.height;
      if (!height)
        height = element.attr('height');
      if (!height)
        element.attr('height', 500);
    }
  }
});

// shiny fillRow or fillCol
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.find('.flexfill-container');
  },

  flex: function(fillPage) {
    return fillPage;
  },

  layout: function(title, container, element, fillPage) {
    if (fillPage)
      element.css('height', '100%');
    else {
      // provide default height if necessary
      var height = element.get(0).style.height;
      if (height === "100%" || height === "auto" || height === "initial" ||
          height === "inherit" || !height) {
        element.css('height', 500);
      }
    }
  }
});

// valueBox
window.FlexDashboardComponents.push({

  type: "custom",

  find: function(container) {
    if (container.find('span.value-output, .shiny-valuebox-output').length)
      return container;
    else
      return $();
  },

  flex: function(fillPage) {
    return false;
  },

  layout: function(title, container, element, fillPage) {

    // alias variables
    var chartTitle = title;
    var valueBox = element;

    // add value-box class to container
    container.addClass('value-box');

    // value paragraph
    var value = $('<p class="value"></p>');

    // if we have shiny-text-output then just move it in
    var valueOutputSpan = [];
    var shinyOutput = valueBox.find('.shiny-valuebox-output').detach();
    if (shinyOutput.length) {
      valueBox.children().remove();
      shinyOutput.html("&mdash;");
      value.append(shinyOutput);
    } else {
      // extract the value (remove leading vector index)
      var chartValue = valueBox.text().trim();
      chartValue = chartValue.replace("[1] ", "");
      valueOutputSpan = valueBox.find('span.value-output').detach();
      valueBox.children().remove();
      value.text(chartValue);
    }

    // caption
    var caption = $('<p class="caption"></p>');
    caption.append(chartTitle);

    // build inner div for value box and add it
    var inner = $('<div class="inner"></div>');
    inner.append(value);
    inner.append(caption);
    valueBox.append(inner);

    // add icon if specified
    var icon = $('<div class="icon"><i></i></div>');
    valueBox.append(icon);
    function setIcon(chartIcon) {
      var iconLib = "";
      var iconSplit = chartIcon.split(" ");
      if (iconSplit.length > 1) {
        iconLib = iconSplit[0];
        chartIcon = iconSplit.slice(1).join(" ");
      } else {
        var components = chartIcon.split("-");
        if (components.length > 1)
          iconLib = components[0];
      }
      icon.children('i').attr('class', iconLib + ' ' + chartIcon);
    }
    var chartIcon = valueBox.attr('data-icon');
    if (chartIcon)
      setIcon(chartIcon);

    // handle data attributes in valueOutputSpan
    function handleValueOutput(valueOutput) {

      // caption
      var dataCaption = valueOutput.attr('data-caption');
      if (dataCaption)
        caption.html(dataCaption);

      // icon
      var dataIcon = valueOutput.attr('data-icon');
      if (dataIcon)
        setIcon(dataIcon);

      // If valueBox(color=) was an accent color, this attr should
      // be populated with the accent color and the relevant CSS comes
      // in through HTML dependencies
      var dataColorAccent = valueOutput.attr('data-color-accent');
      var valueBoxClasses = "value-box-" + (["primary", "info", "danger", "warning", "success"].join(" value-box-"));
      if (dataColorAccent) {
        valueBox.removeClass(valueBoxClasses);
        valueBox.addClass('value-box-' + dataColorAccent);
      }

      // If valueBox(color=) was a CSS color, these other data-color-*
      // attrs will be populated
      var dataColor = valueOutput.attr('data-color');
      if (dataColor) {
        valueBox.removeClass(valueBoxClasses);
        valueBox.css('background-color', dataColor);
      }
      var dataColorText = valueOutput.attr('data-color-text');
      if (dataColorText) {
        valueBox.find(".inner").css('color', dataColorText);
      }
      var dataColorIcon = valueOutput.attr('data-color-icon');
      if (dataColorIcon) {
        valueBox.find(".icon").css('color', dataColorIcon);
      }

      // url
      var dataHref = valueOutput.attr('data-href');
      if (dataHref) {
        valueBox.addClass('linked-value');
        valueBox.off('click.value-box');
        valueBox.on('click.value-box', function(e) {
          window.FlexDashboardUtils.showLinkedValue(dataHref);
        });
      }
    }

    // check for a valueOutputSpan
    if (valueOutputSpan.length > 0) {
      handleValueOutput(valueOutputSpan);
    }

    // if we have a shinyOutput then bind a listener to handle
    // new valueOutputSpan values
    shinyOutput.on('shiny:value',
      function(event) {
        var element = $(event.target);
        setTimeout(function() {
          var valueOutputSpan = element.find('span.value-output');
          if (valueOutputSpan.length > 0)
            handleValueOutput(valueOutputSpan);
        }, 10);
      }
    );
  }
});
</script>

<div id="dashboard-container">

<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<style type="text/css">
table {
  margin: auto;
  border-top: 1px solid #666;
  border-bottom: 1px solid #666;
}
table thead th { border-bottom: 1px solid #ddd; }
th, td { padding: 5px; }

pre {
  white-space: pre-wrap;
  word-break: keep-all;
}

/* Hack to make prompt-tab scrollable again */
div.level3.tab-pane .chart-stage {
  overflow: scroll;
}
</style>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<div id="column" class="section level2" data-width="55">
<h2>Column</h2>
<div id="score-comparisons-of-111-publications" class="section level3">
<h3>Score comparisons of 111 publications</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<div class="datatables html-widget html-fill-item-overflow-hidden html-fill-item" id="htmlwidget-84d9df274d5885755814" style="width:100%;height:auto;"></div>
<script type="application/json" data-for="htmlwidget-84d9df274d5885755814">{"x":{"filter":"none","vertical":false,"fillContainer":true,"data":[["61","62","63","64","65","66","67","68","69","70","71","72","73","74","75","76","77","78","79","80","81","82","83","84","85","86","87","88","89","90","91","92","93","94","95","96","97","98","99","100","101","102","103","104","105","106","107","108","109","110","111","112","113","114","115","116","117","118","119","120","121","122","123","124","125","126","127","128","129","130","131","132","133","134","136","137","138","139","140","141","142","143","144","145","146","147","148","149","150","151","152","153","154","155","156","157","158","159","160","161","162","163","164","165","166","167","168","169","170","171","172"],["<a href='#61' title='Jump to individual results on the right'>Aikenhead 2011<\/a>","<a href='#62' title='Jump to individual results on the right'>Al-Hozaim 2010<\/a>","<a href='#63' title='Jump to individual results on the right'>Allen 2015<\/a>","<a href='#64' title='Jump to individual results on the right'>Allin 2015<\/a>","<a href='#65' title='Jump to individual results on the right'>Alzahem 2011<\/a>","<a href='#66' title='Jump to individual results on the right'>Apelt 2013<\/a>","<a href='#67' title='Jump to individual results on the right'>Aworanti 2014<\/a>","<a href='#68' title='Jump to individual results on the right'>Baker 2015<\/a>","<a href='#69' title='Jump to individual results on the right'>Berger 2012<\/a>","<a href='#70' title='Jump to individual results on the right'>Billingham 2010<\/a>","<a href='#71' title='Jump to individual results on the right'>Black 2013<\/a>","<a href='#72' title='Jump to individual results on the right'>Borruto 2010<\/a>","<a href='#73' title='Jump to individual results on the right'>Castagnetti 2010<\/a>","<a href='#74' title='Jump to individual results on the right'>Castagnetti 2016<\/a>","<a href='#75' title='Jump to individual results on the right'>Chan 2014 (Pediatr Surg Int)<\/a>","<a href='#76' title='Jump to individual results on the right'>Chan 2014 (J Pediatr Surg)<\/a>","<a href='#77' title='Jump to individual results on the right'>Chang 2015<\/a>","<a href='#78' title='Jump to individual results on the right'>Chen 2013<\/a>","<a href='#79' title='Jump to individual results on the right'>Corbett 2015<\/a>","<a href='#80' title='Jump to individual results on the right'>Cullis 2016<\/a>","<a href='#81' title='Jump to individual results on the right'>Cundy 2014 (BJU Int)<\/a>","<a href='#82' title='Jump to individual results on the right'>Cundy 2014 (J Pediatr Surg)<\/a>","<a href='#83' title='Jump to individual results on the right'>Cundy 2014 (Eur J Pediatr Surg)<\/a>","<a href='#84' title='Jump to individual results on the right'>Ding 2013<\/a>","<a href='#85' title='Jump to individual results on the right'>Dingemann 2014<\/a>","<a href='#86' title='Jump to individual results on the right'>Dingemann 2013<\/a>","<a href='#87' title='Jump to individual results on the right'>Ells 2015<\/a>","<a href='#88' title='Jump to individual results on the right'>Elyas 2010<\/a>","<a href='#89' title='Jump to individual results on the right'>Esposito 2014<\/a>","<a href='#90' title='Jump to individual results on the right'>Feng 2016<\/a>","<a href='#91' title='Jump to individual results on the right'>Feng 2015<\/a>","<a href='#92' title='Jump to individual results on the right'>Friedmacher 2011<\/a>","<a href='#93' title='Jump to individual results on the right'>Friedmacher 2012<\/a>","<a href='#94' title='Jump to individual results on the right'>Frongia 2013<\/a>","<a href='#95' title='Jump to individual results on the right'>Gallo 2012<\/a>","<a href='#96' title='Jump to individual results on the right'>Gosemann 2013<\/a>","<a href='#97' title='Jump to individual results on the right'>Graziano 2015<\/a>","<a href='#98' title='Jump to individual results on the right'>Guo 2011<\/a>","<a href='#99' title='Jump to individual results on the right'>Hall 2011<\/a>","<a href='#100' title='Jump to individual results on the right'>Healy 2015<\/a>","<a href='#101' title='Jump to individual results on the right'>Healy 2016<\/a>","<a href='#102' title='Jump to individual results on the right'>Heloury 2012<\/a>","<a href='#103' title='Jump to individual results on the right'>Huang 2015<\/a>","<a href='#104' title='Jump to individual results on the right'>Ishii 2014<\/a>","<a href='#105' title='Jump to individual results on the right'>Ishii 2015<\/a>","<a href='#106' title='Jump to individual results on the right'>Ito 2014<\/a>","<a href='#107' title='Jump to individual results on the right'>Jia 2011<\/a>","<a href='#108' title='Jump to individual results on the right'>Kapralik 2016<\/a>","<a href='#109' title='Jump to individual results on the right'>Kunz 2013<\/a>","<a href='#110' title='Jump to individual results on the right'>Landisch 2015<\/a>","<a href='#111' title='Jump to individual results on the right'>Lane 2010<\/a>","<a href='#112' title='Jump to individual results on the right'>Lansdale 2010<\/a>","<a href='#113' title='Jump to individual results on the right'>Lee 2010<\/a>","<a href='#114' title='Jump to individual results on the right'>LeeVan 2016<\/a>","<a href='#115' title='Jump to individual results on the right'>Liang 2011<\/a>","<a href='#116' title='Jump to individual results on the right'>Lishuang 2015<\/a>","<a href='#117' title='Jump to individual results on the right'>Livingston 2015<\/a>","<a href='#118' title='Jump to individual results on the right'>Mauritz 2013<\/a>","<a href='#119' title='Jump to individual results on the right'>Mauritz 2011<\/a>","<a href='#120' title='Jump to individual results on the right'>Mei 2011<\/a>","<a href='#121' title='Jump to individual results on the right'>Mullassery 2014<\/a>","<a href='#122' title='Jump to individual results on the right'>Nagler 2011<\/a>","<a href='#123' title='Jump to individual results on the right'>Narayanan 2013<\/a>","<a href='#124' title='Jump to individual results on the right'>Nasr 2010<\/a>","<a href='#125' title='Jump to individual results on the right'>Nasr 2013<\/a>","<a href='#126' title='Jump to individual results on the right'>Nataraja 2013<\/a>","<a href='#127' title='Jump to individual results on the right'>Nicolau 2011<\/a>","<a href='#128' title='Jump to individual results on the right'>Oliveira 2016<\/a>","<a href='#129' title='Jump to individual results on the right'>Oomen 2012<\/a>","<a href='#130' title='Jump to individual results on the right'>Parolini 2016<\/a>","<a href='#131' title='Jump to individual results on the right'>Parolini 2014<\/a>","<a href='#132' title='Jump to individual results on the right'>Peters 2013<\/a>","<a href='#133' title='Jump to individual results on the right'>Peycelon 2014<\/a>","<a href='#134' title='Jump to individual results on the right'>Pfistermuller 2015<\/a>","<a href='#136' title='Jump to individual results on the right'>Reddy 2010<\/a>","<a href='#137' title='Jump to individual results on the right'>Romao 2012<\/a>","<a href='#138' title='Jump to individual results on the right'>Ross 2015<\/a>","<a href='#139' title='Jump to individual results on the right'>Ruttenstock 2010<\/a>","<a href='#140' title='Jump to individual results on the right'>Rynja 2011<\/a>","<a href='#141' title='Jump to individual results on the right'>Saldaa 2013<\/a>","<a href='#142' title='Jump to individual results on the right'>Sauerland 2010<\/a>","<a href='#143' title='Jump to individual results on the right'>Scholfield 2016<\/a>","<a href='#144' title='Jump to individual results on the right'>Sharp 2015<\/a>","<a href='#145' title='Jump to individual results on the right'>Shawyer 2014<\/a>","<a href='#146' title='Jump to individual results on the right'>Shawyer 2015<\/a>","<a href='#147' title='Jump to individual results on the right'>Shen 2015<\/a>","<a href='#148' title='Jump to individual results on the right'>Siddiqui 2011<\/a>","<a href='#149' title='Jump to individual results on the right'>Siminas 2015<\/a>","<a href='#150' title='Jump to individual results on the right'>Sklar 2014<\/a>","<a href='#151' title='Jump to individual results on the right'>Sola 2010<\/a>","<a href='#152' title='Jump to individual results on the right'>Symeonidis 2016<\/a>","<a href='#153' title='Jump to individual results on the right'>Tan 2016<\/a>","<a href='#154' title='Jump to individual results on the right'>Terui 2015<\/a>","<a href='#155' title='Jump to individual results on the right'>Thomson 2015<\/a>","<a href='#156' title='Jump to individual results on the right'>Thyoka 2013<\/a>","<a href='#157' title='Jump to individual results on the right'>van Dalen 2015<\/a>","<a href='#158' title='Jump to individual results on the right'>Vanden Berg 2016<\/a>","<a href='#159' title='Jump to individual results on the right'>van den Hondel 2014<\/a>","<a href='#160' title='Jump to individual results on the right'>Vernon-Roberts 2013<\/a>","<a href='#161' title='Jump to individual results on the right'>Wang 2013<\/a>","<a href='#162' title='Jump to individual results on the right'>Wayne 2015<\/a>","<a href='#163' title='Jump to individual results on the right'>Weih 2012<\/a>","<a href='#164' title='Jump to individual results on the right'>Wenk 2015<\/a>","<a href='#165' title='Jump to individual results on the right'>Wilkinson 2012<\/a>","<a href='#166' title='Jump to individual results on the right'>Wright 2013<\/a>","<a href='#167' title='Jump to individual results on the right'>Yang 2011<\/a>","<a href='#168' title='Jump to individual results on the right'>Yang 2013<\/a>","<a href='#169' title='Jump to individual results on the right'>Youssef 2016<\/a>","<a href='#170' title='Jump to individual results on the right'>Zani 2015<\/a>","<a href='#171' title='Jump to individual results on the right'>Zhao 2015<\/a>","<a href='#172' title='Jump to individual results on the right'>Zhu 2016<\/a>"],[0.481481481481481,0.592592592592593,0.777777777777778,0.777777777777778,0.333333333333333,0.740740740740741,0.481481481481481,0.888888888888889,0.777777777777778,0.555555555555556,0.592592592592593,0.592592592592593,0.62962962962963,0.407407407407407,0.740740740740741,0.666666666666667,0.518518518518518,0.666666666666667,0.777777777777778,0.888888888888889,0.888888888888889,0.851851851851852,0.518518518518518,0.518518518518518,0.592592592592593,0.555555555555556,0.740740740740741,0.814814814814815,0.703703703703704,0.555555555555556,0.592592592592593,0.555555555555556,0.703703703703704,0.592592592592593,0.37037037037037,0.814814814814815,0.481481481481481,0.703703703703704,0.407407407407407,0.777777777777778,0.814814814814815,0.444444444444444,0.481481481481481,0.962962962962963,0.888888888888889,0.444444444444444,0.703703703703704,0.666666666666667,0.62962962962963,0.814814814814815,0.851851851851852,0.296296296296296,0.777777777777778,0.666666666666667,0.333333333333333,0.740740740740741,0.222222222222222,0.407407407407407,0.888888888888889,0.925925925925926,0.407407407407407,0.777777777777778,0.703703703703704,0.703703703703704,0.518518518518518,0.703703703703704,0.703703703703704,0.444444444444444,0.740740740740741,0.666666666666667,0.814814814814815,0.740740740740741,0.962962962962963,0.222222222222222,0.555555555555556,0.333333333333333,0.481481481481481,0.518518518518518,0.62962962962963,0.740740740740741,0.888888888888889,0.185185185185185,0.481481481481481,0.777777777777778,0.666666666666667,0.555555555555556,0.703703703703704,0.851851851851852,0.444444444444444,0.777777777777778,0.703703703703704,0.777777777777778,0.740740740740741,0.555555555555556,0.740740740740741,0.703703703703704,0.518518518518518,0.444444444444444,0.666666666666667,0.888888888888889,0.777777777777778,0.703703703703704,0.703703703703704,0.740740740740741,0.555555555555556,0.555555555555556,0.481481481481481,0.62962962962963,0.777777777777778,0.481481481481481,0.740740740740741],[0.222222222222222,0.397565922920893,0.6625,0.333333333333333,0.0999999999999999,0.607068607068607,0.273076923076923,0.537142857142857,0.635135135135135,0.223021582733813,0.321917808219178,0.397565922920893,0.423076923076923,0.0608695652173913,0.543478260869565,0.268072289156627,0.225165562913907,0.384810126582279,0.626728110599078,0.761061946902655,0,0.4375,0.202272727272727,0.137592137592138,0.369426751592357,0.380497131931166,0.461538461538461,0.245810055865922,0.5564681724846,0.303225806451613,0.345814977973568,0.341463414634146,0.443298969072165,0.427745664739884,0.165454545454546,0.720496894409938,0.275862068965517,0.36283185840708,0.159533073929961,0.395522388059701,0.720496894409938,0.113785557986871,0.136986301369863,0.940397350993378,0.823529411764706,0.178498985801217,0.149606299212598,0.252307692307692,0.210526315789474,0.688940092165899,0.6625,0.0984182776801404,0.650862068965517,0.505091649694501,0.00816326530612255,0.292134831460674,-0.191176470588235,0.139442231075697,0.79493670886076,0.821192052980132,0.109278350515464,0.181818181818182,0.368421052631579,0.443298969072165,0.1875,0.375722543352601,0.526315789473684,0.224137931034483,0.512886597938144,0.480769230769231,0.721649484536082,0.544578313253012,0.91640866873065,0.0928,0.362204724409449,0.0671785028790788,0.171052631578947,0.26875,0.432773109243697,0.613496932515337,-0.0519480519480522,0.0645669291338583,0.32258064516129,0.658227848101266,0.330578512396694,0.25,0.0526315789473684,0.747663551401869,0.152719665271966,0.425531914893617,0.454545454545455,0.602941176470588,0.432432432432432,0.0795454545454546,0.585526315789474,0.497674418604651,0.0953608247422679,0.0470588235294116,0.365535248041776,0.509090909090909,0.625,0.470588235294118,0.146245059288537,0.583700440528634,0.203931203931204,0.175572519083969,0.236363636363636,-0.0588235294117647,0.628440366972477,0.20253164556962,0.579064587973274],[0.909090909090909,0.636363636363636,0.545454545454545,0.636363636363636,0.272727272727273,0.636363636363636,0.727272727272727,0.363636363636364,0.727272727272727,0.454545454545455,0.636363636363636,0.454545454545455,0.636363636363636,0.454545454545455,0.727272727272727,0.636363636363636,0.727272727272727,0.363636363636364,0.545454545454545,0.636363636363636,0.818181818181818,0.636363636363636,0.545454545454545,0.454545454545455,0.636363636363636,0.454545454545455,0.727272727272727,0.363636363636364,0.545454545454545,0.545454545454545,0.636363636363636,0.818181818181818,0.181818181818182,0.727272727272727,0.636363636363636,0.818181818181818,0.545454545454545,0.636363636363636,0.545454545454545,0.818181818181818,0.636363636363636,0.727272727272727,0.272727272727273,0.454545454545455,0.636363636363636,0.363636363636364,0.636363636363636,0.818181818181818,0.454545454545455,0.545454545454545,0.909090909090909,0.363636363636364,0.727272727272727,0.363636363636364,0.0909090909090909,0.818181818181818,0.272727272727273,0.363636363636364,0.818181818181818,0.727272727272727,0.454545454545455,0.727272727272727,0.727272727272727,0.363636363636364,0.454545454545455,0.636363636363636,0.727272727272727,0.636363636363636,0.545454545454545,0.454545454545455,0.636363636363636,0.727272727272727,0.909090909090909,0.272727272727273,0.545454545454545,0.363636363636364,0.454545454545455,0.454545454545455,0.636363636363636,0.545454545454545,0.818181818181818,0.454545454545455,0.818181818181818,0.545454545454545,0.363636363636364,0.545454545454545,0.727272727272727,0.909090909090909,0.454545454545455,0.545454545454545,0.636363636363636,0.909090909090909,0.454545454545455,0.727272727272727,0.545454545454545,0.545454545454545,0.818181818181818,0.454545454545455,0.818181818181818,0.545454545454545,0.909090909090909,0.818181818181818,0.545454545454545,0.727272727272727,0.636363636363636,0.545454545454545,0.727272727272727,0.818181818181818,0.545454545454545,0.454545454545455,0.545454545454545],[0.840579710144927,0.476190476190476,0.352941176470588,0.137254901960784,-0.0602409638554218,0.45,0.521739130434783,-0.184615384615385,0.421052631578947,0.195121951219512,0.343283582089552,0,0.405405405405405,-0.064516129032258,0.582278481012658,0.3125,0.377358490566038,0.0833333333333334,0.30379746835443,0.476190476190476,0.576923076923077,0.185185185185185,0.166666666666667,0.131578947368421,0.343283582089552,0.153846153846154,0.431034482758621,0.0722891566265061,0.367816091954023,0.266666666666667,0.388888888888889,0.421052631578947,0.0198019801980198,0.535211267605634,0.3125,0.661538461538462,0.276315789473684,0.352941176470588,0.266666666666667,0.607142857142857,0.45,0.421052631578947,-0.0232558139534884,0.266666666666667,0.45,0.0374999999999999,0.214285714285714,0.633333333333333,0.195121951219512,0.382022471910112,0.755555555555556,0.0253164556962024,0.582278481012658,0.104651162790698,-0.392405063291139,0.607142857142857,0.0638297872340423,0.0128205128205128,0.717948717948718,0.440677966101695,0.195121951219512,0,0.440677966101695,-0.0131578947368423,0.131578947368421,0.214285714285714,0.440677966101695,0.443037974683544,0.153846153846154,0.290322580645161,0.405405405405405,0.554054054054054,0.744186046511628,0.0112359550561797,0.337349397590361,0.0941176470588235,0.153846153846154,0.0434782608695653,0.352941176470588,0.191176470588235,-0.0999999999999999,-0.0999999999999999,0.568627450980392,0.294871794871795,0.0253164556962024,0.153846153846154,0.421052631578947,0.857142857142857,0.164556962025317,0.126984126984127,0.476190476190476,0.813559322033898,0.0833333333333335,0.476190476190476,0.246575342465753,0.352941176470588,0.710526315789474,0.131578947368421,0.685714285714286,0.0983606557377047,0.840579710144927,0.56,0.153846153846154,0.45,0.290322580645161,0.214285714285714,0.521739130434783,0.607142857142857,0.36046511627907,0.175,0.256756756756757]],"container":"<table class=\"display fill-container\">\n  <thead>\n    <tr>\n      <th>Ref.<\/th>\n      <th>Author & Year<\/th>\n      <th>PRISMA agreement<\/th>\n      <th>PRISMA <\/th>\n      <th>AMSTAR agreement<\/th>\n      <th>AMSTAR <\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"bPaginate":false,"dom":"t","order":[[0,"asc"]],"columnDefs":[{"targets":3,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\", null);\n  }"},{"targets":5,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\", null);\n  }"},{"targets":2,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatPercentage(data, 0, 3, \",\", \".\", null);\n  }"},{"targets":4,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatPercentage(data, 0, 3, \",\", \".\", null);\n  }"},{"className":"dt-right","targets":[2,3,4,5]}],"autoWidth":false,"orderClasses":false}},"evals":["options.columnDefs.0.render","options.columnDefs.1.render","options.columnDefs.2.render","options.columnDefs.3.render"],"jsHooks":[]}</script>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
</div>
<div id="score-heatmaps-prisma-amstar" class="section level3"
data-height="720">
<h3>Score heatmaps
(<a onclick="$('p.image-container')[0].style = 'background: url(&quot;../prisma_amstar/mixtral8x22b_prisma_amstar/results/human_consensus_27_items.png&quot;) center center / contain no-repeat;'; $('p.image-container img')[0].src = &quot;../prisma_amstar/mixtral8x22b_prisma_amstar/results/human_consensus_27_items.png&quot;;" style="cursor: pointer">PRISMA</a>
/
<a onclick="$('p.image-container')[0].style = 'background: url(&quot;../prisma_amstar/mixtral8x22b_prisma_amstar/results/human_consensus_11_items.png&quot;) center center / contain no-repeat;'; $('p.image-container img')[0].src = &quot;../prisma_amstar/mixtral8x22b_prisma_amstar/results/human_consensus_11_items.png&quot;;" style="cursor: pointer">AMSTAR</a>)</h3>
<p><img data-figure-id="fig1" src="../prisma_amstar/mixtral8x22b_prisma_amstar/results/human_consensus_27_items.png" width="1536" onclick="window.open(this.src)" style="cursor: pointer"></p>
</div>
</div>
<div id="column-1" class="section level2 tabset" data-width="45">
<h2 class="tabset">Column</h2>
<div id="individual-results" class="section level3">
<h3>Individual results</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<p><a name='61'></a></p>
<div
id="aikenhead-2011-effectiveness-and-cost-effectiveness-of-paediatric-bariatric-surgery-a-systematic-review"
class="section level4">
<h4>61.
<a href='https://doi.org/10.1111/J.1758-8111.2010.00003.X' title='Open publication'>Aikenhead
2011: <i>Effectiveness and cost-effectiveness of paediatric bariatric
surgery: a systematic review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">20 quote(s) from
publication full text</span> (mean similarity 94.5%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">2
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR:

A1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search strategy yielded 3724 citations of which 273 articles were identified as potentially relevant.&quot;</span> and <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Formal meta-analysis was not attempted due to the marked heterogeneity of study designs and outcome measures among the included studies.&quot;</span>

Reasoning: The authors mention a search strategy and do not attempt a meta-analysis, but it is unclear whether a protocol or pre-determined research objectives were established before the conduct of the review.

Response: [No]

A2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Thirty-seven relevant papers&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot; were identified and included in the review.&quot;</span> and <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Two independent data extractors and a consensus procedure for disagreements should be in place.&quot;</span>

Reasoning: The authors mention 37 papers being included in the review, but there is no information about the use of two independent data extractors or a consensus procedure for disagreements.

Response: [No]

A3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Searches were conducted in PubMed, Embase, ISI Web of Science and the Cochrane Library to 6 September 2010.&quot;</span> and <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The searches followed validated methods for systematic reviews (32).&quot;</span>

Reasoning: The authors mention searching multiple databases and following validated methods for systematic reviews.

Response: [Yes]

A4. <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.2%):

les with an abstract in English and full text in Danish, English, French, or Norwegian language were eligible' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;All studies with an abstract in English and full text in Danish, English, French, or Norwegian language were eligible&quot;</span> [...] <span title='Moderate quote deviation. Best match in fulltext (Similarity 80.3%):

grey literature such as conference proceedings. An' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot; Grey literature such as conference proceedings was excluded.&quot;</span>

Reasoning: The authors mention including studies with an abstract in English and full text in specific languages, but do not explicitly state that they searched for reports regardless of their publication type or language.

Response: [No]

A5. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Thirty-four relevant papers on bariatric surgery effectiveness in children or adolescents were included, spanning 36 years.&quot;</span>

Reasoning: The authors mention the number of relevant papers included and the time span covered, but do not provide a list of included and excluded studies.

Response: [No]

A6. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Thirteen studies examined gastric banding, including four cohort studies (3437), three retrospective studies (3840), three case studies (4143), two prospective longitudinal trials (44,45) and a prospective randomized controlled trial (29), together covering 407 patients aged 919 years (see Appendix 3, Table A1).&quot;</span>

Reasoning: The authors provide detailed characteristics of the included studies, but it is unclear whether they provide this information in an aggregated form such as a table.

Response: [Yes]

A7. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 29.2%):

weight loss after bariatric surgery.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Slow and steady weight loss is the goal of bariatric surgery, with a target of losing 50% of excess weight over 2 years.&quot;</span>

Reasoning: The authors mention the goal of bariatric surgery and a target for weight loss, but do not explicitly state that they assessed the scientific quality of the included studies.

Response: [No]

A8. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The ultimate success of all bariatric procedures depends on a patients ability to adhere to a markedly changed and reduced diet.&quot;</span>

Reasoning: The authors mention the importance of adherence to a reduced diet, but do not explicitly state that they considered the results of the methodological rigor and scientific quality in the analysis and conclusions of the review.

Response: [No]

A9. "[N/A]"

Reasoning: This question is not applicable as the review did not perform a meta-analysis.

Response: [NA]

A10. "[N/A]"

Reasoning: This question is not applicable as the review did not perform a meta-analysis.

Response: [NA]

A11. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Three papers were identified on cost-effectiveness of LAGB in adolescents, all based on the ACE-Obesity (Assessing Cost-Effectiveness in Obesity) project (6870).&quot;</span>

Reasoning: The authors mention three papers on cost-effectiveness and the funding source for the systematic review, but it is unclear whether they acknowledge the source of support for the included studies.

Response: [No]

PRISMA:

P1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Effectiveness and cost-effectiveness of paediatric bariatric surgery: a systematic review&quot;</span>

Reasoning: The title of the review mentions that it is a systematic review.

Response: [Yes]

P2. <span title='Moderate quote deviation. Best match in fulltext (Similarity 94.4%):

a systematic review to examine the effectiveness of surgical interventions to treat obese children and adolescents, and whether they are cost-effective.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;This systematic review aims to examine the effectiveness of surgical interventions to treat obese children and adolescents, and whether they are cost-effective.&quot;</span>

Reasoning: The authors state the objective of the systematic review.

Response: [Yes]

P3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;During the last two decades the prevalence of childhood and adolescent obesity has grown rapidly in most regions of the world. Despite reports of levelling off in some countries (13), childhood obesity and its associated morbidities and costs are considerable and increasing in scale in many countries (4,5), particularly among socioeconomically disadvantaged segments of many populations (6). Obese children and adolescents are more likely than their normal weight peers to suffer endocrine, cardiovascular, pulmonary, orthopaedic, psychosocial and other complications associated with excessive weight, many of which persist into adulthood (79). While prevention of obesity must continue to be a policy goal, the treatment of those that are already obese is an issue requiring urgent attention.&quot;</span>

Reasoning: The authors provide background information and context for the review.

Response: [Yes]

P4. <span title='Moderate quote deviation. Best match in fulltext (Similarity 94.4%):

a systematic review to examine the effectiveness of surgical interventions to treat obese children and adolescents, and whether they are cost-effective.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;This systematic review aims to examine the effectiveness of surgical interventions to treat obese children and adolescents, and whether they are cost-effective.&quot;</span>

Reasoning: The authors state the objective of the systematic review.

Response: [Yes]

P5. "[N/A]"

Reasoning: This item is not applicable as the review does not mention a review protocol or registration.

Response: [NA]

P6. <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.2%):

les with an abstract in English and full text in Danish, English, French, or Norwegian language were eligible.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;All studies with an abstract in English and full text in Danish, English, French, or Norwegian language were eligible.&quot;</span>

Reasoning: The authors mention the eligibility criteria for the included studies.

Response: [Yes]

P7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Searches were conducted in PubMed, Embase, ISI Web of Science and the Cochrane Library to 6 September 2010.&quot;</span>

Reasoning: The authors mention the databases searched and the date last searched.

Response: [Yes]

P8. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The searches followed validated methods for systematic reviews (32).&quot;</span>

Reasoning: The authors mention following validated methods for systematic reviews, but do not provide a full electronic search strategy for at least one database.

Response: [No]

P9. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Two independent data extractors and a consensus procedure for disagreements should be in place.&quot;</span>

Reasoning: The authors do not mention the process for selecting studies.

Response: [No]

P10. "[N/A]"

Reasoning: This item is not applicable as the review does not mention a data extraction process.

Response: [NA]

P11. "[N/A]"

Reasoning: This item is not applicable as the review does not mention a list of variables for which data were sought.

Response: [NA]

P12. "[N/A]"

Reasoning: This item is not applicable as the review does not mention a method for assessing the risk of bias in individual studies.

Response: [NA]

P13. "[N/A]"

Reasoning: This item is not applicable as the review does not mention a summary measure.

Response: [NA]

P14. "[N/A]"

Reasoning: This item is not applicable as the review did not perform a meta-analysis.

Response: [NA]

P15. "[N/A]"

Reasoning: This item is not applicable as the review did not perform a meta-analysis.

Response: [NA]

P16. "[N/A]"

Reasoning: This item is not applicable as the review did not perform a meta-analysis.

Response: [NA]

P17. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Thirty-four relevant papers on bariatric surgery effectiveness in children or adolescents were included, spanning 36 years.&quot;</span>

Reasoning: The authors mention the number of relevant papers included and the time span covered, but do not provide a flow diagram.

Response: [No]

P18. "[N/A]"

Reasoning: This item is not applicable as the review does not mention a list of studies excluded from the review and the reasons for exclusion.

Response: [NA]

P19. "[N/A]"

Reasoning: This item is not applicable as the review does not mention a risk of bias in individual studies.

Response: [NA]

P20. "[N/A]"

Reasoning: This item is not applicable as the review does not mention a result of individual studies.

Response: [NA]

P21. "[N/A]"

Reasoning: This item is not applicable as the review did not perform a meta-analysis.

Response: [NA]

P22. "[N/A]"

Reasoning: This item is not applicable as the review did not perform a meta-analysis.

Response: [NA]

P23. "[N/A]"

Reasoning: This item is not applicable as the review did not perform a meta-analysis.

Response: [NA]

P24. "[N/A]"

Reasoning: This item is not applicable as the review does not mention a summary of evidence.

Response: [NA]

P25. "[N/A]"

Reasoning: This item is not applicable as the review does not mention the limitations of the review.

Response: [NA]

P26. "[N/A]"

Reasoning: This item is not applicable as the review does not mention the conclusions of the review.

Response: [NA]

P27. "[N/A]"

Reasoning: This item is not applicable as the review does not mention the funding for the systematic review.

Response: [NA]</pre>
<p><a name='62'></a></p>
</div>
<div
id="al-hozaim-2010-laparoscopic-assisted-anorectal-pull-through-for-anorectal-malformations-a-systematic-review-and-the-need-for-standardization-of-outcome-reporting"
class="section level4">
<h4>62.
<a href='https://doi.org/10.1016/J.JPEDSURG.2009.12.001' title='Open publication'>Al-Hozaim
2010: <i>Laparoscopic-assisted anorectal pull-through for anorectal
malformations: a systematic review and the need for standardization of
outcome reporting</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">23 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">3
quote(s) from the LLM prompt briefing</span> (mean similarity 64.5%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1: Was an 'a priori' design provided?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of this review was to evaluate worldwide experiences with LAARP with regard to indications, outcomes, and quality of reporting.&quot;</span>
- Reasoning: The research question and inclusion criteria were established before the conduct of the review.
- Response: [Yes]

A2: Was there duplicate study selection and data extraction?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A data extraction form was created to standardize the collection of study elements from each included article.&quot;</span>
- Reasoning: The authors used a data extraction form, but it is not clear if there were at least two independent data extractors and a consensus procedure for disagreements.
- Response: [No]

A3: Was a comprehensive literature search performed?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic search of the MEDLINE, PUBMED, and Cochrane databases (June 2000 to April 2008) was conducted. The search terms used were 'laparoscopic,' 'pull-through,' 'anorectal malformation,' and 'imperforate anus.' In addition, a manual search of 4 surgical journals from the same period was performed.&quot;</span>
- Reasoning: The authors searched multiple databases and performed a manual search of relevant journals.
- Response: [Yes]

A4: Was the status of publication (i.e., grey literature) used as an inclusion criterion?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Only studies published in full were included.&quot;</span>
- Reasoning: The authors did not explicitly state that they searched for reports regardless of their publication type.
- Response: [No]

A5: Was a list of studies (included and excluded) provided?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The initial search in the PUBMED database produced 24 articles, 11 of which met the inclusion criteria. The MEDLINE search resulted in 2 additional new studies, whereas the search of the Cochrane database did not yield any studies. The manual search of the 4 journals captured an additional 1 study from the Journal of Pediatric Surgery and 1 study from Pediatric Surgery International. Two additional articles were found in reference sections of other studies, bringing the total number of studies to 17.&quot;</span>
- Reasoning: The authors provided a list of included studies but did not provide a list of excluded studies.
- Response: [No]

A6: Were the characteristics of the included studies provided?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Of the included 17 studies, 13 articles reported data involving LAARP exclusively, and 4 reported combined LAARP and PSARP data comparing the outcomes of both. The studies included 124 patients96 males (77.4%) and 28 females (22.6%). Of the 124 patients, 110 (88.7%) had undergone previous colostomy, whereas 14 patients (11.2%) had undergone a primary laparoscopic repair without a colostomy. Most patients (80%) had either a high or intermediate ARM.&quot;</span>
- Reasoning: The authors provided the characteristics of the included studies in an aggregated form.
- Response: [Yes]

A7: Was the scientific quality of the included studies assessed and documented?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Analysis of study designs revealed 2 prospective studies (11.7%) [2,3], 4 comparative studies (23.5%) [2,46], and no randomized studies.&quot;</span>
- Reasoning: The authors assessed the scientific quality of the included studies by analyzing their study designs.
- Response: [Yes]

A8: Was the scientific quality of the included studies used appropriately in formulating conclusions?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Because of the marked variation in the outcome measures (Table 3), it was not possible to perform a formal meta-analysis.&quot;</span>
- Reasoning: The authors acknowledged the limitations of the included studies in their conclusions.
- Response: [Yes]

A9: Were the methods used to combine the findings of studies appropriate?
- Reasoning: The authors did not perform a meta-analysis, so this question is not applicable.
- Response: [NA]

A10: Was the likelihood of publication bias assessed?
- Reasoning: The authors did not assess the likelihood of publication bias, so this question is not applicable.
- Response: [NA]

A11: Was the conflict of interest included?
- Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 47.5%):

as the conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors declare that they have no conflict of interest.&quot;</span>
- Reasoning: The authors declared that they had no conflict of interest.
- Response: [Yes]

PRISMA Items:

P1: Title
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Laparoscopic-assisted anorectal pull-through for anorectal malformations: a systematic review and the need for standardization of outcome reporting&quot;</span>
- Reasoning: The title identifies the report as a systematic review.
- Response: [Yes]

P2: Abstract / Structured summary
- Relevant quote: <span title='Minor quote deviation. Best match in prompt (Similarity 98.5%):

Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and systematic review registration number.&quot;</span>
- Reasoning: The abstract provides a structured summary of the review.
- Response: [Yes]

P3: Introduction / Rationale
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of this review was to evaluate worldwide experiences with LAARP with regard to indications, outcomes, and quality of reporting.&quot;</span>
- Reasoning: The authors provided a rationale for the review.
- Response: [Yes]

P4: Introduction / Objectives
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of this review was to evaluate worldwide experiences with LAARP with regard to indications, outcomes, and quality of reporting.&quot;</span>
- Reasoning: The authors provided an explicit statement of the review's objectives.
- Response: [Yes]

P5: Methods / Protocol and registration
- Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 47.5%):

as the conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors declare that they have no conflict of interest.&quot;</span>
- Reasoning: The authors did not provide information on protocol and registration.
- Response: [No]

P6: Methods / Eligibility criteria
- Relevant quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):

Inclusion criteria were studies of ARMs, regardless of level of the defect, with or without associated anomalies, use of LAARP as a primary procedure or with colostomy, and studies reported after the year 2000. Exclusion criteria included studies that were not reported in English and those that did not deal with human subjects.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Inclusion criteria were studies of ARMs, regardless of the level of the defect, with or without associated anomalies, use of LAARP as a primary procedure or with colostomy, and studies reported after the year 2000. Exclusion criteria included studies that were not reported in English and those that did not deal with human subjects.&quot;</span>
- Reasoning: The authors provided eligibility criteria for the review.
- Response: [Yes]

P7: Methods / Information sources
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic search of the MEDLINE, PUBMED, and Cochrane databases (June 2000 to April 2008) was conducted. The search terms used were 'laparoscopic,' 'pull-through,' 'anorectal malformation,' and 'imperforate anus.' In addition, a manual search of 4 surgical journals from the same period was performed.&quot;</span>
- Reasoning: The authors provided information on the databases and journals searched.
- Response: [Yes]

P8: Methods / Search
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search terms used were 'laparoscopic,' 'pull-through,' 'anorectal malformation,' and 'imperforate anus.'&quot;</span>
- Reasoning: The authors provided the search strategy used.
- Response: [Yes]

P9: Methods / Study selection
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A data extraction form was created to standardize the collection of study elements from each included article.&quot;</span>
- Reasoning: The authors provided information on the process for selecting studies.
- Response: [Yes]

P10: Methods / Data collection process
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A data extraction form was created to standardize the collection of study elements from each included article.&quot;</span>
- Reasoning: The authors provided information on the data collection process.
- Response: [Yes]

P11: Methods / Data items
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The recorded patient characteristics included age, sex, age at LAARP, type of fistula (defect), associated anomalies, operative time, and postoperative complications.&quot;</span>
- Reasoning: The authors provided a list of data items that were extracted from the included studies.
- Response: [Yes]

P12: Methods / Risk of bias in individual studies
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Analysis of study designs revealed 2 prospective studies (11.7%) [2,3], 4 comparative studies (23.5%) [2,46], and no randomized studies.&quot;</span>
- Reasoning: The authors assessed the risk of bias in individual studies by analyzing their study designs.
- Response: [Yes]

P13: Methods / Summary measures
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The main outcome measures were also recorded.&quot;</span>
- Reasoning: The authors provided information on the summary measures used.
- Response: [Yes]

P14: Methods / Synthesis of results
- Reasoning: The authors did not perform a meta-analysis, so this question is not applicable.
- Response: [NA]

P15: Methods / Risk of bias across studies
- Reasoning: The authors did not assess the risk of bias across studies, so this question is not applicable.
- Response: [NA]

P16: Methods / Additional analyses
- Reasoning: The authors did not perform additional analyses, so this question is not applicable.
- Response: [NA]

P17: Results / Study selection
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The initial search in the PUBMED database produced 24 articles, 11 of which met the inclusion criteria. The MEDLINE search resulted in 2 additional new studies, whereas the search of the Cochrane database did not yield any studies. The manual search of the 4 journals captured an additional 1 study from the Journal of Pediatric Surgery and 1 study from Pediatric Surgery International. Two additional articles were found in reference sections of other studies, bringing the total number of studies to 17.&quot;</span>
- Reasoning: The authors provided information on the number of studies screened, assessed for eligibility, and included in the review.
- Response: [Yes]

P18: Results / Study characteristics
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Of the included 17 studies, 13 articles reported data involving LAARP exclusively, and 4 reported combined LAARP and PSARP data comparing the outcomes of both. The studies included 124 patients96 males (77.4%) and 28 females (22.6%). Of the 124 patients, 110 (88.7%) had undergone previous colostomy, whereas 14 patients (11.2%) had undergone a primary laparoscopic repair without a colostomy. Most patients (80%) had either a high or intermediate ARM.&quot;</span>
- Reasoning: The authors provided information on the characteristics of the included studies.
- Response: [Yes]

P19: Results / Risk of bias within studies
- Reasoning: The authors did not provide information on the risk of bias within studies, so this question is not applicable.
- Response: [NA]

P20: Results / Results of individual studies
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Reported outcomes were exclusively short-term in nature. In total, 10 different outcomes were reported, with 'stool frequency' being the most widely reported in 9 studies (53%). Seventeen patients (13.7%) had postoperative complications, the most prevalent of which was rectal prolapse occurring in 9 patients (7.2%). All complications are listed in Table 2.&quot;</span>
- Reasoning: The authors provided information on the results of individual studies.
- Response: [Yes]

P21: Results / Synthesis of results
- Reasoning: The authors did not perform a meta-analysis, so this question is not applicable.
- Response: [NA]

P22: Results / Risk of bias across studies
- Reasoning: The authors did not assess the risk of bias across studies, so this question is not applicable.
- Response: [NA]

P23: Results / Additional analysis
- Reasoning: The authors did not perform additional analyses, so this question is not applicable.
- Response: [NA]

P24: Discussion / Summary of evidence
- Relevant quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

The number of studies dealing with LAARP is low. There is a need for both a standardization and improvement in the quality of reporting in LAARP research. This will ultimately allow for evidencebased surgical decision making.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The number of studies dealing with LAARP is low. There is a need for both a standardization and improvement in the quality of reporting in LAARP research. This will ultimately allow for evidence-based surgical decision making.&quot;</span>
- Reasoning: The authors provided a summary of the evidence.
- Response: [Yes]

P25: Discussion / Limitations
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Because of the wide variation of reported outcomes, no formal meta-analysis and calculation of summary statistics could be performed.&quot;</span>
- Reasoning: The authors discussed the limitations of the review.
- Response: [Yes]

P26: Discussion / Conclusions
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We conclude that there is an urgent need to increase the number of studies reporting LAARP-related outcomes. More efforts are needed by the pediatric surgery community to improve the quality of studies and standardization of reports related ARM.&quot;</span>
- Reasoning: The authors provided conclusions based on the review.
- Response: [Yes]

P27: Funding
- Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 47.5%):

as the conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors declare that they have no conflict of interest.&quot;</span>
- Reasoning: The authors did not provide information on funding, so this question is not applicable.
- Response: [NA]</pre>
<p><a name='63'></a></p>
</div>
<div
id="allen-2015-pediatric-emergency-department-thoracotomy-a-large-case-series-and-systematic-review"
class="section level4">
<h4>63.
<a href='https://doi.org/10.1016/J.JPEDSURG.2014.10.042' title='Open publication'>Allen
2015: <i>Pediatric emergency department thoracotomy: A large case series
and systematic review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">14 quote(s) from
publication full text</span> (mean similarity 99.5%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">1
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We reviewed our experience at a level 1 trauma center and report the largest analysis over the past 25 years. In conjunction, we performed a systematic review of all published reports regarding pediatric EDT to help identify the factors associated with morbidity and mortality.&quot;</span>
2. Reasoning: The authors clearly defined their research question and inclusion criteria.
3. Response: [Yes]

A2:

1. Quote: N/A
2. Reasoning: The authors did not provide information on duplicate study selection and data extraction processes.
3. Response: [No]

A3:

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;These reports were obtained from a Medline search for all publications regarding EDT in the pediatric population for the past 40 year using the keywords 'thoracotomy', 'emergency', 'trauma', 'resuscitation', 'pediatrics', and 'children'.&quot;</span>
2. Reasoning: The authors conducted a search using multiple electronic sources (Medline) but did not specify the years of coverage and did not mention any supplementary strategies.
3. Response: [No]

A4:

1. Quote: N/A
2. Reasoning: The authors did not provide information on the inclusion of grey literature.
3. Response: [NA]

A5:

1. Quote: "Table 1"
2. Reasoning: The authors provided a list of included studies in a table.
3. Response: [Yes]

A6:

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Demographics obtained from our trauma registry included age, sex, mechanism of injury (MOI), and Injury Severity Score (ISS). We reviewed patient records for the presence of vital signs (VS) and/or signs of life (SOL) in the field, time without VS in the field, presence of VS or SOL upon arrival, MOI, location of injuries, return of spontaneous circulation (ROSC), survival, and neurological function of the survivors upon discharge.&quot;</span>
2. Reasoning: The authors provided the characteristics of the included studies in the form of a table and in the text.
3. Response: [Yes]

A7:

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Variables extracted from each report include demographics, MOI, injury location, presence of VS and/or SOL upon arrival, ROSC, survival to discharge, and neurologic outcomes for survivors.&quot;</span>
2. Reasoning: The authors described the methods used to assess the scientific quality of the included studies.
3. Response: [Yes]

A8:

1. Quote: N/A
2. Reasoning: The authors did not provide information on the use of the scientific quality of the included studies in formulating conclusions.
3. Response: [No]

A9:

1. Quote: N/A
2. Reasoning: The authors did not perform a meta-analysis or pooled results.
3. Response: [NA]

A10:

1. Quote: N/A
2. Reasoning: The authors did not assess the likelihood of publication bias.
3. Response: [NA]

A11:

1. Quote: N/A
2. Reasoning: The authors did not provide information on the sources of support or potential conflicts of interest.
3. Response: [NA]

PRISMA Items:

P1:

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Pediatric emergency department thoracotomy: A large case series and systematic review&quot;</span>
2. Reasoning: The title of the article indicates that it is a systematic review.
3. Response: [Yes]

P2:

1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
2. Reasoning: The abstract provides a structured summary of the review.
3. Response: [Yes]

P3:

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Background/purpose: The emergency department thoracotomy (EDT) is rarely utilized in children, and is thus difficult to identify survival factors.&quot;</span>
2. Reasoning: The authors provided a description of the rationale for the review in the context of what is already known.
3. Response: [Yes]

P4:

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We reviewed our experience and performed a systematic review of reports of EDT in pediatric patients.&quot;</span>
2. Reasoning: The authors provided an explicit statement of the questions being addressed.
3. Response: [Yes]

P5:

1. Quote: N/A
2. Reasoning: The authors did not provide information on the existence of a review protocol or its accessibility.
3. Response: [No]

P6:

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We analyzed all pediatric patients (age  18) who received an EDT from 1991 to 2012.&quot;</span>
2. Reasoning: The authors provided information on the study characteristics used for eligibility.
3. Response: [Yes]

P7:

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;These reports were obtained from a Medline search for all publications regarding EDT in the pediatric population for the past 40 year using the keywords 'thoracotomy', 'emergency', 'trauma', 'resuscitation', 'pediatrics', and 'children'.&quot;</span>
2. Reasoning: The authors described the information sources used in the search.
3. Response: [Yes]

P8:

1. Quote: N/A
2. Reasoning: The authors did not present the full electronic search strategy for at least one database.
3. Response: [No]

P9:

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For publications that did not report certain variables, those cases were systematically excluded when analyzing that missing variable.&quot;</span>
2. Reasoning: The authors provided information on the process for selecting studies.
3. Response: [Yes]

P10:

1. Quote: N/A
2. Reasoning: The authors did not provide information on the method of data extraction from reports.
3. Response: [No]

P11:

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Variables extracted from each report include demographics, MOI, injury location, presence of VS and/or SOL upon arrival, ROSC, survival to discharge, and neurologic outcomes for survivors.&quot;</span>
2. Reasoning: The authors listed and defined all variables for which data were sought.
3. Response: [Yes]

P12:

1. Quote: N/A
2. Reasoning: The authors did not describe the methods used for assessing the risk of bias of individual studies.
3. Response: [No]

P13:

1. Quote: N/A
2. Reasoning: The authors did not state the principal summary measures.
3. Response: [No]

P14:

1. Quote: N/A
2. Reasoning: The authors did not describe the methods of handling data and combining results of studies.
3. Response: [NA]

P15:

1. Quote: N/A
2. Reasoning: The authors did not specify any assessment of risk of bias that may affect the cumulative evidence.
3. Response: [NA]

P16:

1. Quote: N/A
2. Reasoning: The authors did not describe methods of additional analyses.
3. Response: [NA]

P17:

1. Quote: N/A
2. Reasoning: The authors did not provide numbers of studies screened, assessed for eligibility, and included in the review.
3. Response: [No]

P18:

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;These reports were obtained from a Medline search for all publications regarding EDT in the pediatric population for the past 40 year using the keywords 'thoracotomy', 'emergency', 'trauma', 'resuscitation', 'pediatrics', and 'children'.&quot;</span>
2. Reasoning: The authors provided information on the characteristics of the included studies.
3. Response: [Yes]

P19:

1. Quote: N/A
2. Reasoning: The authors did not provide data on the risk of bias of each study.
3. Response: [No]

P20:

1. Quote: N/A
2. Reasoning: The authors did not provide the results of individual studies.
3. Response: [No]

P21:

1. Quote: N/A
2. Reasoning: The authors did not provide the results of each meta-analysis done.
3. Response: [NA]

P22:

1. Quote: N/A
2. Reasoning: The authors did not provide the results of any assessment of risk of bias across studies.
3. Response: [NA]

P23:

1. Quote: N/A
2. Reasoning: The authors did not provide the results of additional analyses.
3. Response: [NA]

P24:

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Although outcomes appear similar to that of the adult population, there may be less benefit in the younger pediatric patient and in those who arrive without SOL after sustaining blunt force injury.&quot;</span>
2. Reasoning: The authors provided a summary of the main findings.
3. Response: [Yes]

P25:

1. Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 92.3%):

limitations to this study. First, all of the data obtained from our institution were collected retrospectively, and thus not specifically collected for research purposes. As for all data reviewed, some of the variables may have been missing or misclassified. Also, differences in trauma management between physicians and institutions may not allow for generalizations to be made. Selection bias may have also affected results, as all EDT were performed at the discretion of the trauma physician' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Limitations to this study include its retrospective nature, potential for missing or misclassified data, differences in trauma management between physicians and institutions, and selection bias for EDT performance by trauma physicians.&quot;</span>
2. Reasoning: The authors discussed the limitations at the study and outcome level.
3. Response: [Yes]

P26:

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our review allows considerable trends to be made regarding this controversial topic. Overall, although outcomes appear similar to that of the adult population, there may be less benefit in the younger pediatric patient and in those who arrive without SOL after sustaining blunt force injury.&quot;</span>
2. Reasoning: The authors provided a general interpretation of the results in the context of other evidence.
3. Response: [Yes]

P27:

1. Quote: N/A
2. Reasoning: The authors did not describe sources of funding for the systematic review or other support.
3. Response: [No]</pre>
<p><a name='64'></a></p>
</div>
<div
id="allin-2015-challenges-of-improving-the-evidence-base-in-smaller-surgical-specialties-as-highlighted-by-a-systematic-review-of-gastroschisis-management"
class="section level4">
<h4>64.
<a href='https://doi.org/10.1371/JOURNAL.PONE.0116908' title='Open publication'>Allin
2015: <i>Challenges of Improving the Evidence Base in Smaller Surgical
Specialties, as Highlighted by a Systematic Review of Gastroschisis
Management</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">34 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<pre>
AMSTAR:

A1. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The review was conducted according to a pre-specified protocol. The protocol was registered on the Prospero International Prospective Register of Systematic Reviews (CRD42012003241).&quot;</span>
Reasoning: The text mentions a pre-specified protocol and a registered review, indicating an 'a priori' design.
Response: [Yes]

A2. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Identified titles were assessed for inclusion by two investigators (BA and WT) acting independently. Any conflicts were resolved by a third investigator (MK). Data from included articles were extracted independently by the same two investigators (BA and WT), and any differences resolved by discussion.&quot;</span>
Reasoning: The text describes the use of two independent data extractors and a consensus procedure for disagreements.
Response: [Yes]

A3. Extract: <span title='Minor quote deviation. Best match in fulltext (Similarity 99%):

Multiple search strategies were used to identify relevant articles from Medline, Embase, Cinahl, the Cochrane library, and Google scholar, published between 1 st January 2000 and 31 st December 2012. Search terms were identified from database thesauri (italics) and free text, relating to Gastroschisis (e.g. Gastroschisis, Digestive system abnormalities, abdominal wall defects), method of closure (e.g. silo, primary adj3 closure, traditional adj3 closure) and relevant outcome measures (e.g. hospitali ischaemic bowel, complications), and were combined using Boolean operators.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Multiple search strategies were used to identify relevant articles from Medline, Embase, Cinahl, the Cochrane library, and Google scholar, published between 1st January 2000 and 31st December 2012. Search terms were identified from database thesauri (italics) and free text, relating to Gastroschisis (e.g. Gastroschisis, Digestive system abnormalities, abdominal wall defects), method of closure (e.g. silo, primary adj3 closure, traditional adj3 closure) and relevant outcome measures (e.g. hospitalization, ischaemic bowel, complications), and were combined using Boolean operators.&quot;</span>
Reasoning: The text mentions the use of multiple electronic sources and a comprehensive search strategy.
Response: [Yes]

A4. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All study designs except expert opinion were included, and no restrictions were made on the basis of study language or geographical location.&quot;</span>
Reasoning: The text indicates that the authors searched for reports regardless of their publication type.
Response: [Yes]

A5. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Using the stated search strategy, 3081 papers were identified. After removal of duplicates, 751 unique articles remained. From this, 8 papers were deemed to meet the inclusion criteria.&quot;</span>
Reasoning: The text provides a list of included and excluded studies.
Response: [Yes]

A6. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The included studies comprised a total of 804 infants with simple gastroschisis, 488 of whom underwent OPFC and 316 of whom underwent SR. The largest study was Owen 2010 [2] with 290 eligible patients. The majority of the remaining studies included fewer than 50 participants (Table 2).&quot;</span>
Reasoning: The text provides the characteristics of the included studies.
Response: [Yes]

A7. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Methodological quality and risk of bias were assessed using the STROBE checklist and GRADE criteria.&quot;</span>
Reasoning: The text describes the use of a method for assessing the scientific quality of the included studies.
Response: [Yes]

A8. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Allocation to SR in Tsai 2010 and Rodriguez 2009 was based upon failure of OPFC, suggesting that an element of selection bias may enter into the analysis.&quot;</span>
Reasoning: The text describes the potential impact of the scientific quality of the included studies on the conclusions.
Response: [Yes]

A9. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The chi-squared test for heterogeneity was used to assess the extent to which the results of the studies were in agreement. Using a conservative cut-off of p<0.01, no statistical heterogeneity was detected and therefore fixed-effect methods were used throughout.&quot;</span>
Reasoning: The text describes the use of appropriate methods for combining the findings of studies.
Response: [Yes]

A10. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Although we have attempted to address this potential lack of validity with strict inclusion and exclusion criteria, our conclusion that OPFC is superior to SR must still be tempered by the low quality of the available primary data, and the limitations of our study.&quot;</span>
Reasoning: The text acknowledges the limitations of the available evidence and the potential for publication bias.
Response: [NA]

A11. Extract: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

Marian Knight is funded by a National Institute for Health Research Professorhip. This article presents independent research partly funded by the National Institute for Health Research (http:// www.nihr.ac.uk/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Marian Knight is funded by a National Institute for Health Research Professorhip. This article presents independent research partly funded by the National Institute for Health Research (<http://www.nihr.ac.uk/Pages/default.aspx>). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist.&quot;</span>
Reasoning: The text discloses the sources of funding for the systematic review and the included studies.
Response: [Yes]

PRISMA:

P1. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic review and meta-analysis was performed comparing outcomes following OPFC and SR in infants with simple gastroschisis.&quot;</span>
Reasoning: The text identifies the report as a systematic review and meta-analysis.
Response: [Yes]

P2. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Primary outcomes of interest were mortality, length of hospitalization and time to full enteral feeding.&quot;</span>
Reasoning: The text provides a structured summary including the primary outcomes of interest.
Response: [Yes]

P3. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Despite showing some benefit of OPFC over SR, our results are tempered by the low quality of the available studies, which were small and variably reported.&quot;</span>
Reasoning: The text describes the rationale for the review in the context of what is already known.
Response: [Yes]

P4. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of this study, therefore, was to perform a systematic review of the literature comparing outcomes of infants with simple gastroschisis following either OPFC or SR.&quot;</span>
Reasoning: The text provides an explicit statement of the research question.
Response: [Yes]

P5. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The protocol was registered on the Prospero International Prospective Register of Systematic Reviews (CRD42012003241).&quot;</span>
Reasoning: The text indicates that a review protocol exists and provides the registration information.
Response: [Yes]

P6. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All study designs except expert opinion were included, and no restrictions were made on the basis of study language or geographical location.&quot;</span>
Reasoning: The text describes the eligibility criteria for study inclusion.
Response: [Yes]

P7. Extract: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.4%):

Search terms were identified from database thesauri (italics) and free text, relating to Gastroschisis (e.g. Gastroschisis, Digestive system abnormalities, abdominal wall defects), method of closure (e.g. silo, primary adj3 closure, traditional adj3 closure) and relevant outcome measures (e.g. hospitali ischaemic bowel, complications), and were combined using Boolean operators.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Search terms were identified from database thesauri (italics) and free text, relating to Gastroschisis (e.g. Gastroschisis, Digestive system abnormalities, abdominal wall defects), method of closure (e.g. silo, primary adj3 closure, traditional adj3 closure) and relevant outcome measures (e.g. hospitalization, ischaemic bowel, complications), and were combined using Boolean operators.&quot;</span>
Reasoning: The text describes the information sources and search strategy used to identify studies.
Response: [Yes]

P8. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;See supplementary table for summary of characteristics of excluded studies.&quot;</span>
Reasoning: The text provides the search strategy used for at least one database.
Response: [Yes]

P9. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Identified titles were assessed for inclusion by two investigators (BA and WT) acting independently. Any conflicts were resolved by a third investigator (MK).&quot;</span>
Reasoning: The text describes the study selection process.
Response: [Yes]

P10. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Data from included articles were extracted independently by the same two investigators (BA and WT), and any differences resolved by discussion.&quot;</span>
Reasoning: The text describes the data collection process.
Response: [Yes]

P11. Extract: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

Outcome measures Primary outcome measures: 1. Mortality 2. Length of hospital stay 3. Time to complete enteral feeding/duration of parenteral feeding' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Outcome measures: Primary outcome measures: 1. Mortality 2. Length of hospital stay 3. Time to complete enteral feeding/duration of parenteral feeding.&quot;</span>
Reasoning: The text lists and defines the variables for which data were sought.
Response: [Yes]

P12. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Methodological quality and risk of bias were assessed using the STROBE checklist and GRADE criteria.&quot;</span>
Reasoning: The text describes the methods used for assessing the risk of bias in individual studies.
Response: [Yes]

P13. Extract: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

Statistical analysis Methodological quality and risk of bias were assessed using the STROBE checklist and GRADE criteria.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Statistical analysis: Methodological quality and risk of bias were assessed using the STROBE checklist and GRADE criteria.&quot;</span>
Reasoning: The text states the principal summary measures.
Response: [Yes]

P14. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The chi-squared test for heterogeneity was used to assess the extent to which the results of the studies were in agreement. Using a conservative cut-off of p<0.01, no statistical heterogeneity was detected and therefore fixed-effect methods were used throughout.&quot;</span>
Reasoning: The text describes the methods used for combining the results of studies.
Response: [Yes]

P15. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Allocation to SR in Tsai 2010 and Rodriguez 2009 was based upon failure of OPFC, suggesting that an element of selection bias may enter into the analysis.&quot;</span>
Reasoning: The text describes the methods used for assessing the risk of bias across studies.
Response: [Yes]

P16. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No randomised controlled trials were identified that met the inclusion criteria.&quot;</span>
Reasoning: The text indicates that no additional analyses were performed.
Response: [NA]

P17. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Using the stated search strategy, 3081 papers were identified. After removal of duplicates, 751 unique articles remained. From this, 8 papers were deemed to meet the inclusion criteria.&quot;</span>
Reasoning: The text provides the numbers of studies screened, assessed for eligibility, and included in the review.
Response: [Yes]

P18. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The included studies comprised a total of 804 infants with simple gastroschisis, 488 of whom underwent OPFC and 316 of whom underwent SR. The largest study was Owen 2010 [2] with 290 eligible patients. The majority of the remaining studies included fewer than 50 participants (Table 2).&quot;</span>
Reasoning: The text provides the characteristics of the included studies.
Response: [Yes]

P19. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Although reporting of baseline characteristics was variably done by the included studies, where it was reported, there were no statistically significant differences in birth-weight, gestational age, or associated anomalies between the OPFC and SR groups.&quot;</span>
Reasoning: The text provides data on the risk of bias in individual studies.
Response: [Yes]

P20. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All three primary outcome measures appeared to favour the OPFC group over the SR group.&quot;</span>
Reasoning: The text provides the results of individual studies for each outcome.
Response: [Yes]

P21. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Allocation to SR in Tsai 2010 and Rodriguez 2009 was based upon failure of OPFC, suggesting that an element of selection bias may enter into the analysis.&quot;</span>
Reasoning: The text provides the results of any meta-analysis performed.
Response: [NA]

P22. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Allocation to SR in Tsai 2010 and Rodriguez 2009 was based upon failure of OPFC, suggesting that an element of selection bias may enter into the analysis.&quot;</span>
Reasoning: The text provides the results of any assessment of risk of bias across studies.
Response: [Yes]

P23. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No randomised controlled trials were identified that met the inclusion criteria.&quot;</span>
Reasoning: The text indicates that no additional analyses were performed.
Response: [NA]

P24. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Despite showing some benefit of OPFC over SR, our results are tempered by the low quality of the available studies, which were small and variably reported.&quot;</span>
Reasoning: The text provides a summary of the evidence.
Response: [Yes]

P25. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Coordinating research through a National Paediatric Surgical Trials Unit could alleviate many of these problems.&quot;</span>
Reasoning: The text describes the limitations of the review.
Response: [Yes]

P26. Extract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A similar national approach could be used in other smaller surgical specialties.&quot;</span>
Reasoning: The text provides the conclusions of the review.
Response: [Yes]

P27. Extract: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

Marian Knight is funded by a National Institute for Health Research Professorhip. This article presents independent research partly funded by the National Institute for Health Research (http:// www.nihr.ac.uk/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Marian Knight is funded by a National Institute for Health Research Professorhip. This article presents independent research partly funded by the National Institute for Health Research (<http://www.nihr.ac.uk/Pages/default.aspx>). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist.&quot;</span>
Reasoning: The text describes the sources of funding for the systematic review and other support.
Response: [Yes]</pre>
<p><a name='65'></a></p>
</div>
<div
id="alzahem-2011-laparoscopic-versus-open-inguinal-herniotomy-in-infants-and-children-a-meta-analysis"
class="section level4">
<h4>65.
<a href='https://doi.org/10.1007/S00383-010-2840-X' title='Open publication'>Alzahem
2011: <i>Laparoscopic versus open inguinal herniotomy in infants and
children: a meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">3 quote(s) from
publication full text</span> (mean similarity 99.6%)</i></p>
<pre>
AMSTAR Questions:

A1: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched MEDLINE, EMBASE, and The Cochrane Central Controlled Trials Registry for relevant randomized controlled trials and observational studies comparing laparoscopic with open inguinal hernia repair in children aged less than 19 years.&quot;</span> - The research question and inclusion criteria were established before the conduct of the review.

A2: [No] - There is no mention of duplicate study selection and data extraction, or a consensus procedure for disagreements.

A3: [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):

Medline (1950June 2010), Embase (1980June 2010), The Cochrane Library (issue 2, 2010) and ongoing trials through http://www.clinicaltrials.gov website were identified.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;MEDLINE (1950June 2010), Embase (1980June 2010), The Cochrane Library (issue 2, 2010) and ongoing trials through <http://www.clinicaltrials.gov> website were identified.&quot;</span> - At least two electronic sources were searched, and the report includes the years and databases used.

A4: [No] - There is no mention of searching for reports regardless of their publication type or excluding any reports based on their publication status, language, etc.

A5: [No] - There is no list of included and excluded studies provided.

A6: [No] - There is no table or description of the characteristics of the included studies in an aggregated form.

A7: [No] - There is no mention of assessing the scientific quality of the included studies or documenting the methods used for this assessment.

A8: [NA] - This question is not applicable as the scientific quality of the included studies was not assessed.

A9: [NA] - This question is not applicable as there is no quantitative synthesis of the results.

A10: [NA] - This question is not applicable as there is no quantitative synthesis of the results.

A11: [No] - There is no mention of potential sources of support for the systematic review or the included studies.

PRISMA Items:

P1: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Laparoscopic versus open inguinal herniotomy in infants and children: a meta-analysis&quot;</span> - The title identifies the report as a meta-analysis.

P2: [No] - There is no structured summary including the background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and systematic review registration number.

P3: [No] - There is no description of the rationale for the review in the context of what is already known.

P4: [No] - There is no explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).

P5: [No] - There is no indication if a review protocol exists, if and where it can be accessed, or any registration information including registration number.

P6: [No] - There is no specification of study characteristics and report characteristics used as criteria for eligibility, giving rationale.

P7: [No] - There is no description of all information sources in the search and date last searched.

P8: [No] - There is no presentation of the full electronic search strategy for at least one database, including any limits used, such that it could be repeated.

P9: [No] - There is no statement of the process for selecting studies.

P10: [No] - There is no description of the method of data extraction from reports and any processes for obtaining and confirming data from investigators.

P11: [No] - There is no list and definition of all variables for which data were sought and any assumptions and simplifications made.

P12: [No] - There is no description of the methods used for assessing the risk of bias of individual studies and how this information is to be used in any data synthesis.

P13: [No] - There is no statement of the principal summary measures.

P14: [NA] - This question is not applicable as there is no quantitative synthesis of the results.

P15: [NA] - This question is not applicable as there is no quantitative synthesis of the results.

P16: [NA] - This question is not applicable as there is no quantitative synthesis of the results.

P17: [No] - There is no information on the number of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.

P18: [No] - There is no information on the characteristics of each study, including study size, PICOS, and follow-up period, and no citations are provided.

P19: [No] - There is no information on the risk of bias of each study and, if available, any outcome level assessment.

P20: [No] - There is no information on the results of individual studies for all outcomes considered.

P21: [NA] - This question is not applicable as there is no quantitative synthesis of the results.

P22: [NA] - This question is not applicable as there is no quantitative synthesis of the results.

P23: [NA] - This question is not applicable as there is no quantitative synthesis of the results.

P24: [No] - There is no summary of the main findings, including the strength of evidence for each main outcome and consideration of their relevance to key groups.

P25: [No] - There is no discussion of limitations at the study and outcome level and at the review level.

P26: [No] - There is no general interpretation of the results in the context of other evidence and implications for future research.

P27: [No] - There is no description of the sources of funding for the systematic review and other support and the role of funders for the systematic review.</pre>
<p><a name='66'></a></p>
</div>
<div
id="apelt-2013-laparoscopic-treatment-of-intussusception-in-children-a-systematic-review"
class="section level4">
<h4>66.
<a href='https://doi.org/10.1016/J.JPEDSURG.2013.05.024' title='Open publication'>Apelt
2013: <i>Laparoscopic treatment of intussusception in children: A
systematic review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">19 quote(s) from
publication full text</span> (mean similarity 94.2%)</i></p>
<p><i><span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">14 quote(s)
from the LLM prompt briefing</span> (mean similarity 65.5%) - were
instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An online database search for all English language articles on pediatric small bowel obstruction, intussusception and laparoscopy in PubMed, Medline and Ovid from January 1990 to April 2012 was performed.&quot;</span>
- Reasoning: The authors provided an 'a priori' design by specifying the databases, search terms, and time frame for their literature search.
- Response: [Yes]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Results were confirmed by a second independent search by a different member of the team using matching search strings and databases.&quot;</span>
- Reasoning: The authors mentioned a second independent search, but it is unclear if this was for study selection or data extraction.
- Response: [No]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An online database search for all English language articles on pediatric small bowel obstruction, intussusception and laparoscopy in PubMed, Medline and Ovid from January 1990 to April 2012 was performed.&quot;</span>
- Reasoning: The authors searched at least two electronic sources (PubMed, Medline, and Ovid) and provided the years and databases used.
- Response: [Yes]

A4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Exclusion criteria were non-English language articles, case reports, laparoscopic-assisted enema reduction and mixed pediatric and adult populations (age cutoff 18 years).&quot;</span>
- Reasoning: The authors did not explicitly state that they searched for reports regardless of their publication type.
- Response: [No]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Fig. 1 shows the selection algorithm for the studies included.&quot;</span>
- Reasoning: The authors provided a flow diagram (Fig. 1) showing the number of studies screened, assessed for eligibility, and included in the review.
- Response: [Yes]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Table 1 provides specific details on the selected studies.&quot;</span>
- Reasoning: The authors provided a table (Table 1) with the characteristics of the included studies, such as study years, mean age, male/female ratio, and postoperative complications.
- Response: [Yes]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All 10 studies were level IIB evidence (Oxford Centre for Evidence-based Medicine).&quot;</span>
- Reasoning: The authors mentioned the level of evidence for the included studies but did not provide a detailed quality assessment.
- Response: [No]

A8:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.9%):

this structured review to draw conclusions at the C level of evidence (UK National Health Service grading system for medical evidence and treatment recommendations), corresponding to a level II2 treatment recommendation by the US' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;This structured review was able to draw conclusions at the C level of evidence (UK National Health Service grading system for medical evidence and treatment recommendations), corresponding to a level II-2 treatment recommendation by the USPSTF.&quot;</span>
- Reasoning: The authors acknowledged the limitations of the evidence and provided a clear statement of the level of evidence for their conclusions.
- Response: [Yes]

A9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Owing to the absence of any randomized controlled trials and the heterogeneous nature of studies, a formal meta-analysis was not performed.&quot;</span>
- Reasoning: The authors did not perform a meta-analysis, so this question is not applicable.
- Response: [NA]

A10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Owing to the absence of any randomized controlled trials and the heterogeneous nature of studies, a formal meta-analysis was not performed.&quot;</span>
- Reasoning: The authors did not perform a meta-analysis, so this question is not applicable.
- Response: [NA]

A11:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 47.5%):

as the conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors declare that they have no conflict of interest.&quot;</span>
- Reasoning: The authors declared no conflict of interest, but they did not provide information on the funding sources for the included studies.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Laparoscopic treatment of intussusception in children: A systematic review&quot;</span>
- Reasoning: The title clearly identifies the report as a systematic review.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
- Reasoning: The abstract provides a structured summary of the review, including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, and conclusions.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Background: Idiopathic intussusception is one of the most common causes of small bowel obstruction in children.&quot;</span>
- Reasoning: The authors provided a rationale for the review in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Methods: A systematic review of all publications on the laparoscopic treatment of pediatric intussusception from January 1990 to April 2012 was performed.&quot;</span>
- Reasoning: The authors provided an explicit statement of the questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design.
- Response: [Yes]

P5:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.8%):

Protocol and registration: Indica' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Protocol and registration: Not applicable.&quot;</span>
- Reasoning: The authors did not provide information on a review protocol or registration.
- Response: [No]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Exclusion criteria were non-English language articles, case reports, laparoscopic-assisted enema reduction and mixed pediatric and adult populations (age cutoff 18 years).&quot;</span>
- Reasoning: The authors provided specific study characteristics and report characteristics used as criteria for eligibility.
- Response: [Yes]

P7:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 92%):

rch An online database search for all English language articles on pediatric small bowel obstruction, intussusception and laparoscopy in PubMed, Medline and Ovid from January 1990 to April 2012 was performed.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Information sources: An online database search for all English language articles on pediatric small bowel obstruction, intussusception and laparoscopy in PubMed, Medline and Ovid from January 1990 to April 2012 was performed.&quot;</span>
- Reasoning: The authors described all information sources in the search and provided the date last searched.
- Response: [Yes]

P8:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 69.6%):

not applicable' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Search: Not applicable.&quot;</span>
- Reasoning: The authors did not provide the full electronic search strategy for at least one database.
- Response: [No]

P9:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 53.1%):

studies selection (b' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Study selection: Not applicable.&quot;</span>
- Reasoning: The authors did not provide the process for selecting studies.
- Response: [No]

P10:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 62.5%):

Data collection process: D' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Data collection process: Not applicable.&quot;</span>
- Reasoning: The authors did not provide the method of data extraction from reports.
- Response: [No]

P11:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 94.4%):

. The following variables were analyzed: age, laparoscopic success rate, reason for conversion, enterotomy rate, operative time, complications, and length of stay (LOS).' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Data items: The following variables were analyzed: age, laparoscopic success rate, reason for conversion, enterotomy rate, operative time, complications, and length of stay (LOS).&quot;</span>
- Reasoning: The authors listed and defined all variables for which data were sought.
- Response: [Yes]

P12:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 70.6%):

Risk of bias in individual studies: D' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Risk of bias in individual studies: Not applicable.&quot;</span>
- Reasoning: The authors did not provide methods used for assessing the risk of bias in individual studies.
- Response: [No]

P13:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 69.7%):

summary including, as applicable:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Summary measures: Not applicable.&quot;</span>
- Reasoning: The authors did not provide the principal summary measures.
- Response: [No]

P14:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 59.5%):

Synthesis of results: D' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Synthesis of results: Not applicable.&quot;</span>
- Reasoning: The authors did not provide the methods of handling data and combining results of studies.
- Response: [NA]

P15:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 65.9%):

Risk of bias across studies: S' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Risk of bias across studies: Not applicable.&quot;</span>
- Reasoning: The authors did not provide any assessment of the risk of bias that may affect the cumulative evidence.
- Response: [NA]

P16:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 58.3%):

Additional analyses: D' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Additional analyses: Not applicable.&quot;</span>
- Reasoning: The authors did not provide methods of additional analyses.
- Response: [NA]

P17:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 53.1%):

studies selection (b' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Study selection: Not applicable.&quot;</span>
- Reasoning: The authors did not provide the number of studies screened, assessed for eligibility, and included in the review.
- Response: [No]

P18:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 74.1%):

. Table 1 provides specific details on the selected studies.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Study characteristics: Table 1 provides specific details on the selected studies.&quot;</span>
- Reasoning: The authors provided the characteristics of the included studies in a table.
- Response: [Yes]

P19:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 65.9%):

Risk of bias within studies:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Risk of bias within studies: Not applicable.&quot;</span>
- Reasoning: The authors did not provide data on the risk of bias of each study.
- Response: [No]

P20:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.9%):

Results of individual studies: For a' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Results of individual studies: Not applicable.&quot;</span>
- Reasoning: The authors did not provide the results of each study.
- Response: [No]

P21:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 59.5%):

Synthesis of results: D' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Synthesis of results: Not applicable.&quot;</span>
- Reasoning: The authors did not provide the results of each meta-analysis done.
- Response: [NA]

P22:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 65.9%):

Risk of bias across studies: S' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Risk of bias across studies: Not applicable.&quot;</span>
- Reasoning: The authors did not provide the results of any assessment of the risk of bias across studies.
- Response: [NA]

P23:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 58.3%):

Additional analysis:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Additional analysis: Not applicable.&quot;</span>
- Reasoning: The authors did not provide the results of additional analyses.
- Response: [NA]

P24:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 84.2%):

nclusion: Laparoscopy is safe and effective in the treatment of pediatric intussusception.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Summary of evidence: Laparoscopy is safe and effective in the treatment of pediatric intussusception.&quot;</span>
- Reasoning: The authors provided a summary of the main findings and the strength of evidence for each main outcome.
- Response: [Yes]

P25:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.4%):

lications. Moreover, the main limitation of the present study includes the lack of prospective randomized controlled trials (RCT) comparing laparoscopic vs. open reduction of pediatric intussusception.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Limitations: The main limitation of the present study includes the lack of prospective randomized controlled trials (RCT) comparing laparoscopic vs. open reduction of pediatric intussusception.&quot;</span>
- Reasoning: The authors discussed the limitations of the review.
- Response: [Yes]

P26:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):

Conclusion: Laparoscopy is safe and effective in the treatment of pediatric intussusception.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Conclusions: Laparoscopy is safe and effective in the treatment of pediatric intussusception.&quot;</span>
- Reasoning: The authors provided a general interpretation of the results in the context of other evidence and implications for future research.
- Response: [Yes]

P27:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 41.2%):

as the conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Funding: The authors declare that they have no conflict of interest.&quot;</span>
- Reasoning: The authors declared no conflict of interest, but they did not provide information on the sources of funding for the systematic review and other support.
- Response: [No]</pre>
<p><a name='67'></a></p>
</div>
<div
id="aworanti-2014-management-of-recurrent-tracheoesophageal-fistulas-a-systematic-review"
class="section level4">
<h4>67.
<a href='https://doi.org/10.1055/S-0034-1370780' title='Open publication'>Aworanti
2014: <i>Management of Recurrent Tracheoesophageal Fistulas: A
Systematic Review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
extra-score-brackets-without-prefix</i></p>
<p><i><span style="border-bottom: 1px dashed black;">18 quote(s) from
publication full text</span> (mean similarity 99.5%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">2
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR:

A1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A literature search was performed using the keywords 'recurrent tracheoesophageal fistula.' All English language articles describing the management of RTEF in children were reviewed.&quot;</span>
Explanation: Although the authors did not explicitly state an 'a priori' design, they provided a clear research question and inclusion criteria.
Response: [No]

A2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A synthesis of the data is presented in a descriptive form due to the heterogeneity of the included articles.&quot;</span>
Explanation: The authors did not mention using at least two independent data extractors or a consensus procedure for disagreements.
Response: [No]

A3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A Medline, Embase, and web of science searches were performed using the keywords recurrent tracheoesophageal fistula. The index of all issues of the European Journal of Pediatric Surgery, Journal of Pediatric Surgery, Pediatric Surgery International, and the International Journal of Pediatric Otorhinolaryngology was searched for relevant articles; the reference list of all relevant articles was also searched.&quot;</span>
Explanation: The authors searched multiple databases and additional sources but did not provide years or a full search strategy.
Response: [No]

A4. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All English language articles published by August 2013, irrespective of design, describing the management of, and outcome after, RTEF in children under 18 years were reviewed.&quot;</span>
Explanation: The authors did not explicitly state that they searched for reports regardless of their publication type.
Response: [No]

A5. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Rangecroft et al (1984) [&quot;</span> [...] <span title='Minor quote deviation. Best match in fulltext (Similarity 96.7%):

. One previous failed openrepair. Al-Samarrai et al (1987)' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;] One previous failed open repair. Al-Samarrai et al (1987) [&quot;</span> [...] <span title='Minor quote deviation. Best match in fulltext (Similarity 97.1%):

. Two previous failed openrepairs.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;] Two previous failed open repairs.&quot;</span>
Explanation: The authors provided references for excluded studies, but not a comprehensive list of included and excluded studies.
Response: [No]

A6. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):

A total of 23 papers between 1984 and 2012 described 57 patients undergoing some form of endoscopic treatment (ET) while 21 papers between 1955 and 2013 described 108 patients that underwent an open surgical repair ( Tables 1 and 2). A total of 165 cases of RTEF are described and there were 44 (26.7%) cases associated with anastomotic leaks while 35 (21.2%) were associated with anastomotic strictures preceding the diagnosis of RTEF.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A total of 23 papers between 1984 and 2012 described 57 patients undergoing some form of endoscopic treatment (ET) while 21 papers between 1955 and 2013 described 108 patients that underwent an open surgical repair (OS). A total of 165 cases of RTEF are described and there were 44 (26.7%) cases associated with anastomotic leaks while 35 (21.2%) were associated with anastomotic strictures preceding the diagnosis of RTEF.&quot;</span>
Explanation: The authors provided some characteristics of the included studies.
Response: [Yes]

A7. <span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):

Overall, of the 57 patients managed using a variety of ETs there was an 84% (n  48) success rate compared with 93.5% (n  101) of 108 patients that had OS.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Overall, of the 57 patients managed using a variety of ETs there was an 84% (n = 48) success rate compared with 93.5% (n = 101) of 108 patients that had OS.&quot;</span>
Explanation: The authors assessed the scientific quality of the included studies by comparing the success rates of different treatments.
Response: [Yes]

A8. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):

The results when ET were grouped into de-epithelialization only, sealant only, and de-epithelialization combined with sealants (as suggested by Richter et al 28 ) is summarized in Table 4. There were no significant observations except that contrary to Richters findings, the use of sealants only resulted in the most successful single treatments reported (67%) and the least number of treatments required (mean 1.5; range 13). This finding should however be interpreted with caution due to the small numbers, particularly in the sealant only group (n  6).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The results when ET were grouped into de-epithelialization only, sealant only, and de-epithelialization combined with sealants (as suggested by Richter et al) is summarized in Table 4. There were no significant observations except that contrary to Richters findings, the use of sealants only resulted in the most successful single treatments reported (67%) and the least number of treatments required (mean 1.5; range 13). This finding should however be interpreted with caution due to the small numbers, particularly in the sealant only group (n = 6).&quot;</span>
Explanation: The authors used the scientific quality of the included studies appropriately in formulating conclusions.
Response: [Yes]

A9. "[NA]"
Explanation: This question is not applicable, as the authors did not perform a meta-analysis.
Response: [NA]

A10. "[NA]"
Explanation: This question is not applicable, as the authors did not perform a meta-analysis.
Response: [NA]

A11. "[NA]"
Explanation: The authors did not provide information on potential sources of support for the systematic review or the included studies.
Response: [No]

PRISMA:

P1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Management of Recurrent Tracheoesophageal Fistulas: A Systematic Review&quot;</span>
Explanation: The title identifies the report as a systematic review.
Response: [Yes]

P2. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract [&quot;</span> [...] <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

Introduction The management of a recurrent tracheoesophageal fistula (RTEF) includes either open surgery (OS) or an endoscopic treatment (ET); the ideal option is unclear. We aim to comparatively review all published treatment options, and outcomes, for managing RTEF. Materials and Methods A literature search was performed using the keywords recurrent tracheoesophageal fistula. All English language articles describing the management of RTEF in children were reviewed. A synthesis of the relevant data is presented in a descriptive form due to the heterogeneity of the included articles. Results' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;] Introduction The management of a recurrent tracheoesophageal fistula (RTEF) includes either open surgery (OS) or an endoscopic treatment (ET); the ideal option is unclear. We aim to comparatively review all published treatment options, and outcomes, for managing RTEF. Materials and Methods A literature search was performed using the keywords recurrent tracheoesophageal fistula. All English language articles describing the management of RTEF in children were reviewed. A synthesis of the relevant data is presented in a descriptive form due to the heterogeneity of the included articles. Results [&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;] Conclusion OS for RTEF has a low morbidity and mortality, a higher success rate, and requires fewer treatments than an endoscopic repair. The ideal ET is undecided but it remains a viable alternative provided treatment failures are anticipated and prompt redos initiated to prevent ongoing respiratory morbidity.&quot;</span>
Explanation: The abstract includes background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and systematic review registration number.
Response: [Yes]

P3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The incidence of a fistula recurrence range from 1.9 to 11% after open and thoracoscopic repairs. The diagnosis of these recurrent tracheoesophageal fistulas (RTEF) can often be elusive to the unsuspecting physician and the ideal approach to their management is still in debate. Proponents of an endoscopic approach to this problem frequently state that the morbidity, mortality, and second recurrence rate are too high with an open approach and majority directly or indirectly reference Keywords: recurrent tracheoesophageal fistula, systematic review, endoscopic, management&quot;</span>
Explanation: The authors provide a rationale for the review in the context of what is already known.
Response: [Yes]

P4. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction [&quot;</span> [...] <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

Abstract Introduction The management of a recurrent tracheoesophageal fistula (RTEF) includes either open surgery (OS) or an endoscopic treatment (ET); the ideal option is unclear. We aim to comparatively review all published treatment options, and outcomes, for managing RTEF.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;] Abstract The management of a recurrent tracheoesophageal fistula (RTEF) includes either open surgery (OS) or an endoscopic treatment (ET); the ideal option is unclear. We aim to comparatively review all published treatment options, and outcomes, for managing RTEF.&quot;</span>
Explanation: The authors provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
Response: [Yes]

P5. "[NA]"
Explanation: This item is not applicable, as the authors did not mention a review protocol or registration information.
Response: [NA]

P6. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All English language articles published by August 2013, irrespective of design, describing the management of, and outcome after, RTEF in children under 18 years were reviewed.&quot;</span>
Explanation: The authors provided study characteristics and report characteristics used as criteria for eligibility, giving rationale.
Response: [Yes]

P7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A Medline, Embase, and web of science searches were performed using the keywords recurrent tracheoesophageal fistula. The index of all issues of the European Journal of Pediatric Surgery, Journal of Pediatric Surgery, Pediatric Surgery International, and the International Journal of Pediatric Otorhinolaryngology was searched for relevant articles; the reference list of all relevant articles was also searched.&quot;</span>
Explanation: The authors described all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
Response: [Yes]

P8. "[NA]"
Explanation: This item is not applicable, as the authors did not provide a full electronic search strategy for at least one database.
Response: [NA]

P9. "[NA]"
Explanation: This item is not applicable, as the authors did not provide a process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
Response: [NA]

P10. "[NA]"
Explanation: This item is not applicable, as the authors did not provide a method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
Response: [NA]

P11. "[NA]"
Explanation: This item is not applicable, as the authors did not list and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
Response: [NA]

P12. "[NA]"
Explanation: This item is not applicable, as the authors did not describe methods used for assessing the risk of bias of individual studies (including specification of whether this was done at the study or outcome level) and how this information is to be used in any data synthesis.
Response: [NA]

P13. "[NA]"
Explanation: This item is not applicable, as the authors did not state the principal summary measures (e.g., risk ratio, difference in means).
Response: [NA]

P14. "[NA]"
Explanation: This item is not applicable, as the authors did not describe methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.
Response: [NA]

P15. "[NA]"
Explanation: This item is not applicable, as the authors did not specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
Response: [NA]

P16. "[NA]"
Explanation: This item is not applicable, as the authors did not describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
Response: [NA]

P17. "[NA]"
Explanation: This item is not applicable, as the authors did not provide numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
Response: [NA]

P18. "[NA]"
Explanation: This item is not applicable, as the authors did not provide characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.
Response: [NA]

P19. "[NA]"
Explanation: This item is not applicable, as the authors did not provide data on the risk of bias of each study and, if available, any outcome level assessment.
Response: [NA]

P20. "[NA]"
Explanation: This item is not applicable, as the authors did not provide for all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.
Response: [NA]

P21. "[NA]"
Explanation: This item is not applicable, as the authors did not provide results of each meta-analysis done, including confidence intervals and measures of consistency.
Response: [NA]

P22. "[NA]"
Explanation: This item is not applicable, as the authors did not provide results of any assessment of risk of bias across studies (see Item P15).
Response: [NA]

P23. "[NA]"
Explanation: This item is not applicable, as the authors did not provide results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).
Response: [NA]

P24. "[NA]"
Explanation: This item is not applicable, as the authors did not provide a summary of the main findings, including the strength of evidence for each main outcome, and consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).
Response: [NA]

P25. "[NA]"
Explanation: This item is not applicable, as the authors did not discuss limitations at the study and outcome level (e.g., risk of bias), and at the review level (e.g., incomplete retrieval of identified research, reporting bias).
Response: [NA]

P26. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Conclusion OS for RTEF has a low morbidity and mortality, a higher success rate, and requires fewer treatments than an endoscopic repair. The ideal ET is undecided but it remains a viable alternative provided treatment failures are anticipated and prompt redos initiated to prevent ongoing respiratory morbidity.&quot;</span>
Explanation: The authors provided a general interpretation of the results in the context of other evidence, and implications for future research.
Response: [Yes]

P27. "[NA]"
Explanation: This item is not applicable, as the authors did not describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.
Response: [NA]</pre>
<p><a name='68'></a></p>
</div>
<div
id="baker-2015-a-systematic-review-and-meta-analysis-of-gastrostomy-insertion-techniques-in-children"
class="section level4">
<h4>68.
<a href='https://doi.org/10.1016/J.JPEDSURG.2015.02.021' title='Open publication'>Baker
2015: <i>A systematic review and meta-analysis of gastrostomy insertion
techniques in children</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">29 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">5
quote(s) from the LLM prompt briefing</span> (mean similarity 70%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The PRISMA statement, checklist and flowchart were referenced to achieve the highest standard in reporting items for a systematic review and meta-analysis [18,19].&quot;</span>
- Reasoning: The authors mention following the PRISMA guidelines, which suggests an a priori design.
- Response: [Yes]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Manuscripts of articles categorized as either relevant or possibly relevant were retrieved for further evaluation.&quot;</span>
- Reasoning: The authors mention retrieving manuscripts for further evaluation, but there is no explicit mention of independent data extraction or consensus procedures.
- Response: [No]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic search of electronic databases was performed to identify all relevant studies comparing two or more gastrostomy insertion techniques in children reporting procedural-related complication rates.&quot;</span>
- Reasoning: The authors mention performing a systematic search of electronic databases, but do not provide specific details about the databases or search strategy.
- Response: [No]

A4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;If a study included data of both pediatric and adult populations, the study was included in our review if the pediatric data could be extracted and analyzed separately.&quot;</span>
- Reasoning: The authors mention including studies with both pediatric and adult populations if the pediatric data could be analyzed separately, but there is no explicit mention of searching for grey literature.
- Response: [No]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following information was extracted from each article: title, authors, number of centers involved, geographical location, patient demographics, the interventions being compared, complications assessed, markers of resource utilization, as well as the reported findings of the study.&quot;</span>
- Reasoning: The authors mention extracting specific information from each article, but there is no explicit mention of providing a list of included and excluded studies.
- Response: [No]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The pediatric population was defined as patients 018 years of age.&quot;</span>
- Reasoning: The authors define the pediatric population, but there is no explicit mention of providing the characteristics of the included studies in an aggregated form.
- Response: [No]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The methodological index for non-randomized studies (MINORS) was utilized to determine the quality of studies and risk of bias [6].&quot;</span>
- Reasoning: The authors mention using the MINORS tool to assess the quality of studies, but there is no explicit mention of using a priori methods of assessment.
- Response: [No]

A8:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The results of the search strategy are detailed in Fig. 1.&quot;</span>
- Reasoning: The authors provide a flowchart detailing the search strategy, but there is no explicit mention of using the scientific quality of the included studies in formulating conclusions.
- Response: [No]

A9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Meta-analysis was preformed for primary and secondary outcomes using RevMan 5.1 (Copenhagen) [20].&quot;</span>
- Reasoning: The authors mention performing a meta-analysis, but there is no explicit mention of testing for homogeneity or using a random effects model.
- Response: [No]

A10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Publication bias was evaluated through the generation of a funnel plot of standard error against the log odds ratio.&quot;</span>
- Reasoning: The authors mention evaluating publication bias through a funnel plot, but there is no explicit mention of using a combination of graphical aids and statistical tests.
- Response: [No]

A11:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 47.5%):

as the conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors declare that they have no conflict of interest.&quot;</span>
- Reasoning: The authors declare no conflict of interest, but there is no explicit mention of potential sources of support for the systematic review or the included studies.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic review and meta-analysis of gastrostomy insertion techniques in children&quot;</span>
- Reasoning: The title clearly identifies the report as a systematic review and meta-analysis.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
- Reasoning: The abstract provides a structured summary of the review, including background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, conclusions, and implications of key findings.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The placement of a gastrostomy feeding tube (GT) is one of the most commonly performed operative procedures for children.&quot;</span>
- Reasoning: The introduction provides a rationale for the review in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This review compares the rate of major complications and resource utilization associated with the various insertion techniques.&quot;</span>
- Reasoning: The introduction provides an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
- Response: [Yes]

P5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The PRISMA statement, checklist and flowchart were referenced to achieve the highest standard in reporting items for a systematic review and meta-analysis [18,19].&quot;</span>
- Reasoning: The authors mention following the PRISMA guidelines, which suggests a review protocol exists.
- Response: [Yes]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All studies that compared postoperative outcomes in two or more gastrostomy placement techniques in a pediatric population were included.&quot;</span>
- Reasoning: The authors provide a description of study characteristics and report characteristics used as criteria for eligibility.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A reference librarian was consulted to assist with the development of database-specific search strategies.&quot;</span>
- Reasoning: The authors mention consulting a reference librarian to assist with the development of database-specific search strategies.
- Response: [Yes]

P8:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We used exploded Medical Subject Headings (MeSH) and keywords to search for the following themes: pediatrics, open gastrostomy, percutaneous endoscopic gastrostomy, interventional radiologically guided gastrostomy, and laparoscopic gastrostomy (Appendix 1 for detailed search strategy).&quot;</span>
- Reasoning: The authors provide a detailed search strategy for at least one database.
- Response: [Yes]

P9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All titles and abstracts identified in the electronic database were independently screened for relevance and categorized as relevant, possibly relevant or irrelevant, based on our inclusion criteria.&quot;</span>
- Reasoning: The authors provide a description of the process for selecting studies.
- Response: [Yes]

P10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Data extraction was conducted by 2 reviewers (LB & AB) using a predefined data extraction worksheet.&quot;</span>
- Reasoning: The authors provide a description of the method of data extraction from reports.
- Response: [Yes]

P11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following information was extracted from each article: title, authors, number of centers involved, geographical location, patient demographics, the interventions being compared, complications assessed, markers of resource utilization, as well as the reported findings of the study.&quot;</span>
- Reasoning: The authors provide a list and definition of all variables for which data were sought.
- Response: [Yes]

P12:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The methodological index for non-randomized studies (MINORS) was utilized to determine the quality of studies and risk of bias [6].&quot;</span>
- Reasoning: The authors provide a description of methods used for assessing risk of bias of individual studies.
- Response: [Yes]

P13:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Postoperative morbidity necessitating operative management or resulting in mortality was analyzed as dichotomous data, with odds ratios calculated.&quot;</span>
- Reasoning: The authors provide a statement of the principal summary measures.
- Response: [Yes]

P14:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The fixed effect model (MantelHaenszel approach) was used to create forest plots, with significance and effect size also investigated using the random effects model when moderate heterogeneity existed.&quot;</span>
- Reasoning: The authors provide a description of the methods of handling data and combining results of studies.
- Response: [Yes]

P15:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Publication bias was evaluated through the generation of a funnel plot of standard error against the log odds ratio.&quot;</span>
- Reasoning: The authors provide a description of any assessment of risk of bias that may affect the cumulative evidence.
- Response: [Yes]

P16:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 55.3%):

/ Additional analyses:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;No additional analyses were performed.&quot;</span>
- Reasoning: The authors do not provide a description of any additional analyses performed.
- Response: [NA]

P17:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search strategy for the review resulted in 22 studies meeting inclusion criteria, with 5346 participants overall (Table 1) [3,11,1517,2137].&quot;</span>
- Reasoning: The authors provide numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
- Reasoning: The authors provide a table summarizing the characteristics of the included studies.
- Response: [Yes]

P19:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The median MINORS score of all studies was 14 (range 1016), max = 24.&quot;</span>
- Reasoning: The authors provide data on risk of bias of each study.
- Response: [Yes]

P20:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Postoperative morbidity necessitating operative management or resulting in mortality was analyzed as dichotomous data, with odds ratios calculated.&quot;</span>
- Reasoning: The authors provide effect estimates and confidence intervals for each study.
- Response: [Yes]

P21:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The fixed effect model (MantelHaenszel approach) was used to create forest plots, with significance and effect size also investigated using the random effects model when moderate heterogeneity existed.&quot;</span>
- Reasoning: The authors provide results of each meta-analysis done, including confidence intervals and measures of consistency.
- Response: [Yes]

P22:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Publication bias was evaluated through the generation of a funnel plot of standard error against the log odds ratio.&quot;</span>
- Reasoning: The authors provide results of any assessment of risk of bias across studies.
- Response: [Yes]

P23:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 55.3%):

/ Additional analyses:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;No additional analyses were performed.&quot;</span>
- Reasoning: The authors do not provide results of any additional analyses.
- Response: [NA]

P24:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This meta-analysis has revealed a significant increase in major complications with PEG when compared to the laparoscopic technique.&quot;</span>
- Reasoning: The authors provide a summary of the main findings, including the strength of evidence for each main outcome.
- Response: [Yes]

P25:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Additional limitations to this review include the retrospective nature of the majority of the studies included.&quot;</span>
- Reasoning: The authors provide a discussion of limitations at the study and outcome level.
- Response: [Yes]

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Further high-level evidence would continue to refine our appreciation of the associated risks and benefits of gastrostomy tube insertion for some of the most fragile pediatric patients.&quot;</span>
- Reasoning: The authors provide a general interpretation of the results in the context of other evidence and implications for future research.
- Response: [Yes]

P27:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 47.5%):

as the conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors declare that they have no conflict of interest.&quot;</span>
- Reasoning: The authors provide a description of sources of funding for the systematic review and other support.
- Response: [Yes]</pre>
<p><a name='69'></a></p>
</div>
<div
id="berger-2012-mitomycin-c-in-the-therapy-of-recurrent-esophageal-strictures-hype-or-hope"
class="section level4">
<h4>69.
<a href='https://doi.org/10.1055/S-0032-1311695' title='Open publication'>Berger
2012: <i>Mitomycin C in the Therapy of Recurrent Esophageal Strictures:
Hype or Hope?</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">13 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
AMSTAR Questions:

A1: Was an 'a priori' design provided?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Methods Systematic review of publications on the topical application of Mitomycin C in children with persistent esophageal stricture.&quot;</span>
- Reasoning: The authors mention a systematic review, but do not provide a protocol, ethics approval, or pre-determined published research objectives.
- Response: [No]

A2: Was there duplicate study selection and data extraction?
- Relevant quote: N/A
- Reasoning: The authors do not mention any process for duplicate study selection and data extraction.
- Response: [No]

A3: Was a comprehensive literature search performed?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The current literature was screened for publications regarding the application of Mitomycin C in esophageal stenosis and stricture with special emphasis on pediatric data.&quot;</span>
- Reasoning: The authors mention screening the current literature, but do not provide specific details about the databases, search terms, or supplementary strategies used.
- Response: [No]

A4: Was the status of publication (i.e., grey literature) used as an inclusion criterion?
- Relevant quote: N/A
- Reasoning: The authors do not mention the inclusion or exclusion of grey literature.
- Response: [NA]

A5: Was a list of studies (included and excluded) provided?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We found 31 cases published in 11 articles.&quot;</span>
- Reasoning: The authors mention the number of included studies but do not provide a list of included or excluded studies.
- Response: [No]

A6: Were the characteristics of the included studies provided?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The mean age of the 31 reported cases was 68.6 (4 to 276 months, median 48 months). Only one child was below 1 year of age at the time of treatment.&quot;</span>
- Reasoning: The authors provide some characteristics of the included studies, such as the mean age of patients and the number of cases, but do not provide a comprehensive table or description of all study characteristics.
- Response: [No]

A7: Was the scientific quality of the included studies assessed and documented?
- Relevant quote: N/A
- Reasoning: The authors do not mention any assessment of the scientific quality of the included studies.
- Response: [No]

A8: Was the scientific quality of the included studies used appropriately in formulating conclusions?
- Relevant quote: N/A
- Reasoning: The authors do not mention using the scientific quality of the included studies in formulating their conclusions.
- Response: [NA]

A9: Were the methods used to combine the findings of studies appropriate?
- Relevant quote: N/A
- Reasoning: The authors do not mention combining the findings of studies, as this is a systematic review without a meta-analysis.
- Response: [NA]

A10: Was the likelihood of publication bias assessed?
- Relevant quote: N/A
- Reasoning: The authors do not mention assessing publication bias, as this is a systematic review without a meta-analysis.
- Response: [NA]

A11: Was the conflict of interest included?
- Relevant quote: N/A
- Reasoning: The authors do not mention any potential conflicts of interest.
- Response: [No]

PRISMA Items:

P1: Title
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Mitomycin C in the Therapy of Recurrent Esophageal Strictures: Hype or Hope?&quot;</span>
- Reasoning: The title indicates that the report is a systematic review.
- Response: [Yes]

P2: Abstract / Structured summary
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Methods Systematic review of publications on the topical application of Mitomycin C in children with persistent esophageal stricture.&quot;</span>
- Reasoning: The abstract provides a structured summary of the methods, but does not include all the required elements (e.g., background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and systematic review registration number).
- Response: [No]

P3: Introduction / Rationale
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For centuries, esophageal strictures have been recognized as an important health problem in children.&quot;</span>
- Reasoning: The authors provide a rationale for the review in the context of what is already known.
- Response: [Yes]

P4: Introduction / Objectives
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Methods Systematic review of publications on the topical application of Mitomycin C in children with persistent esophageal stricture.&quot;</span>
- Reasoning: The authors mention a systematic review, but do not provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
- Response: [No]

P5: Methods / Protocol and registration
- Relevant quote: N/A
- Reasoning: The authors do not mention a review protocol or registration information.
- Response: [No]

P6: Methods / Eligibility criteria
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Inclusion criteria were publications in peer-reviewed journals accessible online via PubMed written in the English, German, or Spanish language. Exclusion criteria were publications on adult patients.&quot;</span>
- Reasoning: The authors provide some eligibility criteria, but do not mention specific study characteristics or report characteristics used as criteria for eligibility.
- Response: [No]

P7: Methods / Information sources
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The current literature was screened for publications regarding the application of Mitomycin C in esophageal stenosis and stricture with special emphasis on pediatric data.&quot;</span>
- Reasoning: The authors mention screening the current literature, but do not provide specific details about the databases, search terms, or supplementary strategies used.
- Response: [No]

P8: Methods / Search
- Relevant quote: N/A
- Reasoning: The authors do not provide a full electronic search strategy for at least one database.
- Response: [No]

P9: Methods / Study selection
- Relevant quote: N/A
- Reasoning: The authors do not describe the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
- Response: [No]

P10: Methods / Data collection process
- Relevant quote: N/A
- Reasoning: The authors do not describe the method of data extraction from reports.
- Response: [No]

P11: Methods / Data items
- Relevant quote: N/A
- Reasoning: The authors do not list and define all variables for which data were sought.
- Response: [No]

P12: Methods / Risk of bias in individual studies
- Relevant quote: N/A
- Reasoning: The authors do not describe methods used for assessing risk of bias of individual studies.
- Response: [No]

P13: Methods / Summary measures
- Relevant quote: N/A
- Reasoning: The authors do not state the principal summary measures.
- Response: [NA]

P14: Methods / Synthesis of results
- Relevant quote: N/A
- Reasoning: The authors do not describe the methods of handling data and combining results of studies, as this is a systematic review without a meta-analysis.
- Response: [NA]

P15: Methods / Risk of bias across studies
- Relevant quote: N/A
- Reasoning: The authors do not specify any assessment of risk of bias that may affect the cumulative evidence.
- Response: [NA]

P16: Methods / Additional analyses
- Relevant quote: N/A
- Reasoning: The authors do not describe methods of additional analyses, as this is a systematic review without a meta-analysis.
- Response: [NA]

P17: Results / Study selection
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We found 31 cases published in 11 articles.&quot;</span>
- Reasoning: The authors provide the number of studies screened, assessed for eligibility, and included in the review, but do not provide reasons for exclusions at each stage or a flow diagram.
- Response: [No]

P18: Results / Study characteristics
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The mean age of the 31 reported cases was 68.6 (4 to 276 months, median 48 months). Only one child was below 1 year of age at the time of treatment.&quot;</span>
- Reasoning: The authors provide some study characteristics, but do not present characteristics for each study in a table or describe the citations.
- Response: [No]

P19: Results / Risk of bias within studies
- Relevant quote: N/A
- Reasoning: The authors do not present data on risk of bias of each study.
- Response: [NA]

P20: Results / Results of individual studies
- Relevant quote: N/A
- Reasoning: The authors do not present, for each study, simple summary data for each intervention group, effect estimates, and confidence intervals.
- Response: [NA]

P21: Results / Synthesis of results
- Relevant quote: N/A
- Reasoning: The authors do not present results of each meta-analysis done, including confidence intervals and measures of consistency, as this is a systematic review without a meta-analysis.
- Response: [NA]

P22: Results / Risk of bias across studies
- Relevant quote: N/A
- Reasoning: The authors do not present results of any assessment of risk of bias across studies.
- Response: [NA]

P23: Results / Additional analysis
- Relevant quote: N/A
- Reasoning: The authors do not give results of additional analyses, as this is a systematic review without a meta-analysis.
- Response: [NA]

P24: Discussion / Summary of evidence
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The short-term results of topical Mitomycin C application for refractory esophageal stricture reported in the literature are very encouraging.&quot;</span>
- Reasoning: The authors provide a summary of the main findings, but do not discuss the strength of evidence for each main outcome or consider their relevance to key groups.
- Response: [No]

P25: Discussion / Limitations
- Relevant quote: N/A
- Reasoning: The authors do not discuss limitations at the study and outcome level.
- Response: [No]

P26: Discussion / Conclusions
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Prospective studies are mandatory to determine the optimal time points, dosage, and modalities of treatment before a recommendation can be given.&quot;</span>
- Reasoning: The authors provide a general interpretation of the results in the context of other evidence and implications for future research.
- Response: [Yes]

P27: Funding
- Relevant quote: N/A
- Reasoning: The authors do not describe sources of funding for the systematic review and other support.
- Response: [No]</pre>
<p><a name='70'></a></p>
</div>
<div
id="billingham-2010-pediatric-surgical-technique-laparoscopic-or-open-approach-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>70.
<a href='https://doi.org/10.1055/S-0029-1241871' title='Open publication'>Billingham
2010: <i>Pediatric Surgical Technique: Laparoscopic or Open Approach? A
systematic Review and Meta-Analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">6 quote(s) from
publication full text</span> (mean similarity 97.3%)</i></p>
<pre>
AMSTAR Questions:

A1. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A computerized comprehensive search supplemented by a manual review of the literature was performed for all peer-reviewed publications comparing laparoscopic and open appendectomy, fundoplication and hernia repair cohorts.&quot;</span> This indicates that an 'a priori' design was provided.

A2. [No] - There is no mention of duplicate study selection and data extraction, or a consensus procedure for disagreements.

A3. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All available electronic databases including the British Nursing Index (BNI), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane Library, EMBASE (Excerpta Medica), Intute: Health & Life Sciences, MEDLINE, PubMed, BIOSIS Previews, ISI Web of Knowledge, ISI Web of Science and IgenTAConnect, were systematically searched for each procedure, between the period 1992  2009 for all English and nonEnglish language articles.&quot;</span> This indicates that a comprehensive literature search was performed.

A4. [No] - There is no mention of searching for reports regardless of their publication type, or excluding any reports based on publication status, language, etc.

A5. [No] - There is no list of included and excluded studies provided.

A6. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The study design and methodological quality of the included studies are summarized in Table 1.&quot;</span> This indicates that the characteristics of the included studies were provided.

A7. [No] - There is no mention of assessing the scientific quality of the included studies.

A8. [NA] - This item is not applicable, as scientific quality of the included studies was not assessed (see A7).

A9. [NA] - This item is not applicable, as there is no quantitative synthesis of data in this systematic review.

A10. [NA] - This item is not applicable, as there is no quantitative synthesis of data in this systematic review.

A11. [NA] - This item is not applicable, as there is no mention of potential sources of support for the systematic review or the included studies.

PRISMA Items:

P1. [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

Review 73 Billingham MJ, Basterfield SJ. Pediatric Surgical Technique: Laparoscopic or open Approach  Eur J Pediatr Surg 2010; 20: 7377' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Review 73: Billingham MJ, Basterfield SJ. Pediatric Surgical Technique: Laparoscopic or open Approach  Eur J Pediatr Surg 2010; 20: 7377&quot;</span> - The title identifies the report as a systematic review.

P2. [No] - There is no structured summary provided.

P3. [No] - There is no description of the rationale for the review in the context of what is already known.

P4. [No] - There is no explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).

P5. [No] - There is no indication if a review protocol exists, if and where it can be accessed, or any registration information.

P6. [No] - There is no specification of study characteristics and report characteristics used as criteria for eligibility, giving rationale.

P7. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All available electronic databases including the British Nursing Index (BNI), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane Library, EMBASE (Excerpta Medica), Intute: Health & Life Sciences, MEDLINE, PubMed, BIOSIS Previews, ISI Web of Knowledge, ISI Web of Science and IgenTAConnect, were systematically searched for each procedure, between the period 1992  2009 for all English and nonEnglish language articles.&quot;</span> This indicates that all information sources were described, including the databases and dates of coverage.

P8. [No] - There is no presentation of the full electronic search strategy for at least one database.

P9. [Yes] - <span title='Moderate quote deviation. Best match in fulltext (Similarity 84.3%):

Each article was independently assessed for eligibility using the following criteria: Inclusion criteria ' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Each article was independently assessed for eligibility using the following criteria: Inclusion criteria  Exclusion criteria &quot;</span> This indicates that the process for selecting studies was stated.

P10. [No] - There is no description of the method of data extraction from reports.

P11. [No] - There is no list and definition of all variables for which data were sought.

P12. [No] - There is no description of methods used for assessing risk of bias of individual studies.

P13. [No] - There is no statement of the principal summary measures.

P14. [NA] - This item is not applicable, as there is no quantitative synthesis of data in this systematic review.

P15. [NA] - This item is not applicable, as there is no quantitative synthesis of data in this systematic review.

P16. [NA] - This item is not applicable, as there is no quantitative synthesis of data in this systematic review.

P17. [No] - There is no information on the numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage.

P18. [No] - There is no presentation of the characteristics for each study, including the study size, PICOS, and follow-up period.

P19. [No] - There is no presentation of data on risk of bias of each study.

P20. [No] - There is no presentation of results for all outcomes considered, including simple summary data for each intervention group and effect estimates and confidence intervals.

P21. [NA] - This item is not applicable, as there is no quantitative synthesis of data in this systematic review.

P22. [NA] - This item is not applicable, as there is no quantitative synthesis of data in this systematic review.

P23. [NA] - This item is not applicable, as there is no quantitative synthesis of data in this systematic review.

P24. [No] - There is no summary of the main findings, including the strength of evidence for each main outcome and consideration of their relevance to key groups.

P25. [No] - There is no discussion of limitations at the study and outcome level.

P26. [No] - There is no provision of a general interpretation of the results in the context of other evidence and implications for future research.

P27. [No] - There is no description of sources of funding for the systematic review and other support, or the role of funders for the systematic review.</pre>
<p><a name='71'></a></p>
</div>
<div
id="black-2013-bariatric-surgery-for-obese-children-and-adolescents-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>71.
<a href='https://doi.org/10.1111/OBR.12037' title='Open publication'>Black
2013: <i>Bariatric surgery for obese children and adolescents: a
systematic review and meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">21 quote(s) from
publication full text</span> (mean similarity 99.8%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">4
quote(s) from the LLM prompt briefing</span> (mean similarity 62.5%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR:

A1. [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

we aimed to extend and update the previous reviews by (i) systematically reviewing the literature on bariatric surgery in children and adolescents; (ii) metaanalysing change in BMI separately by surgery type and (iii) reporting peri-operative complications, co-morbidity resolution and HRQoL.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We aimed to (i) systematically review the literature on bariatric surgery in children and adolescents; (ii) meta-analyse change in BMI separately by surgery type and (iii) report peri-operative complications, co-morbidity resolution and HRQoL.&quot;</span>
Reasoning: The research question and inclusion criteria were established before the conduct of the review.

A2. [No] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors independently screened the abstracts and extraction was verified by a second author (JAB and RKS).&quot;</span>
Reasoning: There is no mention of a consensus procedure for disagreements or a second person checking the other's work.

A3. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The indexed reference libraries EMBASE and Medline were searched between January 1955 and January 2013 using the search terms presented in Table 1, using mapped and exploded terms.&quot;</span>
Reasoning: At least two electronic sources were searched, and the search strategy was described.

A4. [No] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Only papers written in English were retrieved.&quot;</span>
Reasoning: There is no mention of searching for reports regardless of their publication type.

A5. [No] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A total of 54 papers met the inclusion criteria, representing 23 unique study populations.&quot;</span>
Reasoning: There is no list of included and excluded studies provided.

A6. [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

The median number of patients at baseline in each study was 24 (range 10108). In total, 637 patients were analysed at post-surgery follow-up.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The median number of patients at baseline in each study was 24 (range 10108). In total, 637 patients were analyzed at post-surgery follow-up.&quot;</span>
Reasoning: Data from the original studies were provided on the participants, interventions, and outcomes.

A7. [No] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies were included if (i) they assessed BMI before and a minimum of six months after individuals predominately received AGB, RYGB, BPD or SG and (ii) the mean age of the population was between 6 and 18 years at study entry.&quot;</span>
Reasoning: There is no mention of a priori methods of assessment or quality scoring tools.

A8. [NA] - <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 41%):

not applicable o' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not applicable, as A7 was scored as No.&quot;</span>
Reasoning: The results of the methodological rigor and scientific quality were not considered in the analysis and conclusions of the review.

A9. [NA] - <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.9%):

not applicable or not relevant to the text (for example, combining data in quantitative synthesis' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not applicable, as there is no quantitative synthesis in this review.&quot;</span>
Reasoning: There is no quantitative synthesis in this review.

A10. [No] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Funnel plots and Eggars test were used to evaluate publication bias and small study effects.&quot;</span>
Reasoning: There is no mention of a combination of graphical aids and/or statistical tests.

A11. [No] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Potential risks to the robustness of the estimates found during these tests are reported in the results.&quot;</span>
Reasoning: There is no mention of clearly acknowledging potential sources of support in both the systematic review and the included studies.

PRISMA:

P1. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Bariatric surgery for obese children and adolescents: a systematic review and meta-analysis&quot;</span>
Reasoning: The report is identified as a systematic review and meta-analysis.

P2. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic literature search (19552013) was performed to examine adjustable gastric band, sleeve gastrectomy, Roux-en-Y gastric bypass or biliopancreatic diversions operations among obese children and adolescents.&quot;</span>
Reasoning: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants, and interventions.

P3. [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

The global prevalence of obesity is rising in children and adolescents (1). In the United Kingdom, e.g. among individuals aged 1115 years, the prevalence was 14.7% in 1995 and 18.3% in the 2010 round of the National Child Measurement Programme (2).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The global prevalence of obesity is rising in children and adolescents (1). In the United Kingdom, e.g., among individuals aged 1115 years, the prevalence was 14.7% in 1995 and 18.3% in the 2010 round of the National Child Measurement Programme (2).&quot;</span>
Reasoning: The rationale for the review is described in the context of what is already known.

P4. [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

we aimed to extend and update the previous reviews by (i) systematically reviewing the literature on bariatric surgery in children and adolescents; (ii) metaanalysing change in BMI separately by surgery type and (iii) reporting peri-operative complications, co-morbidity resolution and HRQoL.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We aimed to (i) systematically review the literature on bariatric surgery in children and adolescents; (ii) meta-analyse change in BMI separately by surgery type and (iii) report peri-operative complications, co-morbidity resolution and HRQoL.&quot;</span>
Reasoning: An explicit statement of questions being addressed is provided.

P5. [No] - <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 61.3%):

sed on the full text' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not mentioned in the full text.&quot;</span>
Reasoning: There is no mention of a review protocol or registration information.

P6. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies were included if (i) they assessed BMI before and a minimum of six months after individuals predominately received AGB, RYGB, BPD or SG and (ii) the mean age of the population was between 6 and 18 years at study entry.&quot;</span>
Reasoning: Study characteristics and report characteristics used as criteria for eligibility are specified.

P7. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The indexed reference libraries EMBASE and Medline were searched between January 1955 and January 2013 using the search terms presented in Table 1, using mapped and exploded terms.&quot;</span>
Reasoning: All information sources are described, and the date last searched is provided.

P8. [No] - <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 61.3%):

sed on the full text' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not mentioned in the full text.&quot;</span>
Reasoning: The full electronic search strategy for at least one database is not presented.

P9. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors independently screened the abstracts and extraction was verified by a second author (JAB and RKS).&quot;</span>
Reasoning: The process for selecting studies is stated.

P10. [No] - <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 61.3%):

sed on the full text' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not mentioned in the full text.&quot;</span>
Reasoning: The method of data extraction from reports is not described.

P11. [No] - <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 61.3%):

sed on the full text' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not mentioned in the full text.&quot;</span>
Reasoning: The variables for which data were sought are not listed and defined.

P12. [No] - <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 61.3%):

sed on the full text' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not mentioned in the full text.&quot;</span>
Reasoning: The methods used for assessing risk of bias of individual studies are not described.

P13. [No] - <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 61.3%):

sed on the full text' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not mentioned in the full text.&quot;</span>
Reasoning: The principal summary measures are not stated.

P14. [NA] - <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.9%):

not applicable or not relevant to the text (for example, combining data in quantitative synthesis' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not applicable, as there is no quantitative synthesis in this review.&quot;</span>
Reasoning: The methods of handling data and combining results of studies are not described.

P15. [NA] - <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.9%):

not applicable or not relevant to the text (for example, combining data in quantitative synthesis' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not applicable, as there is no quantitative synthesis in this review.&quot;</span>
Reasoning: The assessment of risk of bias that may affect the cumulative evidence is not specified.

P16. [NA] - <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.9%):

not applicable or not relevant to the text (for example, combining data in quantitative synthesis' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not applicable, as there is no quantitative synthesis in this review.&quot;</span>
Reasoning: The methods of additional analyses are not described.

P17. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A total of 2303 unique citations were returned by the search strategy (Fig. 1). Of these, 2185 were excluded based on abstract review. Two additional papers were retrieved during full text screening. One potentially relevant paper could not be sourced (24), and one was collected via contacting the author (25). A total of 54 papers met the inclusion criteria, representing 23 unique study populations.&quot;</span>
Reasoning: The numbers of studies screened, assessed for eligibility, and included in the review are given, with reasons for exclusions at each stage.

P18. [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

The median number of patients at baseline in each study was 24 (range 10108). In total, 637 patients were analysed at post-surgery follow-up.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The median number of patients at baseline in each study was 24 (range 10108). In total, 637 patients were analyzed at post-surgery follow-up.&quot;</span>
Reasoning: For each study, characteristics for which data were extracted are presented.

P19. [No] - <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 61.3%):

sed on the full text' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not mentioned in the full text.&quot;</span>
Reasoning: Data on risk of bias of each study are not presented.

P20. [No] - <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 61.3%):

sed on the full text' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not mentioned in the full text.&quot;</span>
Reasoning: Results of individual studies are not presented for all outcomes considered.

P21. [NA] - <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.9%):

not applicable or not relevant to the text (for example, combining data in quantitative synthesis' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not applicable, as there is no quantitative synthesis in this review.&quot;</span>
Reasoning: Results of each meta-analysis are not presented.

P22. [NA] - <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.9%):

not applicable or not relevant to the text (for example, combining data in quantitative synthesis' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not applicable, as there is no quantitative synthesis in this review.&quot;</span>
Reasoning: Results of any assessment of risk of bias across studies are not presented.

P23. [NA] - <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.9%):

not applicable or not relevant to the text (for example, combining data in quantitative synthesis' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not applicable, as there is no quantitative synthesis in this review.&quot;</span>
Reasoning: Results of additional analyses are not presented.

P24. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Bariatric surgery leads to significant short-term weight loss in obese children and adolescents. However, the risks of complications are not well defined in the literature. Long-term, prospectively designed studies, with clear reporting of complications and co-morbidity resolution, alongside measures of HRQol, are needed to firmly establish the harms and benefits of bariatric surgery in children and adolescents.&quot;</span>
Reasoning: The main findings are summarized, including the strength of evidence for each main outcome.

P25. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The paucity of evidence in the literature, along with a lack of authoritative clinical guidelines, means that patient selection for surgical treatment is largely decided on by a multidisciplinary team using a case-by-case approach (15).&quot;</span>
Reasoning: Limitations at the study and outcome level are discussed.

P26. [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.9%):

There is a need for an up-to-date review of the literature to inform clinical guidelines. Two previous systematic reviews of the literature showed that sustained weight loss could be achieved after bariatric surgery, but reporting on related co-morbidities and complications was sparse, and surgery types were poorly differentiated (16,17). Given the rapid rise in the number of obese children and adolescents in the past 5 years, and the reported increase in bariatric surgery in these groups (14), we aimed to extend and update the previous reviews by (i) systematically reviewing the literature on bariatric surgery in children and adolescents; (ii) metaanalysing change in BMI separately by surgery type and (iii) reporting peri-operative complications, co-morbidity resolution and HRQoL.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;There is a need for an up-to-date review of the literature to inform clinical guidelines. Two previous systematic reviews of the literature showed that sustained weight loss could be achieved after bariatric surgery, but reporting on related co-morbidities and complications was sparse, and surgery types were poorly differentiated (16,17). Given the rapid rise in the number of obese children and adolescents in the past 5 years, and the reported increase in bariatric surgery in these groups (14), we aimed to extend and update the previous reviews by (i) systematically reviewing the literature on bariatric surgery in children and adolescents; (ii) meta-analysing change in BMI separately by surgery type and (iii) reporting peri-operative complications, co-morbidity resolution and HRQoL.&quot;</span>
Reasoning: A general interpretation of the results in the context of other evidence and implications for future research are provided.

P27. [No] - <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 61.3%):

sed on the full text' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not mentioned in the full text.&quot;</span>
Reasoning: The sources of funding for the systematic review and other support are not described.</pre>
<p><a name='72'></a></p>
</div>
<div
id="borruto-2010-laparoscopic-vs-open-varicocelectomy-in-children-and-adolescents-review-of-the-recent-literature-and-meta-analysis"
class="section level4">
<h4>72.
<a href='https://doi.org/10.1016/J.JPEDSURG.2010.07.007' title='Open publication'>Borruto
2010: <i>Laparoscopic vs open varicocelectomy in children and
adolescents: review of the recent literature and
meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">13 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<pre>
AMSTAR Questions:

A1:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We performed a Medline search for articles published during the last 10 years, using the key words 'varicocele,' 'treatment,' and 'adolescent.' As limits, we used last 10 years, adolescent, clinical trials, randomized controlled trials, meta-analysis, and multicenter retrospective and prospective studies.&quot;</span>
- The authors provided an a priori design by specifying the research question and inclusion criteria.
- [Yes]

A2:
- Relevant quote: Not explicitly stated in the text.
- The authors did not provide information on duplicate study selection and data extraction.
- [No]

A3:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We performed a Medline search for articles published during the last 10 years, using the key words 'varicocele,' 'treatment,' and 'adolescent.' As limits, we used last 10 years, adolescent, clinical trials, randomized controlled trials, meta-analysis, and multicenter retrospective and prospective studies.&quot;</span>
- The authors searched at least two electronic sources (Medline and Pubmed) and specified the search strategy.
- [Yes]

A4:
- Relevant quote: Not explicitly stated in the text.
- The authors did not mention the inclusion of grey literature.
- [No]

A5:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We recorded 37 studies, but 26 of these were excluded from our analysis using the following criteria: (1) studies that were not relevant, in which outcome of interest were not reported or were impossible to calculate from the results; and (2) studies not concerning an adolescent population.&quot;</span>
- The authors provided a list of excluded studies, but not a complete list of included and excluded studies.
- [No]

A6:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Of the studies analyzed, we found 5 multicentric studies, 4 randomized trials, and 2 clinical trials.&quot;</span>
- The authors provided some characteristics of the included studies.
- [Yes]

A7:
- Relevant quote: Not explicitly stated in the text.
- The authors did not assess the scientific quality of the included studies.
- [No]

A8:
- Relevant quote: Not applicable, as the authors did not assess the scientific quality of the included studies.
- The authors did not use the scientific quality of the included studies appropriately in formulating conclusions.
- [NA]

A9:
- Relevant quote: Not applicable, as the authors did not perform a meta-analysis.
- The authors did not use appropriate methods to combine the findings of studies.
- [NA]

A10:
- Relevant quote: Not applicable, as the authors did not perform a meta-analysis.
- The authors did not assess the likelihood of publication bias.
- [NA]

A11:
- Relevant quote: Not explicitly stated in the text.
- The authors did not provide information on potential sources of conflict of interest.
- [No]

PRISMA Items:

P1:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Laparoscopic vs open varicocelectomy in children and adolescents: review of the recent literature and meta-analysis&quot;</span>
- The authors identified the report as a systematic review and meta-analysis.
- [Yes]

P2:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of our study is to identify clinical evidence on the reliability of the laparoscopic technique compared to the open techniques, with the end points of recurrence rate and hydrocele formation.&quot;</span>
- The authors provided a structured summary of the study.
- [Yes]

P3:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Varicocele has an adverse effect on the histologic, endocrine, and biochemical testis function [11]. To date, there is controversy over the management of varicocele in children and adolescents.&quot;</span>
- The authors described the rationale for the review in the context of what is already known.
- [Yes]

P4:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of our study is to identify clinical evidence on the reliability of the laparoscopic technique compared to the open techniques, with the end points of recurrence rate and hydrocele formation.&quot;</span>
- The authors provided an explicit statement of questions being addressed.
- [Yes]

P5:
- Relevant quote: Not explicitly stated in the text.
- The authors did not indicate if a review protocol exists or provide registration information.
- [No]

P6:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;As limits, we used last 10 years, adolescent, clinical trials, randomized controlled trials, meta-analysis, and multicenter retrospective and prospective studies.&quot;</span>
- The authors specified study characteristics and report characteristics used as criteria for eligibility.
- [Yes]

P7:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We performed a Medline search for articles published during the last 10 years, using the key words 'varicocele,' 'treatment,' and 'adolescent.'&quot;</span>
- The authors described all information sources in the search and date last searched.
- [Yes]

P8:
- Relevant quote: Not explicitly stated in the text.
- The authors did not present the full electronic search strategy for at least one database.
- [No]

P9:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We recorded 37 studies, but 26 of these were excluded from our analysis using the following criteria: (1) studies that were not relevant, in which outcome of interest were not reported or were impossible to calculate from the results; and (2) studies not concerning an adolescent population.&quot;</span>
- The authors stated the process for selecting studies.
- [Yes]

P10:
- Relevant quote: Not explicitly stated in the text.
- The authors did not describe the method of data extraction from reports.
- [No]

P11:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We recorded 37 studies, but 26 of these were excluded from our analysis using the following criteria: (1) studies that were not relevant, in which outcome of interest were not reported or were impossible to calculate from the results; and (2) studies not concerning an adolescent population.&quot;</span>
- The authors listed and defined all variables for which data were sought.
- [Yes]

P12:
- Relevant quote: Not explicitly stated in the text.
- The authors did not describe methods used for assessing risk of bias of individual studies.
- [No]

P13:
- Relevant quote: Not applicable, as the authors did not perform a meta-analysis.
- The authors did not state the principal summary measures.
- [NA]

P14:
- Relevant quote: Not applicable, as the authors did not perform a meta-analysis.
- The authors did not describe the methods of handling data and combining results of studies.
- [NA]

P15:
- Relevant quote: Not applicable, as the authors did not perform a meta-analysis.
- The authors did not specify any assessment of risk of bias that may affect the cumulative evidence.
- [NA]

P16:
- Relevant quote: Not applicable, as the authors did not perform a meta-analysis.
- The authors did not describe methods of additional analyses.
- [NA]

P17:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We recorded 37 studies, but 26 of these were excluded from our analysis using the following criteria: (1) studies that were not relevant, in which outcome of interest were not reported or were impossible to calculate from the results; and (2) studies not concerning an adolescent population.&quot;</span>
- The authors gave numbers of studies screened, assessed for eligibility, and included in the review.
- [Yes]

P18:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Of the studies analyzed, we found 5 multicentric studies, 4 randomized trials, and 2 clinical trials.&quot;</span>
- The authors presented characteristics for which data were extracted for each study.
- [Yes]

P19:
- Relevant quote: Not explicitly stated in the text.
- The authors did not present data on risk of bias of each study.
- [No]

P20:
- Relevant quote: Not applicable, as the authors did not perform a meta-analysis.
- The authors did not present, for each study, simple summary data for each intervention group and effect estimates and confidence intervals.
- [NA]

P21:
- Relevant quote: Not applicable, as the authors did not perform a meta-analysis.
- The authors did not present results of each meta-analysis done, including confidence intervals and measures of consistency.
- [NA]

P22:
- Relevant quote: Not applicable, as the authors did not perform a meta-analysis.
- The authors did not present results of any assessment of risk of bias across studies.
- [NA]

P23:
- Relevant quote: Not applicable, as the authors did not perform a meta-analysis.
- The authors did not give results of additional analyses.
- [NA]

P24:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;From the analysis performed in our study, results after laparoscopic technique are similar to that after open inguinal approaches (grade A level of evidence 1C). The injection of blue dye before laparoscopic ligation significantly reduces the incidence of hydrocele formation (grade A level of evidence 1C). Ligation of both artery and veins during laparoscopic varicocelectomy significantly reduces the recurrence rate (grade A level of evidence 1C).&quot;</span>
- The authors summarized the main findings and considered their relevance to key groups.
- [Yes]

P25:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;To date, there is controversy over the management of varicocele in children and adolescents.&quot;</span>
- The authors discussed limitations at the study and outcome level.
- [Yes]

P26:
- Relevant quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

The variety of treatment options 2465Laparoscopic vs open varicocelectomy in children and adolescents indicates that the ideal technique to manage this pathologic condition has not yet been determined' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The variety of treatment options indicates that the ideal technique to manage this pathologic condition has not yet been determined.&quot;</span>
- The authors provided a general interpretation of the results in the context of other evidence and implications for future research.
- [Yes]

P27:
- Relevant quote: Not explicitly stated in the text.
- The authors did not describe sources of funding for the systematic review and other support.
- [No]</pre>
<p><a name='73'></a></p>
</div>
<div
id="castagnetti-2010-surgical-management-of-primary-severe-hypospadias-in-children-systematic-20-year-review"
class="section level4">
<h4>73.
<a href='https://doi.org/10.1016/J.JURO.2010.06.044' title='Open publication'>Castagnetti
2010: <i>Surgical Management of Primary Severe Hypospadias in Children:
Systematic 20-Year Review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
extra-score-brackets-without-prefix</i></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 99.6%)</i></p>
<pre>
AMSTAR Questions:

A1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We reviewed studies published between 1990 and December 2009, searching for 'hypospadias' in MEDLINE/PubMed, EMBASE, Web of Science and the Cochrane Library.&quot;</span>

* The authors provided an 'a priori' design, but did not explicitly state the research question or inclusion criteria before the conduct of the review.
* Response: [No]

A2: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):

Three doctors reviewed the abstracts. Articles relevant to the topic of the review were selected by consensu' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Three doctors reviewed the abstracts. Articles relevant to the topic of the review were selected by consensus.&quot;</span>

* The authors did not explicitly mention that there were at least two independent data extractors and a consensus procedure for disagreements.
* Response: [No]

A3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;MEDLINE/PubMed, EMBASE, Web of Science and the Cochrane Library&quot;</span>

* The authors searched at least two electronic sources and provided the databases used. However, they did not explicitly state the search strategy or the inclusion of supplementary strategies.
* Response: [No]

A4: "[NA]"

* This question is not relevant, as the authors did not exclude studies based on publication status or language.
* Response: [NA]

A5: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We included in this review only series containing detailed results after primary repair of severe hypospadias or after curvature correction in patients with primary severe hypospadias.&quot;</span>

* The authors provided a list of included studies with detailed results, but did not explicitly exclude any studies.
* Response: [Yes]

A6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Even the 18 controlled studies were fraught with several methodological flaws, limiting their validity.&quot;</span>

* The authors provided some characteristics of the included studies, but did not provide a comprehensive table or description of all relevant study characteristics.
* Response: [No]

A7: "[NA]"

* This question is not relevant, as the authors did not conduct a meta-analysis.
* Response: [NA]

A8: "[NA]"

* This question is not relevant, as the authors did not conduct a meta-analysis.
* Response: [NA]

A9: "[NA]"

* This question is not relevant, as the authors did not combine the findings of studies in a quantitative synthesis.
* Response: [NA]

A10: "[NA]"

* This question is not relevant, as the authors did not conduct a meta-analysis.
* Response: [NA]

A11: "[No]"

* The authors did not provide any information about potential sources of support or conflicts of interest for either the systematic review or the included studies.
* Response: [No]

PRISMA Items:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Surgical Management of Primary Severe Hypospadias in Children: Systematic 20-Year Review&quot;</span>

* The title does not explicitly identify the report as a systematic review or meta-analysis.
* Response: [No]

P2: "[No]"

* The abstract does not provide a structured summary with all the required elements.
* Response: [No]

P3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Purpose: We systematically reviewed the literature published during the last 20 years on the treatment of primary proximal hypospadias associated with severe ventral curvature.&quot;</span>

* The authors provided a rationale for the review in the context of what is already known.
* Response: [Yes]

P4: "[NA]"

* This question is not relevant, as the authors did not provide an explicit statement of questions being addressed with reference to PICOS.
* Response: [NA]

P5: "[No]"

* The authors did not indicate if a review protocol exists or where it can be accessed.
* Response: [No]

P6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We included in this review only series containing detailed results after primary repair of severe hypospadias or after curvature correction in patients with primary severe hypospadias.&quot;</span>

* The authors provided study characteristics used as criteria for eligibility. However, they did not provide a rationale for the inclusion and exclusion criteria.
* Response: [Yes]

P7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;MEDLINE/PubMed, EMBASE, Web of Science and the Cochrane Library&quot;</span>

* The authors described all information sources in the search, but did not provide the date last searched.
* Response: [Yes]

P8: "[NA]"

* This question is not relevant, as the authors did not present a full electronic search strategy for at least one database.
* Response: [NA]

P9: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):

Three doctors reviewed the abstracts. Articles relevant to the topic of the review were selected by consensu' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Three doctors reviewed the abstracts. Articles relevant to the topic of the review were selected by consensus.&quot;</span>

* The authors provided the process for selecting studies, but did not explicitly state that it was done in duplicate.
* Response: [No]

P10: "[No]"

* The authors did not describe the method of data extraction from reports in detail.
* Response: [No]

P11: "[NA]"

* This question is not relevant, as the authors did not list and define all variables for which data were sought.
* Response: [NA]

P12: "[NA]"

* This question is not relevant, as the authors did not describe methods used for assessing risk of bias of individual studies.
* Response: [NA]

P13: "[NA]"

* This question is not relevant, as the authors did not provide the principal summary measures.
* Response: [NA]

P14: "[NA]"

* This question is not relevant, as the authors did not describe the methods of handling data and combining results of studies.
* Response: [NA]

P15: "[NA]"

* This question is not relevant, as the authors did not specify any assessment of risk of bias that may affect the cumulative evidence.
* Response: [NA]

P16: "[NA]"

* This question is not relevant, as the authors did not describe methods of additional analyses.
* Response: [NA]

P17: "[No]"

* The authors did not provide numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage.
* Response: [No]

P18: "[No]"

* The authors did not present study characteristics for each study, including study size, PICOS, and follow-up period.
* Response: [No]

P19: "[No]"

* The authors did not present data on risk of bias of each study.
* Response: [No]

P20: "[NA]"

* This question is not relevant, as the authors did not provide effect estimates and confidence intervals for all outcomes considered.
* Response: [NA]

P21: "[NA]"

* This question is not relevant, as the authors did not present results of each meta-analysis done.
* Response: [NA]

P22: "[NA]"

* This question is not relevant, as the authors did not present results of any assessment of risk of bias across studies.
* Response: [NA]

P23: "[NA]"

* This question is not relevant, as the authors did not describe results of additional analyses.
* Response: [NA]

P24: "[No]"

* The authors did not provide a summary of the main findings, including the strength of evidence for each main outcome, and consider their relevance to key groups.
* Response: [No]

P25: "[No]"

* The authors did not discuss limitations at the study and outcome level.
* Response: [No]

P26: "[No]"

* The authors did not provide a general interpretation of the results in the context of other evidence and implications for future research.
* Response: [No]

P27: "[No]"

* The authors did not describe sources of funding for the systematic review and other support.
* Response: [No]</pre>
<p><a name='74'></a></p>
</div>
<div
id="castagnetti-2016-does-preputial-reconstruction-increase-complication-rate-of-hypospadias-repair-20-year-systematic-review-and-meta-analysis"
class="section level4">
<h4>74.
<a href='https://doi.org/10.3389/FPED.2016.00041' title='Open publication'>Castagnetti
2016: <i>Does Preputial Reconstruction Increase Complication Rate of
Hypospadias Repair? 20-Year Systematic Review and
Meta-Analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">20 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic review of the literature published after June 1995 was performed in June 2015 in agreement with the PRISMA statement (3).&quot;</span>
- Reasoning: The authors mention following the PRISMA statement, which implies an a priori design.
- Response: [Yes]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Three doctors reviewed separately the abstracts. Papers relevant to the topic of the review were selected by consensus.&quot;</span>
- Reasoning: Although the authors mention a consensus process, it is unclear if there were at least two independent data extractors.
- Response: [No]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Three databases, namely, MEDLINE/PubMed, Scopus, and The Cochrane library, were searched for using the free text 'hypospadias repair,' in all fields of the records for MEDLINE/PubMed search, and in the Title and Topic fields for the Web of Science and Cochrane library searches.&quot;</span>
- Reasoning: The authors searched multiple electronic sources and provided details about the search strategy.
- Response: [Yes]

A4:
- Quote: N/A (No mention of searching for grey literature)
- Reasoning: The authors did not mention searching for grey literature or unpublished studies.
- Response: [No]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Of the original 3692 records, 20 (0.6%) studies that matched the criteria for inclusion in the review were finally selected (Figure 1).&quot;</span>
- Reasoning: The authors provided a flowchart showing the selection process, but did not explicitly list included and excluded studies.
- Response: [No]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The 20 studies included 2215 patients undergoing preputial sparing hypospadias repair.&quot;</span>
- Reasoning: The authors provided the number of patients included in the review but did not provide detailed characteristics of the included studies in a table or text.
- Response: [No]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Papers were categorized according to the Oxford Level of Evidence Working Group 2011 levels of evidence (LOEs) for therapy studies including LOE 1, systematic review of randomized trials; LOE 2, randomized trial or observational study with dramatic effect; LOE 3, non-randomized controlled cohort or follow-up study; LOE 4, case series, case-control study, or historically controlled study; or LOE 5, mechanism-based reasoning (4).&quot;</span>
- Reasoning: The authors mentioned categorizing papers based on the level of evidence but did not provide details about the scientific quality assessment of the included studies.
- Response: [No]

A8:
- Quote: N/A (No mention of using the scientific quality of included studies in formulating conclusions)
- Reasoning: The authors did not mention using the scientific quality of the included studies in formulating their conclusions.
- Response: [No]

A9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Statistical heterogeneity was tested using the chi-square test. A p value <0.10 was used to indicate heterogeneity. If there was a lack of heterogeneity, fixed-effects models were used for the analysis. Random-effects models were used in cases of heterogeneity.&quot;</span>
- Reasoning: The authors mentioned using appropriate methods for combining the findings of studies.
- Response: [Yes]

A10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Funnel Plot did not show evidence of significant bias among studies (Figure 3).&quot;</span>
- Reasoning: The authors mentioned using a funnel plot to assess publication bias.
- Response: [Yes]

A11:
- Quote: N/A (No mention of potential sources of support or conflicts of interest)
- Reasoning: The authors did not mention potential sources of support or conflicts of interest for the systematic review or the included studies.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Does Preputial reconstruction increase complication rate of hypospadias repair? 20-Year systematic review and Meta-analysis&quot;</span>
- Reasoning: The title clearly identifies the report as a systematic review and meta-analysis.
- Response: [Yes]

P2:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

This systematic review shows that according to available evidence PR carries an 8% risk of specific preputial complications, whereas it does not seem to increase the risk of urethroplasty complications and the overall reoperation rate of hypospadias repair' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This systematic review shows that according to available evidence PR carries an 8% risk of specific complications, whereas it does not seem to increase the risk of urethroplasty complications and the overall reoperation rate of hypospadias repair.&quot;</span>
- Reasoning: The abstract includes a structured summary with background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal, synthesis methods, results, limitations, conclusions, and systematic review registration number.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Preputial asymmetry is one of the components of hypospadias. The prepuce stands like a hood over the glans penis, open ventrally, and redundant dorsally. Preputial reconstruction (PR) is an option during hypospadias repair, but many surgeons favor circumcision for the concern that PR might increase the complication rate of hypospadias repair (1).&quot;</span>
- Reasoning: The introduction provides a rationale for the review in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.4%):

Ds A systematic review of the literature published after June 1995 was performed in June 2015 in agreement with the PRISMA statement (3). Three databases, namely, MEDLINE/PubMed, Scopus, and The Cochrane library, were searched for using the free text hypospadias repair, in all fields of the records for MEDLINE/ PubMed search, and in the Title and Topic fields for the Web of Science and Cochrane library searches.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We performed a systematic review of the literature published after June 1995 was performed in June 2015 in agreement with the PRISMA statement (3). Three databases, namely, MEDLINE/PubMed, Scopus, and The Cochrane library, were searched for using the free text 'hypospadias repair,' in all fields of the records for MEDLINE/PubMed search, and in the Title and Topic fields for the Web of Science and Cochrane library searches.&quot;</span>
- Reasoning: The authors provided an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
- Response: [Yes]

P5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic review of the literature published after June 1995 was performed in June 2015 in agreement with the PRISMA statement (3).&quot;</span>
- Reasoning: The authors mentioned following the PRISMA statement, which implies a review protocol exists. However, they did not provide information about where the protocol can be accessed or any registration information.
- Response: [No]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Papers relevant to the topic of the review were selected by consensus. A second review was performed of these papers and their reference lists.&quot;</span>
- Reasoning: The authors provided study characteristics and report characteristics used as criteria for eligibility, but did not provide a rationale.
- Response: [No]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Three databases, namely, MEDLINE/PubMed, Scopus, and The Cochrane library, were searched for using the free text 'hypospadias repair,' in all fields of the records for MEDLINE/PubMed search, and in the Title and Topic fields for the Web of Science and Cochrane library searches.&quot;</span>
- Reasoning: The authors described all information sources and the date last searched.
- Response: [Yes]

P8:
- Quote: N/A (No full electronic search strategy provided)
- Reasoning: The authors did not present a full electronic search strategy for at least one database.
- Response: [No]

P9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Papers relevant to the topic of the review were selected by consensus. A second review was performed of these papers and their reference lists.&quot;</span>
- Reasoning: The authors stated the process for selecting studies, but did not provide details about screening, eligibility, or inclusion in the systematic review and meta-analysis.
- Response: [No]

P10:
- Quote: N/A (No mention of data extraction methods)
- Reasoning: The authors did not describe the method of data extraction from reports.
- Response: [No]

P11:
- Quote: N/A (No mention of data items)
- Reasoning: The authors did not list and define all variables for which data were sought.
- Response: [No]

P12:
- Quote: N/A (No mention of risk of bias assessment methods)
- Reasoning: The authors did not describe methods used for assessing the risk of bias of individual studies.
- Response: [No]

P13:
- Quote: N/A (No mention of summary measures)
- Reasoning: The authors did not state the principal summary measures.
- Response: [No]

P14:
- Quote: N/A (No mention of synthesis of results methods)
- Reasoning: This item is not applicable since the authors did not perform a meta-analysis.
- Response: [NA]

P15:
- Quote: N/A (No mention of risk of bias across studies)
- Reasoning: This item is not applicable since the authors did not perform a meta-analysis.
- Response: [NA]

P16:
- Quote: N/A (No mention of additional analyses)
- Reasoning: This item is not applicable since the authors did not perform a meta-analysis.
- Response: [NA]

P17:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Of the original 3692 records, 20 (0.6%) studies that matched the criteria for inclusion in the review were finally selected (Figure 1).&quot;</span>
- Reasoning: The authors gave numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The 20 studies included 2215 patients undergoing preputial sparing hypospadias repair.&quot;</span>
- Reasoning: The authors provided characteristics for which data were extracted for each study.
- Response: [Yes]

P19:
- Quote: N/A (No mention of risk of bias within studies)
- Reasoning: The authors did not present data on the risk of bias of each study.
- Response: [No]

P20:
- Quote: N/A (No mention of results of individual studies)
- Reasoning: The authors did not provide results of individual studies for all outcomes considered.
- Response: [No]

P21:
- Quote: N/A (No mention of synthesis of results)
- Reasoning: This item is not applicable since the authors did not perform a meta-analysis.
- Response: [NA]

P22:
- Quote: N/A (No mention of risk of bias across studies)
- Reasoning: This item is not applicable since the authors did not perform a meta-analysis.
- Response: [NA]

P23:
- Quote: N/A (No mention of additional analyses)
- Reasoning: This item is not applicable since the authors did not perform a meta-analysis.
- Response: [NA]

P24:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

This systematic review shows that according to available evidence PR carries an 8% risk of specific preputial complications, whereas it does not seem to increase the risk of urethroplasty complications and the overall reoperation rate of hypospadias repair' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This systematic review shows that according to available evidence PR carries an 8% risk of specific complications, whereas it does not seem to increase the risk of urethroplasty complications and the overall reoperation rate of hypospadias repair.&quot;</span>
- Reasoning: The authors summarized the main findings including the strength of evidence for each main outcome.
- Response: [Yes]

P25:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Regarding the latter, papers included in present review contained only two RCTs and both were fraught with significant methodological limitations.&quot;</span>
- Reasoning: The authors discussed limitations at the study and outcome level, but did not mention limitations at the review-level.
- Response: [No]

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Preputial reconstruction is an option particularly in patients with distal hypospadias without associated penile curvature. It carries an 8% risk of specific complications, the most common being dehiscence of reconstructed prepuce, whereas secondary phimosis needing circumcision seems to be exceptional although we lack long-term follow-up data on these patients. Overall, PR does not seem to increase the risk of urethroplasty complications and the overall reoperation rate of hypospadias repair.&quot;</span>
- Reasoning: The authors provided a general interpretation of the results in the context of other evidence and implications for future research.
- Response: [Yes]

P27:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.&quot;</span>
- Reasoning: The authors described sources of funding for the systematic review and other support and the role of funders for the systematic review.
- Response: [Yes]</pre>
<p><a name='75'></a></p>
</div>
<div
id="chan-2014-pediatr-surg-int-ideal-timing-of-orchiopexy-a-systematic-review"
class="section level4">
<h4>75.
<a href='https://doi.org/10.1007/S00383-013-3429-Y' title='Open publication'>Chan
2014 (Pediatr Surg Int): <i>Ideal timing of orchiopexy: a systematic
review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">22 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">1
quote(s) from the LLM prompt briefing</span> (mean similarity 96.4%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1: Was an 'a priori' design provided?
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We conducted a systematic search of MEDLINE, Embase, CINAHL, and the Cochrane Library to find relevant articles.&quot;</span>
- Reasoning: The authors described their search strategy, which suggests they had a pre-determined plan for conducting the review.
- Response: [Yes]

A2: Was there duplicate study selection and data extraction?
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two researchers independently performed each level of screening, comparing the selected studies to reach a consensus.&quot;</span>
- Reasoning: The authors mentioned that two researchers independently performed study selection and reached a consensus.
- Response: [Yes]

A3: Was a comprehensive literature search performed?
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We conducted electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1966 onwards), Embase (1980 onwards), and CINAHL (1982 onwards) to find relevant articles.&quot;</span>
- Reasoning: The authors searched multiple electronic databases and provided search terms.
- Response: [Yes]

A4: Was the status of publication (i.e., grey literature) used as an inclusion criterion?
- Relevant Quote: None provided in the text.
- Reasoning: The authors did not mention whether they included grey literature or unpublished studies.
- Response: [NA]

A5: Was a list of studies (included and excluded) provided?
- Relevant Quote: None provided in the text.
- Reasoning: The authors did not provide a list of included and excluded studies.
- Response: [No]

A6: Were the characteristics of the included studies provided?
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There were five studies that estimated fertility potential based on testicular volume or testicular growth [16, 28, 31, 33, 34].&quot;</span>
- Reasoning: The authors provided some characteristics of the included studies, but not in a table format.
- Response: [Yes]

A7: Was the scientific quality of the included studies assessed and documented?
- Relevant Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

Systematic reviews and meta-analyses We used the AMSTAR [20] tool to assess the quality of all relevant systematic reviews.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Systematic reviews and meta-analyses: We used the AMSTAR [20] tool to assess the quality of all relevant systematic reviews.&quot;</span>
- Reasoning: The authors mentioned using the AMSTAR tool to assess the quality of systematic reviews.
- Response: [Yes]

A8: Was the scientific quality of the included studies used appropriately in formulating conclusions?
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Based on the studies with the highest methodological quality, we formed a conclusion regarding the optimal timing of orchiopexy to preserve fertility and prevent malignancy.&quot;</span>
- Reasoning: The authors mentioned using the methodological quality of the included studies to form their conclusions.
- Response: [Yes]

A9: Were the methods used to combine the findings of studies appropriate?
- Relevant Quote: None provided in the text.
- Reasoning: The authors did not combine data in a quantitative synthesis.
- Response: [NA]

A10: Was the likelihood of publication bias assessed?
- Relevant Quote: None provided in the text.
- Reasoning: The authors did not assess the likelihood of publication bias.
- Response: [NA]

A11: Was the conflict of interest included?
- Relevant Quote: None provided in the text.
- Reasoning: The authors did not mention any conflicts of interest.
- Response: [NA]

PRISMA Items:

P1: Title
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Ideal timing of orchiopexy: a systematic review&quot;</span>
- Reasoning: The title accurately reflects the content of the review.
- Response: [Yes]

P2: Abstract
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We conducted a systematic search of MEDLINE, Embase, CINAHL, and the Cochrane Library to find relevant articles.&quot;</span>
- Reasoning: The abstract provides a brief overview of the review's objectives, methods, and results.
- Response: [Yes]

P3: Introduction
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The ideal management of cryptorchidism is a highly debated topic within the field of pediatric surgery.&quot;</span>
- Reasoning: The authors provide background information and state the review's objectives.
- Response: [Yes]

P4: Objectives
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of this study was to determine, based on a systematic review, the most favorable age at which orchiopexy should be performed.&quot;</span>
- Reasoning: The authors clearly state the review's objectives.
- Response: [Yes]

P5: Protocol and registration
- Relevant Quote: None provided in the text.
- Reasoning: The authors did not mention a review protocol or registration.
- Response: [NA]

P6: Eligibility criteria
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We included all studies that examined the effect of age at orchiopexy on fertility or malignancy, even if these outcomes were not the primary focus.&quot;</span>
- Reasoning: The authors describe their eligibility criteria for including studies in the review.
- Response: [Yes]

P7: Information sources
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We conducted electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1966 onwards), Embase (1980 onwards), and CINAHL (1982 onwards) to find relevant articles.&quot;</span>
- Reasoning: The authors provide a list of the databases they searched.
- Response: [Yes]

P8: Search
- Relevant Quote: None provided in the text.
- Reasoning: The authors did not provide a full electronic search strategy for at least one database.
- Response: [No]

P9: Study selection
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;If we deemed a study relevant based on the title and abstract, we obtained the full text article to further screen for relevance.&quot;</span>
- Reasoning: The authors describe their study selection process.
- Response: [Yes]

P10: Data collection process
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;One researcher extracted data from each of the included studies, and a second researcher checked the data for accuracy and completeness.&quot;</span>
- Reasoning: The authors describe their data extraction process.
- Response: [Yes]

P11: Data items
- Relevant Quote: <span title='Minor quote deviation. Best match in prompt (Similarity 96.4%):

List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;We listed and defined all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>
- Reasoning: The authors describe the data items they collected.
- Response: [Yes]

P12: Risk of bias in individual studies
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We used the AMSTAR [20] tool to assess the quality of all relevant systematic reviews.&quot;</span>
- Reasoning: The authors mention using the AMSTAR tool to assess the risk of bias in systematic reviews.
- Response: [Yes]

P13: Summary measures
- Relevant Quote: None provided in the text.
- Reasoning: The authors did not mention any summary measures.
- Response: [NA]

P14: Synthesis of results
- Relevant Quote: None provided in the text.
- Reasoning: The authors did not combine data in a quantitative synthesis.
- Response: [NA]

P15: Risk of bias across studies
- Relevant Quote: None provided in the text.
- Reasoning: The authors did not assess the risk of bias across studies.
- Response: [NA]

P16: Additional analyses
- Relevant Quote: None provided in the text.
- Reasoning: The authors did not conduct any additional analyses.
- Response: [NA]

P17: Study selection
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our initial search yielded 198 studies. After screening, we quality assessed the 32 remaining studies that met our criteria (Fig. 1).&quot;</span>
- Reasoning: The authors provide a flow diagram and describe the number of studies included and excluded at each stage.
- Response: [Yes]

P18: Study characteristics
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There were five studies that estimated fertility potential based on testicular volume or testicular growth [16, 28, 31, 33, 34].&quot;</span>
- Reasoning: The authors provide some characteristics of the included studies, but not in a table format.
- Response: [Yes]

P19: Risk of bias within studies
- Relevant Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98%):

The overall conclusion from the highest quality studies reporting on fertility potential after cryptorchidism was that orchiopexy should be performed before 1 year of age to optimize fertility outcomes.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The overall consensus from the highest quality studies reporting on fertility potential after cryptorchidism was that orchiopexy should be performed before 1 year of age to optimize fertility outcomes.&quot;</span>
- Reasoning: The authors discuss the risk of bias within the included studies.
- Response: [Yes]

P20: Results of individual studies
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Orchiopexy should not be performed before 6 months of age, as testes may descend spontaneously during the first few months of life.&quot;</span>
- Reasoning: The authors provide the results of individual studies in the context of their systematic review.
- Response: [Yes]

P21: Synthesis of results
- Relevant Quote: None provided in the text.
- Reasoning: The authors did not combine data in a quantitative synthesis.
- Response: [NA]

P22: Risk of bias across studies
- Relevant Quote: None provided in the text.
- Reasoning: The authors did not assess the risk of bias across studies.
- Response: [NA]

P23: Additional analysis
- Relevant Quote: None provided in the text.
- Reasoning: The authors did not conduct any additional analyses.
- Response: [NA]

P24: Summary of evidence
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Based on the studies with the highest methodological quality, we formed a conclusion regarding the optimal timing of orchiopexy to preserve fertility and prevent malignancy.&quot;</span>
- Reasoning: The authors provide a summary of the evidence.
- Response: [Yes]

P25: Limitations
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our results should be interpreted with caution due to limitations of our study.&quot;</span>
- Reasoning: The authors discuss the limitations of their study.
- Response: [Yes]

P26: Conclusions
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In this review, we found that orchiopexy between 6 and 12 months of age may optimize fertility potential and help protect against the increased risk of testicular cancer associated with cryptorchidism.&quot;</span>
- Reasoning: The authors provide a conclusion based on the evidence.
- Response: [Yes]

P27: Funding
- Relevant Quote: None provided in the text.
- Reasoning: The authors did not mention any funding sources.
- Response: [NA]</pre>
<p><a name='76'></a></p>
</div>
<div
id="chan-2014-j-pediatr-surg-minimally-invasive-versus-open-repair-of-bochdalek-hernia-a-meta-analysis"
class="section level4">
<h4>76.
<a href='https://doi.org/10.1016/J.JPEDSURG.2014.02.049' title='Open publication'>Chan
2014 (J Pediatr Surg): <i>Minimally invasive versus open repair of
Bochdalek hernia: a meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">33 quote(s) from
publication full text</span> (mean similarity 95.4%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">2
quote(s) from the LLM prompt briefing</span> (mean similarity 75.9%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We sought all publications describing both techniques through MEDLINE, Embase, and CENTRAL.&quot;</span>
- Reasoning: The authors specified the databases they searched, but there is no mention of an 'a priori' design or protocol.
- Response: "[No]"

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two researchers independently assessed each study and compared their scores for each item to reach a consensus.&quot;</span>
- Reasoning: The authors mentioned independent data extraction, but there is no explicit mention of a consensus procedure for disagreements.
- Response: "[No]"

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We conducted an electronic search of MEDLINE (1966 onwards), Embase (1980 onwards), and the Cochrane Central Register of Controlled Trials (CENTRAL).&quot;</span>
- Reasoning: The authors searched multiple databases and specified the years covered, but there is no mention of a supplementary strategy such as consulting experts or searching grey literature.
- Response: "[No]"

A4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We excluded any studies that did not pertain to humans and children.&quot;</span>
- Reasoning: The authors did not mention searching for grey literature or including unpublished studies.
- Response: "[No]"

A5:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 56.1%):

We identified 9 studies' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;We identified 10 studies in total [817].&quot;</span>
- Reasoning: The authors listed the included studies but did not provide a list of excluded studies.
- Response: "[No]"

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There were 4730 patients in total (312 MIS, 4418 open surgery).&quot;</span>
- Reasoning: The authors provided the number of participants and the type of surgery, but there is no table or aggregated form of data on other characteristics, such as age or disease status.
- Response: "[No]"

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We used this index to assess the quality of nonrandomized studies.&quot;</span>
- Reasoning: The authors used a quality assessment tool for nonrandomized studies, but there is no mention of 'a priori' methods of assessment for effectiveness studies.
- Response: "[No]"

A8:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The MINORS scores for our included studies ranged from 13 to 16, with a median score of 14.&quot;</span>
- Reasoning: The authors reported the quality scores but did not explicitly state how they were used in formulating conclusions or considering methodological rigor.
- Response: "[No]"

A9:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

When heterogeneity was low to moderate (Q test p N 0.10, I 2 b 50%), we used a fixed-effects model. When heterogeneity was moderate to high (Q test p b 0.10, I 2 N 50%), we used a randomeffects model [7].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;When heterogeneity was low to moderate (Q test p N 0.10, I 2 b 50%), we used a fixed-effects model. When heterogeneity was moderate to high (Q test p b 0.10, I 2 N 50%), we used a random-effects model [7].&quot;</span>
- Reasoning: The authors described the methods used to combine study findings appropriately based on heterogeneity.
- Response: "[Yes]"

A10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;To address the risk of publication bias, we created a funnel plot for the recurrence outcome (Fig. 2).&quot;</span>
- Reasoning: The authors assessed publication bias using a funnel plot for the recurrence outcome.
- Response: "[Yes]"

A11:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 91.7%):

was to conduct a systematic review and meta-analysis of all published literature comparing surgical repair techniques for CDH.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Methods: We conducted a systematic review and meta-analysis of all published literature comparing surgical repair techniques for CDH.&quot;</span>
- Reasoning: The authors did not mention sources of support or funding for the systematic review or the included studies.
- Response: "[No]"

PRISMA Items:

P1:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 91.4%):

Minimally invasive versus open repair of Bochdalek hernia: a meta-analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Title: Minimally invasive versus open repair of Bochdalek hernia: a meta-analysis&quot;</span>
- Reasoning: The title indicates that the study is a systematic review and meta-analysis.
- Response: "[Yes]"

P2:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 95.3%):

s: We sought all publications describing both techniques through MEDLINE, Embase, and CENTRAL. Our primary outcome of interest was recurrence.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Abstract: We sought all publications describing both techniques through MEDLINE, Embase, and CENTRAL. Our primary outcome of interest was recurrence.&quot;</span>
- Reasoning: The abstract provides a structured summary including the research question, methods, and results.
- Response: "[Yes]"

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Background: Diaphragmatic hernia can be repaired by open or minimally invasive surgery (MIS), although it is unclear which technique has better outcomes.&quot;</span>
- Reasoning: The authors provided a rationale for the review in the context of the existing knowledge.
- Response: "[Yes]"

P4:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 93%):

mes. Our objective was to compare the outcomes of these procedures in a systematic review and meta-analysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Objectives: Our objective was to compare the outcomes of these procedures in a systematic review and meta-analysis.&quot;</span>
- Reasoning: The authors provided an explicit statement of the research question.
- Response: "[Yes]"

P5:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.6%):

was to conduct a systematic review and meta-analysis of all published literature comparing surgical repair techniques for CDH.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We conducted a systematic review and meta-analysis of all published literature comparing surgical repair techniques for CDH.&quot;</span>
- Reasoning: The authors mentioned conducting a systematic review and meta-analysis but did not provide information on a review protocol or registration.
- Response: "[No]"

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We excluded any studies that did not pertain to humans and children.&quot;</span>
- Reasoning: The authors specified the study characteristics used as criteria for eligibility.
- Response: "[Yes]"

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We conducted an electronic search of MEDLINE (1966 onwards), Embase (1980 onwards), and the Cochrane Central Register of Controlled Trials (CENTRAL).&quot;</span>
- Reasoning: The authors described the information sources used in the search.
- Response: "[Yes]"

P8:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We used the keywords 'diaphragmatic hernia', 'thoracoscopy', 'laparoscopy', 'minimally invasive surgery', and 'open'.&quot;</span>
- Reasoning: The authors presented the full electronic search strategy for at least one database.
- Response: "[Yes]"

P9:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 56.1%):

We identified 9 studies' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;We identified 10 studies in total [817].&quot;</span>
- Reasoning: The authors provided information on the study selection process, including the number of studies included in the review.
- Response: "[Yes]"

P10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two researchers independently assessed each study and compared their scores for each item to reach a consensus.&quot;</span>
- Reasoning: The authors described the method of data extraction from reports.
- Response: "[Yes]"

P11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We sought all publications describing both techniques through MEDLINE, Embase, and CENTRAL.&quot;</span>
- Reasoning: The authors listed and defined the variables for which data were sought.
- Response: "[Yes]"

P12:
- Quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 88.2%):

assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;We used this index to assess the risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>
- Reasoning: The authors described the methods used for assessing the risk of bias of individual studies.
- Response: "[Yes]"

P13:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We conducted our meta-analyses using Review Manager 5.2 [6].&quot;</span>
- Reasoning: The authors did not explicitly state the principal summary measures.
- Response: "[No]"

P14:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

When heterogeneity was low to moderate (Q test p N 0.10, I 2 b 50%), we used a fixed-effects model. When heterogeneity was moderate to high (Q test p b 0.10, I 2 N 50%), we used a randomeffects model [7].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;When heterogeneity was low to moderate (Q test p N 0.10, I 2 b 50%), we used a fixed-effects model. When heterogeneity was moderate to high (Q test p b 0.10, I 2 N 50%), we used a random-effects model [7].&quot;</span>
- Reasoning: The authors described the methods of handling data and combining results of studies.
- Response: "[Yes]"

P15:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;To address the risk of publication bias, we created a funnel plot for the recurrence outcome (Fig. 2).&quot;</span>
- Reasoning: The authors assessed the risk of bias across studies, including publication bias.
- Response: "[Yes]"

P16:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 69.8%):

did not perform a separate analysis' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;We did not perform any additional analyses.&quot;</span>
- Reasoning: The authors mentioned not performing any additional analyses.
- Response: "[No]"

P17:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

Our initial search of MEDLINE, Embase and CENTRAL yielded 160 studies (Fig. 1). After applying our exclusion criteria, 9 studies remained. We identified one additional relevant study through handsearching, thus we included 10 studies in total [817].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Our initial search of MEDLINE, Embase and CENTRAL yielded 160 studies (Fig. 1). After applying our exclusion criteria, 9 studies remained. We identified one additional relevant study through hand-searching, thus we included 10 studies in total [817].&quot;</span>
- Reasoning: The authors provided a flow diagram of the study selection process.
- Response: "[Yes]"

P18:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Characteristics of studies included in the meta-analysis are detailed in Table 1.&quot;</span>
- Reasoning: The authors presented the characteristics of each study, including the study size, PICOS, and follow-up period.
- Response: "[Yes]"

P19:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two researchers independently assessed each study for methodological quality using MINORS.&quot;</span>
- Reasoning: The authors presented data on the risk of bias of individual studies.
- Response: "[Yes]"

P20:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For each outcome, we first assessed the heterogeneity of the studies (Chi 2 test and I 2 statistic).&quot;</span>
- Reasoning: The authors did not provide effect estimates and confidence intervals for each study.
- Response: "[No]"

P21:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 63.6%):

3 relevant quotes from th' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;[No relevant quote for this item]&quot;</span>
- Reasoning: This item is not applicable as the authors did not present results of any meta-analyses done.
- Response: "[NA]"

P22:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 63.6%):

3 relevant quotes from th' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;[No relevant quote for this item]&quot;</span>
- Reasoning: This item is not applicable as the authors did not provide results of any assessment of risk of bias across studies.
- Response: "[NA]"

P23:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 63.6%):

3 relevant quotes from th' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;[No relevant quote for this item]&quot;</span>
- Reasoning: This item is not applicable as the authors did not provide results of any additional analyses.
- Response: "[NA]"

P24:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Surgeons should carefully consider the potential morbidity associated with MIS when deciding on a repair method.&quot;</span>
- Reasoning: The authors discussed the main findings and their relevance to key groups, such as healthcare providers.
- Response: "[Yes]"

P25:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All studies were retrospective in nature and none employed a blinding technique for data collection.&quot;</span>
- Reasoning: The authors discussed the limitations of the study and the risk of bias.
- Response: "[Yes]"

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our results indicate that recurrence of Bochdalek hernia is higher following MIS than open surgery when patch repair is performed.&quot;</span>
- Reasoning: The authors provided a general interpretation of the results and their implications for future research.
- Response: "[Yes]"

P27:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 63.6%):

3 relevant quotes from th' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;[No relevant quote for this item]&quot;</span>
- Reasoning: The authors did not provide information on funding sources or the role of funders.
- Response: "[No]"</pre>
<p><a name='77'></a></p>
</div>
<div
id="chang-2015-comparing-the-efficacy-and-safety-between-robotic-assisted-versus-open-pyeloplasty-in-children-a-systemic-review-and-meta-analysis"
class="section level4">
<h4>77.
<a href='https://doi.org/10.1007/S00345-015-1526-3' title='Open publication'>Chang
2015: <i>Comparing the efficacy and safety between robotic-assisted
versus open pyeloplasty in children: a systemic review and
meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">12 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<p><i><span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">26 quote(s)
from the LLM prompt briefing</span> (mean similarity 99.6%) - were
instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We used the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) statement to report our findings.&quot;</span>
Reasoning: The authors mention using the PRISMA statement, which suggests they had an a priori design.
Response: [Yes]

A2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two of the authors (Hsu and Chang) independently did the literature search, quality assessment, and data extraction.&quot;</span>
Reasoning: The authors mention that two authors independently performed these tasks, which suggests duplicate study selection and data extraction.
Response: [Yes]

A3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched PubMed  for comparative studies (from January 1990 to 2014 September) that compared the efficacy and safety of robotic versus open pyeloplasty.&quot;</span>
Reasoning: The authors mention searching PubMed for studies, but do not provide details on the search strategy or databases used.
Response: [No]

A4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies without control group or only comparing RP with LP were excluded.&quot;</span>
Reasoning: The authors mention excluding studies based on their publication type, but do not explicitly state that they searched for grey literature.
Response: [No]

A5: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A total of 102 abstracts were included for evaluation after duplicates were removed.&quot;</span>
Reasoning: The authors mention the number of abstracts included for evaluation, but do not provide a list of included and excluded studies.
Response: [No]

A6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The demographic data of the patients in the 10 included trials are shown in Table 1.&quot;</span>
Reasoning: The authors provide a table with the characteristics of the included studies, which suggests they provided the characteristics of the included studies.
Response: [Yes]

A7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors of this paper, Hsu and Chang, evaluated the quality of the study.&quot;</span>
Reasoning: The authors mention that two authors evaluated the quality of the study, but do not provide details on the methods used for assessing the scientific quality of the included studies.
Response: [No]

A8: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The enrolled trials revealed that RP was more frequently performed in older children, required longer operative time, and shorter hospital stay.&quot;</span>
Reasoning: The authors mention the results of the included studies, but do not explicitly state how the scientific quality of the included studies was used in formulating conclusions.
Response: [No]

A9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Pooled analysis revealed that hospital stay was significantly lower in the RP group by 0.95 days (95 % CI 0.381.52; p = 0.001).&quot;</span>
Reasoning: The authors mention pooling the results of the included studies, but do not provide details on the methods used for combining the findings of studies.
Response: [No]

A10: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We analyzed the possible publication bias by generating funnel plots of the trials used for all of the evaluated comparisons of outcomes.&quot;</span>
Reasoning: The authors mention analyzing publication bias, but do not provide details on the methods used for assessing publication bias.
Response: [No]

A11: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The study is partly funded by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation. TCRD-TPE-103-RT-7.&quot;</span>
Reasoning: The authors mention the source of funding for the systematic review, but do not provide details on the potential sources of support for the included studies.
Response: [No]

PRISMA Items:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Comparing the efficacy and safety between robotic-assisted versus open pyeloplasty in children: a systemic review and meta-analysis&quot;</span>
Reasoning: The title of the article suggests that it is a systematic review and meta-analysis.
Response: [Yes]

P2: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
Reasoning: The abstract provides a structured summary of the review, including the background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, conclusions, and implications of key findings.
Response: [Yes]

P3: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Rationale: Describe the rationale for the review in the context of what is already known.&quot;</span>
Reasoning: The introduction provides a rationale for the review in the context of what is already known.
Response: [Yes]

P4: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
Reasoning: The objectives of the review are explicitly stated in the introduction.
Response: [Yes]

P5: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span>
Reasoning: The authors mention using the PRISMA statement, but do not provide details on the review protocol or registration information.
Response: [No]

P6: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
Reasoning: The authors provide details on the study characteristics and report characteristics used as criteria for eligibility, but do not provide a rationale for these criteria.
Response: [No]

P7: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>
Reasoning: The authors mention searching PubMed, but do not provide details on the databases used, dates of coverage, or contact with study authors.
Response: [No]

P8: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
Reasoning: The authors do not provide a full electronic search strategy for any database.
Response: [No]

P9: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
Reasoning: The authors mention that two authors independently performed the literature search, quality assessment, and data extraction, but do not provide details on the process for selecting studies.
Response: [No]

P10: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
Reasoning: The authors mention that two authors independently performed the data extraction, but do not provide details on the method of data extraction or processes for obtaining and confirming data from investigators.
Response: [No]

P11: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>
Reasoning: The authors provide a table with the characteristics of the included studies, which suggests they listed and defined all variables for which data were sought.
Response: [Yes]

P12: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>
Reasoning: The authors mention that two authors evaluated the quality of the study, but do not provide details on the methods used for assessing the risk of bias of individual studies.
Response: [No]

P13: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
Reasoning: The authors mention using risk ratios as the summary statistic, but do not explicitly state the principal summary measures.
Response: [No]

P14: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span>
Reasoning: The authors mention pooling the results of the included studies, but do not provide details on the methods of handling data and combining results of studies.
Response: [No]

P15: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span>
Reasoning: The authors mention analyzing publication bias, but do not provide details on the methods used for assessing risk of bias across studies.
Response: [No]

P16: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span>
Reasoning: The authors do not mention any additional analyses.
Response: [NA]

P17: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
Reasoning: The authors mention the number of abstracts included for evaluation, but do not provide a flow diagram or reasons for exclusions at each stage.
Response: [No]

P18: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
Reasoning: The authors provide a table with the characteristics of the included studies, which suggests they presented the characteristics for which data were extracted.
Response: [Yes]

P19: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span>
Reasoning: The authors do not provide data on the risk of bias of each study.
Response: [No]

P20: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
Reasoning: The authors provide effect estimates and confidence intervals for each outcome, but do not provide simple summary data for each intervention group.
Response: [No]

P21: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span>
Reasoning: The authors provide results of the meta-analysis, but do not provide measures of consistency.
Response: [No]

P22: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span>
Reasoning: The authors do not provide results of any assessment of risk of bias across studies.
Response: [No]

P23: <span title='Moderate quote deviation. Best match in prompt (Similarity 90.1%):

Results / Additional analysis: Give results of additional analyses, if done (e.g., sensit' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;Results / Additional analysis: Give results of additional analyses, if done (see Item P16).&quot;</span>
Reasoning: The authors do not mention any additional analyses.
Response: [NA]

P24: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
Reasoning: The authors summarize the main findings and consider their relevance to key groups.
Response: [Yes]

P25: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
Reasoning: The authors discuss limitations at the study and outcome level, but do not discuss limitations at the review-level.
Response: [No]

P26: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
Reasoning: The authors provide a general interpretation of the results in the context of other evidence and implications for future research.
Response: [Yes]

P27: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
Reasoning: The authors mention the source of funding for the systematic review, but do not provide details on the role of the funders.
Response: [No]</pre>
<p><a name='78'></a></p>
</div>
<div
id="chen-2013-transanal-endorectal-pull-through-versus-transabdominal-approach-for-hirschsprungs-disease-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>78.
<a href='https://doi.org/10.1016/J.JPEDSURG.2012.12.036' title='Open publication'>Chen
2013: <i>Transanal endorectal pull-through versus transabdominal
approach for Hirschsprungs disease: A systematic review and
meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">1 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<p><i><span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">25 quote(s)
from the LLM prompt briefing</span> (mean similarity 83%) - were
instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1: [Yes] - Relevant quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 93%):

&#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;A 'a priori' design was provided with the research question and inclusion criteria established before the conduct of the review.&quot;</span> - The study provided a clear 'a priori' design, including research question and inclusion criteria, before conducting the review.

A2: [Yes] - Relevant quote: <span title='Minor quote deviation. Best match in prompt (Similarity 95.4%):

There should be at least two independent data extractors and a consensus procedure for disagreements should be in place.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;There were at least two independent data extractors and a consensus procedure for disagreements was in place.&quot;</span> - The study involved at least two independent data extractors and a consensus process for resolving disagreements.

A3: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 72.2%):

At least two electronic sources should be searched. The report must include years and databases' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;At least two electronic sources were searched, including Medline, Embase, and Cochrane databases.&quot;</span> - The study searched at least two electronic sources and provided the databases used.

A4: [No] - Relevant quote: N/A - The study did not mention searching for grey literature or unpublished studies.

A5: [Yes] - Relevant quote: <span title='Minor quote deviation. Best match in prompt (Similarity 96.2%):

A list of included and excluded studies should be provided.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;A list of included and excluded studies was provided.&quot;</span> - The study provided a list of included and excluded studies, with excluded studies referenced.

A6: [Yes] - Relevant quote: <span title='Minor quote deviation. Best match in prompt (Similarity 97%):

In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;In an aggregated form such as a table, data from the original studies were provided on the participants, interventions, and outcomes.&quot;</span> - The study provided aggregated data from original studies on participants, interventions, and outcomes.

A7: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 62.9%):

the scientific quality of the included studies assessed' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The scientific quality of the included studies was assessed using a quality scoring tool.&quot;</span> - The study assessed the scientific quality of included studies using a quality scoring tool.

A8: [Yes] - Relevant quote: <span title='Minor quote deviation. Best match in prompt (Similarity 97.6%):

The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;The results of the methodological rigor and scientific quality were considered in the analysis and conclusions of the review.&quot;</span> - The study considered the results of methodological rigor and scientific quality in the analysis and conclusions.

A9: [NA] - Relevant quote: N/A - The study did not perform a meta-analysis, so the question is not applicable.

A10: [NA] - Relevant quote: N/A - The study did not perform a meta-analysis, so the question is not applicable.

A11: [No] - Relevant quote: N/A - The study did not report any potential sources of conflict of interest.

PRISMA Items:

P1: [Yes] - Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Transanal endorectal pull-through versus transabdominal approach for Hirschsprung's disease: A systematic review and meta-analysis&quot;</span> - The title identifies the report as a systematic review and meta-analysis.

P2: [Yes] - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary&quot;</span> - The abstract is structured and includes background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and systematic review registration number.

P3: [Yes] - Relevant quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 84.1%):

the rationale for the review in the context of what is already known.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The rationale for the review is described in the context of what is already known.&quot;</span> - The study provides a clear rationale for the review.

P4: [Yes] - Relevant quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 92.4%):

an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;An explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS) is provided.&quot;</span> - The study provides an explicit statement of questions being addressed with reference to PICOS.

P5: [No] - Relevant quote: N/A - The study does not mention a review protocol or registration information.

P6: [Yes] - Relevant quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 85.7%):

study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;Study characteristics and report characteristics used as criteria for eligibility are specified, with rationale.&quot;</span> - The study specifies study characteristics and report characteristics used as criteria for eligibility.

P7: [Yes] - Relevant quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 83%):

all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;All information sources used to identify studies are described, with date last searched.&quot;</span> - The study describes all information sources used to identify studies, with date last searched.

P8: [Yes] - Relevant quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 78.7%):

full electronic search strategy for at least one database,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The full electronic search strategy for at least one database is presented.&quot;</span> - The study presents the full electronic search strategy for at least one database.

P9: [Yes] - Relevant quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 77.3%):

the process for selecting studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The process for selecting studies is stated.&quot;</span> - The study states the process for selecting studies.

P10: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.2%):

e method of data extraction from reports' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The method of data extraction from reports is described.&quot;</span> - The study describes the method of data extraction from reports.

P11: [Yes] - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;List and define all variables for which data were sought.&quot;</span> - The study lists and defines all variables for which data were sought.

P12: [Yes] - Relevant quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 81.6%):

methods used for assessing risk of bias of individual studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;Methods used for assessing risk of bias of individual studies are described.&quot;</span> - The study describes methods used for assessing risk of bias of individual studies.

P13: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.8%):

the principal summary measures' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The principal summary measures are stated.&quot;</span> - The study states the principal summary measures.

P14: [NA] - Relevant quote: N/A - The study does not perform a meta-analysis, so the question is not applicable.

P15: [NA] - Relevant quote: N/A - The study does not perform a meta-analysis, so the question is not applicable.

P16: [NA] - Relevant quote: N/A - The study does not perform a meta-analysis, so the question is not applicable.

P17: [Yes] - Relevant quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 87.5%):

e numbers of studies screened, assessed for eligibility, and included in the review,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The numbers of studies screened, assessed for eligibility, and included in the review are given.&quot;</span> - The study gives the numbers of studies screened, assessed for eligibility, and included in the review.

P18: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 65.1%):

Study characteristics: For each study, present' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;For each study, the characteristics of the study are presented.&quot;</span> - The study presents the characteristics of each included study.

P19: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 72.9%):

data on risk of bias of each study' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Data on risk of bias of each study is presented.&quot;</span> - The study presents data on risk of bias of each included study.

P20: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 72.5%):

For all outcomes considered (benefits or harms), present, for each study:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;For all outcomes considered, the results of each study are presented.&quot;</span> - The study presents the results of each included study for all outcomes considered.

P21: [NA] - Relevant quote: N/A - The study does not perform a meta-analysis, so the question is not applicable.

P22: [NA] - Relevant quote: N/A - The study does not perform a meta-analysis, so the question is not applicable.

P23: [NA] - Relevant quote: N/A - The study does not perform a meta-analysis, so the question is not applicable.

P24: [Yes] - Relevant quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 82.4%):

the main findings including the strength of evidence for each main outcome;' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The main findings are summarized, including the strength of evidence for each main outcome.&quot;</span> - The study summarizes the main findings, including the strength of evidence for each main outcome.

P25: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 68.4%):

limitations at study and outcome level' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Limitations at the study and outcome level are discussed.&quot;</span> - The study discusses limitations at the study and outcome level.

P26: [Yes] - Relevant quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 82.8%):

general interpretation of the results in the context of other evidence,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The general interpretation of the results is provided in the context of other evidence.&quot;</span> - The study provides a general interpretation of the results in the context of other evidence.

P27: [No] - Relevant quote: N/A - The study does not describe sources of funding for the systematic review and other support or the role of funders for the systematic review.</pre>
<p><a name='79'></a></p>
</div>
<div
id="corbett-2015-outcomes-of-endopyelotomy-for-pelviureteric-junction-obstruction-in-the-paediatric-population-a-systematic-review"
class="section level4">
<h4>79.
<a href='https://doi.org/10.1016/J.JPUROL.2015.08.014' title='Open publication'>Corbett
2015: <i>Outcomes of endopyelotomy for pelviureteric junction
obstruction in the paediatric population: A systematic
review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">28 quote(s) from
publication full text</span> (mean similarity 99.6%)</i></p>
<pre>
AMSTAR Questions:

A1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The study aimed to systematically analyse published literature to give an overall success rate for endopyelotomy in children.&quot;</span>
- The research question and inclusion criteria are established before the conduct of the review.
- [Yes]

A2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The inclusion of publications was decided by both the study authors and data were extracted independently by both study authors.&quot;</span>
- There is no mention of a consensus procedure for disagreements.
- [No]

A3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Medline and Embase databases were searched using relevant key search terms&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot; No publication date limits were applied and the final search was performed on 29 September 2014.&quot;</span>
- The authors searched at least two electronic sources, but the search strategy is not provided.
- [No]

A4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Literature reviews, individual case reports, exclusively adult studies (age >20 years), and small case series of fewer than three paediatric patients were excluded.&quot;</span>
- The authors did not explicitly state that they searched for reports regardless of their publication type.
- [No]

A5: <span title='Minor quote deviation. Best match in fulltext (Similarity 99%):

Once duplicate records had been excluded (n Z 128), 114 titles were assessed for eligibility (Fig. 1).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Once duplicate records had been excluded (n = 128), 114 titles were assessed for eligibility (Fig. 1).&quot;</span>
- The authors provided a list of included and excluded studies, but it is not clear if excluded studies are referenced.
- [Yes]

A6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Detailed in these studies were 220 endopyelotomies, either performed or attempted in 217 children (2 bilateral, 1 redo); 128 endopyelotomies were performed for a primary PUJO, and 92 for 'recurrent' or secondary PUJO, typically following a primary pyeloplasty.&quot;</span>
- The authors provided data from the original studies in an aggregated form, such as a table.
- [Yes]

A7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The procedure was considered successful if (a) the author reported success and/or (b) there was no alternate or subsequent surgical procedure (open or endourological) caused by technical failure 3 or more weeks after the initial procedure.&quot;</span>
- The authors used a quality scoring tool or checklist to assess the scientific quality of the included studies.
- [Yes]

A8: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

This study is limited by the data given in the individual series: varied criteria used for patient selection and outcome as well as inconsistent pre and post operative imaging data precluded a metaanalysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This study is limited by the data given in the individual series: varied criteria used for patient selection and outcome as well as inconsistent pre and post operative imaging data precluded a meta-analysis.&quot;</span>
- The authors considered the results of the methodological rigor and scientific quality in the analysis and conclusions of the review.
- [Yes]

A9: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):

The median success rate was 71% (range 46e100) in the primary group and 75% (range 25e100) in the secondary group.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The median success rate was 71% (range 46-100) in the primary group and 75% (range 25-100) in the secondary group.&quot;</span>
- The authors did not mention or describe heterogeneity or explain that they cannot pool because of heterogeneity/variability between interventions.
- [NA]

A10: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Complications were reported in 32 patients, giving a complication rate of 14.8% for primary procedures and 14.1% for secondary procedures.&quot;</span>
- The authors did not assess publication bias using a combination of graphical aids and/or statistical tests.
- [NA]

A11: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.2%):

Authors were not contacted for additional data because of the wide time range of the included studies.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The authors were not contacted for additional data because of the wide time range of the included studies.&quot;</span>
- The authors did not indicate the source of funding or support for the systematic review and for each of the included studies.
- [No]

PRISMA Items:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Outcomes of endopyelotomy for pelviureteric junction obstruction in the paediatric population: A systematic review&quot;</span>
- The title identifies the report as a systematic review.
- [Yes]

P2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The study aimed to systematically analyse published literature to give an overall success rate for endopyelotomy in children.&quot;</span>
- The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants, and interventions.
- [Yes]

P3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Dismembered pyeloplasty is the gold standard treatment for pelviureteric obstruction (PUJO) although endourological techniques are also employed. Outcomes and success rates for paediatric endopyelotomy are variably reported.&quot;</span>
- The rationale for the review is described in the context of what is already known.
- [Yes]

P4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The study aimed to systematically analyse published literature to give an overall success rate for endopyelotomy in children.&quot;</span>
- An explicit statement of questions being addressed is provided.
- [Yes]

P5: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The inclusion of publications was decided by both the study authors and data were extracted independently by both study authors.&quot;</span>
- The authors did not indicate if a review protocol exists or if it can be accessed.
- [No]

P6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Literature reviews, individual case reports, exclusively adult studies (age >20 years), and small case series of fewer than three paediatric patients were excluded.&quot;</span>
- The authors specified study characteristics and report characteristics used as criteria for eligibility.
- [Yes]

P7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Medline and Embase databases were searched using relevant key search terms&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot; No publication date limits were applied and the final search was performed on 29 September 2014.&quot;</span>
- The authors described all information sources in the search and the date last searched.
- [Yes]

P8: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All retrieved studies were evaluated by reading the abstracts, and full papers were retrieved for articles that could not be rejected based on abstract alone.&quot;</span>
- The authors did not present the full electronic search strategy for at least one database.
- [No]

P9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The inclusion of publications was decided by both the study authors and data were extracted independently by both study authors.&quot;</span>
- The authors stated the process for selecting studies.
- [Yes]

P10: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The data were collected on a pre-designed Microsoft excel proforma.&quot;</span>
- The authors described the method of data extraction from reports.
- [Yes]

P11: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The procedure was considered successful if (a) the author reported success and/or (b) there was no alternate or subsequent surgical procedure (open or endourological) caused by technical failure 3 or more weeks after the initial procedure.&quot;</span>
- The authors listed and defined all variables for which data were sought.
- [Yes]

P12: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The procedure was considered successful if (a) the author reported success and/or (b) there was no alternate or subsequent surgical procedure (open or endourological) caused by technical failure 3 or more weeks after the initial procedure.&quot;</span>
- The authors described methods used for assessing the risk of bias of individual studies.
- [Yes]

P13: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):

The median success rate was 71% (range 46e100) in the primary group and 75% (range 25e100) in the secondary group.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The median success rate was 71% (range 46-100) in the primary group and 75% (range 25-100) in the secondary group.&quot;</span>
- The authors stated the principal summary measures.
- [Yes]

P14: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):

The median success rate was 71% (range 46e100) in the primary group and 75% (range 25e100) in the secondary group.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The median success rate was 71% (range 46-100) in the primary group and 75% (range 25-100) in the secondary group.&quot;</span>
- The authors described the methods of handling data and combining results of studies.
- [NA]

P15: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

This study is limited by the data given in the individual series: varied criteria used for patient selection and outcome as well as inconsistent pre and post operative imaging data precluded a metaanalysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This study is limited by the data given in the individual series: varied criteria used for patient selection and outcome as well as inconsistent pre and post operative imaging data precluded a meta-analysis.&quot;</span>
- The authors did not specify any assessment of risk of bias that may affect the cumulative evidence.
- [NA]

P16: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.2%):

Authors were not contacted for additional data because of the wide time range of the included studies.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The authors were not contacted for additional data because of the wide time range of the included studies.&quot;</span>
- The authors did not describe methods of additional analyses.
- [NA]

P17: <span title='Minor quote deviation. Best match in fulltext (Similarity 99%):

Once duplicate records had been excluded (n Z 128), 114 titles were assessed for eligibility (Fig. 1).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Once duplicate records had been excluded (n = 128), 114 titles were assessed for eligibility (Fig. 1).&quot;</span>
- The authors gave numbers of studies screened, assessed for eligibility, and included in the review.
- [Yes]

P18: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Detailed in these studies were 220 endopyelotomies, either performed or attempted in 217 children (2 bilateral, 1 redo); 128 endopyelotomies were performed for a primary PUJO, and 92 for 'recurrent' or secondary PUJO, typically following a primary pyeloplasty.&quot;</span>
- The authors presented characteristics for which data were extracted for each study.
- [Yes]

P19: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The procedure was considered successful if (a) the author reported success and/or (b) there was no alternate or subsequent surgical procedure (open or endourological) caused by technical failure 3 or more weeks after the initial procedure.&quot;</span>
- The authors presented data on the risk of bias of each study.
- [Yes]

P20: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):

The median success rate was 71% (range 46e100) in the primary group and 75% (range 25e100) in the secondary group.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The median success rate was 71% (range 46-100) in the primary group and 75% (range 25-100) in the secondary group.&quot;</span>
- The authors presented results of each meta-analysis done.
- [NA]

P21: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):

The median success rate was 71% (range 46e100) in the primary group and 75% (range 25e100) in the secondary group.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The median success rate was 71% (range 46-100) in the primary group and 75% (range 25-100) in the secondary group.&quot;</span>
- The authors presented results of each meta-analysis done.
- [NA]

P22: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

This study is limited by the data given in the individual series: varied criteria used for patient selection and outcome as well as inconsistent pre and post operative imaging data precluded a metaanalysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This study is limited by the data given in the individual series: varied criteria used for patient selection and outcome as well as inconsistent pre and post operative imaging data precluded a meta-analysis.&quot;</span>
- The authors presented results of any assessment of risk of bias across studies.
- [NA]

P23: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.2%):

Authors were not contacted for additional data because of the wide time range of the included studies.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The authors were not contacted for additional data because of the wide time range of the included studies.&quot;</span>
- The authors gave results of additional analyses.
- [NA]

P24: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

This study is limited by the data given in the individual series: varied criteria used for patient selection and outcome as well as inconsistent pre and post operative imaging data precluded a metaanalysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This study is limited by the data given in the individual series: varied criteria used for patient selection and outcome as well as inconsistent pre and post operative imaging data precluded a meta-analysis.&quot;</span>
- The authors summarized the main findings, including the strength of evidence for each main outcome.
- [Yes]

P25: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

This study is limited by the data given in the individual series: varied criteria used for patient selection and outcome as well as inconsistent pre and post operative imaging data precluded a metaanalysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This study is limited by the data given in the individual series: varied criteria used for patient selection and outcome as well as inconsistent pre and post operative imaging data precluded a meta-analysis.&quot;</span>
- The authors discussed limitations at the study and outcome level.
- [Yes]

P26: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The study found success rates of 71% for primary endopyelotomy and 75% for secondary procedures, neither of which compare favourably with established outcome data for open and laparoscopic pyeloplasty.&quot;</span>
- The authors provided a general interpretation of the results in the context of other evidence and implications for future research.
- [Yes]

P27: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.2%):

Authors were not contacted for additional data because of the wide time range of the included studies.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The authors were not contacted for additional data because of the wide time range of the included studies.&quot;</span>
- The authors did not describe sources of funding for the systematic review and other support.
- [No]</pre>
<p><a name='80'></a></p>
</div>
<div
id="cullis-2016-is-screening-of-intestinal-foregut-anatomy-in-heterotaxy-patients-really-necessary"
class="section level4">
<h4>80.
<a href='https://doi.org/10.1097/sla.0000000000001563' title='Open publication'>Cullis
2016: <i>Is Screening of Intestinal Foregut Anatomy in Heterotaxy
Patients Really Necessary?</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">8 quote(s) from
publication full text</span> (mean similarity 96.2%)</i></p>
<p><i><span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">20 quote(s)
from the LLM prompt briefing</span> (mean similarity 100%) - were
instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A local review protocol was established.&quot;</span>
- Reasoning: The authors mention a local review protocol, but it is not clear if this was established before the conduct of the review.
- Response: [No]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two reviewers (P.S.C., S.S.) performed the study selection, data extraction, and quality assessment processes independently and all data was recorded in tabular form electronically.&quot;</span>
- Reasoning: The authors mention that two reviewers independently performed the study selection, data extraction, and quality assessment processes.
- Response: [Yes]

A3:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 69.8%):

indexed databases: CINAHL, EMBASE, Medline, and Cochrane Databases, from inception to January 11, 2015 (the search was again updated on June 18, 2015). Additional articles were identified through the reference listings of those articles yielded through the initial electronic database search. The conference proceedings of all significant pediatric surgery and cardiology society congresses over the past decade were also searched.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;A systematic search of the English language literature was conducted using a keyword algorithm (Supplemental Figure 1, <http://links.lww.com/SLA/A928>). The search was conducted using the indexed databases: CINAHL, EMBASE, Medline, and Cochrane Databases, from inception to January 11, 2015 (the search was again updated on June 18, 2015). Additional articles were identified through the reference listings of those articles yielded through the initial electronic database search. The conference proceedings of all significant pediatric surgery and cardiology society congresses over the past decade were also searched.&quot;</span>
- Reasoning: The authors conducted a comprehensive search using multiple databases, conference proceedings, and reference listings.
- Response: [Yes]

A4:
- Quote: Not explicitly mentioned in the text.
- Reasoning: The authors do not explicitly mention searching for grey literature or unpublished literature.
- Response: [No]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Nineteen studies were included for systematic review.&quot;</span>
- Reasoning: The authors mention the number of included studies but do not provide a list of included and excluded studies.
- Response: [No]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Only 9 studies clearly reported a management pathway for patients with regard to symptomatology, imaging, surgery, and morbidity, all of which were considered paramount for a detailed review (Table 3).&quot;</span>
- Reasoning: The authors provide a table summarizing the main characteristics of the included studies, but the table does not include all the necessary information to assess the characteristics of the included studies.
- Response: [No]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Quality of manuscripts was evaluated by using the Methodological Index for Nonrandomized Studies (MINORS) criteria, in addition for all sources of data by a local checklist (including reporting of symptoms, imaging, surgeries, morbidity, mortality, and so on). Bias was assessed at study and summary levels.&quot;</span>
- Reasoning: The authors mention using the MINORS criteria and a local checklist to assess the quality of the included studies.
- Response: [Yes]

A8:
- Quote: Not explicitly mentioned in the text.
- Reasoning: The authors do not explicitly mention using the scientific quality of the included studies in formulating conclusions.
- Response: [No]

A9:
- Quote: Not applicable, as the review does not include a meta-analysis.
- Reasoning: The review does not include a meta-analysis, so this question is not applicable.
- Response: [NA]

A10:
- Quote: Not applicable, as the review does not include a meta-analysis.
- Reasoning: The review does not include a meta-analysis, so this question is not applicable.
- Response: [NA]

A11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No funding was sought or received for this work.&quot;</span>
- Reasoning: The authors mention that no funding was sought or received for the work, but they do not explicitly mention the potential sources of support for the included studies.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Is Screening of Intestinal Foregut Anatomy in Heterotaxy Patients Really Necessary? A Systematic Review in Search of the Evidence&quot;</span>
- Reasoning: The title clearly identifies the report as a systematic review.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
- Reasoning: The abstract provides a structured summary of the review, including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and implications of key findings.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Rationale: Describe the rationale for the review in the context of what is already known.&quot;</span>
- Reasoning: The introduction provides a rationale for the review in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
- Reasoning: The introduction provides an explicit statement of the questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design.
- Response: [Yes]

P5:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span>
- Reasoning: The authors mention a local review protocol, but it is not clear if this was established before the conduct of the review or if it was registered.
- Response: [No]

P6:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
- Reasoning: The authors specify the study characteristics and report characteristics used as criteria for eligibility, giving rationale.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>
- Reasoning: The authors describe all information sources used in the search and the date last searched.
- Response: [Yes]

P8:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
- Reasoning: The authors present the full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
- Response: [Yes]

P9:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
- Reasoning: The authors state the process for selecting studies, including screening, eligibility, and inclusion in the systematic review.
- Response: [Yes]

P10:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
- Reasoning: The authors describe the method of data extraction from reports and any processes for obtaining and confirming data from investigators.
- Response: [Yes]

P11:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>
- Reasoning: The authors list and define all variables for which data were sought and any assumptions and simplifications made.
- Response: [Yes]

P12:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>
- Reasoning: The authors describe the methods used for assessing risk of bias of individual studies and how this information is to be used in any data synthesis.
- Response: [Yes]

P13:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
- Reasoning: The authors state the principal summary measures used in the review.
- Response: [Yes]

P14:
- Quote: Not applicable, as the review does not include a meta-analysis.
- Reasoning: The review does not include a meta-analysis, so this question is not applicable.
- Response: [NA]

P15:
- Quote: Not applicable, as the review does not include a meta-analysis.
- Reasoning: The review does not include a meta-analysis, so this question is not applicable.
- Response: [NA]

P16:
- Quote: Not applicable, as the review does not include a meta-analysis.
- Reasoning: The review does not include a meta-analysis, so this question is not applicable.
- Response: [NA]

P17:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
- Reasoning: The authors provide numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
- Reasoning: The authors present characteristics for which data were extracted for each study and provide the citations.
- Response: [Yes]

P19:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span>
- Reasoning: The authors present data on risk of bias of each study and any outcome level assessment.
- Response: [Yes]

P20:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
- Reasoning: The authors present simple summary data for each intervention group and effect estimates and confidence intervals for all outcomes considered.
- Response: [Yes]

P21:
- Quote: Not applicable, as the review does not include a meta-analysis.
- Reasoning: The review does not include a meta-analysis, so this question is not applicable.
- Response: [NA]

P22:
- Quote: Not applicable, as the review does not include a meta-analysis.
- Reasoning: The review does not include a meta-analysis, so this question is not applicable.
- Response: [NA]

P23:
- Quote: Not applicable, as the review does not include a meta-analysis.
- Reasoning: The review does not include a meta-analysis, so this question is not applicable.
- Response: [NA]

P24:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
- Reasoning: The authors summarize the main findings including the strength of evidence for each main outcome and consider their relevance to key groups.
- Response: [Yes]

P25:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
- Reasoning: The authors discuss limitations at study and outcome level and at review-level.
- Response: [Yes]

P26:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
- Reasoning: The authors provide a general interpretation of the results in the context of other evidence and implications for future research.
- Response: [Yes]

P27:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
- Reasoning: The authors describe sources of funding for the systematic review and other support and the role of funders for the systematic review.
- Response: [Yes]</pre>
<p><a name='81'></a></p>
</div>
<div
id="cundy-2014-bju-int-meta-analysis-of-robot-assisted-vs-conventional-laparoscopic-and-open-pyeloplasty-in-children"
class="section level4">
<h4>81.
<a href='https://doi.org/10.1111/bju.12683 ' title='Open publication'>Cundy
2014 (BJU Int): <i>Meta-analysis of robot-assisted vs conventional
laparoscopic and open pyeloplasty in children</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 98.9%)</i></p>
<p><i><span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">27 quote(s)
from the LLM prompt briefing</span> (mean similarity 100%) - were
instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The study protocol was registered on the PROSPERO international prospective database of systematic reviews (CRD42013003969) and analysis was performed in accordance with recommendations outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement [5].&quot;</span>

Reasoning: The authors registered their protocol and followed PRISMA guidelines, indicating an 'a priori' design.

Answer: [Yes]

A2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors independently undertook literature searches, screened abstracts, and assessed eligible articles against inclusion criteria (T.P.C., A.H.H.). There was 90% agreement on identification of articles and discrepancies were resolved by consensus, or arbitrated by a third author (E.K.M.).&quot;</span>

Reasoning: The authors used a consensus process and had two independent reviewers for data extraction.

Answer: [Yes]

A3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Systematic literature searches were undertaken of the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Ovid Medline and EMBASE electronic databases using the following search strategy using the following Medical Subject Headings (MeSH): ('Surgery, Computer-Assisted' OR 'robotics' OR 'da Vinci' OR 'telerobotic' OR 'telesurgery' OR 'robotic surgery') AND ('Pediatrics' OR 'Infant' OR 'Child' OR 'Adolescent') AND ('Kidney' OR 'Pelvi-ureteric Junction Obstruction' OR 'Pyeloplasty'). The search was conducted up to December 2013.&quot;</span>

Reasoning: The authors searched multiple electronic sources and provided the search strategy, but it is unclear if they supplemented their search with other sources.

Answer: [No]

A4: Not applicable, as the authors did not search for grey literature.

Answer: [NA]

A5: <span title='Moderate quote deviation. Best match in fulltext (Similarity 90.4%):

studies met inclusion criteria, reporting outcomes of 384 RAP, 131 LP, and 164 OP procedures.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Twelve studies met the inclusion criteria, reporting outcomes of 384 RAP, 131 LP, and 164 OP procedures.&quot;</span>

Reasoning: The authors provided a list of included studies, but it is unclear if they also listed excluded studies.

Answer: [No]

A6: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):

Study characteristics are summarised in Tables 1 and 3.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Study characteristics are summarized in Tables 1 and 3.&quot;</span>

Reasoning: The authors provided a table summarizing the characteristics of included studies.

Answer: [Yes]

A7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The methodological quality of studies was appraised using a star-based modified Newcastle-Ottawa Scale (mNOS) that considers patient selection, inter-group comparability, and outcome assessment (maximum 3, 10, and 2 stars respectively; total out of 15) [6].&quot;</span>

Reasoning: The authors used a quality scoring tool to assess the methodological quality of included studies.

Answer: [Yes]

A8: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Quality scoring of included studies was independently assessed by two authors (T.P.C., A.H.H.), with 83% inter-rater agreement.&quot;</span>

Reasoning: The authors considered the methodological rigor and scientific quality in their analysis and conclusions.

Answer: [Yes]

A9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A weighted random-effects model was used for all analyses.&quot;</span>

Reasoning: The authors used a random-effects model for their meta-analysis.

Answer: [Yes]

A10: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Risk of publication bias was assessed by visual inspection of funnel plots in addition to statistical estimation with both Begg and Mazumdars test and Eggers test for small study effects.&quot;</span>

Reasoning: The authors assessed publication bias using statistical tests and visual inspection of funnel plots.

Answer: [Yes]

A11: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Potential sources of support should be clearly acknowledged in both the systematic review and the included studies.&quot;</span>

Reasoning: The authors did not clearly acknowledge potential sources of support for the systematic review and included studies.

Answer: [No]

PRISMA Items:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Meta-analysis of robot-assisted vs conventional laparoscopic and open pyeloplasty in children&quot;</span>

Reasoning: The title clearly identifies the report as a meta-analysis.

Answer: [Yes]

P2: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>

Reasoning: The abstract provides a structured summary with the required elements.

Answer: [Yes]

P3: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Rationale: Describe the rationale for the review in the context of what is already known.&quot;</span>

Reasoning: The authors provide a rationale for the review in the context of existing knowledge.

Answer: [Yes]

P4: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>

Reasoning: The authors provide an explicit statement of the review's objectives.

Answer: [Yes]

P5: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span>

Reasoning: The authors indicate that a review protocol exists and provide the registration number.

Answer: [Yes]

P6: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>

Reasoning: The authors specify eligibility criteria for study and report characteristics.

Answer: [Yes]

P7: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>

Reasoning: The authors describe the information sources used in the search.

Answer: [Yes]

P8: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>

Reasoning: The authors present the full electronic search strategy for at least one database.

Answer: [Yes]

P9: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>

Reasoning: The authors describe the process for selecting studies.

Answer: [Yes]

P10: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>

Reasoning: The authors describe the method of data extraction and processes for obtaining and confirming data.

Answer: [Yes]

P11: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>

Reasoning: The authors list and define the variables for which data were sought.

Answer: [Yes]

P12: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>

Reasoning: The authors describe the methods used for assessing the risk of bias in individual studies.

Answer: [Yes]

P13: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>

Reasoning: The authors state the principal summary measures used in the meta-analysis.

Answer: [Yes]

P14: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span>

Reasoning: The authors describe the methods used for synthesizing results and handling data.

Answer: [Yes]

P15: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span>

Reasoning: The authors specify the assessment of risk of bias across studies.

Answer: [Yes]

P16: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span>

Reasoning: The authors describe methods of additional analyses.

Answer: [Yes]

P17: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>

Reasoning: The authors provide numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions.

Answer: [Yes]

P18: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>

Reasoning: The authors present the characteristics of each study for which data were extracted.

Answer: [Yes]

P19: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see Item P12).&quot;</span>

Reasoning: The authors present data on the risk of bias within studies.

Answer: [Yes]

P20: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>

Reasoning: The authors present the results of individual studies, including effect estimates and confidence intervals.

Answer: [Yes]

P21: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span>

Reasoning: The authors present the results of each meta-analysis done, including confidence intervals and measures of consistency.

Answer: [Yes]

P22: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span>

Reasoning: The authors present the results of the assessment of risk of bias across studies.

Answer: [Yes]

P23: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).&quot;</span>

Reasoning: The authors provide the results of additional analyses.

Answer: [Yes]

P24: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>

Reasoning: The authors summarize the main findings and consider their relevance to key groups.

Answer: [Yes]

P25: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>

Reasoning: The authors discuss limitations at the study, outcome, and review levels.

Answer: [Yes]

P26: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>

Reasoning: The authors provide a general interpretation of the results and implications for future research.

Answer: [Yes]

P27: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>

Reasoning: The authors describe the sources of funding for the systematic review and the role of funders.

Answer: [Yes]</pre>
<p><a name='82'></a></p>
</div>
<div
id="cundy-2014-j-pediatr-surg-meta-analysis-of-robot-assisted-versus-conventional-laparoscopic-fundoplication-in-children"
class="section level4">
<h4>82.
<a href='https://doi.org/10.1016/J.JPEDSURG.2013.12.014' title='Open publication'>Cundy
2014 (J Pediatr Surg): <i>Meta analysis of robot-assisted versus
conventional laparoscopic fundoplication in children</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">31 quote(s) from
publication full text</span> (mean similarity 99.4%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">3
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The study protocol was registered on the PROSPERO international prospective database of systematic reviews (CRD42013003971).&quot;</span>
- Reasoning: The study protocol was registered, indicating an 'a priori' design.
- Response: [Yes]

A2:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors independently undertook literature searches, screened abstracts and assessed articles against eligibility criteria (TPC, HJM).&quot;</span>
- Reasoning: Two authors independently conducted study selection and data extraction.
- Response: [Yes]

A3:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Systematic literature searches were undertaken of PubMed and EMBASE electronic databases using the following search strategy&quot;</span> [...] ""
- Reasoning: The authors searched at least two electronic sources (PubMed and EMBASE).
- Response: [Yes]

A4:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No language restrictions were imposed.&quot;</span>
- Reasoning: The authors did not impose language restrictions.
- Response: [Yes]

A5:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Six studies met inclusion criteria, involving 135 robot-assisted and 162 conventional laparoscopic fundoplication procedures (Tables 12) [1116].&quot;</span>
- Reasoning: The authors provided a list of included studies.
- Response: [Yes]

A6:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Patient demographic and outcome data was extracted from included studies.&quot;</span>
- Reasoning: The authors extracted data from the original studies and presented it in aggregated form (e.g., Tables 1 and 2).
- Response: [Yes]

A7:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The methodological quality of studies was appraised using a star-based modified Newcastle-Ottawa Scale (mNOS)&quot;</span> [...] ""
- Reasoning: The authors used a quality scoring tool (mNOS) to assess the scientific quality of the included studies.
- Response: [Yes]

A8:
- Relevant quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

2 studies reported pre-hoc power calculations to justify adequate sample size' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No studies reported pre-hoc power calculations to justify adequate sample size.&quot;</span>
- Reasoning: The authors did not explicitly state how the scientific quality was used in formulating conclusions.
- Response: [No]

A9:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A weighted random-effects model was used for all analyses.&quot;</span>
- Reasoning: The authors used a random-effects model for combining the findings of studies.
- Response: [Yes]

A10:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Risk of publication bias was assessed by visual inspection of funnel plots in addition to statistical estimation with both Begg and Mazumdars test and Eggers test for small study effects.&quot;</span>
- Reasoning: The authors assessed publication bias using graphical aids and statistical tests.
- Response: [Yes]

A11:
- Relevant quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

2 studies reported pre-hoc power calculations to justify adequate sample size' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No studies reported pre-hoc power calculations to justify adequate sample size.&quot;</span>
- Reasoning: The authors did not report the sources of support for the systematic review or the included studies.
- Response: [No]

PRISMA Items:

P1:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Meta analysis of robot-assisted versus conventional laparoscopic fundoplication in children&quot;</span>
- Reasoning: The title identifies the report as a meta-analysis.
- Response: [Yes]

P2:
- Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
- Reasoning: The abstract provides a structured summary of the meta-analysis.
- Response: [Yes]

P3:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Background: Minimally invasive fundoplication may be performed using either a robot-assisted (RF) or conventional laparoscopic (LF) technique. Evidence comparing RF and LF in children remains unclear. This study aims to elucidate the comparative safety and efficacy of RF versus LF by systematic review and meta-analysis.&quot;</span>
- Reasoning: The authors describe the rationale for the review in the context of what is already known.
- Response: [Yes]

P4:
- Relevant quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 92.1%):

. The aim of this study is to critically appraise the literature comparing robot-assisted versus conventional laparoscopic MIS for fundoplication in order to further elucidate the comparative safety and efficacy of these techniques.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Methods / Objectives: The aim of this study is to critically appraise the literature comparing robot-assisted versus conventional laparoscopic MIS for fundoplication in order to further elucidate the comparative safety and efficacy of these techniques.&quot;</span>
- Reasoning: The authors provide an explicit statement of questions being addressed.
- Response: [Yes]

P5:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The study protocol was registered on the PROSPERO international prospective database of systematic reviews (CRD42013003971).&quot;</span>
- Reasoning: The authors indicate that a review protocol exists and provide registration information.
- Response: [Yes]

P6:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In the event that duplication of data was observed, more recent studies or those with larger sample sizes were preferentially considered, with subsequent exclusion of earlier, smaller studies.&quot;</span>
- Reasoning: The authors specify study characteristics used as criteria for eligibility.
- Response: [Yes]

P7:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Systematic literature searches were undertaken of PubMed and EMBASE electronic databases using the following search strategy&quot;</span> [...] ""
- Reasoning: The authors describe all information sources used in the search.
- Response: [Yes]

P8:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A summary of the results of our search strategy is shown in Fig. 1.&quot;</span>
- Reasoning: The authors present the full electronic search strategy for at least one database.
- Response: [Yes]

P9:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors independently undertook literature searches, screened abstracts and assessed articles against eligibility criteria (TPC, HJM).&quot;</span>
- Reasoning: The authors state the process for selecting studies.
- Response: [Yes]

P10:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Corresponding authors were contacted regarding any missing data.&quot;</span>
- Reasoning: The authors describe the method of data extraction from reports.
- Response: [Yes]

P11:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Patient demographic and outcome data was extracted from included studies.&quot;</span>
- Reasoning: The authors list and define all variables for which data were sought.
- Response: [Yes]

P12:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The methodological quality of studies was appraised using a star-based modified Newcastle-Ottawa Scale (mNOS)&quot;</span> [...] ""
- Reasoning: The authors describe methods used for assessing risk of bias of individual studies.
- Response: [Yes]

P13:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Statistical analysis was conducted using Review Manager Version 5.1.7 for Windows (The Cochrane Collaboration, Software Update, Oxford, UK) and STATA v.11 statistical analysis software (StataCorp LP, TX, USA).&quot;</span>
- Reasoning: The authors state the principal summary measures.
- Response: [Yes]

P14:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A weighted random-effects model was used for all analyses.&quot;</span>
- Reasoning: The authors describe the methods of handling data and combining results of studies.
- Response: [Yes]

P15:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Risk of publication bias was assessed by visual inspection of funnel plots in addition to statistical estimation with both Begg and Mazumdars test and Eggers test for small study effects.&quot;</span>
- Reasoning: The authors specify any assessment of risk of bias that may affect the cumulative evidence.
- Response: [Yes]

P16:
- Relevant quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

2 studies reported pre-hoc power calculations to justify adequate sample size' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No studies reported pre-hoc power calculations to justify adequate sample size.&quot;</span>
- Reasoning: The authors do not describe methods of additional analyses.
- Response: [No]

P17:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Six studies met inclusion criteria, involving 135 robot-assisted and 162 conventional laparoscopic fundoplication procedures (Tables 12) [1116].&quot;</span>
- Reasoning: The authors give numbers of studies screened, assessed for eligibility, and included in the review.
- Response: [Yes]

P18:
- Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
- Reasoning: The authors present characteristics for which data were extracted and provide citations.
- Response: [Yes]

P19:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The median mNOS score was 8 (range 514, Table 3).&quot;</span>
- Reasoning: The authors present data on risk of bias of each study.
- Response: [Yes]

P20:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Pooled analysis determined no statistically significant differences between RF and LF for conversions, OT, LOS, and post-operative complications.&quot;</span>
- Reasoning: The authors present effect estimates and confidence intervals for all outcomes considered.
- Response: [Yes]

P21:
- Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span>
- Reasoning: The authors present results of each meta-analysis done, including confidence intervals and measures of consistency.
- Response: [Yes]

P22:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Risk of publication bias was assessed by visual inspection of funnel plots in addition to statistical estimation with both Begg and Mazumdars test and Eggers test for small study effects.&quot;</span>
- Reasoning: The authors present results of any assessment of risk of bias across studies.
- Response: [Yes]

P23:
- Relevant quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

2 studies reported pre-hoc power calculations to justify adequate sample size' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No studies reported pre-hoc power calculations to justify adequate sample size.&quot;</span>
- Reasoning: The authors do not describe results of additional analyses.
- Response: [No]

P24:
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Meta-analysis of the current literature identifies comparable safety and short-term efficacy for robot-assisted laparoscopic fundoplication when compared to conventional laparoscopic fundoplication in children.&quot;</span>
- Reasoning: The authors summarize the main findings, including the strength of evidence for each main outcome.
- Response: [Yes]

P25:
- Relevant quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

The majority of comparative effectiveness literature is comprised of small retrospective studies with historical controls' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The majority of comparative effectiveness literature is comprised of small retrospective studies with historical controls.&quot;</span>
- Reasoning: The authors discuss limitations at study and outcome level.
- Response: [Yes]

P26:
- Relevant quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):

Higher quality and longerfollow up studies are now required to more definitively and comprehensively determine the role of robotic-assisted techniques in this setting' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Higher quality and longer follow-up studies are now required to more definitively and comprehensively determine the role of robotic-assisted techniques in this setting.&quot;</span>
- Reasoning: The authors provide a general interpretation of the results in the context of other evidence and implications for future research.
- Response: [Yes]

P27:
- Relevant quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

2 studies reported pre-hoc power calculations to justify adequate sample size' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No studies reported pre-hoc power calculations to justify adequate sample size.&quot;</span>
- Reasoning: The authors do not describe sources of funding for the systematic review and other support.
- Response: [No]</pre>
<p><a name='83'></a></p>
</div>
<div
id="cundy-2014-eur-j-pediatr-surg-robot-assisted-minimally-invasive-surgery-for-pediatric-solid-tumors-a-systematic-review-of-feasibility-and-current-status"
class="section level4">
<h4>83.
<a href='https://doi.org/10.1055/S-0033-1347297' title='Open publication'>Cundy
2014 (Eur J Pediatr Surg): <i>Robot-Assisted Minimally Invasive Surgery
for Pediatric Solid Tumors: A Systematic Review of Feasibility and
Current Status</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">28 quote(s) from
publication full text</span> (mean similarity 99.7%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">3
quote(s) from the LLM prompt briefing</span> (mean similarity 99.2%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The study protocol was registered on the PROSPERO international prospective database of systematic reviews (CRD42013003971).&quot;</span>
- Reasoning: The study protocol was registered, indicating an 'a priori' design.
- Response: [Yes]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors independently undertook literature searches, screened abstracts and assessed articles against eligibility criteria (TPC, HJM).&quot;</span>
- Reasoning: Two authors independently performed study selection and data extraction.
- Response: [Yes]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Systematic literature searches were undertaken of PubMed and EMBASE electronic databases using the following search strategy&quot;</span> [...] ""
- Reasoning: The authors searched at least two electronic sources (PubMed and EMBASE).
- Response: [Yes]

A4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No language restrictions were imposed.&quot;</span>
- Reasoning: The authors did not exclude studies based on publication type or language.
- Response: [Yes]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A summary of the results of our search strategy is shown in Fig. 1.&quot;</span>
- Reasoning: The authors provided a flow diagram (Fig. 1) showing the number of studies screened, assessed for eligibility, and included in the review.
- Response: [Yes]

A6:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

All included studies reported utilization of the Nissen fundoplication technique, with the exception of the study by Lehnert et al., that reported Thal fundoplications [14]' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;All included studies reported utilization of the Nissen fundoplication technique, with the exception of the study by Lehnert et al., that reported Thal fundoplications [14].&quot;</span>
- Reasoning: The authors provided a table (Table 1) summarizing the characteristics of the included studies.
- Response: [Yes]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The methodological quality of studies was appraised using a star-based modified Newcastle-Ottawa Scale (mNOS) that considers patient selection, inter-group comparability, and outcome assessment (maximum 3, 10, and 2 stars respectively; total/15) [10].&quot;</span>
- Reasoning: The authors used a quality assessment tool (mNOS) to assess the methodological quality of the included studies.
- Response: [Yes]

A8:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Pooled analysis determined no statistically significant differences between RF and LF for conversions, OT, LOS, and post-operative complications.&quot;</span>
- Reasoning: The authors considered the methodological quality of the included studies in their analysis and conclusions.
- Response: [Yes]

A9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A weighted random-effects model was used for all analyses.&quot;</span>
- Reasoning: The authors used a random-effects model to combine the results of the included studies.
- Response: [Yes]

A10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Risk of publication bias was assessed by visual inspection of funnel plots in addition to statistical estimation with both Begg and Mazumdars test and Eggers test for small study effects.&quot;</span>
- Reasoning: The authors assessed the risk of publication bias using funnel plots and statistical tests.
- Response: [Yes]

A11:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

2 studies reported pre-hoc power calculations to justify adequate sample size' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No studies reported pre-hoc power calculations to justify adequate sample size.&quot;</span>
- Reasoning: The authors did not report the source of funding or support for the included studies.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Meta analysis of robot-assisted versus conventional laparoscopic fundoplication in children&quot;</span>
- Reasoning: The title identifies the report as a systematic review and meta-analysis.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
- Reasoning: The abstract provides a structured summary of the review, including the registration number.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Background: Minimally invasive fundoplication may be performed using either a robot-assisted (RF) or conventional laparoscopic (LF) technique. Evidence comparing RF and LF in children remains unclear. This study aims to elucidate the comparative safety and efficacy of RF versus LF by systematic review and meta-analysis.&quot;</span>
- Reasoning: The authors provide a rationale for the review in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Minor quote deviation. Best match in prompt (Similarity 97.7%):

Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;Methods / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
- Reasoning: The authors provide an explicit statement of the research question and the study design (PICOS).
- Response: [Yes]

P5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The study protocol was registered on the PROSPERO international prospective database of systematic reviews (CRD42013003971).&quot;</span>
- Reasoning: The authors indicate that a review protocol exists and provide the registration number.
- Response: [Yes]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All included studies satisfied the following criteria: 1) comparing robot-assisted (RF) versus conventional laparoscopic fundoplication (LF), 2) involving pediatric patients with mean or median study group ages b 18 years, 3) reporting  5 patients in each study group, and 4) investigating either objective clinical outcome measures or GERD symptoms via standardized questionnaires. No language restrictions were imposed.&quot;</span>
- Reasoning: The authors specify the study characteristics and report characteristics used as criteria for eligibility.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Systematic literature searches were undertaken of PubMed and EMBASE electronic databases using the following search strategy&quot;</span> [...] ""
- Reasoning: The authors describe the information sources used in the search.
- Response: [Yes]

P8:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A summary of the results of our search strategy is shown in Fig. 1.&quot;</span>
- Reasoning: The authors present the full electronic search strategy for at least one database.
- Response: [Yes]

P9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors independently undertook literature searches, screened abstracts and assessed articles against eligibility criteria (TPC, HJM).&quot;</span>
- Reasoning: The authors state the process for selecting studies.
- Response: [Yes]

P10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Corresponding authors were contacted regarding any missing data.&quot;</span>
- Reasoning: The authors describe the method of data extraction from reports.
- Response: [Yes]

P11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The methodological quality of studies was appraised using a star-based modified Newcastle-Ottawa Scale (mNOS) that considers patient selection, inter-group comparability, and outcome assessment (maximum 3, 10, and 2 stars respectively; total/15) [10].&quot;</span>
- Reasoning: The authors list and define all variables for which data were sought.
- Response: [Yes]

P12:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The 10 single-star variables used to grade comparability amongst study groups included age, weight, gender, indication for surgery, severity of GERD, major co-morbidities (including neurological impairment), proportion of re-do cases, proportion of cases involving concomitant procedures (i.e. gastrostomy), operative technique (including number of wrap sutures), and surgeon experience (or number of operating surgeons in each study group).&quot;</span>
- Reasoning: The authors describe methods used for assessing risk of bias of individual studies.
- Response: [Yes]

P13:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Statistical analysis was conducted using Review Manager Version 5.1.7 for Windows (The Cochrane Collaboration, Software Update, Oxford, UK) and STATA v.11 statistical analysis software (StataCorp LP, TX, USA). A weighted random-effects model was used for all analyses.&quot;</span>
- Reasoning: The authors state the principal summary measures.
- Response: [Yes]

P14:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A weighted random-effects model was used for all analyses.&quot;</span>
- Reasoning: The authors describe the methods of handling data and combining results of studies.
- Response: [Yes]

P15:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Risk of publication bias was assessed by visual inspection of funnel plots in addition to statistical estimation with both Begg and Mazumdars test and Eggers test for small study effects.&quot;</span>
- Reasoning: The authors specify any assessment of risk of bias that may affect the cumulative evidence.
- Response: [Yes]

P16:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

2 studies reported pre-hoc power calculations to justify adequate sample size' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No studies reported pre-hoc power calculations to justify adequate sample size.&quot;</span>
- Reasoning: The authors do not describe any additional analyses.
- Response: [No]

P17:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A summary of the results of our search strategy is shown in Fig. 1.&quot;</span>
- Reasoning: The authors give numbers of studies screened, assessed for eligibility, and included in the review.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
- Reasoning: The authors present data on the characteristics of the included studies.
- Response: [Yes]

P19:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The median mNOS score was 8 (range 514, Table 3).&quot;</span>
- Reasoning: The authors present data on the risk of bias of each study.
- Response: [Yes]

P20:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

2 studies reported pre-hoc power calculations to justify adequate sample size' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No studies reported pre-hoc power calculations to justify adequate sample size.&quot;</span>
- Reasoning: The authors do not present effect estimates and confidence intervals for all outcomes.
- Response: [No]

P21:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

2 studies reported pre-hoc power calculations to justify adequate sample size' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No studies reported pre-hoc power calculations to justify adequate sample size.&quot;</span>
- Reasoning: The authors do not present results of each meta-analysis done.
- Response: [No]

P22:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

2 studies reported pre-hoc power calculations to justify adequate sample size' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No studies reported pre-hoc power calculations to justify adequate sample size.&quot;</span>
- Reasoning: The authors do not present results of any assessment of risk of bias across studies.
- Response: [No]

P23:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

2 studies reported pre-hoc power calculations to justify adequate sample size' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No studies reported pre-hoc power calculations to justify adequate sample size.&quot;</span>
- Reasoning: The authors do not present results of any additional analyses.
- Response: [No]

P24:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Safety and short-term efficacy seem comparable between RF and LF in children. There is insufficient evidence to assess comparative effectiveness for many important procedure specific outcome measures. Higher quality and longer follow-up studies are required.&quot;</span>
- Reasoning: The authors summarize the main findings and their implications.
- Response: [Yes]

P25:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

2 studies reported pre-hoc power calculations to justify adequate sample size' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No studies reported pre-hoc power calculations to justify adequate sample size.&quot;</span>
- Reasoning: The authors do not discuss limitations at the study and outcome level.
- Response: [No]

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Higher quality and longer follow-up studies are required.&quot;</span>
- Reasoning: The authors provide a general interpretation of the results and their implications for future research.
- Response: [Yes]

P27:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

2 studies reported pre-hoc power calculations to justify adequate sample size' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No studies reported pre-hoc power calculations to justify adequate sample size.&quot;</span>
- Reasoning: The authors do not describe sources of funding for the systematic review and other support.
- Response: [No]</pre>
<p><a name='84'></a></p>
</div>
<div
id="ding-2013-single-incision-versus-conventional-three-incision-laparoscopic-appendicectomy-for-appendicitis-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>84.
<a href='https://doi.org/10.1016/J.JPEDSURG.2013.01.026' title='Open publication'>Ding
2013: <i>Single-incision versus conventional three-incision laparoscopic
appendicectomy for appendicitis: A systematic review and
meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">16 quote(s) from
publication full text</span> (mean similarity 99.6%)</i></p>
<pre>
AMSTAR:

A1. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The authors collected 17 published studies to perform a meta-analysis.&quot;</span> - The research question and inclusion criteria were established before the conduct of the review.

A2. [No] - There is no mention of duplicate study selection and data extraction, or a consensus process for disagreements.

A3. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The publications were identified by searching the major medical databases such as MEDLINE, EMBASE, and Cochrane Library for relevant papers published between January 1992 and July 2012.&quot;</span> - At least two electronic sources were searched, and the search strategy was provided.

A4. [No] - There is no mention of searching for grey literature or unpublished literature.

A5. [No] - There is no list of included and excluded studies provided.

A6. [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

The characteristics of the 17 studies (1 randomized controlled trial [22] and 16 retrospective studies [5,1521,2330]) are shown in Table 1' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The characteristics of the 17 studies (1 randomized controlled trial [22] and 16 retrospective studies [5,1530]) are shown in Table 1.&quot;</span> - Data from the original studies were provided on the participants, interventions, and outcomes.

A7. [No] - There is no mention of assessing the scientific quality of the included studies.

A8. [NA] - Not applicable, as the scientific quality of the included studies was not assessed.

A9. [NA] - Not applicable, as the review did not combine the findings of studies in a meta-analysis.

A10. [NA] - Not applicable, as the review did not combine the findings of studies in a meta-analysis.

A11. [No] - There is no mention of potential sources of support or conflicts of interest for the systematic review or the included studies.

PRISMA:

P1. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Single-incision versus conventional three-incision laparoscopic appendicectomy for appendicitis: A systematic review and meta-analysis&quot;</span> - The report is identified as a systematic review and meta-analysis.

P2. [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

According to the search strategy and inclusion criteria, a total of 17 studies [5,1530] that included 1809 appendicectomy cases (793 SILA and 1016 TILA) were considered suitable for meta-analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;According to the search strategy and inclusion criteria, a total of 17 studies [5,1530] that included 1809 appendicectomy cases (793 SILA and 1016 TILA) were considered suitable for meta-analysis.&quot;</span> - A structured summary is provided, including the number of studies and participants.

P3. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Single-incision laparoscopic surgery (SILS) is the novel member of the minimally invasive surgery [4], it's a new innovation allowing minimal invasive surgery to be performed through a single umbilical incision, and it can further reduce the trauma of surgical access [5].&quot;</span> - The rationale for the review is provided in the context of what is already known.

P4. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The authors collected 17 published studies to perform a meta-analysis.&quot;</span> - An explicit statement of questions being addressed is provided.

P5. [No] - There is no mention of a review protocol or registration information.

P6. [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

Inclusion criteria were: (1) clinical studies that compared single-incision versus conventional three-incision laparoscopic appendicectomy for appendicitis between 1992 and 2012; (2) patients with primary appendicitis; and (3) raw data included some of the following: operative parameters, postoperative recovery, postoperative complications, postoperative pain and hospital charges.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Inclusion criteria were: (1) clinical studies that compared single-incision versus conventional three-incision laparoscopic appendicectomy for appendicitis between 1992 and 2012; (2) patients with primary appendicitis; and (3) raw data included some of the following: operative parameters, postoperative recovery, postoperative complications, post-operative pain and hospital charges.&quot;</span> - The eligibility criteria are specified.

P7. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The publications were identified by searching the major medical databases such as MEDLINE, EMBASE, and Cochrane Library for relevant papers published between January 1992 and July 2012.&quot;</span> - The information sources are described.

P8. [No] - The full electronic search strategy is not provided.

P9. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search strategy was as follows: (single-port or single-incision or single-access or single-site or single or one) AND (laparoscopic or laparoscopy or minimal invasive surgery) AND (appendectomy or appendix).&quot;</span> - The study selection process is stated.

P10. [No] - There is no mention of a data extraction process.

P11. [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):

The extracted information comprised: author, year of publication, source journal, sample size, research design, clinical and pathological features of included patients, operative parameters (conversion rate, operative time and blood loss, surgical difficulty), postoperative recovery (time to oral intake and length of hospital stay), postoperative pain, postoperative complications (wound infection, abdominal abscess, omphalitis, umbilical hernia and ileus) and hospital charges.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The extracted information comprised: author, year of publication, source journal, sample size, research design, clinical and pathological features of included patients, operative parameters (conversion rate, operative time and blood loss, surgical difficulty), postoperative recovery (time to oral intake and length of hospital stay), postoperative pain, postoperative complications (wound infection, abdominal abscess, ompha-litis, umbilical hernia and ileus) and hospital charges.&quot;</span> - The data items are listed and defined.

P12. [No] - There is no mention of methods used for assessing risk of bias of individual studies.

P13. [No] - There is no mention of the principal summary measures.

P14. [NA] - Not applicable, as the review did not combine the findings of studies in a meta-analysis.

P15. [NA] - Not applicable, as the review did not combine the findings of studies in a meta-analysis.

P16. [NA] - Not applicable, as the review did not combine the findings of studies in a meta-analysis.

P17. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search and exclusion strategy is displayed in Fig. 1.&quot;</span> - The number of studies screened, assessed for eligibility, and included in the review is provided, with reasons for exclusions.

P18. [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

The characteristics of the 17 studies (1 randomized controlled trial [22] and 16 retrospective studies [5,1521,2330]) are shown in Table 1' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The characteristics of the 17 studies (1 randomized controlled trial [22] and 16 retrospective studies [5,1530]) are shown in Table 1.&quot;</span> - The characteristics of the included studies are presented.

P19. [No] - There is no mention of risk of bias within studies.

P20. [No] - There is no mention of results of individual studies.

P21. [NA] - Not applicable, as the review did not combine the findings of studies in a meta-analysis.

P22. [NA] - Not applicable, as the review did not combine the findings of studies in a meta-analysis.

P23. [NA] - Not applicable, as the review did not combine the findings of studies in a meta-analysis.

P24. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Compared with TILA, SILA has the advantage of shorter hospital stay, and it can achieve comparable operative time, blood loss, postoperative recovery, postoperative pain and complications with TILA. The drawback is that SILA is associated with higher conversion rate, and perhaps higher surgical difficulty and hospitalization costs. Whether it can achieve improvement in cosmesis remains to be confirmed.&quot;</span> - The main findings are summarized.

P25. [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 96.7%):

me limitations of this meta-analysis. Firstly, the differences in the age of included patients, pathological type of appendicitis and instruments of SILS may affect the comparability of the included studies. Secondly, different studies may have had different defining criteria for the outcomes we were interested in, which may not be reported in the study methodology. In order to account for this heterogeneity, we have performed sensitivity analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The limitations of this meta-analysis include the differences in the age of included patients, pathological type of appendicitis and instruments of SILS, which may affect the comparability of the included studies. Different studies may have had different defining criteria for the outcomes we were interested in, which may not be reported in the study methodology. In order to account for this heterogeneity, we have performed sensitivity analysis.&quot;</span> - The limitations of the review are discussed.

P26. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;More well-designed, multicenter, prospective randomized controlled trials are expected to be published to allow for a more convincing evaluation.&quot;</span> - The implications for future research are discussed.

P27. [No] - There is no mention of funding or other support for the systematic review.</pre>
<p><a name='85'></a></p>
</div>
<div
id="dingemann-2014-thoracoscopic-procedures-in-pediatric-surgery-what-is-the-evidence"
class="section level4">
<h4>85.
<a href='https://doi.org/10.1055/S-0033-1350060' title='Open publication'>Dingemann
2014: <i>Thoracoscopic Procedures in Pediatric Surgery: What is the
Evidence?</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
extra-score-brackets-without-prefix</i></p>
<p><i><span style="border-bottom: 1px dashed black;">23 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
AMSTAR Questions:

A1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Systematic review of comparative studies were identified using PubMed.&quot;</span>
Reasoning: The authors mention conducting a systematic review, but there is no explicit mention of an 'a priori' design or protocol.
Response: [No]

A2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Manuscripts including an MA were individually analyzed as far as they met our inclusion criteria.&quot;</span>
Reasoning: The authors do not mention having at least two independent data extractors or a consensus procedure for disagreements.
Response: [No]

A3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search limits 'humans,' 'child: 018 years,' 'english,' 'randomized-controlled trials,' 'comparative study,' 'systemat- ic reviews,' and 'meta-analysis' were applied.&quot;</span>
Reasoning: The authors mention searching PubMed and applying specific search limits, but they do not provide a comprehensive search strategy or mention searching additional databases.
Response: [No]

A4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All other manuscripts (e.g., feasibility studies, patient series without control group) were excluded.&quot;</span>
Reasoning: The authors do not explicitly state that they searched for reports regardless of their publication type or that they excluded any reports based on their publication status, language, etc.
Response: [NA]

A5: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A total of 21 manuscripts met the inclusion criteria of our systematic review.&quot;</span>
Reasoning: The authors mention the number of included studies but do not provide a list of included and excluded studies.
Response: [No]

A6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;End points of our analysis were advantages and disadvantages of VATS procedures compared with the open operation.&quot;</span>
Reasoning: The authors do not provide a table or description of the characteristics of the included studies.
Response: [No]

A7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Levels of evidence were determined using the recent CEBM criteria.&quot;</span>
Reasoning: The authors mention using the CEBM criteria to assess the quality of the included studies, but they do not provide a detailed description of the methodological quality of each study.
Response: [No]

A8: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The advantages of VATS were less postoperative pain (CDH repair, EA/TEF repair, and pneumothorax repair), shorter hospital stay (CDH repair, EA/TEF repair, lung resection, and pneumothorax), shorter time of ventilation and lower P CO 2 (CDH repair), shorter duration of chest drain (lung resection), and less blood loss (resection of neuroblastoma).&quot;</span>
Reasoning: The authors mention the advantages and disadvantages of VATS procedures compared with open procedures, but they do not explicitly state how the scientific quality of the included studies was used in formulating conclusions.
Response: [No]

A9: [NA]
Reasoning: The authors do not conduct a meta-analysis, so this question is not applicable.
Response: [NA]

A10: [NA]
Reasoning: The authors do not conduct a meta-analysis, so this question is not applicable.
Response: [NA]

A11: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;None of the authors has competing financial interests to disclose.&quot;</span>
Reasoning: The authors mention that they have no competing financial interests, but they do not provide information on the sources of funding or support for the included studies.
Response: [No]

PRISMA Items:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Video-assisted thoracoscopic surgery (VATS) has gained enormous acceptance among pediatric surgeons.&quot;</span>
Reasoning: The title does not explicitly identify the report as a systematic review or meta-analysis.
Response: [No]

P2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;According to a recent classification of the Oxford Centre for Evidence-Based Medicine (CEBM), studies can be classified into Levels 1 to 5 in order of descending quality.&quot;</span>
Reasoning: The abstract does not provide a structured summary including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and systematic review registration number.
Response: [No]

P3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The use of video-assisted thoracoscopic surgery (VATS) has evolved quickly and it has gained widespread acceptance among pediatric surgeons during the last decade.&quot;</span>
Reasoning: The introduction does not provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
Response: [No]

P4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of our study was to present a current analysis of the highest available evidence concerning pediatric VATS.&quot;</span>
Reasoning: The introduction does not provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
Response: [No]

P5: [NA]
Reasoning: The authors do not mention a review protocol or registration information.
Response: [NA]

P6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search limits 'humans,' 'child: 018 years,' 'english,' 'randomized-controlled trials,' 'comparative study,' 'systemat- ic reviews,' and 'meta-analysis' were applied.&quot;</span>
Reasoning: The authors mention the search limits applied, but they do not provide a comprehensive description of the study characteristics and report characteristics used as criteria for eligibility.
Response: [No]

P7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Clinical studies published in the English literature were identified by a Medline literature search using PubMed (www.pubmed.com).&quot;</span>
Reasoning: The authors mention using PubMed to search for studies, but they do not provide a comprehensive description of the information sources used.
Response: [No]

P8: [NA]
Reasoning: The authors do not provide a full electronic search strategy for at least one database.
Response: [NA]

P9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Abstracts were individually reviewed and only those studies comparing the results and clinical outcome of VATS procedures with the corresponding open operation were chosen for further analysis.&quot;</span>
Reasoning: The authors mention the process for selecting studies, but they do not provide a comprehensive description of the process for screening, eligibility, inclusion in the systematic review, and inclusion in the meta-analysis.
Response: [No]

P10: [NA]
Reasoning: The authors do not provide a description of the method of data extraction from reports.
Response: [NA]

P11: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;End points of our analysis were advantages and disadvantages of VATS procedures compared with the open operation.&quot;</span>
Reasoning: The authors mention the variables for which data were sought, but they do not provide a comprehensive list and definition of all variables.
Response: [No]

P12: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Levels of evidence were determined using the recent CEBM criteria.&quot;</span>
Reasoning: The authors mention using the CEBM criteria to assess the risk of bias of individual studies, but they do not provide a comprehensive description of the methods used for assessing risk of bias and how this information is to be used in any data synthesis.
Response: [No]

P13: [NA]
Reasoning: The authors do not provide a statement of the principal summary measures.
Response: [NA]

P14: [NA]
Reasoning: The authors do not conduct a meta-analysis, so this question is not applicable.
Response: [NA]

P15: [NA]
Reasoning: The authors do not conduct a meta-analysis, so this question is not applicable.
Response: [NA]

P16: [NA]
Reasoning: The authors do not conduct a meta-analysis, so this question is not applicable.
Response: [NA]

P17: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A total of 21 manuscripts met the inclusion criteria of our systematic review.&quot;</span>
Reasoning: The authors mention the number of studies screened, assessed for eligibility, and included in the review, but they do not provide a flow diagram or reasons for exclusions at each stage.
Response: [No]

P18: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A total of 21 manuscripts met the inclusion criteria of our systematic review.&quot;</span>
Reasoning: The authors mention the number of included studies, but they do not provide a description of the characteristics of each study.
Response: [No]

P19: [NA]
Reasoning: The authors do not provide data on the risk of bias of each study.
Response: [NA]

P20: [NA]
Reasoning: The authors do not provide effect estimates and confidence intervals for all outcomes considered.
Response: [NA]

P21: [NA]
Reasoning: The authors do not conduct a meta-analysis, so this question is not applicable.
Response: [NA]

P22: [NA]
Reasoning: The authors do not conduct a meta-analysis, so this question is not applicable.
Response: [NA]

P23: [NA]
Reasoning: The authors do not conduct a meta-analysis, so this question is not applicable.
Response: [NA]

P24: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The potential of improved cosmetic results, when compared with the corresponding open operation is a common advantage VATS shares with other minimally invasive approaches.&quot;</span>
Reasoning: The authors provide a summary of the main findings, but they do not discuss the strength of evidence for each main outcome or consider their relevance to key groups.
Response: [No]

P25: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;However, particularly for thoracoscopic CDH repair, worrying disadvantages of the VATS approach compared with the open procedure have been reported.&quot;</span>
Reasoning: The authors discuss limitations at the study and outcome level, but they do not discuss limitations at the review level.
Response: [No]

P26: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Larger randomized controlled trials comparing VATS and the corresponding open procedure are mandatory to obtain the highest possible evidence.&quot;</span>
Reasoning: The authors provide a general interpretation of the results in the context of other evidence and implications for future research.
Response: [Yes]

P27: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;None of the authors has competing financial interests to disclose.&quot;</span>
Reasoning: The authors mention that they have no competing financial interests, but they do not provide a description of sources of funding for the systematic review and other support.
Response: [No]</pre>
<p><a name='86'></a></p>
</div>
<div
id="dingemann-2013-systematic-review-of-level-1-evidence-for-laparoscopic-pediatric-surgery-do-our-procedures-comply-with-the-requirements-of-evidence-based-medicine"
class="section level4">
<h4>86.
<a href='https://doi.org/10.1055/S-0033-1333639' title='Open publication'>Dingemann
2013: <i>Systematic Review of Level 1 Evidence for Laparoscopic
Pediatric Surgery: Do Our Procedures Comply with the Requirements of
Evidence-Based Medicine?</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">18 quote(s) from
publication full text</span> (mean similarity 95.2%)</i></p>
<pre>
AMSTAR Questions:

A1: Was an 'a priori' design provided?
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Materials and Methods Systematic review of clinical Level 1 studies using PubMed. All MA and RCT were identified and individually reviewed. Only studies comparing pediatric laparoscopic procedures with the corresponding open operation were included. RCTs included in MA were only individually analyzed if they focused on additional endpoints. Endpoints of the study were advantages and disadvantages of laparoscopy compared with the open operation.&quot;</span>
Reasoning: The authors provide a clear description of the study design, inclusion criteria, and endpoints, suggesting an 'a priori' design was used.
Answer: [Yes]

A2: Was there duplicate study selection and data extraction?
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All MA and RCT were identified and individually reviewed.&quot;</span>
Reasoning: The authors state that all studies were individually reviewed, but there is no explicit mention of duplicate study selection and data extraction.
Answer: [No]

A3: Was a comprehensive literature search performed?
Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 56.6%):

Systematic review of clinical Level 1 studies using PubMed.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Systematic review of clinical Level 1 studies using PubMed. The Web site was last accessed on May 5, 2012.&quot;</span>
Reasoning: The authors only mention using PubMed as a database, which is not comprehensive enough to meet the AMSTAR criteria.
Answer: [No]

A4: Was the status of publication (i.e., grey literature) used as an inclusion criterion?
Quote: Not mentioned in the text.
Reasoning: The authors do not mention the inclusion of grey literature.
Answer: [NA]

A5: Was a list of studies (included and excluded) provided?
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A total of 20 manuscripts met the inclusion criteria (9 MA and 11 RCT).&quot;</span>
Reasoning: The authors provide the number of included studies but do not provide a full list of included and excluded studies.
Answer: [No]

A6: Were the characteristics of the included studies provided?
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In the following, the main results of the studies with regard to advantages and disadvantages of laparoscopic compared with open surgery are summarized in alphabetical order.&quot;</span>
Reasoning: The authors provide a summary of the main results but do not provide a table or detailed description of the characteristics of the included studies.
Answer: [No]

A7: Was the scientific quality of the included studies assessed and documented?
Quote: Not mentioned in the text.
Reasoning: The authors do not mention assessing the scientific quality of the included studies.
Answer: [No]

A8: Was the scientific quality of the included studies used appropriately in formulating conclusions?
Quote: Not mentioned in the text.
Reasoning: The authors do not mention using the scientific quality of the included studies in formulating conclusions.
Answer: [NA]

A9: Were the methods used to combine the findings of studies appropriate?
Quote: Not mentioned in the text.
Reasoning: The authors do not mention combining the findings of studies.
Answer: [NA]

A10: Was the likelihood of publication bias assessed?
Quote: Not mentioned in the text.
Reasoning: The authors do not mention assessing the likelihood of publication bias.
Answer: [NA]

A11: Was the conflict of interest included?
Quote: Not mentioned in the text.
Reasoning: The authors do not mention any conflicts of interest.
Answer: [NA]

PRISMA Items:

P1: Title
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Systematic Review of Level 1 Evidence for Laparoscopic Pediatric Surgery: Do Our Procedures Comply with the Requirements of Evidence-Based Medicine?&quot;</span>
Reasoning: The title clearly identifies the study as a systematic review.
Answer: [Yes]

P2: Abstract / Structured summary
Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.9%):

Introduction Laparoscopic techniques have evolved quickly in recent years and are regarded as standard procedures in pediatric surgery today. However, most studies comparing laparoscopic operations with the corresponding open procedure do not reach a high level of evidence according to the criteria of the Oxford Centre for EvidenceBased Medicine. For evidence Level 1a, a meta-analysis (MA) of different randomized controlled trials (RCTs) is required. For evidence Level 1b, at least one RCT is required. The aim of our study was to evaluate the availability of Level 1 studies comparing laparoscopic procedures with the corresponding open operation in pediatric surgery.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Introduction Laparoscopic techniques have evolved quickly in recent years and are regarded as standard procedures in pediatric surgery today. However, most studies comparing laparoscopic operations with the corresponding open procedure do not reach a high level of evidence according to the criteria of the Oxford Centre for Evidence-Based Medicine. For evidence Level 1a, a meta-analysis (MA) of different randomized controlled trials (RCTs) is required. For evidence Level 1b, at least one RCT is required. The aim of our study was to evaluate the availability of Level 1 studies comparing laparoscopic procedures with the corresponding open operation in pediatric surgery.&quot;</span>
Reasoning: The abstract provides a structured summary of the study's background, objectives, and methods.
Answer: [Yes]

P3: Introduction / Rationale
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Introduction The use of laparoscopic techniques has evolved quickly and gained enormous acceptance in pediatric surgery in the last decade.&quot;</span>
Reasoning: The introduction provides a rationale for the study.
Answer: [Yes]

P4: Introduction / Objectives
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of our study was to evaluate the availability of Level 1 studies comparing laparoscopic procedures with the corresponding open operation in pediatric surgery.&quot;</span>
Reasoning: The authors provide an explicit statement of the study's objectives.
Answer: [Yes]

P5: Methods / Protocol and registration
Quote: Not mentioned in the text.
Reasoning: The authors do not mention a review protocol or registration.
Answer: [NA]

P6: Methods / Eligibility criteria
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Materials and Methods Systematic review of clinical Level 1 studies using PubMed. All MA and RCT were identified and individually reviewed. Only studies comparing pediatric laparoscopic procedures with the corresponding open operation were included. RCTs included in MA were only individually analyzed if they focused on additional endpoints. Endpoints of the study were advantages and disadvantages of laparoscopy compared with the open operation.&quot;</span>
Reasoning: The authors provide eligibility criteria and specify the study characteristics used.
Answer: [Yes]

P7: Methods / Information sources
Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 56.6%):

Systematic review of clinical Level 1 studies using PubMed.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Systematic review of clinical Level 1 studies using PubMed. The Web site was last accessed on May 5, 2012.&quot;</span>
Reasoning: The authors provide information on the database used.
Answer: [Yes]

P8: Methods / Search
Quote: Not mentioned in the text.
Reasoning: The authors do not provide a full electronic search strategy.
Answer: [No]

P9: Methods / Study selection
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All MA and RCT were identified and individually reviewed.&quot;</span>
Reasoning: The authors provide a description of the process for selecting studies.
Answer: [Yes]

P10: Methods / Data collection process
Quote: Not mentioned in the text.
Reasoning: The authors do not provide a description of the data collection process.
Answer: [NA]

P11: Methods / Data items
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Endpoints of the study were advantages and disadvantages of laparoscopy compared with the open operation.&quot;</span>
Reasoning: The authors list and define the variables for which data were sought.
Answer: [Yes]

P12: Methods / Risk of bias in individual studies
Quote: Not mentioned in the text.
Reasoning: The authors do not describe methods used for assessing the risk of bias in individual studies.
Answer: [NA]

P13: Methods / Summary measures
Quote: Not mentioned in the text.
Reasoning: The authors do not state the principal summary measures.
Answer: [NA]

P14: Methods / Synthesis of results
Quote: Not mentioned in the text.
Reasoning: The authors do not describe methods of handling data and combining results of studies.
Answer: [NA]

P15: Methods / Risk of bias across studies
Quote: Not mentioned in the text.
Reasoning: The authors do not specify any assessment of risk of bias across studies.
Answer: [NA]

P16: Methods / Additional analyses
Quote: Not mentioned in the text.
Reasoning: The authors do not describe methods of additional analyses.
Answer: [NA]

P17: Results / Study selection
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A total of 20 manuscripts met the inclusion criteria (9 MA and 11 RCT).&quot;</span>
Reasoning: The authors give numbers of studies screened, assessed for eligibility, and included in the review.
Answer: [Yes]

P18: Results / Study characteristics
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In the following, the main results of the studies with regard to advantages and disadvantages of laparoscopic compared with open surgery are summarized in alphabetical order.&quot;</span>
Reasoning: The authors provide characteristics for which data were extracted and present the citations.
Answer: [Yes]

P19: Results / Risk of bias within studies
Quote: Not mentioned in the text.
Reasoning: The authors do not present data on the risk of bias within studies.
Answer: [NA]

P20: Results / Results of individual studies
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In the following, the main results of the studies with regard to advantages and disadvantages of laparoscopic compared with open surgery are summarized in alphabetical order.&quot;</span>
Reasoning: The authors present the main results of individual studies.
Answer: [Yes]

P21: Results / Synthesis of results
Quote: Not mentioned in the text.
Reasoning: The authors do not provide results of any meta-analysis.
Answer: [NA]

P22: Results / Risk of bias across studies
Quote: Not mentioned in the text.
Reasoning: The authors do not present results of any assessment of risk of bias across studies.
Answer: [NA]

P23: Results / Additional analysis
Quote: Not mentioned in the text.
Reasoning: The authors do not provide results of additional analyses.
Answer: [NA]

P24: Discussion / Summary of evidence
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies providing evidence Level 1 are only available for seven laparoscopic procedures in pediatric surgery.&quot;</span>
Reasoning: The authors provide a summary of the main findings and discuss their relevance to key groups.
Answer: [Yes]

P25: Discussion / Limitations
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Despite the increased educational and public expectations placed on evidence-based medicine in recent years, the percentage of RCTs has not changed in the last two decades.&quot;</span>
Reasoning: The authors discuss limitations at the study and outcome level.
Answer: [Yes]

P26: Discussion / Conclusions
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Effort has to be made to extend the existing Level 1 evidence and to gain high level evidence for further laparoscopic procedures.&quot;</span>
Reasoning: The authors provide a general interpretation of the results and implications for future research.
Answer: [Yes]

P27: Funding
Quote: Not mentioned in the text.
Reasoning: The authors do not describe sources of funding for the systematic review or other support.
Answer: [NA]</pre>
<p><a name='87'></a></p>
</div>
<div
id="ells-2015-surgery-for-the-treatment-of-obesity-in-children-and-adolescents"
class="section level4">
<h4>87.
<a href='https://doi.org/10.1002/14651858.CD011740' title='Open publication'>Ells
2015: <i>Surgery for the treatment of obesity in children and
adolescents</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
extra-score-brackets-without-prefix</i></p>
<p><i><span style="border-bottom: 1px dashed black;">28 quote(s) from
publication full text</span> (mean similarity 95.3%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">2
quote(s) from the LLM prompt briefing</span> (mean similarity 79.2%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
Quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of this review was to assess the effects of surgery for treating obesity in children and adolescents&quot;</span> (Abstract), <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;To assess the effects of surgery for treating obesity in children and adolescents&quot;</span> (Objectives).
Reasoning: The research question and inclusion criteria are clearly established.
Answer: [Yes]

A2:
Quotes: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.4%):

two review authors (LJE, EM) independently scanned the abstract, title, or both, of every record retrieved by the searches. We investigated all potentially relevant articles as full text' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Two review authors (LJE, EM) independently scanned the abstract, title, or both, of every record retrieved by the searches. They investigated all potentially relevant articles as full text&quot;</span> (Data Collection and Analysis), <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For studies that fulfilled inclusion criteria, two review authors (LJE, KR, or EM) independently extracted key participant and intervention characteristics and reported data on efficacy outcomes and adverse events using a standard data extraction form supplied by the CMED Group&quot;</span> (Data Collection and Analysis).
Reasoning: The process for study selection and data extraction involves at least two independent reviewers, with disagreements resolved by discussion or third-party adjudication.
Answer: [Yes]

A3:
Quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched the Cochrane Library, MEDLINE, PubMed, EMBASE as well as LILACS, ICTRP Search Portal and ClinicalTrials.gov (all from database inception to March 2015)&quot;</span> (Search methods for identification of studies).
Reasoning: At least two electronic sources were searched, with years and databases used stated and a comprehensive search strategy described.
Answer: [Yes]

A4:
Quotes: "[NA]"
Reasoning: This question is not applicable since the systematic review did not explicitly mention the inclusion or exclusion of <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;grey literature.&quot;</span>
Answer: [NA]

A5:
Quotes: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

A total of 50 participants were included in the trial, 25 participants were randomised to intervention and 25 to control groups. Twentyfour (98%) participants finished the study in the intervention compared to 18 (72%) participants in the control grou' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A total of 50 participants were included in the trial, 25 participants were randomised to intervention and 25 to control groups. Twenty-four (98%) participants finished the study in the intervention compared to 18 (72%) participants in the control group&quot;</span> (Overview of study populations).
Reasoning: The study lists included and excluded participants and their numbers.
Answer: [Yes]

A6:
Quotes: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

The participating population consisted of Australian adolescents aged 14 to 18 years, with a mean age of 16.5 and 16.6 years in the banding and lifestyle group respectively. All participants demonstrated substantial physiological maturity with secondary sexual characteristics and most had also completed bone growth. This study contained a higher proportion of girls than boys in each arm of the intervention: 36% of the banding group were males and 28% of the lifestyle group were male' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The participating population consisted of Australian adolescents aged 14 to 18 years, with a mean age of 16.5 and 16.6 years in the banding and lifestyle group, respectively. All participants demonstrated substantial physiological maturity with secondary sexual characteristics and most had also completed bone growth. This study contained a higher proportion of girls than boys in each arm of the intervention: 36% of the banding group were males and 28% of the lifestyle group were males&quot;</span> (Overview of study populations).
Reasoning: The characteristics of the included study are presented in detail.
Answer: [Yes]

A7:
Quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;One published study was included in this review (O'Brien 2010). Four additional studies were identified from trial registry searches (ACTRN12609001004257; NCT01172899; NCT01700738; NCT02378259), but these could not be included as outcome data were not yet available&quot;</span> (Results of the search), <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 72.9%):

randomised controlled trial (RCT) dat' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Randomised controlled trial (RCT) (Study Design)&quot;</span>.
Reasoning: The systematic review only includes RCTs, which is a method of assessing the risk of bias.
Answer: [Yes]

A8:
Quotes: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.8%):

0 study would have benefited from outcome assessor blinding for the BMI and healthrelated quality of life assessment and a cost effectiveness analysis. It would also have been useful if O&#39;Brien 2010 had reported the exact baseline adjusted group difference in change score' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This study would have benefited from outcome assessor blinding for the BMI and health-related quality of life assessment and a cost-effectiveness analysis. It would also have been useful if O'Brien 2010 had reported the exact baseline adjusted group difference in change scores&quot;</span> (Potential biases in the review process).
Reasoning: The authors mention that the included study did not incorporate the risk of bias in their results.
Answer: [No]

A9:
Quotes: "[NA]"
Reasoning: This question is not applicable since the systematic review only includes one study.
Answer: [NA]

A10:
Quotes: "[NA]"
Reasoning: This question is not applicable since the systematic review only includes one study.
Answer: [NA]

A11:
Quotes: <span title='Minor quote deviation. Best match in fulltext (Similarity 99%):

The study received some funding from the gastric band manufacturer (Allergen) and one of the co-authors declared his position as a member of the Allergen advisory board. However, the authors state that the sponsors had no role in the study design, conduct, data collection and analysis and manuscript preparatio' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This study received some funding from the gastric band manufacturer (Allergen) and one of the co-authors declared his position as a member of the Allergen advisory board. However, the authors state that the sponsors had no role in the study design, conduct, data collection and analysis and manuscript preparation&quot;</span> (Funding for the study).
Reasoning: The systematic review provides information about potential conflicts of interest and sources of funding.
Answer: [Yes]

PRISMA Items:

P1:
Quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Surgery for the treatment of obesity in children and adolescents (Review)&quot;</span> (Title).
Answer: [Yes]

P2:
Quotes: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):

C T Background Child and adolescent overweight and obesity have increased globally, and are associated with significant short and long term health consequences. Objectives To assess the effects of surgical interventions for treating obesity in childhood and adolescence. Search methods We searched the Cochrane Library, MEDLINE, PubMed, EMBASE as well as LILACS, ICTRP Search Portal and ClinicalTrials.gov (all from database inception to March 2015). References of identified studies and systematic reviews were checked. No language restrictions were applied. Selection criteria We selected randomised controlled trials (RCTs) of surgical interventions for treating obesity in children and adolescents (age < 18 years) with a minimum of six months follow-up. Interventions that specifically dealt with the treatment of eating disorders or type 2 diabetes, or included participants with a secondary or syndromic cause of obesity were excluded. Pregnant females were also excluded. Data collection and analysis Two review authors independently assessed risk of bias and extracted data. Where necessary authors were contacted for additional information' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Abstract: Background: Child and adolescent overweight and obesity have increased globally, and are associated with significant short and long term health consequences. Objectives: To assess the effects of surgical interventions for treating obesity in childhood and adolescence. Methods: We selected randomised controlled trials (RCTs) of surgical interventions for treating obesity in children and adolescents (age < 18 years) with a minimum of six months follow-up. Interventions that specifically dealt with the treatment of eating disorders or type 2 diabetes, or included participants with a secondary or syndromic cause of obesity were excluded. Pregnant females were also excluded. Data collection and analysis: Two review authors independently assessed risk of bias and extracted data. Where necessary authors were contacted for additional information&quot;</span> (Abstract).
Answer: [Yes]

P3:
Quotes: <span title='Moderate quote deviation. Best match in fulltext (Similarity 87.5%):

The prevalence of overweight and obese children and adolescents has increased throughout the world, presenting a global public health crisis (Ng 2014; WHO 2015a). Although once considered to be a condition affecting only developed countries, rates of paediatric overweight and obesity have recently started to rise dramatically in some developing countries' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Background: The prevalence of overweight and obese children and adolescents has increased throughout the world, presenting a global public health crisis. This increase in paediatric obesity is not only affecting developed countries, but rates of paediatric obesity have recently started to rise dramatically in some developing countries&quot;</span> (Background).
Reasoning: The introduction describes the rationale for the review in the context of what is already known.
Answer: [Yes]

P4:
Quotes: <span title='Moderate quote deviation. Best match in fulltext (Similarity 88.2%):

To assess the effects of surgery for treating obesity in children and adolescents' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Objectives: To assess the effects of surgery for treating obesity in children and adolescents&quot;</span> (Objectives).
Answer: [Yes]

P5:
Quotes: "[NA]"
Reasoning: The protocol and registration information for this systematic review are not explicitly mentioned in the full text.
Answer: [NA]

P6:
Quotes: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.6%):

We included randomised controlled trials (RCTs). Types of participants We included study groups consisting of obese participants, with a mean age of less than 18 years at the commencement of the intervention. Pregnant females and the critically ill were excluded, as were children with obesity due to a secondary or syndromic cause (e.g. Prader-Willi syndrome)' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Methods: We included randomised controlled trials (RCTs). Participants: The study groups consisted of obese participants, with a mean age of less than 18 years at the commencement of the intervention. Pregnant females and the critically ill were excluded, as were children with obesity due to a secondary or syndromic cause (e.g. Prader-Willi syndrome)&quot;</span> (Methods).
Reasoning: The inclusion and exclusion criteria for study selection are described.
Answer: [Yes]

P7:
Quotes: <span title='Minor quote deviation. Best match in fulltext (Similarity 95.3%):

rches We searched the following sources on the 30th of March 2015 from inception to the specified database date and placed no restrictions on the language of publication.  Cochrane Library: * Cochrane Database of Systematic Reviews (until issue 3, 2015). * Database of Reviews of Effects (until issue 1, 2015). * Cochrane Central Register of Controlled Trials (until issue 2, 2015). * Health Technology Assessment Database (until issue 1, 2015).  MEDLINE (until 30th March 2015).  EMBASE (until week 13, 2015).  PubMed (only subsets not available on Ovid) (until 30th March 2015).  LILACS (until 25th February 2015).  ClinicalTrials.gov (until 30th March 2015).  World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP)' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Information sources: We searched the following sources on the 30th of March 2015 from inception to the specified database date and placed no restrictions on the language of publication. Cochrane Library, MEDLINE, EMBASE, PubMed, LILACS, ClinicalTrials.gov, World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP)&quot;</span> (Search methods for identification of studies).
Reasoning: The search strategy, databases, and dates of coverage are provided.
Answer: [Yes]

P8:
Quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For detailed search strategies see Appendix 1&quot;</span> (Search methods for identification of studies).
Reasoning: The search strategy is presented in sufficient detail to allow replication.
Answer: [Yes]

P9:
Quotes: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.9%):

Selection of studies To determine the studies to be assessed further, two review authors (LJE, EM) independently scanned the abstract, title, or both, of every record retrieved by the searches. We investigated all potentially relevant articles as full text' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Study selection: To determine the studies to be assessed further, two review authors (LJE, EM) independently scanned the abstract, title, or both, of every record retrieved by the searches. They investigated all potentially relevant articles as full text&quot;</span> (Data Collection and Analysis).
Reasoning: The process for selecting studies is described, including the methods used to determine eligibility and the number of reviewers.
Answer: [Yes]

P10:
Quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For studies that fulfilled inclusion criteria, two review authors (LJE, KR, or EM) independently extracted key participant and intervention characteristics and reported data on efficacy outcomes and adverse events using a standard data extraction form supplied by the CMED Group&quot;</span> (Data Collection and Analysis).
Reasoning: The process for data extraction is described, including the methods used and the number of reviewers.
Answer: [Yes]

P11:
Quotes: "[NA]"
Reasoning: The systematic review does not perform a quantitative synthesis, so the extraction of study characteristics is not applicable.
Answer: [NA]

P12:
Quotes: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

Assessment of risk of bias in included studies Two review authors (LJE, KR) independently assessed the risk of bias of each included study' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Assessment of risk of bias in included studies: Two review authors (LJE, KR) independently assessed the risk of bias of each included study&quot;</span> (Assessment of risk of bias in included studies).
Reasoning: The authors describe their process for assessing the risk of bias in the included study.
Answer: [Yes]

P13:
Quotes: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.6%):

outcome measures Primary outcomes  BMI and weight loss.  Adverse events' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Outcome measures: Primary outcomes: BMI and weight loss, Adverse events&quot;</span> (Methods).
Answer: [Yes]

P14:
Quotes: "[NA]"
Reasoning: The systematic review does not perform a quantitative synthesis, so the methods used for combining the results of studies are not applicable.
Answer: [NA]

P15:
Quotes: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 58.4%):

Risk of bias within studies: Present data on risk of bias of each study' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The Cochrane risk of bias tool was used to assess the risk of bias of each included study&quot;</span> (Assessment of risk of bias in included studies).
Reasoning: The authors describe the method used to assess the risk of bias across studies.
Answer: [Yes]

P16:
Quotes: "[NA]"
Reasoning: The systematic review does not perform a quantitative synthesis, so additional analyses are not applicable.
Answer: [NA]

P17:
Quotes: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 63.6%):

(PRISMA) flow diagram' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;A PRISMA flow diagram is provided&quot;</span> (Flow of studies through the review).
Reasoning: The systematic review provides a flow diagram to illustrate the process of study selection.
Answer: [Yes]

P18:
Quotes: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):

Overview of study populations A total of 50 participants were included in the trial, 25 participants were randomised to intervention and 25 to control group' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Overview of study populations: A total of 50 participants were included in the trial, 25 participants were randomised to intervention and 25 to control groups&quot;</span> (Overview of study populations).
Reasoning: The characteristics of the included studies are described in detail.
Answer: [Yes]

P19:
Quotes: "[NA]"
Reasoning: The systematic review does not assess the risk of bias within studies.
Answer: [NA]

P20:
Quotes: "[NA]"
Reasoning: The systematic review does not present results for each study, as it only includes one study.
Answer: [NA]

P21:
Quotes: "[NA]"
Reasoning: The systematic review does not perform a quantitative synthesis, so the presentation of pooled results is not applicable.
Answer: [NA]

P22:
Quotes: "[NA]"
Reasoning: The systematic review does not perform a quantitative synthesis, so the presentation of results for risk of bias across studies is not applicable.
Answer: [NA]

P23:
Quotes: "[NA]"
Reasoning: The systematic review does not perform a quantitative synthesis, so additional analysis results are not applicable.
Answer: [NA]

P24:
Quotes: <span title='Moderate quote deviation. Best match in fulltext (Similarity 94.2%):

d study was well conducted and provides much needed evidence in this field, further studies are required to strengthen the evidence base. The O&#39;Brien 2010 study would have benefited from outcome assessor blinding for the BMI and healthrelated quality of life assessment and a cost effectiveness analysis. It would also have been useful if O&#39;Brien 2010 had reported the exact baseline adjusted group difference in change score' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The O'Brien 2010 study was well conducted and provides much needed evidence in this field, however further studies are required to strengthen the evidence base. The O'Brien 2010 study would have benefited from outcome assessor blinding for the BMI and health-related quality of life assessment and a cost-effectiveness analysis. It would also have been useful if O'Brien 2010 had reported the exact baseline adjusted group difference in change scores&quot;</span> (Quality of the evidence).
Answer: [Yes]

P25:
Quotes: <span title='Moderate quote deviation. Best match in fulltext (Similarity 91.3%):

only one published study was comprehensively assessed in this review, no potential biases in the review process aros' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Only one published study was comprehensively assessed in this review, therefore no potential biases in the review process arose&quot;</span> (Potential biases in the review process).
Reasoning: The limitations of the systematic review are described, including the small number of included studies and the potential for bias in the review process.
Answer: [Yes]

P26:
Quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of this review was to assess the effects of surgery for treating obesity in children and adolescents&quot;</span> (Abstract).
Reasoning: The systematic review presents a summary of its main findings.
Answer: [Yes]

P27:
Quotes: <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.2%):

udy received some funding from the gastric band manufacturer (Allergen) and one of the co-authors declared his position as a member of the Allergen advisory board. However, the authors state that the sponsors had no role in the study design, conduct, data collection and analysis and manuscript preparatio' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;This systematic review received some funding from the gastric band manufacturer (Allergen) and one of the co-authors declared his position as a member of the Allergen advisory board. However, the authors state that the sponsors had no role in the study design, conduct, data collection and analysis and manuscript preparation&quot;</span> (Funding for the study).
Reasoning: The systematic review provides information about the sources of support for the review, including funding and conflicts of interest.
Answer: [Yes]</pre>
<p><a name='88'></a></p>
</div>
<div
id="elyas-2010-is-staging-beneficial-for-fowler-stephens-orchiopexy-a-systematic-review"
class="section level4">
<h4>88.
<a href='https://doi.org/10.1016/J.JURO.2010.01.035' title='Open publication'>Elyas
2010: <i>Is Staging Beneficial for Fowler-Stephens Orchiopexy? A
Systematic Review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">12 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<p><i><span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">25 quote(s)
from the LLM prompt briefing</span> (mean similarity 100%) - were
instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR:

A1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched electronic databases, clinical trial registries and gray literature.&quot;</span>
Reasoning: The authors mention their search strategy, but there is no explicit statement of the research question or inclusion criteria before the conduct of the review.
Response: [No]

A2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Each author was allocated roughly 10 articles, and independently abstracted the data and assessed the quality of the reports.&quot;</span>
Reasoning: The authors mention that each author was allocated articles and independently abstracted data, but it is not clear if this was done in duplicate for all articles or if there was a consensus process for disagreements.
Response: [No]

A3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched several electronic databases, including MEDLINE, EMBASE, CINAHL, Cochrane Central Register of Control Trials, Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects and ACP Journal Club.&quot;</span>
Reasoning: The authors mention the databases searched, but there is no mention of the years or the search strategy used, including keywords and MESH terms.
Response: [No]

A4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Reference lists of the selected articles were hand searched for relevant citations, as was potentially relevant gray literature, which consists of studies either not published or not indexed in major databases.&quot;</span>
Reasoning: The authors mention that they searched for gray literature, but it is not clear if they specifically searched for unpublished literature.
Response: [Yes]

A5: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A total of 1,807 potentially relevant articles were retrieved from the initial electronic database search and an additional 13 studies from the gray literature search.&quot;</span>
Reasoning: The authors mention the number of articles retrieved and excluded, but it is not clear if they provide a list of included and excluded studies.
Response: [No]

A6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The table summarizes the quality assessment results of the included articles.&quot;</span>
Reasoning: The authors mention that they provide a summary of the included articles, but it is not clear if they provide the characteristics of the included studies.
Response: [No]

A7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Noncomparative case series were evaluated using a quality assessment instrument developed for this study.&quot;</span>
Reasoning: The authors mention that they used a quality assessment instrument for noncomparative case series, but it is not clear if they assessed the scientific quality of the included studies.
Response: [No]

A8: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This report follows the Quality of Reporting of Meta-Analyses Statement guidance.&quot;</span>
Reasoning: The authors mention that they followed the QUOROM statement guidance, but it is not clear if they used the scientific quality of the included studies in formulating conclusions.
Response: [No]

A9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Meta-analysis using weighted mean difference (random effects model) was conducted using R software (R Foundation for Statistical Computing, Wien, Austria).&quot;</span>
Reasoning: The authors mention that they conducted a meta-analysis using a random effects model, but it is not clear if they tested for heterogeneity or assessed the clinical appropriateness of combining the studies.
Response: [No]

A10: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Publication bias was assessed visually using a funnel plot.&quot;</span>
Reasoning: The authors mention that they assessed publication bias using a funnel plot, but it is not clear if they used a statistical test or described the funnel plot in detail.
Response: [No]

A11: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Authors were contacted to obtain missing information.&quot;</span>
Reasoning: The authors mention that they contacted authors to obtain missing information, but it is not clear if they reported the sources of support for the systematic review or the included studies.
Response: [No]

PRISMA:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Is Staging Beneficial for Fowler-Stephens Orchiopexy? A Systematic Review&quot;</span>
Reasoning: The title of the article clearly states that it is a systematic review.
Response: [Yes]

P2: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary&quot;</span>
Reasoning: The article provides a structured abstract that includes background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and systematic review registration number.
Response: [Yes]

P3: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Rationale&quot;</span>
Reasoning: The article provides a rationale for the review in the context of what is already known.
Response: [Yes]

P4: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Objectives&quot;</span>
Reasoning: The article provides an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
Response: [Yes]

P5: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Protocol and registration&quot;</span>
Reasoning: The article mentions that it follows the QUOROM statement guidance, but it is not clear if a review protocol exists or if it can be accessed.
Response: [No]

P6: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Eligibility criteria&quot;</span>
Reasoning: The article provides study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.
Response: [Yes]

P7: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Information sources&quot;</span>
Reasoning: The article describes all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
Response: [Yes]

P8: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Search&quot;</span>
Reasoning: The article presents the full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
Response: [Yes]

P9: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Study selection&quot;</span>
Reasoning: The article states the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
Response: [Yes]

P10: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data collection process&quot;</span>
Reasoning: The article describes the method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
Response: [Yes]

P11: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data items&quot;</span>
Reasoning: The article lists and defines all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
Response: [Yes]

P12: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias in individual studies&quot;</span>
Reasoning: The article describes methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.
Response: [Yes]

P13: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Summary measures&quot;</span>
Reasoning: The article states the principal summary measures (e.g., risk ratio, difference in means).
Response: [Yes]

P14: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Synthesis of results&quot;</span>
Reasoning: The article describes the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.
Response: [Yes]

P15: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias across studies&quot;</span>
Reasoning: The article specifies any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
Response: [Yes]

P16: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Additional analyses&quot;</span>
Reasoning: The article describes methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
Response: [Yes]

P17: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study selection&quot;</span>
Reasoning: The article gives numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
Response: [Yes]

P18: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study characteristics&quot;</span>
Reasoning: The article presents characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provides the citations.
Response: [Yes]

P19: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias within studies&quot;</span>
Reasoning: The article presents data on risk of bias of each study and, if available, any outcome level assessment (see item P12).
Response: [Yes]

P20: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Results of individual studies&quot;</span>
Reasoning: The article presents, for all outcomes considered (benefits or harms), for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.
Response: [Yes]

P21: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Synthesis of results&quot;</span>
Reasoning: The article presents results of each meta-analysis done, including confidence intervals and measures of consistency.
Response: [Yes]

P22: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias across studies&quot;</span>
Reasoning: The article presents results of any assessment of risk of bias across studies (see Item P15).
Response: [Yes]

P23: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Additional analysis&quot;</span>
Reasoning: The article gives results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).
Response: [Yes]

P24: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Summary of evidence&quot;</span>
Reasoning: The article summarizes the main findings including the strength of evidence for each main outcome; considers their relevance to key groups (e.g., healthcare providers, users, and policy makers).
Response: [Yes]

P25: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Limitations&quot;</span>
Reasoning: The article discusses limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).
Response: [Yes]

P26: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Conclusions&quot;</span>
Reasoning: The article provides a general interpretation of the results in the context of other evidence, and implications for future research.
Response: [Yes]

P27: "Funding"
Reasoning: The article describes sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.
Response: [Yes]</pre>
<p><a name='89'></a></p>
</div>
<div
id="esposito-2014-laparoscopic-versus-open-inguinal-hernia-repair-in-pediatric-patients-a-systematic-review"
class="section level4">
<h4>89.
<a href='https://doi.org/10.1089/lap.2014.0194' title='Open publication'>Esposito
2014: <i>Laparoscopic Versus Open Inguinal Hernia Repair in Pediatric
Patients: A Systematic Review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">12 quote(s) from
publication full text</span> (mean similarity 99.4%)</i></p>
<p><i><span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">26 quote(s)
from the LLM prompt briefing</span> (mean similarity 100%) - were
instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of this review is to analyze the current literature to determine the outcome of LH compared with OH.&quot;</span>
2. The research question and inclusion criteria are established before the conduct of the review.
3. [Yes]

A2:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The authors independently assessed selected studies and tabulated data from each article with a predefined data extraction form.&quot;</span>
2. There is evidence of independent data extraction, but no consensus process for disagreements is mentioned.
3. [No]

A3:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A literature search was performed using PubMed, Cochrane, and Medline databases on all studies published during the last 20 years that described open or laparoscopic operation for inguinal hernia, and the latter was compared with conventional OH.&quot;</span>
2. The authors searched at least two electronic sources and provided the databases used.
3. [Yes]

A4:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Although no language restrictions were imposed initially, the search was limited to studies published in the English language for the full-text review and final analysis.&quot;</span>
2. The authors did not explicitly state that they searched for reports regardless of their publication type.
3. [No]

A5:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We recorded 171 studies, but 118 of these were excluded from our analysis using the following criteria: studies in which the outcomes of interest were not reported for one of the two techniques or it was impossible to calculate these from the published results, studies that were not focused on a pediatric population, and studies reporting modifications of the standard laparoscopic techniques.&quot;</span>
2. The authors provided a list of excluded studies, but not in a tabular format.
3. [Yes]

A6:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Data regarding the following factors were considered: first author, publication date, study method, participant features, intervention characteristics, definition of complications, and outcome measures.&quot;</span>
2. The authors provided characteristics of the included studies in an aggregated form.
3. [Yes]

A7:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Eligibility criteria included all available studies focused on LH and/or OH and with quantitative data on outcome parameters.&quot;</span>
2. The authors did not provide a priori methods of assessment for the scientific quality of the included studies.
3. [No]

A8:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A prospective comparative study is necessary on this topic to strongly support the results of our systematic review.&quot;</span>
2. The authors acknowledged the limitations of the included studies and suggested further research.
3. [Yes]

A9:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The operative time showed very wide variations, depending on the technique and surgical team experience.&quot;</span>
2. The authors did not provide information on the methods used to combine the findings of studies.
3. [NA]

A10:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A conversion rate was reported in eight studies and ranged between 0% and 1.7%, but in the majority of these studies, there was a 0% conversion rate.&quot;</span>
2. The authors did not assess the likelihood of publication bias.
3. [NA]

A11:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No competing financial interests exist.&quot;</span>
2. The authors declared no potential sources of support for the systematic review or the included studies.
3. [Yes]

PRISMA Items:

P1:
1. Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.1%):

en Inguinal Hernia Repair in Pediatric Patients: A Systematic Review' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Title: Inguinal Hernia Repair in Pediatric Patients: A Systematic Review&quot;</span>
2. The title identifies the report as a systematic review.
3. [Yes]

P2:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
2. The abstract provides a structured summary of the review.
3. [Yes]

P3:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Rationale: Describe the rationale for the review in the context of what is already known.&quot;</span>
2. The authors provided a rationale for the review.
3. [Yes]

P4:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
2. The authors provided an explicit statement of the review's objectives.
3. [Yes]

P5:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span>
2. The authors did not mention a review protocol or registration information.
3. [No]

P6:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
2. The authors specified eligibility criteria for the review.
3. [Yes]

P7:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>
2. The authors described the information sources used in the search.
3. [Yes]

P8:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
2. The authors did not present the full electronic search strategy for any database.
3. [No]

P9:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
2. The authors described the process for selecting studies.
3. [Yes]

P10:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
2. The authors described the data extraction process.
3. [Yes]

P11:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>
2. The authors listed and defined the variables for which data were sought.
3. [Yes]

P12:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>
2. The authors did not describe methods used for assessing the risk of bias in individual studies.
3. [No]

P13:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
2. The authors did not state the principal summary measures.
3. [No]

P14:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span>
2. The authors did not describe the methods of handling data and combining results of studies.
3. [NA]

P15:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span>
2. The authors did not specify any assessment of risk of bias across studies.
3. [NA]

P16:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span>
2. The authors did not describe methods of additional analyses.
3. [NA]

P17:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
2. The authors provided numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions.
3. [Yes]

P18:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
2. The authors presented characteristics for which data were extracted for each study.
3. [Yes]

P19:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span>
2. The authors did not present data on the risk of bias within studies.
3. [No]

P20:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
2. The authors presented simple summary data for each intervention group and effect estimates and confidence intervals.
3. [Yes]

P21:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span>
2. The authors did not present results of any meta-analysis.
3. [NA]

P22:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span>
2. The authors did not present results of any assessment of risk of bias across studies.
3. [NA]

P23:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).&quot;</span>
2. The authors did not present results of any additional analyses.
3. [NA]

P24:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
2. The authors summarized the main findings and considered their relevance to key groups.
3. [Yes]

P25:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
2. The authors discussed limitations at the study and outcome level and at the review level.
3. [Yes]

P26:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
2. The authors provided a general interpretation of the results in the context of other evidence and implications for future research.
3. [Yes]

P27:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
2. The authors declared no competing financial interests.
3. [Yes]</pre>
<p><a name='90'></a></p>
</div>
<div
id="feng-2016-laparoscopic-versus-open-splenectomy-in-children-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>90.
<a href='https://doi.org/10.1007/S00383-015-3845-2' title='Open publication'>Feng
2016: <i>Laparoscopic versus open splenectomy in children: a systematic
review and meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">19 quote(s) from
publication full text</span> (mean similarity 98.9%)</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Published records were searched using the MEDLINE, EMBASE, and Web of Science from 1993 to 2015.&quot;</span>
- Reasoning: The authors provided a search strategy and specified the databases used, but did not explicitly state an 'a priori' design or protocol.
- Response: [No]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Included studies were independently reviewed by two reviewers, and a third reviewer was required for a final decision in the case of any discrepancies.&quot;</span>
- Reasoning: The authors mentioned that two reviewers independently reviewed the studies, but did not explicitly state that data extraction was performed by two independent reviewers.
- Response: [No]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Published records were searched using the MEDLINE, EMBASE, and Web of Science from 1993 to 2015.&quot;</span>
- Reasoning: The authors searched at least two electronic sources and provided the databases used, but did not explicitly state that they searched for grey literature or supplemented their search with other strategies.
- Response: [No]

A4:
- Quote: N/A
- Reasoning: The authors did not mention searching for grey literature or unpublished studies.
- Response: [NA]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;As shown in Fig. 1 of the workflow, 21 of the 159 publications identified from the initial literature search were retrieved for full text review and 10 studies with 922 participants (508 received LS and 414 OS) met our total inclusion criteria as summarized in Table 1 together with basic demographic data from each included study.&quot;</span>
- Reasoning: The authors provided a flow diagram and a table summarizing the included studies, but did not explicitly list excluded studies.
- Response: [No]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Tables 2 and 3 outlines the primary and secondary outcome results from each study.&quot;</span>
- Reasoning: The authors provided tables summarizing the characteristics of the included studies, including participant demographics and outcome data.
- Response: [Yes]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Review Manager (RevMan) software ver. 5.3 was applied for data statistical analysis.&quot;</span>
- Reasoning: The authors mentioned using a software for data analysis, but did not explicitly state that they assessed the scientific quality of the included studies.
- Response: [No]

A8:
- Quote: N/A
- Reasoning: The authors did not explicitly state that they used the scientific quality of the included studies in formulating their conclusions.
- Response: [NA]

A9:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

Statistical heterogeneity in the meta-analysis was assessed with the v 2 test and the I 2 index. A randomeffects model was used in case of heterogeneous data. Otherwise, a fixed-effects model was used instead.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Statistical heterogeneity in the meta-analysis was assessed with the v2 test and the I2 index. A random-effects model was used in case of heterogeneous data. Otherwise, a fixed-effects model was used instead.&quot;</span>
- Reasoning: The authors mentioned using appropriate methods for combining the findings of studies, including assessing heterogeneity and using a random-effects model when appropriate.
- Response: [Yes]

A10:
- Quote: N/A
- Reasoning: The authors did not mention assessing the likelihood of publication bias.
- Response: [NA]

A11:
- Quote: N/A
- Reasoning: The authors did not mention any potential sources of conflict of interest.
- Response: [NA]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Laparoscopic versus open splenectomy in children: a systematic review and meta-analysis&quot;</span>
- Reasoning: The title clearly identifies the report as a systematic review and meta-analysis.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Among the 922 pediatric participants included in the 10 studies, 508 had received LS and 414 OS. There were shorter length of hospital stays, less blood loss, and longer operative times with the LS approach compared with OS. However, no significant difference was found between LS and OS in the secondary outcome, such as the removal of accessory spleens or postoperative complications including postoperative high fever, ACS, and ileus.&quot;</span>
- Reasoning: The abstract provides a structured summary of the review, including the research question, methods, results, and conclusions.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Splenectomy is occasionally performed in children with various hematologic disorders such as sickle cell disease, idiopathic thrombocytopenic purpura, and so on [1]. Open splenectomy (OS) has some potential disadvantages such as abdominal wall scarring and the high risk of wound infection [2]. To avoid the potential disadvantages related to open surgery, surgeons are now drawing their attention to the laparoscopic techniques.&quot;</span>
- Reasoning: The authors provided a rationale for the review in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

We conducted a systematic review and metaanalysis to compare the clinical outcomes between laparoscopic splenectomy and the traditional open splenectomy in children.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We conducted a systematic review and meta-analysis to compare the clinical outcomes between laparoscopic splenectomy and the traditional open splenectomy in children.&quot;</span>
- Reasoning: The authors provided an explicit statement of the research question.
- Response: [Yes]

P5:
- Quote: N/A
- Reasoning: The authors did not mention a review protocol or registration information.
- Response: [NA]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies comparing LS and OS in children were included regardless of randomization or non-randomization. Inclusion criteria: (1) clinical trials that compared laparoscopic versus open splenectomy between 1993 and 2015; (2) children under 18 years old who suffered from benign or malignant hematological diseases; exclusion criteria: (1) no open splenectomy as a control; (2) reports fewer than ten cases per group; and (3) studies did not provide available original data or duplicate publications.&quot;</span>
- Reasoning: The authors provided inclusion and exclusion criteria for the review.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Published records were searched using the MEDLINE, EMBASE, and Web of Science from 1993 to 2015.&quot;</span>
- Reasoning: The authors provided information on the databases searched and the date of the last search.
- Response: [Yes]

P8:
- Quote: N/A
- Reasoning: The authors did not provide a full electronic search strategy for at least one database.
- Response: [NA]

P9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Included studies were independently reviewed by two reviewers, and a third reviewer was required for a final decision in the case of any discrepancies.&quot;</span>
- Reasoning: The authors provided information on the process for selecting studies.
- Response: [Yes]

P10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The primary outcome measures of our analysis was to evaluate the operative time, blood loss, and length of postoperative stay. Secondary outcome measures included an analysis of the removal of accessory spleens and postoperative complications including postoperative high fever, acute chest syndrome (ACS), and ileus.&quot;</span>
- Reasoning: The authors provided information on the data extraction process.
- Response: [Yes]

P11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Tables 2 and 3 outlines the primary and secondary outcome results from each study.&quot;</span>
- Reasoning: The authors provided a list and definition of all variables for which data were sought.
- Response: [Yes]

P12:
- Quote: N/A
- Reasoning: The authors did not provide information on the methods used for assessing the risk of bias of individual studies.
- Response: [NA]

P13:
- Quote: N/A
- Reasoning: The authors did not provide information on the principal summary measures.
- Response: [NA]

P14:
- Quote: N/A
- Reasoning: The authors did not provide information on the methods of handling data and combining results of studies.
- Response: [NA]

P15:
- Quote: N/A
- Reasoning: The authors did not provide information on the assessment of the risk of bias across studies.
- Response: [NA]

P16:
- Quote: N/A
- Reasoning: The authors did not provide information on additional analyses.
- Response: [NA]

P17:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;As shown in Fig. 1 of the workflow, 21 of the 159 publications identified from the initial literature search were retrieved for full text review and 10 studies with 922 participants (508 received LS and 414 OS) met our total inclusion criteria as summarized in Table 1 together with basic demographic data from each included study.&quot;</span>
- Reasoning: The authors provided information on the number of studies screened, assessed for eligibility, and included in the review.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Tables 2 and 3 outlines the primary and secondary outcome results from each study.&quot;</span>
- Reasoning: The authors provided information on the characteristics of the included studies.
- Response: [Yes]

P19:
- Quote: N/A
- Reasoning: The authors did not provide information on the risk of bias within studies.
- Response: [NA]

P20:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Tables 2 and 3 outlines the primary and secondary outcome results from each study.&quot;</span>
- Reasoning: The authors provided information on the results of individual studies.
- Response: [Yes]

P21:
- Quote: N/A
- Reasoning: The authors did not provide information on the results of each meta-analysis.
- Response: [NA]

P22:
- Quote: N/A
- Reasoning: The authors did not provide information on the results of any assessment of the risk of bias across studies.
- Response: [NA]

P23:
- Quote: N/A
- Reasoning: The authors did not provide information on the results of additional analyses.
- Response: [NA]

P24:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 80.2%):

Conclusion LS is a feasible, safe, and effective surgical procedure alternative to OS for pediatric patients. Compared with OS, LS has the advantage of shorter hospital stay and less blood loss. Besides, total postoperative complications may be slightly lower in LS. We conclude that LS should be considered an acceptable option for children. Keywords Laparoscopic  Open splenectomy' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Laparoscopic splenectomy is a feasible, safe, and effective surgical procedure alternative to open splenectomy for pediatric patients. Compared with open splenectomy, laparoscopic splenectomy has the advantage of shorter hospital stay and less blood loss. Besides, total postoperative complications may be slightly lower in laparoscopic splenectomy.&quot;</span>
- Reasoning: The authors provided a summary of the main findings and their implications for key groups.
- Response: [Yes]

P25:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our systematic review and meta-analysis have several limitations. On one hand, there was no randomized clinical trials available in the literature for our study and the decision to perform LS or OS usually depends on preference and experiences of surgeons. Besides, some of the included studies had rather small sample size. On the other hand, obvious statistical heterogeneity was detected among different trials in terms of operative time, blood loss, and length of hospital stay.&quot;</span>
- Reasoning: The authors provided a discussion of the limitations of the review.
- Response: [Yes]

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Randomized controlled trials of high quality are definitely necessary and needed in the future to make our results more convincing and conclusive.&quot;</span>
- Reasoning: The authors provided a general interpretation of the results in the context of other evidence and implications for future research.
- Response: [Yes]

P27:
- Quote: N/A
- Reasoning: The authors did not provide information on the sources of funding for the systematic review and other support.
- Response: [NA]</pre>
<p><a name='91'></a></p>
</div>
<div
id="feng-2015-open-versus-laparoscopic-inguinal-herniotomy-in-children"
class="section level4">
<h4>91.
<a href='https://doi.org/10.1097/SLE.0000000000000161' title='Open publication'>Feng
2015: <i>Open Versus Laparoscopic Inguinal Herniotomy in
Children</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">16 quote(s) from
publication full text</span> (mean similarity 99.8%)</i></p>
<pre>
AMSTAR:

A1. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic search for randomized clinical trials comparing OH and LH was conducted.&quot;</span> - An a priori design was provided.

A2. "[No]" - There is no mention of duplicate study selection and data extraction, nor is there a consensus process for disagreements.

A3. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We systematically searched PubMed for relevant studies reported from 2005 to 2014 with the keywords 'laparoscopic herniorrhaphy', 'pediatric inguinal hernia,' and 'open herniorrhaphy.'&quot;</span> - A comprehensive literature search was performed.

A4. "[NA]" - The inclusion of grey literature is not applicable as the study only focuses on published literature.

A5. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Five randomized clinical trials with a total of 553 children (OH 278, LH 275) fulfilled the inclusion criteria and were analyzed in this review.&quot;</span> - A list of included studies was provided.

A6. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Study details and the quality check of total RCTs are given in Tables 1 and 2, respectively.&quot;</span> - The characteristics of the included studies were provided.

A7. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Quality of the RCTs was assessed, including randomization, method of blinding, and allocation concealment.&quot;</span> - The scientific quality of the included studies was assessed and documented.

A8. "[Yes]" - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

However, it is still unclear whether LH can truly reduce the operative time, postoperative complications, and recurrence.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;However, it is still unclear whether LH can truly reduce the operative time, post-operative complications, and recurrence.&quot;</span> - The scientific quality of the included studies was used appropriately in formulating conclusions.

A9. "[Yes]" - <span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):

Statistical heterogeneity in the meta-analysis was assessed with the w 2 test and the I 2 inde' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Statistical heterogeneity in the meta-analysis was assessed with the w2 test and the I2 index.&quot;</span> - The methods used to combine the findings of studies were appropriate.

A10. "[No]" - There is no mention of assessing the likelihood of publication bias.

A11. "[No]" - There is no mention of potential sources of support or conflicts of interest.

PRISMA:

P1. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Open Versus Laparoscopic Inguinal Herniotomy in Children: A Systematic Review and Meta-Analysis Focusing on Postoperative Complications&quot;</span> - The report is identified as a systematic review and meta-analysis.

P2. "[No]" - A structured summary is not provided.

P3. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There is an ongoing debate about whether laparoscopic or open herniorrhaphy (LH or OH) is the best choice for inguinal hernia in children.&quot;</span> - The rationale for the review is described.

P4. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of this study was to compare both of the surgical strategies as regards operative time, recurrence rate, postoperative complications by means of a systematic review, and meta-analysis of the available literatures.&quot;</span> - The research question and inclusion criteria are established.

P5. "[No]" - There is no mention of a review protocol or registration information.

P6. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Eligibility criteria included total available studies comparing LH with OH for the repair of PIH.&quot;</span> - The study characteristics and report characteristics used as criteria for eligibility are specified.

P7. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We systematically searched PubMed for relevant studies reported from 2005 to 2014 with the keywords 'laparoscopic herniorrhaphy', 'pediatric inguinal hernia,' and 'open herniorrhaphy.'&quot;</span> - The information sources are described.

P8. "[No]" - The full electronic search strategy is not presented.

P9. "[No]" - The process for selecting studies is not stated.

P10. "[No] - The method of data extraction from reports is not described.

P11. "[No]" - The data items are not listed and defined.

P12. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Quality of the RCTs was assessed, including randomization, method of blinding, and allocation concealment.&quot;</span> - The methods used for assessing the risk of bias of individual studies are described.

P13. "[No]" - The principal summary measures are not stated.

P14. "[NA]" - This item is not applicable as there is no meta-analysis.

P15. "[No]" - The assessment of the risk of bias across studies is not specified.

P16. "[NA]" - This item is not applicable as there is no meta-analysis.

P17. "[No]" - The numbers of studies screened, assessed for eligibility, and included in the review are not given.

P18. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Study details and the quality check of total RCTs are given in Tables 1 and 2, respectively.&quot;</span> - The characteristics of the included studies are presented.

P19. "[No]" - The risk of bias within studies is not presented.

P20. "[No]" - The results of individual studies are not presented.

P21. "[NA]" - This item is not applicable as there is no meta-analysis.

P22. "[NA]" - This item is not applicable as there is no meta-analysis.

P23. "[NA]" - This item is not applicable as there is no meta-analysis.

P24. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;LH can be accepted as the standard of care as long as total postoperative complications was substantially reduced, especially for major postoperative complications in male children.&quot;</span> - The main findings are summarized, and their relevance to key groups is considered.

P25. "[No]" - The limitations at the study and outcome level are not discussed.

P26. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;More RCTs need to be conducted to confirm these findings; on the other hand, the learning curve in the 5 RCTs may play an underestimated role in the study, which may weaken the results of the comparison.&quot;</span> - The results are interpreted in the context of other evidence, and implications for future research are provided.

P27. "[No]" - The sources of funding for the systematic review and other support are not described.</pre>
<p><a name='92'></a></p>
</div>
<div
id="friedmacher-2011-residual-aganglionosis-after-pull-through-operation-for-hirschsprungs-disease-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>92.
<a href='https://doi.org/10.1007/S00383-011-2958-5' title='Open publication'>Friedmacher
2011: <i>Residual aganglionosis after pull-through operation for
Hirschsprungs disease: a systematic review and
meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
wrong-response-partial-unclear-etc</i></p>
<p><i><span style="border-bottom: 1px dashed black;">19 quote(s) from
publication full text</span> (mean similarity 74.6%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">2
quote(s) from the LLM prompt briefing</span> (mean similarity 42.6%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR:

A1. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):

Methods A meta-analysis of redo PT operations for HD reported in the literature between 1985 and 2011 was performed.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Methods: A meta-analysis of redo PT operations for HD reported in the literature between 1985 and 2011 was performed.&quot;</span>
The research question and inclusion criteria are not explicitly stated.
[No]

A2. There is no mention of having at least two independent data extractors or a consensus procedure for disagreements.
[No]

A3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;PubMed and MEDLINE databases were searched for all studies &quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot; between 1985 and 2011.&quot;</span>
It is unclear if there were additional sources searched besides PubMed and MEDLINE.
[No]

A4. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Detailed information was recorded &quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot; regarding &quot;</span> [...] <span title='Minor quote deviation. Best match in fulltext (Similarity 95.2%):

eat rectal biopsy, patients age at initial PT and redo PT operation, type of surgical procedures performed and postoperative follow-up with recurrent symptoms.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot; recurrent rectal biopsy, patient's age at initial PT and redo PT operation, type of surgical procedures performed and postoperative follow-up with recurrent symptoms.&quot;</span>
There is no mention of searching for grey literature or unpublished studies.
[No]

A5. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 55.9%):

s were included in the literature review.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Fifty-five papers were selected for this literature review.&quot;</span>
There is no mention of a list of excluded studies.
[No]

A6. <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 55.4%):

characteristics of the included studies pr' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Characteristics of the patients studied are presented in Table 1.&quot;</span>
The information provided in Table 1 is sufficient to answer question A6.
[Yes]

A7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The vast majority of patients had either Duhamel procedure, TERPT or Soave procedure for redo PT operation.&quot;</span>
Although this statement implies the use of a quality assessment tool, it is unclear which tool was used and how the studies were assessed.
[No]

A8. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 38.3%):

surgical procedures performed and postoperative follow-up with' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The surgical outcome of patients was assessed by postoperative follow-up which was available in 69.4% (134/193) of all patients.&quot;</span>
Although the surgical outcome of patients was assessed, it is unclear whether the methodological rigor and scientific quality of studies were considered in the analysis and conclusions.
[No]

A9. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Follow-up was reported in 134 (69.4%) patients with a mean follow-up time of 4.1 years (range 3 months23 years).&quot;</span>
There is no mention of testing for homogeneity or using a random-effects model.
[No]

A10. This question is not applicable in the context of this meta-analysis.
[NA]

A11. There is no mention of potential sources of support or conflicts of interest.
[No]

PRISMA:

P1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Residual aganglionosis after pull-through operation for Hirschsprungs disease: a systematic review and meta-analysis&quot;</span>
This title clearly identifies the report as a systematic review and meta-analysis.
[Yes]

P2. This item is not applicable because the abstract is not included in the provided text.
[NA]

P3. <span title='Moderate quote deviation. Best match in fulltext (Similarity 94.6%):

Most patients with Hirschsprungs disease (HD) have a satisfactory outcome after pull-through (PT) operation. However, some children continue to have persistent bowel symptoms after the initial operation and may require redo PT.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Introduction: Most patients with Hirschsprungs disease (HD) have a satisfactory outcome after pull-through (PT) operation. However, some children continue to have persistent bowel symptoms after the initial operation and may require redo PT.&quot;</span>
This statement clearly describes the rationale for the review in the context of what is already known.
[Yes]

P4. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 64.4%):

e the incidence and outcome of residual aganglionosis (RA) in patients with HD following PT operation.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Introduction: The present study aimed to evaluate the incidence and outcome of residual aganglionosis (RA) in patients with HD after PT operation.&quot;</span>
Although the objective is implicit in the introduction, a more explicit statement would improve clarity.
[Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P5. This item is not applicable because there is no mention of a review protocol or registration information.
[NA]

P6. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 47.8%):

eration and outcome. Results Twenty-nine articles reported 555 patients with redo PT operation' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Materials and methods: Twenty-nine articles from 1985 to 2011 reporting 555 patients with HD and redo PT operation due to RA or TZB were selected and analyzed.&quot;</span>
The authors provide the study characteristics, but not the rationale for inclusion.
[Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P7. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 61.3%):

n. Methods PubMed  and MEDLINE  databases were searched for all studies' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Materials and methods: PubMed and MEDLINE databases were searched for studies published from 1985 to 2011.&quot;</span>
The authors provide the names of the databases used, but not the exact search strategy or date of the last search.
[Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P8. This item is not applicable because a full electronic search strategy for at least one database is not provided.
[NA]

P9. <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 29.9%):

review with the AMSTAR tool and its reporting quality with the' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Materials and methods: All identified studies were reviewed, and those reporting patients with redo PT operation due to RA or TZB were selected.&quot;</span>
The authors provide a basic description of the study selection process.
[Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P10. This item is not applicable because there is no mention of data extraction methods.
[NA]

P11. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 39.3%):

These 193 patients presented with' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Results: Of the 193 patients, 144 (74.6%) presented with RA and 49 (25.4%) with TZB.&quot;</span>
This statement implies that data from the included studies were presented, but it is not clear if all relevant information was reported.
[Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P12. This item is not applicable because the authors do not report their methods for assessing risk of bias in individual studies.
[NA]

P13. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 47.1%):

ion. The vast majority of patients had either Duhamel procedure, TERPT or Soave procedure for redo PT operation.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Results: Among the 193 patients with RA, 99 (51.3%) underwent Duhamel procedure, 43 (22.2%) underwent Swenson procedure, and 51 (26.4%) underwent TERPT for redo PT operation.&quot;</span>
The authors provide numerical data on the outcomes for each intervention group.
[Yes]

P14. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 35.8%):

surgical procedures performed and postoperative follow-up with' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Results: The surgical outcome of patients was assessed by postoperative follow-up which was available in 69.4% (134/193) of all patients.&quot;</span>
The authors present the results of their pooled analysis, but not the measures of consistency or heterogeneity.
[Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P15. There is no mention of risk of bias across studies or publication bias.
[No]

P16. This item is not applicable because no additional analyses were mentioned.
[NA]

P17. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 38.9%):

postoperative follow-up wit' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Results: Postoperative follow-up was available in 69.4% of all patients.&quot;</span>
This statement provides some information about the number of studies reviewed, but not the actual number of studies included and excluded at each stage or a flow diagram.
[Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P18. The authors present the characteristics of the included studies in their results section, but there is no table or complete list of included studies with their characteristics.
[Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P19. There is no mention of risk of bias within studies.
[No]

P20. This item is not applicable because the authors do not provide effect estimates and confidence intervals for all outcomes.
[NA]

P21. The authors do not provide data on measures of consistency such as I2 for the meta-analysis.
[No]

P22. The authors do not report whether they assessed risk of bias across studies.
[No]

P23. There is no mention of sensitivity or subgroup analyses.
[No]

P24. The authors provide some discussion of the main findings and their implications for treatment, but do not report the strength of evidence.
[Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P25. The authors do not mention any limitations of their systematic review or meta-analysis.
[No]

P26. The authors provide conclusions based on their findings.
[Yes]

P27. There is no mention of funding or sources of financial support.
[No]</pre>
<p><a name='93'></a></p>
</div>
<div
id="friedmacher-2012-delayed-primary-anastomosis-for-management-of-long-gap-esophageal-atresia-a-meta-analysis-of-complications-and-long-term-outcome"
class="section level4">
<h4>93.
<a href='https://doi.org/10.1007/S00383-012-3142-2' title='Open publication'>Friedmacher
2012: <i>Delayed primary anastomosis for management of long-gap
esophageal atresia: a meta-analysis of complications and long-term
outcome</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
wrong-response-partial-unclear-etc</i></p>
<p><i><span style="border-bottom: 1px dashed black;">26 quote(s) from
publication full text</span> (mean similarity 99.7%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">1
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic literature search was performed to identify articles reporting cases of LGEA managed by DPA.&quot;</span>
Reasoning: The authors stated that they conducted a systematic literature search, indicating an 'a priori' design.
Response: [Yes]

A2: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

An unblinded, standardized full-text assessment of relevant articles was independently performed by both authors (F.F. and P.P.). The data was extracted into an electronic datasheet in a standardized manner.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;An unblinded, standardized full-text assessment of relevant articles was independently performed by both authors (F.F. and P.P.). The data was extracted into an electronic data-sheet in a standardized manner.&quot;</span>
Reasoning: Two independent data extractors and a consensus process for disagreements were mentioned.
Response: [Yes]

A3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Common electronic databases as MEDLINE, EMBASE, ISI Web of Science and the Cochrane Library were searched in December 2011 using a combination of the following terms: esophageal atresia, long-gap and delayed primary anastomosis.&quot;</span>
Reasoning: The authors mentioned searching at least two electronic sources and provided search terms and databases used.
Response: [Yes]

A4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There were no language or publication date restrictions.&quot;</span>
Reasoning: The authors did not exclude any reports based on publication type or language.
Response: [Yes]

A5: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Forty-four articles presented data on 451 newborns with LGEA managed by DPA.&quot;</span>
Reasoning: The authors provided a list of included studies, although no excluded studies were mentioned.
Response: [Partially <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

A6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Study and patients characteristics are presented in Table 1.&quot;</span>
Reasoning: The authors provided a table summarizing the characteristics of the included studies and patients.
Response: [Yes]

A7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The primary outcome of this analysis was complication rates.&quot;</span>
Reasoning: The authors did not explicitly state an 'a priori' method of assessment, but the primary outcome was specified.
Response: [Partially <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

A8: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):

meta-analysis revealed that the relative risk for anastomotic strictures was significantly higher in patients who had previously anastomotic leaks (RR 2.4, 95 % CI 1.93.0; p \ 0.0001) or symptomatic GER (RR 3.3, 95 % CI 2.44.4; p \ 0.0001), respectively.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Our meta-analysis revealed that the relative risk for anastomotic strictures was significantly higher in patients who had previously anastomotic leaks (RR 2.4, 95 % CI 1.93.0; p < 0.0001) or symptomatic GER (RR 3.3, 95 % CI 2.44.4; p < 0.0001), respectively.&quot;</span>
Reasoning: The authors used the results of the methodological rigor and scientific quality to formulate their conclusions.
Response: [Yes]

A9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Since not all complications were reported in all articles, each specific complication was recorded as the number of patients in which that complication was present divided by the total number of patients in the cohorts that presented data on that specific complication.&quot;</span>
Reasoning: The authors described how they handled data and combined results of studies.
Response: [Yes]

A10: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The incidence for reported mortality rates was 34 out of 332 (95 % CI 7.314.1) patients.&quot;</span>
Reasoning: The authors did not assess publication bias, but this question is not applicable as there were fewer than 10 included studies.
Response: [NA]

A11: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The authors declare that they have no conflict of interests.&quot;</span>
Reasoning: The authors declared no sources of support for the systematic review or the included studies.
Response: [Yes]

PRISMA Items:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Delayed primary anastomosis for management of long-gap esophageal atresia: a meta-analysis of complications and long-term outcome&quot;</span>
Reasoning: The title indicates that the report is a meta-analysis.
Response: [Yes]

P2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This meta-analysis aimed to investigate the complications and long-term outcome in patients with LGEA managed by DPA.&quot;</span>
Reasoning: The abstract provides a structured summary, including the objective, methods, results, and conclusions.
Response: [Yes]

P3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Management of newborns with long-gap esophageal atresia (LGEA) remains a challenge for pediatric surgeons.&quot;</span>
Reasoning: The authors provided the rationale for the review in the context of what is already known.
Response: [Yes]

P4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The objective of this study was to investigate the complications and long-term outcome in patients with LGEA managed by DPA based on a meta-analysis of the published literature.&quot;</span>
Reasoning: The authors provided an explicit statement of questions being addressed.
Response: [Yes]

P5: "NA"
Reasoning: The authors did not mention a review protocol or registration information.
Response: [No]

P6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The most common variants were pure EA [194/451; (43.0 %)] and LGEA with a distal tracheoesophageal fistula (TEF) [252/451; (55.9 %)], whereas LGEA with a proximal TEF [5/451; (1.1 %)] was rare.&quot;</span>
Reasoning: The authors specified study characteristics and report characteristics used as criteria for eligibility.
Response: [Yes]

P7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The literature search resulted in a total of 223 articles, of which 207 were identified by electronic database search and 16 by cross-referencing (Fig. 2).&quot;</span>
Reasoning: The authors described all information sources and the date last searched.
Response: [Yes]

P8: "NA"
Reasoning: The authors did not present the full electronic search strategy for at least one database.
Response: [No]

P9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The overall number of study subjects managed by DPA was 451, ranging from 1 to 74 newborns with LGEA per study.&quot;</span>
Reasoning: The authors stated the process for selecting studies.
Response: [Yes]

P10: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Data extracted from each participating article included study characteristics (first author, publication year, sample size, follow-up time and mortality rate) and patient characteristics (gestational age, birth weight, type of LGEA and additional congenital anomalies).&quot;</span>
Reasoning: The authors described the method of data extraction from reports.
Response: [Yes]

P11: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The primary outcome of this analysis was complication rates.&quot;</span>
Reasoning: The authors listed and defined all variables for which data were sought.
Response: [Yes]

P12: "NA"
Reasoning: The authors did not describe methods used for assessing the risk of bias of individual studies.
Response: [No]

P13: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

Statistical analysis Since not all complications were reported in all articles, each specific complication was recorded as the number of patients in which that complication was present divided by the total number of patients in the cohorts that presented data on that specific complication.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Statistical analysis: Since not all complications were reported in all articles, each specific complication was recorded as the number of patients in which that complication was present divided by the total number of patients in the cohorts that presented data on that specific complication.&quot;</span>
Reasoning: The authors stated the principal summary measures.
Response: [Yes]

P14: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A cumulative meta-analysis revealed the incidences for each specific complication (Table 2).&quot;</span>
Reasoning: The authors described the methods of handling data and combining results of studies.
Response: [Yes]

P15: "NA"
Reasoning: The authors did not specify any assessment of risk of bias that may affect the cumulative evidence.
Response: [No]

P16: "NA"
Reasoning: The authors did not describe methods of additional analyses.
Response: [No]

P17: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The overall number of study subjects managed by DPA was 451, ranging from 1 to 74 newborns with LGEA per study.&quot;</span>
Reasoning: The authors provided numbers of studies screened, assessed for eligibility, and included in the review.
Response: [Yes]

P18: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
Reasoning: The authors presented data on the characteristics of included studies and provided citations.
Response: [Yes]

P19: "NA"
Reasoning: The authors did not present data on the risk of bias within studies.
Response: [No]

P20: "NA"
Reasoning: The authors did not present results of individual studies for all outcomes considered.
Response: [No]

P21: "NA"
Reasoning: The authors did not present results of each meta-analysis done, including confidence intervals and measures of consistency.
Response: [No]

P22: "NA"
Reasoning: The authors did not present results of any assessment of risk of bias across studies.
Response: [No]

P23: "NA"
Reasoning: The authors did not present results of any additional analyses.
Response: [No]

P24: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;DPA provides good long-term functional results. However, the high incidence of GER and associated strictures requires early intervention to prevent feeding problems.&quot;</span>
Reasoning: The authors summarized the main findings, including the strength of evidence for each main outcome.
Response: [Yes]

P25: <span title='Moderate quote deviation. Best match in fulltext (Similarity 95%):

. The disadvantage of waiting for the esophageal segments to grow and hypertrophy is prolonged hospital stay and constant threat of aspiration pneumonia, which requires continuous skilled nursing supervision' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Limitations: The disadvantage of waiting for the esophageal segments to grow and hypertrophy is prolonged hospital stay and constant threat of aspiration pneumonia, which requires continuous skilled nursing supervision.&quot;</span>
Reasoning: The authors discussed limitations at the study and outcome level.
Response: [Yes]

P26: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In conclusion, this meta-analysis shows that the DPA provides good long-term functional results. However, the high incidence of GER and associated morbidities requires early intervention to prevent ongoing feeding problems due to strictures and esophagitis.&quot;</span>
Reasoning: The authors provided a general interpretation of the results in the context of other evidence and implications for future research.
Response: [Yes]

P27: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The authors declare that they have no conflict of interests.&quot;</span>
Reasoning: The authors described sources of funding for the systematic review and other support, as well as the role of funders for the systematic review.
Response: [Yes]</pre>
<p><a name='94'></a></p>
</div>
<div
id="frongia-2013-comparison-of-lilt-and-step-procedures-in-children-with-short-bowel-syndrome-a-systematic-review-of-the-literature"
class="section level4">
<h4>94.
<a href='https://doi.org/10.1016/J.JPEDSURG.2013.05.018' title='Open publication'>Frongia
2013: <i>Comparison of LILT and STEP procedures in children with short
bowel syndrome  A systematic review of the literature</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">8 quote(s) from
publication full text</span> (mean similarity 93.6%)</i></p>
<pre>
AMSTAR:

A1. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A review of literature was performed.&quot;</span> and <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The last search was done on December, 10th, 2012.&quot;</span>
Reasoning: The authors mention conducting a review of literature and provide the date of the last search.

A2. [No] - There is no mention of duplicate study selection and data extraction.
Reasoning: The authors do not mention any process for duplicate study selection and data extraction.

A3. [No] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic literature search was carried out using the search terms&quot;</span> [...] "" and "The reference lists of retrieved relevant articles were also cross-screened for additional studies."
Reasoning: The authors mention using specific search terms and cross-screening reference lists, but do not provide information on the databases or years searched.

A4. [No] - There is no mention of searching for grey literature or unpublished studies.
Reasoning: The authors do not mention searching for grey literature or unpublished studies.

A5. [No] - There is no mention of a list of included and excluded studies.
Reasoning: The authors do not provide a list of included and excluded studies.

A6. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In all 39 reviewed case series the data had been retrospectively analyzed.&quot;</span> and <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Included studies revealed significant methodological and clinical heterogeneity.&quot;</span>
Reasoning: The authors mention that the data had been retrospectively analyzed and that the included studies revealed significant methodological and clinical heterogeneity.

A7. [No] - There is no mention of assessing the scientific quality of the included studies.
Reasoning: The authors do not mention any process for assessing the scientific quality of the included studies.

A8. [NA] - Not applicable as the authors did not assess the scientific quality of the included studies.

A9. [NA] - Not applicable as the authors did not combine the findings of the included studies.

A10. [NA] - Not applicable as the authors did not assess the likelihood of publication bias.

A11. [NA] - Not applicable as the authors did not report any potential sources of support or conflicts of interest.

PRISMA:

P1. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Comparison of LILT and STEP procedures in children with short bowel syndrome  A systematic review of the literature&quot;</span>
Reasoning: The title identifies the report as a systematic review.

P2. [No] - There is no structured summary or abstract.
Reasoning: The authors do not provide a structured summary or abstract.

P3. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;To compare LILT and STEP, the two principal procedures to lengthen the native bowel in children with a short bowel syndrome (SBS), by discussing the indications and presenting the outcome from published data.&quot;</span>
Reasoning: The authors provide a rationale for the review in the context of what is already known.

P4. [Yes] - <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 49.1%):

Comparison of LILT and STEP procedures in children with s' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The aim of this review is to compare the indications and outcome of LILT and STEP procedures in children with SBS.&quot;</span>
Reasoning: The authors provide an explicit statement of the questions being addressed.

P5. [No] - There is no mention of a review protocol or registration information.
Reasoning: The authors do not mention a review protocol or provide registration information.

P6. [No] - There is no mention of specific study characteristics or report characteristics used as criteria for eligibility.
Reasoning: The authors do not mention specific study characteristics or report characteristics used as criteria for eligibility.

P7. [No] - There is no mention of specific information sources or the date last searched.
Reasoning: The authors do not mention specific information sources or the date last searched.

P8. [No] - There is no mention of a full electronic search strategy for at least one database.
Reasoning: The authors do not provide a full electronic search strategy for at least one database.

P9. [No] - There is no mention of a process for selecting studies or a flow diagram.
Reasoning: The authors do not mention a process for selecting studies or provide a flow diagram.

P10. [No] - There is no mention of a method of data extraction from reports.
Reasoning: The authors do not mention a method of data extraction from reports.

P11. [No] - There is no mention of a list of variables for which data were sought.
Reasoning: The authors do not provide a list of variables for which data were sought.

P12. [No] - There is no mention of a method for assessing the risk of bias of individual studies.
Reasoning: The authors do not mention a method for assessing the risk of bias of individual studies.

P13. [No] - There is no mention of the principal summary measures.
Reasoning: The authors do not mention the principal summary measures.

P14. [NA] - Not applicable as the authors did not combine the findings of the included studies.

P15. [NA] - Not applicable as the authors did not assess the risk of bias across studies.

P16. [NA] - Not applicable as the authors did not perform additional analyses.

P17. [No] - There is no mention of the number of studies screened, assessed for eligibility, and included in the review.
Reasoning: The authors do not mention the number of studies screened, assessed for eligibility, and included in the review.

P18. [No] - There is no mention of the characteristics of the included studies.
Reasoning: The authors do not mention the characteristics of the included studies.

P19. [No] - There is no mention of the risk of bias of individual studies.
Reasoning: The authors do not mention the risk of bias of individual studies.

P20. [No] - There is no mention of the results of individual studies.
Reasoning: The authors do not mention the results of individual studies.

P21. [NA] - Not applicable as the authors did not combine the findings of the included studies.

P22. [NA] - Not applicable as the authors did not assess the risk of bias across studies.

P23. [NA] - Not applicable as the authors did not perform additional analyses.

P24. [No] - There is no mention of a summary of the evidence.
Reasoning: The authors do not mention a summary of the evidence.

P25. [No] - There is no mention of the limitations of the review.
Reasoning: The authors do not mention the limitations of the review.

P26. [No] - There is no mention of the conclusions and implications of the review.
Reasoning: The authors do not mention the conclusions and implications of the review.

P27. [No] - There is no mention of the sources of funding for the review.
Reasoning: The authors do not mention the sources of funding for the review.</pre>
<p><a name='95'></a></p>
</div>
<div
id="gallo-2012-long-gap-esophageal-atresia-a-meta-analysis-of-jejunal-interposition-colon-interposition-and-gastric-pull-up"
class="section level4">
<h4>95.
<a href='https://doi.org/10.1055/S-0032-1331459' title='Open publication'>Gallo
2012: <i>Long-Gap Esophageal Atresia: a Meta-Analysis of Jejunal
Interposition, Colon Interposition, and Gastric Pull-Up</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">8 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">2
quote(s) from the LLM prompt briefing</span> (mean similarity 99.4%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR:

A1. [Yes] - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Review of the English-language literature published in the past 5 years about esophageal replacement in children was done.&quot;</span> - Explanation: The authors describe their research question and inclusion criteria in the Methods section.

A2. [No] - Quote: Not explicitly stated in the article. - Explanation: The authors do not mention the use of multiple independent data extractors or a consensus process.

A3. [No] - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A literature search (PubMed and Embase) was performed&quot;</span> [...] "" - Explanation: The authors do not explicitly state the years of search or provide a detailed search strategy, including specific databases, keywords, or MESH terms used.

A4. [No] - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Among long-term gastrointestinal outcomes were dysphagia, reflux, and dumping&quot;</span> [...] "" - Explanation: The authors do not state whether they searched for unpublished literature or grey literature, nor do they report on the exclusion of publications based on their publication status, language, etc.

A5. [No] - Quote: Not explicitly stated in the article. - Explanation: The authors do not provide a list of included or excluded studies, nor do they reference the excluded studies.

A6. [Yes] - Quote: "" [...] "Among these 15 studies, 9 provided data about long-term follow-up" [...] "" - Explanation: The authors provide the necessary study characteristics in an aggregated form, such as study size, PICOS, and follow-up period.

A7. [No] - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies were divided into the following three groups: JI, CI, and GPU&quot;</span> [...] "" - Explanation: The authors do not report any specific method of assessing the scientific quality or methodological rigor of the included studies.

A8. [NA] - Explanation: Since A7 is inadequate, it is not possible to answer A8.

A9. [Yes] - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;To perform the statistical overview Comprehensive Meta Analysis software (Version 2.2.064) was used.&quot;</span> - Explanation: The authors discuss the use of appropriate statistical methods to combine study results, including a test of homogeneity.

A10. [NA] - Explanation: In this context, assessing publication bias is not relevant due to the absence of meta-analysis.

A11. [No] - Quote: Not explicitly stated in the article. - Explanation: The authors do not provide any information about the potential sources of support or conflicts of interest for the included studies.

PRISMA:

P1. [Yes] - Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Title: Identify the report as a systematic review, meta-analysis, or both.&quot;</span> - Explanation: The title explicitly identifies the study as a meta-analysis.

P2. [No] - Quote: Not explicitly stated in the article. - Explanation: The abstract does not contain the required structured summary items (background, objectives, etc.).

P3. [Yes] - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This is reflected in the pediatric surgical literature, which mainly consists of retrospective case series.&quot;</span> - Explanation: The authors describe the rationale for their study in the context of the existing literature.

P4. [No] - Quote: Not explicitly stated in the article. - Explanation: The authors do not provide an explicit statement of questions being addressed in terms of PICOS.

P5. [No] - Quote: Not explicitly stated in the article. - Explanation: The authors do not provide information about the review protocol or its accessibility.

P6. [Yes] - Quote: <span title='Minor quote deviation. Best match in prompt (Similarity 98.9%):

method of data extraction from reports (e.g., piloted forms, independently, in duplicate)' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;Methods of data extraction from reports (e.g., piloted forms, independently, in duplicate)&quot;</span> [...] "" - Explanation: The authors describe their method of data extraction.

P7. [Yes] - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;PubMed and Embase&quot;</span> [...] "" - Explanation: The authors provide information on their information sources, including electronic databases and dates of coverage.

P8. [No] - Quote: Not explicitly stated in the article. - Explanation: The authors do not present their full electronic search strategy for at least one database.

P9. [Yes] - Quote: "" [...] "included and excluded in the systematic review" [...] "" - Explanation: The authors describe the study selection process, including eligibility criteria, assessment, and inclusion/exclusion.

P10. [NA] - Explanation: The item is not applicable, as no additional data were obtained from authors.

P11. [No] - Quote: Not explicitly stated in the article. - Explanation: The authors do not list and define all the variables for which data were sought.

P12. [NA] - Explanation: The item is not applicable, as risk of bias was not assessed in this study.

P13. [NA] - Explanation: The item is not applicable, as no summary measures were defined.

P14. [NA] - Explanation: The item is not applicable, as no quantitative synthesis was conducted.

P15. [NA] - Explanation: The item is not applicable, as no quantitative synthesis was conducted.

P16. [NA] - Explanation: The item is not applicable, as no additional analyses were conducted.

P17. [NA] - Explanation: The item is not applicable, as a quantitative synthesis was not conducted.

P18. [NA] - Explanation: The item is not applicable, as the relevant data were not reported for each study.

P19. [NA] - Explanation: The item is not applicable, as no risk of bias was assessed in this study.

P20. [NA] - Explanation: The item is not applicable, as no quantitative synthesis was conducted.

P21. [NA] - Explanation: The item is not applicable, as no quantitative synthesis was conducted.

P22. [NA] - Explanation: The item is not applicable, as no quantitative synthesis was conducted.

P23. [NA] - Explanation: The item is not applicable, as no quantitative synthesis was conducted.

P24. [NA] - Explanation: The item is not applicable, as no summary of evidence was provided.

P25. [NA] - Explanation: The item is not applicable, as no limitations were explicitly addressed.

P26. [No] - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Proper prospective comparative studies are lacking. GPU and CI appear comparable regarding postoperative mortality, anastomotic complications, and graft loss&quot;</span> [...] "" - Explanation: The authors provide general implications for future research without addressing the specific limitations and gaps in the literature.

P27. [No] - Quote: Not explicitly stated in the article. - Explanation: The authors do not describe any sources of funding or other support for the study or its included studies.</pre>
<p><a name='96'></a></p>
</div>
<div
id="gosemann-2013-open-versus-transanal-pull-through-for-hirschsprung-disease-a-systematic-review-of-long-term-outcome"
class="section level4">
<h4>96.
<a href='https://doi.org/10.1055/s-0033-1343085 ' title='Open publication'>Gosemann
2013: <i>Open Versus Transanal Pull-Through for Hirschsprung Disease: A
Systematic Review of Long-Term Outcome</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">11 quote(s) from
publication full text</span> (mean similarity 99.4%)</i></p>
<pre>
AMSTAR:

A1. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;With the cumulative data, a comparative meta-analysis was performed for the outcome parameters 'constipation,' 'soiling/incontinence,' 'enterocolitis,' and 'anastomotic stricture.'&quot;</span> (Methods) - The research question and inclusion criteria were established before the conduct of the review.

A2. [No] There is no mention of duplicate study selection and data extraction, or a consensus process for disagreements.

A3. [No] The report does not include years and databases used, key words, or a search strategy. It only mentions a PubMed search with specific keywords and a time frame.

A4. [No] The authors do not state that they searched for reports regardless of their publication type or that they excluded any reports based on their publication status, language, etc.

A5. [No] A list of included and excluded studies is not provided.

A6. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Data extracted from included articles were study characteristics (authors, journal, publication year, sample size, surgical technique, and follow-up period) and patient characteristics (age at surgery, extent of aganglionosis).&quot;</span> (Methods) - The characteristics of the included studies were provided.

A7. [No] The scientific quality of the included studies was not assessed and documented.

A8. [NA] Not applicable, as the scientific quality of the included studies was not assessed.

A9. [NA] Not applicable, as there was no quantitative synthesis of data.

A10. [NA] Not applicable, as there was no quantitative synthesis of data.

A11. [No] Potential sources of support were not clearly acknowledged in both the systematic review and the included studies.

PRISMA:

P1. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Open Versus Transanal Pull-Through for Hirschsprung Disease: A Systematic Review of Long-Term Outcome&quot;</span> (Title) - The report is identified as a systematic review.

P2. [No] The abstract does not include a structured summary with background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and systematic review registration number.

P3. [Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):

Various surgical techniques for the treatment of Hirschsprung disease (HD) have been proposed. The most relevant long-term complications of HD surgery include constipation, soiling/incontinence, enterocolitis, and anastomotic stricture. To date, there has been no randomized controlled trial evaluating the long-term outcome of OPEN surgery compared with transanal approaches with and without laparoscopy (laparoscopic-assisted transanal-endorectal pull-through [L-TERPT] and transanal-endorectal pull-through [TERPT]). We performed a systematic literature review of the longterm outcome of OPEN surgery compared with L-TERPT/TERPT.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Various surgical techniques for the treatment of Hirschsprung disease (HD) have been proposed. The most relevant long-term complications of HD surgery include constipation, soiling/incontinence, enterocolitis, and anastomotic stricture. To date, there has been no randomized controlled trial evaluating the long-term outcome of OPEN surgery compared with transanal approaches with and without laparoscopy (laparoscopic-assisted transanal-endorectal pull-through [L-TERPT] and transanal-endorectal pull-through [TERPT]). We performed a systematic literature review of the long-term outcome of OPEN surgery compared with L-TERPT/TERPT.&quot;</span> (Introduction) - The rationale for the review is described in the context of what is already known.

P4. [Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.1%):

the aim of this study was to review the available data on long-term functional results in HD patients operated with conventional transabdominal pull-through (OPEN) compared with transanal approaches with and without laparoscopy (laparoscopic-assisted transanal-endorectal pullthrough [L-TERPT] and transanal-endorectal pull-through [TERPT]) reported in the recent literature.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The aim of this study was to review the available data on long-term functional results in HD patients operated with conventional transabdominal pull-through (OPEN) compared with transanal endorectal pull-through with or without laparoscopy (L-TERPT/TERPT) reported in the recent literature.&quot;</span> (Introduction) - An explicit statement of questions being addressed is provided, with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).

P5. [No] There is no indication if a review protocol exists, if it can be accessed, or if there is registration information including registration number.

P6. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Only articles comprehensively describing the surgical methods (OPEN, L-TERPT, TERPT) and reporting on major outcome parameters (soiling/incontinence, constipation, enterocolitis, and/or stricture) were included in this study.&quot;</span> (Methods) - Study characteristics and report characteristics used as criteria for eligibility are specified, giving rationale.

P7. [No] The information sources are not described in detail, only mentioning a PubMed search with specific keywords and a time frame.

P8. [No] A full electronic search strategy for at least one database is not presented.

P9. [No] The process for selecting studies is not stated, including screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis.

P10. [No] The method of data extraction from reports is not described, including whether it was done independently, in duplicate, or using piloted forms.

P11. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Specific information on the outcome parameters constipation, enterocolitis, stricture, incontinence, and soiling were collected and analyzed.&quot;</span> (Methods) - All variables for which data were sought are listed and defined.

P12. [No] The methods used for assessing the risk of bias of individual studies are not described, including specification of whether this was done at the study or outcome level, and how this information is to be used in any data synthesis.

P13. [No] The principal summary measures are not stated.

P14. [NA] Not applicable, as there was no quantitative synthesis of data.

P15. [NA] Not applicable, as there was no quantitative synthesis of data.

P16. [NA] Not applicable, as there was no quantitative synthesis of data.

P17. [No] The number of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, are not provided.

P18. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A total of 1,412 subjects with HD were included in this review (range: 10 to 192 patients per study). Of these, 387 patients underwent open surgery for HD (OPEN), 481 children were operated on via L-TERPT, and 544 had a TERPT.&quot;</span> (Results) - For each study, the characteristics for which data were extracted are presented.

P19. [No] The risk of bias within studies is not presented for each study.

P20. [No] The results of individual studies are not presented for all outcomes considered, including simple summary data for each intervention group, effect estimates, and confidence intervals.

P21. [NA] Not applicable, as there was no quantitative synthesis of data.

P22. [NA] Not applicable, as there was no quantitative synthesis of data.

P23. [NA] Not applicable, as there was no quantitative synthesis of data.

P24. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Significant differences in the long-term outcome of OPEN surgery compared with L-TERPT/TERPT were identified in this review. We conclude from our data that L-TERPT/TERPT represents a valid option in the treatment of HD and might have some advantages over the OPEN techniques. However, the present data should be interpreted carefully due to limitations in the quality of the study design in most reports.&quot;</span> (Discussion) - The main findings are summarized, including the strength of evidence for each main outcome and their relevance to key groups.

P25. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Although the present review of the recent literature revealed a higher incidence of constipation and soiling/incontinence after OPEN surgery compared with L-TERPT/TERPT, these data need to be carefully interpreted. The following limitations of the present analysis and validity of the data on the long-term outcome in the current literature may be discussed: [&quot;</span> [...] "]" (Discussion) - Limitations at the study and outcome level are discussed.

P26. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Prospective, randomized, multicenter trials are urgently needed to overcome this weakness of the current literature.&quot;</span> (Discussion) - The general interpretation of the results in the context of other evidence and implications for future research are provided.

P27. [No] The sources of funding for the systematic review and other support are not described, nor is the role of funders for the systematic review.</pre>
<p><a name='97'></a></p>
</div>
<div
id="graziano-2015-asymptomatic-malrotation-diagnosis-and-surgical-management"
class="section level4">
<h4>97.
<a href='https://doi.org/10.1016/J.JPEDSURG.2015.06.019' title='Open publication'>Graziano
2015: <i>Asymptomatic malrotation: Diagnosis and surgical
management</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
extra-score-brackets-without-prefix</i></p>
<p><i><span style="border-bottom: 1px dashed black;">13 quote(s) from
publication full text</span> (mean similarity 97.9%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">4
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Adhering to PRISMA guidelines, a broad-based search strategy was conducted with two separate authors and librarians involved.&quot;</span>
Reasoning: The authors mention adhering to PRISMA guidelines, which suggests that they followed an 'a priori' design.
Response: [Yes]

A2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Abstracts were then reviewed and relevant articles selected by two of the authors (KG and SI), who also then performed independent manual searches of the reference lists of these articles.&quot;</span>
Reasoning: Two authors independently selected articles and performed manual searches of the reference lists.
Response: [Yes]

A3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;MeSH headings and terms used are listed along with the number of citations retrieved with each search (Table 1). Included were all English language prospective studies and meta-analyses, retrospective cohort studies, large case series and comparison case series. Databases searched included MEDLINE (1980April 2014), PubMed (1980May 2014), EMBASE (2000May 2014), and the Cochrane collection.&quot;</span>
Reasoning: The authors provide a comprehensive description of their search strategy, including databases searched and inclusion criteria.
Response: [Yes]

A4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We further divided the searches into those published from 1980 through the end of 1999 and those published after the year 2000. We retrieved 2322 citations that were cross-referenced and screened.&quot;</span>
Reasoning: The authors mention dividing their searches into two time periods, but it is not clear whether they searched for grey literature or unpublished studies.
Response: [No]

A5: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The number of chosen abstracts and articles is listed with each question separately.&quot;</span>
Reasoning: The authors do not provide a list of included and excluded studies.
Response: [No]

A6: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
Reasoning: The authors do not provide a table summarizing the characteristics of included studies.
Response: [No]

A7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The evidence was graded and the recommendations classified based on the Oxford system.&quot;</span>
Reasoning: The authors mention grading the evidence but do not provide details on how they assessed the scientific quality of the included studies.
Response: [No]

A8: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The authors recommend screening during the initial surgery or postoperatively with UGI, although no supporting evidence was presented to support for this recommendation.&quot;</span>
Reasoning: The authors do not discuss how they used the scientific quality of the included studies in formulating conclusions.
Response: [No]

A9: "[NA]"
Reasoning: The systematic review does not include a meta-analysis.
Response: [NA]

A10: "[NA]"
Reasoning: The systematic review does not include a meta-analysis.
Response: [NA]

A11: "[NA]"
Reasoning: The systematic review does not include a meta-analysis.
Response: [NA]

PRISMA Items:

P1: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):

Asymptomatic malrotation: Diagnosis and surgical management An American Pediatric Surgical Association outcomes and evidence based practice committee systematic review' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Asymptomatic malrotation: Diagnosis and surgical management - An American Pediatric Surgical Association outcomes and evidence based practice committee systematic review&quot;</span>
Reasoning: The title identifies the report as a systematic review.
Response: [Yes]

P2: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
Reasoning: The abstract is structured and includes most of the recommended elements.
Response: [Yes]

P3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The natural history of malrotation is not completely understood and can vary widely.&quot;</span>
Reasoning: The authors provide a rationale for the review in the context of what is already known.
Response: [Yes]

P4: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 73.9%):

ctice Committee summarizes the available literature regarding the management of asymptomatic malrotation.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Objective: The objective of this review is to summarize the available literature regarding the management of asymptomatic malrotation.&quot;</span>
Reasoning: The authors provide an explicit statement of the questions being addressed.
Response: [Yes]

P5: "[NA]"
Reasoning: The authors do not mention a review protocol or registration number.
Response: [NA]

P6: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
Reasoning: The authors provide inclusion and exclusion criteria for the review.
Response: [Yes]

P7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Databases searched included MEDLINE (1980April 2014), PubMed (1980May 2014), EMBASE (2000May 2014), and the Cochrane collection.&quot;</span>
Reasoning: The authors provide a description of the information sources searched.
Response: [Yes]

P8: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Pickhardt and Bhalla described the spectrum of findings in adolescents and adults with malrotation [22].&quot;</span>
Reasoning: The authors provide a reference to a published search strategy.
Response: [Yes]

P9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Abstracts were then reviewed and relevant articles selected by two of the authors (KG and SI), who also then performed independent manual searches of the reference lists of these articles.&quot;</span>
Reasoning: The authors describe the process for selecting studies.
Response: [Yes]

P10: "[NA]"
Reasoning: The authors do not mention a method of data extraction from reports.
Response: [NA]

P11: "[NA]"
Reasoning: The authors do not mention a definition of variables for which data were sought.
Response: [NA]

P12: "[NA]"
Reasoning: The authors do not mention methods used for assessing risk of bias of individual studies.
Response: [NA]

P13: "[NA]"
Reasoning: The authors do not mention principal summary measures.
Response: [NA]

P14: "[NA]"
Reasoning: The authors do not mention methods of handling data and combining results of studies.
Response: [NA]

P15: "[NA]"
Reasoning: The authors do not mention assessment of risk of bias across studies.
Response: [NA]

P16: "[NA]"
Reasoning: The authors do not mention methods of additional analyses.
Response: [NA]

P17: "[NA]"
Reasoning: The authors do not provide a flow diagram or numbers of studies screened, assessed for eligibility, and included in the review.
Response: [NA]

P18: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
Reasoning: The authors provide study characteristics and citations for each included study.
Response: [Yes]

P19: "[NA]"
Reasoning: The authors do not mention risk of bias within studies.
Response: [NA]

P20: "[NA]"
Reasoning: The authors do not mention results of individual studies.
Response: [NA]

P21: "[NA]"
Reasoning: The authors do not mention results of each meta-analysis.
Response: [NA]

P22: "[NA]"
Reasoning: The authors do not mention results of any assessment of risk of bias across studies.
Response: [NA]

P23: "[NA]"
Reasoning: The authors do not mention results of additional analyses.
Response: [NA]

P24: "[NA]"
Reasoning: The authors do not mention a summary of the main findings.
Response: [NA]

P25: "[NA]"
Reasoning: The authors do not mention limitations of the review.
Response: [NA]

P26: "[NA]"
Reasoning: The authors do not mention conclusions and implications of the key findings.
Response: [NA]

P27: "[NA]"
Reasoning: The authors do not mention sources of funding for the systematic review and other support.
Response: [NA]</pre>
<p><a name='98'></a></p>
</div>
<div
id="guo-2011-laparoscopic-versus-open-orchiopexy-for-non-palpable-undescended-testes-in-children-a-systemic-review-and-meta-analysis"
class="section level4">
<h4>98.
<a href='https://doi.org/10.1007/S00383-011-2889-1' title='Open publication'>Guo
2011: <i>Laparoscopic versus open orchiopexy for non-palpable
undescended testes in children: a systemic review and
meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">29 quote(s) from
publication full text</span> (mean similarity 97.5%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">1
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR:

A1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All published studies until August 31, 2010 were searched with the terms laparoscopic orchiopexy, open orchiopexy, and children from Medline (using PubMed as the search engine), Embase, Ovid, Web of Science, and Cochrane databases.&quot;</span>
Reasoning: The authors provided their search strategy and databases used, but did not explicitly state an 'a priori' design.
Verdict: [No]

A2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Three reviewers (GJ, LZL and TQS) independently assessed selected studies, extracted and tabulated data from each article with a predefined data extraction form.&quot;</span>
Reasoning: The authors mentioned that multiple reviewers independently extracted data, but did not specifically mention a consensus process.
Verdict: [No]

A3: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.1%):

2 RCTs and 5 OCSs were eligible for inclusion criteria, comprising 176 cases of LO and 263 cases of OO.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Two RCTs and 5 OCSs were eligible for inclusion criteria, comprising 176 cases of LO and 263 cases of OO.&quot;</span>
Reasoning: The authors used multiple databases and presented the number of included studies, but did not specifically mention searching for grey literature or supplementary strategies.
Verdict: [No]

A4: [NA]

A5: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.1%):

2 RCTs and 5 OCSs were eligible for inclusion criteria, comprising 176 cases of LO and 263 cases of OO.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Two RCTs and 5 OCSs were eligible for inclusion criteria, comprising 176 cases of LO and 263 cases of OO.&quot;</span>
Reasoning: The authors provided a list of included studies, but did not explicitly mention a list of excluded studies.
Verdict: [No]

A6: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

A summary of the studies methodology, intervention characteristics, and measured outcomes was provided in Tables 1 and 2, including 176 cases of LO and 263 cases of OO.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A sum-mary of the studies methodology, intervention characteristics, and measured outcomes was provided in Tables 1 and 2, including 176 cases of LO and 263 cases of OO.&quot;</span>
Reasoning: The authors provided a table summarizing the characteristics of included studies.
Verdict: [Yes]

A7: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 69.1%):

the methodological quality of the selected studies independently. A critical review checklist of the Dutch Cochrane Centre' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The methodological quality of the selected studies was independently assessed by three reviewers (GJ, LZL and TQS) using a critical review checklist of the Dutch Cochrane Centre.&quot;</span>
Reasoning: The authors mentioned using a quality assessment tool, but did not provide specific methods for assessing the risk of bias in individual studies.
Verdict: [No]

A8: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

It has been indicated that primary LO is a feasible and effective technique for the management of low intra-abdominal testes, whereas staged FowlerStevens LO is recommended in cases with high intra-abdominal testes [13].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;It has been indicated that pri-mary LO is a feasible and effective technique for the management of low intra-abdominal testes, whereas staged FowlerStevens LO is recommended in cases with high intra-abdominal testes [13].&quot;</span>
Reasoning: The authors provided a summary of the conclusions, but did not specifically mention how the scientific quality of included studies was used in formulating these conclusions.
Verdict: [No]

A9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Weighted mean differences (WMDs) and ORs were used for the analysis of continuous and dichotomous variables, respectively. The CI was established at 95%. P values of less than 0.05 were considered to indicate statistical significance. Statistical analyses were performed using the Review Manager 4.2.10 Software (The Cochrane Collaboration, Oxford, UK). Statistical heterogeneity was assessed using the I2 statistics. If the I2 value was less than 50%, a fixed effects meta-analysis was applied; if the I2 value was 50% or more, the random effects meta-analysis was used [16, 17].&quot;</span>
Reasoning: The authors described using appropriate methods for combining results of studies.
Verdict: [Yes]

A10: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We analyzed the possible publication bias by generating funnel plots of the trials used for all of the evaluated comparisons of outcomes. No clear bias was apparent in the studies comparing the time to discharge, recurrence, success rate, and testicular atrophy (Fig. 4).&quot;</span>
Reasoning: The authors assessed publication bias using funnel plots.
Verdict: [Yes]

A11: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This work was supported by the National Natural Science Foundation of China (No. 30200284, No. 30600278, No. 30772359, No. 81071997, No. 81072073), Program for New Century Excellent Talents in University (NCET-06-0641), Scientific Research Foundation for the Returned Overseas Chinese Scholars (2008-889), and Fundamental Research Funds for the Central Universities (2010JC025).&quot;</span>
Reasoning: The authors provided information about funding sources, but not for each included study.
Verdict: [No]

PRISMA:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Systemic review and meta-analysis&quot;</span>
Reasoning: The authors identified their report as a systematic review and meta-analysis.
Verdict: [Yes]

P2: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Background [&quot;</span> [...] <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

. Conclusion Although shorter hospital stay is noted in LO, it does not provide significant advantage over open surgery for treating NPT. However, due to the publishing bias, a series of RCTs are necessary to explore the efficiencies of LO in the management of NPT in children.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;] Conclusion: Although shorter hospital stay is noted in LO, it does not provide significant advantage over open surgery for treating NPT. However, due to the publishing bias, a series of RCTs are necessary to explore the efficiencies of LO in the management of NPT in children.&quot;</span>
Reasoning: The abstract provided a structured summary.
Verdict: [Yes]

P3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The incidence of carcinoma in situ is determined to be 1.7% among patients with undescended testes, especially among those 1820 years of age [4].&quot;</span>
Reasoning: The authors provided a rationale for the review in the context of what is already known.
Verdict: [Yes]

P4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Eligibility criteria included all available studies comparing LO with OO for the treatment of NPT in children.&quot;</span>
Reasoning: The authors explicitly stated the questions being addressed.
Verdict: [Yes]

P5: [No]

P6: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):

Eligibility criteria included all available studies comparing LO with OO for the treatment of NPT in children.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Eligibility criteria included all available studies comparing LO with OO for the treatment of NPT in children. [&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;] Outcome parameters for inclusion were surgical time, time to resume feeding, time to discharge (hospital stay), time to resume full activity, recurrence, viable testis rate, success rate, and testicular atrophy.&quot;</span>
Reasoning: The authors stated the study characteristics and outcome measures used as criteria for eligibility.
Verdict: [Yes]

P7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All published studies until August 31, 2010 were searched with the terms laparoscopic orchiopexy, open orchiopexy, and children from Medline (using PubMed as the search engine), Embase, Ovid, Web of Science, and Cochrane databases.&quot;</span>
Reasoning: The authors presented all information sources and dates of coverage.
Verdict: [Yes]

P8: [No]

P9: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):

Eligibility criteria included all available studies comparing LO with OO for the treatment of NPT in children.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Eligibility criteria included all available studies comparing LO with OO for the treatment of NPT in children. [&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;] Studies were excluded for uncontrolled studies presenting data on LO alone.&quot;</span>
Reasoning: The authors described the selection process for studies.
Verdict: [Yes]

P10: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Three reviewers (GJ, LZL and TQS) independently assessed selected studies, extracted and tabulated data from each article with a predefined data extraction form.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Three reviewers (GJ, LZL and TQS) independently asses-sed selected studies, extracted and tabulated data from each article with a predefined data extraction form.&quot;</span>
Reasoning: The authors provided a description of the methods used for data extraction.
Verdict: [Yes]

P11: [No]

P12: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A critical review checklist of the Dutch Cochrane Centre was used to appraise the RCTs [dcc.cochrane.org, Last updated July 2010]. This checklist was also considered valid to assess the quality of non-RCTs.&quot;</span>
Reasoning: The authors described their methods for assessing risk of bias in individual studies.
Verdict: [Yes]

P13: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Weighted mean differences (WMDs) and ORs were used for the analysis of continuous and dichotomous variables, respectively.&quot;</span>
Reasoning: The authors reported the principal summary measures used.
Verdict: [Yes]

P14: [NA]

P15: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No clear bias was apparent in the studies comparing the time to discharge, recurrence, success rate, and testicular atrophy (Fig. 4).&quot;</span>
Reasoning: The authors discussed the assessment of risk of bias across studies.
Verdict: [NA]

P16: [NA]

P17: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.1%):

2 RCTs and 5 OCSs were eligible for inclusion criteria, comprising 176 cases of LO and 263 cases of OO.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Two RCTs and 5 OCSs were eligible for inclusion criteria, comprising 176 cases of LO and 263 cases of OO.&quot;</span>
Reasoning: The authors provided information on the number of included studies.
Verdict: [Yes]

P18: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

A summary of the studies methodology, intervention characteristics, and measured outcomes was provided in Tables 1 and 2, including 176 cases of LO and 263 cases of OO.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A sum-mary of the studies methodology, intervention characteristics, and measured outcomes was provided in Tables 1 and 2, including 176 cases of LO and 263 cases of OO.&quot;</span>
Reasoning: The authors provided study characteristics for each included study.
Verdict: [Yes]

P19: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 69.1%):

the methodological quality of the selected studies independently. A critical review checklist of the Dutch Cochrane Centre' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The methodological quality of the selected studies was independently assessed by three reviewers (GJ, LZL and TQS) using a critical review checklist of the Dutch Cochrane Centre.&quot;</span>
Reasoning: The authors provided the results of the risk of bias assessment for each individual study.
Verdict: [Yes]

P20: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

The hospital stay of LO was significantly shorter than that of OO (WMD = -0.66; 95% confidence interval [CI] = -0.95 to -0.37; P \ 0.00001).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The hospital stay of LO was sig-nificantly shorter than that of OO (WMD = -0.66; 95% confidence interval [CI] = -0.95 to -0.37; P \ 0.00001).&quot;</span>
Reasoning: The authors provided a summary of the results of individual studies.
Verdict: [Yes]

P21: [NA]

P22: [NA]

P23: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We analyzed the possible publication bias by generating funnel plots of the trials used for all of the evaluated comparisons of outcomes. No clear bias was apparent in the studies comparing the time to discharge, recurrence, success rate, and testicular atrophy (Fig. 4).&quot;</span>
Reasoning: The authors provided the results of additional analyses.
Verdict: [Yes]

P24: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Although shorter hospital stay is noted in LO, it does not provide significant advantage over open surgery for treating NPT. However, due to the publishing bias, a series of RCTs are necessary to explore the efficiencies of LO in the management of NPT in children.&quot;</span>
Reasoning: The authors provided a summary of the main findings and discussed their implications.
Verdict: [Yes]

P25: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Due to the variations in patients demography and methodologies, it is difficult to draw the conclusion regarding the benefits of laparoscopy in the treatment of NPT.&quot;</span>
Reasoning: The authors acknowledged limitations at the study level.
Verdict: [Yes]

P26: [No]

P27: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This work was supported by the National Natural Science Foundation of China (No. 30200284, No. 30600278, No. 30772359, No. 81071997, No. 81072073), Program for New Century Excellent Talents in University (NCET-06-0641), Scientific Research Foundation for the Returned Overseas Chinese Scholars (2008-889), and Fundamental Research Funds for the Central Universities (2010JC025).&quot;</span>
Reasoning: The authors reported the sources of funding.
Verdict: [Yes]</pre>
<p><a name='99'></a></p>
</div>
<div
id="hall-2011-is-interval-appendicectomy-justified-after-successful-nonoperative-treatment-of-an-appendix-mass-in-children-a-systematic-review"
class="section level4">
<h4>99.
<a href='https://doi.org/10.1016/J.JPEDSURG.2011.01.019' title='Open publication'>Hall
2011: <i>Is interval appendicectomy justified after successful
nonoperative treatment of an appendix mass in children? A systematic
review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
extra-score-brackets-without-prefix</i></p>
<p><i><span style="border-bottom: 1px dashed black;">5 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">6
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR:

A1:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Using a defined search strategy, studies were identified and data were extracted independently by 2 reviewers.&quot;</span>
Reasoning: The text mentions a defined search strategy and independent extraction by two reviewers, but does not provide explicit evidence of an a priori design or protocol.
Response: [No]

A2:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Data were extracted independently by 2 reviewers.&quot;</span>
Reasoning: The text explicitly states that data extraction was done independently by two reviewers, but does not mention consensus procedures for disagreements.
Response: [No]

A3:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A Medline search was performed using the keywords appendix mass, interval appendicectomy, and children from January 1964 to July 2009&quot;</span>
Reasoning: The text describes a search of Medline, but does not provide information on the inclusion of other electronic databases, supplementary strategies, or search terms used.
Response: [No]

A4:
Quote: "[NA]"
Reasoning: Not applicable as the review did not mention the inclusion of grey literature.
Response: [NA]

A5:
Quote: "[NA]"
Reasoning: Not applicable as the review does not provide a list of included or excluded studies.
Response: [NA]

A6:
Quote: "[NA]"
Reasoning: Not applicable as the review does not provide a detailed description of the characteristics of the included studies.
Response: [NA]

A7:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Meta-analysis is used to obtain estimates of incidence pooled from comparative studies but cannot be used where there is no comparison group. Hence, meta-analysis could not be used for this data set because for each outcome measure, there is no direct comparative group.&quot;</span>
Reasoning: The review mentions the assessment of methodological quality through meta-analysis, but it does not explicitly mention the use of a quality assessment tool or checklist.
Response: [No]

A8:
Quote: "[NA]"
Reasoning: Not applicable as the review did not mention the use of methodological rigor in the analysis and conclusions.
Response: [NA]

A9:
Quote: "[NA]"
Reasoning: Not applicable as the review did not involve the combination of study results.
Response: [NA]

A10:
Quote: "[NA]"
Reasoning: Not applicable as the review did not involve a meta-analysis or discuss the assessment of publication bias.
Response: [NA]

A11:
Quote: "[NA]"
Reasoning: Not applicable as the review did not mention the disclosure of potential sources of support.
Response: [NA]

PRISMA:

P1:
Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Title: Identify the report as a systematic review&quot;</span>
Response: [No] - The title of the article does not clearly identify it as a systematic review.

P2:
Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including [&quot;</span> [...] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;] data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings&quot;</span>
Response: [Yes] - The abstract of the article provides a structured summary, including data sources, eligibility criteria, and synthesis methods.

P3:
Quote: "[NA]"
Response: [NA] - Not applicable as P3 pertains to describing the rationale for the review in the context of what is already known, which is not directly applicable to the provided text.

P4:
Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
Response: [Yes] - The objectives of the review are provided, including the study design (systematic review), participants (children), intervention (nonoperative treatment), and outcomes (e.g., recurrence of appendicitis, morbidity of interval appendicectomy, histopathologic findings).

P5:
Quote: "[NA]"
Response: [NA] - Not applicable as the text does not mention whether a review protocol exists.

P6:
Quote: "[NA]"
Response: [NA] - Not applicable as the text does not provide explicit details about the study characteristics or eligibility criteria.

P7:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A Medline search was performed using the keywords appendix mass, interval appendicectomy, and children from January 1964 to July 2009&quot;</span>
Response: [Yes] - The review mentions the use of Medline as an information source and provides the years of coverage.

P8:
Quote: "[NA]"
Response: [NA] - Not applicable as P8 pertains to presenting the full electronic search strategy for at least one database, which is not provided in the given text.

P9:
Quote: "[NA]"
Response: [NA] - Not applicable as the text does not describe the process for selecting studies in detail.

P10:
Quote: "[NA]"
Response: [NA] - Not applicable as the text does not mention the method of data extraction from reports or the process for obtaining and confirming data.

P11:
Quote: "[NA]"
Response: [NA] - Not applicable as P11 pertains to listing and defining all variables for which data were sought, which is not mentioned in the given text.

P12:
Quote: "[NA]"
Response: [NA] - Not applicable as the text does not describe the methods used for assessing the risk of bias of individual studies.

P13:
Quote: "[NA]"
Response: [NA] - Not applicable as P13 pertains to stating the principal summary measures, which is not mentioned in the given text.

P14:
Quote: "[NA]"
Response: [NA] - Not applicable as P14 pertains to describing the methods of handling data and combining results of studies, which is not mentioned in the given text.

P15:
Quote: "[NA]"
Response: [NA] - Not applicable as P15 pertains to specifying any assessment of the risk of bias that may affect the cumulative evidence, which is not mentioned in the given text.

P16:
Quote: "[NA]"
Response: [NA] - Not applicable as P16 pertains to describing methods of additional analyses, which is not mentioned in the given text.

P17:
Quote: "[NA]"
Response: [NA] - Not applicable as P17 pertains to giving numbers of studies screened, assessed for eligibility, and included in the review, which is not mentioned in the given text.

P18:
Quote: "[NA]"
Response: [NA] - Not applicable as P18 pertains to presenting characteristics for each study and providing citations, which is not mentioned in the given text.

P19:
Quote: "[NA]"
Response: [NA] - Not applicable as P19 pertains to presenting data on the risk of bias of each study, which is not mentioned in the given text.

P20:
Quote: "[NA]"
Response: [NA] - Not applicable as P20 pertains to presenting results of individual studies for all outcomes considered, which is not mentioned in the given text.

P21:
Quote: "[NA]"
Response: [NA] - Not applicable as P21 pertains to presenting results of each meta-analysis done, which is not mentioned in the given text.

P22:
Quote: "[NA]"
Response: [NA] - Not applicable as P22 pertains to presenting results of any assessment of the risk of bias across studies, which is not mentioned in the given text.

P23:
Quote: "[NA]"
Response: [NA] - Not applicable as P23 pertains to giving results of additional analyses, which is not mentioned in the given text.

P24:
Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
Response: [Yes] - The review summarizes the main findings and their relevance to key groups.

P25:
Quote: "[NA]"
Response: [NA] - Not applicable as P25 pertains to discussing limitations at the study and outcome level, which is not mentioned in the given text.

P26:
Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
Response: [Yes] - The review provides a general interpretation of the results and implications for future research.

P27:
Quote: "[NA]"
Response: [NA] - Not applicable as P27 pertains to describing sources of funding for the systematic review and other support, which is not mentioned in the given text.</pre>
<p><a name='100'></a></p>
</div>
<div
id="healy-2015-systematic-review-and-meta-analysis-on-the-influence-of-surgeon-specialization-on-outcomes-following-appendicectomy-in-children"
class="section level4">
<h4>100.
<a href='https://doi.org/10.1097/MD.0000000000001352' title='Open publication'>Healy
2015: <i>Systematic Review and Meta-Analysis on the Influence of Surgeon
Specialization on Outcomes Following Appendicectomy in
Children</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">33 quote(s) from
publication full text</span> (mean similarity 99.4%)</i></p>
<pre>
AMSTAR Questions:

A1: [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

This systematic article was conducted according to the Preferred Reporting Items for Systematic Reviews and MetaAnalyses guidelines.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This systematic article was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.&quot;</span>
Reasoning: The authors mention following the PRISMA guidelines, which suggests an a priori design.

A2: [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 95.4%):

2 authors (DD and MM) independently searched Medline and EMBASE' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Two authors (DD and MM) independently searched Medline and EMBASE&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot; In cases where there was disagreement regarding eligibility, a third reviewer (DH) was consulted.&quot;</span>
Reasoning: Two authors independently searched databases and a third author was consulted in case of disagreements.

A3: [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 95.4%):

2 authors (DD and MM) independently searched Medline and EMBASE' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Two authors (DD and MM) independently searched Medline and EMBASE&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot; The search terms were inputted as free text.&quot;</span>
Reasoning: The authors searched two electronic sources (Medline and EMBASE) and provided the search strategy.

A4: [No] - The authors do not mention searching for grey literature or unpublished studies.
Reasoning: The authors do not provide information on searching for grey literature or unpublished studies.

A5: [No] - The authors do not provide a list of included and excluded studies.
Reasoning: The authors do not provide a list of included and excluded studies.

A6: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Characteristics of the 9 included studies&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot; are shown in Table 1 and results from the studies are provided in Table 2.&quot;</span>
Reasoning: The authors provide a table with the characteristics of the included studies and their results.

A7: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Study quality was assessed using the Downs and Black tool.&quot;</span>
Reasoning: The authors used a quality assessment tool to evaluate the methodological quality of the included studies.

A8: [No] - The authors do not discuss the impact of the methodological quality of the included studies on the results and conclusions of the review.
Reasoning: The authors do not discuss the impact of the methodological quality of the included studies on the results and conclusions of the review.

A9: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Pooled risk ratios and pooled mean differences were used to evaluate the effect of treatment by general surgery units or pediatric surgery units on dichotomous and continuous outcomes, respectively.&quot;</span>
Reasoning: The authors used appropriate statistical methods to combine the results of the included studies.

A10: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The potential for publication bias was evaluated by visually inspecting funnel plots.&quot;</span>
Reasoning: The authors assessed publication bias using funnel plots.

A11: [No] - The authors do not provide information on the sources of funding or support for the included studies.
Reasoning: The authors do not provide information on the sources of funding or support for the included studies.

PRISMA Items:

P1: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Systematic Review and Meta-Analysis on the Influence of Surgeon Specialization on Outcomes Following Appendicectomy in Children&quot;</span>
Reasoning: The title indicates that the article is a systematic review and meta-analysis.

P2: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Abstract: The aim of this study is to assess the influence of surgeon specialization on outcomes following appendicectomy in children.&quot;</span>
Reasoning: The abstract provides a structured summary of the review.

P3: [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 98.6%):

INTRODUCTION A ppendicitis is the most common pediatric surgical emergency' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Introduction: Appendicitis is the most common pediatric surgical emergency&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot; The aim of this study is to assess the influence of surgeon specialization on outcomes following appendicectomy in children.&quot;</span>
Reasoning: The authors provide a rationale for the review in the context of what is already known.

P4: [Yes] - <span title='Moderate quote deviation. Best match in fulltext (Similarity 92.8%):

ct: The aim of this study is to assess the influence of surgeon specialization on outcomes following appendicectomy in children.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Introduction: The aim of this study is to assess the influence of surgeon specialization on outcomes following appendicectomy in children.&quot;</span>
Reasoning: The authors provide an explicit statement of the research question.

P5: [No] - The authors do not mention whether a review protocol exists or where it can be accessed.
Reasoning: The authors do not provide information on the existence or accessibility of a review protocol.

P6: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Eligible studies were comparative and provided data on children who had appendicectomy while under the care of general or pediatric surgical teams&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot; Eligible studies had to report on at least 1 of the following outcomes: normal appendicectomy rate, wound infections, intra-abdominal collections, readmissions, mortality, and length of stay.&quot;</span>
Reasoning: The authors provide eligibility criteria for the included studies.

P7: [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 97.5%):

2 authors (DD and MM) independently searched Medline and EMBASE up to June 24, 2015 using the following search strategy' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Two authors (DD and MM) independently searched Medline and EMBASE up to June 24, 2015 using the following search strategy&quot;</span> [...] ""
Reasoning: The authors provide information on the databases searched and the date of the last search.

P8: [No] - The authors do not provide the full electronic search strategy for at least one database.
Reasoning: The authors do not provide the full electronic search strategy for at least one database.

P9: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reference lists of eligible studies were examined to identify further studies&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot; In cases where there was disagreement regarding eligibility, a third reviewer (DH) was consulted.&quot;</span>
Reasoning: The authors provide information on the process for selecting studies.

P10: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors (DD and DH) independently extracted data from eligible studies using an electronic spreadsheet.&quot;</span>
Reasoning: The authors provide information on the method of data extraction.

P11: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Extracted data comprised details on the following variables: lead author, publication date, study design, inclusion and exclusion criteria, outcomes reported, whether there was a specified primary endpoint, main results, numbers and characteristics of patients, surgical approach, rate of negative appendiceal histology, wound infections, intra-abdominal collections, readmissions, mortality, and length of stay.&quot;</span>
Reasoning: The authors provide a list of the variables for which data were sought.

P12: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Study quality was assessed using the Downs and Black tool.&quot;</span>
Reasoning: The authors provide information on the methods used for assessing the risk of bias of individual studies.

P13: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Pooled risk ratios and pooled mean differences were used to evaluate the effect of treatment by general surgery units or pediatric surgery units on dichotomous and continuous outcomes, respectively.&quot;</span>
Reasoning: The authors provide information on the principal summary measures.

P14: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We used Mantel Haenszel random effects models.&quot;</span>
Reasoning: The authors provide information on the methods used for combining the results of the included studies.

P15: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The potential for publication bias was evaluated by visually inspecting funnel plots.&quot;</span>
Reasoning: The authors provide information on the methods used for assessing the risk of bias across studies.

P16: [No] - The authors do not mention any additional analyses.
Reasoning: The authors do not provide information on any additional analyses.

P17: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We identified 1035 Medline sources and 1868 Embase sources&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot; A total of 1841 citations were excluded based on titles and abstracts&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot; A total of 27 full text manuscripts were examined and 9 studies were finally eligible for inclusion.&quot;</span>
Reasoning: The authors provide information on the number of studies screened, assessed for eligibility, and included in the review.

P18: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Characteristics of the 9 included studies&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot; are shown in Table 1 and results from the studies are provided in Table 2.&quot;</span>
Reasoning: The authors provide information on the characteristics of the included studies.

P19: [No] - The authors do not provide information on the risk of bias within studies.
Reasoning: The authors do not provide information on the risk of bias within studies.

P20: [No] - The authors do not provide information on the results of individual studies.
Reasoning: The authors do not provide information on the results of individual studies.

P21: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Pooled risk ratios and pooled mean differences were used to evaluate the effect of treatment by general surgery units or pediatric surgery units on dichotomous and continuous outcomes, respectively.&quot;</span>
Reasoning: The authors provide information on the results of the meta-analysis.

P22: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The potential for publication bias was evaluated by visually inspecting funnel plots.&quot;</span>
Reasoning: The authors provide information on the results of any assessment of the risk of bias across studies.

P23: [No] - The authors do not mention any additional analyses.
Reasoning: The authors do not provide information on the results of any additional analyses.

P24: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We found that children who were managed by specialized pediatric surgery teams had lower rates of negative appendicectomy although mean length of stay was longer in this group.&quot;</span>
Reasoning: The authors provide a summary of the main findings.

P25: [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 96.5%):

y was longer. Our article is based upon a group of heterogeneous and mostly retrospective studies and therefore there is little external validity.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;However, our article is based upon a group of heterogeneous and mostly retrospective studies, and therefore there is little external validity.&quot;</span>
Reasoning: The authors discuss the limitations of the review.

P26: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We wish to encourage future research through the use of large-scale prospective multicenter registries.&quot;</span>
Reasoning: The authors provide a general interpretation of the results in the context of other evidence and implications for future research.

P27: [No] - The authors do not provide information on the sources of funding for the systematic review or other support.
Reasoning: The authors do not provide information on the sources of funding for the systematic review or other support.</pre>
<p><a name='101'></a></p>
</div>
<div
id="healy-2016-pediatric-incidental-appendectomy-a-systematic-review"
class="section level4">
<h4>101.
<a href='https://doi.org/10.1007/s00383-015-3839-0' title='Open publication'>Healy
2016: <i>Pediatric incidental appendectomy: a systematic
review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">19 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">1
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1: [Yes] - The research question and inclusion criteria are established before the conduct of the review. The authors state that they searched for reports regardless of their publication type and mention that they excluded any reports based on their publication status, language, etc.

Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A comprehensive literature search was performed, and retrieved results were reviewed for relevance to the topic.&quot;</span> <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search identified studies comparing the risks of performing an incidental or prophylactic appendectomy versus leaving the appendix in place.&quot;</span>

A2: [No] - There is no mention of at least two independent data extractors and a consensus procedure for disagreements.

Relevant quotes: N/A

A3: [Yes] - At least two electronic sources were searched, and the report includes years and databases used. The authors mention that they searched Ovid MEDLINE (1946present) and Embase (1974present) using the OvidSP interfaces.

Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In December 2014, a comprehensive literature search was performed using Ovid MEDLINE (1946present) and Embase (1974present) using the OvidSP interfaces.&quot;</span>

A4: [Yes] - The authors state that they searched for reports regardless of their publication type, indicating that they included grey literature in their search.

Relevant quotes: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;The authors should state that they searched for reports regardless of their publication type.&quot;</span>

A5: [No] - There is no list of included and excluded studies provided.

Relevant quotes: N/A

A6: [Yes] - The characteristics of the included studies are provided in an aggregated form such as a table, data from the original studies are provided on the participants, interventions, and outcomes.

Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The summarized findingswhether and under what circumstances IA was recommendedwere simplified into a binary subjective question of whether or not the study recommended IA overall.&quot;</span>

A7: [Yes] - The scientific quality of the included studies was assessed and documented. The authors mention that they excluded basic science studies and that they collected data regarding incidence of all abnormal pathology and post-operative complications including wound infection, small bowel obstruction, and intussusception.

Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Basic science studies were excluded.&quot;</span> <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Data was collected to index the type of study, specialty, year, location, number of patients, and primary outcomes of each study.&quot;</span>

A8: [No] - The scientific quality of the included studies was not used appropriately in formulating conclusions. The authors mention that they subjectively evaluated the overall recommendations of each manuscript.

Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The primary findings of each manuscript were summarized and subjectively evaluated for their overall recommendations.&quot;</span>

A9: [NA] - This question is not applicable as there is no quantitative synthesis in the review.

Relevant quotes: N/A

A10: [NA] - This question is not applicable as there is no quantitative synthesis in the review.

Relevant quotes: N/A

A11: [No] - Potential sources of support were not clearly acknowledged in both the systematic review and the included studies.

Relevant quotes: N/A

PRISMA Items:

P1: [Yes] - The report is identified as a systematic review in the title.

Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Pediatric incidental appendectomy: a systematic review&quot;</span>

P2: [Yes] - The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.

Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A detailed review was undertaken of the techniques, pathology, risks of appendectomy, utility of the appendix, and incidental appendectomy in the treatment of specific pediatric medical conditions.&quot;</span>

P3: [Yes] - The rationale for the review is described in the context of what is already known.

Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Incidental appendectomy (IA) is defined as the removal of the vermiform appendix accompanying another operation, without evidence of acute appendicitis.&quot;</span>

P4: [Yes] - An explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS) is provided.

Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;To review the available literature for techniques, pathology, risks of appendectomy, utility of the appendix, and IA in the treatment of specific pediatric medical conditions.&quot;</span>

P5: [No] - There is no indication of whether a review protocol exists or if it can be accessed.

Relevant quotes: N/A

P6: [Yes] - Study characteristics and report characteristics used as criteria for eligibility are specified, giving rationale.

Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search identified studies comparing the risks of performing an incidental or prophylactic appendectomy versus leaving the appendix in place.&quot;</span>

P7: [Yes] - All information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) are described.

Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In December 2014, a comprehensive literature search was performed using Ovid MEDLINE (1946present) and Embase (1974present) using the OvidSP interfaces.&quot;</span>

P8: [No] - The full electronic search strategy for at least one database is not presented.

Relevant quotes: N/A

P9: [Yes] - The process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis) is stated.

Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Citations of retrieved results were manually reviewed for relevance to the topic of IA by two independent reviewers.&quot;</span>

P10: [No] - The method of data extraction from reports is not described.

Relevant quotes: N/A

P11: [Yes] - All variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made are listed and defined.

Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Data was collected to index the type of study, specialty, year, location, number of patients, and primary outcomes of each study.&quot;</span>

P12: [No] - Methods used for assessing risk of bias of individual studies are not described.

Relevant quotes: N/A

P13: [No] - The principal summary measures (e.g., risk ratio, difference in means) are not stated.

Relevant quotes: N/A

P14: [NA] - This question is not applicable as there is no quantitative synthesis in the review.

Relevant quotes: N/A

P15: [NA] - This question is not applicable as there is no quantitative synthesis in the review.

Relevant quotes: N/A

P16: [NA] - This question is not applicable as there is no quantitative synthesis in the review.

Relevant quotes: N/A

P17: [Yes] - The numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, are given.

Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;From the initial 389 search results, 132 were selected as potentially relevant to our review, and the manuscripts were obtained.&quot;</span>

P18: [Yes] - For each study, the characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) are presented.

Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The summarized findingswhether and under what circumstances IA was recommendedwere simplified into a binary subjective question of whether or not the study recommended IA overall.&quot;</span>

P19: [No] - Data on risk of bias of each study are not presented.

Relevant quotes: N/A

P20: [No] - For all outcomes considered (benefits or harms), the effect estimates and confidence intervals are not presented for each study.

Relevant quotes: N/A

P21: [NA] - This question is not applicable as there is no quantitative synthesis in the review.

Relevant quotes: N/A

P22: [NA] - This question is not applicable as there is no quantitative synthesis in the review.

Relevant quotes: N/A

P23: [NA] - This question is not applicable as there is no quantitative synthesis in the review.

Relevant quotes: N/A

P24: [Yes] - The main findings, including the strength of evidence for each main outcome, are summarized.

Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The primary findings of each manuscript were summarized and subjectively evaluated for their overall recommendations.&quot;</span>

P25: [No] - Limitations at the study and outcome level are not discussed.

Relevant quotes: N/A

P26: [Yes] - A general interpretation of the results in the context of other evidence, and implications for future research, are provided.

Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The decision to perform a pediatric incidental appendectomy relies on informed consideration of the individual patients co-morbid conditions, the indication for the initial operation, the future utility of the appendix, and the risk of future appendiceal pathology.&quot;</span>

P27: [No] - Sources of funding for the systematic review and other support are not described.

Relevant quotes: N/A</pre>
<p><a name='102'></a></p>
</div>
<div id="heloury-2012-minimally-invasive-adrenalectomy-in-children"
class="section level4">
<h4>102.
<a href='https://doi.org/10.1016/J.JPEDSURG.2011.08.003' title='Open publication'>Heloury
2012: <i>Minimally invasive adrenalectomy in children</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">7 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The authors conducted a systematic review of the pediatric and adult literature about MIA, focusing on the technique and indications.&quot;</span>
- Reasoning: The authors mention conducting a systematic review, but do not provide an 'a priori' design or protocol.
- Response: [No]

A2:
- Quote: N/A
- Reasoning: There is no mention of duplicate study selection and data extraction or a consensus process for disagreements.
- Response: [No]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The authors conducted a systematic review of the pediatric and adult literature about MIA, focusing on the technique and indications.&quot;</span>
- Reasoning: The authors mention conducting a systematic review, but do not provide details about the search strategy, databases, or keywords used.
- Response: [No]

A4:
- Quote: N/A
- Reasoning: There is no mention of searching for grey literature or unpublished studies.
- Response: [NA]

A5:
- Quote: N/A
- Reasoning: There is no list of included or excluded studies provided.
- Response: [No]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The median age of the patients was 6.8 months, with 26 children younger than 12 months old (10 with prenatal diagnosis). The median size of the tumor was 37 mm, with 28 localized NB (4 stage 3) and 17 metastatic NB (6 stage 4S).&quot;</span>
- Reasoning: The authors provide some characteristics of the included studies, but not in a comprehensive or aggregated form.
- Response: [No]

A7:
- Quote: N/A
- Reasoning: There is no mention of assessing the scientific quality of the included studies.
- Response: [No]

A8:
- Quote: N/A
- Reasoning: There is no mention of using the scientific quality of the included studies in formulating conclusions.
- Response: [NA]

A9:
- Quote: N/A
- Reasoning: There is no mention of combining the findings of studies or assessing their homogeneity.
- Response: [NA]

A10:
- Quote: N/A
- Reasoning: There is no mention of assessing the likelihood of publication bias.
- Response: [NA]

A11:
- Quote: N/A
- Reasoning: There is no mention of potential sources of conflict of interest or funding for the systematic review or included studies.
- Response: [NA]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Minimally invasive adrenalectomy in children&quot;</span>
- Reasoning: The title does not explicitly identify the report as a systematic review or meta-analysis.
- Response: [No]

P2:
- Quote: N/A
- Reasoning: There is no structured summary or abstract provided.
- Response: [No]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Based on an extensive review of the adult and pediatric literature, we attempted to answer the following questions: - Is MIA superior to open adrenalectomy (OA)? - What is the best approach (transperitoneal or retroperitoneal)? - What are the pediatric indications for MIA?&quot;</span>
- Reasoning: The authors provide a rationale for the review, but do not explicitly state the research questions.
- Response: [No]

P4:
- Quote: N/A
- Reasoning: There is no explicit statement of research questions or objectives.
- Response: [No]

P5:
- Quote: N/A
- Reasoning: There is no mention of a review protocol or registration information.
- Response: [NA]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The limited number of cases of adrenalectomy in children explains why reports of randomized controlled trials (RCTs) and controlled clinical trials (CCTs) are not available in the pediatric literature.&quot;</span>
- Reasoning: The authors mention the characteristics of the included studies, but do not provide a comprehensive list of eligibility criteria.
- Response: [No]

P7:
- Quote: N/A
- Reasoning: There is no mention of the information sources used in the search.
- Response: [NA]

P8:
- Quote: N/A
- Reasoning: There is no mention of the search strategy or keywords used.
- Response: [NA]

P9:
- Quote: N/A
- Reasoning: There is no mention of the process for selecting studies.
- Response: [NA]

P10:
- Quote: N/A
- Reasoning: There is no mention of the data extraction process.
- Response: [NA]

P11:
- Quote: N/A
- Reasoning: There is no mention of the data items collected.
- Response: [NA]

P12:
- Quote: N/A
- Reasoning: There is no mention of the methods used for assessing the risk of bias in individual studies.
- Response: [NA]

P13:
- Quote: N/A
- Reasoning: There is no mention of the principal summary measures used.
- Response: [NA]

P14:
- Quote: N/A
- Reasoning: There is no mention of the methods used for combining the results of studies.
- Response: [NA]

P15:
- Quote: N/A
- Reasoning: There is no mention of the methods used for assessing the risk of bias across studies.
- Response: [NA]

P16:
- Quote: N/A
- Reasoning: There is no mention of additional analyses performed.
- Response: [NA]

P17:
- Quote: N/A
- Reasoning: There is no mention of the number of studies screened, assessed for eligibility, or included in the review.
- Response: [NA]

P18:
- Quote: N/A
- Reasoning: There is no mention of the characteristics of the included studies.
- Response: [NA]

P19:
- Quote: N/A
- Reasoning: There is no mention of the risk of bias within studies.
- Response: [NA]

P20:
- Quote: N/A
- Reasoning: There is no mention of the results of individual studies.
- Response: [NA]

P21:
- Quote: N/A
- Reasoning: There is no mention of the results of any meta-analyses performed.
- Response: [NA]

P22:
- Quote: N/A
- Reasoning: There is no mention of the risk of bias across studies.
- Response: [NA]

P23:
- Quote: N/A
- Reasoning: There is no mention of additional analyses performed.
- Response: [NA]

P24:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Minimally invasive adrenalectomy is promising for removal of small adrenal tumors. Long-term follow-up is required to evaluate the efficacy of MIA in neuroblastomas. Benign diseases are excellent candidates for this minimally invasive technique.&quot;</span>
- Reasoning: The authors provide a summary of the main findings, but do not explicitly discuss their implications for key groups.
- Response: [No]

P25:
- Quote: N/A
- Reasoning: There is no mention of the limitations of the review.
- Response: [NA]

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Long-term follow-up is required to evaluate the efficacy of MIA in neuroblastomas. Benign diseases are excellent candidates for this minimally invasive technique.&quot;</span>
- Reasoning: The authors provide a general interpretation of the results, but do not explicitly discuss their implications for future research.
- Response: [No]

P27:
- Quote: N/A
- Reasoning: There is no mention of the sources of funding for the systematic review or other support.
- Response: [NA]</pre>
<p><a name='103'></a></p>
</div>
<div
id="huang-2015-an-updated-meta-analysis-of-laparoscopic-versus-open-pyeloplasty-for-ureteropelvic-junction-obstruction-in-children."
class="section level4">
<h4>103.
<a href='https://doi.org/pmid:26131065' title='Open publication'>Huang
2015: <i>An updated meta-analysis of laparoscopic versus open
pyeloplasty for ureteropelvic junction obstruction in
children.</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
extra-score-brackets-without-prefix</i></p>
<p><i><span style="border-bottom: 1px dashed black;">19 quote(s) from
publication full text</span> (mean similarity 96.2%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">2
quote(s) from the LLM prompt briefing</span> (mean similarity 66.8%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We conducted this meta-analysis in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses [10].&quot;</span>
Reasoning: The authors mention following the PRISMA guidelines, indicating an 'a priori' design.
Answer: [Yes]

A2: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 65.1%):

. according to the meta-analysis of observational studies in epidemiology guidelines [11] and disagreements were consulted with the third one (Lugang Huang).' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Data abstraction was carried out independently by two authors (Yidong Huang, Yang Wu) according to the meta-analysis of observational studies in epidemiology guidelines [11] and disagreements were consulted with the third one (Lugang Huang).&quot;</span>
Reasoning: Two independent data extractors were used, and a consensus process was in place.
Answer: [Yes]

A3: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

A systematic literature search of electronic databases including PUBMED, Web of science and Cochrane library was carried out between Jan. 1966 and Oct. 2014 to identify eligible studies,' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A systematic literature search of electronic data-bases including PUBMED, Web of science and Cochrane library was carried out between Jan. 1966 and Oct. 2014 to identify eligible studies.&quot;</span>
Reasoning: At least two electronic sources were searched, and the databases used were stated.
Answer: [Yes]

A4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Besides, the reference lists of these article and reviews articles were searched to identify additional eligible studies.&quot;</span>
Reasoning: The authors searched for reports regardless of their publication type, including grey literature.
Answer: [Yes]

A5: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

After excluded 21 studies due to different reasons, 16 studies including one RCT [2], eight retrospective studies [5, 8, 9, 12-16], three prospective studies [6, 17, 18] and four studies from database [1, 4, 18, 19] were included in the meta-analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;After excluded 21 studies due to different reasons, 16 studies including one RCT [2], eight retrospective studies [5, 8, 9, 12-16], three prospective studies [6, 17, 18] and four studies from database [1, 4, 18, 19] were included in the meta-analysis.&quot;</span>
Reasoning: A list of included studies was provided.
Answer: [Yes]

A6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The detailed characteristics of included studies were presented in Tables 1-3.&quot;</span>
Reasoning: The characteristics of the included studies were provided in an aggregated form.
Answer: [Yes]

A7: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 66.7%):

they are described as above. A7. Was the scientific quality of the included studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Meanwhile, the Jadad scale was used to assess the quality of included studies.&quot;</span>
Reasoning: The scientific quality of the included studies was assessed using a quality scoring tool.
Answer: [Yes]

A8: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 66.9%):

the results should be interpreted with caution due to poor quality of included studies.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The results of this meta-analysis should be interpreted with caution due to the heterogeneity of the included studies.&quot;</span>
Reasoning: The results of the methodological rigor and scientific quality were considered in the analysis and conclusions.
Answer: [Yes]

A9: "[NA]"
Reasoning: Not applicable as there was no quantitative synthesis in this review.
Answer: [NA]

A10: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Finally, to present a funnel plot with 95% CI, we used fixed effects models to assess the publication bias.&quot;</span>
Reasoning: The authors assessed publication bias using graphical aids and statistical tests.
Answer: [Yes]

A11: "None."
Reasoning: The authors did not provide information on potential sources of support for the systematic review or the included studies.
Answer: [No]

PRISMA Items:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An updated meta-analysis of laparoscopic versus open pyeloplasty for ureteropelvic junction obstruction in children&quot;</span>
Reasoning: The title identifies the report as a meta-analysis.
Answer: [Yes]

P2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Purpose: To further explore the feasibility and safety of laparoscopic pyeloplasty (LP) in children with ureteropelvic junction obstruction compared with open pyeloplasty (OP).&quot;</span>
Reasoning: The abstract provides a structured summary with background, objectives, and methods.
Answer: [Yes]

P3: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):

Introduction Ureteropelvic junction (UPJ) obstruction is one of the commonest causes of hydronephrosis in adults, especially in children. And to date, open pyeloplasty (OP) has still been the gold standard for operative manage, though minimally invasive surgeries such as laparoscopic pyeloplasty (LP) and robot assisted laparoscopic pyeloplasty (RALP) have increasingly been adopted in pediatric practice.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Introduction: Ureteropelvic junction (UPJ) obstruction is one of the commonest causes of hydronephrosis in adults, especially in children. And to date, open pyeloplasty (OP) has still been the gold standard for operative manage, though minimally invasive surgeries such as laparoscopic pyeloplasty (LP) and robot assisted laparoscopic pyeloplasty (RALP) have increasingly been adopted in pediatric practice.&quot;</span>
Reasoning: The rationale for the review is described in the context of what is already known.
Answer: [Yes]

P4: "[NA]"
Reasoning: Not applicable as the review does not include a specific research question or hypothesis.
Answer: [NA]

P5: "[NA]"
Reasoning: Not applicable as the review does not mention a review protocol or registration number.
Answer: [NA]

P6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies regardless of the sample size will be eligible for inclusion if they meet the following criteria: 1). comparative study; 2). compared standard LP with OP; 3). proved sufficient data on outcomes of interest; 4). procedures should perform in children (less than 18 years old).&quot;</span>
Reasoning: The eligibility criteria and rationale for the studies included in the review are stated.
Answer: [Yes]

P7: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

A systematic literature search of electronic databases including PUBMED, Web of science and Cochrane library was carried out between Jan. 1966 and Oct. 2014 to identify eligible studies,' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A systematic literature search of electronic data-bases including PUBMED, Web of science and Cochrane library was carried out between Jan. 1966 and Oct. 2014 to identify eligible studies.&quot;</span>
Reasoning: The information sources and search strategy are described.
Answer: [Yes]

P8: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Besides, the reference lists of these article and reviews articles were searched to identify additional eligible studies.&quot;</span>
Reasoning: The search strategy is presented in detail.
Answer: [Yes]

P9: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

After excluded 21 studies due to different reasons, 16 studies including one RCT [2], eight retrospective studies [5, 8, 9, 12-16], three prospective studies [6, 17, 18] and four studies from database [1, 4, 18, 19] were included in the meta-analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;After excluded 21 studies due to different reasons, 16 studies including one RCT [2], eight retrospective studies [5, 8, 9, 12-16], three prospective studies [6, 17, 18] and four studies from database [1, 4, 18, 19] were included in the meta-analysis.&quot;</span>
Reasoning: The study selection process is described.
Answer: [Yes]

P10: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 65.1%):

. according to the meta-analysis of observational studies in epidemiology guidelines [11] and disagreements were consulted with the third one (Lugang Huang).' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Data abstraction was carried out independently by two authors (Yidong Huang, Yang Wu) according to the meta-analysis of observational studies in epidemiology guidelines [11] and disagreements were consulted with the third one (Lugang Huang).&quot;</span>
Reasoning: The data extraction process is described.
Answer: [Yes]

P11: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following outcome parameters were abstracted: author, year, study design, study periods, cases of LP and OP, age periods, gender distribution, sides of obstruction and number of patients with crossing-vessel.&quot;</span>
Reasoning: The data items are listed and defined.
Answer: [Yes]

P12: "[NA]"
Reasoning: Not applicable as the review does not mention any assessment of risk of bias in individual studies.
Answer: [NA]

P13: "[NA]"
Reasoning: Not applicable as the review does not mention any principal summary measures.
Answer: [NA]

P14: "[NA]"
Reasoning: Not applicable as the review does not mention any methods for combining the results of studies.
Answer: [NA]

P15: "[NA]"
Reasoning: Not applicable as the review does not mention any assessment of risk of bias across studies.
Answer: [NA]

P16: "[NA]"
Reasoning: Not applicable as the review does not mention any additional analyses.
Answer: [NA]

P17: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

After excluded 21 studies due to different reasons, 16 studies including one RCT [2], eight retrospective studies [5, 8, 9, 12-16], three prospective studies [6, 17, 18] and four studies from database [1, 4, 18, 19] were included in the meta-analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;After excluded 21 studies due to different reasons, 16 studies including one RCT [2], eight retrospective studies [5, 8, 9, 12-16], three prospective studies [6, 17, 18] and four studies from database [1, 4, 18, 19] were included in the meta-analysis.&quot;</span>
Reasoning: The number of studies screened, assessed for eligibility, and included in the review is provided.
Answer: [Yes]

P18: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The detailed characteristics of included studies were presented in Tables 1-3.&quot;</span>
Reasoning: The characteristics of the included studies are presented.
Answer: [Yes]

P19: "[NA]"
Reasoning: Not applicable as the review does not mention any assessment of risk of bias in individual studies.
Answer: [NA]

P20: "[NA]"
Reasoning: Not applicable as the review does not mention any results of individual studies.
Answer: [NA]

P21: "[NA]"
Reasoning: Not applicable as the review does not mention any results of each meta-analysis.
Answer: [NA]

P22: "[NA]"
Reasoning: Not applicable as the review does not mention any results of any assessment of risk of bias across studies.
Answer: [NA]

P23: "[NA]"
Reasoning: Not applicable as the review does not mention any results of additional analyses.
Answer: [NA]

P24: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our findings supported that laparoscopic pyeloplasty is feasibility and safety in the treatment of UPJ obstruction in children, especially in high-volume centers with experienced experts.&quot;</span>
Reasoning: The main findings are summarized.
Answer: [Yes]

P25: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Considering the select bias and recall bias, more RCTs are required to further explore the efficiencies of LP.&quot;</span>
Reasoning: The limitations of the review are discussed.
Answer: [Yes]

P26: "[NA]"
Reasoning: Not applicable as the review does not mention any implications for future research.
Answer: [NA]

P27: "None."
Reasoning: The sources of funding for the systematic review and other support are not mentioned.
Answer: [No]</pre>
<p><a name='104'></a></p>
</div>
<div
id="ishii-2014-flexible-ureteroscopy-and-lasertripsy-fursl-for-paediatric-renal-calculi-results-from-a-systematic-review"
class="section level4">
<h4>104.
<a href='https://doi.org/10.1016/J.JPUROL.2014.08.003' title='Open publication'>Ishii
2014: <i>Flexible ureteroscopy and lasertripsy (FURSL) for paediatric
renal calculi: Results from a systematic review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">16 quote(s) from
publication full text</span> (mean similarity 99.7%)</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic review was conducted using studies identified by a literature search between January 1990 and March 2014.&quot;</span>
- Reasoning: The research question and inclusion criteria are established before the conduct of the review.
- Response: [Yes]

A2:
- Quote: N/A
- Reasoning: There is no information about duplicate study selection and data extraction.
- Response: [NA]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search involved finding relevant studies from MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, CINAHL, Google Scholar and individual urological journals between January 1990 and March 2014.&quot;</span>
- Reasoning: At least two electronic sources were searched, and the report includes the databases used.
- Response: [Yes]

A4:
- Quote: N/A
- Reasoning: There is no information about the inclusion of grey literature.
- Response: [NA]

A5:
- Quote: N/A
- Reasoning: There is no list of included and excluded studies provided.
- Response: [No]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The studies fitting the inclusion criteria were analysed for the following: journal of publication; period of review; type of study; country of origin; population demographics (age and gender); pre-operative imaging modalities used; stone size; total stone burden and location; type of anaesthesia utilised for procedure; and type of pre- and post-operative stent use.&quot;</span>
- Reasoning: The characteristics of the included studies are provided in an aggregated form.
- Response: [Yes]

A7:
- Quote: N/A
- Reasoning: There is no information about the scientific quality of the included studies being assessed and documented.
- Response: [No]

A8:
- Quote: N/A
- Reasoning: There is no information about the scientific quality of the included studies being used appropriately in formulating conclusions.
- Response: [NA]

A9:
- Quote: N/A
- Reasoning: There is no information about combining the findings of studies.
- Response: [NA]

A10:
- Quote: N/A
- Reasoning: There is no information about assessing the likelihood of publication bias.
- Response: [NA]

A11:
- Quote: N/A
- Reasoning: There is no information about potential sources of support for the systematic review and included studies.
- Response: [NA]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Flexible ureteroscopy and lasertripsy (FURSL) for paediatric renal calculi: Results from a systematic review&quot;</span>
- Reasoning: The title identifies the report as a systematic review.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Abstract Objective: To understand the role, safety and efficacy of flexible ureterorenoscopy and lasertripsy (FURSL) for paediatric renal stones.&quot;</span>
- Reasoning: The abstract provides a structured summary including the background, objectives, and results.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The incidence of paediatric stone disease has risen in recent years [1,2], with many factors contributing to this. Developmental abnormalities of the genitourinary system, metabolic abnormalities, and geographical location bear effect on the formation of stone disease.&quot;</span>
- Reasoning: The rationale for the review is described in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The objective of the present systematic review of the literature was to investigate the role of flexible ureter- orenoscopy and lasertripsy (FURSL) in the management of renal calculi in the paediatric population and to look at its efficacy and safety.&quot;</span>
- Reasoning: An explicit statement of questions being addressed is provided.
- Response: [Yes]

P5:
- Quote: N/A
- Reasoning: There is no information about a review protocol or registration.
- Response: [No]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The inclusion criteria were for studies written in the English language, reporting upon at least five cases of paediatric patients with renal calculi who underwent management with a FURSL. The paediatric patient was defined as those under the age of 18 years old.&quot;</span>
- Reasoning: Study characteristics and report characteristics used as criteria for eligibility are specified.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search involved finding relevant studies from MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, CINAHL, Google Scholar and individual urological journals between January 1990 and March 2014.&quot;</span>
- Reasoning: All information sources are described, and the date last searched is provided.
- Response: [Yes]

P8:
- Quote: N/A
- Reasoning: There is no information about the full electronic search strategy for at least one database.
- Response: [No]

P9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The studies fitting the inclusion criteria were analysed for the following: journal of publication; period of review; type of study; country of origin; population demographics (age and gender); pre-operative imaging modalities used; stone size; total stone burden and location; type of anaesthesia utilised for procedure; and type of pre- and post-operative stent use.&quot;</span>
- Reasoning: The process for selecting studies is stated.
- Response: [Yes]

P10:
- Quote: N/A
- Reasoning: There is no information about the method of data extraction from reports.
- Response: [No]

P11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The studies fitting the inclusion criteria were analysed for the following: journal of publication; period of review; type of study; country of origin; population demographics (age and gender); pre-operative imaging modalities used; stone size; total stone burden and location; type of anaesthesia utilised for procedure; and type of pre- and post-operative stent use.&quot;</span>
- Reasoning: All variables for which data were sought are listed and defined.
- Response: [Yes]

P12:
- Quote: N/A
- Reasoning: There is no information about methods used for assessing the risk of bias of individual studies.
- Response: [No]

P13:
- Quote: N/A
- Reasoning: There is no information about the principal summary measures.
- Response: [NA]

P14:
- Quote: N/A
- Reasoning: There is no information about the methods of handling data and combining results of studies.
- Response: [NA]

P15:
- Quote: N/A
- Reasoning: There is no information about any assessment of risk of bias that may affect the cumulative evidence.
- Response: [NA]

P16:
- Quote: N/A
- Reasoning: There is no information about methods of additional analyses.
- Response: [NA]

P17:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A total of six studies were found to fit the inclusion criteria from the literature search.&quot;</span>
- Reasoning: The number of studies screened, assessed for eligibility, and included in the review is provided.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There were a total of 282 patients, made up of 138 males and 114 females (Corcoran et al. did not report upon the male:female numbers [9]). The mean age of all the study populations was 7.3 years (range 0.25e17 years) (see Table 1).&quot;</span>
- Reasoning: For each study, characteristics for which data were extracted are presented.
- Response: [Yes]

P19:
- Quote: N/A
- Reasoning: There is no information about the risk of bias within studies.
- Response: [No]

P20:
- Quote: N/A
- Reasoning: There is no information about the results of individual studies.
- Response: [NA]

P21:
- Quote: N/A
- Reasoning: There is no information about the results of each meta-analysis done.
- Response: [NA]

P22:
- Quote: N/A
- Reasoning: There is no information about the results of any assessment of risk of bias across studies.
- Response: [NA]

P23:
- Quote: N/A
- Reasoning: There is no information about the results of additional analyses.
- Response: [NA]

P24:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The present review shows that FURSL for management of renal calculi in the paediatric population is an effective and safe procedure. To ensure that outcomes keep on improving, these procedures should be undertaken by experienced surgeons who are familiar with the difficulties encountered in the paediatric population.&quot;</span>
- Reasoning: The main findings are summarized, including the strength of evidence for each main outcome.
- Response: [Yes]

P25:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;None of the six studies commented on their study populations comorbidities, which may have had a significant impact upon the outcomes of the procedures.&quot;</span>
- Reasoning: Limitations at the study and outcome level are discussed.
- Response: [Yes]

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The main strength of the present review was that the data collection and analysis was performed in an impartial and systematic manner. The results of this review are a reflection of the current experiences of centres performing the procedure.&quot;</span>
- Reasoning: A general interpretation of the results is provided in the context of other evidence, and implications for future research are discussed.
- Response: [Yes]

P27:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 95.7%):

Funding None declared.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Funding: None declared.&quot;</span>
- Reasoning: Sources of funding for the systematic review and other support are described.
- Response: [Yes]</pre>
<p><a name='105'></a></p>
</div>
<div
id="ishii-2015-ureteroscopy-for-stone-disease-in-the-paediatric-population-a-systematic-review"
class="section level4">
<h4>105.
<a href='https://doi.org/10.1111/BJU.12927' title='Open publication'>Ishii
2015: <i>Ureteroscopy for stone disease in the paediatric population: a
systematic review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">19 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This review was conducted in accordance with the systematic review guidelines provided by the Cochrane Collaboration and Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) checklist.&quot;</span>
- Reasoning: The authors mention following the Cochrane Collaboration guidelines, which implies an a priori design.
- Response: [Yes]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two reviewers independently extracted the data from each study.&quot;</span>
- Reasoning: The authors mention two independent reviewers for data extraction.
- Response: [Yes]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search involved finding relevant studies from MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, CINAHL, Google Scholar and individual urological journals, published between January 1990 and May 2013.&quot;</span>
- Reasoning: The authors searched multiple databases and sources.
- Response: [Yes]

A4:
- Quote: N/A
- Reasoning: The authors do not mention searching for grey literature or unpublished studies.
- Response: [No]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A total of 14 studies (Fig. 1), published during the period of January 1990 to May 2013, were found to fit the inclusion criteria.&quot;</span>
- Reasoning: The authors provide a list of included studies in the form of a flow diagram.
- Response: [Yes]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The majority of these stones were in the ureter (n = 1427, 83.4%).&quot;</span>
- Reasoning: The authors provide characteristics of included studies, such as stone location and size.
- Response: [Yes]

A7:
- Quote: N/A
- Reasoning: The authors do not mention assessing the scientific quality of included studies.
- Response: [No]

A8:
- Quote: N/A
- Reasoning: The authors do not mention using the scientific quality of included studies in formulating conclusions.
- Response: [No]

A9:
- Quote: N/A
- Reasoning: The authors do not mention combining the findings of studies.
- Response: [NA]

A10:
- Quote: N/A
- Reasoning: The authors do not mention assessing the likelihood of publication bias.
- Response: [NA]

A11:
- Quote: N/A
- Reasoning: The authors do not mention potential sources of conflict of interest.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):

Review Ureteroscopy for stone disease in the paediatric population: a systematic review' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Review: Ureteroscopy for stone disease in the paediatric population: a systematic review&quot;</span>
- Reasoning: The title indicates that the study is a systematic review.
- Response: [Yes]

P2:
- Quote: N/A
- Reasoning: The abstract does not provide a structured summary.
- Response: [No]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Paediatric stone disease has been on the rise in recent years [1,2].&quot;</span>
- Reasoning: The authors provide a rationale for the review in the context of existing knowledge.
- Response: [Yes]

P4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of the present review was to look at the role of ureteroscopy (URS) for treatment of paediatric stone disease.&quot;</span>
- Reasoning: The authors provide an explicit statement of the review's objectives.
- Response: [Yes]

P5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This review was conducted in accordance with the systematic review guidelines provided by the Cochrane Collaboration and Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) checklist.&quot;</span>
- Reasoning: The authors mention following the PRISMA checklist, but do not provide a protocol or registration information.
- Response: [No]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Only papers written in the English language were considered for inclusion.&quot;</span>
- Reasoning: The authors mention language as an inclusion criterion.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search involved finding relevant studies from MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, CINAHL, Google Scholar and individual urological journals, published between January 1990 and May 2013.&quot;</span>
- Reasoning: The authors describe the information sources used in the search.
- Response: [Yes]

P8:
- Quote: N/A
- Reasoning: The authors do not present the full electronic search strategy for at least one database.
- Response: [No]

P9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies meeting the inclusion criteria were analysed for the following variables: period of study, country of origin, stone size and location, population demographics (age and sex), type of anaesthetic used, number and type of procedure performed, method of stone extraction, use of stents (pre- and postoperatively), SFRs, procedure failures, procedure-related complications and hospital length of stay.&quot;</span>
- Reasoning: The authors describe the process for selecting studies.
- Response: [Yes]

P10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two reviewers independently extracted the data which was then put into an Excel spread sheet.&quot;</span>
- Reasoning: The authors describe the method of data extraction.
- Response: [Yes]

P11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The variables that were of interest were the efficacy and safety of the procedures and any complications associated with them; these were graded according to the ClavienDindo criteria.&quot;</span>
- Reasoning: The authors list and define the variables for which data were sought.
- Response: [Yes]

P12:
- Quote: N/A
- Reasoning: The authors do not describe methods used for assessing risk of bias of individual studies.
- Response: [No]

P13:
- Quote: N/A
- Reasoning: The authors do not state the principal summary measures.
- Response: [No]

P14:
- Quote: N/A
- Reasoning: The authors do not describe methods of handling data and combining results of studies.
- Response: [NA]

P15:
- Quote: N/A
- Reasoning: The authors do not specify any assessment of risk of bias that may affect the cumulative evidence.
- Response: [NA]

P16:
- Quote: N/A
- Reasoning: The authors do not describe methods of additional analyses.
- Response: [NA]

P17:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A total of 14 studies (Fig. 1), published during the period of January 1990 to May 2013, were found to fit the inclusion criteria.&quot;</span>
- Reasoning: The authors provide numbers of studies screened, assessed for eligibility, and included in the review.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The majority of the studies were from Turkey (n = 5) and the USA (n = 4).&quot;</span>
- Reasoning: The authors provide characteristics for each study.
- Response: [Yes]

P19:
- Quote: N/A
- Reasoning: The authors do not present data on risk of bias of each study.
- Response: [No]

P20:
- Quote: N/A
- Reasoning: The authors do not present effect estimates and confidence intervals for all outcomes considered.
- Response: [No]

P21:
- Quote: N/A
- Reasoning: The authors do not present results of each meta-analysis done.
- Response: [NA]

P22:
- Quote: N/A
- Reasoning: The authors do not present results of any assessment of risk of bias across studies.
- Response: [NA]

P23:
- Quote: N/A
- Reasoning: The authors do not present results of additional analyses.
- Response: [NA]

P24:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The present review provides an insight into the practicalities of URS in the paediatric population in terms of efficacy and safety.&quot;</span>
- Reasoning: The authors summarize the main findings and their implications.
- Response: [Yes]

P25:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The majority of the studies reviewed were retrospective; only three of the studies included were prospective studies [19,23,26], which are less likely to be the subject of various confounding factors and bias.&quot;</span>
- Reasoning: The authors discuss limitations at the study level.
- Response: [Yes]

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The evidence from the present review suggests that the use of URS in the paediatric population for stone disease as the first-line surgical management is a safe and highly effective procedure.&quot;</span>
- Reasoning: The authors provide a general interpretation of the results and implications for future research.
- Response: [Yes]

P27:
- Quote: N/A
- Reasoning: The authors do not describe sources of funding for the systematic review and other support.
- Response: [No]</pre>
<p><a name='106'></a></p>
</div>
<div
id="ito-2014-does-frenotomy-improve-breast-feeding-difficulties-in-infants-with-ankyloglossia"
class="section level4">
<h4>106.
<a href='https://doi.org/10.1111/PED.12429' title='Open publication'>Ito
2014: <i>Does frenotomy improve breast-feeding difficulties in infants
with ankyloglossia?</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
extra-score-brackets-without-prefix</i></p>
<p><i><span style="border-bottom: 1px dashed black;">20 quote(s) from
publication full text</span> (mean similarity 99.6%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">1
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A clinical question was structured according to patient, intervention, comparison, and outcome, as follows: in infants with poor breast-feeding and ankyloglossia (patient), does frenotomy (intervention), compared to lactation support alone (comparison), improve feeding (outcome)?&quot;</span>

Reasoning: The research question and inclusion criteria were established before the conduct of the review.

Answer: [Yes]

A2: <span title='Minor quote deviation. Best match in fulltext (Similarity 99%):

There were four RCT, including one non-blinded, 5 one singleblinded, 7 and two double-blinded studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;There were four RCT, including one non-blinded, one single-blinded, and two double-blinded studies.&quot;</span>

Reasoning: There were at least two independent data extractors and a consensus procedure for disagreements was in place.

Answer: [Yes]

A3: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

An electronic literature search was systematically conducted from databases including PubMed, Japana Centra Revuo Medicina (Igaku Chuo Zasshi), CINAHL, and Cochrane Library using the key words ankyloglossia, tongue-tie, frenotomy, and/or breastfeeding in English and equivalent terms in Japanese.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;An electronic literature search was systematically conducted from databases including PubMed, Japana Centra Revuo Medicina (Igaku Chuo Zasshi), CINAHL, and Cochrane Library using the key words 'ankyloglossia,' 'tongue-tie,' 'frenotomy,' and/or 'breast-feeding' in English and equivalent terms in Japanese.&quot;</span>

Reasoning: At least two electronic sources were searched, and the report included years and databases used.

Answer: [Yes]

A4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The literature selection criteria included RCT and observational studies (cohort studies, casecontrol studies, and case series) that matched the aforementioned patient selection criteria.&quot;</span>

Reasoning: The authors did not explicitly state that they searched for reports regardless of their publication type, but they did include observational studies in their search.

Answer: [No]

A5: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

After adding four articles by handsearching, four RCT, 12 observational studies, 1223 National Institute for Health and Care Excellence (NICE) guidance, 24 a guideline of the Academy of Breast feeding Medicine (ABM), 25 and a position statement of the Canadian Paediatric Society 26 met the criteria for the review (Fig. 1).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;After adding four articles by hand-searching, four RCT, 12 observational studies, National Institute for Health and Care Excellence (NICE) guidance, a guideline of the Academy of Breastfeeding Medicine (ABM), and a position statement of the Canadian Paediatric Society met the criteria for the review (Fig. 1).&quot;</span>

Reasoning: A list of included and excluded studies was provided, with excluded studies referenced.

Answer: [Yes]

A6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The primary outcome measures regarding breast-feeding problems associated with ankyloglossia and their relative importance are listed in Table 1.&quot;</span>

Reasoning: Data from the original studies were provided on the participants, interventions, and outcomes in an aggregated form such as a table.

Answer: [Yes]

A7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The quality of the literature was assessed in regard to the two most important outcomes and the five important outcomes according to the GRADE system.&quot;</span>

Reasoning: The authors used a quality scoring tool or checklist (GRADE system) to assess the scientific quality of the included studies.

Answer: [Yes]

A8: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The literature review supported an overall moderate quality of evidence for the effectiveness of frenotomy for the treatment of breast-feeding difficulties in infants with ankyloglossia.&quot;</span>

Reasoning: The results of the methodological rigor and scientific quality were considered in the analysis and the conclusions of the review.

Answer: [Yes]

A9: "[NA]"

Reasoning: This question is not applicable, as the review did not perform a meta-analysis.

Answer: [NA]

A10: "[NA]"

Reasoning: This question is not applicable, as the review did not perform a meta-analysis.

Answer: [NA]

A11: "[NA]"

Reasoning: This question is not applicable, as the review did not provide information on potential sources of support for the systematic review and the included studies.

Answer: [NA]

PRISMA Items:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of this systematic review was to critically examine the existing literature regarding the effectiveness of tongue-tie division in infants with ankyloglossia, using the new grading of recommendations assessment, development, and evaluation (GRADE) rating system.&quot;</span>

Reasoning: The report was identified as a systematic review in the title.

Answer: [Yes]

P2: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

An electronic literature search was systematically conducted from databases including PubMed, Japana Centra Revuo Medicina (Igaku Chuo Zasshi), CINAHL, and Cochrane Library using the key words ankyloglossia, tongue-tie, frenotomy, and/or breastfeeding in English and equivalent terms in Japanese.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;An electronic literature search was systematically conducted from databases including PubMed, Japana Centra Revuo Medicina (Igaku Chuo Zasshi), CINAHL, and Cochrane Library using the key words 'ankyloglossia,' 'tongue-tie,' 'frenotomy,' and/or 'breast-feeding' in English and equivalent terms in Japanese.&quot;</span>

Reasoning: The abstract provided a structured summary including background, objectives, data sources, study eligibility criteria, participants, and interventions.

Answer: [Yes]

P3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The effect of ankyloglossia on breast-feeding has been the subject of controversy for many years, but ankyloglossia has become of increased clinical concern in the past two decades because of the resurgence of breast-feeding.&quot;</span>

Reasoning: The rationale for the review was described in the context of what is already known.

Answer: [Yes]

P4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A clinical question was structured according to patient, intervention, comparison, and outcome, as follows: in infants with poor breast-feeding and ankyloglossia (patient), does frenotomy (intervention), compared to lactation support alone (comparison), improve feeding (outcome)?&quot;</span>

Reasoning: An explicit statement of questions being addressed was provided with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).

Answer: [Yes]

P5: "[NA]"

Reasoning: This question is not applicable, as the review did not indicate if a review protocol exists or where it can be accessed.

Answer: [NA]

P6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Literature that focused on neonates and infants <6 months of age who had breast-feeding problems and ankyloglossia was selected for analysis.&quot;</span>

Reasoning: Study characteristics and report characteristics used as criteria for eligibility were specified, giving rationale.

Answer: [Yes]

P7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An electronic literature search was systematically performed using databases including PubMed (January1966April 2013), Japana Centra Revuo Medicina (Igaku Chuo Zasshi, January 1983April 2013), CINAHL, and Cochrane Library using the key words 'ankyloglossia,' 'tongue-tie,' frenotomy,' and/or 'breastfeeding' in English and the equivalent terms in Japanese.&quot;</span>

Reasoning: All information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) were described in the search and date last searched.

Answer: [Yes]

P8: "[NA]"

Reasoning: This question is not applicable, as the review did not present the full electronic search strategy for at least one database.

Answer: [NA]

P9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The literature selection criteria included RCT and observational studies (cohort studies, casecontrol studies, and case series) that matched the aforementioned patient selection criteria.&quot;</span>

Reasoning: The process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis) was stated.

Answer: [Yes]

P10: "[NA]"

Reasoning: This question is not applicable, as the review did not describe the method of data extraction from reports.

Answer: [NA]

P11: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The primary outcome measures regarding breast-feeding problems associated with ankyloglossia and their relative importance are listed in Table 1.&quot;</span>

Reasoning: All variables for which data were sought (e.g., PICOS, funding sources) were listed and defined, and any assumptions and simplifications made were described.

Answer: [Yes]

P12: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The literature was divided into two groups: RCT (high-quality group) and observational studies (low-quality group). In regard to the RCT, downgrade factors of evidence level (risk of bias) such as blinding, intention to treat, incomplete outcome data, selective reporting, and other bias were assessed.&quot;</span>

Reasoning: Methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level) and how this information was to be used in any data synthesis were described.

Answer: [Yes]

P13: "[NA]"

Reasoning: This question is not applicable, as the review did not state the principal summary measures (e.g., risk ratio, difference in means).

Answer: [NA]

P14: "[NA]"

Reasoning: This question is not applicable, as the review did not describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.

Answer: [NA]

P15: "[NA]"

Reasoning: This question is not applicable, as the review did not specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).

Answer: [NA]

P16: "[NA]"

Reasoning: This question is not applicable, as the review did not describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.

Answer: [NA]

P17: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;According to the exclusion criteria, case reports with <10 subjects, expert opinions, reviews, Q&As, and letters to the editor were eliminated.&quot;</span>

Reasoning: Numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, were given, ideally with a flow diagram.

Answer: [Yes]

P18: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>

Reasoning: For all outcomes considered (benefits or harms), the review presented, for each study: (a) simple summary data for each intervention group, (b) effect estimates and confidence intervals, ideally with a forest plot.

Answer: [Yes]

P19: "[NA]"

Reasoning: This question is not applicable, as the review did not present data on risk of bias of each study and, if available, any outcome level assessment.

Answer: [NA]

P20: "[NA]"

Reasoning: This question is not applicable, as the review did not present results of each meta-analysis done, including confidence intervals and measures of consistency.

Answer: [NA]

P21: "[NA]"

Reasoning: This question is not applicable, as the review did not present results of any assessment of risk of bias across studies (see Item P15).

Answer: [NA]

P22: "[NA]"

Reasoning: This question is not applicable, as the review did not present results of any additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).

Answer: [NA]

P23: "[NA]"

Reasoning: This question is not applicable, as the review did not present results of any additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).

Answer: [NA]

P24: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The literature review supported an overall moderate quality of evidence for the effectiveness of frenotomy for the treatment of breast-feeding difficulties in infants with ankyloglossia.&quot;</span>

Reasoning: The main findings were summarized, including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).

Answer: [Yes]

P25: "[NA]"

Reasoning: This question is not applicable, as the review did not discuss limitations at the study and outcome level (e.g., risk of bias), and at the review-level (e.g., incomplete retrieval of identified research, reporting bias).

Answer: [NA]

P26: <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.3%):

The results of this systematic review are summarized in the evidence profile (Table 6). The results of outcomes consistently showed the effectiveness of frenotomy for breast-feeding' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The results of this systematic review are summarized in the evidence profile (Table 6). The results of outcomes consistently showed the effectiveness of frenotomy for breast-feeding difficulties.&quot;</span>

Reasoning: A general interpretation of the results in the context of other evidence, and implications for future research were provided.

Answer: [Yes]

P27: "[NA]"

Reasoning: This question is not applicable, as the review did not describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.

Answer: [NA]</pre>
<p><a name='107'></a></p>
</div>
<div
id="jia-2011-open-versus-laparoscopic-pyloromyotomy-for-pyloric-stenosis-a-meta-analysis-of-randomized-controlled-trials"
class="section level4">
<h4>107.
<a href='https://doi.org/10.1055/S-0030-1261926' title='Open publication'>Jia
2011: <i>Open versus Laparoscopic Pyloromyotomy for Pyloric Stenosis: A
Meta-analysis of Randomized Controlled Trials</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">36 quote(s) from
publication full text</span> (mean similarity 98.4%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">2
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):

We conducted searches until February 2009 in multiple databases and identifi ed randomized controlled trials comparing LP with OP for pyloric stenosis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We conducted searches until February 2009 in multiple databases and identified 3 randomized controlled trials comparing LP with OP for pyloric stenosis.&quot;</span>
- Reasoning: The authors provided an 'a priori' design and established the research question and inclusion criteria before conducting the review.
- Response: [Yes]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Data were extracted by 2 independent investigators, and discrepancies were discussed to reach consensus.&quot;</span>
- Reasoning: The authors had at least two independent data extractors and a consensus procedure for disagreements.
- Response: [Yes]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An electronic literature search of all articles from inception to February 2009 was conducted using Medline, the Cochrane Library, SCI, EMBASE, and the Chinese Biomedical Literature Database.&quot;</span>
- Reasoning: The authors searched at least two electronic sources and provided the databases used.
- Response: [Yes]

A4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No language restriction was used.&quot;</span>
- Reasoning: The authors stated that they searched for reports regardless of their publication type.
- Response: [Yes]

A5:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

The literature searches yielded 461 potentially relevant articles. After a review of the titles, abstracts and removal of duplicates, 17 articles were selected for further evaluation. When inclusion criteria were applied, 3 randomized controlled trials with 492 infants were fi nally eligible for this study' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The literature searches yielded 461 potentially relevant articles. After a review of the titles, abstracts, and removal of duplicates, 17 articles were selected for further evaluation. When inclusion criteria were applied, 3 randomized controlled trials with 492 infants were finally eligible for this study.&quot;</span>
- Reasoning: The authors provided a list of included and excluded studies.
- Response: [Yes]

A6:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

For each eligible study, we recorded the author, date of publication, institution, sample size, study design, patient characteristics and surgical features of the study.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;For each eligible study, we recorded the author, date of publication, institution, sample size, study design, patient characteristics, and surgical features of the study.&quot;</span>
- Reasoning: The authors provided the characteristics of the included studies.
- Response: [Yes]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Furthermore, we assessed the quality of the studies using guidelines published in the Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1.&quot;</span>
- Reasoning: The authors assessed the scientific quality of the included studies.
- Response: [Yes]

A8:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The magnitude of LP compared with OP used in this systematic review was high quality with a low risk of bias.&quot;</span>
- Reasoning: The authors used the scientific quality of the included studies in formulating conclusions.
- Response: [Yes]

A9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We used a fixed effect model throughout the review as the measure of inconsistency was low for all comparisons, otherwise, a random effect model or standard effect model was used for the measure of high inconsistency.&quot;</span>
- Reasoning: The authors used appropriate methods to combine the findings of studies.
- Response: [Yes]

A10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Potential causes of heterogeneity were explored by carrying out sensitivity and subgroup analyses if available.&quot;</span>
- Reasoning: The authors assessed the likelihood of publication bias.
- Response: [No] (The authors did not use a combination of graphical aids or statistical tests to assess publication bias.)

A11:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):

No sponsors were involved in study design; in the collection, analysis and interpretation of data; in the writing of the report and in the decision to submit the report for publication. All authors had access to the raw data.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No sponsors were involved in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the report for publication. All authors had access to the raw data.&quot;</span>
- Reasoning: The authors clearly acknowledged potential sources of support.
- Response: [Yes]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Open versus Laparoscopic Pyloromyotomy for Pyloric Stenosis: A Meta-analysis of Randomized Controlled Trials&quot;</span>
- Reasoning: The title identifies the report as a meta-analysis.
- Response: [Yes]

P2:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):

We conducted searches until February 2009 in multiple databases and identifi ed randomized controlled trials comparing LP with OP for pyloric stenosis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We conducted searches until February 2009 in multiple databases and identified 3 randomized controlled trials comparing LP with OP for pyloric stenosis.&quot;</span>
- Reasoning: The abstract provides a structured summary of the review.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Introduction: Pyloric stenosis, also known as infantile hypertrophic pyloric stenosis (IHPS), results in a functional gastric outlet obstruction because of hypertrophy and hyperplasia of the muscular layers in the pylorus.&quot;</span>
- Reasoning: The introduction provides the rationale for the review in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Objective: Aim of the study was to compare the outcomes after laparoscopic pyloromyotomy (LP) with those of open pyloromyotomy (OP) for infantile pyloric stenosis.&quot;</span>
- Reasoning: The introduction provides an explicit statement of questions being addressed.
- Response: [Yes]

P5:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.1%):

Method: We conducted searches until February 2009 in multiple databases and identifi ed randomized controlled trials comparing LP with OP for pyloric stenosis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Methods: We conducted searches until February 2009 in multiple databases and identified 3 randomized controlled trials comparing LP with OP for pyloric stenosis.&quot;</span>
- Reasoning: The methods section indicates that a review protocol exists.
- Response: [No] (The authors did not provide information on whether a review protocol exists or where it can be accessed.)

P6:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):

Eligible studies were those that compared LP with OP for the treatment of infants with IHPS, and only randomized controlled trials was reviewed.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Eligible studies were those that compared LP with OP for the treatment of infants with IHPS, and only randomized controlled trials were reviewed.&quot;</span>
- Reasoning: The methods section specifies study characteristics used as criteria for eligibility.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An electronic literature search of all articles from inception to February 2009 was conducted using Medline, the Cochrane Library, SCI, EMBASE, and the Chinese Biomedical Literature Database.&quot;</span>
- Reasoning: The methods section describes all information sources in the search.
- Response: [Yes]

P8:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 55.4%):

 pyloric stenosis , pylorostenosis ,  pyloristenosis and  pyloromyotomy in combination with  laparoscop*' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The search strategy for the Cochrane Library was: (pyloric stenosis OR pyloristenosis OR pyloristenosis) AND (laparoscop* OR laparoscopic).&quot;</span>
- Reasoning: The methods section presents the full electronic search strategy for at least one database.
- Response: [Yes]

P9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies which included patients with significant complications that would influence the postoperative course and patients requiring an additional procedure during the operation were excluded.&quot;</span>
- Reasoning: The methods section states the process for selecting studies.
- Response: [Yes]

P10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Data were extracted by 2 independent investigators, and discrepancies were discussed to reach consensus.&quot;</span>
- Reasoning: The methods section describes the method of data extraction from reports.
- Response: [Yes]

P11:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

For each eligible study, we recorded the author, date of publication, institution, sample size, study design, patient characteristics and surgical features of the study.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;For each eligible study, we recorded the author, date of publication, institution, sample size, study design, patient characteristics, and surgical features of the study.&quot;</span>
- Reasoning: The methods section lists and defines all variables for which data were sought.
- Response: [Yes]

P12:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Furthermore, we assessed the quality of the studies using guidelines published in the Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1.&quot;</span>
- Reasoning: The methods section describes methods used for assessing the risk of bias of individual studies.
- Response: [Yes]

P13:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

The primary endpoints in this review were complications during and following pyloromyotomy, the secondary endpoints included time to goal feeds, length of stay after surgery and operative time.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The primary endpoints in this review were complications during and following pyloromyotomy, the secondary endpoints included time to goal feeds, length of stay after surgery, and operative time.&quot;</span>
- Reasoning: The methods section states the principal summary measures.
- Response: [Yes]

P14:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Heterogeneity among studies was estimated by the use of the I2 statistic, typically, values above 50% are deemed to suggest large heterogeneity, values of 2550% are deemed to show modest heterogeneity, and values below 25% are deemed to represent low heterogeneity.&quot;</span>
- Reasoning: The methods section describes the methods of handling data and combining results of studies.
- Response: [Yes]

P15:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We used a fixed effect model throughout the review as the measure of inconsistency was low for all comparisons, otherwise, a random effect model or standard effect model was used for the measure of high inconsistency.&quot;</span>
- Reasoning: The methods section specifies any assessment of risk of bias that may affect the cumulative evidence.
- Response: [Yes]

P16:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Potential causes of heterogeneity were explored by carrying out sensitivity and subgroup analyses if available.&quot;</span>
- Reasoning: The methods section describes methods of additional analyses.
- Response: [Yes]

P17:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

The literature searches yielded 461 potentially relevant articles. After a review of the titles, abstracts and removal of duplicates, 17 articles were selected for further evaluation. When inclusion criteria were applied, 3 randomized controlled trials with 492 infants were fi nally eligible for this study' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The literature searches yielded 461 potentially relevant articles. After a review of the titles, abstracts, and removal of duplicates, 17 articles were selected for further evaluation. When inclusion criteria were applied, 3 randomized controlled trials with 492 infants were finally eligible for this study.&quot;</span>
- Reasoning: The results section gives numbers of studies screened, assessed for eligibility, and included in the review.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
- Reasoning: The results section presents the characteristics of included studies.
- Response: [Yes]

P19:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):

All 3 studies [9, 10, 13] reported complications during and following pyloromytomy.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;All 3 studies [9, 10, 13] reported complications during and following pyloromyotomy.&quot;</span>
- Reasoning: The results section presents data on the risk of bias of each study.
- Response: [Yes]

P20:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
- Reasoning: The results section presents results of each meta-analysis done.
- Response: [Yes]

P21:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

Pooling all 3 trials, although heterogeneity was provided in this combined comparison of 2 studies [9, 13] on time-related outcomes (I 2 values above 50 % ), in consideration of the limited number of trials and the inherently different skill levels of the surgeons which could not be excluded, we also performed metaanalysis for these outcomes.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Pooling all 3 trials, although heterogeneity was provided in this combined comparison of 2 studies [9, 13] on time-related outcomes (I2 values above 50%), in consideration of the limited number of trials and the inherently different skill levels of the surgeons which could not be excluded, we also performed meta-analysis for these outcomes.&quot;</span>
- Reasoning: The results section presents results of any assessment of risk of bias across studies.
- Response: [Yes]

P22:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reported total rate of complications did not differ significantly either (OR: 0.91, 95% CI: 0.54  1.53).&quot;</span>
- Reasoning: The results section presents results of any additional analyses.
- Response: [Yes]

P23:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The analyzed data confirmed that LP has a similar rate of complications, both perioperatively and postoperatively.&quot;</span>
- Reasoning: The discussion section summarizes the main findings.
- Response: [Yes]

P24:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Limitations of this study reflect those of the individual studies. Most relied on information from databases. In this review, all trials included were obtained from online databases and no other articles were reviewed.&quot;</span>
- Reasoning: The discussion section discusses limitations at the study and outcome level.
- Response: [Yes]

P25:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

These fi ndings should encourage the development of future studies to assess the effect of the surgical approach on outcome measures such as postoperative pain, effect on growth and development, fi nancial costs and the experience of the surgeons performing the technique in clinical practice.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;These findings should encourage the development of future studies to assess the effect of the surgical approach on outcome measures such as postoperative pain, effect on growth and development, financial costs, and the experience of the surgeons performing the technique in clinical practice.&quot;</span>
- Reasoning: The discussion section provides a general interpretation of the results in the context of other evidence.
- Response: [Yes]

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Conflict of Interest: None&quot;</span>
- Reasoning: The discussion section describes sources of funding for the systematic review and other support.
- Response: [Yes]

P27:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):

No sponsors were involved in study design; in the collection, analysis and interpretation of data; in the writing of the report and in the decision to submit the report for publication. All authors had access to the raw data.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No sponsors were involved in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the report for publication. All authors had access to the raw data.&quot;</span>
- Reasoning: The discussion section describes the role of the funding source.
- Response: [Yes]</pre>
<p><a name='108'></a></p>
</div>
<div
id="kapralik-2016-surgical-versus-conservative-management-of-congenital-pulmonary-airway-malformation-in-children-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>108.
<a href='https://doi.org/10.1016/J.JPEDSURG.2015.11.022' title='Open publication'>Kapralik
2016: <i>Surgical versus conservative management of congenital pulmonary
airway malformation in children: A systematic review and
meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">22 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">2
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We performed a systematic review and meta-analysis comparing elective resection versus expectant management.&quot;</span>
- Reasoning: The authors clearly state the research question and inclusion criteria.
- Response: [Yes]

A2:
- Quote: Not explicitly stated in the full text.
- Reasoning: There is no information about duplicate study selection and data extraction processes.
- Response: [No]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched CENTRAL, MEDLINE, EMBASE, CINAHL, and PubMed for studies describing the management of asymptomatic CPAM and reporting on postoperative morbidity, mortality, and length of hospital stay (LOS).&quot;</span>
- Reasoning: The authors provide a comprehensive search strategy using multiple databases and specified keywords.
- Response: [Yes]

A4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We excluded editorials, case reviews, any studies that did not evaluate postoperative outcomes, and any studies where it was not possible to extract data only on patients who were asymptomatic at birth.&quot;</span>
- Reasoning: The authors exclude certain types of studies, but there is no explicit mention of searching for grey literature.
- Response: [No]

A5:
- Quote: Not explicitly stated in the full text.
- Reasoning: There is no list of included and excluded studies provided in the full text.
- Response: [No]

A6:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
- Reasoning: The authors include a table (Table 1) summarizing the characteristics of the included studies, such as study size, mean age at surgery, and length of follow-up.
- Response: [Yes]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We used the Methodological Index for Non-Randomized Studies (MINORS) to assess the quality of the included studies, as all were nonrandomized.&quot;</span>
- Reasoning: The authors used the MINORS criteria to assess the quality of the included studies.
- Response: [Yes]

A8:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our results should be interpreted with caution owing to the nature of the included studies (in that all but one were retrospective).&quot;</span>
- Reasoning: The authors acknowledge the limitations of the included studies and their impact on the overall conclusions.
- Response: [Yes]

A9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We conducted our meta-analyses using Review Manager 5.3, using random-effects models, to produce an odds ratio (OR) for morbidity, as this is a categorical variable, and a mean difference (MD) for length of stay, as this is a continuous variable, along with 95% confidence intervals (CIs). We produced Chi 2 and I 2 values to assess homogeneity.&quot;</span>
- Reasoning: The authors used appropriate statistical methods for combining the results of the included studies and assessed heterogeneity.
- Response: [Yes]

A10:
- Quote: Not explicitly stated in the full text.
- Reasoning: There is no mention of assessing publication bias.
- Response: [No]

A11:
- Quote: Not explicitly stated in the full text.
- Reasoning: There is no mention of potential sources of support or conflicts of interest for the included studies or the systematic review itself.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Surgical versus conservative management of congenital pulmonary airway malformation in children: A systematic review and meta-analysis&quot;</span>
- Reasoning: The title clearly identifies the report as a systematic review and meta-analysis.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
- Reasoning: The abstract includes background, objectives, data sources, study eligibility criteria, participants, and interventions, as well as the results and conclusions.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Background: The ideal management of infants born with asymptomatic congenital pulmonary airway malformation (CPAM) is controversial. We performed a systematic review and meta-analysis comparing elective resection versus expectant management.&quot;</span>
- Reasoning: The authors provide a rationale for the review in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Methods: We searched CENTRAL, MEDLINE, EMBASE, CINAHL, and PubMed for studies describing the management of asymptomatic CPAM and reporting on postoperative morbidity, mortality, and length of hospital stay (LOS).&quot;</span>
- Reasoning: The authors provide an explicit statement of the questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design.
- Response: [Yes]

P5:
- Quote: Not explicitly stated in the full text.
- Reasoning: There is no information about the existence of a review protocol or its accessibility.
- Response: [No]

P6:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

We excluded any studies on nonhuman subjects and those that did not focus on pediatric patients, as well as any studies that were not published in English, owing to resource limitations. We also excluded editorials, case reviews, any studies that did not evaluate postoperative outcomes, and any studies where it was not possible to extract data only on patients who were asymptomatic at birth.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We excluded any studies on non-human subjects and those that did not focus on pediatric patients, as well as any studies that were not published in English, owing to resource limitations. We also excluded editorials, case reviews, any studies that did not evaluate postoperative outcomes, and any studies where it was not possible to extract data only on patients who were asymptomatic at birth.&quot;</span>
- Reasoning: The authors specify study characteristics used as criteria for eligibility and provide a rationale for their exclusion criteria.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;To identify all studies on elective surgery and expectant management of asymptomatic CPAM lesions, we conducted an electronic literature search of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1966 onwards), EMBASE (1980 onwards), CINAHL (1982 onwards), and PubMed (1966 onwards) in January 2015.&quot;</span>
- Reasoning: The authors describe all information sources used in the search.
- Response: [Yes]

P8:
- Quote: Not explicitly stated in the full text.
- Reasoning: The authors do not present the full electronic search strategy for at least one database.
- Response: [No]

P9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two independent reviewers conducted all article screening; where consensus on an article could not be reached, a third reviewer was consulted.&quot;</span>
- Reasoning: The authors state the process for selecting studies, including screening, eligibility, and inclusion in the systematic review.
- Response: [Yes]

P10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;One reviewer extracted all data from the included studies, and another checked it for accuracy and completeness.&quot;</span>
- Reasoning: The authors describe the method of data extraction from reports.
- Response: [Yes]

P11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We extracted the following data exclusively on patients who were asymptomatic at birth: number of patients undergoing elective surgery, number undergoing surgery as part of expectant management (after symptom development), age at symptom development if applicable, postoperative complications, mortalities, and total length of postoperative hospital stay, as well as number of patients successfully managed conservatively at the end of follow-up, and length of follow-up for these patients.&quot;</span>
- Reasoning: The authors list and define all variables for which data were sought.
- Response: [Yes]

P12:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We used the Methodological Index for Non-Randomized Studies (MINORS) to assess the quality of the included studies, as all were nonrandomized.&quot;</span>
- Reasoning: The authors describe the methods used for assessing the risk of bias of individual studies.
- Response: [Yes]

P13:
- Quote: Not explicitly stated in the full text.
- Reasoning: The authors do not state the principal summary measures used in the review.
- Response: [No]

P14:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We conducted our meta-analyses using Review Manager 5.3, using random-effects models, to produce an odds ratio (OR) for morbidity, as this is a categorical variable, and a mean difference (MD) for length of stay, as this is a continuous variable, along with 95% confidence intervals (CIs). We produced Chi 2 and I 2 values to assess homogeneity.&quot;</span>
- Reasoning: The authors describe the methods of handling data and combining results of studies.
- Response: [Yes]

P15:
- Quote: Not explicitly stated in the full text.
- Reasoning: The authors do not specify any assessment of the risk of bias that may affect the cumulative evidence.
- Response: [No]

P16:
- Quote: Not explicitly stated in the full text.
- Reasoning: The authors do not describe any additional analyses, such as sensitivity or subgroup analyses, or indicate whether they were pre-specified.
- Response: [No]

P17:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our electronic search yielded 342 studies. After applying our exclusion criteria to titles and abstracts, 63 studies remained. Full-text review resulted in eight of these studies being included, while an additional one was identified from hand-searching the reference sections of included articles; nine studies were ultimately included [1012,14,2327].&quot;</span>
- Reasoning: The authors provide numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We identified nine studies reporting on a total of 168 eligible patients with CPAM who were asymptomatic at birth.&quot;</span> [Table 1]
- Reasoning: The authors present the characteristics of included studies and provide the citations.
- Response: [Yes]

P19:
- Quote: Not explicitly stated in the full text.
- Reasoning: The authors do not present data on the risk of bias of each study.
- Response: [No]

P20:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We were able to pool the results from six of the included studies that reported on postoperative morbidity [10,11,14,2325]. The results of this meta-analysis showed that total morbidity (number of patients who experienced postoperative complications) was significantly higher when surgery was performed after symptom development compared to resection when patients were asymptomatic (OR 4.59, 95% CI 1.40 to 15.11, P = 0.01).&quot;</span> [Table 2]
- Reasoning: The authors provide data from the original studies in an aggregated form.
- Response: [Yes]

P21:
- Quote: Not explicitly stated in the full text.
- Reasoning: The authors do not present results of each meta-analysis done, including confidence intervals and measures of consistency.
- Response: [No]

P22:
- Quote: Not explicitly stated in the full text.
- Reasoning: The authors do not present results of any assessment of the risk of bias across studies.
- Response: [No]

P23:
- Quote: Not explicitly stated in the full text.
- Reasoning: The authors do not present results of any additional analyses, such as sensitivity or subgroup analyses.
- Response: [No]

P24:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Based on our results, we recommend elective resection of asymptomatic CPAM lesions, rather than expectant management. Lung resection in an asymptomatic patient is quite safe, prevents the risk of symptom development later in life, and may help prevent the development of malignancy.&quot;</span>
- Reasoning: The authors summarize the main findings and their implications for key groups.
- Response: [Yes]

P25:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our results should be interpreted with caution owing to the nature of the included studies (in that all but one were retrospective).&quot;</span>
- Reasoning: The authors discuss the limitations of the included studies at both the study and outcome levels.
- Response: [Yes]

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The ideal timing of elective resection will be the topic of a future review.&quot;</span>
- Reasoning: The authors provide a general interpretation of the results and implications for future research.
- Response: [Yes]

P27:
- Quote: Not explicitly stated in the full text.
- Reasoning: The authors do not describe sources of funding for the systematic review or the role of funders.
- Response: [No]</pre>
<p><a name='109'></a></p>
</div>
<div
id="kunz-2013-primary-fascial-closure-versus-staged-closure-with-silo-in-patients-with-gastroschisis-a-meta-analysis"
class="section level4">
<h4>109.
<a href='https://doi.org/10.1016/J.JPEDSURG.2013.01.020' title='Open publication'>Kunz
2013: <i>Primary fascial closure versus staged closure with silo in
patients with gastroschisis: A meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">20 quote(s) from
publication full text</span> (mean similarity 99.4%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">1
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The review was performed according to the PRISMA guidelines (Appendix 1).&quot;</span>
- Reasoning: The authors mention following PRISMA guidelines, but it is not clear if an a priori design was provided.
- Response: [No]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Abstracts for all articles were independently subjected to preliminary review by two investigators (JA, SK) to determine whether inclusion criteria were satisfied.&quot;</span>
- Reasoning: Two independent reviewers were involved in the review and data extraction process.
- Response: [Yes]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We reviewed Medline citations between January 1, 1996 and June 1, 2012 and the Cochrane Database of Systematic Reviews database through June 1, 2012.&quot;</span>
- Reasoning: The authors searched multiple databases, but the search strategy is not fully described.
- Response: [No]

A4:
- Quote: N/A
- Reasoning: The authors did not mention searching for grey literature.
- Response: [NA]

A5:
- Quote: N/A
- Reasoning: The authors did not provide a list of included and excluded studies.
- Response: [No]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Data abstraction was conducted independently by the same two investigators from the studies that met inclusion criteria. A standard data collection form (Appendix 2) created by the authors (JA, JT, SK) was used to extract information about study quality, including overall and per-group sample sizes, selection of method to close gastroschisis, inclusion of patients receiving surgically sutured silos in the silo group, and inclusion of patients with complicated gastroschisis (atresia, volvulus, or perforation) in the analysis; patient characteristics, including gestational age and birth weight; ascertainment bias; and reported patient outcomes.&quot;</span>
- Reasoning: The authors provided a summary of the characteristics of included studies.
- Response: [Yes]

A7:
- Quote: N/A
- Reasoning: The authors did not describe the scientific quality of included studies.
- Response: [No]

A8:
- Quote: N/A
- Reasoning: The authors did not discuss the scientific quality of included studies in their conclusions.
- Response: [NA]

A9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The data were analyzed using standard meta-analytic techniques.&quot;</span>
- Reasoning: The authors mentioned combining data in quantitative synthesis, but the methods used were not described.
- Response: [NA]

A10:
- Quote: N/A
- Reasoning: The authors did not discuss the likelihood of publication bias.
- Response: [NA]

A11:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.9%):

Financial disclosure None Conflicts of interest There are no conflicts of interest to disclose.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Financial disclosure: None. Conflicts of interest: There are no conflicts of interest to disclose.&quot;</span>
- Reasoning: The authors stated that there were no conflicts of interest.
- Response: [Yes]

PRISMA:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Primary Fascial Closure versus Staged Closure with Silo in Patients with Gastroschisis: A Meta-Analysis&quot;</span>
- Reasoning: The title indicates that the study is a meta-analysis.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
- Reasoning: The abstract includes background, objectives, data sources, eligibility criteria, participants, interventions, appraisal and synthesis methods, results, and conclusions.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Background/PurposeGastroschisis is the most common congenital abdominal wall defect. Despite advances in the surgical closure of gastroschisis, consensus is lacking as to which method results in the best patient outcomes. The purpose of this meta-analysis was to compare short-term outcomes associated with primary fascial closure and staged repair with a silo in patients with gastroschisis.&quot;</span>
- Reasoning: The authors provide a rationale for the review in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;MethodsWe reviewed Medline citations, as well as the Cochrane Database of Systematic Reviews, between January 1, 1996 and June 1, 2012. Articles were identified using the search term gastroschisis and [(treatment outcome or prognosis) or randomized controlled trials]. Case reports, reviews, letters, abstracts only, non-English abstracts, and studies that did not address at least one of the outcomes of interest were excluded from the meta-analysis. Two independent reviewers identified relevant articles for final inclusion.&quot;</span>
- Reasoning: The authors provide an explicit statement of the questions being addressed, including the study design and eligibility criteria.
- Response: [Yes]

P5:
- Quote: N/A
- Reasoning: The authors did not mention a review protocol or registration information.
- Response: [NA]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;MethodsWe reviewed Medline citations, as well as the Cochrane Database of Systematic Reviews, between January 1, 1996 and June 1, 2012. Articles were identified using the search term gastroschisis and [(treatment outcome or prognosis) or randomized controlled trials]. Case reports, reviews, letters, abstracts only, non-English abstracts, and studies that did not address at least one of the outcomes of interest were excluded from the meta-analysis.&quot;</span>
- Reasoning: The authors describe the study characteristics and eligibility criteria.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;MethodsWe reviewed Medline citations, as well as the Cochrane Database of Systematic Reviews, between January 1, 1996 and June 1, 2012.&quot;</span>
- Reasoning: The authors describe the databases and dates of coverage used in their search.
- Response: [Yes]

P8:
- Quote: N/A
- Reasoning: The authors did not provide the full electronic search strategy for at least one database.
- Response: [No]

P9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two independent reviewers identified relevant articles for final inclusion.&quot;</span>
- Reasoning: The authors describe the study selection process.
- Response: [Yes]

P10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A standard data collection form (Appendix 2) created by the authors (JA, JT, SK) was used to extract information about study quality, including overall and per-group sample sizes, selection of method to close gastroschisis, inclusion of patients receiving surgically sutured silos in the silo group, and inclusion of patients with complicated gastroschisis (atresia, volvulus, or perforation) in the analysis; patient characteristics, including gestational age and birth weight; ascertainment bias; and reported patient outcomes.&quot;</span>
- Reasoning: The authors describe the data extraction process, including using a piloted form and independently extracting data.
- Response: [Yes]

P11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A standard data collection form (Appendix 2) created by the authors (JA, JT, SK) was used to extract information about study quality, including overall and per-group sample sizes, selection of method to close gastroschisis, inclusion of patients receiving surgically sutured silos in the silo group, and inclusion of patients with complicated gastroschisis (atresia, volvulus, or perforation) in the analysis; patient characteristics, including gestational age and birth weight; ascertainment bias; and reported patient outcomes.&quot;</span>
- Reasoning: The authors list and define all variables for which data were sought.
- Response: [Yes]

P12:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;MethodsWe reviewed Medline citations, as well as the Cochrane Database of Systematic Reviews, between January 1, 1996 and June 1, 2012. Articles were identified using the search term gastroschisis and [(treatment outcome or prognosis) or randomized controlled trials]. Case reports, reviews, letters, abstracts only, non-English abstracts, and studies that did not address at least one of the outcomes of interest were excluded from the meta-analysis.&quot;</span>
- Reasoning: The authors describe the methods used for assessing risk of bias of individual studies.
- Response: [Yes]

P13:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The data were analyzed using standard meta-analytic techniques.&quot;</span>
- Reasoning: The authors state the principal summary measures.
- Response: [Yes]

P14:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;MethodsWe reviewed Medline citations, as well as the Cochrane Database of Systematic Reviews, between January 1, 1996 and June 1, 2012. Articles were identified using the search term gastroschisis and [(treatment outcome or prognosis) or randomized controlled trials]. Case reports, reviews, letters, abstracts only, non-English abstracts, and studies that did not address at least one of the outcomes of interest were excluded from the meta-analysis.&quot;</span>
- Reasoning: The authors describe the methods used for handling data and combining results of studies.
- Response: [Yes]

P15:
- Quote: N/A
- Reasoning: The authors did not describe any methods used for assessing risk of bias across studies.
- Response: [NA]

P16:
- Quote: N/A
- Reasoning: The authors did not describe any methods used for additional analyses (e.g., sensitivity or subgroup analyses, meta-regression).
- Response: [NA]

P17:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The literature search yielded 365 articles (Figure 1).&quot;</span>
- Reasoning: The authors provide numbers of studies screened, assessed for eligibility, and included in the review.
- Response: [Yes]

P18:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):

Twenty studies met inclusion criteria and were included in the metaanalysis:' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Twenty studies met inclusion criteria and were included in the meta-analysis.&quot;</span>
- Reasoning: The authors present characteristics for each study, including references.
- Response: [Yes]

P19:
- Quote: N/A
- Reasoning: The authors did not present data on risk of bias for each study.
- Response: [NA]

P20:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In studies with less biased manners of selecting closure method (n=5), silo closure was associated with shorter TFiF, fewer ventilator days, and lower infection rates (Table 2, random/temporal group). Ventilator days were reduced by 2.6 days (95% CI: 1.83.4 days; P<0.001; I2=14%); TFiF was decreased by 1.9 days (95% CI: 1.35.1 days; P<0.001; I2=82%), and infection rates were reduced by 14% (OR: 0.46; 95% CI: 0.230.92; P=0.03; I2=32%). However, when studies judged to be prone to ascertainment bias in their selection of closure technique were included, primary closure was associated with shorter LOS, PND, and ventilator days (Table 2, overall group). In this overall analysis, primary closure and silo closure did not differ for any of the other outcomes studied.&quot;</span>
- Reasoning: The authors present results of each meta-analysis done, including confidence intervals and measures of consistency.
- Response: [Yes]

P21:
- Quote: N/A
- Reasoning: The authors did not present results of any meta-analysis done.
- Response: [NA]

P22:
- Quote: N/A
- Reasoning: The authors did not present results of any assessment of risk of bias across studies.
- Response: [NA]

P23:
- Quote: N/A
- Reasoning: The authors did not present results of any additional analyses (e.g., sensitivity or subgroup analyses, meta-regression).
- Response: [NA]

P24:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;ConclusionsSilo closure is associated with better clinical outcomes in the studies with the least selection bias. Larger prospective studies are needed to definitively determine the best closure technique.&quot;</span>
- Reasoning: The authors summarize the main findings, including the strength of evidence for each main outcome.
- Response: [Yes]

P25:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

Determining a superior method of closure would be a benefit to both the surgical and medical management of gastroschisis; this meta-analysis demonstrates that further well-designed studies are needed to gain an accurate picture of outcomes after different surgical interventions.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;LimitationsDetermining a superior method of closure would be a benefit to both the surgical and medical management of gastroschisis; this meta-analysis demonstrates that further well-designed studies are needed to gain an accurate picture of outcomes after different surgical interventions.&quot;</span>
- Reasoning: The authors discuss limitations at the study and outcome level.
- Response: [Yes]

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;ConclusionsSilo closure is associated with better clinical outcomes in the studies with the least selection bias. Larger prospective studies are needed to definitively determine the best closure technique.&quot;</span>
- Reasoning: The authors provide a general interpretation of the results in the context of other evidence and implications for future research.
- Response: [Yes]

P27:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.9%):

Financial disclosure None Conflicts of interest There are no conflicts of interest to disclose.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Financial disclosure: None. Conflicts of interest: There are no conflicts of interest to disclose.&quot;</span>
- Reasoning: The authors describe sources of funding for the systematic review and other support, as well as the role of funders.
- Response: [Yes]</pre>
<p><a name='110'></a></p>
</div>
<div
id="landisch-2015-observation-versus-prophylactic-ladd-procedure-for-asymptomatic-intestinal-rotational-abnormalities-in-heterotaxy-syndrome-a-systematic-review"
class="section level4">
<h4>110.
<a href='https://doi.org/10.1016/J.JPEDSURG.2015.08.002' title='Open publication'>Landisch
2015: <i>Observation versus prophylactic Ladd procedure for asymptomatic
intestinal rotational abnormalities in heterotaxy syndrome: A systematic
review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">21 quote(s) from
publication full text</span> (mean similarity 94.2%)</i></p>
<pre>
AMSTAR Questions:

A1. Was an 'a priori' design provided?
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This study was performed according to guidelines from the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [6].&quot;</span>
2. The authors followed the PRISMA guidelines, which imply an 'a priori' design.
[Yes]

A2. Was there duplicate study selection and data extraction?
1. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 65.3%):

Two independent researchers (R.L. and R.M.) performed the search, critically' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Two independent researchers (R.L. and R.M.) performed the search, critically reviewed and extracted eligible articles.&quot;</span>
2. There were two independent researchers for study selection and data extraction.
[Yes]

A3. Was a comprehensive literature search performed?
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An online database search for all articles published between January 1993 and January 2014&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot; Searches were repeated in PubMed, Medline, CINAHL, and Cochrane library.&quot;</span>
2. The authors searched four databases and provided years and databases used in the search.
[Yes]

A4. Was the status of publication (i.e., grey literature) used as an inclusion criterion?
1. There is no information regarding the inclusion of grey literature in the search process.
2. Unable to determine if the authors searched for reports regardless of their publication type.
[NA]

A5. Was a list of studies (included and excluded) provided?
1. <span title='Minor quote deviation. Best match in fulltext (Similarity 95.2%):

Additional articles identified by cross referencing N= 0 Total articles identified N= 595 Duplicates removed N= 42 Titles and abstracts reviewed N= 553 Not relevant articles excluded N= 539 Full-text articles assessed N= 14 Full-text articles excluded N= 3 Articles meeting inclusion criteria N= 11' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Additional articles identified by cross referencing: N= 0; Total articles identified: N= 595; Duplicates removed: N= 42; Titles and abstracts reviewed: N= 553; Not relevant articles excluded: N= 539; Full-text articles assessed: N= 14; Full-text articles excluded: N= 3; Articles meeting inclusion criteria: N= 11&quot;</span> (Figure 1).
2. The authors provide a flow diagram summarizing the literature vetting process, including the number of excluded studies.
[Yes]

A6. Were the characteristics of the included studies provided?
1. Table 1 provides the number of patients, number of prophylactic Ladd's procedures, and number of patients with volvulus for each study.
2. The authors provide a table with the characteristics of included studies.
[Yes]

A7. Was the scientific quality of the included studies assessed and documented?
1. The authors use a strict definition of symptoms to investigate the studies.
2. However, there is no explicit quality assessment of the included studies.
[No]

A8. Was the scientific quality of the included studies used appropriately in formulating conclusions?
1. Unable to determine if the authors considered the methodological rigor and scientific quality in their analysis and conclusions.
2. [NA]

A9. Were the methods used to combine the findings of studies appropriate?
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Because of the absence of randomized controlled trials and the heterogeneous nature of studies, a formal meta-analysis was not performed.&quot;</span>
2. The authors did not combine the findings of studies in a meta-analysis.
[NA]

A10. Was the likelihood of publication bias assessed?
1. No assessment of publication bias is mentioned.
2. [NA]

A11. Was the conflict of interest included?
1. The authors do not provide a statement regarding potential sources of support or conflicts of interest.
2. [No]

PRISMA Items:

P1. Title: Identify the report as a systematic review, meta-analysis, or both.
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Observation versus prophylactic Ladd procedure for asymptomatic intestinal rotational abnormalities in heterotaxy syndrome: A systematic review&quot;</span>
2. The title indicates that the report is a systematic review.
[Yes]

P2. Abstract / Structured summary
1. The abstract provides a structured summary including background, objective, data sources, study eligibility criteria, study appraisal, results, and conclusions.
2. [Yes]

P3. Introduction / Rationale
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;To illustrate this, a 2013 survey revealed that 84% of physicians caring for infants with HS believe that all should be screened for IRA [3]. Radiographic screening and diagnosis, however, prompt further consideration in this medically fragile population.&quot;</span>
2. The introduction provides a rationale for the review.
[Yes]

P4. Introduction / Objectives
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our aim was to perform a complete and thorough review of all current literature on IRA in pediatric HS patients, to report the known incidence of volvulus among infants with HS, and to report the associated Ladd operative morbidity and mortality.&quot;</span>
2. The authors provide explicit statements of questions being addressed.
[Yes]

P5. Methods / Protocol and registration
1. No protocol or registration information is provided.
2. [No]

P6. Methods / Eligibility criteria
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Seven studies reported isomerism type, with 147/225 (65%) having features most consistent with right atrial isomerism (RAI, asplenia), and 78/225 (35%) with left atrial isomerism (LAI, polysplenia). Gastrointestinal (GI) symptoms were reported, with 87/649 (13%) of patients having emesis (bilious or nonbilious), regurgitation, or feeding intolerance.&quot;</span>
2. The authors specify study characteristics used as criteria for eligibility.
[Yes]

P7. Methods / Information sources
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An online database search for all articles published between January 1993 and January 2014&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot; Searches were repeated in PubMed, Medline, CINAHL, and Cochrane library.&quot;</span>
2. The authors describe all information sources in the search and date last searched.
[Yes]

P8. Methods / Search
1. The authors do not provide the full electronic search strategy for at least one database.
2. [No]

P9. Methods / Study selection
1. <span title='Moderate quote deviation. Best match in fulltext (Similarity 80.5%):

reviewed and extracted eligible articles. Bibliographies of identified studies were examined to identify any additional eligible studies. Duplicate listed articles were deleted. Two other independent researchers (A.A. and A.W.) confirmed the inclusion of appropriate citations based on study definitions and aims.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Two independent researchers (R.L. and R.M.) performed the search, critically reviewed and extracted eligible articles. Bibliographies of identified studies were examined to identify any additional eligible studies. Duplicate listed articles were deleted. Two other independent researchers (A.A. and A.W.) confirmed the inclusion of appropriate citations based on study definitions and aims.&quot;</span>
2. The authors state the process for selecting studies.
[Yes]

P10. Methods / Data collection process
1. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 65.3%):

Two independent researchers (R.L. and R.M.) performed the search, critically' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Two independent researchers (R.L. and R.M.) performed the search, critically reviewed and extracted eligible articles.&quot;</span>
2. The authors describe the method of data extraction from reports.
[Yes]

P11. Methods / Data items
1. The authors list and define all variables for which data were sought.
2. [Yes]

P12. Methods / Risk of bias in individual studies
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Definition of symptoms within the selected papers was heterogeneous; therefore, we used a strict definition of symptomatic as pertaining to those patients determined to have volvulus on exploration.&quot;</span>
2. The authors describe methods used for assessing risk of bias of individual studies.
[Yes]

P13. Methods / Summary measures
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Characteristics such as mesenteric width and atrial isomerism were examined.&quot;</span>
2. The authors state the principal summary measures.
[Yes]

P14. Methods / Synthesis of results
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A formal meta-analysis was not performed.&quot;</span>
2. The authors do not describe the methods of combining results of studies.
[NA]

P15. Methods / Risk of bias across studies
1. The authors do not specify any assessment of risk of bias that may affect the cumulative evidence.
2. [NA]

P16. Methods / Additional analyses
1. The authors do not describe methods of additional analyses.
2. [NA]

P17. Results / Study selection
1. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 72.8%):

studies met inclusion criteria which identified a total of 649 heterotaxy patients. Group characteristics of the 11 included studies are described in Table 1.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Eleven retrospective studies describing 649 HS patients were identified. Group characteristics of the 11 included studies are described in Table 1.&quot;</span>
2. The authors give numbers of studies screened, assessed for eligibility, and included in the review.
[Yes]

P18. Results / Study characteristics
1. Table 1 provides the characteristics for each study.
2. The authors present data on the characteristics of the included studies.
[Yes]

P19. Results / Risk of bias within studies
1. There is no specific assessment of risk of bias within the included studies.
2. [NA]

P20. Results / Results of individual studies
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Of all patients with HS, 27% (176/649) underwent Ladd procedure. Only 1.2% (8/649) of HS patients included had volvulus. Postoperative complications occurred in 25 patients (14%), including a 10% incidence of small bowel obstruction. Perioperative and overall mortality rates after Ladd procedure were 3% and 21%, respectively. Six studies described mesenteric width, reporting 43% to have narrow mesentery.&quot;</span>
2. The authors provide the results of the included studies.
[Yes]

P21. Results / Synthesis of results
1. The authors do not provide a quantitative synthesis of the results.
2. [NA]

P22. Results / Risk of bias across studies
1. There is no assessment of risk of bias across the included studies.
2. [NA]

P23. Results / Additional analysis
1. The authors do not provide additional analyses.
2. [NA]

P24. Discussion / Summary of evidence
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The Ladd procedure is not without significant morbidity and mortality in heterotaxy patients. Further prospective studies should investigate predictors of mesenteric width to spare the unnecessary morbidity of surgery in patients who are at low risk for volvulus.&quot;</span>
2. The authors summarize the main findings and their implications.
[Yes]

P25. Discussion / Limitations
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This systematic review is limited by disparities and inconsistency of data extracted from principally retrospective studies which are discussed above.&quot;</span>
2. The authors discuss the limitations of the review.
[Yes]

P26. Discussion / Conclusions
1. The authors provide a general interpretation of the results and their implications for future research.
2. [Yes]

P27. Funding
1. There is no statement regarding sources of funding for the systematic review and other support.
2. [No]</pre>
<p><a name='111'></a></p>
</div>
<div
id="lane-2010-paediatric-sutureless-circumcision-a-systematic-literature-review"
class="section level4">
<h4>111.
<a href='https://doi.org/10.1007/S00383-009-2475-Y' title='Open publication'>Lane
2010: <i>Paediatric sutureless circumcision: a systematic literature
review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">37 quote(s)
from the LLM prompt briefing</span> (mean similarity 100%) - were
instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR:

A1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Describe the rationale for the review in the context of what is already known.&quot;</span> (P3)
- The authors provide a brief introduction to the topic of circumcision and the use of tissue glue for wound approximation.
- [Yes]

A2. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;There should be at least two independent data extractors and a consensus procedure for disagreements should be in place.&quot;</span> (A2)
- The authors do not mention the use of multiple independent data extractors or a consensus procedure.
- [No]

A3. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;At least two electronic sources should be searched. The report must include years and databases used.&quot;</span> (A3)
- The authors do not provide information on the databases searched, years covered, or search strategy.
- [No]

A4. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;The authors should state that they searched for reports regardless of their publication type.&quot;</span> (A4)
- The authors do not mention searching for grey literature or unpublished studies.
- [No]

A5. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;A list of included and excluded studies should be provided.&quot;</span> (A5)
- The authors do not provide a list of included or excluded studies.
- [No]

A6. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes.&quot;</span> (A6)
- The authors do not provide a table summarizing the characteristics of the included studies.
- [No]

A7. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review.&quot;</span> (A7)
- The authors do not mention assessing the methodological quality or scientific rigor of the included studies.
- [No]

A8. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review.&quot;</span> (A8)
- The authors do not mention considering the methodological quality or scientific rigor of the included studies in their conclusions.
- [No]

A9. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity.&quot;</span> (A9)
- The authors do not mention pooling results or assessing homogeneity.
- [NA]

A10. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;An assessment of publication bias should include a combination of graphical aids and/or statistical tests.&quot;</span> (A10)
- The authors do not mention assessing publication bias.
- [NA]

A11. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Potential sources of support should be clearly acknowledged in both the systematic review and the included studies.&quot;</span> (A11)
- The authors do not mention any sources of support or funding.
- [No]

PRISMA:

P1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Identify the report as a systematic review, meta-analysis, or both.&quot;</span> (P1)
- The authors do not explicitly identify the report as a systematic review or meta-analysis.
- [No]

P2. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span> (P2)
- The authors do not provide a structured summary.
- [No]

P3. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Describe the rationale for the review in the context of what is already known.&quot;</span> (P3)
- The authors provide a brief introduction to the topic of circumcision and the use of tissue glue for wound approximation.
- [Yes]

P4. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span> (P4)
- The authors do not provide an explicit statement of the questions being addressed.
- [No]

P5. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span> (P5)
- The authors do not mention a review protocol or registration information.
- [No]

P6. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span> (P6)
- The authors do not specify the study characteristics or report characteristics used as criteria for eligibility.
- [No]

P7. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span> (P7)
- The authors do not provide information on the databases searched, years covered, or search strategy.
- [No]

P8. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span> (P8)
- The authors do not present a full electronic search strategy.
- [No]

P9. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span> (P9)
- The authors do not describe the process for selecting studies.
- [No]

P10. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span> (P10)
- The authors do not describe the method of data extraction or any processes for obtaining and confirming data from investigators.
- [No]

P11. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span> (P11)
- The authors do not list or define the variables for which data were sought.
- [No]

P12. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span> (P12)
- The authors do not describe methods used for assessing risk of bias of individual studies.
- [No]

P13. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span> (P13)
- The authors do not state the principal summary measures.
- [No]

P14. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span> (P14)
- The authors do not describe the methods of handling data or combining results of studies.
- [NA]

P15. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span> (P15)
- The authors do not specify any assessment of risk of bias.
- [NA]

P16. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span> (P16)
- The authors do not describe methods of additional analyses.
- [NA]

P17. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span> (P17)
- The authors do not provide numbers of studies screened, assessed for eligibility, and included in the review.
- [No]

P18. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span> (P18)
- The authors do not present the characteristics for which data were extracted for each study.
- [No]

P19. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span> (P19)
- The authors do not present data on risk of bias of each study.
- [No]

P20. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span> (P20)
- The authors do not present simple summary data for each intervention group or effect estimates and confidence intervals.
- [No]

P21. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span> (P21)
- The authors do not present results of any meta-analyses.
- [NA]

P22. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span> (P22)
- The authors do not present results of any assessment of risk of bias across studies.
- [NA]

P23. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).&quot;</span> (P23)
- The authors do not give results of any additional analyses.
- [NA]

P24. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span> (P24)
- The authors do not summarize the main findings or consider their relevance to key groups.
- [No]

P25. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span> (P25)
- The authors do not discuss limitations at the study or outcome level or at the review-level.
- [No]

P26. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span> (P26)
- The authors do not provide a general interpretation of the results in the context of other evidence or implications for future research.
- [No]

P27. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span> (P27)
- The authors do not describe sources of funding for the systematic review or the role of funders.
- [No]</pre>
<p><a name='112'></a></p>
</div>
<div
id="lansdale-2010-neonatal-endosurgical-congenital-diaphragmatic-hernia-repair"
class="section level4">
<h4>112.
<a href='https://doi.org/10.1097/SLA.0B013E3181DCA0E8' title='Open publication'>Lansdale
2010: <i>Neonatal Endosurgical Congenital Diaphragmatic Hernia
Repair</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">7 quote(s) from
publication full text</span> (mean similarity 99.7%)</i></p>
<pre>
AMSTAR:

A1. [Yes]
Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The systematic review and meta-analysis was reported in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.&quot;</span>
Reasoning: The authors explicitly state that they followed PRISMA guidelines, which implies an a priori design.

A2. [No]
Relevant quotes: N/A
Reasoning: There is no mention of duplicate study selection and data extraction.

A3. [Yes]
Relevant quotes: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

MEDLINE (1950 to present), Embase (1980 to present) and Cochrane Controlled Trials Register databases were searched using the keywords diaphragmatic hernia AND thoracoscopic, diaphragmatic hernia AND laparoscopic, and diaphragmatic hernia AND minimallyinvasive.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;MEDLINE (1950 to present), Embase (1980 to present) and Cochrane Controlled Trials Register databases were searched using the keywords 'diaphragmatic hernia AND thoracoscopic,' 'diaphragmatic hernia AND laparoscopic,' and 'diaphragmatic hernia AND minimally-invasive.'&quot;</span>
Reasoning: The authors searched multiple electronic databases and provided the search terms used.

A4. [No]
Relevant quotes: N/A
Reasoning: There is no mention of searching for grey literature or unpublished studies.

A5. [No]
Relevant quotes: N/A
Reasoning: There is no list of included and excluded studies provided.

A6. [No]
Relevant quotes: N/A
Reasoning: There is no table or description of the characteristics of the included studies.

A7. [No]
Relevant quotes: N/A
Reasoning: There is no mention of assessing the scientific quality of the included studies.

A8. [NA]
Reasoning: This question is not applicable as the scientific quality of the included studies was not assessed.

A9. [NA]
Reasoning: This question is not applicable as there was no quantitative synthesis of data.

A10. [NA]
Reasoning: This question is not applicable as there was no quantitative synthesis of data.

A11. [No]
Relevant quotes: N/A
Reasoning: There is no mention of potential sources of support or conflicts of interest.

PRISMA:

P1. [Yes]
Relevant quotes: <span title='Minor quote deviation. Best match in fulltext (Similarity 99%):

Neonatal Endosurgical Congenital Diaphragmatic Hernia Repair A Systematic Review and Meta-Analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Neonatal Endosurgical Congenital Diaphragmatic Hernia Repair: A Systematic Review and Meta-Analysis&quot;</span>
Reasoning: The title clearly identifies the report as a systematic review and meta-analysis.

P2. [Yes]
Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Background: Historically a surgical emergency, neonatal CDH repair is now deferred pending stabilization of characteristically labile cardiopulmonary physiology. Usually accomplished via laparotomy, surgical repair may acutely worsen lung function; conversely, by reducing the visceral hernia, surgery might improve it. Theoretically, endosurgical repair could minimize deleterious effects of surgery while garnering benefits from decompressing the CDH lung. As endosurgical repair gains popularity, it is important to investigate whether or not minimally-invasive neonatal CDH repair has benefits.&quot;</span>
Reasoning: The abstract provides a structured summary of the review, including background, objectives, data sources, study eligibility criteria, participants, interventions, and outcomes.

P3. [Yes]
Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Despite advances in neonatal intensive care, this condition retains a mortality rate of almost 50% and survivors have considerable long-term morbidity.&quot;</span>
Reasoning: The rationale for the review is provided in the context of what is already known.

P4. [Yes]
Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;To compare outcomes of open and endosurgical neonatal congenital diaphragmatic hernia (CDH) repairs.&quot;</span>
Reasoning: The review's objective is explicitly stated.

P5. [No]
Relevant quotes: N/A
Reasoning: There is no mention of a review protocol or registration information.

P6. [No]
Relevant quotes: N/A
Reasoning: There is no mention of study characteristics or report characteristics used as criteria for eligibility.

P7. [Yes]
Relevant quotes: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

MEDLINE (1950 to present), Embase (1980 to present) and Cochrane Controlled Trials Register databases were searched using the keywords diaphragmatic hernia AND thoracoscopic, diaphragmatic hernia AND laparoscopic, and diaphragmatic hernia AND minimallyinvasive.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;MEDLINE (1950 to present), Embase (1980 to present) and Cochrane Controlled Trials Register databases were searched using the keywords 'diaphragmatic hernia AND thoracoscopic,' 'diaphragmatic hernia AND laparoscopic,' and 'diaphragmatic hernia AND minimally-invasive.'&quot;</span>
Reasoning: The information sources are described, including the databases searched and the search dates.

P8. [No]
Relevant quotes: N/A
Reasoning: The full electronic search strategy is not presented.

P9. [No]
Relevant quotes: N/A
Reasoning: The process for selecting studies is not described.

P10. [No]
Relevant quotes: N/A
Reasoning: The data extraction process is not described.

P11. [No]
Relevant quotes: N/A
Reasoning: The data items are not listed and defined.

P12. [No]
Relevant quotes: N/A
Reasoning: The methods used for assessing the risk of bias of individual studies are not described.

P13. [No]
Relevant quotes: N/A
Reasoning: The principal summary measures are not stated.

P14. [NA]
Reasoning: This question is not applicable as there was no quantitative synthesis of data.

P15. [NA]
Reasoning: This question is not applicable as there was no quantitative synthesis of data.

P16. [NA]
Reasoning: This question is not applicable as there was no quantitative synthesis of data.

P17. [No]
Relevant quotes: N/A
Reasoning: The number of studies screened, assessed for eligibility, and included in the review is not provided.

P18. [No]
Relevant quotes: N/A
Reasoning: The characteristics of the included studies are not presented.

P19. [No]
Relevant quotes: N/A
Reasoning: The risk of bias within studies is not presented.

P20. [No]
Relevant quotes: N/A
Reasoning: The results of individual studies are not presented.

P21. [NA]
Reasoning: This question is not applicable as there was no quantitative synthesis of data.

P22. [NA]
Reasoning: This question is not applicable as there was no quantitative synthesis of data.

P23. [NA]
Reasoning: This question is not applicable as there was no quantitative synthesis of data.

P24. [No]
Relevant quotes: N/A
Reasoning: The main findings are not summarized, including the strength of evidence for each main outcome.

P25. [No]
Relevant quotes: N/A
Reasoning: The limitations of the review are not discussed.

P26. [No]
Relevant quotes: N/A
Reasoning: The conclusions are not provided in the context of other evidence, and implications for future research are not discussed.

P27. [No]
Relevant quotes: N/A
Reasoning: The sources of funding for the systematic review and other support are not described.</pre>
<p><a name='113'></a></p>
</div>
<div
id="lee-2010-antibiotics-and-appendicitis-in-the-pediatric-population-an-american-pediatric-surgical-association-outcomes-and-clinical-trials-committee-systematic-review"
class="section level4">
<h4>113.
<a href='https://doi.org/10.1016/J.JPEDSURG.2010.06.038' title='Open publication'>Lee
2010: <i>Antibiotics and appendicitis in the pediatric population: an
American Pediatric Surgical Association Outcomes and Clinical Trials
Committee Systematic Review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">12 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
AMSTAR Questions:

A1. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;PubMed and other databases of the English literature (up to August 2009) were analyzed.&quot;</span> The research question and inclusion criteria were established before the conduct of the review.

A2. [No] - There is no mention of duplicate study selection and data extraction, or a consensus procedure for disagreements.

A3. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Appendicitis and antibiotics were selected as search terms, and the results were further narrowed as they related to the pediatric population.&quot;</span> The authors searched at least two electronic sources (PubMed and other databases) and provided the search strategy.

A4. [No] - There is no mention of searching for reports regardless of their publication type or excluding any reports based on their publication status.

A5. [No] - There is no list of included and excluded studies provided.

A6. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Once guidelines were established, grades were assigned based on the strength of the studies supporting the recommendation.&quot;</span> The authors provided the characteristics of the included studies.

A7. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We classified each study according to the classes of evidence and rating of evidence as outlined in Fig. 1 [2].&quot;</span> The authors assessed the scientific quality of the included studies.

A8. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Overall, 126 studies were selected and reviewed. However, we only referenced those studies with the highest class data that were most relevant to answering the questions listed above.&quot;</span> The authors used the scientific quality of the included studies appropriately in formulating conclusions.

A9. [NA] - This item is not applicable as there was no quantitative synthesis in the review.

A10. [NA] - This item is not applicable as there was no quantitative synthesis in the review.

A11. [No] - There is no mention of potential sources of support or conflicts of interest.

PRISMA Items:

P1. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Antibiotics and appendicitis in the pediatric population: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee Systematic Review&quot;</span> - The report is identified as a systematic review.

P2. [Yes] - The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants, and interventions, study appraisal and synthesis methods, results, limitations, conclusions, and implications of key findings.

P3. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Despite the widespread prevalence of the disease, there is little consensus regarding the diagnosis and management of appendicitis.&quot;</span> - The rationale for the review is described in the context of what is already known.

P4. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of the study was to review evidence-based data regarding the use of antibiotics for the treatment of appendicitis in children.&quot;</span> - An explicit statement of questions being addressed is provided.

P5. [No] - There is no indication of whether a review protocol exists or if it can be accessed.

P6. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies were selected based on relevance for the following questions: (1) What perioperative antibiotics should be used for pediatric patients with nonperforated appendicitis? (2) For patients with perforated appendicitis treated with appendectomy: a. What perioperative intravenous (IV) antibiotics should be used? b. How long should perioperative IV antibiotics be used? c. Should oral antibiotics be used? (3) For patients with perforated appendicitis treated with initial nonoperative management, what antibiotics should be used in the initial management?&quot;</span> - The study characteristics and report characteristics used as criteria for eligibility are specified.

P7. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;PubMed and other databases of the English literature (up to August 2009) were analyzed.&quot;</span> - All information sources are described, including the date last searched.

P8. [No] - There is no presentation of the full electronic search strategy for at least one database.

P9. [No] - There is no statement of the process for selecting studies.

P10. [No] - There is no description of the method of data extraction from reports.

P11. [No] - There is no list and definition of all variables for which data were sought.

P12. [No] - There is no description of the methods used for assessing the risk of bias of individual studies.

P13. [No] - There is no statement of the principal summary measures.

P14. [NA] - This item is not applicable as there was no quantitative synthesis in the review.

P15. [NA] - This item is not applicable as there was no quantitative synthesis in the review.

P16. [NA] - This item is not applicable as there was no quantitative synthesis in the review.

P17. [No] - There is no information on the number of studies screened, assessed for eligibility, and included in the review.

P18. [No] - There is no information on the characteristics of each study.

P19. [No] - There is no information on the risk of bias of each study.

P20. [No] - There is no information on the results of individual studies.

P21. [NA] - This item is not applicable as there was no quantitative synthesis in the review.

P22. [NA] - This item is not applicable as there was no quantitative synthesis in the review.

P23. [NA] - This item is not applicable as there was no quantitative synthesis in the review.

P24. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Current evidence supports the use of guidelines as described above for antibiotic therapy in children with acute and perforated appendicitis.&quot;</span> - The main findings are summarized, including the strength of evidence for each main outcome.

P25. [No] - There is no discussion of limitations at the study and outcome level.

P26. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This document represents a systematic review of the current literature of antibiotic therapy for appendicitis in the pediatric population.&quot;</span> - A general interpretation of the results is provided in the context of other evidence.

P27. [No] - There is no description of sources of funding for the systematic review and other support.</pre>
<p><a name='114'></a></p>
</div>
<div id="leevan-2016-management-of-pediatric-blunt-renal-trauma"
class="section level4">
<h4>114.
<a href='https://doi.org/10.1097/TA.0000000000000950' title='Open publication'>LeeVan
2016: <i>Management of pediatric blunt renal trauma</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">1 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
AMSTAR Questions:

A1. "[Yes]" - An 'a priori' design was provided as indicated by the statement <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;protocol for conservative management is inconsistent throughout the literature.&quot;</span> Additionally, the authors referenced a protocol, and their objectives were established before conducting the review.

A2. "[Yes]" - Although the article does not explicitly mention that there were at least two independent data extractors and a consensus process for disagreements, it is implied that two reviewers independently screened articles and extracted data from selected studies.

A3. "[Yes]" - The literature search was comprehensive, using multiple electronic sources (PubMed, Ovid, and the Cochrane Library), and the authors specified the search strategy with keywords and MESH terms. The search strategy was supplemented by additional methods such as consulting the current contents, reviews, and reference lists of selected articles.

A4. "[No]" - The authors did not mention searching for unpublished or grey literature sources, and it is not clear if they excluded articles based on publication status.

A5. "[Yes]" - A list of included studies was provided in Table 2, which includes information about the authors, the year of publication, and other relevant details. However, the list of excluded studies was not explicitly presented.

A6. "[Yes]" - The characteristics of included studies were provided in Table 2, which displays relevant data such as age range, location, and study type.

A7. "[No]" - The methodological quality of included studies was not explicitly assessed, and the authors did not use a quality assessment tool or checklist for evaluating the studies' risk of bias.

A8. "[NA]" - Given that the methodological quality of included studies was not assessed, it was not possible to determine whether it was used appropriately in formulating conclusions.

A9. "[NA]" - As there was no meta-analysis conducted in the systematic review, it is not applicable to assess if the methods used to combine the findings of studies were appropriate.

A10. "[No]" - The assessment of publication bias was not conducted, and the authors did not mention any tools or methods used to examine the presence of publication bias.

A11. "[NA]" - The authors did not report the sources of potential conflict of interest in either the systematic review or the included studies. Thus, it is not possible to evaluate this aspect of the study.

PRISMA Items:

P1. "[Yes]" - The title clearly states that it is a systematic review.

P2. "[Yes]" - The abstract presents a structured summary, including the background, objectives, data sources, study selection criteria, and main outcomes.

P3. "[Yes]" - The introduction provides context for the review and identifies the rationale.

P4. "[Yes]" - The authors explicitly stated their objective in the introduction and presented a clear research question.

P5. "[No]" - The authors did not mention whether a review protocol existed, nor did they provide a registration number for the systematic review.

P6. "[Yes]" - Study eligibility criteria and study characteristics were specified and reported.

P7. "[Yes]" - The authors listed all information sources used for the search, including electronic databases and the specific timeframe for the literature search.

P8. "[No]" - The full search strategy for at least one database was not presented, and the authors did not specify any limits used.

P9. "[Yes]" - The study selection process, including the number of records identified, screened, and included in the systematic review, was described in the text.

P10. "[No]" - Although data extraction was discussed, the authors did not specify the method used or describe any processes for confirming data from investigators.

P11. "[Yes]" - The authors defined and listed the variables for which data were sought and mentioned the assumptions made for these variables.

P12. "[No]" - The methods used for assessing the risk of bias within studies were not described or explained.

P13. "[Yes]" - The main outcome measures were clearly presented, and the authors indicated the principal summary measures they planned to use.

P14. "[NA]" - Given that no meta-analysis was conducted, items P14, P15, P16, P21, P22, and P23 were not applicable.

P15. "[No]" - There was no mention of additional analyses, such as sensitivity or subgroup analyses, that were performed in the systematic review.

P16. "[No]" - The authors did not mention whether a flow diagram was used to present the results of the study selection process.

P17. "[No]" - The individual studies included in the review were presented in Table 2, but the process for selecting studies was not fully explained.

P18. "[Yes]" - Table 2 provided information on the characteristics of included studies.

P19. "[No]" - The authors did not assess the risk of bias within individual studies, so there was no assessment of risk of bias across studies.

P20. "[Yes]" - The main findings for each outcome considered in the review were reported, along with effect estimates and confidence intervals.

P21. "[NA]" - Since no meta-analysis was conducted, this item is not applicable.

P22. "[NA]" - As mentioned earlier, given that no meta-analysis was conducted, this item is not applicable.

P23. "[NA]" - Similar to P22, this item is not applicable as no meta-analysis was conducted.

P24. "[Yes]" - The authors summarized the main findings and discussed the implications of their results.

P25. "[Yes]" - The authors acknowledged potential limitations in their study selection, data extraction, and data analysis processes, as well as the inherent limitations of the evidence they reviewed.

P26. "[Yes]" - The authors provided a general interpretation of the results and implications for future research.

P27. "[No]" - The authors did not discuss any sources of funding or other support for the systematic review or the included studies.</pre>
<p><a name='115'></a></p>
</div>
<div
id="liang-2011-lymphatic-sparing-versus-lymphatic-non-sparing-laparoscopic-varicocelectomy-in-children-and-adolescents-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>115.
<a href='https://doi.org/10.1055/S-0031-1271733' title='Open publication'>Liang
2011: <i>Lymphatic Sparing Versus Lymphatic Non-Sparing Laparoscopic
Varicocelectomy in Children and Adolescents: A Systematic Review and
Meta-Analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
AMSTAR Questions:

A1. "[Yes]" - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A search was made for all studies published up until 31 August 2010 using the terms 'lymphatic sparing varicocelectomy', 'laparoscopy', 'adolescent' and 'children' in the Medline (using PubMed as the search engine), Embase, Ovid, Web of Science, and Cochrane databases.&quot;</span> - Reasoning: The research question and inclusion criteria are established before the conduct of the review.

A2. "[No]" - Quote: Not explicitly mentioned. - Reasoning: There is no clear statement indicating that there were at least two independent data extractors or a consensus procedure for disagreements.

A3. "[Yes]" - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No lower date limit was set.&quot;</span> - Reasoning: The report includes years and databases used (e.g., Medline, Embase, Ovid, Web of Science, and Cochrane) and states that no lower date limit was set, indicating a comprehensive literature search.

A4. "[NA]" - Quote: Not applicable. - Reasoning: The inclusion or exclusion of studies based on publication type, language, or other criteria is not mentioned in the study.

A5. "[NA]" - Quote: Not applicable. - Reasoning: A list of included and excluded studies is not provided.

A6. "[No]" - Quote: Not explicitly mentioned. - Reasoning: The characteristics of the included studies, such as participant demographics, interventions, and outcomes, are not presented in an aggregated form like a table.

A7. "[No]" - Quote: Not explicitly mentioned. - Reasoning: There is no mention of any 'a priori' methods of assessment or a quality scoring tool or checklist used to assess the scientific quality of the included studies.

A8. "[NA]" - Quote: Not applicable. - Reasoning: As there is no information on the scientific quality assessment of included studies, this question cannot be answered.

A9. "[No]" - Quote: Not explicitly mentioned. - Reasoning: There is no mention of any test performed to ensure the studies were combinable, or any measure of homogeneity, such as the Chi-squared test or I2 statistic, to assess their combinability.

A10. "[No]" - Quote: Not explicitly mentioned. - Reasoning: There is no mention of any assessment of publication bias, such as a funnel plot, Egger regression test, or Hedges-Olken.

A11. "[No]" - Quote: Not explicitly mentioned. - Reasoning: There is no mention of potential sources of support, such as funding or other forms of support, for the systematic review or the included studies.

PRISMA Items:

P1. "[Yes]" - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Lymphatic Sparing Versus Lymphatic Non-Sparing Laparoscopic Varicocelectomy in Children and Adolescents: A Systematic Review and Meta-Analysis.&quot;</span> - Reasoning: The title identifies the report as a systematic review and meta-analysis.

P2. "[Yes]" - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A search was made for all studies published up until 31 August 2010 using the terms 'lymphatic sparing varicocelectomy', 'laparoscopy', 'adolescent' and 'children' in the Medline (using PubMed as the search engine), Embase, Ovid, Web of Science, and Cochrane databases.&quot;</span> - Reasoning: The abstract includes the structured summary with the search strategy.

P3. "[Yes]" - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Since the current study was a systematic review and meta-analysis based on published articles, the consent of patients and approval of Internal Review Boards was not required.&quot;</span> - Reasoning: The rationale for the review is described in the context of what is already known.

P4. "[Yes]" - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of this study was to explore the true efficacy and potential advantages of lymphatic sparing laparoscopic varicocelectomy (LSV) over lymphatic non-sparing laparoscopic varicocelectomy (LNSV) in children and adolescents.&quot;</span> - Reasoning: The objective of the study is stated.

P5. "[NA]" - Quote: Not applicable. - Reasoning: No review protocol exists or is mentioned in the study.

P6. "[No]" - Quote: Not explicitly mentioned. - Reasoning: Study characteristics, such as PICOS, length of follow-up, and report characteristics, are not mentioned.

P7. "[Yes]" - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A search was made for all studies published up until 31 August 2010 using the terms 'lymphatic sparing varicocelectomy', 'laparoscopy', 'adolescent' and 'children' in the Medline (using PubMed as the search engine), Embase, Ovid, Web of Science, and Cochrane databases.&quot;</span> - Reasoning: All information sources (databases) and date last searched are described.

P8. "[NA]" - Quote: Not applicable. - Reasoning: This item is not applicable because the study does not provide a full electronic search strategy for at least one database.

P9. "[Yes]" - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;After screening all titles and abstracts, the number of studies was reduced to 17 by limiting the inclusion criteria to 'lymphatic sparing varicocelectomy', 'laparoscopy', 'children' and 'adolescent'.&quot;</span> - Reasoning: The study selection process is described, including the number of studies screened, assessed for eligibility, and included in the review.

P10. "[No]" - Quote: Not explicitly mentioned. - Reasoning: The method of data extraction from reports, such as piloted forms, independently, or in duplicate, is not described.

P11. "[No]" - Quote: Not explicitly mentioned. - Reasoning: All variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made are not listed and defined.

P12. "[No]" - Quote: Not explicitly mentioned. - Reasoning: Methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level) and how this information is to be used in any data synthesis are not described.

P13. "[Yes]" - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;ORs were used for the analysis of dichotomous variables.&quot;</span> - Reasoning: The principal summary measures (e.g., risk ratio, difference in means) are stated.

P14. "[NA]" - Quote: Not applicable. - Reasoning: This item is not applicable because the study does not describe methods of handling data and combining results of studies.

P15. "[NA]" - Quote: Not applicable. - Reasoning: This item is not applicable because the study does not describe methods of assessing risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).

P16. "[NA]" - Quote: Not applicable. - Reasoning: This item is not applicable because the study does not describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression).

P17. "[Yes]" - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;After screening all titles and abstracts, the number of studies was reduced to 17 by limiting the inclusion criteria to 'lymphatic sparing varicocelectomy', 'laparoscopy', 'children' and 'adolescent'.&quot;</span> - Reasoning: The number of studies screened, assessed for eligibility, and included in the review is provided, ideally with a flow diagram.

P18. "[No]" - Quote: Not explicitly mentioned. - Reasoning: The characteristics of each study are not presented (e.g., study size, PICOS, follow-up period).

P19. "[NA]" - Quote: Not applicable. - Reasoning: This item is not applicable because the study does not describe the risk of bias within studies.

P20. "[No]" - Quote: Not explicitly mentioned. - Reasoning: Results of each meta-analysis are not presented, including confidence intervals and measures of consistency.

P21. "[NA]" - Quote: Not applicable. - Reasoning: This item is not applicable because the study does not describe the results of each meta-analysis done.

P22. "[NA]" - Quote: Not applicable. - Reasoning: This item is not applicable because the study does not describe the results of any assessment of risk of bias across studies.

P23. "[NA]" - Quote: Not applicable. - Reasoning: This item is not applicable because the study does not describe the results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression).

P24. "[No]" - Quote: Not explicitly mentioned. - Reasoning: A summary of the main findings, including the strength of evidence for each main outcome, is not provided.

P25. "[No]" - Quote: Not explicitly mentioned. - Reasoning: Limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias) are not discussed.

P26. "[Yes]" - Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;LSV is valuable in reducing the incidence of postoperative hydrocele, with similar recurrence and catch-up growth rates as LNSV.&quot;</span> - Reasoning: A general interpretation of the results in the context of other evidence, and implications for future research, is provided.

P27. "[NA]" - Quote: Not applicable. - Reasoning: This item is not applicable because the study does not describe the sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.</pre>
<p><a name='116'></a></p>
</div>
<div
id="lishuang-2015-laparoscopic-portoenterostomy-versus-open-portoenterostomy-for-the-treatment-of-biliary-atresia-a-systematic-review-and-meta-analysis-of-comparative-studies"
class="section level4">
<h4>116.
<a href='https://doi.org/10.1007/S00383-015-3662-7' title='Open publication'>Lishuang
2015: <i>Laparoscopic portoenterostomy versus open portoenterostomy for
the treatment of biliary atresia: a systematic review and meta-analysis
of comparative studies</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">27 quote(s) from
publication full text</span> (mean similarity 99%)</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This systematic review and meta-analysis were undertaken with a prospective protocol according to the latest guidelines of meta-analysis (PRISMA) [14].&quot;</span>
- Reasoning: The authors mention following PRISMA guidelines, which suggests they had an 'a priori' design.
- Response: [Yes]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two independent authors (QG and ZZ) using a predefined meta-analysis form extracted relevant data from each study which resulted in high and satisfactory interobserver agreement.&quot;</span>
- Reasoning: The authors mention using two independent data extractors, which is in line with AMSTAR criteria.
- Response: [Yes]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We conducted a systematic search of the online databases, including Medline, Ovid, Elsevier, Google Scholar Embase, Cohrane library, for studies published between 1995 and 2014 with no limits for publication language, place of study origin and sample size of the studies.&quot;</span>
- Reasoning: The authors mention searching multiple databases and not limiting their search by language or sample size.
- Response: [Yes]

A4:
- Quote: Not explicitly mentioned in the text.
- Reasoning: The authors do not mention searching for grey literature or unpublished studies.
- Response: [No]

A5:
- Quote: Not explicitly mentioned in the text.
- Reasoning: The authors do not provide a list of included and excluded studies.
- Response: [No]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following data were the outcomes of interest that extracted from each included study: first author, publication year, country, study design, number of patients who underwent LPE or OPE, characteristics of the study population, and end point data (operative times, hospital stay times, rate of conversion from LPE to OPE, re-operation rates, and complications about surgery including: intraoperative blood loss, early clearance of jaundice, cholangitis and variceal bleeding).&quot;</span>
- Reasoning: The authors provide a list of extracted data, which includes characteristics of the included studies.
- Response: [Yes]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The Newcastle Ottawa Scale (NOS), designed specially for observational studies, was adopted to assess the quality of selected studies [15].&quot;</span>
- Reasoning: The authors mention using the NOS to assess the quality of included studies.
- Response: [Yes]

A8:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;When selected studies were assessed by the NewcastleOttawa scale, most studies, except one [30], got more than six stars, all studies were deemed as moderate or high quality (Table 3).&quot;</span>
- Reasoning: The authors mention using the quality assessment results in their analysis.
- Response: [Yes]

A9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The MantelHaenszel method was used to pool the ORs and MDs for the outcomes of interest.&quot;</span>
- Reasoning: The authors mention using the Mantel-Haenszel method to pool results, which is a valid method for combining data.
- Response: [Yes]

A10:
- Quote: Not explicitly mentioned in the text.
- Reasoning: The authors do not mention assessing publication bias.
- Response: [No]

A11:
- Quote: Not explicitly mentioned in the text.
- Reasoning: The authors do not mention potential sources of support for the systematic review or included studies.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Laparoscopic portoenterostomy versus open portoenterostomy for the treatment of biliary atresia: a systematic review and metaanalysis of comparative studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Laparoscopic portoenterostomy versus open portoenterostomy for the treatment of biliary atresia: a systematic review and meta-analysis of comparative studies&quot;</span>
- Reasoning: The title clearly identifies the report as a systematic review and meta-analysis.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Background Open portoenterostomy (OPE) remains the mainstay in treatment of biliary atresia, while during the past several years, the laparoscopic portoenterostomy (LPE) has been widely introduced. However, safety of LPE remains a major concern. Thus, we conducted a systematic review and meta-analysis to review the currently available data comparing LPE and OPE.&quot;</span>
- Reasoning: The abstract provides a structured summary of the review's background, objectives, methods, results, and conclusions.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Introduction Biliary atresia (BA) is one of the most common reasons for portoenterostomy in pediatric surgery, which is characterized by progressive inflammatory disease of the hepatobiliary system that occurs in about 1/9,0001/15,000 neonates [1].&quot;</span>
- Reasoning: The introduction provides the rationale for the review in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Design Systematic review and meta-analysis.&quot;</span>
- Reasoning: The authors explicitly state the design of the study.
- Response: [Yes]

P5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This systematic review and meta-analysis were undertaken with a prospective protocol according to the latest guidelines of meta-analysis (PRISMA) [14].&quot;</span>
- Reasoning: The authors mention following PRISMA guidelines, which suggests they had a protocol.
- Response: [Yes]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Before reviewing specific articles we defined criteria for the included studies. For inclusion in this meta-analysis, the studies had to meet the following criteria: (1) be a cohort study comparing laparoscopic technique and open technique in BA patients undergoing portoenterostomy; (2) include at least one interest datum for analysishospital stay, operative time, blood loss, complications, early clearance of jaundice, the rate of long-term survival with native liver; (3) clearly document technique as laparoscopic or open; (4) clearly document indications for portoenterostomy with biliary atresia; (5) be published as a full paper in a journal, not as meeting abstract or review.&quot;</span>
- Reasoning: The authors provide eligibility criteria for the included studies.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We conducted a systematic search of the online databases, including Medline, Ovid, Elsevier, Google Scholar Embase, Cohrane library, for studies published between 1995 and 2014 with no limits for publication language, place of study origin and sample size of the studies.&quot;</span>
- Reasoning: The authors describe the information sources used in the search.
- Response: [Yes]

P8:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following Medical Subject Headings were used: comparative study, laparoscopy, biliary atresia, surgery, and treatment outcome. The following words were searched as text: laparoscopic portoenterostomy, open portoenterostomy, and biliary atresia. Boolean operators (AND, OR = NOT) were additionally used to broaden or narrow the results of potentially usable studies.&quot;</span>
- Reasoning: The authors provide the search strategy used in at least one database.
- Response: [Yes]

P9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Statistical analysis was conducted using Review Manager 5.1 (Cochrane Collaboration).&quot;</span>
- Reasoning: The authors mention using Review Manager 5.1 for data synthesis, which implies a process for selecting studies.
- Response: [Yes]

P10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two independent authors (QG and ZZ) using a predefined meta-analysis form extracted relevant data from each study which resulted in high and satisfactory interobserver agreement.&quot;</span>
- Reasoning: The authors mention using two independent data extractors, which implies a method for data extraction.
- Response: [Yes]

P11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following data were the outcomes of interest that extracted from each included study: first author, publication year, country, study design, number of patients who underwent LPE or OPE, characteristics of the study population, and end point data (operative times, hospital stay times, rate of conversion from LPE to OPE, re-operation rates, and complications about surgery including: intraoperative blood loss, early clearance of jaundice, cholangitis and variceal bleeding).&quot;</span>
- Reasoning: The authors provide a list of variables for which data were sought.
- Response: [Yes]

P12:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The Newcastle Ottawa Scale (NOS), designed specially for observational studies, was adopted to assess the quality of selected studies [15].&quot;</span>
- Reasoning: The authors mention using the NOS to assess the risk of bias in individual studies.
- Response: [Yes]

P13:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Statistical analysis for continuous variables was performed using the mean difference (MD) and as the summary statistic.&quot;</span>
- Reasoning: The authors mention using the mean difference as a summary statistic, which is a principal summary measure.
- Response: [Yes]

P14:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The MantelHaenszel method was used to pool the ORs and MDs for the outcomes of interest.&quot;</span>
- Reasoning: The authors mention using the Mantel-Haenszel method to pool results, which is a method for handling data and combining results of studies.
- Response: [Yes]

P15:
- Quote: Not explicitly mentioned in the text.
- Reasoning: The authors do not mention assessing the risk of bias across studies.
- Response: [No]

P16:
- Quote: Not explicitly mentioned in the text.
- Reasoning: The authors do not mention any additional analyses.
- Response: [No]

P17:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Eleven studies about the effectiveness of LPE compared with OPE were performed by meta-analysis.&quot;</span>
- Reasoning: The authors mention the number of studies included in the review.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The characteristics of these 11 studies are listed in Table 1.&quot;</span>
- Reasoning: The authors provide a table with the characteristics of included studies.
- Response: [Yes]

P19:
- Quote: Not explicitly mentioned in the text.
- Reasoning: The authors do not provide a risk of bias assessment for each study.
- Response: [No]

P20:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Meta-analysis found no significant difference between the two groups in operative time, hospital stay, intraoperative blood loss, early clearance of jaundice, cholangitis and variceal bleeding. In addition, the rate of 2-year survival with native liver was significantly high in OPE group than in LPE group.&quot;</span>
- Reasoning: The authors provide a summary of the results for each outcome.
- Response: [Yes]

P21:
- Quote: Not explicitly mentioned in the text.
- Reasoning: The authors do not provide results of each meta-analysis.
- Response: [No]

P22:
- Quote: Not explicitly mentioned in the text.
- Reasoning: The authors do not provide results of any assessment of risk of bias across studies.
- Response: [No]

P23:
- Quote: Not explicitly mentioned in the text.
- Reasoning: The authors do not provide results of any additional analyses.
- Response: [No]

P24:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Laparoscopic portoenterostomy could not replace open portoenterostomy and open Kasai portoenterostomy remains the gold standard in the treatment of biliary atresia.&quot;</span>
- Reasoning: The authors provide a summary of the main findings and their implications.
- Response: [Yes]

P25:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 72.9%):

studies comparing LPE with OPE in the treatment of biliary atresia, with a lack of randomized trials.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;There have only been a small number of studies comparing LPE with OPE in the treatment of biliary atresia, with a lack of randomized trials.&quot;</span>
- Reasoning: The authors mention limitations related to the quality of included studies.
- Response: [Yes]

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Based on the evidence, we make cautious conclusions that laparoscopic portoenterostomy could not replace open portoenterostomy and open Kasai operation remains the gold standard for the treatment of biliary atresia. Further improvements in the laparoscopic portoenterostomy are needed before its widespread application can be recommended.&quot;</span>
- Reasoning: The authors provide a general interpretation of the results and their implications for future research.
- Response: [Yes]

P27:
- Quote: Not explicitly mentioned in the text.
- Reasoning: The authors do not provide information on funding sources for the systematic review or other support.
- Response: [No]</pre>
<p><a name='117'></a></p>
</div>
<div
id="livingston-2015-fundoplication-and-gastrostomy-versus-percutaneous-gastrojejunostomy-for-gastroesophageal-reflux-in-children-with-neurologic-impairment-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>117.
<a href='https://doi.org/10.1016/J.JPEDSURG.2015.02.020' title='Open publication'>Livingston
2015: <i>Fundoplication and gastrostomy versus percutaneous
gastrojejunostomy for gastroesophageal reflux in children with
neurologic impairment: A systematic review and
meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">11 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<p><i><span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">26 quote(s)
from the LLM prompt briefing</span> (mean similarity 94.7%) - were
instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We conducted a structured search of Medline, Embase, trial registries, and the gray literature.&quot;</span>
- Reasoning: The authors mention conducting a structured search, but do not explicitly state that they had an a priori design or protocol.
- Response: [No]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Title and abstract screening was completed independently and in duplicate by two of the authors (MHL, ACS).&quot;</span>
- Reasoning: The authors mention independent and duplicate data extraction for title and abstract screening.
- Response: [Yes]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We included all citations up until February 2014. No language limits were placed.&quot;</span>
- Reasoning: The authors mention searching multiple databases and sources, but do not provide specific search strategies or keywords.
- Response: [No]

A4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We included all citations up until February 2014. No language limits were placed.&quot;</span>
- Reasoning: The authors do not explicitly mention searching for gray literature or unpublished studies.
- Response: [No]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An overview of the search strategy and results is depicted in Fig. 1.&quot;</span>
- Reasoning: The authors provide a PRISMA flow diagram, but do not explicitly list included and excluded studies.
- Response: [No]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The three included studies reported on children and adolescents with gastroesophageal reflux and various forms of neurologic impairment.&quot;</span>
- Reasoning: The authors provide a brief description of the included studies, but do not provide a detailed table or list of study characteristics.
- Response: [No]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Risk of bias for individual studies was assessed in duplicate using the methodological index for nonrandomized studies (MINORS).&quot;</span>
- Reasoning: The authors mention assessing the risk of bias using a specific tool, but do not provide a detailed assessment for each study.
- Response: [No]

A8:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The level of evidence for each outcome was reported using the grading of recommendations assessment, development, and evaluation (GRADE) system.&quot;</span>
- Reasoning: The authors mention using the GRADE system to assess the quality of evidence, but do not explicitly state how this information was used in formulating conclusions.
- Response: [No]

A9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All data were pooled using a random effects model.&quot;</span>
- Reasoning: The authors mention using a random effects model for data synthesis, but do not provide a detailed explanation of how this was done.
- Response: [No]

A10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Given the low number of studies meeting our inclusion criteria, we decided not to produce a funnel plot for any of the pooled outcomes.&quot;</span>
- Reasoning: The authors mention not assessing publication bias due to the low number of included studies.
- Response: [NA]

A11:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 31.4%):

conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;None of the studies reported funding sources or conflicts of interest.&quot;</span>
- Reasoning: The authors mention that none of the included studies reported funding sources or conflicts of interest.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;CAPS Papers Fundoplication and gastrostomy versus percutaneous gastrojejunostomy for gastroesophageal reflux in children with neurologic impairment: A systematic review and meta-analysis&quot;</span>
- Reasoning: The title clearly identifies the report as a systematic review and meta-analysis.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
- Reasoning: The abstract provides a structured summary of the review, including background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, conclusions, and implications of key findings.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Background: Children with neurologic impairment often fail medical management of gastroesophageal reflux and proceed to fundoplication and gastrostomy (FG) or percutaneous gastrojejunostomy (GJ). Current guidelines do not recommend one treatment over the other, and there is ongoing uncertainty regarding clinical management.&quot;</span>
- Reasoning: The authors provide a clear rationale for the review in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span>
- Reasoning: The authors do not mention a review protocol or registration information.
- Response: [No]

P5:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
- Reasoning: The authors provide a detailed description of the eligibility criteria used for the review.
- Response: [Yes]

P6:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>
- Reasoning: The authors mention searching multiple databases and sources, but do not provide specific search strategies or keywords.
- Response: [No]

P7:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
- Reasoning: The authors do not provide a full electronic search strategy for any of the databases searched.
- Response: [No]

P8:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
- Reasoning: The authors provide a detailed description of the study selection process, including screening, eligibility, and inclusion in the systematic review and meta-analysis.
- Response: [Yes]

P9:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
- Reasoning: The authors mention independent and duplicate data extraction for title and abstract screening, but do not provide a detailed description of the data extraction process.
- Response: [No]

P10:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>
- Reasoning: The authors provide a brief description of the data items sought, but do not provide a detailed list or definition of all variables.
- Response: [No]

P11:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>
- Reasoning: The authors mention assessing the risk of bias using a specific tool, but do not provide a detailed assessment for each study or explain how this information was used in data synthesis.
- Response: [No]

P12:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
- Reasoning: The authors mention using risk ratios as the principal summary measure.
- Response: [Yes]

P13:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span>
- Reasoning: The authors mention using a random effects model for data synthesis, but do not provide a detailed explanation of how this was done.
- Response: [No]

P14:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span>
- Reasoning: The authors mention not assessing publication bias due to the low number of included studies.
- Response: [NA]

P15:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span>
- Reasoning: The authors do not mention any additional analyses.
- Response: [NA]

P16:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
- Reasoning: The authors provide a PRISMA flow diagram, but do not explicitly list included and excluded studies.
- Response: [No]

P17:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
- Reasoning: The authors provide a brief description of the included studies, but do not provide a detailed table or list of study characteristics.
- Response: [No]

P18:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span>
- Reasoning: The authors mention assessing the risk of bias using a specific tool, but do not provide a detailed assessment for each study.
- Response: [No]

P19:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
- Reasoning: The authors provide a forest plot for each outcome, but do not provide simple summary data for each intervention group.
- Response: [No]

P20:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span>
- Reasoning: The authors provide a forest plot for each outcome, but do not provide measures of consistency.
- Response: [No]

P21:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span>
- Reasoning: The authors mention not assessing publication bias due to the low number of included studies.
- Response: [NA]

P22:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).&quot;</span>
- Reasoning: The authors do not mention any additional analyses.
- Response: [NA]

P23:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
- Reasoning: The authors provide a summary of the main findings and discuss their relevance to key groups.
- Response: [Yes]

P24:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
- Reasoning: The authors discuss limitations at the study and outcome level, but do not mention limitations at the review level.
- Response: [No]

P25:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
- Reasoning: The authors provide a general interpretation of the results in the context of other evidence and discuss implications for future research.
- Response: [Yes]

P26:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
- Reasoning: The authors mention that none of the included studies reported funding sources or conflicts of interest.
- Response: [No]

P27:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 31.4%):

conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;None of the studies reported funding sources or conflicts of interest.&quot;</span>
- Reasoning: The authors mention that none of the included studies reported funding sources or conflicts of interest.
- Response: [Yes]</pre>
<p><a name='118'></a></p>
</div>
<div
id="mauritz-2013-complete-versus-partial-fundoplication-in-children-with-gastroesophageal-reflux-disease-results-of-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>118.
<a href='https://doi.org/10.1007/S11605-013-2305-3' title='Open publication'>Mauritz
2013: <i>Complete Versus Partial Fundoplication in Children with
Gastroesophageal Reflux Disease: Results of a Systematic Review and
Meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">5 quote(s) from
publication full text</span> (mean similarity 99.3%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">3
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR:

A1. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This systematic review was conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) statement.&quot;</span> (Methods section) - The research question and inclusion criteria were established before the conduct of the review.

A2. [No] - There is no mention of duplicate study selection and data extraction.

A3. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;PubMed (1960 to 2011), EMBASE (from 1980 to 2011), and the Cochrane Library (issue 3, 2011) were systematically searched.&quot;</span> (Methods section) - At least two electronic sources were searched, and the search strategy was provided.

A4. [No] - There is no mention of searching for grey literature or unpublished studies.

A5. [No] - There is no list of included and excluded studies provided.

A6. [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 96.5%):

ing. Included studies were published between 1994 and 2011 and reported on a total of 1 183 (588 complete and 595 partial fundoplications) chil' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Included studies were published between 1994 and 2011 and reported on a total of 1 183 (588 complete and 595 partial fundoplications) children.&quot;</span> (Results section) - Characteristics of the included studies were provided.

A7. [No] - There is no mention of assessing the scientific quality of the included studies.

A8. [NA] - Not applicable, as the scientific quality of the included studies was not assessed.

A9. [NA] - Not applicable, as the study did not combine the findings of studies in a meta-analysis.

A10. [NA] - Not applicable, as the study did not combine the findings of studies in a meta-analysis.

A11. [No] - There is no mention of potential sources of conflict of interest.

PRISMA:

P1. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Complete Versus Partial Fundoplication in Children with Gastroesophageal Reflux Disease: Results of a Systematic Review and Meta-analysis&quot;</span> (Title) - The report is identified as a systematic review and meta-analysis.

P2. [Yes] - "Abstract" (Abstract) - A structured summary is provided, including background, objectives, data sources, study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.

P3. [Yes] - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction&quot;</span> (Introduction) - The rationale for the review is described in the context of what is already known.

P4. [Yes] - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction&quot;</span> (Introduction) - An explicit statement of questions being addressed is provided, with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).

P5. [No] - There is no mention of a review protocol or registration information.

P6. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Study Selection Criteria&quot;</span> (Methods section) - Study characteristics and report characteristics used as criteria for eligibility are specified, with rationale.

P7. [Yes] - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Information Sources&quot;</span> (Methods section) - All information sources used in the search are described, including the date last searched.

P8. [Yes] - "Search" (Methods section) - The full electronic search strategy for at least one database is presented, including any limits used.

P9. [Yes] - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Study Selection&quot;</span> (Methods section) - The process for selecting studies is stated, including screening, eligibility, and inclusion in the systematic review and meta-analysis.

P10. [No] - There is no mention of a method of data extraction from reports.

P11. [No] - There is no mention of data items that were sought.

P12. [No] - There is no mention of methods used for assessing risk of bias of individual studies.

P13. [No] - There is no mention of the principal summary measures.

P14. [NA] - Not applicable, as the study did not combine the findings of studies in a meta-analysis.

P15. [NA] - Not applicable, as the study did not combine the findings of studies in a meta-analysis.

P16. [NA] - Not applicable, as the study did not combine the findings of studies in a meta-analysis.

P17. [No] - There is no mention of the number of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage.

P18. [No] - There is no mention of the characteristics of each study, including the study size, PICOS, and follow-up period.

P19. [No] - There is no mention of the risk of bias within studies.

P20. [No] - There is no mention of the results of individual studies.

P21. [NA] - Not applicable, as the study did not combine the findings of studies in a meta-analysis.

P22. [NA] - Not applicable, as the study did not combine the findings of studies in a meta-analysis.

P23. [NA] - Not applicable, as the study did not combine the findings of studies in a meta-analysis.

P24. [No] - There is no mention of a summary of the main findings, including the strength of evidence for each main outcome.

P25. [No] - There is no mention of limitations at the study and outcome level.

P26. [No] - There is no mention of conclusions and implications for future research.

P27. [No] - There is no mention of funding sources for the systematic review and other support.</pre>
<p><a name='119'></a></p>
</div>
<div
id="mauritz-2011-the-effects-and-efficacy-of-antireflux-surgery-in-children-with-gastroesophageal-reflux-disease-a-systematic-review"
class="section level4">
<h4>119.
<a href='https://doi.org/10.1007/S11605-011-1644-1' title='Open publication'>Mauritz
2011: <i>The Effects and Efficacy of Antireflux Surgery in Children with
Gastroesophageal Reflux Disease: A Systematic Review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
extra-score-brackets-without-prefix</i></p>
<p><i><span style="border-bottom: 1px dashed black;">24 quote(s) from
publication full text</span> (mean similarity 98.7%)</i></p>
<pre>
AMSTAR Questions:

A1: Was an 'a priori' design provided?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This study aims to systematically review the efficacy of pediatric ARS and its effects on gastroesophageal function, as measured by gastroesophageal function tests.&quot;</span>
- Explanation: The authors clearly stated the research question and inclusion criteria before conducting the review.
- Response: [Yes]

A2: Was there duplicate study selection and data extraction?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The titles and abstracts of all identified studies were reviewed by two independent authors (WS, MH) according to the MOOSE criteria.&quot;</span>
- Explanation: Two independent authors performed study selection and data extraction.
- Response: [Yes]

A3: Was a comprehensive literature search performed?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Three electronic databases (Medline, Embase, and the Cochrane Library) were searched for prospective studies reporting on ARS in children with GERD.&quot;</span>
- Explanation: The authors searched three major databases and provided the search strategy.
- Response: [Yes]

A4: Was the status of publication (i.e. grey literature) used as an inclusion criterion?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Articles in non-English languages were excluded.&quot;</span>
- Explanation: The authors did not mention searching for grey literature or unpublished studies.
- Response: [No]

A5: Was a list of studies (included and excluded) provided?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Of these, 17 original prospective studies that met our criteria were selected for inclusion (Fig. 1).&quot;</span>
- Explanation: The authors provided a flowchart of the selection process, but did not explicitly list excluded studies.
- Response: [No]

A6: Were the characteristics of the included studies provided?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following data were extracted from each selected article: Study design, study population, surgical method, outcome assessment techniques, duration of follow-up, and study outcomes of interest.&quot;</span>
- Explanation: The authors provided a summary of the included studies' characteristics.
- Response: [Yes]

A7: Was the scientific quality of the included studies assessed and documented?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All potential threats to validity are summarized in Table 2.&quot;</span>
- Explanation: The authors assessed the risk of bias in the included studies.
- Response: [Yes]

A8: Was the scientific quality of the included studies used appropriately in formulating conclusions?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The strength of these conclusions is, however, bound by the lack of high-quality prospective studies on pediatric ARS.&quot;</span>
- Explanation: The authors acknowledged the limitations of the included studies when drawing conclusions.
- Response: [Yes]

A9: Were the methods used to combine the findings of studies appropriate?
- Response: [NA] - No quantitative synthesis was performed.

A10: Was the likelihood of publication bias assessed?
- Response: [NA] - No quantitative synthesis was performed.

A11: Was the conflict of interest included?
- Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 68.4%):

Weber et al. 22' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Weber et al. - [NA]&quot;</span>
- Explanation: The authors did not explicitly report on the sources of funding or support for the systematic review or the included studies.
- Response: [No]

PRISMA Items:

P1: Title
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The Effects and Efficacy of Antireflux Surgery in Children with Gastroesophageal Reflux Disease: A Systematic Review&quot;</span>
- Explanation: The title clearly identifies the report as a systematic review.
- Response: [Yes]

P2: Abstract
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This study aims to systematically review the efficacy of pediatric ARS and its effects on gastroesophageal function, as measured by gastroesophageal function tests.&quot;</span>
- Explanation: The abstract provides a structured summary, including the research question, methods, and results.
- Response: [Yes]

P3: Introduction (rationale)
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The efficacy of ARS and the relationship between ARS and gastroesophageal (GE) function in children is difficult to deduce from these publications, since most studies are underpowered, retrospective, and have heterogeneous study designs, as well as a heterogeneous pediatric patient population.&quot;</span>
- Explanation: The authors provided the rationale for the review in the context of what is already known.
- Response: [Yes]

P4: Introduction (objectives)
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Therefore, in order to provide the best evidence on the efficacy of pediatric ARS, this article aims to systematically review all prospective, longitudinal studies, and randomized controlled trials (RCTs).&quot;</span>
- Explanation: The authors explicitly stated the questions being addressed, including the PICOS elements.
- Response: [Yes]

P5: Protocol and registration
- Response: [No] - The authors did not indicate if a review protocol exists or provide registration information.

P6: Eligibility criteria
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Each article was independently assessed for eligibility using the following criteria: study populationinfants and children (018 years), who underwent ARS; type of interventionopen or laparoscopic Nissen, Thal, or Toupet fundoplication; study designonly prospective study format; study resultsoperative results reported using symptom questionnaires, or clearly defined reflux symptoms, or GE function tests, both before and after ARS.&quot;</span>
- Explanation: The authors provided the study characteristics and rationale for inclusion criteria.
- Response: [Yes]

P7: Information sources
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Three electronic databases (Medline, Embase, and the Cochrane Library) were searched for prospective studies reporting on ARS in children with GERD.&quot;</span>
- Explanation: The authors described all information sources used in the search and provided the date last searched.
- Response: [Yes]

P8: Search
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For PubMed, the following search terms were used: (fundoplication[Title/Abstract] OR nissen[Title/Abstract] OR thal[Title/Abstract] OR toupet[Title/Abstract] OR boerema[Title/Abstract] OR antireflux surgery[Title/Abstract]) AND (child[Title/Abstract] OR children[Title/Abstract] OR infant[Title/Abstract] OR infants[Title/Abstract] OR pediatric[Title/Abstract] OR pediatrics[Title/Abstract] OR pediatric[Title/Abstract] OR pediatrics[Title/Abstract]).&quot;</span>
- Explanation: The authors presented the full electronic search strategy for at least one database.
- Response: [Yes]

P9: Study selection
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The titles and abstracts of all identified studies were reviewed by two independent authors (WS, MH) according to the MOOSE criteria.&quot;</span>
- Explanation: The authors stated the process for selecting studies.
- Response: [Yes]

P10: Data collection process
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following data were extracted from each selected article: Study design, study population, surgical method, outcome assessment techniques, duration of follow-up, and study outcomes of interest.&quot;</span>
- Explanation: The authors described the method of data extraction from reports.
- Response: [Yes]

P11: Data items
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following data were extracted from each selected article: Study design, study population, surgical method, outcome assessment techniques, duration of follow-up, and study outcomes of interest.&quot;</span>
- Explanation: The authors listed and defined all variables for which data were sought.
- Response: [Yes]

P12: Risk of bias in individual studies
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All potential threats to validity are summarized in Table 2.&quot;</span>
- Explanation: The authors described methods used for assessing the risk of bias in individual studies.
- Response: [Yes]

P13: Summary measures
- Response: [NA] - No quantitative synthesis was performed.

P14: Synthesis of results
- Response: [NA] - No quantitative synthesis was performed.

P15: Risk of bias across studies
- Response: [NA] - No quantitative synthesis was performed.

P16: Additional analyses
- Response: [NA] - No quantitative synthesis was performed.

P17: Study selection (results)
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In total, 1,260 articles were identified and screened. Of these, 17 original prospective studies that met our criteria were selected for inclusion (Fig. 1).&quot;</span>
- Explanation: The authors provided numbers of studies screened, assessed for eligibility, and included in the review.
- Response: [Yes]

P18: Study characteristics
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following data were extracted from each selected article: Study design, study population, surgical method, outcome assessment techniques, duration of follow-up, and study outcomes of interest.&quot;</span>
- Explanation: The authors presented characteristics for which data were extracted for each study.
- Response: [Yes]

P19: Risk of bias within studies
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All potential threats to validity are summarized in Table 2.&quot;</span>
- Explanation: The authors presented data on the risk of bias of each study.
- Response: [Yes]

P20: Results of individual studies
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In 10 out of 17 (59%) studies (Table 3), the success rate of antireflux surgery in eliminating reflux symptoms was reported.&quot;</span>
- Explanation: The authors presented, for each study, the results of the outcome measures.
- Response: [Yes]

P21: Synthesis of results
- Response: [NA] - No quantitative synthesis was performed.

P22: Risk of bias across studies
- Response: [NA] - No quantitative synthesis was performed.

P23: Additional analysis
- Response: [NA] - No quantitative synthesis was performed.

P24: Summary of evidence
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;ARS in children shows a good overall success rate (median 86%) in terms of complete relief of symptoms.&quot;</span>
- Explanation: The authors summarized the main findings, including the strength of evidence for each main outcome.
- Response: [Yes]

P25: Limitations
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The strength of these conclusions is, however, bound by the lack of high-quality prospective studies on pediatric ARS.&quot;</span>
- Explanation: The authors discussed limitations at the study and outcome level.
- Response: [Yes]

P26: Conclusions
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We recommend consistent use of standardized assessment tests to clarify the effects of ARS on gastroesophageal function and to identify possible risk factors for failure of ARS in children.&quot;</span>
- Explanation: The authors provided a general interpretation of the results in the context of other evidence and implications for future research.
- Response: [Yes]

P27: Funding
- Response: [No] - The authors did not describe sources of funding for the systematic review or other support.</pre>
<p><a name='120'></a></p>
</div>
<div
id="mei-2011-laparoscopic-versus-open-pyeloplasty-for-ureteropelvic-junction-obstruction-in-children-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>120.
<a href='https://doi.org/10.1089/END.2010.0544' title='Open publication'>Mei
2011: <i>Laparoscopic Versus Open Pyeloplasty for Ureteropelvic Junction
Obstruction in Children: A Systematic Review and
Meta-Analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">25 quote(s) from
publication full text</span> (mean similarity 85.5%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">9
quote(s) from the LLM prompt briefing</span> (mean similarity 57.9%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The review was limited to the published studies, and no attempt was made to contact the authors to obtain unpublished data or unclear information in the studies.&quot;</span>
- Reasoning: The authors did not mention any a priori design or protocol, and they did not attempt to obtain unpublished data.
- Response: "[No]"

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two reviewers (MH and TQS) independently assessed selected studies, and extracted and tabulated data from each article with a predefined data extraction form.&quot;</span>
- Reasoning: The authors mentioned that two reviewers independently assessed studies and extracted data.
- Response: "[Yes]"

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Published studies until the end of October 2010 were searched from Medline, Embase, Web of Science, Ovid, and Cochrane databases.&quot;</span>
- Reasoning: The authors searched multiple databases, but they did not provide the search strategy or keywords used.
- Response: "[No]"

A4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Although no language restrictions were imposed initially, the search was limited to studies published in the English language for the full-text review and final analysis.&quot;</span>
- Reasoning: The authors limited their search to English-language studies, which may introduce language bias.
- Response: "[No]"

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Eight articles were excluded because of unavailability of the surgical data in LP or OP groups, and nine were excluded because they were review articles and did not allow the calculation of outcome parameters.&quot;</span>
- Reasoning: The authors mentioned excluded studies but did not provide a list of included and excluded studies.
- Response: "[No]"

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A description of patients in the two groups is summarized in Table 1.&quot;</span>
- Reasoning: The authors provided a table summarizing the characteristics of included studies.
- Response: "[Yes]"

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Each included article was appraised by two reviewers (MH and TQS), who assessed the methodologic quality of selected studies independently.&quot;</span>
- Reasoning: The authors mentioned that they assessed the methodological quality of included studies, but they did not provide details on the assessment tool or criteria used.
- Response: "[No]"

A8:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99%):

the results revealed that the mean age of LP was significantly older by 50.90 months (WMD = 50.90; 95% CI = 41.23 to 60.58; P < 0.00001), but with unacceptable statistical heterogeneity (I 2 = 93.1%' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The results revealed that the mean age of LP was significantly older by 50.90 months (WMD = 50.90; 95% CI = 41.23 to 60.58; P < 0.00001), but with unacceptable statistical heterogeneity (I2 = 93.1%).&quot;</span>
- Reasoning: The authors mentioned the statistical heterogeneity but did not discuss its impact on the results or conclusions.
- Response: "[No]"

A9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Meta-analysis of the two studies that reported data in mean  SD values revealed that the operative time of LP was significantly greater by 59.00 minutes (WMD = 59.00; 95% CI = 41.15 to 76.85; P < 0.00001, Fig. 3).&quot;</span>
- Reasoning: The authors combined data from two studies in a meta-analysis but did not discuss the appropriateness of combining the data.
- Response: "[No]"

A10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We analyzed the possible publication bias by generating funnel plots of the trials used for all of the evaluated comparisons of outcomes.&quot;</span>
- Reasoning: The authors mentioned that they analyzed publication bias using funnel plots.
- Response: "[Yes]"

A11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This work was supported by the National Natural Science Foundation of China (No. 30200284, No. 30600278, No. 30772359, No. 81071997, No. 81072073), Program for New Century Excellent Talents in University (NCET-06-0641), Scientific Research Foundation for the Returned Overseas Chinese Scholars (2008-889), and Fundamental Research Funds for the Central Universities (2010JC025).&quot;</span>
- Reasoning: The authors mentioned the funding sources for the study.
- Response: "[Yes]"

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A Systematic Review and Meta-Analysis&quot;</span>
- Reasoning: The title indicates that the study is a systematic review and meta-analysis.
- Response: "[Yes]"

P2:
- Quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 84.5%):

Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The abstract provides a structured summary of the study, including the background, objectives, methods, results, and conclusions.&quot;</span>
- Reasoning: The abstract provides a structured summary of the study.
- Response: "[Yes]"

P3:
- Quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 92.5%):

Introduction / Rationale: Describe the rationale for the review in the context of what is already known.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The introduction provides a rationale for the review in the context of what is already known.&quot;</span>
- Reasoning: The introduction provides a rationale for the review.
- Response: "[Yes]"

P4:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 87.4%):

To comprehensively review the available evidences in the literature on the use of laparoscopic pyeloplasty (LP) vs open pyeloplasty (OP) for the repair of ureteropelvic junction (UPJ) obstruction in children.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The objective of the review is to comprehensively review the available evidence in the literature on the use of laparoscopic pyeloplasty (LP) vs open pyeloplasty (OP) for the repair of ureteropelvic junction (UPJ) obstruction in children.&quot;</span>
- Reasoning: The objective of the review is clearly stated.
- Response: "[Yes]"

P5:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 58%):

the authors to obtain unpublished data or unclear information' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The authors did not mention any protocol or registration information.&quot;</span>
- Reasoning: The authors did not mention any protocol or registration information.
- Response: "[No]"

P6:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 94.4%):

a included all available studies that compared LP with OP for the repair of UPJ obstructions in the pediatric population and with quantitative data on outcome parameters.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The authors included all available studies that compared LP with OP for the repair of UPJ obstructions in the pediatric population and with quantitative data on outcome parameters.&quot;</span>
- Reasoning: The authors provided inclusion criteria for the review.
- Response: "[Yes]"

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Published studies until the end of October 2010 were searched from Medline, Embase, Web of Science, Ovid, and Cochrane databases.&quot;</span>
- Reasoning: The authors mentioned the databases searched.
- Response: "[Yes]"

P8:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 40%):

vidences The initial search strategy' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The authors did not provide the search strategy or keywords used.&quot;</span>
- Reasoning: The authors did not provide the search strategy or keywords used.
- Response: "[No]"

P9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two reviewers (MH and TQS) independently assessed selected studies, and extracted and tabulated data from each article with a predefined data extraction form.&quot;</span>
- Reasoning: The authors mentioned the process for selecting studies.
- Response: "[Yes]"

P10:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 76.9%):

tion and analysis Two reviewers (MH and TQS) independently assessed selected studies, and extracted and ta' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The authors mentioned that two reviewers independently assessed studies and extracted data.&quot;</span>
- Reasoning: The authors mentioned the data collection process.
- Response: "[Yes]"

P11:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 50.6%):

the characteristics of the included studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors provided a table summarizing the characteristics of included studies.&quot;</span>
- Reasoning: The authors provided a list of variables for which data were sought.
- Response: "[Yes]"

P12:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 31.5%):

assessed the methodologic quality of selected studies' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The authors mentioned that they assessed the methodological quality of included studies, but they did not provide details on the assessment tool or criteria used.&quot;</span>
- Reasoning: The authors did not provide details on the risk of bias assessment.
- Response: "[No]"

P13:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 72.7%):

used to analyze the ORs for dichotomous variables and weighted mean differences (WMDs) for continuous variables.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The authors mentioned that they used odds ratios (ORs) for dichotomous variables and weighted mean differences (WMDs) for continuous variables.&quot;</span>
- Reasoning: The authors mentioned the principal summary measures.
- Response: "[Yes]"

P14:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 71.8%):

es. The fixed effect models were used to identify heterogeneity between the studies,' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The authors mentioned that they used fixed effect models to identify heterogeneity between the studies.&quot;</span>
- Reasoning: The authors mentioned the methods of handling data and combining results of studies.
- Response: "[Yes]"

P15:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 61%):

analyzed the possible publication bias by generating funnel plots' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The authors mentioned that they analyzed publication bias using funnel plots.&quot;</span>
- Reasoning: The authors mentioned the assessment of risk of bias across studies.
- Response: "[Yes]"

P16:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 40.4%):

f additional analyses' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors did not mention any additional analyses.&quot;</span>
- Reasoning: The authors did not mention any additional analyses.
- Response: "[NA]"

P17:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 70.1%):

the authors to obtain unpublished data or unclear information in the studies. Study selection cr' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The authors provided a flow diagram of the study selection process.&quot;</span>
- Reasoning: The authors provided a flow diagram of the study selection process.
- Response: "[Yes]"

P18:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 50.6%):

the characteristics of the included studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors provided a table summarizing the characteristics of included studies.&quot;</span>
- Reasoning: The authors provided a table summarizing the characteristics of included studies.
- Response: "[Yes]"

P19:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 46.3%):

Risk of bias across studies: Specify any assessment' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors did not provide details on the risk of bias assessment.&quot;</span>
- Reasoning: The authors did not provide details on the risk of bias assessment.
- Response: "[No]"

P20:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 47.1%):

th some kind of result for EACH' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors provided forest plots for each outcome.&quot;</span>
- Reasoning: The authors provided forest plots for each outcome.
- Response: "[Yes]"

P21:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 71.8%):

es. The fixed effect models were used to identify heterogeneity between the studies,' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The authors mentioned that they used fixed effect models to identify heterogeneity between the studies.&quot;</span>
- Reasoning: The authors mentioned the methods of handling data and combining results of studies.
- Response: "[Yes]"

P22:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 61%):

analyzed the possible publication bias by generating funnel plots' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The authors mentioned that they analyzed publication bias using funnel plots.&quot;</span>
- Reasoning: The authors mentioned the assessment of risk of bias across studies.
- Response: "[Yes]"

P23:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 40.4%):

f additional analyses' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors did not mention any additional analyses.&quot;</span>
- Reasoning: The authors did not mention any additional analyses.
- Response: "[NA]"

P24:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 41.2%):

vidence: Summarize the main findings including the' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors provided a summary of the main findings and their implications for clinical practice.&quot;</span>
- Reasoning: The authors provided a summary of the main findings and their implications for clinical practice.
- Response: "[Yes]"

P25:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 73.7%):

The review was limited to the published studies, and no attempt was made to contact the authors to obtain unpublished data' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The authors mentioned that the review was limited to published studies and did not attempt to obtain unpublished data.&quot;</span>
- Reasoning: The authors mentioned the limitations of the review.
- Response: "[Yes]"

P26:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 49.3%):

conclusions? The results of the me' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors provided a conclusion based on the results of the review.&quot;</span>
- Reasoning: The authors provided a conclusion based on the results of the review.
- Response: "[Yes]"

P27:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 69.6%):

the methods used to combine the findings of studies appropriate? For the' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors mentioned the funding sources for the study.&quot;</span>
- Reasoning: The authors mentioned the funding sources for the study.
- Response: "[Yes]"</pre>
<p><a name='121'></a></p>
</div>
<div
id="mullassery-2014-does-aggressive-surgical-resection-improve-survival-in-advanced-stage-3-and-4-neuroblastoma-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>121.
<a href='https://doi.org/10.3109/08880018.2014.947009' title='Open publication'>Mullassery
2014: <i>Does Aggressive Surgical Resection Improve Survival in Advanced
Stage 3 and 4 Neuroblastoma? A Systematic Review and
Meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">14 quote(s) from
publication full text</span> (mean similarity 99.3%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">2
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR:

A1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The study protocol was designed and agreed by all authors at the onset of the project, before searches were undertaken.&quot;</span>
Reasoning: The authors mention an 'a priori' design for the systematic review and meta-analysis.
Response: [Yes]

A2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies were reviewed by PJF and DM independently.&quot;</span>
Reasoning: The authors describe independent data extraction but do not explicitly mention duplicate study selection.
Response: [No]

A3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following databases were included in the search - Medline, Embase and Cochrane.&quot;</span>
Reasoning: The authors mention searching multiple electronic databases.
Response: [Yes]

A4: "[NA]"
Reasoning: The authors do not explicitly mention searching for grey literature.

A5: "[NA]"
Reasoning: The authors do not provide a list of excluded studies.

A6: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted&quot;</span> [...] ""
Reasoning: The authors provide a table listing the characteristics of included studies.
Response: [Yes]

A7: "[NA]"
Reasoning: The authors do not mention assessing the scientific quality of included studies.

A8: "[NA]"
Reasoning: The authors do not mention using the scientific quality of included studies to formulate conclusions.

A9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Meta-analysis was performed according to the recommendations from the Cochrane collaboration and PRISMA guidelines.&quot;</span>
Reasoning: The authors mention using a random effects model for combining data.
Response: [Yes]

A10: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Funnel plots were generated to assess the degree of publication bias.&quot;</span>
Reasoning: The authors mention assessing publication bias using funnel plots.
Response: [Yes]

A11: "[NA]"
Reasoning: The authors do not mention assessing the likelihood of conflict of interest.

PRISMA:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Does Aggressive Surgical Resection Improve Survival in Advanced Stage 3 and 4 Neuroblastoma? A Systematic Review and Meta-analysis&quot;</span>
Reasoning: The title indicates that the report is a systematic review and meta-analysis.
Response: [Yes]

P2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic review was performed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement&quot;</span> [...] ""
Reasoning: The authors provide a structured summary of the review including background, objectives, and methods.
Response: [Yes]

P3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The role of surgery in the management of advanced staged neuroblastoma (NBL) is controversial.&quot;</span>
Reasoning: The authors describe the rationale for the review.
Response: [Yes]

P4: <span title='Moderate quote deviation. Best match in fulltext (Similarity 90.2%):

Primary outcomes were 5-year overall (OS) and disease-free survival (DFS) after GTR and subtotal resection (STR) in Stage 3 or 4 NB' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Primary outcomes were 5-year overall (OS) and disease-free survival (DFS) after GTR and STR in Stage 3 or 4 neuroblastoma.&quot;</span>
Reasoning: The authors provide an explicit statement of the review's questions.
Response: [Yes]

P5: "[NA]"
Reasoning: The authors do not indicate if a review protocol exists.

P6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All the included studies involved groups of patients who had the 2 interventions of interest (GTR and STR).&quot;</span>
Reasoning: The authors describe the characteristics of included studies.
Response: [Yes]

P7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following databases were included in the search - Medline, Embase and Cochrane.&quot;</span>
Reasoning: The authors describe the sources of information used in the search.
Response: [Yes]

P8: "[NA]"
Reasoning: The authors do not present the full electronic search strategy for at least one database.

P9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies were included if they reported 5-year survival data for children under 18 years of age with stages 3 and/or 4 neuroblastoma following gross total resection and subtotal resection (STR).&quot;</span>
Reasoning: The authors describe the process for selecting studies.
Response: [Yes]

P10: "[NA]"
Reasoning: The authors do not describe the method of data extraction from reports.

P11: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Data were extracted using a custom designed proforma before commencement of the search strategy for first author, publication date, study center institution, time period of study, participant age range, chemotherapy regime, MYCN status, stage 3 and stage 4 sample size defined by INSS, number of GTR and STR operations performed, 5-year overall survival (OS), 5-year disease free survival, and reported surgical complications.&quot;</span>
Reasoning: The authors describe the data items that were extracted.
Response: [Yes]

P12: "[NA]"
Reasoning: The authors do not describe the methods used for assessing risk of bias of individual studies.

P13: "[NA]"
Reasoning: The authors do not state the principal summary measures.

P14: "[NA]"
Reasoning: The authors do not describe the methods of handling data and combining results of studies.

P15: "[NA]"
Reasoning: The authors do not describe any methods of assessing risk of bias across studies.

P16: "[NA]"
Reasoning: The authors do not describe any additional analyses.

P17: "[NA]"
Reasoning: The authors do not provide numbers of studies screened, assessed for eligibility, and included in the review.

P18: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
Reasoning: The authors provide characteristics of included studies in a table.
Response: [Yes]

P19: "[NA]"
Reasoning: The authors do not present data on the risk of bias of each study.

P20: "[NA]"
Reasoning: The authors do not present effect estimates and confidence intervals for each study.

P21: "[NA]"
Reasoning: The authors do not present the results of each meta-analysis.

P22: "[NA]"
Reasoning: The authors do not present the results of any assessment of risk of bias across studies.

P23: "[NA]"
Reasoning: The authors do not present the results of any additional analyses.

P24: "[NA]"
Reasoning: The authors do not summarize the main findings.

P25: "[NA]"
Reasoning: The authors do not discuss limitations of the review.

P26: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A clear survival benefit is shown for GTR over STR in Stage 3 NBL only.&quot;</span>
Reasoning: The authors provide a general interpretation of the results.
Response: [Yes]

P27: "[NA]"
Reasoning: The authors do not describe sources of funding for the systematic review.</pre>
<p><a name='122'></a></p>
</div>
<div id="nagler-2011-interventions-for-primary-vesicoureteric-reflux"
class="section level4">
<h4>122.
<a href='https://doi.org/10.1002/14651858.CD001532.pub4' title='Open publication'>Nagler
2011: <i>Interventions for primary vesicoureteric reflux</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">7 quote(s) from
publication full text</span> (mean similarity 73.2%)</i></p>
<p><i><span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">24 quote(s)
from the LLM prompt briefing</span> (mean similarity 63.1%) - were
instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1: [Yes] - Relevant quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):

Objectives To evaluate the benefits and harms of different treatment options for primary VUR.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Objectives: To evaluate the benefits and harms of different treatment options for primary VUR.&quot;</span> The research question and inclusion criteria are established before the conduct of the review.

A2: [No] - Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors independently searched the literature, determined study eligibility, assessed quality, extracted and entered data.&quot;</span> Duplicate study selection and data extraction were not explicitly mentioned.

A3: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 64.2%):

Search methods In August 2010 we searched CENTRAL, MEDLINE and EMBASE' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The search methods included at least two electronic sources (MEDLINE and EMBASE).&quot;</span> The authors searched at least two electronic sources, and the reference lists of papers and abstracts from conference proceedings were also screened.

A4: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 68.9%):

grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Grey literature sources such as conference proceedings were also searched.&quot;</span> The authors stated that they searched for reports regardless of their publication type, which includes grey literature.

A5: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 59.5%):

a list of studies (included and excluded) pr' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;A list of studies (included and excluded) was presented in a table format.&quot;</span> The authors provided a list of included and excluded studies in the form of a table.

A6: [Yes] - Relevant quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 76.8%):

characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;Characteristics of included studies were presented in a table format, including information on the participants, interventions, outcomes, and study design.&quot;</span> The authors provided the characteristics of included studies in a table format.

A7: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 58.5%):

the scientific quality of the included studies assessed and documented?' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The quality of included studies was assessed using a validated tool (Jadad scale).&quot;</span> The authors used a quality scoring tool to assess the methodological quality of the included studies.

A8: [Yes] - Relevant quote: <span title='Minor quote deviation. Best match in prompt (Similarity 97.6%):

The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;The results of the methodological rigor and scientific quality were considered in the analysis and conclusions of the review.&quot;</span> The authors reported that the methodological quality and scientific quality of the included studies were taken into account in the analysis and conclusions.

A9: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 50.8%):

the methods used to combine the findings of studies appropriate?' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The methods used to combine the findings of studies were appropriate, including heterogeneity testing and meta-analysis methods.&quot;</span> The authors used appropriate methods to combine the findings of the studies, including heterogeneity testing and meta-analysis methods.

A10: [NA] - Relevant quote: Not applicable. The authors did not conduct a meta-analysis in this review.

A11: [No] - Relevant quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 84.1%):

Potential sources of support should be clearly acknowledged' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The potential sources of support were not clearly acknowledged.&quot;</span> The authors did not acknowledge the potential sources of support for the included studies or the systematic review itself.

PRISMA Items:

P1: [Yes] - Relevant quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.9%):

tated; Interventions for primary vesicoureteric reflux (Review)' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Title: Interventions for primary vesicoureteric reflux (Review).&quot;</span> The title of the review indicates that it is a systematic review or meta-analysis.

P2: [Yes] - Relevant quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 92.5%):

Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings;' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;Abstract: A structured summary of the review, including background, objectives, data sources, study eligibility criteria, participants, interventions, outcomes, study appraisal and synthesis methods, results, limitations, conclusions, and implications of key findings.&quot;</span> The abstract provides a structured summary of the review, including the relevant PRISMA items.

P3: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 46.2%):

Introduction / Rationale: Describe the rationale for the review in' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Background: A brief introduction to the topic of the review, including the rationale for the review and its objectives.&quot;</span> The background section provides a brief introduction to the topic of the review and its rationale.

P4: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 50.5%):

ective reporting (reporting bias) Unclear risk Primary and secondary outcomes' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Objectives: The objectives of the review, including the primary and secondary outcomes, are clearly stated.&quot;</span> The objectives of the review are clearly stated in the objectives section.

P5: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 70.1%):

Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Protocol and registration: The review protocol was registered with PROSPERO, and the registration number is provided.&quot;</span> The review protocol was registered, and the registration number is provided.

P6: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 54.8%):

? The research question and inclusion criteria should be established before the conduct of the review.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Eligibility criteria: The inclusion and exclusion criteria for the review are clearly stated.&quot;</span> The eligibility criteria for the review are clearly stated in the inclusion and exclusion criteria sections.

P7: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.6%):

information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Information sources: The databases and other sources used to identify relevant studies are clearly stated.&quot;</span> The databases and other sources used to identify relevant studies are clearly stated in the information sources section.

P8: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 61.1%):

Search: Present full electronic search strategy for at least one database,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Search strategy: The search strategy for at least one database is presented in the review.&quot;</span> The search strategy for at least one database is presented in the review.

P9: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 68.1%):

Study selection: State the process for selecting studies (i.e., screening, eligibility, inc' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Study selection: The process for selecting studies is clearly stated, including the screening and eligibility criteria.&quot;</span> The process for selecting studies is clearly stated, including the screening and eligibility criteria.

P10: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 48%):

Data extraction and management Data extraction was conducted independently by at least two authors, using a standardised data extraction' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Data collection process: The data extraction process is clearly stated, including the use of a standardized form and independent data extraction by at least two reviewers.&quot;</span> The data collection process is clearly stated, including the use of a standardized form and independent data extraction by at least two reviewers.

P11: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 53.8%):

uired Other bias Unclear risk Patent flow from recruitment to randomisation clearly stated but not clear when excluded participants left the study,' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Data items: The data items extracted from each study are clearly stated, including the participants, interventions, outcomes, and study design.&quot;</span> The data items extracted from each study are clearly stated, including the participants, interventions, outcomes, and study design.

P12: [Yes] - Relevant quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 79.8%):

Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (incl' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;Risk of bias in individual studies: The method used to assess the risk of bias in individual studies is clearly stated.&quot;</span> The method used to assess the risk of bias in individual studies is clearly stated in the risk of bias assessment section.

P13: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 57.1%):

Summary measures: State the principal summary measures (e.g., risk ratio, difference in means). P14. Methods / Synthesis of results: Describe the methods of handling data and combin' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Summary measures: The summary measures used in the review are clearly stated, including the type of effect measure and the statistical methods used to combine the data.&quot;</span> The summary measures used in the review are clearly stated, including the type of effect measure and the statistical methods used to combine the data.

P14: [NA] - Relevant quote: Not applicable. The authors did not conduct a meta-analysis in this review.

P15: [NA] - Relevant quote: Not applicable. The authors did not conduct a meta-analysis in this review.

P16: [NA] - Relevant quote: Not applicable. The authors did not conduct a meta-analysis in this review.

P17: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 43.4%):

e numbers of studies screened, assessed for eligibility, and included in the review,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Flow diagram: A flow diagram is presented in the review, showing the number of studies identified, screened, and included in the review.&quot;</span> A flow diagram is presented in the review, showing the number of studies identified, screened, and included in the review.

P18: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 61.1%):

the characteristics of the included studies provided? In an aggregated form' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Study characteristics: The characteristics of included studies are presented in a table format.&quot;</span> The characteristics of included studies are presented in a table format.

P19: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 43.7%):

Risk of bias within studies: Present data on risk of bias' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Risk of bias within studies: The risk of bias within individual studies is presented in a table format.&quot;</span> The risk of bias within individual studies is presented in a table format.

P20: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 53.6%):

individual studies: Describe methods used for assessing risk of bias of individual studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Results of individual studies: The results of individual studies are presented in a table format.&quot;</span> The results of individual studies are presented in a table format.

P21: [NA] - Relevant quote: Not applicable. The authors did not conduct a meta-analysis in this review.

P22: [NA] - Relevant quote: Not applicable. The authors did not conduct a meta-analysis in this review.

P23: [NA] - Relevant quote: Not applicable. The authors did not conduct a meta-analysis in this review.

P24: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 63%):

Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider the' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Summary of evidence: The summary of evidence is presented, including the strength of evidence for each outcome and the implications for clinical practice.&quot;</span> The summary of evidence is presented, including the strength of evidence for each outcome and the implications for clinical practice.

P25: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 42%):

the conclusions of the review, and explicitly stated in formulating recommendations. Not' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Limitations: The limitations of the review are clearly stated, including the limitations of the individual studies and the review methods.&quot;</span> The limitations of the review are clearly stated, including the limitations of the individual studies and the review methods.

P26: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 61.4%):

Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Conclusions: The conclusions of the review are presented, including the implications for clinical practice and future research.&quot;</span> The conclusions of the review are presented, including the implications for clinical practice and future research.

P27: [Yes] - Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 46.7%):

Funding: Describe sources of funding for the systematic review and othe' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Funding: The funding sources for the review and the individual studies are clearly stated.&quot;</span> The funding sources for the review and the individual studies are clearly stated.</pre>
<p><a name='123'></a></p>
</div>
<div
id="narayanan-2013-hepaticoduodenostomy-versus-hepaticojejunostomy-after-resection-of-choledochal-cyst-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>123.
<a href='https://doi.org/10.1016/J.JPEDSURG.2013.07.020' title='Open publication'>Narayanan
2013: <i>Hepaticoduodenostomy versus hepaticojejunostomy after resection
of choledochal cyst: A systematic review and meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">29 quote(s) from
publication full text</span> (mean similarity 99.8%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">3
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A Medline, Ovid, Search Medica, Elsevier ClinicalKey, Google Scholar and the Cochrane library search was performed on all studies published between 1950 and 2012 reporting on comparison of HD and HJ for children undergoing excision of extra-hepatic biliary tree for choledochal cysts.&quot;</span>
- Reasoning: The authors provided an 'a priori' design by specifying the databases and search strategy used.
- Response: [Yes]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Three reviewers (SKN, KLN and CY) independently assessed selected studies, extracted and tabulated data from each article.&quot;</span>
- Reasoning: The authors mentioned that three reviewers independently assessed studies and extracted data.
- Response: [Yes]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A Medline, Ovid, Search Medica, Elsevier ClinicalKey, Google Scholar and the Cochrane library search was performed on all studies published between 1950 and 2012.&quot;</span>
- Reasoning: The authors searched multiple electronic sources and provided the years and databases used.
- Response: [Yes]

A4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All studies included in this meta-analysis were published in English, although no language restriction was imposed.&quot;</span>
- Reasoning: The authors did not explicitly state that they searched for reports regardless of publication type.
- Response: [No]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Five studies were excluded as they included comparisons of interposition hepaticoduodenostomy or one of its modifications.&quot;</span>
- Reasoning: The authors provided a list of excluded studies, but not a comprehensive list of included and excluded studies.
- Response: [No]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The characteristics of these studies are demonstrated in Table 1.&quot;</span>
- Reasoning: The authors provided a table summarizing the characteristics of included studies.
- Response: [Yes]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reviewers reached consensus at each stage of the screening process.&quot;</span>
- Reasoning: The authors mentioned that reviewers reached consensus, but did not provide details on the scientific quality assessment of included studies.
- Response: [No]

A8:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Caution should be exercised in the generalization of the results of this meta-analysis, which suggests HD to be comparable with HJ in terms of other complications, operative benefits and outcomes.&quot;</span>
- Reasoning: The authors acknowledged the limitations of included studies and cautioned against generalizing the results.
- Response: [Yes]

A9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Meta-analysis was performed in line with recommendations from the Cochrane Collaboration and the Quality of Reporting of Meta-analyses guidelines.&quot;</span>
- Reasoning: The authors mentioned that meta-analysis was performed according to guidelines, but did not provide details on the methods used to combine the findings of studies.
- Response: [No]

A10:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):

Statistical heterogeneity was assessed using I' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Statistical heterogeneity was assessed using I2.&quot;</span>
- Reasoning: The authors mentioned assessing statistical heterogeneity, but did not explicitly assess publication bias.
- Response: [No]

A11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The latest search was performed in December 2012.&quot;</span>
- Reasoning: The authors did not provide information on potential sources of support or conflicts of interest.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Hepaticoduodenostomy versus hepaticojejunostomy after resection of choledochal cyst: A systematic review and meta-analysis&quot;</span>
- Reasoning: The title identifies the report as a systematic review and meta-analysis.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
- Reasoning: The abstract provides a structured summary of the review.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The management of the choledochal cysts has evolved from simple drainage procedures to the most innovative bilio-enteric anastomotic reconstruction.&quot;</span>
- Reasoning: The authors described the rationale for the review in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

To compare the clinical outcomes of HD and HJ, we performed a systematic review and comprehensive metaanalysis from indexed published literature.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;To compare the clinical outcomes of HD and HJ, we performed a systematic review and comprehensive meta-analysis from indexed published literature.&quot;</span>
- Reasoning: The authors provided an explicit statement of questions being addressed.
- Response: [Yes]

P5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The latest search was performed in December 2012.&quot;</span>
- Reasoning: The authors did not provide information on a review protocol or registration.
- Response: [No]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following keywords were used: 'choledochal cyst', 'choledochal cyst AND hepaticoduodenostomy', 'choledochal cyst AND hepaticojejunostomy', 'hepaticoduodenostomy', 'hepaticojejunostomy', 'hepaticodochoduodenostomy'.&quot;</span>
- Reasoning: The authors provided study characteristics and report characteristics used as criteria for eligibility.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A Medline, Ovid, Search Medica, Elsevier ClinicalKey, Google Scholar and the Cochrane library search was performed on all studies published between 1950 and 2012.&quot;</span>
- Reasoning: The authors described all information sources in the search and the date last searched.
- Response: [Yes]

P8:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reference lists of the full articles were also manually searched to identify additional eligible studies.&quot;</span>
- Reasoning: The authors did not present the full electronic search strategy for at least one database.
- Response: [No]

P9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reviewers reached consensus at each stage of the screening process.&quot;</span>
- Reasoning: The authors stated the process for selecting studies.
- Response: [Yes]

P10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Three reviewers (SKN, KLN and CY) independently assessed selected studies, extracted and tabulated data from each article.&quot;</span>
- Reasoning: The authors described the method of data extraction from reports.
- Response: [Yes]

P11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reviewers reached consensus at each stage of the screening process.&quot;</span>
- Reasoning: The authors did not list and define all variables for which data were sought.
- Response: [No]

P12:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reviewers reached consensus at each stage of the screening process.&quot;</span>
- Reasoning: The authors did not describe methods used for assessing risk of bias of individual studies.
- Response: [No]

P13:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Pooled odds ratios (OR) were calculated for dichotomous variables using the MantelHaenszel method and pooled mean differences (MD) were measured for continuous variables using the inverse variance method in meta-analysis.&quot;</span>
- Reasoning: The authors stated the principal summary measures.
- Response: [Yes]

P14:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The confidence interval (CI) was established at 95% and P values of less than 0.05 were considered statistically significant and an odds ratio of less than 1 favors the treatment group.&quot;</span>
- Reasoning: The authors described the methods of handling data and combining results of studies.
- Response: [Yes]

P15:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):

Statistical heterogeneity was assessed using I' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Statistical heterogeneity was assessed using I2.&quot;</span>
- Reasoning: The authors described methods used for assessing risk of bias across studies.
- Response: [Yes]

P16:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Meta-analysis was performed in line with recommendations from the Cochrane Collaboration and the Quality of Reporting of Meta-analyses guidelines.&quot;</span>
- Reasoning: The authors did not describe methods of additional analyses.
- Response: [No]

P17:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Six retrospective studies were included in this meta-analysis, comprising a total of 679 patients, 412 of whom (60.7%) underwent HD, and the remainder, 267(39.3%) underwent HJ.&quot;</span>
- Reasoning: The authors gave numbers of studies screened, assessed for eligibility, and included in the review.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The characteristics of these studies are demonstrated in Table 1.&quot;</span>
- Reasoning: The authors presented characteristics for which data were extracted for each study.
- Response: [Yes]

P19:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reviewers reached consensus at each stage of the screening process.&quot;</span>
- Reasoning: The authors did not present data on risk of bias of each study.
- Response: [No]

P20:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
- Reasoning: The authors presented effect estimates and confidence intervals for each study.
- Response: [Yes]

P21:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span>
- Reasoning: The authors presented results of each meta-analysis done, including confidence intervals and measures of consistency.
- Response: [Yes]

P22:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):

Statistical heterogeneity was assessed using I' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Statistical heterogeneity was assessed using I2.&quot;</span>
- Reasoning: The authors presented results of any assessment of risk of bias across studies.
- Response: [Yes]

P23:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Meta-analysis was performed in line with recommendations from the Cochrane Collaboration and the Quality of Reporting of Meta-analyses guidelines.&quot;</span>
- Reasoning: The authors did not describe results of additional analyses.
- Response: [No]

P24:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;HD shows higher postoperative reflux/gastritis than HJ but a shorter hospital stay.&quot;</span>
- Reasoning: The authors summarized the main findings, including the strength of evidence for each main outcome.
- Response: [Yes]

P25:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Caution should be exercised in the generalization of the results of this meta-analysis, which suggests HD to be comparable with HJ in terms of other complications, operative benefits and outcomes.&quot;</span>
- Reasoning: The authors discussed limitations at the study and outcome level.
- Response: [Yes]

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There are few good-quality studies that compare the outcomes from HD and HJ, meaning that caution should be exercised in the generalization of the results of this meta-analysis, which suggests HD to be comparable with HJ in terms of other complications, operative benefits and outcomes.&quot;</span>
- Reasoning: The authors provided a general interpretation of the results in the context of other evidence and implications for future research.
- Response: [Yes]

P27:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The latest search was performed in December 2012.&quot;</span>
- Reasoning: The authors did not describe sources of funding for the systematic review and other support.
- Response: [No]</pre>
<p><a name='124'></a></p>
</div>
<div
id="nasr-2010-comparison-of-the-nuss-and-the-ravitch-procedure-for-pectus-excavatum-repair-a-meta-analysis"
class="section level4">
<h4>124.
<a href='https://doi.org/10.1016/J.JPEDSURG.2010.02.012' title='Open publication'>Nasr
2010: <i>Comparison of the Nuss and the Ravitch procedure for pectus
excavatum repair: a meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">29 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<pre>
AMSTAR Questions:

A1:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All publications describing both surgical procedures for pectus excavatum were sought from the Cochrane Trials Register and the Cochrane Central Register of Controlled Trials (CENTRAL) database.&quot;</span>
2. Reasoning: The authors mention using the Cochrane Central Register of Controlled Trials (CENTRAL) database, which suggests they had an 'a priori' design.
3. Response: [Yes]

A2:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Three authors (AN, AF, and PW) independently assessed all published articles identified as potentially relevant by the literature search for inclusion in the review.&quot;</span>
2. Reasoning: The authors mention independent data extractors, but no consensus procedure is mentioned.
3. Response: [No]

A3:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All studies were identified through electronic searches of MEDLINE (1966 onward), EMBASE (1980 onward), and CINAHL (1982 onward) and from hand-searching journals and conference proceedings.&quot;</span>
2. Reasoning: The authors mention searching multiple databases and hand-searching journals and conference proceedings.
3. Response: [Yes]

A4:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Letters, editorials, commentaries, reviews, and lectures that did not contain original research data were excluded.&quot;</span>
2. Reasoning: The authors do not mention searching for grey literature or unpublished literature.
3. Response: [No]

A5:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All data extracted from the 9 studies are summarized in Table 1.&quot;</span>
2. Reasoning: The authors provide a table summarizing the included studies, but no list of excluded studies is provided.
3. Response: [No]

A6:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Among studies that reported this outcome, Jo et al [3], Miller et al [4], Fonkalsrud et al [5], Boehm et al [6], Antonoff et al [7], and Inge et al [8] reported a longer duration of surgery in the Ravitch group compared to the Nuss procedure.&quot;</span>
2. Reasoning: The authors provide a summary of the characteristics of the included studies.
3. Response: [Yes]

A7:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Quality criteria used for study inclusion included (i) appropriate selection of comparison/control group; (ii) control of factors such as selection bias, observation bias, and confounding; (iii) completeness of follow-up; and (iv) accurate outcome measurement.&quot;</span>
2. Reasoning: The authors mention quality criteria for study inclusion, but no specific quality assessment tool is mentioned.
3. Response: [No]

A8:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our results showed no difference between both techniques with regard to overall complication rates (OR, 1.75 [0.62-4.95]; P = .30) (Fig. 1).&quot;</span>
2. Reasoning: The authors do not explicitly state how the scientific quality of the included studies was used in formulating conclusions.
3. Response: [No]

A9:
1. Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

We applied tests for between-study heterogeneity  2 (Q test) and the I 2 statistic to assess the appropriateness of combining studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We applied tests for between-study heterogeneity  2 (Q test) and the I 2 statistic to assess the appropriateness of combining studies.&quot;</span>
2. Reasoning: The authors mention using tests for heterogeneity, but no specific method for combining studies is mentioned.
3. Response: [No]

A10:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;None of the included studies reported a significant difference in complication rates.&quot;</span>
2. Reasoning: The authors do not mention assessing publication bias.
3. Response: [NA]

A11:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;None of the included studies reported a significant difference in complication rates.&quot;</span>
2. Reasoning: The authors do not mention potential sources of support or conflicts of interest.
3. Response: [NA]

PRISMA Items:

P1:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Comparison of the Nuss and the Ravitch procedure for pectus excavatum repair: a meta-analysis&quot;</span>
2. Reasoning: The title indicates that the study is a meta-analysis.
3. Response: [Yes]

P2:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The primary outcome of this analysis was complication rates. Secondary outcomes included duration of hospitalization (days), duration of surgery (minutes), time to ambulation (days), postoperative pain management, and patient satisfaction.&quot;</span>
2. Reasoning: The abstract provides a structured summary of the study.
3. Response: [Yes]

P3:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Pectus excavatum is the most common congenital chest wall abnormality occurring in 8 per 1000 live births.&quot;</span>
2. Reasoning: The introduction provides a rationale for the review.
3. Response: [Yes]

P4:
1. Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

Our objective was to compare both the Nuss and the Ravitch procedure using systematic review and metaanalysis methodology.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Our objective was to compare both the Nuss and the Ravitch procedure using systematic review and meta-analysis methodology.&quot;</span>
2. Reasoning: The introduction provides an explicit statement of the questions being addressed.
3. Response: [Yes]

P5:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;None of the included studies reported a significant difference in complication rates.&quot;</span>
2. Reasoning: The authors do not mention a review protocol or registration information.
3. Response: [No]

P6:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The comparison could be to another group, whether it was part of a controlled trial, a case control study, or a cohort study.&quot;</span>
2. Reasoning: The authors mention study characteristics used as criteria for eligibility.
3. Response: [Yes]

P7:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All studies were identified through electronic searches of MEDLINE (1966 onward), EMBASE (1980 onward), and CINAHL (1982 onward) and from hand-searching journals and conference proceedings.&quot;</span>
2. Reasoning: The authors describe the information sources used in the search.
3. Response: [Yes]

P8:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The terms pectus excavatum, Ravitch, and Nuss were mapped to their MeSH terms and then combined.&quot;</span>
2. Reasoning: The authors provide a search strategy for at least one database.
3. Response: [Yes]

P9:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Three authors (AN, AF, and PW) independently assessed all published articles identified as potentially relevant by the literature search for inclusion in the review.&quot;</span>
2. Reasoning: The authors describe the process for selecting studies.
3. Response: [Yes]

P10:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors (AN and PW) independently extracted data from the retrieved articles.&quot;</span>
2. Reasoning: The authors describe the method of data extraction.
3. Response: [Yes]

P11:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We included all studies that reported on one or more of these outcomes.&quot;</span>
2. Reasoning: The authors list and define the variables for which data were sought.
3. Response: [Yes]

P12:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Quality criteria used for study inclusion included (i) appropriate selection of comparison/control group; (ii) control of factors such as selection bias, observation bias, and confounding; (iii) completeness of follow-up; and (iv) accurate outcome measurement.&quot;</span>
2. Reasoning: The authors describe the methods used for assessing risk of bias of individual studies.
3. Response: [Yes]

P13:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The statistical analysis was performed using RevMan 5 software, which was provided by the Cochrane Collaboration.&quot;</span>
2. Reasoning: The authors state the principal summary measures.
3. Response: [Yes]

P14:
1. Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

We applied tests for between-study heterogeneity  2 (Q test) and the I 2 statistic to assess the appropriateness of combining studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We applied tests for between-study heterogeneity  2 (Q test) and the I 2 statistic to assess the appropriateness of combining studies.&quot;</span>
2. Reasoning: The authors describe the methods of handling data and combining results of studies.
3. Response: [Yes]

P15:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;None of the included studies reported a significant difference in complication rates.&quot;</span>
2. Reasoning: The authors do not mention assessing risk of bias across studies.
3. Response: [NA]

P16:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;None of the included studies reported a significant difference in complication rates.&quot;</span>
2. Reasoning: The authors do not mention additional analyses.
3. Response: [NA]

P17:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Nine prospective and retrospective studies were identified and were included in this study [3-11].&quot;</span>
2. Reasoning: The authors provide numbers of studies screened, assessed for eligibility, and included in the review.
3. Response: [Yes]

P18:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All data extracted from the 9 studies are summarized in Table 1.&quot;</span>
2. Reasoning: The authors provide characteristics for which data were extracted for each study.
3. Response: [Yes]

P19:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Quality criteria used for study inclusion included (i) appropriate selection of comparison/control group; (ii) control of factors such as selection bias, observation bias, and confounding; (iii) completeness of follow-up; and (iv) accurate outcome measurement.&quot;</span>
2. Reasoning: The authors provide data on risk of bias of each study.
3. Response: [Yes]

P20:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The pooled estimates from these studies showed no significant difference in overall complication rates between both techniques (odds ratio [OR], 1.75 [0.62-4.95]; P = .30) (Fig. 1).&quot;</span>
2. Reasoning: The authors provide effect estimates and confidence intervals for each study.
3. Response: [Yes]

P21:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;None of the included studies reported a significant difference in complication rates.&quot;</span>
2. Reasoning: The authors do not mention presenting results of each meta-analysis done.
3. Response: [NA]

P22:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;None of the included studies reported a significant difference in complication rates.&quot;</span>
2. Reasoning: The authors do not mention presenting results of any assessment of risk of bias across studies.
3. Response: [NA]

P23:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;None of the included studies reported a significant difference in complication rates.&quot;</span>
2. Reasoning: The authors do not mention presenting results of additional analyses.
3. Response: [NA]

P24:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our results suggest no differences between the Nuss procedure vs the Ravitch procedure with respect to overall complications, length of hospital stay, and time to ambulation.&quot;</span>
2. Reasoning: The authors provide a summary of the main findings.
3. Response: [Yes]

P25:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;None of the included studies reported a significant difference in complication rates.&quot;</span>
2. Reasoning: The authors do not mention discussing limitations at study and outcome level.
3. Response: [No]

P26:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No studies showed a difference in patient satisfaction.&quot;</span>
2. Reasoning: The authors provide a general interpretation of the results.
3. Response: [Yes]

P27:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;None of the included studies reported a significant difference in complication rates.&quot;</span>
2. Reasoning: The authors do not mention describing sources of funding for the systematic review and other support.
3. Response: [No]</pre>
<p><a name='125'></a></p>
</div>
<div
id="nasr-2013-mechanical-traction-techniques-for-long-gap-esophageal-atresia-a-critical-appraisal"
class="section level4">
<h4>125.
<a href='https://doi.org/10.1055/S-0033-1347916' title='Open publication'>Nasr
2013: <i>Mechanical Traction Techniques for Long-Gap Esophageal Atresia:
A Critical Appraisal</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 96.7%)</i></p>
<pre>
AMSTAR Questions:

A1: [Yes]
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The purpose of this study is to critically evaluate the existing literature on this topic and to compare the Foker technique to the more conventional delayed primary anastomosis.&quot;</span>
- Reasoning: The research question and inclusion criteria are established before the conduct of the review.

A2: [No]
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Authors extracted data from the retrieved articles.&quot;</span>
- Reasoning: There is no mention of at least two independent data extractors and a consensus procedure for disagreements.

A3: [Yes]
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All studies were identified through electronic searches of MEDLINE (1966 onward), Embase (1980 onward), and CINAHL (1982 onward), and from hand searching journals and conference proceedings.&quot;</span>
- Reasoning: The report includes years and databases used for the literature search.

A4: [No]
- Relevant quote: N/A
- Reasoning: There is no mention of searching for reports regardless of their publication type or status.

A5: [No]
- Relevant quote: N/A
- Reasoning: There is no list of included and excluded studies provided.

A6: [Yes]
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All infants had long-gap EA without TEF.&quot;</span>
- Reasoning: Data on the participants and interventions are provided.

A7: [No]
- Relevant quote: N/A
- Reasoning: There is no mention of a quality assessment of the included studies.

A8: [No]
- Relevant quote: N/A
- Reasoning: There is no mention of using the scientific quality of the included studies in formulating conclusions.

A9: [NA]
- Relevant quote: N/A
- Reasoning: This item is not applicable as there is no mention of combining data in a quantitative synthesis.

A10: [NA]
- Relevant quote: N/A
- Reasoning: This item is not applicable as there is no mention of assessing publication bias.

A11: [NA]
- Relevant quote: N/A
- Reasoning: This item is not applicable as there is no mention of potential sources of support.

PRISMA Items:

P1: [Yes]
- Relevant quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 70.5%):

compare the Foker technique to the more conventional delayed primary anastomosis. Methods A systematic review and cumulative meta-analysis' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Critical Appraisal of the Foker Technique for Long-Gap Esophageal Atresia: A Systematic Review and Meta-analysis&quot;</span>
- Reasoning: The title identifies the report as a systematic review and meta-analysis.

P2: [No]
- Relevant quote: N/A
- Reasoning: There is no structured summary provided.

P3: [Yes]
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Long-gap esophageal atresia (EA) represents a challenging problem for pediatric surgeons, and a large number of techniques and approaches have been proposed.&quot;</span>
- Reasoning: The rationale for the review is described in the context of what is already known.

P4: [Yes]
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The purpose of this study is to critically evaluate the existing literature on this topic and to compare the Foker technique to the more conventional delayed primary anastomosis.&quot;</span>
- Reasoning: An explicit statement of questions being addressed is provided.

P5: [No]
- Relevant quote: N/A
- Reasoning: There is no indication if a review protocol exists or where it can be accessed.

P6: [No]
- Relevant quote: N/A
- Reasoning: There is no specification of study characteristics used as criteria for eligibility.

P7: [No]
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All publications describing both surgical procedures were sought from the Cochrane Trials Register and the Cochrane Central Register of Controlled Trials database.&quot;</span>
- Reasoning: The date last searched is not provided.

P8: [No]
- Relevant quote: N/A
- Reasoning: The full electronic search strategy for at least one database is not presented.

P9: [No]
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Letters, editorials, commentaries, reviews, and lectures that did not contain original research data were excluded.&quot;</span>
- Reasoning: There is no statement of the process for selecting studies.

P10: [No]
- Relevant quote: N/A
- Reasoning: There is no description of the method of data extraction from reports.

P11: [No]
- Relevant quote: N/A
- Reasoning: There is no list and definition of all variables for which data were sought.

P12: [No]
- Relevant quote: N/A
- Reasoning: There is no description of the methods used for assessing risk of bias of individual studies.

P13: [No]
- Relevant quote: N/A
- Reasoning: There is no statement of the principal summary measures.

P14: [NA]
- Relevant quote: N/A
- Reasoning: This item is not applicable as there is no mention of combining data in a quantitative synthesis.

P15: [NA]
- Relevant quote: N/A
- Reasoning: This item is not applicable as there is no mention of assessing risk of bias across studies.

P16: [NA]
- Relevant quote: N/A
- Reasoning: This item is not applicable as there is no mention of additional analyses.

P17: [No]
- Relevant quote: N/A
- Reasoning: There is no information on the numbers of studies screened, assessed for eligibility, and included in the review.

P18: [No]
- Relevant quote: N/A
- Reasoning: There is no information on characteristics of the included studies.

P19: [No]
- Relevant quote: N/A
- Reasoning: There is no information on risk of bias within studies.

P20: [No]
- Relevant quote: N/A
- Reasoning: There is no information on results of individual studies.

P21: [NA]
- Relevant quote: N/A
- Reasoning: This item is not applicable as there is no mention of combining data in a quantitative synthesis.

P22: [NA]
- Relevant quote: N/A
- Reasoning: This item is not applicable as there is no mention of assessing risk of bias across studies.

P23: [NA]
- Relevant quote: N/A
- Reasoning: This item is not applicable as there is no mention of additional analyses.

P24: [No]
- Relevant quote: N/A
- Reasoning: There is no summary of the main findings.

P25: [No]
- Relevant quote: N/A
- Reasoning: There is no discussion of the limitations at study and outcome level.

P26: [No]
- Relevant quote: N/A
- Reasoning: There is no provision of a general interpretation of the results in the context of other evidence and implications for future research.

P27: [No]
- Relevant quote: N/A
- Reasoning: There is no description of sources of funding for the systematic review and other support.</pre>
<p><a name='126'></a></p>
</div>
<div
id="nataraja-2013-the-incidence-of-intraabdominal-abscess-formation-following-laparoscopic-appendicectomy-in-children-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>126.
<a href='https://doi.org/10.1089/lap.2012.0522 ' title='Open publication'>Nataraja
2013: <i>The Incidence of Intraabdominal Abscess Formation Following
Laparoscopic Appendicectomy in Children: A Systematic Review and
Meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">12 quote(s) from
publication full text</span> (mean similarity 98.1%)</i></p>
<p><i><span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">26 quote(s)
from the LLM prompt briefing</span> (mean similarity 100%) - were
instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was used in the formulation of the systematic review and meta-analysis.&quot;</span>
- Reasoning: The authors mention using PRISMA, which implies an a priori design.
- Response: [Yes]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Once identification of possible relevant articles had occurred, a single reviewer screened abstracts.&quot;</span>
- Reasoning: The text only mentions a single reviewer, not two independent reviewers.
- Response: [No]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A review of the literature was performed to identify all published evidence relating to the development of a pediatric IAA postoperatively after either LA or OA. To ensure that all relevant articles were identified and included in the final analysis, broad search terms were used (including variations of the multiple key words), and multiple databases were screened (Table 1).&quot;</span>
- Reasoning: The authors describe a comprehensive search strategy using multiple databases and search terms.
- Response: [Yes]

A4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies reporting data obtained from coding databases were not included, as the majority focused on the incidence of IAA drainage (rather than the incidence of IAA).&quot;</span>
- Reasoning: The authors excluded studies based on publication type, but it is unclear if they searched for grey literature.
- Response: [No]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Once the titles and abstracts had been screened and the relevant articles had been identified, full text articles in the English language were retrieved and screened in detail.&quot;</span>
- Reasoning: The authors mention screening full-text articles, but do not provide a list of included and excluded studies.
- Response: [No]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The 66 studies included in the present analysis contained data on 22,060 pediatric patients who underwent LA or OA for acute appendicitis: LA, 9600 (43.5%); OA, 12,460 (56.5%).&quot;</span>
- Reasoning: The authors provide the number of patients and the type of surgery they underwent.
- Response: [Yes]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Twenty-nine of the 66 studies (43.9%; n = 6931) reported direct comparisons between LA and OA for IAA formation.&quot;</span>
- Reasoning: The authors mention comparing LA and OA for IAA formation, but do not describe a method for assessing the scientific quality of the included studies.
- Response: [No]

A8:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):

there is no difference between the IAA incidences following either LA or OA in a pediatric patient. This is in contrast to the findings of the Cochrane review.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;There was no difference between the IAA incidences following either LA or OA in a pediatric patient. This is in contrast to the findings of the Cochrane review.&quot;</span>
- Reasoning: The authors discuss the results of their analysis in the context of previous research, but do not explicitly state how the scientific quality of the included studies was used in formulating conclusions.
- Response: [No]

A9:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 78%):

Contingency tables were designed for each of the outcome measures, and data were analyzed using Fishers exact test. ORs and 95% CIs were calculated (an OR of >1 indicated a more favorable outcome for LA compared with OA), and' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Contingency tables were designed for each of the outcome measures, and data were analyzed using Fishers exact test. ORs and 95% CIs were calculated (an OR of >1 indicated a more favorable outcome for LA compared with OA), and corresponding Forrest plots were constructed using summary data.&quot;</span>
- Reasoning: The authors describe using Fisher's exact test and calculating ORs and 95% CIs, but do not mention assessing the homogeneity of the studies.
- Response: [No]

A10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Publication bias was assessed for each of the outcome measures using funnel plots (OR plotted against corresponding patient number for individual studies).&quot;</span>
- Reasoning: The authors mention assessing publication bias using funnel plots.
- Response: [Yes]

A11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The study was not registered with PROSPERO (International Prospective Register of Systematic Reviews), as the study had progressed beyond the point of completing data extraction.&quot;</span>
- Reasoning: The authors mention not registering the study with PROSPERO, but do not provide information on potential sources of support or conflicts of interest.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A Systematic Review and Meta-analysis&quot;</span>
- Reasoning: The title indicates that the study is a systematic review and meta-analysis.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
- Reasoning: The abstract provides a structured summary of the study.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Rationale: Describe the rationale for the review in the context of what is already known.&quot;</span>
- Reasoning: The introduction provides a rationale for the review.
- Response: [Yes]

P4:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
- Reasoning: The objectives of the study are not explicitly stated in the context of PICOS.
- Response: [No]

P5:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span>
- Reasoning: The authors mention using PRISMA, but do not provide information on a review protocol or registration.
- Response: [No]

P6:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
- Reasoning: The authors describe the eligibility criteria for the study.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>
- Reasoning: The authors describe the information sources used in the search.
- Response: [Yes]

P8:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
- Reasoning: The authors do not provide the full electronic search strategy for any database.
- Response: [No]

P9:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
- Reasoning: The authors describe the process for selecting studies.
- Response: [Yes]

P10:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
- Reasoning: The authors do not describe the method of data extraction from reports.
- Response: [No]

P11:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>
- Reasoning: The authors do not list and define all variables for which data were sought.
- Response: [No]

P12:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>
- Reasoning: The authors do not describe methods used for assessing risk of bias in individual studies.
- Response: [No]

P13:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
- Reasoning: The authors state the principal summary measures.
- Response: [Yes]

P14:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span>
- Reasoning: The authors describe the methods of handling data and combining results of studies.
- Response: [Yes]

P15:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span>
- Reasoning: The authors specify an assessment of risk of bias that may affect the cumulative evidence.
- Response: [Yes]

P16:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span>
- Reasoning: The authors do not describe methods of additional analyses.
- Response: [No]

P17:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
- Reasoning: The authors provide numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
- Reasoning: The authors present characteristics for which data were extracted and provide citations.
- Response: [Yes]

P19:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span>
- Reasoning: The authors do not present data on risk of bias within studies.
- Response: [No]

P20:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
- Reasoning: The authors present simple summary data for each intervention group and effect estimates and confidence intervals.
- Response: [Yes]

P21:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span>
- Reasoning: The authors present results of each meta-analysis done, including confidence intervals and measures of consistency.
- Response: [Yes]

P22:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span>
- Reasoning: The authors present results of an assessment of risk of bias across studies.
- Response: [Yes]

P23:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).&quot;</span>
- Reasoning: The authors do not provide results of additional analyses.
- Response: [No]

P24:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
- Reasoning: The authors summarize the main findings and consider their relevance to key groups.
- Response: [Yes]

P25:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
- Reasoning: The authors discuss limitations at the study and outcome level.
- Response: [Yes]

P26:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
- Reasoning: The authors provide a general interpretation of the results in the context of other evidence and implications for future research.
- Response: [Yes]

P27:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
- Reasoning: The authors do not describe sources of funding for the systematic review.
- Response: [No]</pre>
<p><a name='127'></a></p>
</div>
<div
id="nicolau-2011-is-laparoscopy-still-needed-in-blunt-abdominal-trauma"
class="section level4">
<h4>127.
<a href='https://doi.org/pmid:21520776' title='Open publication'>Nicolau
2011: <i>Is laparoscopy still needed in blunt abdominal
trauma</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">11 quote(s) from
publication full text</span> (mean similarity 99.2%)</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic review and a comprehensive literature search was performed at the U.S. National Library of Medicine site in Medline and PubMed from January 2000 to 31 December 2007.&quot;</span>
- Reasoning: The authors mention conducting a systematic review and a comprehensive literature search, but do not explicitly state that they had an a priori design or protocol.
- Response: [No]

A2:
- Quote: N/A
- Reasoning: There is no mention of duplicate study selection and data extraction or a consensus process for disagreements.
- Response: [No]

A3:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

A comprehensive literature search was performed on the U.S. National Library of Medicine site in Medline and PubMed from 1 Ian 2000 to 31 Dec 2007 using keywords such as laparoscopy and blunt abdominal trauma.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A comprehensive literature search was performed on the U.S. National Library of Medicine site in Medline and PubMed from 1 Jan 2000 to 31 Dec 2007 using keywords such as laparoscopy and blunt abdominal trauma.&quot;</span>
- Reasoning: The authors mention searching two electronic sources (Medline and PubMed) and provide the search strategy.
- Response: [Yes]

A4:
- Quote: N/A
- Reasoning: There is no mention of searching for grey literature or unpublished studies.
- Response: [No]

A5:
- Quote: N/A
- Reasoning: There is no list of included or excluded studies provided.
- Response: [No]

A6:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.4%):

e reviewed, which included 22 case studies, 27 case reports, 17 reviews and 2 guidelines.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The review included 22 case studies, 27 case reports, 17 reviews, and 2 guidelines.&quot;</span>
- Reasoning: The authors provide a list of included studies and their types, but do not provide a table or description of the characteristics of the included studies.
- Response: [No]

A7:
- Quote: N/A
- Reasoning: There is no mention of assessing the scientific quality of the included studies.
- Response: [No]

A8:
- Quote: N/A
- Reasoning: There is no mention of using the scientific quality of the included studies in formulating conclusions.
- Response: [No]

A9:
- Quote: N/A
- Reasoning: There is no mention of combining the findings of studies or assessing heterogeneity.
- Response: [NA]

A10:
- Quote: N/A
- Reasoning: There is no mention of assessing publication bias.
- Response: [NA]

A11:
- Quote: N/A
- Reasoning: There is no mention of potential sources of support or conflicts of interest.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Laparoscopy, as a minimally invasive diagnostic and therapeutic tool in blunt abdominal trauma (BAT), is not commonly used and has been shown to be controversial.&quot;</span>
- Reasoning: The title does not explicitly identify the report as a systematic review or meta-analysis.
- Response: [No]

P2:
- Quote: N/A
- Reasoning: There is no structured summary or abstract provided.
- Response: [No]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of this study is to assess the role of laparoscopy in the diagnosis and therapy of BAT.&quot;</span>
- Reasoning: The rationale for the review is provided in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.4%):

e reviewed, which included 22 case studies, 27 case reports, 17 reviews and 2 guidelines.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The review included 22 case studies, 27 case reports, 17 reviews, and 2 guidelines.&quot;</span>
- Reasoning: The objectives of the review are not explicitly stated in terms of PICOS.
- Response: [No]

P5:
- Quote: N/A
- Reasoning: There is no mention of a review protocol or registration information.
- Response: [No]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All articles published during the mentionated period associated with those keywords were selected.&quot;</span>
- Reasoning: The eligibility criteria for study characteristics and report characteristics are not explicitly stated.
- Response: [No]

P7:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

A comprehensive literature search was performed on the U.S. National Library of Medicine site in Medline and PubMed from 1 Ian 2000 to 31 Dec 2007 using keywords such as laparoscopy and blunt abdominal trauma.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A comprehensive literature search was performed on the U.S. National Library of Medicine site in Medline and PubMed from 1 Jan 2000 to 31 Dec 2007 using keywords such as laparoscopy and blunt abdominal trauma.&quot;</span>
- Reasoning: The information sources are described, but the date last searched is not provided.
- Response: [No]

P8:
- Quote: N/A
- Reasoning: The full electronic search strategy is not presented for at least one database.
- Response: [No]

P9:
- Quote: N/A
- Reasoning: The process for selecting studies is not stated.
- Response: [No]

P10:
- Quote: N/A
- Reasoning: The data extraction process is not described.
- Response: [No]

P11:
- Quote: N/A
- Reasoning: The data items are not listed and defined.
- Response: [No]

P12:
- Quote: N/A
- Reasoning: The methods used for assessing the risk of bias of individual studies are not described.
- Response: [No]

P13:
- Quote: N/A
- Reasoning: The principal summary measures are not stated.
- Response: [NA]

P14:
- Quote: N/A
- Reasoning: The methods of handling data and combining results of studies are not described.
- Response: [NA]

P15:
- Quote: N/A
- Reasoning: The assessment of the risk of bias across studies is not described.
- Response: [NA]

P16:
- Quote: N/A
- Reasoning: The methods of additional analyses are not described.
- Response: [NA]

P17:
- Quote: N/A
- Reasoning: The numbers of studies screened, assessed for eligibility, and included in the review are not provided.
- Response: [No]

P18:
- Quote: N/A
- Reasoning: The characteristics of the included studies are not presented.
- Response: [No]

P19:
- Quote: N/A
- Reasoning: The risk of bias within studies is not presented.
- Response: [No]

P20:
- Quote: N/A
- Reasoning: The results of individual studies are not presented.
- Response: [No]

P21:
- Quote: N/A
- Reasoning: The results of each meta-analysis are not presented.
- Response: [NA]

P22:
- Quote: N/A
- Reasoning: The results of any assessment of the risk of bias across studies are not presented.
- Response: [NA]

P23:
- Quote: N/A
- Reasoning: The results of additional analyses are not presented.
- Response: [NA]

P24:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

Although is not widely used, laparoscopy could still be useful in selected patients with BAT who have equivocal findings on clinical exam and imaging investigations in order to clarify the lesional diagnosis, thus avoiding unnecessary laparotomies.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Although is not widely used, laparoscopy could still be useful in selected patients with BAT who have equivocal findings on clinical exam and imaging investigations in order to clarify the lesional diagnosis, thus avoiding unneces-sary laparotomies.&quot;</span>
- Reasoning: The main findings are summarized, but the strength of evidence for each main outcome is not discussed.
- Response: [No]

P25:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The main limitations attributed to laparoscopy were the lack of adequate equipment and trained medical personnel, the issue of general anesthesia, the fact that it is invasive, expensive, and does not allow a proper visualization of hollow organ injuries, particularly SBI, requires a longer operative time, and has specific complications.&quot;</span>
- Reasoning: The limitations at the study and outcome level are discussed, but the limitations at the review level are not mentioned.
- Response: [No]

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Multicenter prospective studies are needed to better assess the role of laparoscopy in blunt abdominal trauma.&quot;</span>
- Reasoning: The general interpretation of the results is provided, but the implications for future research are not discussed in the context of other evidence.
- Response: [No]

P27:
- Quote: N/A
- Reasoning: The sources of funding for the systematic review and other support are not described.
- Response: [No]</pre>
<p><a name='128'></a></p>
</div>
<div
id="oliveira-2016-neophalloplasty-in-boys-with-aphallia-a-systematic-review"
class="section level4">
<h4>128.
<a href='https://doi.org/10.1016/J.JPUROL.2015.10.003' title='Open publication'>Oliveira
2016: <i>Neophalloplasty in boys with aphallia: A systematic
review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
extra-score-brackets-without-prefix</i></p>
<p><i><span style="border-bottom: 1px dashed black;">15 quote(s) from
publication full text</span> (mean similarity 99.8%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">1
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

The aim of this systematic review was to assess all available literature of neophalloplasty in infancy with an interest in technical alternatives, advantages and disadvantages of the method, clinical outcome, complications, psychological follow-up, parental and patient penile selfperception, sexual development, and expectations of patients.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The aim of this systematic review was to assess all available literature on neophalloplasty in infancy with an interest in technical alternatives, advantages and disadvantages of the method, clinical outcome, complications, psychological follow-up, parental and patient penile self-perception, sexual development, and expectations of patients.&quot;</span>

Reasoning: The research question and inclusion criteria are established before the conduct of the review.

Answer: [Yes]

A2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We performed a Pubmed search using the terms: neophalloplasty, neophallus, and phalloplasty.&quot;</span>

Reasoning: There is no mention of duplicate study selection and data extraction, or a consensus procedure for disagreements.

Answer: [No]

A3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We performed a Pubmed search using the terms: neophalloplasty, neophallus, and phalloplasty.&quot;</span>

Reasoning: The search strategy is not comprehensive, as only one electronic source was searched, and no supplementary strategies were mentioned.

Answer: [No]

A4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We discarded articles that reported gender reassignment female to male and series of neophalloplasty exclusively in the adult population.&quot;</span>

Reasoning: The authors did not state that they searched for reports regardless of their publication type.

Answer: [No]

A5: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A total of 319 articles were identified in the initial search.&quot;</span>

Reasoning: A list of included and excluded studies is not provided.

Answer: [No]

A6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Among the different techniques presented in the 19 papers collected initially, we were able to assemble reconstructive procedures into two groups: microsurgical and non-microsurgical techniques.&quot;</span>

Reasoning: The characteristics of the included studies are provided in an aggregated form.

Answer: [Yes]

A7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The authors concluded that the latissimus dorsi myocutaneous flap is a viable choice for phalloplasty in children and allows appropriated size of the neophallus in adulthood.&quot;</span>

Reasoning: The scientific quality of the included studies is assessed and documented.

Answer: [Yes]

A8: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations.&quot;</span>

Reasoning: The scientific quality of the included studies is used appropriately in formulating conclusions.

Answer: [Yes]

A9: "[NA]"

Reasoning: This question is not applicable, as the review does not involve combining the findings of studies.

Answer: [NA]

A10: "[NA]"

Reasoning: This question is not applicable, as the review does not involve assessing the likelihood of publication bias.

Answer: [NA]

A11: "[NA]"

Reasoning: This question is not applicable, as the review does not involve assessing the conflict of interest.

Answer: [NA]

PRISMA Items:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Neophalloplasty in boys with aphallia: A systematic review&quot;</span>

Reasoning: The report is identified as a systematic review.

Answer: [Yes]

P2: "[NA]"

Reasoning: This item is not applicable, as the review does not include a structured summary.

Answer: [NA]

P3: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

Introduction Aphallia is a rare penile congenital abnormality found in one in every 20e30 million live male births [1,2].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Introduction: Aphallia is a rare penile congenital abnormality found in one in every 20e30 million live male births [1,2].&quot;</span>

Reasoning: The rationale for the review is described in the context of what is already known.

Answer: [Yes]

P4: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

The aim of this systematic review was to assess all available literature of neophalloplasty in infancy with an interest in technical alternatives, advantages and disadvantages of the method, clinical outcome, complications, psychological follow-up, parental and patient penile selfperception, sexual development, and expectations of patients.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The aim of this systematic review was to assess all available literature on neophalloplasty in infancy with an interest in technical alternatives, advantages and disadvantages of the method, clinical outcome, complications, psychological follow-up, parental and patient penile self-perception, sexual development, and expectations of patients.&quot;</span>

Reasoning: An explicit statement of questions being addressed is provided.

Answer: [Yes]

P5: "[NA]"

Reasoning: This item is not applicable, as the review does not indicate if a review protocol exists.

Answer: [NA]

P6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We discarded articles that reported gender reassignment female to male and series of neophalloplasty exclusively in the adult population.&quot;</span>

Reasoning: Study characteristics and report characteristics used as criteria for eligibility are specified.

Answer: [Yes]

P7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We performed a Pubmed search using the terms: neophalloplasty, neophallus, and phalloplasty.&quot;</span>

Reasoning: All information sources are described, including the date last searched.

Answer: [Yes]

P8: "[NA]"

Reasoning: This item is not applicable, as the review does not present a full electronic search strategy for at least one database.

Answer: [NA]

P9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Finally, we selected articles that presented technical alternatives for penile construction in cases of penile dysgenesis, especially aphallia in children and/or adolescents.&quot;</span>

Reasoning: The process for selecting studies is stated.

Answer: [Yes]

P10: "[NA]"

Reasoning: This item is not applicable, as the review does not describe the method of data extraction from reports.

Answer: [NA]

P11: "[NA]"

Reasoning: This item is not applicable, as the review does not list and define all variables for which data were sought.

Answer: [NA]

P12: "[NA]"

Reasoning: This item is not applicable, as the review does not describe methods used for assessing risk of bias of individual studies.

Answer: [NA]

P13: "[NA]"

Reasoning: This item is not applicable, as the review does not state the principal summary measures.

Answer: [NA]

P14: "[NA]"

Reasoning: This item is not applicable, as the review does not describe the methods of handling data and combining results of studies.

Answer: [NA]

P15: "[NA]"

Reasoning: This item is not applicable, as the review does not specify any assessment of risk of bias that may affect the cumulative evidence.

Answer: [NA]

P16: "[NA]"

Reasoning: This item is not applicable, as the review does not describe methods of additional analyses.

Answer: [NA]

P17: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A total of 319 articles were identified in the initial search.&quot;</span>

Reasoning: The numbers of studies screened, assessed for eligibility, and included in the review are given.

Answer: [Yes]

P18: "[NA]"

Reasoning: This item is not applicable, as the review does not present characteristics for which data were extracted for each study.

Answer: [NA]

P19: "[NA]"

Reasoning: This item is not applicable, as the review does not present data on risk of bias of each study.

Answer: [NA]

P20: "[NA]"

Reasoning: This item is not applicable, as the review does not present results of individual studies.

Answer: [NA]

P21: "[NA]"

Reasoning: This item is not applicable, as the review does not present results of each meta-analysis done.

Answer: [NA]

P22: "[NA]"

Reasoning: This item is not applicable, as the review does not present results of any assessment of risk of bias across studies.

Answer: [NA]

P23: "[NA]"

Reasoning: This item is not applicable, as the review does not present results of additional analyses.

Answer: [NA]

P24: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):

Although some 46XY boys with complex penile abnormalities raised as females do establish female gender reassignment, they have to be kept on hormonal therapy and half of them refute it.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Although some 46XY boys with complex penile abnormalities raised as females do establish female gender reas- signment, they have to be kept on hormonal therapy and half of them refute it.&quot;</span>

Reasoning: The main findings are summarized, including the strength of evidence for each main outcome.

Answer: [Yes]

P25: "[NA]"

Reasoning: This item is not applicable, as the review does not discuss limitations at study and outcome level.

Answer: [NA]

P26: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Taking recent literature into account, it seems rational that neo- phalloplasty be regarded as the preferred strategy for boys born with aphallia.&quot;</span>

Reasoning: A general interpretation of the results is provided in the context of other evidence, and implications for future research are discussed.

Answer: [Yes]

P27: "[NA]"

Reasoning: This item is not applicable, as the review does not describe sources of funding for the systematic review and other support.

Answer: [NA]</pre>
<p><a name='129'></a></p>
</div>
<div
id="oomen-2012-open-versus-laparoscopic-pyloromyotomy-for-hypertrophic-pyloric-stenosis-a-systematic-review-and-meta-analysis-focusing-on-major-complications"
class="section level4">
<h4>129.
<a href='https://doi.org/10.1007/S00464-012-2174-Y' title='Open publication'>Oomen
2012: <i>Open Versus Laparoscopic Pyloromyotomy for Hypertrophic Pyloric
Stenosis: A Systematic Review and Meta-Analysis Focusing on Major
Complications</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">33 quote(s) from
publication full text</span> (mean similarity 98.5%)</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic search for randomized clinical trials (RCTs) comparing OP and LP was conducted.&quot;</span>
- Reasoning: The authors mention conducting a systematic search, but do not explicitly state an 'a priori' design or protocol.
- Response: [No]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies were reviewed independently for quality, inclusion and exclusion criteria, and outcomes.&quot;</span>
- Reasoning: The authors mention independent review but do not explicitly state that data extraction was performed independently or that a consensus process was in place.
- Response: [No]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Retrieval of studies was performed through a systematic search of the databases PubMed, Ovid (Ovid Technologies, New York, NY) and Cochrane (Cochrane database of systematic reviews).&quot;</span>
- Reasoning: The authors mention searching multiple databases, but do not provide specific search strategies or keywords.
- Response: [No]

A4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There were no language restrictions. No unpublished data were encountered.&quot;</span>
- Reasoning: The authors mention no language restrictions but do not explicitly state that they searched for grey literature or unpublished studies.
- Response: [No]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Fifteen full papers were retrieved for more information of which 11 studies were excluded from the systematic review.&quot;</span>
- Reasoning: The authors mention excluding studies but do not provide a list of excluded studies.
- Response: [No]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;From the included studies, data on setting, methodological quality [according to the Cochrane handbook for systematic reviews of interventions (http://dcc.cochrane.org/sites/dcc.cochrane.org/files/uploads/RCT)], population, and type of surgery were extracted by two authors independently, as well as data on primary and secondary outcome measures.&quot;</span>
- Reasoning: The authors mention extracting data on study characteristics and outcomes.
- Response: [Yes]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reporting checklist proposed by the Consolidated Standards of Reporting Trials (CONSORT) group [14, 15] was used as a guideline when performing this review.&quot;</span>
- Reasoning: The authors mention using the CONSORT checklist, but do not explicitly state that they assessed the methodological quality of included studies.
- Response: [No]

A8:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Review Manager (RevMan) software ver. 5.0 (The Nordic Cochrane Center, The Cochrane Collaboration, Copenhagen, 2008) was used for data entry and statistical analysis.&quot;</span>
- Reasoning: The authors mention using RevMan software for data analysis, but do not explicitly state that they considered the methodological rigor and scientific quality of included studies in their analysis and conclusions.
- Response: [No]

A9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A meta-analysis was planned if the included studies were clinically homogeneous.&quot;</span>
- Reasoning: The authors mention planning a meta-analysis, but do not explicitly state that they assessed the homogeneity of included studies or used appropriate methods for combining results.
- Response: [No]

A10:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):

If I 2 was over 60%, we would refrain from meta-analysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;If I was over 60%, we would refrain from meta-analysis.&quot;</span>
- Reasoning: The authors mention considering heterogeneity in their decision to perform a meta-analysis, but do not explicitly state that they assessed the likelihood of publication bias.
- Response: [No]

A11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There were no language restrictions. No unpublished data were encountered.&quot;</span>
- Reasoning: The authors mention no language restrictions and no unpublished data, but do not explicitly state that they considered potential sources of support or conflicts of interest in included studies.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Open Versus Laparoscopic Pyloromyotomy for Hypertrophic Pyloric Stenosis: A Systematic Review and Meta-Analysis&quot;</span>
- Reasoning: The title indicates that the study is a systematic review and meta-analysis.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of this study was to compare the results of both surgical strategies by means of a systematic review and meta-analysis of the available literature.&quot;</span>
- Reasoning: The abstract provides a structured summary of the study's objectives and methods.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There is an ongoing debate about whether laparoscopic pyloromyotomy (LP) or open pyloromyotomy (OP) is the best option for treating hypertrophic pyloric stenosis (HPS).&quot;</span>
- Reasoning: The introduction provides a rationale for the review in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The primary outcome was major postoperative complications (i.e., incomplete pyloromyotomy, perforation, and need for reoperation). Secondary outcomes were time to full feed, postoperative hospital stay, and any other postoperative complications.&quot;</span>
- Reasoning: The introduction provides an explicit statement of the study's questions and outcomes.
- Response: [Yes]

P5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic search for RCTs that compared open and LP was conducted.&quot;</span>
- Reasoning: The methods section mentions a systematic search, but does not explicitly state whether a review protocol exists or where it can be accessed.
- Response: [No]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies were included in the review if they were RCTs that compared the results of LP and OP in children with HPS with admission time after pyloromyotomy and postoperative complication rate as outcomes.&quot;</span>
- Reasoning: The methods section provides a description of study characteristics and report characteristics used as criteria for eligibility.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Retrieval of studies was performed through a systematic search of the databases PubMed, Ovid (Ovid Technologies, New York, NY) and Cochrane (Cochrane database of systematic reviews).&quot;</span>
- Reasoning: The methods section describes the information sources used in the search.
- Response: [Yes]

P8:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Keywords and medical subject heading (MeSH) terms used were 'pyloric stenosis,' 'pyloromyotomy,' 'comparative studies,' 'open,' 'laparoscopic,' and 'postoperative complications.'&quot;</span>
- Reasoning: The methods section provides a description of the search strategy, but does not present the full electronic search strategy for at least one database.
- Response: [No]

P9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies were reviewed independently for quality, inclusion and exclusion criteria, and outcomes.&quot;</span>
- Reasoning: The methods section describes the process for selecting studies.
- Response: [Yes]

P10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;From the included studies, data on setting, methodological quality [according to the Cochrane handbook for systematic reviews of interventions (http://dcc.cochrane.org/sites/dcc.cochrane.org/files/uploads/RCT)], population, and type of surgery were extracted by two authors independently, as well as data on primary and secondary outcome measures.&quot;</span>
- Reasoning: The methods section describes the method of data extraction from reports.
- Response: [Yes]

P11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reporting checklist proposed by the Consolidated Standards of Reporting Trials (CONSORT) group [14, 15] was used as a guideline when performing this review.&quot;</span>
- Reasoning: The methods section lists and defines all variables for which data were sought.
- Response: [Yes]

P12:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reporting checklist proposed by the Consolidated Standards of Reporting Trials (CONSORT) group [14, 15] was used as a guideline when performing this review.&quot;</span>
- Reasoning: The methods section describes methods used for assessing risk of bias of individual studies.
- Response: [Yes]

P13:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Continuous data are expressed as mean differences, with standard deviations (SD) or medians and interquartile ranges (IQR) where appropriate. Results for comparisons of dichotomous outcomes (e.g., major postoperative complications) are expressed as risk differences [or absolute risk reduction, ARR) with 95% confidence intervals (CI).&quot;</span>
- Reasoning: The methods section states the principal summary measures.
- Response: [Yes]

P14:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A meta-analysis was planned if the included studies were clinically homogeneous.&quot;</span>
- Reasoning: The methods section describes the methods of handling data and combining results of studies, but does not provide measures of consistency for each meta-analysis.
- Response: [No]

P15:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):

If I 2 was over 60%, we would refrain from meta-analysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;If I was over 60%, we would refrain from meta-analysis.&quot;</span>
- Reasoning: The methods section mentions considering heterogeneity in their decision to perform a meta-analysis, but does not explicitly state that they assessed the risk of bias across studies.
- Response: [No]

P16:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 60.5%):

tment; analysis was performed' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;No additional analyses were performed.&quot;</span>
- Reasoning: The methods section does not describe any additional analyses.
- Response: [NA]

P17:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Fifteen full papers were retrieved for more information of which 11 studies were excluded from the systematic review.&quot;</span>
- Reasoning: The results section provides numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage.
- Response: [Yes]

P18:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.7%):

Study details and the quality check of all RCTs are given in Tables 1, 2, respectively.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Study details and the quality check of all RCTs are given in Tables 1 and 2, respectively.&quot;</span>
- Reasoning: The results section presents characteristics for which data were extracted for each study.
- Response: [Yes]

P19:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reporting checklist proposed by the Consolidated Standards of Reporting Trials (CONSORT) group [14, 15] was used as a guideline when performing this review.&quot;</span>
- Reasoning: The results section presents data on risk of bias of each study.
- Response: [Yes]

P20:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Three RCTs reported on the results of the mean time after surgery to return to full feedings [6, 8, 13]. Two studies [8, 13] showed no difference in time to full feed between LP and OP and one study [6] did report a difference.&quot;</span>
- Reasoning: The results section presents, for each study, simple summary data for each intervention group and effect estimates and confidence intervals.
- Response: [Yes]

P21:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The data of Hall et al. [7] were medians and thus not suitable for the random-effects model.&quot;</span>
- Reasoning: The results section presents results of each meta-analysis done, including confidence intervals and measures of consistency.
- Response: [Yes]

P22:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 60.5%):

tment; analysis was performed' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;No additional analyses were performed.&quot;</span>
- Reasoning: The results section does not present results of any assessment of risk of bias across studies.
- Response: [NA]

P23:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 60.5%):

tment; analysis was performed' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;No additional analyses were performed.&quot;</span>
- Reasoning: The results section does not present results of any additional analyses.
- Response: [NA]

P24:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.1%):

systematic review of high-level evidence, LP was found to be superior to OP with respect to a shorter time to full feed but not regarding (major) postoperative complications or length of hospital stay.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;In our systematic review of high-level evidence, LP was found to be superior to OP with respect to a shorter time to full feed but not regarding (major) postoperative complications or length of hospital stay.&quot;</span>
- Reasoning: The discussion section summarizes the main findings, including the strength of evidence for each main outcome.
- Response: [Yes]

P25:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Despite this small benefit, LP can be acknowledged as the standard of care only if the major postoperative complication rate is substantially reduced.&quot;</span>
- Reasoning: The discussion section discusses limitations at the study and outcome level.
- Response: [Yes]

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;If the surgeon is able to perform both procedures, it is at the discretion of the surgeon or center to make a well-founded decision between the two options.&quot;</span>
- Reasoning: The discussion section provides a general interpretation of the results in the context of other evidence and implications for future research.
- Response: [Yes]

P27:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There were no language restrictions. No unpublished data were encountered.&quot;</span>
- Reasoning: The discussion section does not provide a description of sources of funding for the systematic review and other support.
- Response: [No]</pre>
<p><a name='130'></a></p>
</div>
<div
id="parolini-2016-the-management-of-newborns-with-esophageal-atresia-and-right-aortic-arch-a-systematic-review-or-still-unsolved-problem"
class="section level4">
<h4>130.
<a href='https://doi.org/10.1016/J.JPEDSURG.2015.10.043' title='Open publication'>Parolini
2016: <i>The management of newborns with esophageal atresia and right
aortic arch: A systematic review or still unsolved problem</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">24 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">1
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1. Was an 'a priori' design provided?
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We adhered to PRISMA guidelines for this systematic review [6].&quot;</span>
- Reasoning: The authors stated that they adhered to PRISMA guidelines, suggesting an a priori design.
- Response: [Yes]

A2. Was there duplicate study selection and data extraction?
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two independent authors extracted information related to each eligible study.&quot;</span>
- Reasoning: Two authors independently extracted data, indicating duplicate study selection and data extraction.
- Response: [Yes]

A3. Was a comprehensive literature search performed?
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The PubMed database was searched for studies of children with EA and RAA published from January 1990 to December 2014.&quot;</span>
- Reasoning: The authors searched a single database and did not mention any additional search strategies.
- Response: [No]

A4. Was the status of publication (i.e. grey literature) used as an inclusion criterion?
- Quote: N/A
- Reasoning: The authors did not mention the inclusion or exclusion of grey literature.
- Response: [NA]

A5. Was a list of studies (included and excluded) provided?
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The full text of the selected articles was examined.&quot;</span>
- Reasoning: The authors mentioned examining the full text of selected articles but did not provide a list of included or excluded studies.
- Response: [No]

A6. Were the characteristics of the included studies provided?
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For each study, data were extracted for the following outcomes: overall number of patients, associated cardiovascular anomalies, type of surgical repair, morbidity and mortality rate.&quot;</span>
- Reasoning: The authors provided some characteristics of the included studies.
- Response: [Yes]

A7. Was the scientific quality of the included studies assessed and documented?
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The methodological quality of the studies was assessed with the level of evidence and the strength of guideline recommendations in diagnostic scales [7,8].&quot;</span>
- Reasoning: The authors used a method to assess the methodological quality of the included studies.
- Response: [Yes]

A8. Was the scientific quality of the included studies used appropriately in formulating conclusions?
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No statistically significant differences were found between the primary LT and LT following RT approaches in terms of leaks (P = 0.89), anastomotic strictures (P = 1), or mortality (P = 1).&quot;</span>
- Reasoning: The authors considered the scientific quality of the included studies in formulating conclusions.
- Response: [Yes]

A9. Were the methods used to combine the findings of studies appropriate?
- Quote: N/A
- Reasoning: The study did not involve a meta-analysis or other quantitative synthesis.
- Response: [NA]

A10. Was the likelihood of publication bias assessed?
- Quote: N/A
- Reasoning: The authors did not assess publication bias.
- Response: [NA]

A11. Was the conflict of interest included?
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The authors have no conflict of interest to disclose.&quot;</span>
- Reasoning: The authors declared no conflicts of interest.
- Response: [Yes]

PRISMA Items:

P1. Title: Identify the report as a systematic review, meta-analysis, or both
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The management of newborns with esophageal atresia and right aortic arch: A systematic review or still unsolved problem&quot;</span>
- Reasoning: The title identifies the report as a systematic review.
- Response: [Yes]

P2. Abstract / Structured summary
- Quote: The abstract/structured summary is provided in the full text.
- Reasoning: The abstract provides a structured summary of the review.
- Response: [Yes]

P3. Introduction / Rationale
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This study provides a systematic review of epidemiology, diagnostic assessment and management of children with EA and RAA, comparing the morbidity and mortality rates of different surgical strategies.&quot;</span>
- Reasoning: The authors provided the rationale for the review in the context of what is already known.
- Response: [Yes]

P4. Introduction / Objectives
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

Aim of the study: The management of newborns with esophageal atresia (EA) and right aortic arch (RAA) is still an unsolved problem. This study provides a systematic review of epidemiology, diagnosis, management and shortterm results of children with EA and RAA.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Aim of the study: The management of newborns with esophageal atresia (EA) and right aortic arch (RAA) is still an unsolved problem. This study provides a systematic review of epidemiology, diagnosis, management and short-term results of children with EA and RAA.&quot;</span>
- Reasoning: The authors stated the explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
- Response: [Yes]

P5. Methods / Protocol and registration
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We adhered to PRISMA guidelines for this systematic review [6].&quot;</span>
- Reasoning: The authors did not provide information regarding a review protocol or registration.
- Response: [No]

P6. Methods / Eligibility criteria
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99%):

All were single-institution, retrospective studies, case reports or case series (class of evidence III and evidence rating scale E) [6]. No randomizedcontrolled trials or prospective studies were found' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;All were single-institution, retrospective studies, case reports or case series (class of evidence III and evidence rating scale E) [6]. No randomized-controlled trials or prospective studies were found.&quot;</span>
- Reasoning: The authors provided the eligibility criteria and rationale for the studies included in the review.
- Response: [Yes]

P7. Methods / Information sources
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The PubMed database was searched for studies of children with EA and RAA published from January 1990 to December 2014.&quot;</span>
- Reasoning: The authors described the information sources and date last searched.
- Response: [Yes]

P8. Methods / Search
- Quote: N/A
- Reasoning: The authors did not present the full electronic search strategy for at least one database.
- Response: [No]

P9. Methods / Study selection
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The full text of the selected articles was examined.&quot;</span>
- Reasoning: The authors described the process for selecting studies, but did not provide a clear flow diagram or detailed information on study selection.
- Response: [No]

P10. Methods / Data collection process
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two independent authors extracted information related to each eligible study.&quot;</span>
- Reasoning: The authors described the method of data extraction, but did not provide specific details on the data collection process.
- Response: [No]

P11. Methods / Data items
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For each study, data were extracted for the following outcomes: overall number of patients, associated cardiovascular anomalies, type of surgical repair, morbidity and mortality rate.&quot;</span>
- Reasoning: The authors listed and defined all variables for which data were sought.
- Response: [Yes]

P12. Methods / Risk of bias in individual studies
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The methodological quality of the studies was assessed with the level of evidence and the strength of guideline recommendations in diagnostic scales [7,8].&quot;</span>
- Reasoning: The authors described the methods used for assessing risk of bias of individual studies.
- Response: [Yes]

P13. Methods / Summary measures
- Quote: N/A
- Reasoning: The authors did not state the principal summary measures.
- Response: [NA]

P14. Methods / Synthesis of results
- Quote: N/A
- Reasoning: The authors did not describe the methods of handling data and combining results of studies.
- Response: [NA]

P15. Methods / Risk of bias across studies
- Quote: N/A
- Reasoning: The authors did not specify any assessment of risk of bias that may affect the cumulative evidence.
- Response: [NA]

P16. Methods / Additional analyses
- Quote: N/A
- Reasoning: The authors did not describe methods of additional analyses, if done.
- Response: [NA]

P17. Results / Study selection
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Eight eligible articles met the inclusion criteria in the end.&quot;</span>
- Reasoning: The authors provided the number of studies screened, assessed for eligibility, and included in the review.
- Response: [Yes]

P18. Results / Study characteristics
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All were single-institution, retrospective studies, case reports or case series (class of evidence III and evidence rating scale E) [6].&quot;</span>
- Reasoning: The authors provided the characteristics of each included study.
- Response: [Yes]

P19. Results / Risk of bias within studies
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The methodological quality of the studies was assessed with the level of evidence and the strength of guideline recommendations in diagnostic scales [7,8].&quot;</span>
- Reasoning: The authors presented data on risk of bias of each study.
- Response: [Yes]

P20. Results / Results of individual studies
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
- Reasoning: The authors did not provide simple summary data for each intervention group, effect estimates, and confidence intervals for each outcome.
- Response: [No]

P21. Results / Synthesis of results
- Quote: N/A
- Reasoning: The authors did not provide the results of each meta-analysis done, including confidence intervals and measures of consistency.
- Response: [NA]

P22. Results / Risk of bias across studies
- Quote: N/A
- Reasoning: The authors did not present results of any assessment of risk of bias across studies.
- Response: [NA]

P23. Results / Additional analysis
- Quote: N/A
- Reasoning: The authors did not provide the results of additional analyses, if done.
- Response: [NA]

P24. Discussion / Summary of evidence
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Skills and preferences of the surgeon still guide the choice of surgical approach even when preoperatively faced with RAA. A multicenter, prospective randomized study is strongly required.&quot;</span>
- Reasoning: The authors summarized the main findings and considered their relevance to key groups.
- Response: [Yes]

P25. Discussion / Limitations
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

This systematic review had some inherent limitations. Firstly, it includes a relatively small number of patients, and many endpoints of the study could not be compared in a statistically significant way' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This systematic review had some inherent limitations. Firstly, it includes a relatively small number of patients, and many endpoints of the study could not be compared in a statistically significant way.&quot;</span>
- Reasoning: The authors discussed limitations at the study and outcome level.
- Response: [Yes]

P26. Discussion / Conclusions
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A multicenter prospective study comparing RT and LT in infants with EA and RAA is strongly required.&quot;</span>
- Reasoning: The authors provided a general interpretation of the results in the context of other evidence and implications for future research.
- Response: [Yes]

P27. Funding
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Funding Source: No funding was necessary for this study.&quot;</span>
- Reasoning: The authors described sources of funding for the systematic review.
- Response: [Yes]</pre>
<p><a name='131'></a></p>
</div>
<div
id="parolini-2014-cervicalthoracotomicthoracoscopic-approaches-for-h-type-congenital-tracheo-esophageal-fistula-a-systematic-review"
class="section level4">
<h4>131.
<a href='https://doi.org/10.1016/J.IJPORL.2014.04.011' title='Open publication'>Parolini
2014: <i>Cervical/thoracotomic/thoracoscopic approaches for H-type
congenital tracheo-esophageal fistula: A systematic review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">22 quote(s) from
publication full text</span> (mean similarity 97.4%)</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For this systematic review we adhered to PRISMA guidelines [4,5].&quot;</span>
- Reasoning: The authors mention following PRISMA guidelines, which suggests an a priori design.
- Response: [Yes]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two independent authors extracted information related to the study.&quot;</span>
- Reasoning: The authors mention two independent authors extracting information, indicating duplicate study selection and data extraction.
- Response: [Yes]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The PubMed database was searched for studies on treatment of H-type TEF that were published since January 1977.&quot;</span>
- Reasoning: The authors mention searching the PubMed database, but do not provide details on the search strategy or supplementary strategies.
- Response: [No]

A4:
- Quote: N/A
- Reasoning: The authors do not mention searching for grey literature or unpublished studies.
- Response: [No]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The initial PubMed search yielded 185 potentially relevant articles. Finally, 22 eligible articles met the inclusion criteria and were divided into open or thoracoscopic surgery categories.&quot;</span>
- Reasoning: The authors mention the number of articles included and excluded, but do not provide a list of included and excluded studies.
- Response: [No]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For open surgery group 17 studies were selected [2,823], encompassing a total of 90 children. The three primary outcomes were assessed in all the studies, while the level of the TEF, the mortality rate and the complication rate were noted in 9, 17 and 16 series, respectively.&quot;</span>
- Reasoning: The authors provide some characteristics of the included studies, but not in a comprehensive or aggregated form.
- Response: [No]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Methodological quality of the studies was assessed with the level of evidence and the strength of guideline recommendations in diagnosis scales [6,7].&quot;</span>
- Reasoning: The authors mention assessing the methodological quality of the studies, but do not provide details on the methods used or the results of the assessment.
- Response: [No]

A8:
- Quote: N/A
- Reasoning: The authors do not mention using the scientific quality of the included studies in formulating conclusions.
- Response: [No]

A9:
- Quote: N/A
- Reasoning: The authors do not mention combining the findings of studies, as this is not a meta-analysis.
- Response: [NA]

A10:
- Quote: N/A
- Reasoning: The authors do not mention assessing the likelihood of publication bias, as this is not a meta-analysis.
- Response: [NA]

A11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The authors have no financial relationships relevant to this article to disclose.&quot;</span>
- Reasoning: The authors mention not having any financial relationships to disclose, but do not mention potential sources of support for the included studies.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Aim of this systematic review is to investigate the thoracic and cervical surgical approaches of H-type tracheo-esophageal fistula (TEF) according to the position of the fistula.&quot;</span>
- Reasoning: The authors provide a clear statement of the review's purpose.
- Response: [Yes]

P2:
- Quote: N/A
- Reasoning: The authors do not provide a structured summary.
- Response: [No]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Tracheo-esophageal fistula (TEF) without esophageal atresia (H-type TEF) is a rare congenital malformation that accounts for about 4% of tracheo-esophageal malformations and has an incidence of around 1:50,00080,000 births [1].&quot;</span>
- Reasoning: The authors provide background information on the topic.
- Response: [Yes]

P4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Aim of this systematic review is to investigate the thoracic and cervical surgical approaches of H-type tracheo-esophageal fistula (TEF) according to the position of the fistula.&quot;</span>
- Reasoning: The authors provide an explicit statement of the review's objectives.
- Response: [Yes]

P5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For this systematic review we adhered to PRISMA guidelines [4,5].&quot;</span>
- Reasoning: The authors mention following PRISMA guidelines, but do not provide information on a review protocol or registration.
- Response: [No]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Eligible study designs were cohort, case report, case series and review.&quot;</span>
- Reasoning: The authors provide some information on study characteristics and report characteristics used as criteria for eligibility.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The PubMed database was searched for studies on treatment of H-type TEF that were published since January 1977.&quot;</span>
- Reasoning: The authors mention searching the PubMed database, but do not provide details on the search strategy or date last searched.
- Response: [No]

P8:
- Quote: N/A
- Reasoning: The authors do not present the full electronic search strategy for at least one database.
- Response: [No]

P9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Titles and abstracts of identified publications were checked and reviewed against the predefined inclusion criteria, and afterward, the full text the articles were similarly assessed for eligibility.&quot;</span>
- Reasoning: The authors describe the process for selecting studies.
- Response: [Yes]

P10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two independent authors extracted information related to the study.&quot;</span>
- Reasoning: The authors mention two independent authors extracting information, but do not provide details on the method of data extraction.
- Response: [No]

P11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For each study, data were extracted for three primary outcomes and many secondary outcomes.&quot;</span>
- Reasoning: The authors list and define some variables for which data were sought.
- Response: [Yes]

P12:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Methodological quality of the studies was assessed with the level of evidence and the strength of guideline recommendations in diagnosis scales [6,7].&quot;</span>
- Reasoning: The authors mention assessing the methodological quality of the studies, but do not provide details on the methods used or the results of the assessment.
- Response: [No]

P13:
- Quote: N/A
- Reasoning: The authors do not mention stating the principal summary measures.
- Response: [No]

P14:
- Quote: N/A
- Reasoning: The authors do not mention describing the methods of handling data and combining results of studies, as this is not a meta-analysis.
- Response: [NA]

P15:
- Quote: N/A
- Reasoning: The authors do not mention specifying any assessment of risk of bias that may affect the cumulative evidence, as this is not a meta-analysis.
- Response: [NA]

P16:
- Quote: N/A
- Reasoning: The authors do not mention describing methods of additional analyses, as this is not a meta-analysis.
- Response: [NA]

P17:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The initial PubMed search yielded 185 potentially relevant articles. Finally, 22 eligible articles met the inclusion criteria and were divided into open or thoracoscopic surgery categories.&quot;</span>
- Reasoning: The authors provide numbers of studies screened, assessed for eligibility, and included in the review.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For open surgery group 17 studies were selected [2,823], encompassing a total of 90 children.&quot;</span>
- Reasoning: The authors provide some characteristics for each study, but not in a comprehensive or aggregated form.
- Response: [No]

P19:
- Quote: N/A
- Reasoning: The authors do not mention presenting data on risk of bias of each study.
- Response: [No]

P20:
- Quote: N/A
- Reasoning: The authors do not mention presenting effect estimates and confidence intervals for all outcomes considered.
- Response: [No]

P21:
- Quote: N/A
- Reasoning: The authors do not mention presenting results of each meta-analysis done, as this is not a meta-analysis.
- Response: [NA]

P22:
- Quote: N/A
- Reasoning: The authors do not mention presenting results of any assessment of risk of bias across studies, as this is not a meta-analysis.
- Response: [NA]

P23:
- Quote: N/A
- Reasoning: The authors do not mention giving results of additional analyses, as this is not a meta-analysis.
- Response: [NA]

P24:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The evidence base in regard to the treatment of H-type fistula in children is poor and the skills and preferences of the surgeons guide the choice of the procedure.&quot;</span>
- Reasoning: The authors provide a summary of the main findings and their implications.
- Response: [Yes]

P25:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 42.4%):

randomized-controlled trials or prospective studies comparing the different surgical approaches' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The limitations of this systematic review are mainly related to the small number of patients included in the studies and the lack of randomized controlled trials or prospective studies comparing the different surgical approaches.&quot;</span>
- Reasoning: The authors discuss limitations at the study and outcome level.
- Response: [Yes]

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Further well-designed prospective studies which take into account of selection and performance bias are strongly required.&quot;</span>
- Reasoning: The authors provide a general interpretation of the results and implications for future research.
- Response: [Yes]

P27:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The authors have no financial relationships relevant to this article to disclose.&quot;</span>
- Reasoning: The authors mention not having any financial relationships to disclose, but do not provide details on sources of funding for the systematic review or other support.
- Response: [No]</pre>
<p><a name='132'></a></p>
</div>
<div
id="peters-2013-morbidity-and-mortality-in-total-esophagogastric-dissociation-a-systematic-review"
class="section level4">
<h4>132.
<a href='https://doi.org/10.1016/J.JPEDSURG.2012.11.049' title='Open publication'>Peters
2013: <i>Morbidity and mortality in total esophagogastric dissociation:
A systematic review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">18 quote(s) from
publication full text</span> (mean similarity 99.4%)</i></p>
<pre>
AMSTAR:

A1:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The main objective of this study was to determine morbidity and mortality for this procedure.&quot;</span>
Reasoning: The research question is established, but there is no clear mention of a priori design, protocol, or pre-determined objectives.
Response: "[No]"

A2:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Raw data were available from Manchester for neurologically impaired children and this was used rather than published series although 26 of these cases had previously been published [8].&quot;</span>
Reasoning: There is no mention of independent data extractors or a consensus process for disagreements.
Response: "[No]"

A3:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Medline, PubMed, National Library of Health and Google Scholarly articles from year 1997 to August 2011 were searched. Search terms used were [total] ([o]esophago-gastric/gastro-[o]esophageal) (dissociation/disconnection/separation).&quot;</span>
Reasoning: The authors mention using multiple databases and keywords, but there is no mention of a comprehensive search strategy, such as the use of supplementary strategies or grey literature.
Response: "[No]"

A4:
Quote: N/A
Reasoning: There is no mention of the inclusion or exclusion of studies based on publication status, language, or other relevant criteria.
Response: "[NA]"

A5:
Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):

One hundred eighty-one patients who had undergone TOGD were identified from 10 articles, personal communication with authors of these articles and data held at our institution (Table 1, Fig. 1) [26,913].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;One hundred eighty-one cases were identified from 10 articles, personal communication with authors of these articles and data held at our institution (Table 1, Fig. 1) [26,913].&quot;</span>
Reasoning: Although the authors provide a list of included studies, they do not explicitly state that they excluded any reports based on specific criteria.
Response: "[No]"

A6:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The majority of identified cases of TOGD were for children with neurological impairment (n = 157, 86.7%). Twenty-four (13.3%) were performed in neurologically normal children.&quot;</span>
Reasoning: The authors provide aggregated data on participant characteristics, but the information is relatively limited.
Response: "[Yes]"

A7:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Only the most recent publication from a center was analyzed where this previous case series was updated.&quot;</span>
Reasoning: The authors do not provide a description of the scientific quality assessment or documentation of the included studies.
Response: "[No]"

A8:
Quote: N/A
Reasoning: Since the authors did not adequately assess the scientific quality of the included studies, they could not use this information appropriately in formulating conclusions.
Response: "[NA]"

A9:
Quote: N/A
Reasoning: This question is not applicable, as the authors did not perform a meta-analysis.
Response: "[NA]"

A10:
Quote: N/A
Reasoning: This question is not applicable, as the authors did not perform a meta-analysis.
Response: "[NA]"

A11:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Conflicts of interest: None.&quot;</span>
Reasoning: The authors declare no conflicts of interest, but they do not provide information about the funding sources for the included studies.
Response: "[No]"

PRISMA:

P1:
Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 94%):

Total esophagogastric dissociation has been described as both a primary and a rescue procedure for patients with severe gastroesophageal reflu' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Total esophagogastric dissociation (TOGD) has been described as both a primary and a rescue procedure for patients with severe gastroesophageal reflux.&quot;</span>
Reasoning: The title does not explicitly identify the report as a systematic review or meta-analysis.
Response: "[No]"

P2:
Quote: N/A
Reasoning: The abstract does not provide a structured summary, including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal, synthesis methods, results, limitations, conclusions, and systematic review registration number.
Response: "[No]"

P3:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The main objective of this study was to determine morbidity and mortality for this procedure.&quot;</span>
Reasoning: The introduction provides a rationale for the review, but it does not explicitly describe the context of what is already known.
Response: "[No]"

P4:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Methods: All published cases of esophagogastric dissociation in children were identified. Series were updated where possible by personal communication with the author. Patient characteristics, indications, morbidity, and mortality were analyzed.&quot;</span>
Reasoning: The objectives are not explicitly stated in the context of participants, interventions, comparisons, outcomes, and study design (PICOS).
Response: "[No]"

P5:
Quote: N/A
Reasoning: The authors do not indicate if a review protocol exists or provide information about its accessibility and registration.
Response: "[No]"

P6:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Medline, PubMed, National Library of Health and Google Scholarly articles from year 1997 to August 2011 were searched. Search terms used were [total] ([o]esophago-gastric/gastro-[o]esophageal) (dissociation/disconnection/separation).&quot;</span>
Reasoning: The authors mention using multiple databases and keywords, but they do not specify the study characteristics or report characteristics used as eligibility criteria.
Response: "[No]"

P7:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Medline, PubMed, National Library of Health and Google Scholarly articles from year 1997 to August 2011 were searched.&quot;</span>
Reasoning: The authors mention the databases used but do not provide the date last searched.
Response: "[No]"

P8:
Quote: N/A
Reasoning: The authors do not present a full electronic search strategy for at least one database.
Response: "[No]"

P9:
Quote: N/A
Reasoning: The authors do not state the process for selecting studies, including screening, eligibility, inclusion in the systematic review, and inclusion in the meta-analysis (if applicable).
Response: "[No]"

P10:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Raw data were available from Manchester for neurologically impaired children and this was used rather than published series although 26 of these cases had previously been published [8].&quot;</span>
Reasoning: The authors mention using raw data from one institution, but they do not describe the method of data extraction from reports or any processes for obtaining and confirming data from investigators.
Response: "[No]"

P11:
Quote: N/A
Reasoning: The authors do not list and define all variables for which data were sought or provide any assumptions and simplifications made.
Response: "[No]"

P12:
Quote: N/A
Reasoning: The authors do not describe methods used for assessing the risk of bias of individual studies.
Response: "[No]"

P13:
Quote: N/A
Reasoning: The authors do not state the principal summary measures (e.g., risk ratio, difference in means).
Response: "[No]"

P14:
Quote: N/A
Reasoning: The authors do not describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.
Response: "[NA]"

P15:
Quote: N/A
Reasoning: The authors do not specify any assessment of the risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
Response: "[NA]"

P16:
Quote: N/A
Reasoning: The authors do not describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
Response: "[NA]"

P17:
Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):

One hundred eighty-one patients who had undergone TOGD were identified from 10 articles, personal communication with authors of these articles and data held at our institution (Table 1, Fig. 1) [26,913].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;One hundred eighty-one cases were identified from 10 articles, personal communication with authors of these articles and data held at our institution (Table 1, Fig. 1) [26,913].&quot;</span>
Reasoning: The authors provide the number of studies screened, assessed for eligibility, and included in the review, but they do not provide reasons for exclusions at each stage or a flow diagram.
Response: "[No]"

P18:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The majority of identified cases of TOGD were for children with neurological impairment (n = 157, 86.7%). Twenty-four (13.3%) were performed in neurologically normal children.&quot;</span>
Reasoning: The authors provide some study characteristics for each study, but they do not present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) or provide citations.
Response: "[No]"

P19:
Quote: N/A
Reasoning: The authors do not present data on the risk of bias of each study or any outcome level assessment.
Response: "[No]"

P20:
Quote: N/A
Reasoning: The authors do not present, for each study, simple summary data for each intervention group, effect estimates, and confidence intervals, ideally with a forest plot.
Response: "[No]"

P21:
Quote: N/A
Reasoning: The authors do not present the results of each meta-analysis done, including confidence intervals and measures of consistency.
Response: "[NA]"

P22:
Quote: N/A
Reasoning: The authors do not present the results of any assessment of the risk of bias across studies.
Response: "[NA]"

P23:
Quote: N/A
Reasoning: The authors do not give the results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression).
Response: "[NA]"

P24:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Esophagogastric dissociation has an acceptable morbidity and mortality. It is useful as both a primary and a rescue procedure.&quot;</span>
Reasoning: The authors summarize the main findings, including the strength of evidence for each main outcome, but they do not consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).
Response: "[No]"

P25:
Quote: N/A
Reasoning: The authors do not discuss limitations at the study and outcome level (e.g., risk of bias) or at the review level (e.g., incomplete retrieval of identified research, reporting bias).
Response: "[No]"

P26:
Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.6%):

The aim of this study was to analyze data from all published cases of TOGD in children with particular attention to patient characteristics, indications, complications and mortality. Where available, unpublished cases were added by personal communication with authors of published' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The aim of this study was to analyze data from all published cases of TOGD in children with particular attention to patient characteristics, indications, complications and mortality. Where available, unpublished cases were added by personal communication with authors of published series.&quot;</span>
Reasoning: The authors provide a general interpretation of the results in the context of other evidence and implications for future research.
Response: "[Yes]"

P27:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Conflicts of interest: None.&quot;</span>
Reasoning: The authors declare no conflicts of interest but do not describe sources of funding for the systematic review or other support (e.g., supply of data) or the role of funders for the systematic review.
Response: "[No]"</pre>
<p><a name='133'></a></p>
</div>
<div
id="peycelon-2014-minimally-invasive-surgery-in-childhood-cancer-a-challenging-future"
class="section level4">
<h4>133.
<a href='https://doi.org/10.1055/S-0034-1396419' title='Open publication'>Peycelon
2014: <i>Minimally Invasive Surgery in Childhood Cancer: A Challenging
Future</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
extra-score-brackets-without-prefix</i></p>
<pre>
AMSTAR Questions:

A1: "[No]" - The full text does not provide an 'a priori' design, as there is no mention of a protocol, ethics approval, or pre-determined published research objectives.

A2: "[No]" - The full text does not mention the use of at least two independent data extractors or a consensus procedure for disagreements.

A3: "[No]" - The full text does not provide a comprehensive literature search, as it only mentions references from PubMed searches using search terms and the authors' own files. There is no mention of searching multiple electronic sources, databases, or supplementary strategies.

A4: "[No]" - The full text does not mention the use of a search for grey literature or unpublished literature.

A5: "[No]" - The full text does not provide a list of included and excluded studies, as it only references the papers published in English between 2009 and 2014.

A6: "[No]" - The full text does not provide the characteristics of the included studies in an aggregated form such as a table, data from the original studies, or ranges of characteristics.

A7: "[No]" - The full text does not mention the use of 'a priori' methods of assessment or a quality scoring tool or checklist for the included studies.

A8: "[NA]" - As the previous item (A7) was scored "[No]", this item is not applicable.

A9: "[NA]" - As the full text does not report a meta-analysis or quantitative synthesis, this item is not applicable.

A10: "[NA]" - As the previous item (A9) was not applicable, this item is also not applicable.

A11: "[No]" - The full text does not mention the sources of support for the systematic review or the included studies.

PRISMA Items:

P1: "[No]" - The title does not explicitly identify the report as a systematic review or meta-analysis.

P2: "[No]" - The abstract does not provide a structured summary including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and systematic review registration number.

P3: "[No]" - The introduction does not describe the rationale for the review in the context of what is already known.

P4: "[No]" - The introduction does not provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).

P5: "[No]" - The methods do not indicate if a review protocol exists or where it can be accessed.

P6: "[No]" - The methods do not specify study characteristics and report characteristics used as criteria for eligibility, giving rationale.

P7: "[No]" - The methods do not describe all information sources (e.g., databases with dates of coverage, contact with study authors) in the search.

P8: "[No]" - The methods do not present the full electronic search strategy for at least one database, including any limits used.

P9: "[No]" - The methods do not state the process for selecting studies (i.e., screening, eligibility, included in the systematic review, and included in the meta-analysis).

P10: "[No]" - The methods do not describe the method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.

P11: "[No]" - The methods do not list and define all variables for which data were sought and any assumptions and simplifications made.

P12: "[No]" - The methods do not describe the methods used for assessing the risk of bias of individual studies.

P13: "[NA]" - As there is no meta-analysis reported, this item is not applicable.

P14: "[NA]" - As there is no meta-analysis reported, this item is not applicable.

P15: "[NA]" - As there is no meta-analysis reported, this item is not applicable.

P16: "[NA]" - As there is no meta-analysis reported, this item is not applicable.

P17: "[No]" - The results do not give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage.

P18: "[No]" - The results do not present the characteristics of each study, including study size, PICOS, and follow-up period.

P19: "[No]" - The results do not present data on the risk of bias of each study.

P20: "[NA]" - As there is no meta-analysis reported, this item is not applicable.

P21: "[NA]" - As there is no meta-analysis reported, this item is not applicable.

P22: "[NA]" - As there is no meta-analysis reported, this item is not applicable.

P23: "[NA]" - As there is no meta-analysis reported, this item is not applicable.

P24: "[No]" - The discussion does not summarize the main findings, including the strength of evidence for each main outcome, and consider their relevance to key groups.

P25: "[No]" - The discussion does not discuss the limitations at the study and outcome level.

P26: "[No]" - The discussion does not provide a general interpretation of the results in the context of other evidence and implications for future research.

P27: "[No]" - The full text does not describe sources of funding for the systematic review and other support, or the role of funders for the systematic review.</pre>
<p><a name='134'></a></p>
</div>
<div
id="pfistermuller-2015-meta-analysis-of-complication-rates-of-the-tubularized-incised-plate-tip-repair"
class="section level4">
<h4>134.
<a href='https://doi.org/10.1016/J.JPUROL.2014.12.006' title='Open publication'>Pfistermuller
2015: <i>Meta-analysis of complication rates of the tubularized incised
plate (TIP) repair</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
extra-score-brackets-without-prefix</i></p>
<p><i><span style="border-bottom: 1px dashed black;">14 quote(s) from
publication full text</span> (mean similarity 99.8%)</i></p>
<pre>
AMSTAR Questions:

A1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic literature search was undertaken, using Medline and Pubmed, in order to identify relevant articles.&quot;</span>
- The authors provided an 'a priori' design for their systematic review by conducting a literature search using Medline and Pubmed.
- [Yes]

A2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following data were extracted independently from each article by two reviewers (K.P and P.C).&quot;</span>
- The authors did not explicitly state that there was a consensus process for disagreements, but they did mention independent data extraction by two reviewers.
- [No]

A3: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

Medline and Pubmed were searched in order to identify articles published between 1994 and 2012. The search terms tubularized incised plate urethroplasty/Snodgrass repair/ technique  outcomes/complications  follow-up/long term follow-up were used.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Medline and Pubmed were searched in order to identify articles published between 1994 and 2012. The search terms 'tubularized incised plate urethroplasty/Snodgrass repair/technique - outcomes - complications - follow-up/long term follow-up' were used.&quot;</span>
- The authors performed a comprehensive literature search using Medline and Pubmed, but they did not provide a full search strategy or state whether they searched for grey literature.
- [No]

A4: "[NA]"
- This item is not applicable since the authors did not search for grey literature.
- [NA]

A5: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Of the 189 studies identified, only 49 (4675 patients) [14,17e64] fulfilled the inclusion criteria, as detailed below.&quot;</span>
- The authors provided a list of included studies, but they did not explicitly state that excluded studies were referenced.
- [No]

A6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following data were extracted&quot;</span> [...] <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

: study size; degree of hypospadias (classified by meatal location: distal e midshaft distally, proximal e proximal shaft proximally); primary or secondary repair; repair type (standard vs modified TIP); modification (if used); mean length of follow-up; study duration; geographical location; and rates of meatal stenosis, fistula, urethral stricture and unplanned re-operation to treat complications.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;: study size; degree of hypospadias (classified by meatal location: distal - midshaft distally, proximal - proximal shaft proximally); primary or secondary repair; repair type (standard vs modified TIP); modification (if used); mean length of follow-up; study duration; geographical location; and rates of meatal stenosis, fistula, urethral stricture and unplanned re-operation to treat complications.&quot;</span>
- The authors provided the characteristics of included studies in an aggregated form, such as a table, as they listed the data extracted from each study.
- [Yes]

A7: "[NA]"
- This item is not applicable since the authors did not assess the scientific quality of the included studies.
- [NA]

A8: "[NA]"
- This item is not applicable since the authors did not assess the scientific quality of the included studies.
- [NA]

A9: "[NA]"
- This item is not applicable since the authors did not combine the findings of studies in a meta-analysis.
- [NA]

A10: "[NA]"
- This item is not applicable since the authors did not assess the likelihood of publication bias.
- [NA]

A11: "[NA]"
- This item is not applicable since the authors did not provide information on potential sources of support for the systematic review or included studies.
- [NA]

PRISMA Items:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Meta-analysis of complication rates of the tubularized incised plate (TIP) repair&quot;</span>
- The title indicates that the report is a meta-analysis.
- [Yes]

P2: "[NA]"
- This item is not applicable since the abstract does not provide a structured summary.
- [NA]

P3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Over 300 methods of surgical repair have been described for the correction of hypospadias, with no one procedure accepted as the gold standard for each degree of hypospadias. First described in 1994 by Snodgrass [1], the tubularized incised plate (TIP) urethroplasty has become the most popular technique for distal hypospadias [2,3].&quot;</span>
- The authors described the rationale for the review in the context of what is already known.
- [Yes]

P4: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

Assessing the appropriateness of its application to all degrees of hypospadias. 2. Evaluating the long-term results by analysing the pooled complication rates to accurately determine representative complication rates for this technique. 3. Reviewing the effects of technical modifications, length of follow-up and geographical location of these complications.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Assessing the appropriateness of its application to all degrees of hypospadias. Evaluating the long-term results by analyzing the pooled complication rates to accurately determine representative complication rates for this technique. Reviewing the effects of technical modifications, length of follow-up and geographical location of these complications.&quot;</span>
- The authors provided an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
- [Yes]

P5: "[NA]"
- This item is not applicable since the authors did not indicate if a review protocol exists.
- [NA]

P6: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

Medline and Pubmed were searched in order to identify articles published between 1994 and 2012. The search terms tubularized incised plate urethroplasty/Snodgrass repair/ technique  outcomes/complications  follow-up/long term follow-up were used.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Medline and Pubmed were searched in order to identify articles published between 1994 and 2012. The search terms 'tubularized incised plate urethroplasty/Snodgrass repair/technique - outcomes - complications - follow-up/long term follow-up' were used.&quot;</span>
- The authors specified study characteristics and report characteristics used as criteria for eligibility.
- [Yes]

P7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Medline and Pubmed were searched in order to identify articles published between 1994 and 2012.&quot;</span>
- The authors described all information sources used in the search.
- [Yes]

P8: "[NA]"
- This item is not applicable since the authors did not present a full electronic search strategy for at least one database.
- [NA]

P9: "[NA]"
- This item is not applicable since the authors did not state the process for selecting studies.
- [NA]

P10: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following data were extracted independently from each article by two reviewers (K.P and P.C).&quot;</span>
- The authors described the method of data extraction from reports.
- [Yes]

P11: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following data were extracted&quot;</span> [...] <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

: study size; degree of hypospadias (classified by meatal location: distal e midshaft distally, proximal e proximal shaft proximally); primary or secondary repair; repair type (standard vs modified TIP); modification (if used); mean length of follow-up; study duration; geographical location; and rates of meatal stenosis, fistula, urethral stricture and unplanned re-operation to treat complications.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;: study size; degree of hypospadias (classified by meatal location: distal - midshaft distally, proximal - proximal shaft proximally); primary or secondary repair; repair type (standard vs modified TIP); modification (if used); mean length of follow-up; study duration; geographical location; and rates of meatal stenosis, fistula, urethral stricture and unplanned re-operation to treat complications.&quot;</span>
- The authors listed and defined all variables for which data were sought.
- [Yes]

P12: "[NA]"
- This item is not applicable since the authors did not describe methods used for assessing risk of bias of individual studies.
- [NA]

P13: "[NA]"
- This item is not applicable since the authors did not state the principal summary measures.
- [NA]

P14: "[NA]"
- This item is not applicable since the authors did not describe the methods of handling data and combining results of studies.
- [NA]

P15: "[NA]"
- This item is not applicable since the authors did not specify any assessment of risk of bias that may affect the cumulative evidence.
- [NA]

P16: "[NA]"
- This item is not applicable since the authors did not describe methods of additional analyses.
- [NA]

P17: "[NA]"
- This item is not applicable since the authors did not give numbers of studies screened, assessed for eligibility, and included in the review.
- [NA]

P18: "[NA]"
- This item is not applicable since the authors did not present characteristics for each study.
- [NA]

P19: "[NA]"
- This item is not applicable since the authors did not present data on risk of bias of each study.
- [NA]

P20: "[NA]"
- This item is not applicable since the authors did not present results of individual studies.
- [NA]

P21: "[NA]"
- This item is not applicable since the authors did not present results of each meta-analysis done.
- [NA]

P22: "[NA]"
- This item is not applicable since the authors did not present results of any assessment of risk of bias across studies.
- [NA]

P23: "[NA]"
- This item is not applicable since the authors did not present results of additional analyses.
- [NA]

P24: "[NA]"
- This item is not applicable since the authors did not summarize the main findings including the strength of evidence for each main outcome.
- [NA]

P25: "[NA]"
- This item is not applicable since the authors did not discuss limitations at the study and outcome level.
- [NA]

P26: "[NA]"
- This item is not applicable since the authors did not provide a general interpretation of the results in the context of other evidence and implications for future research.
- [NA]

P27: "[NA]"
- This item is not applicable since the authors did not describe sources of funding for the systematic review and other support.
- [NA]</pre>
<p><a name='136'></a></p>
</div>
<div
id="reddy-2010-ureteroscopy-the-standard-of-care-in-the-management-of-upper-tract-urolithiasis-in-children"
class="section level4">
<h4>136.
<a href='https://doi.org/10.4103/0970-1591.74459' title='Open publication'>Reddy
2010: <i>Ureteroscopy: The standard of care in the management of upper
tract urolithiasis in children</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 98.9%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">1
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic review of articles written about ureteroscopy (URS) in the contemporary urological literature (19902009) on PubMed was undertaken.&quot;</span>
- Reasoning: The research question and inclusion criteria were established before the conduct of the review, as indicated by the systematic review process.
- Response: "[Yes]"

A2:
- Quote: N/A
- Reasoning: There is no information about the study selection and data extraction process, including whether it was done by at least two independent data extractors or if there was a consensus process for disagreements.
- Response: "[NA]"

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic review of the contemporary urological citations was conducted using the National Library of Medicine (PubMed) search engine.&quot;</span>
- Reasoning: The authors searched at least two electronic sources (PubMed) and provided the database used in the search. However, they did not provide the search strategy or any supplementary strategies.
- Response: "[No]"

A4:
- Quote: N/A
- Reasoning: There is no information about searching for grey literature or unpublished studies.
- Response: "[NA]"

A5:
- Quote: N/A
- Reasoning: There is no list of included and excluded studies provided in the paper.
- Response: "[No]"

A6:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Demographic information, including patient age, gender, presenting symptoms, number of URS procedures performed and stone-free rate, were abstracted from the papers reviewed.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Demographic information, including patient age, gender, presenting symptoms, number of URS procedures performed, and stone-free rate, were abstracted from the papers reviewed.&quot;</span>
- Reasoning: The authors provided the characteristics of the included studies in an aggregated form such as a table, including information on participants, interventions, and outcomes.
- Response: "[Yes]"

A7:
- Quote: N/A
- Reasoning: There is no information about the scientific quality assessment of the included studies.
- Response: "[No]"

A8:
- Quote: N/A
- Reasoning: There is no information about the scientific quality of the included studies being used appropriately in formulating conclusions.
- Response: "[NA]"

A9:
- Quote: N/A
- Reasoning: There is no information about combining the findings of studies or assessing their homogeneity.
- Response: "[NA]"

A10:
- Quote: N/A
- Reasoning: There is no information about assessing the likelihood of publication bias.
- Response: "[NA]"

A11:
- Quote: N/A
- Reasoning: There is no information about potential sources of support for the systematic review or the included studies.
- Response: "[NA]"

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Indian Journal of Urology, Oct-Dec 2010, Vol 26, Issue 4 555&quot;</span>
- Reasoning: The report is identified as a systematic review in the title.
- Response: "[Yes]"

P2:
- Quote: N/A
- Reasoning: There is no structured summary provided.
- Response: "[No]"

P3:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 91.3%):

Advances in the design of ureteroscopes and ancillary instruments over the past 20 years have resulted in miniaturization and increased durability of the small caliber rigid, semi-rigid and flexible ureteroscopes required for use' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Advances in the design of ureteroscopes and ancillary instruments over the past 20 years have resulted in miniaturization and increased durability of the small caliber rigid, semi-rigid and flexible ureteroscopes required for use in pediatric patients.&quot;</span>
- Reasoning: The rationale for the review is provided in the context of what is already known.
- Response: "[Yes]"

P4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This review article is to demonstrate that ureteroscopic lithotripsy is now to be considered the standard of care in the management of upper tract urolithiasis in the pediatric patient, replacing shockwave lithotripsy (ESWL) as the first line of therapy.&quot;</span>
- Reasoning: An explicit statement of questions being addressed is provided.
- Response: "[Yes]"

P5:
- Quote: N/A
- Reasoning: There is no information about the existence of a review protocol or its accessibility.
- Response: "[No]"

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The success rate of URS is 93.4% (compared with 80.3% for ESWL).&quot;</span>
- Reasoning: The study characteristics and report characteristics used as criteria for eligibility are provided, along with the rationale.
- Response: "[Yes]"

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic review of the contemporary urological citations was conducted using the National Library of Medicine (PubMed) search engine.&quot;</span>
- Reasoning: Information sources and the date last searched are described.
- Response: "[Yes]"

P8:
- Quote: N/A
- Reasoning: The full electronic search strategy for at least one database is not presented.
- Response: "[No]"

P9:
- Quote: N/A
- Reasoning: The process for selecting studies is not stated.
- Response: "[No]"

P10:
- Quote: N/A
- Reasoning: There is no information about the method of data extraction from reports.
- Response: "[NA]"

P11:
- Quote: N/A
- Reasoning: There is no list of variables for which data were sought or any assumptions and simplifications made.
- Response: "[NA]"

P12:
- Quote: N/A
- Reasoning: There is no information about methods used for assessing the risk of bias in individual studies.
- Response: "[NA]"

P13:
- Quote: N/A
- Reasoning: There is no information about the principal summary measures.
- Response: "[NA]"

P14:
- Quote: N/A
- Reasoning: There is no information about the methods of handling data and combining results of studies.
- Response: "[NA]"

P15:
- Quote: N/A
- Reasoning: There is no information about the assessment of the risk of bias that may affect the cumulative evidence.
- Response: "[NA]"

P16:
- Quote: N/A
- Reasoning: There is no information about methods for additional analyses.
- Response: "[NA]"

P17:
- Quote: N/A
- Reasoning: There is no information about the number of studies screened, assessed for eligibility, and included in the review.
- Response: "[NA]"

P18:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
- Reasoning: The characteristics of the included studies are not presented in the required format.
- Response: "[No]"

P19:
- Quote: N/A
- Reasoning: There is no information about the risk of bias within studies.
- Response: "[NA]"

P20:
- Quote: N/A
- Reasoning: There is no information about the results of individual studies for all outcomes.
- Response: "[NA]"

P21:
- Quote: N/A
- Reasoning: There is no information about the results of each meta-analysis done.
- Response: "[NA]"

P22:
- Quote: N/A
- Reasoning: There is no information about the results of any assessment of the risk of bias across studies.
- Response: "[NA]"

P23:
- Quote: N/A
- Reasoning: There is no information about the results of additional analyses.
- Response: "[NA]"

P24:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):

ureteroscopic lithotripsy in the management of pediatric urolithiasis now justify that this treatment modality be considered the standard of care and first line of therapy in the management of children who present with upper tract stones.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Ureteroscopic lithotripsy in the management of pediatric urolithiasis now justifies that this treatment modality be considered the standard of care and first line of therapy in the management of children who present with upper tract stones.&quot;</span>
- Reasoning: The main findings are summarized, including the strength of evidence for each main outcome.
- Response: "[Yes]"

P25:
- Quote: N/A
- Reasoning: There is no discussion of limitations at the study and outcome level or at the review level.
- Response: "[NA]"

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The safety and outcomes of ureteroscopic lithotripsy in the management of pediatric urolithiasis now justify that this treatment modality be considered the standard of care and first line of therapy in the management of children who present with upper tract stones.&quot;</span>
- Reasoning: A general interpretation of the results is provided in the context of other evidence and implications for future research.
- Response: "[Yes]"

P27:
- Quote: N/A
- Reasoning: There is no information about the sources of funding for the systematic review or other support.
- Response: "[NA]"</pre>
<p><a name='137'></a></p>
</div>
<div
id="romao-2012-what-is-the-best-prosthetic-material-for-patch-repair-of-congenital-diaphragmatic-hernia-comparison-and-meta-analysis-of-porcine-small-intestinal-submucosa-and-polytetrafluoroethylene"
class="section level4">
<h4>137.
<a href='https://doi.org/10.1016/J.JPEDSURG.2012.01.009' title='Open publication'>Romao
2012: <i>What is the best prosthetic material for patch repair of
congenital diaphragmatic hernia? Comparison and meta-analysis of porcine
small intestinal submucosa and polytetrafluoroethylene</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">14 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">1
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A retrospective chart review was performed for all neonates with Bochdalek CDH undergoing patch closure at our institution from January 2000 to December 2009.&quot;</span>
2. Reasoning: The research question and inclusion criteria were established before the conduct of the review.
3. Response: [Yes]

A2:
1. Quote: N/A
2. Reasoning: There is no information on duplicate study selection and data extraction.
3. Response: [NA]

A3:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All publications describing both absorbable (SIS) and nonabsorbable (PTFE) material for treatment of CDH were sought from the Cochrane Trials Register and the Cochrane Central Register of Controlled Trials (CENTRAL) database. All studies were identified through electronic searches of MEDLINE (1966 onwards), EMBASE (1980 onwards), and CINAHL (1982 onwards) and from hand-searching journals and conference proceedings.&quot;</span>
2. Reasoning: The authors searched at least two electronic sources and provided the databases used.
3. Response: [Yes]

A4:
1. Quote: N/A
2. Reasoning: There is no information on the inclusion of grey literature.
3. Response: [NA]

A5:
1. Quote: N/A
2. Reasoning: There is no list of included and excluded studies provided.
3. Response: [No]

A6:
1. Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

In all cases where a patch was chosen, it was secured in place with nonabsorbable sutures (usually 2-0 or 30 polyester or polypropylene) through the mesh and the muscle, with the stitch going around the ribs if the lateral rim of diaphragmatic muscle was lacking. Care was taken to allow for enough slack in the patch to create a tension-free, dome-like shape to mimic the normal diaphragm' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;In all cases where a patch was chosen, it was secured in place with nonabsorbable sutures (usually 2-0 or 3-0 polyester or polypropylene) through the mesh and the muscle, with the stitch going around the ribs if the lateral rim of diaphragmatic muscle was lacking. Care was taken to allow for enough slack in the patch to create a tension-free, dome-like shape to mimic the normal diaphragm.&quot;</span>
2. Reasoning: The authors provided a description of the surgical technique used for patch repair.
3. Response: [Yes]

A7:
1. Quote: N/A
2. Reasoning: There is no information on the scientific quality assessment of the included studies.
3. Response: [No]

A8:
1. Quote: N/A
2. Reasoning: There is no information on the use of the scientific quality of the included studies in formulating conclusions.
3. Response: [NA]

A9:
1. Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

The statistical analysis was performed using RevMan 5 software, which was provided by the Cochrane Collaboration. We applied tests for interstudy heterogeneity  2 (Q test) and the I 2 statistic to assess the appropriateness of combining studies. If the results of these tests showed heterogeneity (cutoff of 0.10 or larger for the Q test or N50% heterogeneity with the I 2 statistic), a random effect model was used for meta-analysi' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The statistical analysis was performed using RevMan 5 software, which was provided by the Cochrane Collaboration. We applied tests for interstudy heterogeneity 2 (Q test) and the I2 statistic to assess the appropriateness of combining studies. If the results of these tests showed heterogeneity (cutoff of 0.10 or larger for the Q test or N50% heterogeneity with the I2 statistic), a random effect model was used for meta-analysis.&quot;</span>
2. Reasoning: The authors used appropriate methods to combine the findings of studies.
3. Response: [Yes]

A10:
1. Quote: N/A
2. Reasoning: There is no information on the assessment of publication bias.
3. Response: [NA]

A11:
1. Quote: N/A
2. Reasoning: There is no information on the conflict of interest.
3. Response: [NA]

PRISMA Items:

P1:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Comparison and meta-analysis of porcine small intestinal submucosa and polytetrafluoroethylene&quot;</span>
2. Reasoning: The title identifies the report as a systematic review and meta-analysis.
3. Response: [Yes]

P2:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Methods: This is a retrospective review of all neonates with CDH undergoing patch closure at our institution over 10 years. Meta-analysis was also performed combining our data with the published literature examining the effect of patch type on recurrence and small bowel obstruction (SBO).&quot;</span>
2. Reasoning: The abstract provides a structured summary of the methods used.
3. Response: [Yes]

P3:
1. Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

the past 2 decades have witnessed an improvement in medical management of patients with CDH with the use of gentle ventilation and delayed surgical  Corresponding author. Robert M. Filler Chair and Chief, General and Thoracic Surgery, Hospital for Sick Children, Toronto ON M5G 1X8. Tel.: +1 416 813 7340; fax: +1 416 813 7477. E-mail address: jacob.langer@sickkids.ca (J.C. Langer). www.elsevier.com/locate/jpedsurg 0022-3468/$  see front matter  2012 Elsevier Inc. All rights reserved. doi:10.1016/j.jpedsurg.2012.01.009 Journal of Pediatric Surgery (2012) 47, 14961500 repair, thus leading to improved survival rates in many centers [2]. Concomitantly, there has been a rise in the incidence of patch repairs [3,11] and also increased longterm morbidity [4].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The past 2 decades have witnessed an improvement in medical management of patients with CDH with the use of gentle ventilation and delayed surgical repair, thus leading to improved survival rates in many centers [2]. Concomitantly, there has been a rise in the incidence of patch repairs [3,11] and also increased long-term morbidity [4].&quot;</span>
2. Reasoning: The authors provide a rationale for the review in the context of what is already known.
3. Response: [Yes]

P4:
1. Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

The aim of our study was to compare recurrence, small bowel obstruction (SBO), and mortality rates for CDH repair between an absorbable (Surgisis [SIS]; Cook Biotech, Inc, West Lafayette, IN) and a nonabsorbable polytetrafluoroethylene (PTFE) (Gore-Tex; W.L. Gore & Associates, Inc, Neward, DE) material at our institution.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The aim of our study was to compare recurrence, small bowel obstruction (SBO), and mortality rates for CDH repair between an absorbable (Surgisis [SIS]; Cook Biotech, Inc, West Lafayette, IN) and a nonabsorbable polytetrafluor-oethylene (PTFE) (Gore-Tex; W.L. Gore & Associates, Inc, Neward, DE) material at our institution.&quot;</span>
2. Reasoning: The authors provide an explicit statement of the questions being addressed.
3. Response: [Yes]

P5:
1. Quote: N/A
2. Reasoning: There is no information on the existence of a review protocol or registration information.
3. Response: [NA]

P6:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A retrospective chart review was performed for all neonates with Bochdalek CDH undergoing patch closure at our institution from January 2000 to December 2009.&quot;</span>
2. Reasoning: The authors provide study characteristics used as criteria for eligibility.
3. Response: [Yes]

P7:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All publications describing both absorbable (SIS) and nonabsorbable (PTFE) material for treatment of CDH were sought from the Cochrane Trials Register and the Cochrane Central Register of Controlled Trials (CENTRAL) database. All studies were identified through electronic searches of MEDLINE (1966 onwards), EMBASE (1980 onwards), and CINAHL (1982 onwards) and from hand-searching journals and conference proceedings.&quot;</span>
2. Reasoning: The authors describe all information sources used in the search.
3. Response: [Yes]

P8:
1. Quote: N/A
2. Reasoning: There is no information on the full electronic search strategy for at least one database.
3. Response: [NA]

P9:
1. Quote: N/A
2. Reasoning: There is no information on the process for selecting studies.
3. Response: [NA]

P10:
1. Quote: N/A
2. Reasoning: There is no information on the method of data extraction from reports.
3. Response: [NA]

P11:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following data were extracted: demographics, side of the defect, need for high-frequency oscillatory ventilation (HFOV) and/or extracorporeal membrane oxygenation (ECMO), age at operation in days, type of patch (SIS or PTFE), number of days on mechanical ventilation, length of first hospital admission in days, mortality, recurrence, time to recurrence, occurrence of bowel obstruction, and time of follow-up.&quot;</span>
2. Reasoning: The authors list and define all variables for which data were sought.
3. Response: [Yes]

P12:
1. Quote: N/A
2. Reasoning: There is no information on the methods used for assessing risk of bias of individual studies.
3. Response: [NA]

P13:
1. Quote: N/A
2. Reasoning: There is no information on the principal summary measures.
3. Response: [NA]

P14:
1. Quote: N/A
2. Reasoning: There is no information on the methods of handling data and combining results of studies.
3. Response: [NA]

P15:
1. Quote: N/A
2. Reasoning: There is no information on the assessment of risk of bias that may affect the cumulative evidence.
3. Response: [NA]

P16:
1. Quote: N/A
2. Reasoning: There is no information on the methods of additional analyses.
3. Response: [NA]

P17:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In the study period, 84 patients underwent CDH repair. Of these, 22 (26%) required a patch (13 SIS and 9 PTFE).&quot;</span>
2. Reasoning: The authors give numbers of studies screened, assessed for eligibility, and included in the review.
3. Response: [Yes]

P18:
1. Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
2. Reasoning: The authors present the characteristics for which data were extracted.
3. Response: [Yes]

P19:
1. Quote: N/A
2. Reasoning: There is no information on the risk of bias within studies.
3. Response: [NA]

P20:
1. Quote: N/A
2. Reasoning: There is no information on the results of individual studies.
3. Response: [NA]

P21:
1. Quote: N/A
2. Reasoning: There is no information on the results of each meta-analysis done.
3. Response: [NA]

P22:
1. Quote: N/A
2. Reasoning: There is no information on the results of any assessment of risk of bias across studies.
3. Response: [NA]

P23:
1. Quote: N/A
2. Reasoning: There is no information on the results of additional analyses.
3. Response: [NA]

P24:
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Congenital diaphragmatic hernia is a rare condition. The need for patch repair occurs in less than one third of cases in most series. Issues with sample size are common in studies dealing with rare diseases in pediatric surgery. A large cohort would be required to find statistically significant differences in complication rates after CDH patch repair. A meta-analysis offers the possibility of combining multi-institutional data, thus achieving a larger population for analysis with a better chance of showing differences between groups.&quot;</span>
2. Reasoning: The authors summarize the main findings and their relevance to key groups.
3. Response: [Yes]

P25:
1. Quote: N/A
2. Reasoning: There is no information on the limitations at study and outcome level.
3. Response: [NA]

P26:
1. Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

. It may be that based on the current pattern of practice, a randomized controlled trial comparing these 2 surgical approaches can never be done. This is unfortunate because the resistance is based more on bias from treating surgeons rather than on conclusive data. The results of this metaanalysis fail to provide overwhelming support to either approach, and therefore, we would conclude that both approaches are acceptable. It is likely that there will be further comparisons made in the future. To facilitate these comparisons, attention to standardized methodology would improve the quality of such studie' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;It may be that based on the current pattern of practice, a randomized controlled trial comparing these 2 surgical approaches can never be done. This is unfortunate because the resistance is based more on bias from treating surgeons rather than on conclusive data. The results of this meta-analysis fail to provide overwhelming support to either approach, and therefore, we would conclude that both approaches are acceptable. It is likely that there will be further comparisons made in the future. To facilitate these comparisons, attention to standardized methodology would improve the quality of such studies.&quot;</span>
2. Reasoning: The authors provide a general interpretation of the results in the context of other evidence and implications for future research.
3. Response: [Yes]

P27:
1. Quote: N/A
2. Reasoning: There is no information on the sources of funding for the systematic review and other support.
3. Response: [NA]</pre>
<p><a name='138'></a></p>
</div>
<div
id="ross-2015-the-role-of-preformed-silos-in-the-management-of-infants-with-gastroschisis-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>138.
<a href='https://doi.org/10.1007/S00383-015-3691-2' title='Open publication'>Ross
2015: <i>The role of preformed silos in the management of infants with
gastroschisis: a systematic review and meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">11 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<pre>
AMSTAR Questions:

A1. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All outcomes were selected a priori.&quot;</span> The research questions and inclusion criteria were established before the conduct of the review.

A2. "[No]" - There is no mention of duplicate study selection and data extraction.

A3. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched Medline, Embase and the Cochrane controlled trials register from inception to July 2014.&quot;</span> The authors searched at least two electronic sources.

A4. "[No]" - There is no mention of searching for grey literature.

A5. "[No]" - There is no list of included and excluded studies provided.

A6. "[Yes]" - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

For infants treated with a PFS no selection was made on the basis of final technique of abdominal wall closure (i.e. all were included).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;For infants treated with a PFS no selection was made on the basis of final technique of abdominal wall closure (i.e., all were included).&quot;</span> The characteristics of the included studies were provided.

A7. "[No]" - There is no mention of assessing the scientific quality of the included studies.

A8. "[NA]" - Not applicable as the scientific quality of the included studies was not assessed.

A9. "[NA]" - Not applicable as the review did not involve a meta-analysis.

A10. "[NA]" - Not applicable as the review did not involve a meta-analysis.

A11. "[No]" - There is no mention of potential sources of conflict of interest.

PRISMA Items:

P1. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The role of preformed silos in the management of infants with gastroschisis: a systematic review and meta-analysis.&quot;</span> The title identifies the report as a systematic review and meta-analysis.

P2. "[Yes]" - The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and implications of key findings.

P3. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The optimum surgical treatment of infants born with gastroschisis remains unclear.&quot;</span> The introduction provides a rationale for the review in the context of what is already known.

P4. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of this study was to evaluate current evidence comparing the use of a PFS with alternate treatment strategies in infants with gastroschisis.&quot;</span> The introduction provides an explicit statement of the questions being addressed.

P5. "[No]" - There is no mention of a review protocol or registration information.

P6. "[Yes]" - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

Studies were excluded if they reported a cohort of infants treated only with a PFS with no comparative group, reported a cohort of infants treated with a PFS grouped with infants treated with another treatment strategy such as a hand-sewn silo, originated from a non-developed country or were not in English.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Studies were excluded if they reported a cohort of infants treated only with a PFS with no comparative group, reported a cohort of infants treated with a PFS grouped with infants treated with another treatment strategy such as a hand-sewn silo, originated from a non-developed country, or were not in English.&quot;</span> The study characteristics and report characteristics used as criteria for eligibility are specified.

P7. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched Medline, Embase and the Cochrane controlled trials register from inception to July 2014.&quot;</span> The information sources are described.

P8. "[No]" - There is no presentation of the full electronic search strategy for at least one database.

P9. "[No]" - There is no statement of the process for selecting studies.

P10. "[No]" - There is no description of the method of data extraction from reports.

P11. "[No]" - There is no list and definition of all variables for which data were sought.

P12. "[No]" - There is no description of methods used for assessing risk of bias of individual studies.

P13. "[No]" - There is no statement of the principal summary measures.

P14. "[NA]" - Not applicable as the review did not involve a meta-analysis.

P15. "[NA]" - Not applicable as the review did not involve a meta-analysis.

P16. "[NA]" - Not applicable as the review did not involve a meta-analysis.

P17. "[No]" - There is no information on the number of studies screened, assessed for eligibility, and included in the review.

P18. "[No]" - There is no information on the characteristics of the included studies.

P19. "[No]" - There is no information on the risk of bias within studies.

P20. "[No]" - There is no information on the results of individual studies.

P21. "[NA]" - Not applicable as the review did not involve a meta-analysis.

P22. "[NA]" - Not applicable as the review did not involve a meta-analysis.

P23. "[NA]" - Not applicable as the review did not involve a meta-analysis.

P24. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The quality of evidence comparing PFS with alternate treatment strategies for gastroschisis is poor.&quot;</span> The main findings are summarized.

P25. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Only routine use of PFS is associated with fewer days on a ventilator compared with other strategies.&quot;</span> The limitations of the review are discussed.

P26. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Prospective studies are required to investigate the optimum management of gastroschisis.&quot;</span> The implications for future research are discussed.

P27. "[No]" - There is no information on the sources of funding for the systematic review.</pre>
<p><a name='139'></a></p>
</div>
<div
id="ruttenstock-2010-systematic-review-and-meta-analysis-of-enterocolitis-after-one-stage-transanal-pull-through-procedure-for-hirschsprungs-disease"
class="section level4">
<h4>139.
<a href='https://doi.org/10.1007/S00383-010-2695-1' title='Open publication'>Ruttenstock
2010: <i>Systematic review and meta-analysis of enterocolitis after
one-stage transanal pull-through procedure for Hirschsprungs
disease</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
wrong-response-partial-unclear-etc</i></p>
<p><i><span style="border-bottom: 1px dashed black;">22 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">2
quote(s) from the LLM prompt briefing</span> (mean similarity 47.5%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR:

A1. Was an 'a priori' design provided?

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This meta-analysis was designed to evaluate postoperative incidence of HAEC following TERPT procedure.&quot;</span>
2. The authors stated the research question and inclusion criteria before conducting the review.
3. [Yes]

A2. Was there duplicate study selection and data extraction?

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All published studies and abstracts presented at various meetings were evaluated.&quot;</span>
2. The authors did not mention a consensus procedure for disagreements, but it can be assumed that they checked each other's work.
3. [Yes]

A3. Was a comprehensive literature search performed?

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;PubMed and Medline were searched for all studies that reported cases of patients who had undergone surgical correction of HD on transanal one-stage pull-through operation between 1998 and 2009.&quot;</span>
2. The authors searched at least two electronic sources and provided keywords and search strategy.
3. [Yes]

A4. Was the status of publication (i.e. grey literature) used as an inclusion criterion?

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All published studies and abstracts presented at various meetings were evaluated.&quot;</span>
2. The authors included published studies and abstracts presented at meetings, but it is not clear if they searched for grey literature.
3. [No]

A5. Was a list of studies (included and excluded) provided?

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Table 1 Published articles reporting TERPT procedures between 1998 and 2009&quot;</span>
2. The authors provided a table listing included studies, but they did not list excluded studies.
3. [Partially <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

A6. Were the characteristics of the included studies provided?

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There were a total of 899 patients. Information about patients gender was reported in 760 (84.5%) patients. 563 (74.1%) patients were male and 197 (25.9%) patients were female. A male-to-female ratio of 2.8:1 was observed. Patients age at the time of operation was reported in 811 (90.2%) patients (median 9.2 months, range 6 days to 14 years).&quot;</span>
2. The authors provided the characteristics of the included studies in aggregated form such as a table.
3. [Yes]

A7. Was the scientific quality of the included studies assessed and documented?

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Detailed information was recorded regarding the type of study, patients age and gender, intraoperative details, and postoperative complications with particular emphasis on the incidence and outcome of HAEC.&quot;</span>
2. The authors did not use any specific method to assess the scientific quality of the included studies.
3. [No]

A8. Was the scientific quality of the included studies used appropriately in formulating conclusions?

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This systematic review reveals that TERPT is a safe and less-invasive procedure with a low incidence of postoperative HAEC.&quot;</span>
2. The authors did not use the scientific quality of the included studies to formulate their conclusions.
3. [No]

A9. Were the methods used to combine the findings of studies appropriate?

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Postoperative HAEC occurred in 92 patients (10.2%).&quot;</span>
2. The authors did not perform a quantitative synthesis, so this item is not applicable.
3. [NA]

A10. Was the likelihood of publication bias assessed?

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Out of these 54 articles, 27 articles, identified as reporting entirely TERPT without additional laparotomy, laparoscopy or preoperative colostomy, formed the basis of our study.&quot;</span>
2. The authors did not assess the likelihood of publication bias.
3. [No]

A11. Was the conflict of interest included?

1. Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 47.5%):

as the conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors declare that they have no conflict of interest.&quot;</span>
2. The authors declared that they have no conflict of interest.
3. [Yes]

PRISMA:

P1. Title

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Systematic review and meta-analysis of enterocolitis after one-stage transanal pull-through procedure for Hirschsprungs disease&quot;</span>
2. The title identifies the report as a systematic review and meta-analysis.
3. [Yes]

P2. Abstract / Structured summary

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This meta-analysis was designed to evaluate postoperative incidence of HAEC following TERPT procedure.&quot;</span>
2. The abstract provides a structured summary including the research question, methods, results, and conclusions.
3. [Yes]

P3. Introduction / Rationale

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The transanal one-stage pull-through procedure (TERPT) has gained worldwide popularity over open and laparoscopic-assisted one-stage techniques in children with Hirschsprungs disease (HD).&quot;</span>
2. The authors provide the rationale for the review in the context of what is already known.
3. [Yes]

P4. Introduction / Objectives

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This meta-analysis was designed to evaluate postoperative incidence of HAEC following TERPT procedure.&quot;</span>
2. The authors provide an explicit statement of the research question.
3. [Yes]

P5. Methods / Protocol and registration

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reference list from retrieved articles was reviewed for additional cases.&quot;</span>
2. The authors did not provide information on whether a review protocol exists, but they did mention that they reviewed the reference list from retrieved articles.
3. [No]

P6. Methods / Eligibility criteria

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search terms were one-stage transanal pull-through, transanal one-stage endorectal pull-through, one-stage Soave pull-through, single-stage transanal endorectal pull-through, primary pull-through, or Soave procedure.&quot;</span>
2. The authors provide the inclusion criteria for studies.
3. [Yes]

P7. Methods / Information sources

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;PubMed and Medline were searched for all studies that reported cases of patients who had undergone surgical correction of HD on transanal one-stage pull-through operation between 1998 and 2009.&quot;</span>
2. The authors provide information on the databases searched and the date last searched.
3. [Yes]

P8. Methods / Search

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search terms were one-stage transanal pull-through, transanal one-stage endorectal pull-through, one-stage Soave pull-through, single-stage transanal endorectal pull-through, primary pull-through, or Soave procedure.&quot;</span>
2. The authors provide the search strategy for at least one database.
3. [Yes]

P9. Methods / Study selection

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Out of these 54 articles, 27 articles, identified as reporting entirely TERPT without additional laparotomy, laparoscopy or preoperative colostomy, formed the basis of our study.&quot;</span>
2. The authors provide the process for selecting studies.
3. [Yes]

P10. Methods / Data collection process

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Detailed information was recorded regarding the type of study, patients age and gender, intraoperative details, and postoperative complications with particular emphasis on the incidence and outcome of HAEC.&quot;</span>
2. The authors provide the method of data extraction from reports.
3. [Yes]

P11. Methods / Data items

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The diagnosis of HAEC in a HD patient was based on the clinical presentation of diarrhoea, abdominal distension, and fever.&quot;</span>
2. The authors provide a list of variables for which data were sought.
3. [Yes]

P12. Methods / Risk of bias in individual studies

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reference list from retrieved articles was reviewed for additional cases.&quot;</span>
2. The authors did not describe any methods for assessing risk of bias in individual studies.
3. [No]

P13. Methods / Summary measures

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Postoperative HAEC occurred in 92 patients (10.2%).&quot;</span>
2. The authors provide the principal summary measures for the outcome of interest.
3. [Yes]

P14. Methods / Synthesis of results

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Postoperative HAEC occurred in 92 patients (10.2%).&quot;</span>
2. The authors provide a descriptive synthesis of the results.
3. [Yes]

P15. Methods / Risk of bias across studies

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Out of these 54 articles, 27 articles, identified as reporting entirely TERPT without additional laparotomy, laparoscopy or preoperative colostomy, formed the basis of our study.&quot;</span>
2. The authors did not assess the risk of bias across studies.
3. [No]

P16. Methods / Additional analyses

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Postoperative HAEC occurred in 92 patients (10.2%).&quot;</span>
2. The authors did not perform any additional analyses.
3. [NA]

P17. Results / Study selection

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Out of these 54 articles, 27 articles, identified as reporting entirely TERPT without additional laparotomy, laparoscopy or preoperative colostomy, formed the basis of our study.&quot;</span>
2. The authors provide the number of studies screened, assessed for eligibility, and included in the review.
3. [Yes]

P18. Results / Study characteristics

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There were a total of 899 patients.&quot;</span>
2. The authors provide the characteristics of the included studies, including the number of patients.
3. [Yes]

P19. Results / Risk of bias within studies

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reference list from retrieved articles was reviewed for additional cases.&quot;</span>
2. The authors did not provide data on risk of bias within studies.
3. [No]

P20. Results / Results of individual studies

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Postoperative HAEC occurred in 92 patients (10.2%).&quot;</span>
2. The authors provide the results of individual studies.
3. [Yes]

P21. Results / Synthesis of results

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Postoperative HAEC occurred in 92 patients (10.2%).&quot;</span>
2. The authors provide a descriptive synthesis of the results.
3. [Yes]

P22. Results / Risk of bias across studies

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Out of these 54 articles, 27 articles, identified as reporting entirely TERPT without additional laparotomy, laparoscopy or preoperative colostomy, formed the basis of our study.&quot;</span>
2. The authors did not assess the risk of bias across studies.
3. [No]

P23. Results / Additional analysis

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Postoperative HAEC occurred in 92 patients (10.2%).&quot;</span>
2. The authors did not perform any additional analyses.
3. [NA]

P24. Discussion / Summary of evidence

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This systematic review reveals that TERPT is a safe and less-invasive procedure with a low incidence of postoperative HAEC.&quot;</span>
2. The authors provide a summary of the evidence.
3. [Yes]

P25. Discussion / Limitations

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reported incidence of post pull-through HAEC ranges from 4.6 to 54% in various series, which may be partially due to the use of different diagnostic criteria.&quot;</span>
2. The authors provide a discussion of limitations at the study and outcome level.
3. [Yes]

P26. Discussion / Conclusions

1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This systematic review reveals that TERPT is a safe and less-invasive procedure with a low incidence of postoperative HAEC.&quot;</span>
2. The authors provide a general interpretation of the results and implications for future research.
3. [Yes]

P27. Funding

1. Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 47.5%):

as the conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors declare that they have no conflict of interest.&quot;</span>
2. The authors did not provide information on funding sources for the systematic review.
3. [No]</pre>
<p><a name='140'></a></p>
</div>
<div
id="rynja-2011-functional-cosmetic-and-psychosexual-results-in-adult-men-who-underwent-hypospadias-correction-in-childhood"
class="section level4">
<h4>140.
<a href='https://doi.org/10.1016/J.JPUROL.2011.02.008' title='Open publication'>Rynja
2011: <i>Functional, cosmetic and psychosexual results in adult men who
underwent hypospadias correction in childhood</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">28 quote(s) from
publication full text</span> (mean similarity 98.6%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">2
quote(s) from the LLM prompt briefing</span> (mean similarity 75.8%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A meta-analysis of cases of TERPT reported between 1998 and 2009 was performed.&quot;</span> & <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Detailed information was recorded regarding the type of study, patients age and gender, intraoperative details, and postoperative complications with particular emphasis on the incidence and outcome of HAEC.&quot;</span>
- The research question and inclusion criteria were established before the conduct of the review, but there is no explicit mention of an a priori design or protocol.
- [No]

A2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All published studies and abstracts presented at various meetings were evaluated.&quot;</span>
- It is not clear whether there was a process of duplicate study selection and data extraction with a consensus procedure for disagreements.
- [NA]

A3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;PubMed and Medline were searched for all studies that reported cases of patients who had undergone surgical correction of HD on transanal one-stage pull-through operation between 1998 and 2009.&quot;</span>
- The authors searched at least two electronic sources and provided the years and databases used, but the search strategy is not explicitly stated.
- [No]

A4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reference list from retrieved articles was reviewed for additional cases.&quot;</span>
- The authors did not explicitly state that they searched for reports regardless of their publication type, but they did review the reference list for additional cases.
- [No]

A5: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Twenty-two articles (81.5%) were from single centers, and 5 (18.5%) were from multicenter studies.&quot;</span>
- The authors provided a list of included studies but did not explicitly list excluded studies.
- [No]

A6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There were a total of 899 patients. Information about patients gender was reported in 760 (84.5%) patients. 563 (74.1%) patients were male and 197 (25.9%) patients were female. A male-to-female ratio of 2.8:1 was observed.&quot;</span> & <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Patients age at the time of operation was reported in 811 (90.2%) patients (median 9.2 months, range 6 days to 14 years).&quot;</span>
- The authors provided the characteristics of the included studies in aggregated form, such as a table, including data on the participants, interventions, and outcomes.
- [Yes]

A7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The diagnosis of HAEC in a HD patient was based on the clinical presentation of diarrhoea, abdominal distension, and fever.&quot;</span>
- The authors did not provide a description of the method used for assessing the scientific quality of the included studies, but they did specify the criteria for diagnosing HAEC.
- [No]

A8: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This systematic review reveals that TERPT is a safe and less-invasive procedure with a low incidence of postoperative HAEC.&quot;</span>
- The authors used the scientific quality of the included studies appropriately in formulating conclusions, as they acknowledged the limitations of the studies.
- [Yes]

A9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reported incidence of post pull-through HAEC ranges from 4.6 to 54% in various series, which may be partially due to the use of different diagnostic criteria.&quot;</span>
- The authors did not explicitly describe the methods used to combine the findings of studies, but they acknowledged the variability in the reported incidence of HAEC.
- [NA]

A10: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;However, the majority of recent reports found the incidence of HAEC to be unrelated to type and timing of definitive surgery.&quot;</span>
- The authors did not explicitly assess the likelihood of publication bias.
- [NA]

A11: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
- The authors did not provide information on the sources of funding for the systematic review or the role of the funders.
- [NA]

PRISMA Items:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Systematic review and meta-analysis of enterocolitis after one-stage transanal pull-through procedure for Hirschsprungs disease&quot;</span>
- The title identifies the report as a systematic review and meta-analysis.
- [Yes]

P2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This meta-analysis was designed to evaluate postoperative incidence of HAEC following TERPT procedure.&quot;</span>
- The abstract provides a structured summary, including the background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and systematic review registration number.
- [Yes]

P3: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):

TERPT) has gained worldwide popularity over open and laparoscopic-assisted one-stage techniques in children with Hirschsprungs disease (HD). It offers the advantages of avoiding laparotomy, laparoscopy, scars, abdominal contamination, and adhesions. However, enterocolitis associated with Hirschsprungs disease (HAEC) still remains to be a potentially life-threatening complication after pullthrough operation.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;TERPT has gained worldwide popularity over open and laparoscopic-assisted one-stage techniques in children with Hirschsprungs disease (HD). It offers the advantages of avoiding laparotomy, laparoscopy, scars, abdominal contamination, and adhesions. However, enterocolitis associated with Hirschsprungs disease (HAEC) still remains to be a potentially life-threatening complication after pull-through operation.&quot;</span>
- The authors describe the rationale for the review in the context of what is already known.
- [Yes]

P4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This meta-analysis was designed to evaluate postoperative incidence of HAEC following TERPT procedure.&quot;</span>
- The authors provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
- [Yes]

P5: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All published studies and abstracts presented at various meetings were evaluated.&quot;</span>
- The authors do not indicate if a review protocol exists or provide registration information.
- [No]

P6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search terms were one-stage transanal pull-through, transanal one-stage endorectal pull-through, one-stage Soave pull-through, single-stage transanal endorectal pull-through, primary pull-through, or Soave procedure.&quot;</span>
- The authors specify study characteristics and report characteristics used as criteria for eligibility, giving rationale.
- [Yes]

P7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;PubMed and Medline were searched for all studies that reported cases of patients who had undergone surgical correction of HD on transanal one-stage pull-through operation between 1998 and 2009.&quot;</span>
- The authors describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
- [Yes]

P8: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reference list from retrieved articles was reviewed for additional cases.&quot;</span>
- The authors do not present the full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
- [No]

P9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Detailed information was recorded regarding the type of study, patients age and gender, intraoperative details, and postoperative complications with particular emphasis on the incidence and outcome of HAEC.&quot;</span>
- The authors state the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
- [Yes]

P10: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The diagnosis of HAEC in a HD patient was based on the clinical presentation of diarrhoea, abdominal distension, and fever.&quot;</span>
- The authors describe the method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
- [Yes]

P11: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Detailed information was recorded regarding the type of study, patients age and gender, intraoperative details, and postoperative complications with particular emphasis on the incidence and outcome of HAEC.&quot;</span>
- The authors list and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
- [Yes]

P12: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The diagnosis of HAEC in a HD patient was based on the clinical presentation of diarrhoea, abdominal distension, and fever.&quot;</span>
- The authors describe methods used for assessing the risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.
- [Yes]

P13: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Of the 54 published articles worldwide, 27 articles, including 899 patients were identified as reporting entirely TERPT procedure.&quot;</span>
- The authors state the principal summary measures (e.g., risk ratio, difference in means).
- [Yes]

P14: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reported incidence of post pull-through HAEC ranges from 4.6 to 54% in various series, which may be partially due to the use of different diagnostic criteria.&quot;</span>
- The authors describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.
- [NA]

P15: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reported incidence of post pull-through HAEC ranges from 4.6 to 54% in various series, which may be partially due to the use of different diagnostic criteria.&quot;</span>
- The authors specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
- [NA]

P16: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 51.6%):

not applicable' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;[Not applicable to this review]&quot;</span>
- The authors describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
- [NA]

P17: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Of the 54 published articles worldwide, 27 articles, including 899 patients were identified as reporting entirely TERPT procedure.&quot;</span>
- The authors give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
- [Yes]

P18: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There were a total of 899 patients. Information about patients gender was reported in 760 (84.5%) patients. 563 (74.1%) patients were male and 197 (25.9%) patients were female. A male-to-female ratio of 2.8:1 was observed.&quot;</span> & <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Patients age at the time of operation was reported in 811 (90.2%) patients (median 9.2 months, range 6 days to 14 years).&quot;</span>
- For each study, the authors present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.
- [Yes]

P19: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 51.6%):

not applicable' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;[Not applicable to this review]&quot;</span>
- The authors present data on the risk of bias of each study and, if available, any outcome level assessment (see item P12).
- [NA]

P20: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Postoperative HAEC occurred in 92 patients (10.2%).&quot;</span>
- For all outcomes considered (benefits or harms), the authors present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.
- [Yes]

P21: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 51.6%):

not applicable' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;[Not applicable to this review]&quot;</span>
- The authors present results of each meta-analysis done, including confidence intervals and measures of consistency.
- [NA]

P22: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 51.6%):

not applicable' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;[Not applicable to this review]&quot;</span>
- The authors present results of any assessment of risk of bias across studies (see Item P15).
- [NA]

P23: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 51.6%):

not applicable' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;[Not applicable to this review]&quot;</span>
- The authors give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).
- [NA]

P24: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This systematic review reveals that TERPT is a safe and less-invasive procedure with a low incidence of postoperative HAEC.&quot;</span>
- The authors summarize the main findings, including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).
- [Yes]

P25: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reported incidence of post pull-through HAEC ranges from 4.6 to 54% in various series, which may be partially due to the use of different diagnostic criteria.&quot;</span>
- The authors discuss limitations at the study and outcome level (e.g., risk of bias), and at the review-level (e.g., incomplete retrieval of identified research, reporting bias).
- [Yes]

P26: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This systematic review reveals that TERPT is a safe and less-invasive procedure with a low incidence of postoperative HAEC.&quot;</span>
- The authors provide a general interpretation of the results in the context of other evidence, and implications for future research.
- [Yes]

P27: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 62.1%):

er in this review.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;[Not reported in this review]&quot;</span>
- The authors describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.
- [No]</pre>
<p><a name='141'></a></p>
</div>
<div
id="saldaa-2013-single-incision-pediatric-endosurgery-a-systematic-review"
class="section level4">
<h4>141.
<a href='https://doi.org/10.1089/lap.2012.0467' title='Open publication'>Saldaa
2013: <i>Single-Incision Pediatric Endosurgery: A Systematic
Review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">12 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">4
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We performed an electronic search in PubMed up to March 2012 with the terms single AND incision OR site OR port OR trocar AND children including related articles and obtained 197 articles.&quot;</span>
- Reasoning: The authors provided an 'a priori' design by specifying the research question and inclusion criteria in their search strategy.
- Response: [Yes]

A2:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Two independent data extractors and a consensus procedure for disagreements&quot;</span> is not explicitly mentioned.
- Reasoning: The article does not provide clear information on whether there were two independent data extractors and a consensus procedure for disagreements.
- Response: [No]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An electronic search in PubMed up to March 2012 was conducted with the following terms: single AND incision OR site OR port OR trocar AND children.&quot;</span>
- Reasoning: The authors searched at least two electronic sources (PubMed) and provided the search strategy and keywords used.
- Response: [Yes]

A4:
- Quote: The article does not mention searching for <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;grey literature&quot;</span> or <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;unpublished literature.&quot;</span>
- Reasoning: The authors did not explicitly state that they searched for grey literature or unpublished literature.
- Response: [No]

A5:
- Quote: The article does not provide a list of included and excluded studies.
- Reasoning: The authors did not provide a specific list of included and excluded studies in their review.
- Response: [No]

A6:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

In total, 4212 patients had been operated on by SIPES and were separated by systems: gastrointestinal (n = 2888), urologic (n = 390), gynecologic (n = 27), other abdominal (n = 874), and thoracic (n = 33) procedures.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;In total, 4212 patients had been operated on by SIPES and were separated by systems: gastro-intestinal (n = 2888), urologic (n = 390), gynecologic (n = 27), other abdominal (n = 874), and thoracic (n = 33) procedures.&quot;</span>
- Reasoning: The authors provided aggregated data on the participants, interventions, and outcomes for the included studies.
- Response: [Yes]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Articles were classified according to types of operations, levels of evidence, and age groups.&quot;</span>
- Reasoning: The authors assessed the scientific quality of the included studies by classifying them based on the type of operation, level of evidence, and age groups. However, they did not provide a clear methodology for assessing the risk of bias or quality of the studies.
- Response: [No]

A8:
- Quote: The authors did not explicitly state how they used the scientific quality of the included studies to formulate their conclusions.
- Reasoning: Since the authors did not adequately address the scientific quality of the included studies in formulating their conclusions, it is unclear how they accounted for this in their review.
- Response: [No]

A9:
- Quote: The article does not mention combining the findings of studies.
- Reasoning: Since the review does not appear to involve a meta-analysis, assessing the appropriateness of methods used to combine the findings of studies is not applicable.
- Response: [NA]

A10:
- Quote: The article does not mention assessing the likelihood of publication bias.
- Reasoning: The authors did not assess the likelihood of publication bias in their review.
- Response: [No]

A11:
- Quote: The article does not mention potential sources of conflict of interest or funding sources for the included studies.
- Reasoning: The authors did not report the potential sources of conflict of interest or funding sources for the included studies.
- Response: [No]

PRISMA Items:

P1:
- Quote: The title states <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;A Systematic Review&quot;</span>
- Reasoning: The title appropriately identifies the report as a systematic review.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We performed an electronic search in PubMed up to March 2012 with the terms single AND incision OR site OR port OR trocar AND children including related articles and obtained 197 articles.&quot;</span>
- Reasoning: The abstract provides a structured summary, including the background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and systematic review registration number.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Several publications exist, but no previous systematic review has been made to evaluate the real benefits of this approach in terms of feasibility and clinical outcomes.&quot;</span>
- Reasoning: The authors described the rationale for the review in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The objective of this review is to show the initial published experience about SIPES to evaluate its real benefits in terms of feasibility and clinical outcomes.&quot;</span>
- Reasoning: The authors explicitly stated the research question and the outcomes of interest.
- Response: [Yes]

P5:
- Quote: The article does not mention a review protocol or registration information.
- Reasoning: The authors did not provide information on a review protocol or registration.
- Response: [No]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Articles were considered eligible if they met the following inclusion criteria: (1) Operations were performed through a single incision. (2) The target population was children under 18 years of age. (3) Operations performed exclusively by pediatric surgeons. (4) Series larger than 100 patients were included for appendectomy operations. (5) Case reports, case series, and comparative and prospective randomized trials were included in other, nonappendectomy, operations because of their low incidence. (6) Articles should include age, operative technical aspects, and operative outcomes.&quot;</span>
- Reasoning: The authors provided the study characteristics and the rationale for the inclusion criteria.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An electronic search in PubMed up to March 2012 was conducted with the following terms: single AND incision OR site OR port OR trocar AND children.&quot;</span>
- Reasoning: The authors described the information sources (e.g., databases, dates of coverage, contact with study authors) in the search and the date last searched.
- Response: [Yes]

P8:
- Quote: The article does not present a full electronic search strategy for at least one database.
- Reasoning: The authors did not provide the full electronic search strategy for any database.
- Response: [No]

P9:
- Quote: The article does not state the process for selecting studies.
- Reasoning: The authors did not provide a clear description of the study selection process.
- Response: [No]

P10:
- Quote: The article does not describe the method of data extraction from reports.
- Reasoning: The authors did not provide information on the method of data extraction from reports.
- Response: [No]

P11:
- Quote: The article does not list and define all variables for which data were sought.
- Reasoning: The authors did not list and define all variables for which data were sought.
- Response: [No]

P12:
- Quote: The article does not describe methods used for assessing the risk of bias of individual studies.
- Reasoning: The authors did not provide information on the methods used for assessing the risk of bias of individual studies.
- Response: [No]

P13:
- Quote: The article does not state the principal summary measures.
- Reasoning: The authors did not provide the principal summary measures used in the review.
- Response: [No]

P14:
- Quote: The article does not describe the methods of handling data and combining results of studies.
- Reasoning: The authors did not provide information on the methods of handling data and combining results of studies.
- Response: [NA]

P15:
- Quote: The article does not describe methods of additional analyses.
- Reasoning: The authors did not provide information on methods of additional analyses, such as sensitivity or subgroup analyses.
- Response: [NA]

P16:
- Quote: The article does not describe methods of additional analyses.
- Reasoning: The authors did not provide information on methods of additional analyses, such as sensitivity or subgroup analyses.
- Response: [NA]

P17:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;After applying our eligibility criteria, we selected 78 articles to be included in this systematic review (Fig. 1).&quot;</span>
- Reasoning: The authors provided the number of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage.
- Response: [Yes]

P18:
- Quote: The article does not present the characteristics of the included studies.
- Reasoning: The authors did not provide a table or list of included studies with their characteristics.
- Response: [No]

P19:
- Quote: The article does not present data on the risk of bias of each study.
- Reasoning: The authors did not provide a table or other means of presenting data on the risk of bias of each study.
- Response: [No]

P20:
- Quote: The article does not present the results of individual studies.
- Reasoning: The authors did not provide the results of individual studies.
- Response: [No]

P21:
- Quote: The article does not present the results of each meta-analysis.
- Reasoning: The authors did not provide the results of each meta-analysis, as there was no meta-analysis conducted.
- Response: [NA]

P22:
- Quote: The article does not present the results of any assessment of the risk of bias across studies.
- Reasoning: The authors did not provide the results of any assessment of the risk of bias across studies.
- Response: [NA]

P23:
- Quote: The article does not present the results of additional analyses.
- Reasoning: The authors did not provide the results of additional analyses, such as sensitivity or subgroup analyses.
- Response: [NA]

P24:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A wide experience in SIPES and feasibility has already been described with good clinical outcomes and low rate of conversion.&quot;</span>
- Reasoning: The authors provided a summary of the evidence and its implications for key groups, such as healthcare providers, users, and policy makers.
- Response: [Yes]

P25:
- Quote: The article does not discuss the limitations of the review.
- Reasoning: The authors did not discuss the limitations of the review in terms of the study and outcome level (e.g., risk of bias), and at the review level (e.g., incomplete retrieval of identified research, reporting bias).
- Response: [No]

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;It is pending the execution of prospective controlled trials for other operations to demonstrate, with objective evidence, the real benefits of this less invasive approach.&quot;</span>
- Reasoning: The authors provided a general interpretation of the results in the context of other evidence, and discussed the implications for future research.
- Response: [Yes]

P27:
- Quote: The article does not describe the sources of funding for the systematic review and other support (e.g., supply of data).
- Reasoning: The authors did not provide information on the sources of funding for the systematic review and other support.
- Response: [No]</pre>
<p><a name='142'></a></p>
</div>
<div
id="sauerland-2010-laparoscopic-versus-open-surgery-for-suspected-appendicitis"
class="section level4">
<h4>142.
<a href='https://doi.org/10.1002/14651858.CD001546.PUB3' title='Open publication'>Sauerland
2010: <i>Laparoscopic versus open surgery for suspected
appendicitis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">27 quote(s) from
publication full text</span> (mean similarity 99%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">8
quote(s) from the LLM prompt briefing</span> (mean similarity 76.9%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1. Was an 'a priori' design provided?
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following search strategies were employed to identify all relevant studies irrespective of language.&quot;</span>
- Reasoning: The authors describe their search strategies, indicating an 'a priori' design.
- Response: [Yes]

A2. Was there duplicate study selection and data extraction?
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two reviewers independently assessed trial quality.&quot;</span>
- Reasoning: The authors mention that two reviewers independently assessed trial quality, which implies duplicate study selection and data extraction.
- Response: [Yes]

A3. Was a comprehensive literature search performed?
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Electronically, we searched the Cochrane Library, MEDLINE (PubMed), EMBASE, SciSearch and Biosis.&quot;</span>
- Reasoning: The authors describe searching multiple databases, indicating a comprehensive literature search.
- Response: [Yes]

A4. Was the status of publication (i.e. grey literature) used as an inclusion criterion?
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies predating 1983 were not searched for, because the first laparoscopic appendectomy was described in that year.&quot;</span>
- Reasoning: The authors did not search for grey literature or unpublished studies.
- Response: [No]

A5. Was a list of studies (included and excluded) provided?
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 38.6%):

A list of included and excluded studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;A list of excluded studies is available from the authors upon request.&quot;</span>
- Reasoning: The authors mention that a list of excluded studies is available upon request.
- Response: [Yes]

A6. Were the characteristics of the included studies provided?
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 49.5%):

characteristics: For each study, present characteristics' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Characteristics of included studies are presented in the 'Characteristics of included studies' table.&quot;</span>
- Reasoning: The authors provide a table with the characteristics of included studies.
- Response: [Yes]

A7. Was the scientific quality of the included studies assessed and documented?
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two reviewers independently assessed trial quality.&quot;</span>
- Reasoning: The authors mention that two reviewers independently assessed trial quality, indicating that the scientific quality of included studies was assessed.
- Response: [Yes]

A8. Was the scientific quality of the included studies used appropriately in formulating conclusions?
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations.&quot;</span>
- Reasoning: The authors mention that the scientific quality of included studies should be considered in formulating conclusions.
- Response: [Yes]

A9. Were the methods used to combine the findings of studies appropriate?
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For dichotomous variables relative risks (RR) with 95% confidence intervals (95% CIs) were the preferred measure.&quot;</span>
- Reasoning: The authors describe using appropriate methods to combine the findings of studies.
- Response: [Yes]

A10. Was the likelihood of publication bias assessed?
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken).&quot;</span>
- Reasoning: The authors mention assessing publication bias using appropriate methods.
- Response: [Yes]

A11. Were the conflicts of interest included?
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Potential sources of support should be clearly acknowledged in both the systematic review and the included studies.&quot;</span>
- Reasoning: The authors mention acknowledging potential sources of support in both the systematic review and included studies.
- Response: [Yes]

PRISMA Items:

P1. Title: Identify the report as a systematic review, meta-analysis, or both.
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Laparoscopic versus open surgery for suspected appendicitis (Review)&quot;</span>
- Reasoning: The title identifies the report as a systematic review.
- Response: [Yes]

P2. Abstract: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):

Background Laparoscopic surgery for acute appendicitis has been proposed to have advantages over conventional surgery. Objectives To compare the diagnostic and therapeutic effects of laparoscopic and conventional &#39;open&#39; surgery.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Background: Laparoscopic surgery for acute appendicitis has been proposed to have advantages over conventional surgery. Objectives: To compare the diagnostic and therapeutic effects of laparoscopic and conventional 'open' surgery.&quot;</span>
- Reasoning: The abstract provides a structured summary of the review.
- Response: [Yes]

P3. Introduction: Describe the rationale for the review in the context of what is already known.
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The evolution of endoscopic surgery led to the idea of performing appendectomy in laparoscopy, which was first described by Semm in 1983.&quot;</span>
- Reasoning: The authors describe the rationale for the review in the context of what is already known.
- Response: [Yes]

P4. Introduction: Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes (PICOS), and study design of interest.
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This review compares laparoscopic and conventional surgery with regard to several peri- and post-operative variables.&quot;</span>
- Reasoning: The authors provide an explicit statement of questions being addressed.
- Response: [Yes]

P5. Methods: Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 86%):

Criteria for considering studies for this review' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Methods: Criteria for considering studies for this review&quot;</span>
- Reasoning: The authors describe the methods used in the review, but do not provide information on a review protocol or registration.
- Response: [No]

P6. Methods: Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up, publication status) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

Types of studies All randomized controlled trials comparing laparoscopic surgery and open appendectomy for acute appendicitis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Types of studies: All randomized controlled trials comparing laparoscopic surgery and open appendectomy for acute appendicitis.&quot;</span>
- Reasoning: The authors specify study characteristics used as criteria for eligibility.
- Response: [Yes]

P7. Methods: Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies, handsearching of journals, etc.), and date last searched.
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Electronically, we searched the Cochrane Library, MEDLINE (PubMed), EMBASE, SciSearch and Biosis.&quot;</span>
- Reasoning: The authors describe all information sources used in the review.
- Response: [Yes]

P8. Methods: Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 89.4%):

the Cochrane Collaboration search strategy for randomized controlled trials with the MeSH term "appendectomy".' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The Cochrane Collaboration search strategy for randomized controlled trials was combined with the MeSH term 'appendectomy'.&quot;</span>
- Reasoning: The authors present the full electronic search strategy for at least one database.
- Response: [Yes]

P9. Methods: Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two reviewers independently assessed trial quality.&quot;</span>
- Reasoning: The authors describe the process for selecting studies.
- Response: [Yes]

P10. Methods: Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two observers independently extracted the results of each paper on a data sheet; disagreements were resolved by discussion.&quot;</span>
- Reasoning: The authors describe the method of data extraction from reports.
- Response: [Yes]

P11. Methods: Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The therapeutic outcome measures (with their according measurement units) are: (1) wound infections (rate); (2) intraabdominal abscesses (rate); (3) operation time (minutes) (4) anaesthesia time (minutes)&quot;</span>
- Reasoning: The authors list and define all variables for which data were sought.
- Response: [Yes]

P12. Methods: Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The quality of all included studies was moderate to poor.&quot;</span>
- Reasoning: The authors describe methods used for assessing risk of bias of individual studies.
- Response: [Yes]

P13. Methods: Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For dichotomous variables relative risks (RR) with 95% confidence intervals (95% CIs) were the preferred measure.&quot;</span>
- Reasoning: The authors state the principal summary measures used in the review.
- Response: [Yes]

P14. Methods: Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For dichotomous variables relative risks (RR) with 95% confidence intervals (95% CIs) were the preferred measure.&quot;</span>
- Reasoning: The authors describe the methods of handling data and combining results of studies.
- Response: [Yes]

P15. Methods: Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken).&quot;</span>
- Reasoning: The authors specify any assessment of risk of bias that may affect the cumulative evidence.
- Response: [Yes]

P16. Methods: Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Sensitivity analyses were a priori planned to compare the study results for their inclusion criteria (i.e. sex ratio, percentage of perforated or gangrenous cases), technique of laparoscopic appendectomy (loops vs stapler for closure of appendix stump, learning-curve apparent vs not) and study design and reporting (adequate vs unclear allocation concealment, studies that reported means vs medians).&quot;</span>
- Reasoning: The authors describe methods of additional analyses.
- Response: [Yes]

P17. Results: Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.1%):

A total of 67 studies were included in this review, but not all them reported clinically relevant data which contributed to the results of this review.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A total of 67 studies were included in this review, but not all of them reported clinically relevant data which contributed to the results of this review.&quot;</span>
- Reasoning: The authors give numbers of studies screened, assessed for eligibility, and included in the review.
- Response: [Yes]

P18. Results: Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 49.5%):

characteristics: For each study, present characteristics' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Characteristics of included studies are presented in the 'Characteristics of included studies' table.&quot;</span>
- Reasoning: The authors present characteristics for which data were extracted for each study.
- Response: [Yes]

P19. Results: Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see Item P12).
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The quality of all included studies was moderate to poor.&quot;</span>
- Reasoning: The authors present data on risk of bias of each study.
- Response: [Yes]

P20. Results: Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Wound infections were about half as likely (Analysis 1.1; Peto OR 0.43; 95%-CI 0.34 to 0.54) after LA than after OA.&quot;</span>
- Reasoning: The authors present results of individual studies for all outcomes considered.
- Response: [Yes]

P21. Results: Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency (e.g., I2) for each meta-analysis.
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The duration of surgery was 10 minutes (95%-CI 6 to 15) longer for LA (Analysis 1.3).&quot;</span>
- Reasoning: The authors present results of each meta-analysis done.
- Response: [Yes]

P22. Results: Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The funnel plot showed no signs of publication bias.&quot;</span>
- Reasoning: The authors present results of any assessment of risk of bias across studies.
- Response: [Yes]

P23. Results: Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The results for anaesthesia time or operating time were similarly prolonged.&quot;</span>
- Reasoning: The authors give results of additional analyses.
- Response: [Yes]

P24. Discussion: Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In those clinical settings where surgical expertise and equipment are available and affordable, diagnostic laparoscopy and LA (either in combination or separately) seem to have various advantages over OA.&quot;</span>
- Reasoning: The authors summarize the main findings and consider their relevance to key groups.
- Response: [Yes]

P25. Discussion: Limitations: Discuss limitations at study and outcome level (e.g., risk of bias, inconsistency, indirectness, imprecision, publication bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The large number of trials allowed us to exclude the trials without adequate allocation concealment, but still the exact randomizations method of many trials remained unclear.&quot;</span>
- Reasoning: The authors discuss limitations at study and outcome level and at review-level.
- Response: [Yes]

P26. Discussion: Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In summary, laparoscopic surgery for suspected appendicitis has diagnostic and therapeutic advantages as compared to conventional surgery.&quot;</span>
- Reasoning: The authors provide a general interpretation of the results in the context of other evidence and implications for future research.
- Response: [Yes]

P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.
- Quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 77.5%):

. Funding: Describe sources of funding for the systematic review' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;No funding was received for this review.&quot;</span>
- Reasoning: The authors describe sources of funding for the systematic review and other support.
- Response: [Yes]</pre>
<p><a name='143'></a></p>
</div>
<div
id="scholfield-2016-laparoscopic-duhamel-procedure-for-hirschsprungs-disease-systematic-review-and-meta-analysis"
class="section level4">
<h4>143.
<a href='https://doi.org/10.1089/lap.2015.0121' title='Open publication'>Scholfield
2016: <i>Laparoscopic Duhamel Procedure for Hirschsprungs Disease:
Systematic Review and Meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
extra-score-brackets-without-prefix</i></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 98.2%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">5
quote(s) from the LLM prompt briefing</span> (mean similarity 98.1%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR:

A1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Materials and Methods: We undertook a systematic review of all studies published over a period of 20 years (19942014) that assessed functional outcomes for OD and/or LD procedures.&quot;</span>

Reasoning: The authors stated that they undertook a systematic review, but there is no explicit mention of an a priori design or protocol.

Response: [No]

A2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Not all outcome parameters were reported in every article. Our review only included published studies, and no contact with authors was made to obtain unpublished data, nor were conference abstracts included due to the limited data available.&quot;</span>

Reasoning: This statement suggests that the authors did not use independent data extractors or a consensus process for disagreements.

Response: [No]

A3: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

A systematic PubMed search was performed to identify publications that analyzed outcomes for LD or OD pull-through procedures for HD. All studies between January 1994 and December 2014 were included in the search, as the first LD pullthrough was described in 1994.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A systematic PubMed search was performed to identify publications that analyzed outcomes for LD or OD pull-through procedures for HD. All studies between January 1994 and December 2014 were included in the search, as the first LD pull-through was described in 1994.&quot;</span>

Reasoning: The authors provided a search strategy, but it is unclear if they searched multiple databases and included supplementary strategies such as consulting experts or reviewing references.

Response: [No]

A4: "[NA]"

Reasoning: This question is not applicable as the authors did not mention searching for grey literature.

Response: [NA]

A5: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Eleven articles met our strict inclusion criteria and were included in the meta-analysis.&quot;</span>

Reasoning: The authors provided a list of included studies but did not provide a list of excluded studies.

Response: [No]

A6: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

Study population characteristics Four hundred fifty-six patients with HD were included in this review (range, 2076 patients per study). Of these, 253 patients underwent an OD procedure, and 203 underwent a LD procedure.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Study population characteristics: Four hundred fifty-six patients with HD were included in this review (range, 2076 patients per study). Of these, 253 patients underwent an OD procedure, and 203 underwent a LD procedure.&quot;</span>

Reasoning: The authors provided a list of patient characteristics but did not provide all the required information in a table or aggregated form.

Response: [No]

A7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The risk of bias was assessed and summarized (Fig. 2).&quot;</span>

Reasoning: The authors mentioned assessing the risk of bias but did not provide information on the methods used or the results for each study.

Response: [No]

A8: "[NA]"

Reasoning: This question is not applicable as the authors did not adequately address the risk of bias in the included studies.

Response: [NA]

A9: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

A randomeffects analysis model was used for all outcomes, as it acknowledges a degree of heterogeneity between studies that makes it well suited for meta-analysis in pediatric surgery.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A random-effects analysis model was used for all outcomes, as it acknowledges a degree of heterogeneity between studies that makes it well suited for meta-analysis in pediatric surgery.&quot;</span>

Reasoning: The authors mentioned using a random-effects analysis model, which suggests they considered heterogeneity.

Response: [Yes]

A10: "[NA]"

Reasoning: This question is not applicable as the authors did not assess publication bias.

Response: [NA]

A11: "[NA]"

Reasoning: This question is not applicable as the authors did not provide information on potential sources of support or conflict of interest.

Response: [NA]

PRISMA:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Systematic Review and Meta-analysis&quot;</span>

Reasoning: The title includes the terms <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;systematic review&quot;</span> and <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;meta-analysis.&quot;</span>

Response: [Yes]

P2: <span title='Minor quote deviation. Best match in prompt (Similarity 96.9%):

Abstract / Structured summary:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;Abstract / Structured summary: [&quot;</span> [...] "]"

Reasoning: The abstract provides a structured summary with the required elements.

Response: [Yes]

P3: "[NA]"

Reasoning: This question is not applicable as the authors did not provide a separate introduction or rationale section.

Response: [NA]

P4: <span title='Moderate quote deviation. Best match in fulltext (Similarity 85%):

etained. This study compared long-term outcomes for open Duhamel (OD) and laparoscopic Duhamel (LD) procedures for HD, to identify any added advantage of the laparoscopic technique.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Introduction / Objectives: The study aimed to compare long-term outcomes for open Duhamel (OD) and laparoscopic Duhamel (LD) procedures for HD, to identify any added advantage of the laparoscopic technique.&quot;</span>

Reasoning: The authors provided an explicit statement of the study's objectives.

Response: [Yes]

P5: "[NA]"

Reasoning: This question is not applicable as the authors did not mention a review protocol or registration.

Response: [NA]

P6: <span title='Minor quote deviation. Best match in prompt (Similarity 97%):

Methods / Eligibility criteria:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;Methods / Eligibility criteria: [&quot;</span> [...] "]"

Reasoning: The authors specified the inclusion and exclusion criteria for the review.

Response: [Yes]

P7: <span title='Minor quote deviation. Best match in prompt (Similarity 96.9%):

Methods / Information sources:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;Methods / Information sources: [&quot;</span> [...] "]"

Reasoning: The authors described a single information source and the time frame of the search.

Response: [Yes]

P8: "[NA]"

Reasoning: This question is not applicable as the authors did not provide a full electronic search strategy for at least one database.

Response: [NA]

P9: "[NA]"

Reasoning: This question is not applicable as the authors did not provide a detailed description of the study selection process.

Response: [NA]

P10: "[NA]"

Reasoning: This question is not applicable as the authors did not provide a description of the data extraction process.

Response: [NA]

P11: "[NA]"

Reasoning: This question is not applicable as the authors did not provide a list of variables for which data were sought.

Response: [NA]

P12: "[NA]"

Reasoning: This question is not applicable as the authors did not provide information on the methods used to assess the risk of bias in individual studies.

Response: [NA]

P13: "[NA]"

Reasoning: This question is not applicable as the authors did not provide a statement of the principal summary measures.

Response: [NA]

P14: "[NA]"

Reasoning: This question is not applicable as the authors did not provide information on the methods used for combining results of studies or measures of consistency.

Response: [NA]

P15: "[NA]"

Reasoning: This question is not applicable as the authors did not provide information on the assessment of the risk of bias across studies.

Response: [NA]

P16: "[NA]"

Reasoning: This question is not applicable as the authors did not provide information on additional analyses.

Response: [NA]

P17: "[NA]"

Reasoning: This question is not applicable as the authors did not provide a flow diagram or the required numbers of studies at each stage of the review.

Response: [NA]

P18: "[NA]"

Reasoning: This question is not applicable as the authors did not provide a table or description of the characteristics of included studies.

Response: [NA]

P19: "[NA]"

Reasoning: This question is not applicable as the authors did not provide information on the risk of bias within studies.

Response: [NA]

P20: "[NA]"

Reasoning: This question is not applicable as the authors did not provide information on the results of individual studies.

Response: [NA]

P21: "[NA]"

Reasoning: This question is not applicable as the authors did not provide a meta-analysis.

Response: [NA]

P22: "[NA]"

Reasoning: This question is not applicable as the authors did not provide information on the risk of bias across studies.

Response: [NA]

P23: "[NA]"

Reasoning: This question is not applicable as the authors did not provide information on additional analyses.

Response: [NA]

P24: "[NA]"

Reasoning: This question is not applicable as the authors did not provide a summary of evidence or implications for key groups.

Response: [NA]

P25: "[NA]"

Reasoning: This question is not applicable as the authors did not provide a discussion of limitations.

Response: [NA]

P26: "[NA]"

Reasoning: This question is not applicable as the authors did not provide conclusions and implications for future research.

Response: [NA]

P27: "[NA]"

Reasoning: This question is not applicable as the authors did not provide information on funding or sources of support.

Response: [NA]</pre>
<p><a name='144'></a></p>
</div>
<div
id="sharp-2015-treatment-of-idiopathic-achalasia-in-the-pediatric-population-a-systematic-review"
class="section level4">
<h4>144.
<a href='https://doi.org/10.1055/S-0035-1544174' title='Open publication'>Sharp
2015: <i>Treatment of Idiopathic Achalasia in the Pediatric Population:
A Systematic Review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
AMSTAR:

A1. [No] - The research question and inclusion criteria are not explicitly established before the conduct of the review. The authors do not refer to a protocol, ethics approval, or pre-determined published research objectives.

A2. [No] - There is no mention of at least two independent data extractors and a consensus procedure for disagreements.

A3. [No] - The authors do not provide a comprehensive literature search, including at least two electronic sources, years, and databases used. They also do not state the key words and/or MESH terms or provide the search strategy.

A4. [No] - The authors do not state that they searched for reports regardless of their publication type or that they excluded any reports based on publication status, language, etc.

A5. [No] - A list of included and excluded studies is not provided.

A6. [No] - The characteristics of the included studies are not provided in an aggregated form such as a table, data from the original studies are not provided on the participants, interventions, and outcomes.

A7. [No] - The scientific quality of the included studies is not assessed and documented. The authors do not provide 'a priori' methods of assessment or a quality scoring tool or checklist.

A8. [NA] - This question is not applicable as the authors did not assess the scientific quality of the included studies.

A9. [NA] - This question is not applicable as the authors did not combine the findings of studies.

A10. [NA] - This question is not applicable as the authors did not assess the likelihood of publication bias.

A11. [No] - The authors do not acknowledge potential sources of support for the systematic review and the included studies.

PRISMA:

P1. [Yes] - The report is identified as a systematic review in the title.

P2. [No] - A structured summary is not provided, including background, objectives, data sources, study eligibility criteria, participants, and interventions, study appraisal and synthesis methods, results, limitations, conclusions, and implications of key findings.

P3. [Yes] - The rationale for the review is described in the context of what is already known.

P4. [No] - An explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS) is not provided.

P5. [No] - The authors do not indicate if a review protocol exists, if and where it can be accessed, or provide registration information including registration number.

P6. [No] - The authors do not specify study characteristics and report characteristics used as criteria for eligibility, giving rationale.

P7. [No] - The authors do not describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.

P8. [No] - The authors do not present the full electronic search strategy for at least one database, including any limits used, such that it could be repeated.

P9. [No] - The authors do not state the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).

P10. [No] - The authors do not describe the method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.

P11. [No] - The authors do not list and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.

P12. [No] - The authors do not describe methods used for assessing the risk of bias of individual studies (including specification of whether this was done at the study or outcome level) and how this information is to be used in any data synthesis.

P13. [No] - The authors do not state the principal summary measures (e.g., risk ratio, difference in means).

P14. [NA] - This question is not applicable as the authors did not perform a meta-analysis.

P15. [NA] - This question is not applicable as the authors did not perform a meta-analysis.

P16. [NA] - This question is not applicable as the authors did not perform additional analyses.

P17. [No] - The authors do not give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.

P18. [No] - The authors do not present, for each study, characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.

P19. [No] - The authors do not present data on the risk of bias of each study and, if available, any outcome level assessment.

P20. [No] - The authors do not present, for all outcomes considered (benefits or harms), simple summary data for each intervention group and effect estimates and confidence intervals, ideally with a forest plot.

P21. [NA] - This question is not applicable as the authors did not perform a meta-analysis.

P22. [NA] - This question is not applicable as the authors did not perform a meta-analysis.

P23. [NA] - This question is not applicable as the authors did not perform additional analyses.

P24. [No] - The authors do not summarize the main findings, including the strength of evidence for each main outcome, and consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).

P25. [No] - The authors do not discuss limitations at the study and outcome level (e.g., risk of bias) and at the review level (e.g., incomplete retrieval of identified research, reporting bias).

P26. [No] - The authors do not provide a general interpretation of the results in the context of other evidence and implications for future research.

P27. [No] - The authors do not describe sources of funding for the systematic review and other support (e.g., supply of data) and the role of funders for the systematic review.</pre>
<p><a name='145'></a></p>
</div>
<div
id="shawyer-2014-the-management-of-postoperative-reflux-in-congenital-esophageal-atresiatracheoesophageal-fistula-a-systematic-review"
class="section level4">
<h4>145.
<a href='https://doi.org/10.1007/S00383-014-3548-0' title='Open publication'>Shawyer
2014: <i>The management of postoperative reflux in congenital esophageal
atresiatracheoesophageal fistula: a systematic review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">13 quote(s) from
publication full text</span> (mean similarity 99.3%)</i></p>
<pre>
AMSTAR Questions:

A1: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A comprehensive search was conducted using MEDLINE/PubMed, CINHAL, EMBASE/OVID, and CENTRAL (the Cochrane library) electronic databases.&quot;</span> The authors provide a clear a priori design and inclusion criteria for their review.

A2: [No] - The authors do not mention the use of duplicate study selection and data extraction.

A3: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Gray literature was searched in Papers first, Proceedings first and Pro Quest electronic databases.&quot;</span> The authors conducted a comprehensive literature search using multiple databases and supplemented it with a gray literature search.

A4: [No] - The authors do not explicitly state that they searched for reports regardless of their publication type.

A5: [No] - The authors do not provide a list of included and excluded studies.

A6: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Included articles reported a primary diagnosis of EA-TEF, a secondary diagnosis of postoperative GER, and primary treatment of GER with anti-reflux medications.&quot;</span> The authors provide the characteristics of the included studies in an aggregated form.

A7: [No] - The authors do not mention the use of a quality scoring tool or checklist to assess the scientific quality of the included studies.

A8: [NA] - Not applicable since the scientific quality of the included studies was not assessed (A7).

A9: [NA] - Not applicable since the review does not involve a meta-analysis.

A10: [NA] - Not applicable since the review does not involve a meta-analysis.

A11: [No] - The authors do not mention any potential sources of conflict of interest or funding.

PRISMA Items:

P1: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The management of postoperative reflux in congenital esophageal atresia-tracheoesophageal fistula: a systematic review&quot;</span> The title clearly identifies the report as a systematic review.

P2: [No] - The abstract does not provide a structured summary including background, objectives, data sources, study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; and systematic review registration number.

P3: [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):

Esophageal atresia (EA), with or without tracheoesophageal fistula (TEF), is associated with postoperative gastroesophageal reflux (GER). We performed a systematic review of the literature regarding routine antireflux medication post EA-TEF repair and its impact on postoperative GER and associated complications.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Esophageal atresia (EA), with or without tra- cheoesophageal fistula (TEF), is associated with postoperative gastroesophageal reflux (GER). We performed a systematic review of the literature regarding routine anti- reflux medication post EA-TEF repair and its impact on postoperative GER and associated complications.&quot;</span> The authors provide a clear rationale for the review.

P4: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The objective of this study was to determine the prevalence of anti-reflux medication use in postoperative EA-TEF patients, and the impact of routine anti-reflux medication on postoperative GER and its associated complications.&quot;</span> The authors provide an explicit statement of the review's objectives.

P5: [No] - The authors do not mention whether a review protocol exists or if it can be accessed.

P6: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies were included if they fulfilled the following criteria: (1) published between inception of database and November 2012, (2) primary diagnosis of EA with or without TEF, (3) secondary diagnosis of postopera- tive GER, (4) primary treatment for GER with anti- reflux medications (not limited by type of agent, dose or mode of delivery).&quot;</span> The authors provide clear study and report characteristics used as criteria for eligibility.

P7: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A comprehensive search was conducted using MEDLINE/PubMed, CINHAL, EMBASE/OVID, and CENTRAL (the Cochrane library) electronic databases.&quot;</span> The authors describe all information sources used in the search.

P8: [No] - The authors do not present the full electronic search strategy for at least one database.

P9: [Yes] - <span title='Moderate quote deviation. Best match in fulltext (Similarity 94.1%):

Title and abstract screening was carried out independently and in duplicate (AS and JD). Disagreements were settled by consensus.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Titles and abstracts were screened independently and in duplicate (AS and JD). Disagreements were settled by consensus.&quot;</span> The authors provide a clear description of the study selection process.

P10: [No] - The authors do not describe the method of data extraction from reports or any processes for obtaining and confirming data from investigators.

P11: [No] - The authors do not list and define all variables for which data were sought or any assumptions and simplifications made.

P12: [No] - The authors do not describe methods used for assessing the risk of bias of individual studies.

P13: [NA] - Not applicable since the review does not involve a meta-analysis.

P14: [NA] - Not applicable since the review does not involve a meta-analysis.

P15: [NA] - Not applicable since the review does not involve a meta-analysis.

P16: [NA] - Not applicable since the review does not involve a meta-analysis.

P17: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Screening of 2,910 articles resulted in 25 articles (1,663 patients) for analysis.&quot;</span> The authors provide a flow diagram or a clear description of the number of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage.

P18: [Yes] - The authors provide a table summarizing the characteristics of the included studies and included patients.

P19: [No] - The authors do not provide data on the risk of bias of each study.

P20: [No] - The authors do not provide results of individual studies for all outcomes considered.

P21: [NA] - Not applicable since the review does not involve a meta-analysis.

P22: [NA] - Not applicable since the review does not involve a meta-analysis.

P23: [NA] - Not applicable since the review does not involve a meta-analysis.

P24: [Yes] - <span title='Minor quote deviation. Best match in fulltext (Similarity 98.5%):

The quality of literature regarding antireflux medication for GER post EA-TEF repair is poor. There are no well-outlined algorithms for anti-reflux agents, doses, or duration of therapy. Standardized protocols and reliable reporting are necessary to develop guidelines to better manage postoperative GER in EATEF patients.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The quality of literature regarding anti- reflux medication for GER post EA-TEF repair is poor. There are no well-outlined algorithms for anti-reflux agents, doses, or duration of therapy. Standardized pro- tocols and reliable reporting are necessary to develop guidelines to better manage postoperative GER in EA-TEF patients.&quot;</span> The authors provide a summary of the main findings and their implications for key groups.

P25: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies consistently scored poorly on provision of a sample size calculation and similar groups at baseline, adequate controls, reporting of unbiased assessments, and prospective data collection.&quot;</span> The authors discuss limitations at the study and outcome level.

P26: [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Collaboration with other centers and experts in the field to develop databases with standardized reporting forms would improve the data collection and subsequent analysis of the outcomes of these patients.&quot;</span> The authors provide a general interpretation of the results in the context of other evidence and implications for future research.

P27: [No] - The authors do not describe sources of funding for the systematic review and other support or the role of funders for the systematic review.</pre>
<p><a name='146'></a></p>
</div>
<div
id="shawyer-2015-laparoscopic-versus-open-repair-of-recto-bladderneck-and-recto-prostatic-anorectal-malformations-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>146.
<a href='https://doi.org/10.1007/S00383-014-3626-3' title='Open publication'>Shawyer
2015: <i>Laparoscopic versus open repair of recto-bladderneck and
recto-prostatic anorectal malformations: a systematic review and
meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<p><i><span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">21 quote(s)
from the LLM prompt briefing</span> (mean similarity 98.4%) - were
instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR:

A1: "[Yes]" - Relevant quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

We conducted a systematic review to assess the impact of a laparoscopic repair on rates of mucosal prolapse and defection dysfunction of male children born with RB/RPARMs (i.e., require an abdominal approach to their repair, either through laparoscopy or laparotomy).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We conducted a systematic review to assess the impact of a laparoscopic repair on rates of mucosal prolapse and defecation dysfunction of male children born with RB/RP-ARMs (i.e., require an abdominal approach to their repair, either through laparoscopy or laparotomy).&quot;</span> - The research question and inclusion criteria were established before the conduct of the review.

A2: "[No]" - Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Data abstraction was performed in duplicate (AS and ML) and verified for accuracy and quality via a pre-piloted standardized data abstraction form; discrepancies were resolved by discussion and consensus.&quot;</span> - Although data extraction was conducted in duplicate, there was no mention of independent data extractors or a consensus procedure for disagreements.

A3: "[Yes]" - Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A comprehensive search was conducted of MEDLINE/PubMed, EMBASE/OVID and CENTRAL (the Cochrane Library) electronic databases from 2000 to March 2014.&quot;</span> - At least two electronic sources were searched, and the report included years and databases used.

A4: "[No]" - Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Grey literature was searched in PapersFirst, ProceedingsFirst and ProQuest electronic databases (keyword search).&quot;</span> - Although grey literature was searched, it was not explicitly stated that reports were searched regardless of publication type.

A5: "[No]" - Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Of these, seven studies (N = 187) were eligible for inclusion and final analysis (Fig. 1; Table 1a, b).&quot;</span> - A list of excluded studies was not provided.

A6: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 66.7%):

1-3 relevant quote' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;[Yes] - Relevant quote: &quot;</span>Four studies described a global assessment of defecation function [3537, 40]." - The characteristics of the included studies were provided in an aggregated form such as a table, data from the original studies were provided on the participants, interventions, and outcomes.

A7: "[No]" - Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Quality appraisal was performed using the MINORS, excluding the RCT [17].&quot;</span> - Although the quality of the included studies was assessed, it was not clear if a priori methods of assessment were provided.

A8: "[No]" - Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Several were close to the value for excellent comparative non-randomized studies [38, 39].&quot;</span> - The results of the methodological rigor and scientific quality were not considered in the analysis and the conclusions of the review.

A9: "[NA]" - Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Due to the small number of studies included in this review (\10), funnel plots to evaluate publication bias were not constructed as they would be non-informative [29].&quot;</span> - The question is not applicable as the systematic review did not perform a meta-analysis.

A10: "[NA]" - Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Due to the small number of studies included in this review (\10), funnel plots to evaluate publication bias were not constructed as they would be non-informative [29].&quot;</span> - The question is not applicable as the systematic review did not perform a meta-analysis.

A11: "[No]" - Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No studies reported on conflict of interest.&quot;</span> - Potential sources of support were not clearly acknowledged in both the systematic review and the included studies.

PRISMA:

P1: "[Yes]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Title: Identify the report as a systematic review, meta-analysis, or both.&quot;</span> - The title identifies the report as a systematic review.

P2: "[Yes]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span> - The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings.

P3: "[Yes]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Rationale: Describe the rationale for the review in the context of what is already known.&quot;</span> - The rationale for the review is described in the context of what is already known.

P4: "[Yes]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span> - The objectives of the review are explicitly stated with reference to participants, interventions, comparisons, outcomes, and study design.

P5: "[No]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span> - A review protocol was not mentioned, and registration information was not provided.

P6: "[Yes]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span> - The study characteristics and report characteristics used as criteria for eligibility are specified, giving rationale.

P7: "[Yes]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span> - All information sources used in the search are described, including the databases with dates of coverage and the date last searched.

P8: "[Yes]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span> - The full electronic search strategy for at least one database is presented, including any limits used, such that it could be repeated.

P9: "[Yes]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span> - The process for selecting studies is stated, including the screening, eligibility, and inclusion in the systematic review.

P10: "[Yes]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span> - The method of data extraction from reports is described, including the use of a pre-piloted standardized data abstraction form, and data were extracted in duplicate.

P11: "[Yes]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span> - All variables for which data were sought are listed and defined, including PICOS and funding sources.

P12: "[Yes]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span> - The methods used for assessing the risk of bias of individual studies are described, including the use of the MINORS tool.

P13: "[Yes]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span> - The principal summary measures are stated, including odds ratios and mean differences.

P14: "[NA]" - Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Due to the small number of studies included in this review (\10), funnel plots to evaluate publication bias were not constructed as they would be non-informative [29].&quot;</span> - The question is not applicable as the systematic review did not perform a meta-analysis.

P15: "[NA]" - Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Due to the small number of studies included in this review (\10), funnel plots to evaluate publication bias were not constructed as they would be non-informative [29].&quot;</span> - The question is not applicable as the systematic review did not perform a meta-analysis.

P16: "[NA]" - Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Due to the small number of studies included in this review (\10), funnel plots to evaluate publication bias were not constructed as they would be non-informative [29].&quot;</span> - The question is not applicable as the systematic review did not perform a meta-analysis.

P17: "[Yes]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span> - The numbers of studies screened, assessed for eligibility, and included in the review are given, with reasons for exclusions at each stage, ideally with a flow diagram.

P18: "[Yes]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span> - For each study, the characteristics for which data were extracted are presented, including study size, PICOS, and follow-up period.

P19: "[No]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span> - Although the methods used for assessing the risk of bias of individual studies are described, the results of the risk of bias assessment are not presented for each study.

P20: "[Yes]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span> - For all outcomes considered, simple summary data for each intervention group, effect estimates, and confidence intervals are presented for each study, ideally with a forest plot.

P21: "[NA]" - Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Due to the small number of studies included in this review (\10), funnel plots to evaluate publication bias were not constructed as they would be non-informative [29].&quot;</span> - The question is not applicable as the systematic review did not perform a meta-analysis.

P22: "[NA]" - Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Due to the small number of studies included in this review (\10), funnel plots to evaluate publication bias were not constructed as they would be non-informative [29].&quot;</span> - The question is not applicable as the systematic review did not perform a meta-analysis.

P23: "[NA]" - Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Due to the small number of studies included in this review (\10), funnel plots to evaluate publication bias were not constructed as they would be non-informative [29].&quot;</span> - The question is not applicable as the systematic review did not perform a meta-analysis.

P24: "[Yes]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span> - The main findings are summarized, including the strength of evidence for each main outcome, and their relevance to key groups is considered.

P25: "[Yes]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span> - Limitations at the study and outcome level, as well as at the review-level, are discussed.

P26: "[Yes]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span> - A general interpretation of the results in the context of other evidence is provided, and implications for future research are discussed.

P27: "[No]" - Relevant quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span> - Sources of funding for the systematic review and other support are not described, and the role of funders for the systematic review is not discussed.</pre>
<p><a name='147'></a></p>
</div>
<div
id="shen-2015-laparoscopic-versus-open-surgery-in-children-with-choledochal-cysts-a-meta-analysis"
class="section level4">
<h4>147.
<a href='https://doi.org/10.1007/S00383-015-3705-0' title='Open publication'>Shen
2015: <i>Laparoscopic versus open surgery in children with choledochal
cysts: a meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
wrong-response-partial-unclear-etc</i></p>
<p><i><span style="border-bottom: 1px dashed black;">21 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The outcomes were operative time, intraoperative blood loss, time to food intake, postoperative morbidity and mortality, length of hospital stay.&quot;</span>
- Reasoning: The research question and inclusion criteria are established before the conduct of the review.
- Response: [Yes]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two reviewers (Huo-Jian Shen and Ming Xu) abstracted relevant information from each eligible article using a standardized form independently.&quot;</span>
- Reasoning: There were at least two independent data extractors, and a consensus process for disagreements was in place.
- Response: [Yes]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched databases, including PubMed, Embase, the Science Citation Index, and Cochrane Library updated to November 2014, to identify all related published studies comparing the laparoscopic and the open choledochal cyst excision with hepaticojejunostomy.&quot;</span>
- Reasoning: At least two electronic sources were searched, and the report includes the databases used.
- Response: [Yes]

A4:
- Quote: N/A
- Reasoning: The authors did not state that they searched for reports regardless of their publication type.
- Response: [No]

A5:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Reviewers had perfect agreement in selecting the 7 studies [915] considered to be suitable for the final metaanalysis using the stated eligibility criteria.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Reviewers had perfect agreement in selecting the 7 studies [915] considered to be suitable for the final meta-analysis using the stated eligibility criteria.&quot;</span>
- Reasoning: A list of included studies was provided, but excluded studies were not referenced.
- Response: [Partially <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The characteristics, quality assessment, and outcomes for the included studies are summarized in Table 1.&quot;</span>
- Reasoning: Data from the original studies were provided in an aggregated form such as a table.
- Response: [Yes]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The quality of the literature was assessed independently by two authors (Huo-Jian Shen and Ming Xu) using the 9-star NewcastleOttawa Scale [7].&quot;</span>
- Reasoning: The scientific quality of the included studies was assessed and documented using a quality scoring tool.
- Response: [Yes]

A8:
- Quote: N/A
- Reasoning: The results of the methodological rigor and scientific quality were not explicitly stated in formulating recommendations.
- Response: [No]

A9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In case of lack of heterogeneity, fixed-effects model was used for the meta-analysis, or else random-effects model was used to explain it.&quot;</span>
- Reasoning: The methods used to combine the findings of studies were appropriate.
- Response: [Yes]

A10:
- Quote: N/A
- Reasoning: An assessment of publication bias was not provided.
- Response: [No]

A11:
- Quote: N/A
- Reasoning: Potential sources of support were not clearly acknowledged in both the systematic review and the included studies.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Laparoscopic versus open surgery in children with choledochal cysts: a meta-analysis&quot;</span>
- Reasoning: The report is identified as a meta-analysis.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The outcomes were operative time, intraoperative blood loss, time to food intake, postoperative morbidity and mortality, length of hospital stay.&quot;</span>
- Reasoning: A structured summary was provided, including the outcomes.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Choledochal cysts are rare congenital cystic dilations of the biliary tree that present primarily in female infants and young children and are more prevalent in East Asian populations [1, 2].&quot;</span>
- Reasoning: The rationale for the review was described in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

To compare the safety and efficacy between laparoscopic and open cyst excision with hepaticojejunostomy for children with choledochal cysts using metaanalysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;To compare the safety and efficacy between laparoscopic and open cyst excision with hepaticojejunostomy for children with choledochal cysts using meta-analysis.&quot;</span>
- Reasoning: An explicit statement of questions being addressed was provided.
- Response: [Yes]

P5:
- Quote: N/A
- Reasoning: The authors did not indicate if a review protocol exists.
- Response: [No]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The studies that published up to and including November 2014 were considered eligible if they met the following inclusion criteria: (1) study reported on at least one of the outcome measures mentioned below: operative time, intraoperative blood loss, time to food intake, postoperative morbidity (including bile leakage, pancreatic leakage, cholangitis, pancreatitis, adhesive intestinal obstruction, abdominal bleeding, etc.,) and mortality, length of hospital stay; (2) population: children younger than 18 years with choledochal cysts; (3) intervention: laparoscopic cyst excision and Roux-en-Y hepaticojejunostomy (LH) versus open cyst excision and Roux-en-Y hepaticojejunostomy (OH).&quot;</span>
- Reasoning: Study characteristics and report characteristics used as criteria for eligibility were specified.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched databases, including PubMed, Embase, the Science Citation Index, and Cochrane Library updated to November 2014, to identify all related published studies comparing the laparoscopic and the open choledochal cyst excision with hepaticojejunostomy.&quot;</span>
- Reasoning: All information sources were described, including the date last searched.
- Response: [Yes]

P8:
- Quote: N/A
- Reasoning: The full electronic search strategy for at least one database was not presented.
- Response: [No]

P9:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Reviewers had perfect agreement in selecting the 7 studies [915] considered to be suitable for the final metaanalysis using the stated eligibility criteria.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Reviewers had perfect agreement in selecting the 7 studies [915] considered to be suitable for the final meta-analysis using the stated eligibility criteria.&quot;</span>
- Reasoning: The process for selecting studies was stated.
- Response: [Yes]

P10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two reviewers (Huo-Jian Shen and Ming Xu) abstracted relevant information from each eligible article using a standardized form independently.&quot;</span>
- Reasoning: The method of data extraction from reports was described.
- Response: [Yes]

P11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Information about the characteristics of the study population, authors, publication year, study period, country, sample size, interventions, outcomes details of the surgical techniques used, and relevant outcomes were recorded.&quot;</span>
- Reasoning: All variables for which data were sought were listed and defined.
- Response: [Yes]

P12:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The quality of the literature was assessed independently by two authors (Huo-Jian Shen and Ming Xu) using the 9-star NewcastleOttawa Scale [7].&quot;</span>
- Reasoning: The methods used for assessing the risk of bias of individual studies were described.
- Response: [Yes]

P13:
- Quote: N/A
- Reasoning: The principal summary measures were not stated.
- Response: [No]

P14:
- Quote: N/A
- Reasoning: The methods of handling data and combining results of studies were not described.
- Response: [NA]

P15:
- Quote: N/A
- Reasoning: An assessment of the risk of bias that may affect the cumulative evidence was not specified.
- Response: [NA]

P16:
- Quote: N/A
- Reasoning: Methods of additional analyses were not described.
- Response: [NA]

P17:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Reviewers had perfect agreement in selecting the 7 studies [915] considered to be suitable for the final metaanalysis using the stated eligibility criteria.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Reviewers had perfect agreement in selecting the 7 studies [915] considered to be suitable for the final meta-analysis using the stated eligibility criteria.&quot;</span>
- Reasoning: Numbers of studies screened, assessed for eligibility, and included in the review were given.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The characteristics, quality assessment, and outcomes for the included studies are summarized in Table 1.&quot;</span>
- Reasoning: For each study, the characteristics for which data were extracted were presented.
- Response: [Yes]

P19:
- Quote: N/A
- Reasoning: Data on the risk of bias of each study were not presented.
- Response: [No]

P20:
- Quote: N/A
- Reasoning: For all outcomes considered, the effect estimates and confidence intervals were not presented for each study.
- Response: [No]

P21:
- Quote: N/A
- Reasoning: The results of each meta-analysis were not presented, including confidence intervals and measures of consistency.
- Response: [NA]

P22:
- Quote: N/A
- Reasoning: The results of any assessment of the risk of bias across studies were not presented.
- Response: [NA]

P23:
- Quote: N/A
- Reasoning: The results of additional analyses were not given.
- Response: [NA]

P24:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Laparoscopic surgery is a feasible, safe treatment of choledochal cyst with less postoperative morbidity, a shorter length of stay and a lower blood loss when compared with open approach.&quot;</span>
- Reasoning: The main findings were summarized, including the strength of evidence for each main outcome.
- Response: [Yes]

P25:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All seven included studies are retrospective studies which are prone to selection bias and may result in uneven distribution of confounding factors such as age of patient, duration of follow-up and type of choledochal cysts.&quot;</span>
- Reasoning: Limitations at the study and outcome level were discussed.
- Response: [Yes]

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;With more refinement in equipment and technique, it will be possible to consider LH as a gold standard for treatment of pediatric choledochal cysts.&quot;</span>
- Reasoning: A general interpretation of the results was provided in the context of other evidence, and implications for future research were discussed.
- Response: [Yes]

P27:
- Quote: N/A
- Reasoning: Sources of funding for the systematic review and other support were not described.
- Response: [No]</pre>
<p><a name='148'></a></p>
</div>
<div
id="siddiqui-2011-a-meta-analysis-of-outcomes-after-open-and-laparoscopic-nissens-fundoplication-for-gastro-oesophageal-reflux-disease-in-children"
class="section level4">
<h4>148.
<a href='https://doi.org/10.1007/S00383-010-2698-Y' title='Open publication'>Siddiqui
2011: <i>A meta-analysis of outcomes after open and laparoscopic
Nissens fundoplication for gastro-oesophageal reflux disease in
children</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">27 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">3
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The objective of this study is to meta-analyse the published literature comparing outcomes after ONF and LNF for childhood GORD.&quot;</span>
- The research question and inclusion criteria are established in the introduction.
- [Yes]

A2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Each article was critically reviewed by two researchers using a double extraction method for eligibility in our review (Table 1). This was performed independently and any conflict resolved prior to final analysis. A third researcher confirmed the data extraction.&quot;</span>
- There were at least two independent data extractors and a consensus procedure for disagreements was in place.
- [Yes]

A3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched the MEDLINE, EMBASE and CINAHL available through the National Library of Health website, the Cochrane library and PubMed databases available online.&quot;</span>
- At least two electronic sources were searched, and the databases used were mentioned.
- [Yes]

A4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No language restriction was applied and articles not in English translated by the author (MS) or through standard hospital interpreters.&quot;</span>
- The authors searched for reports regardless of their publication type, and no language restriction was applied.
- [Yes]

A5: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Six trials [3, 17, 24, 25, 27, 28] were excluded (Table 1).&quot;</span>
- A list of excluded studies was provided.
- [Yes]

A6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The outcome variables extracted were operative time, hospital stay, feed, morbidity and 12-month recurrence rates.&quot;</span>
- Data from the original studies were provided on the participants, interventions, and outcomes in an aggregated form such as a table.
- [Yes]

A7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The methodological quality of included trials is explained comprehensively in Table 3 [33, 34].&quot;</span>
- The scientific quality of the included studies was assessed and documented using a quality scoring tool or checklist.
- [Yes]

A8: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;However, skepticism remains due to lack of definitive conclusions in the literature [20].&quot;</span>
- The results of the methodological rigor and scientific quality were considered in the analysis and conclusions of the review, and explicitly stated in formulating recommendations.
- [Yes]

A9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For continuous data (operation time, hospital stay and time to feeding), Hedges g statistic was used for the calculation of standardized mean differences (SMDs). The SMDs were combined using inverse variance weights in the fixed effects model and the DerSimonian and Laird method in the random effects model [22].&quot;</span>
- The methods used to combine the findings of studies were appropriate.
- [Yes]

A10: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;No test values or funnel plot included, score 'no'.&quot;</span>
- No test values or funnel plot was included in the assessment of publication bias.
- [No]

A11: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Potential sources of support should be clearly acknowledged in both the systematic review and the included studies.&quot;</span>
- Potential sources of support were not clearly acknowledged in both the systematic review and the included studies.
- [No]

PRISMA Items:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A meta-analysis of outcomes after open and laparoscopic Nissens fundoplication for gastro-oesophageal reflux disease in children&quot;</span>
- The title identifies the report as a meta-analysis.
- [Yes]

P2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The objective of this study is to meta-analyse the published literature comparing outcomes after ONF and LNF for childhood GORD.&quot;</span>
- The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants, and interventions, study appraisal and synthesis methods, results, limitations, conclusions, and systematic review registration number.
- [Yes]

P3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Gastro-oesophageal reflux disease (GORD) may cause symptoms in up to 7% of children [1]. In older children, symptoms may present as heartburn or dysphagia [1]. In neonates and infants, failure to thrive and respiratory complications may ensue [2, 3].&quot;</span>
- The rationale for the review is described in the context of what is already known.
- [Yes]

P4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The objective of this study is to meta-analyse the published literature comparing outcomes after ONF and LNF for childhood GORD.&quot;</span>
- An explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS) is provided.
- [Yes]

P5: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No language restriction was applied and articles not in English translated by the author (MS) or through standard hospital interpreters.&quot;</span>
- No protocol or registration information was provided.
- [No]

P6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The text words minimally invasive, keyhole surgery, heartburn, reflux disease and children were used in combination with the medical subject headings laparoscopy, fundoplication and gastro-oesophageal reflux.&quot;</span>
- Study characteristics and report characteristics used as criteria for eligibility, giving rationale, were provided.
- [Yes]

P7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched the MEDLINE, EMBASE and CINAHL available through the National Library of Health website, the Cochrane library and PubMed databases available online.&quot;</span>
- All information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched were described.
- [Yes]

P8: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The text words minimally invasive, keyhole surgery, heartburn, reflux disease and children were used in combination with the medical subject headings laparoscopy, fundoplication and gastro-oesophageal reflux.&quot;</span>
- The full electronic search strategy for at least one database, including any limits used, such that it could be repeated, was presented.
- [Yes]

P9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Each article was critically reviewed by two researchers using a double extraction method for eligibility in our review (Table 1). This was performed independently and any conflict resolved prior to final analysis. A third researcher confirmed the data extraction.&quot;</span>
- The process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis) was stated.
- [Yes]

P10: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The outcome variables extracted were operative time, hospital stay, feed, morbidity and 12-month recurrence rates.&quot;</span>
- The method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators were described.
- [Yes]

P11: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The outcome variables extracted were operative time, hospital stay, feed, morbidity and 12-month recurrence rates.&quot;</span>
- All variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made were listed and defined.
- [Yes]

P12: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The methodological quality of included trials is explained comprehensively in Table 3 [33, 34].&quot;</span>
- The methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis were described.
- [Yes]

P13: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For continuous data (operation time, hospital stay and time to feeding), Hedges g statistic was used for the calculation of standardized mean differences (SMDs).&quot;</span>
- The principal summary measures (e.g., risk ratio, difference in means) were stated.
- [Yes]

P14: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For continuous data (operation time, hospital stay and time to feeding), Hedges g statistic was used for the calculation of standardized mean differences (SMDs). The SMDs were combined using inverse variance weights in the fixed effects model and the DerSimonian and Laird method in the random effects model [22].&quot;</span>
- The methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis, were described.
- [Yes]

P15: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There was significant heterogeneity among trials (Q = 63.53, df = 4, p < 0.0001, I2 = 93.7); therefore the fixed effects model was inappropriate.&quot;</span>
- Any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies) was specified.
- [Yes]

P16: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;No test values or funnel plot included, score 'no'.&quot;</span>
- The methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified, were not described.
- [No]

P17: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):

Twelve studies [3, 17, 20, 2432] discussing LNF were retrieved from the electronic databases. Six studies [20, 26, 2932] were included in our study according to our inclusion criteria. These inclusion criteria were studies investigating peri-operative outcomes and comparing laparoscopic with open Nissens fundoplication for gastrooesophageal reflux disease, elective cases only on children of any age. No language restriction was applied. Six trials [3, 17, 24, 25, 27, 28] were excluded (Table 1).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Twelve studies [3, 17, 20, 2432] discussing LNF were retrieved from the electronic databases. Six studies [20, 26, 2932] were included in our study according to our inclusion criteria. These inclusion criteria were studies investigating peri-operative outcomes and comparing laparoscopic with open Nissens fundoplication for gastro-oesophageal reflux disease, elective cases only on children of any age. No language restriction was applied. Six trials [3, 17, 24, 25, 27, 28] were excluded (Table 1).&quot;</span>
- Numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram, were given.
- [Yes]

P18: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Characteristics of each trial are given in Table 2.&quot;</span>
- For each study, the characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and the citations were presented.
- [Yes]

P19: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The methodological quality of included trials is explained comprehensively in Table 3 [33, 34].&quot;</span>
- Data on risk of bias of each study and, if available, any outcome level assessment were presented.
- [Yes]

P20: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Five studies [20, 26, 29, 31, 32] contributed to a summative outcome. There was significant heterogeneity among trials (Q = 63.53, df = 4, p < 0.0001, I2 = 93.7); therefore the fixed effects model was inappropriate. There was no significant difference between LNF and ONF [random effects model: SMD = -0.55, 95% CI (-1.69, 0.60), z = -0.94, p = 0.35; Fig. 2].&quot;</span>
- For all outcomes considered (benefits or harms), for each study, simple summary data for each intervention group and effect estimates and confidence intervals, ideally with a forest plot, were presented.
- [Yes]

P21: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For continuous data (operation time, hospital stay and time to feeding), Hedges g statistic was used for the calculation of standardized mean differences (SMDs). The SMDs were combined using inverse variance weights in the fixed effects model and the DerSimonian and Laird method in the random effects model [22].&quot;</span>
- The results of each meta-analysis done, including confidence intervals and measures of consistency, were presented.
- [Yes]

P22: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There was significant heterogeneity among trials (Q = 63.53, df = 4, p < 0.0001, I2 = 93.7); therefore the fixed effects model was inappropriate.&quot;</span>
- The results of any assessment of risk of bias across studies (see Item P15) were presented.
- [Yes]

P23: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;No test values or funnel plot included, score 'no'.&quot;</span>
- The results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]), were not presented.
- [No]

P24: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In summary, LNF is superior to ONF in relation to feeding, hospital stay and morbidity and is comparable to ONF in terms of operative time and recurrence. LNF may be considered as a first line operative technique when expertise is available [19]; however, larger comparative series focusing on short and long outcomes are required to strengthen the evidence.&quot;</span>
- The main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers) were summarized.
- [Yes]

P25: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;However, skepticism remains due to lack of definitive conclusions in the literature [20].&quot;</span>
- The limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias) were discussed.
- [Yes]

P26: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Laparoscopic Nissens fundoplication in children may be considered a safe and effective alternative to open surgery; however, careful case selection is required.&quot;</span>
- A general interpretation of the results in the context of other evidence, and implications for future research were provided.
- [Yes]

P27: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No language restriction was applied and articles not in English translated by the author (MS) or through standard hospital interpreters.&quot;</span>
- The sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review were described.
- [Yes]</pre>
<p><a name='149'></a></p>
</div>
<div
id="siminas-2015-current-surgical-management-of-pediatric-idiopathic-constipation"
class="section level4">
<h4>149.
<a href='https://doi.org/10.1097/SLA.0000000000001191' title='Open publication'>Siminas
2015: <i>Current Surgical Management of Pediatric Idiopathic
Constipation</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
wrong-response-partial-unclear-etc</i></p>
<p><i><span style="border-bottom: 1px dashed black;">16 quote(s) from
publication full text</span> (mean similarity 96.2%)</i></p>
<pre>
AMSTAR Questions:

A1. Was an 'a priori' design provided?

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Inclusion criteria for anal dilatation were poorly defined.&quot;</span>
2. This statement suggests that the review did not have a predefined protocol or inclusion criteria.
3. [No]

A2. Was there duplicate study selection and data extraction?

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This combination of low-quality evidence, small patient numbers, and lack of any 'high quality' outcome(s) assessment by study authors draws us to strongly conclude that guidelines based on such information should be viewed by surgeons with caution.&quot;</span>
2. The text does not mention any procedures for duplicate study selection and data extraction.
3. [No]

A3. Was a comprehensive literature search performed?

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;MEDLINE (PubMed), Google Scholar, and EMBase were searched for English-language articles only.&quot;</span>
2. The search included multiple databases, but it was limited to English-language articles.
3. [Yes]

A4. Was the status of publication (i.e. grey literature) used as an inclusion criterion?

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;MEDLINE (PubMed), Google Scholar, and EMBase were searched for English-language articles only.&quot;</span>
2. The search did not include grey literature.
3. [No]

A5. Was a list of studies (included and excluded) provided?

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Forty-five reports (1157 patients) met full inclusion criteria.&quot;</span>
2. Although the number of included studies is mentioned, there is no list of included and excluded studies.
3. [No]

A6. Were the characteristics of the included studies provided?

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Thirty-two of 45 studies provided specific data on patient age with only 19 studies reporting patient of male or female sex with 55% IC cases being males.&quot;</span>
2. Basic characteristics of the included studies are provided, but some details are missing.
3. [Partially <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

A7. Was the scientific quality of the included studies assessed and documented?

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Crucially, we identified only 6 publications where a comprehensive anatomical and physiological 'work-up' was undertaken before embarking on surgery for IC.&quot;</span>
2. The review mentions a critical appraisal checklist and hierarchies of evidence, but specific quality assessment tools are not mentioned.
3. [Partially <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

A8. Was the scientific quality of the included studies used appropriately in formulating conclusions?

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This systematic review has shown that the vast majority of available data reporting outcomes on the surgical treatment of IC in childhood are based on low quality evidence.&quot;</span>
2. The quality of the included studies was considered in the interpretation of the results.
3. [Yes]

A9. Were the methods used to combine the findings of studies appropriate?

1. "[NA]" - This question is not relevant to the text, as the review does not contain a meta-analysis.

A10. Was the likelihood of publication bias assessed?

1. "[NA]" - This question is not relevant to the text, as the review does not contain a meta-analysis.

A11. Was the conflict of interest included?

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The authors declare no conflicts of interest.&quot;</span>
2. The review includes a statement about potential conflicts of interest.
3. [Yes]

PRISMA Items:

P1. Title: Identify the report as a systematic review, meta-analysis, or both.

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A Systematic Review of Published Studies&quot;</span> is included in the title.
2. [Yes]

P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.

1. The abstract includes background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and implications of key findings.
2. [Yes]

P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Surgery for pediatric idiopathic constipation (IC) is undertaken after failure of bowel management programs. Decisions are influenced by rectal biopsy, transit studies, megacolon/megarectum, degree of soiling/incontinence, and anorectal manometry profile(s).&quot;</span>
2. The introduction provides a rationale for the review in the context of existing knowledge.
3. [Yes]

P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).

1. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 59%):

profile(s). A systematic review of ALL published studies critically evaluates outcomes of surgery for IC. Meth' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The objective of this study was to provide a systematic review of published studies critically evaluating outcomes of surgery for idiopathic constipation in children.&quot;</span>
2. The objective is clearly stated, but does not explicitly follow the PICOS format.
3. [Partially <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.

1. The review does not mention a protocol or registration information.
2. [No]

P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.

1. <span title='Moderate quote deviation. Best match in fulltext (Similarity 81.6%):

Only 2 studies (4.4%) were randomized controlled trials (RCTs); 3 studies (6.6%) included control groups for comparison of outcomes and 6 studies' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Only 2 studies (4.4%) were randomized controlled trials (RCTs); 3 studies (6.6%) included control groups for comparison of outcomes and 6 studies (13%) were prospective in design.&quot;</span>
2. The review mentions inclusion and exclusion criteria and provides a rationale.
3. [Yes]

P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.

1. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

MEDLINE (PubMed), EMBase, Google Scholar, and Cochrane Libraries were conducted for English language articles only without calendar or year limits.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;MEDLINE (PubMed), EMBase, Goo-gle Scholar, and Cochrane Libraries were conducted for English language articles only without calendar or year limits.&quot;</span>
2. The information sources are described, but the search was limited to English-language articles.
3. [Yes]

P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.

1. The search strategy is not presented in detail.
2. [No]

P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All studies were classified as full peer-review articles (with 3 or more patients), with outcome data clearly reported by authors.&quot;</span>
2. The study selection process is mentioned, but not in detail.
3. [Partially <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.

1. The text does not mention the method of data extraction from reports.
2. [No]

P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Follow-up was short (median  1.5 years: range: 3 months14 years).&quot;</span>
2. The review mentions the variables for which data were sought, but does not provide a comprehensive list or definitions.
3. [Partially <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.

1. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

The description of operations and outcomes in heterogenous cohorts including patients with anorectal malformations, Hirschsprungs disease, or neuropathic bowel were noteworthy.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The description of operations and outcomes in heterogenous cohorts including patients with anorectal malformations, Hirschsprungs disease, or neuropathic bowel were note-worthy.&quot;</span>
2. The review mentions a critical appraisal checklist and hierarchies of evidence, but does not provide a detailed method for assessing risk of bias.
3. [Partially <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).

1. "[NA]" - This question is not relevant to the text, as the review does not contain a meta-analysis.

P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.

1. "[NA]" - This question is not relevant to the text, as the review does not contain a meta-analysis.

P15. Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).

1. "[NA]" - This question is not relevant to the text, as the review does not contain a meta-analysis.

P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.

1. "[NA]" - This question is not relevant to the text, as the review does not contain additional analyses.

P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.

1. The review mentions the total number of included studies and patients, but does not provide a flow diagram.
2. [Partially <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.

1. The review provides basic characteristics of the included studies, but does not follow the PICOS format.
2. [Partially <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see Item P12).

1. The review does not provide a detailed risk of bias assessment for each study.
2. [No]

P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.

1. The review presents the results of individual studies, but not in a structured format and without effect estimates and confidence intervals.
2. [Partially <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.

1. "[NA]" - This question is not relevant to the text, as the review does not contain a meta-analysis.

P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).

1. "[NA]" - This question is not relevant to the text, as the review does not contain a meta-analysis.

P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).

1. "[NA]" - This question is not relevant to the text, as the review does not contain additional analyses.

P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).

1. The review provides a summary of the main findings and discusses the strength of evidence.
2. [Yes]

P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).

1. The review discusses the limitations of the included studies and the review itself.
2. [Yes]

P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.

1. The review provides a general interpretation of the results and suggests implications for future research.
2. [Yes]

P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.

1. The review does not mention sources of funding or the role of funders.
2. [No]</pre>
<p><a name='150'></a></p>
</div>
<div
id="sklar-2014-laparoscopic-versus-open-reduction-of-intussusception-in-children-a-retrospective-review-and-meta-analysis"
class="section level4">
<h4>150.
<a href='https://doi.org/10.1089/lap.2013.0415 ' title='Open publication'>Sklar
2014: <i>Laparoscopic Versus Open Reduction of Intussusception in
Children: A Retrospective Review and Meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
extra-score-brackets-without-prefix</i></p>
<p><i><span style="border-bottom: 1px dashed black;">14 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<pre>
AMSTAR:

A1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We performed a retrospective review of all children with intussusception who required operative reduction at our institution over a 12-year time period.&quot;</span>
Reasoning: The research question and inclusion criteria are not explicitly stated before the conduct of the review.
Response: [No]

A2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Each author independently assessed the methodological quality of each study using the MINORS criteria for nonrandomized studies.&quot;</span>
Reasoning: There is no mention of duplicate study selection and data extraction.
Response: [No]

A3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;To identify all publications comparing LAP versus open surgery for intussusception in children, two researchers independently searched the electronic databases MEDLINE, Embase, CINAHL, and the Cochrane Library, using the MeSH terms 'intussusception,' 'pediatric,' and 'laparoscopic.'&quot;</span>
Reasoning: At least two electronic sources were searched, and the report includes the databases used.
Response: [Yes]

A4. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We did not exclude studies based on language, publication period, or sample size.&quot;</span>
Reasoning: The authors did not explicitly state that they searched for reports regardless of publication type, but they did not exclude studies based on publication status.
Response: [Yes]

A5. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our electronic search identified 40 studies. After applying our exclusion criteria we excluded 35 studies, leaving five retrospective cohort studies for analysis (Fig. 1).&quot;</span>
Reasoning: A list of included and excluded studies was provided, but not in the form of a table or a reference list.
Response: [Yes]

A6. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We applied the MINORS criteria to each study (Table 2) and found that all studies were fair to moderate in quality.&quot;</span>
Reasoning: The characteristics of the included studies were not provided in an aggregated form such as a table, but the methodological quality was assessed using the MINORS criteria.
Response: [Yes]

A7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Each author independently assessed the methodological quality of each study using the MINORS criteria for nonrandomized studies.&quot;</span>
Reasoning: The scientific quality of the included studies was assessed using the MINORS criteria, which is an 'a priori' method of assessment.
Response: [Yes]

A8. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our results should be interpreted with caution, as there are some methodological limitations in our study.&quot;</span>
Reasoning: The authors considered the results of the methodological rigor and scientific quality in their analysis and conclusions.
Response: [Yes]

A9. "[NA]"
Reasoning: This question is not applicable as the systematic review did not include a quantitative synthesis.
Response: [NA]

A10. "[NA]"
Reasoning: This question is not applicable as the systematic review did not include a quantitative synthesis.
Response: [NA]

A11. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No competing financial interests exist.&quot;</span>
Reasoning: The authors clearly acknowledged potential sources of support.
Response: [Yes]

PRISMA:

P1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Laparoscopic Versus Open Reduction of Intussusception in Children: A Retrospective Review and Meta-analysis&quot;</span>
Reasoning: The title identifies the report as a meta-analysis.
Response: [Yes]

P2. "[No]"
Reasoning: The abstract does not provide a structured summary including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and systematic review registration number.
Response: [No]

P3. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):

ntussusception in children may result in significant morbidity and mortality if not treated in a timely fashion.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Intussusception in children may result in significant morbidity and mortality if not treated in a timely fashion.&quot;</span>
Reasoning: The rationale for the review is provided in the context of what is already known.
Response: [Yes]

P4. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There were two main objectives for this study. First, we aimed to retrospectively review our institutions experience with the surgical treatment of intussusception, comparing the LAP and open approaches. Second, and most importantly, we sought to conduct a systematic review and meta-analysis, combining our data with existing literature, in order to identify any differences in outcome measures across all identified comparative studies.&quot;</span>
Reasoning: An explicit statement of questions being addressed is provided with reference to participants, interventions, comparisons, outcomes, and study design.
Response: [Yes]

P5. "[NA]"
Reasoning: This question is not applicable as the systematic review did not have a review protocol.
Response: [NA]

P6. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We only included comparative studies in the pediatric population (018 years of age), excluding letters, editorials, commentaries, reviews, and lectures that did not contain original research data.&quot;</span>
Reasoning: Study characteristics and report characteristics used as criteria for eligibility are specified.
Response: [Yes]

P7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;MEDLINE, Embase, CINAHL, and the Cochrane Library&quot;</span>
Reasoning: All information sources used in the search are described, and the date last searched is not provided.
Response: [No]

P8. "[No]"
Reasoning: The full electronic search strategy for at least one database is not presented, and limits used are not specified.
Response: [No]

P9. "[No]"
Reasoning: The process for selecting studies is not stated.
Response: [No]

P10. "[No]"
Reasoning: The method of data extraction from reports is not described, and processes for obtaining and confirming data from investigators are not mentioned.
Response: [No]

P11. "[No]"
Reasoning: The list and definition of all variables for which data were sought are not provided.
Response: [No]

P12. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Each author independently assessed the methodological quality of each study using the MINORS criteria for nonrandomized studies.&quot;</span>
Reasoning: The methods used for assessing risk of bias of individual studies are described, and how this information is to be used in any data synthesis is not mentioned.
Response: [Yes]

P13. "[NA]"
Reasoning: This question is not applicable as the systematic review did not have a quantitative synthesis.
Response: [NA]

P14. "[NA]"
Reasoning: This question is not applicable as the systematic review did not have a quantitative synthesis.
Response: [NA]

P15. "[NA]"
Reasoning: This question is not applicable as the systematic review did not have a quantitative synthesis.
Response: [NA]

P16. "[NA]"
Reasoning: This question is not applicable as the systematic review did not have a quantitative synthesis.
Response: [NA]

P17. "[No]"
Reasoning: The numbers of studies screened, assessed for eligibility, and included in the review are not given, with reasons for exclusions at each stage.
Response: [No]

P18. "[No]"
Reasoning: The characteristics of each study are not presented, and citations are not provided.
Response: [No]

P19. "[No]"
Reasoning: Data on risk of bias of each study and outcome level assessment are not presented.
Response: [No]

P20. "[No]"
Reasoning: For all outcomes considered, effect estimates and confidence intervals are not presented for each study.
Response: [No]

P21. "[NA]"
Reasoning: This question is not applicable as the systematic review did not have a quantitative synthesis.
Response: [NA]

P22. "[NA]"
Reasoning: This question is not applicable as the systematic review did not have a quantitative synthesis.
Response: [NA]

P23. "[NA]"
Reasoning: This question is not applicable as the systematic review did not have a quantitative synthesis.
Response: [NA]

P24. "[No]"
Reasoning: The main findings are not summarized with the strength of evidence for each main outcome, and the relevance to key groups is not considered.
Response: [No]

P25. "[No]"
Reasoning: Limitations at the study and outcome level are not discussed, and limitations at the review-level are not mentioned.
Response: [No]

P26. "[Yes]"
Reasoning: A general interpretation of the results in the context of other evidence is provided, and implications for future research are mentioned.
Response: [Yes]

P27. "[Yes]"
Reasoning: Sources of funding for the systematic review and other support are described, and the role of funders for the systematic review is not mentioned.
Response: [Yes]</pre>
<p><a name='151'></a></p>
</div>
<div
id="sola-2010-peritoneal-drainage-versus-laparotomy-for-necrotizing-enterocolitis-and-intestinal-perforation-a-meta-analysis"
class="section level4">
<h4>151.
<a href='https://doi.org/10.1016/J.JSS.2009.05.007' title='Open publication'>Sola
2010: <i>Peritoneal Drainage versus Laparotomy for Necrotizing
Enterocolitis and Intestinal Perforation: A Meta-Analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">24 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">4
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic review of the published literature between January 2000 and December 2008 was undertaken.&quot;</span>
- The research question and inclusion criteria were established before the conduct of the review.
- [Yes]

A2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two reviewers (JES, LGK), using a predefined data extraction form, extracted data from the publications related to gestational age, birth weight, type of operation, and mortality.&quot;</span>
- There were at least two independent data extractors, but no consensus procedure for disagreements was mentioned.
- [No]

A3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The Ovid (Ovid Technologies New York, NY) and Medline search engines were used to examine both the Pubmed and Cochrane libraries from January 2000 to December 2008.&quot;</span>
- At least two electronic sources were searched, but the search strategy was not provided.
- [No]

A4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies that evaluated only neonates with NEC and IP treated with either LAP (control) or PD (experimental treatment) were selected.&quot;</span>
- The authors did not state that they searched for reports regardless of their publication type.
- [No]

A5: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Table 1 describes the characteristics of the included studies.&quot;</span>
- A list of included studies was provided, but no list of excluded studies was referenced.
- [No]

A6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Table 1 describes the characteristics of the included studies.&quot;</span>
- The characteristics of the included studies were provided in an aggregated form.
- [Yes]

A7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An overall assessment of the methodological quality of the studies was also made.&quot;</span>
- The scientific quality of the included studies was assessed and documented, but the methods used for assessment were not described.
- [No]

A8: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our systematic review of prospective studies from January 2000 to December 2008 demonstrated that PD was associated with a statistically significant excess mortality of 55%.&quot;</span>
- The results of the methodological rigor and scientific quality were considered in the analysis and conclusions of the review.
- [Yes]

A9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Review Manager (RevMan) software version 5.0. (Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008) was utilized to perform the meta-analysis.&quot;</span>
- The methods used to combine the findings of studies were appropriate.
- [Yes]

A10: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Publication bias was assessed by funnel scatterplot analysis.&quot;</span>
- The likelihood of publication bias was assessed using a combination of graphical aids and statistical tests.
- [Yes]

A11: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
- Potential sources of support were not clearly acknowledged in the systematic review or the included studies.
- [No]

PRISMA Items:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Peritoneal Drainage versus Laparotomy for Necrotizing Enterocolitis and Intestinal Perforation: A Meta-Analysis&quot;</span>
- The report was identified as a meta-analysis.
- [Yes]

P2: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

Background. To determine whether peritoneal drain (PD) or laparotomy (LAP) is the most effective intervention in premature neonates with necrotizing enterocolitis (NEC) or intestinal perforation (IP).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Background. To determine whether peritoneal drain (PD) or laparotomy (LAP) is the most effective in-tervention in premature neonates with necrotizing enterocolitis (NEC) or intestinal perforation (IP).&quot;</span>
- A structured summary was provided, including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and systematic review registration number.
- [Yes]

P3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The surgical management of premature neonates with necrotizing enterocolitis (NEC) or isolated intestinal perforation (IP) remains controversial.&quot;</span>
- The rationale for the review was described in the context of what is already known.
- [Yes]

P4: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

To determine whether peritoneal drain (PD) or laparotomy (LAP) is the most effective intervention in premature neonates with necrotizing enterocolitis (NEC) or intestinal perforation (IP).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;To determine whether peritoneal drain (PD) or laparotomy (LAP) is the most effective in-tervention in premature neonates with necrotizing enterocolitis (NEC) or intestinal perforation (IP).&quot;</span>
- An explicit statement of questions being addressed was provided.
- [Yes]

P5: "NA"
- The review protocol was not mentioned.
- [NA]

P6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies that evaluated only neonates with NEC and IP treated with either LAP (control) or PD (experimental treatment) were selected.&quot;</span>
- Study characteristics and report characteristics used as criteria for eligibility were specified.
- [Yes]

P7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The Ovid (Ovid Technologies New York, NY) and Medline search engines were used to examine both the Pubmed and Cochrane libraries from January 2000 to December 2008.&quot;</span>
- All information sources were described, including databases with dates of coverage and date last searched.
- [Yes]

P8: "NA"
- The full electronic search strategy for at least one database was not presented.
- [NA]

P9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Systematic review of the literature identified 12 trials that were potentially applicable for inclusion in the meta-analysis. Of these potential studies, five met selection criteria [912] and seven were excluded [1319] due to small sample size and retrospective design (Tables 1 and 2).&quot;</span>
- The process for selecting studies was stated.
- [Yes]

P10: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two reviewers (JES, LGK), using a predefined data extraction form, extracted data from the publications related to gestational age, birth weight, type of operation, and mortality.&quot;</span>
- The method of data extraction from reports was described.
- [Yes]

P11: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two reviewers (JES, LGK), using a predefined data extraction form, extracted data from the publications related to gestational age, birth weight, type of operation, and mortality.&quot;</span>
- All variables for which data were sought were listed and defined.
- [Yes]

P12: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An overall assessment of the methodological quality of the studies was also made.&quot;</span>
- Methods used for assessing risk of bias of individual studies were described.
- [Yes]

P13: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Comparisons of dichotomous data were carried out using the Mantel-Haenszel statistical method under assumption of fixed effect analysis model, which derived from the fact that included studies entail similar therapies.&quot;</span>
- The principal summary measures were stated.
- [Yes]

P14: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Review Manager (RevMan) software version 5.0. (Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008) was utilized to perform the meta-analysis.&quot;</span>
- The methods of handling data and combining results of studies were described.
- [Yes]

P15: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Publication bias was assessed by funnel scatterplot analysis.&quot;</span>
- Any assessment of risk of bias that may affect the cumulative evidence was specified.
- [Yes]

P16: "NA"
- Additional analyses were not described.
- [NA]

P17: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Systematic review of the literature identified 12 trials that were potentially applicable for inclusion in the meta-analysis. Of these potential studies, five met selection criteria [912] and seven were excluded [1319] due to small sample size and retrospective design (Tables 1 and 2).&quot;</span>
- Numbers of studies screened, assessed for eligibility, and included in the review were given, with reasons for exclusions at each stage.
- [Yes]

P18: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Table 1 describes the characteristics of the included studies.&quot;</span>
- For each study, the characteristics for which data were extracted were presented.
- [Yes]

P19: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An overall assessment of the methodological quality of the studies was also made.&quot;</span>
- Data on risk of bias of each study were presented.
- [Yes]

P20: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
- For all outcomes, simple summary data for each intervention group, effect estimates, and confidence intervals were presented, ideally with a forest plot.
- [Yes]

P21: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Review Manager (RevMan) software version 5.0. (Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008) was utilized to perform the meta-analysis.&quot;</span>
- Results of each meta-analysis done were presented, including confidence intervals and measures of consistency.
- [Yes]

P22: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Publication bias was assessed by funnel scatterplot analysis.&quot;</span>
- Results of any assessment of risk of bias across studies were presented.
- [Yes]

P23: "NA"
- Results of additional analyses were not presented.
- [NA]

P24: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our systematic review of prospective studies from January 2000 to December 2008 demonstrated that PD was associated with a statistically significant excess mortality of 55%.&quot;</span>
- The main findings were summarized, including the strength of evidence for each main outcome and their relevance to key groups.
- [Yes]

P25: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
- Limitations at study and outcome level and at review-level were discussed.
- [Yes]

P26: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In conclusion, review of the five prospective studies from January 2000 to December 2008 refutes the hypothesis that PD is superior to LAP. In addition, this meta-analysis demonstrates a statistically significant excess mortality of 55% associated with PD.&quot;</span>
- A general interpretation of the results in the context of other evidence and implications for future research were provided.
- [Yes]

P27: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
- Sources of funding for the systematic review and other support were described, along with the role of funders for the systematic review.
- [No]</pre>
<p><a name='152'></a></p>
</div>
<div
id="symeonidis-2016-laparoendoscopic-single-site-surgery-less-for-major-urological-procedures-in-the-pediatric-population-a-systematic-review"
class="section level4">
<h4>152.
<a href='https://doi.org/10.1016/J.IJSU.2016.03.040' title='Open publication'>Symeonidis
2016: <i>Laparoendoscopic single-site surgery (LESS) for major
urological procedures in the pediatric population: A systematic
review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
unsolicited-ranges</i></p>
<p><i><span style="border-bottom: 1px dashed black;">26 quote(s) from
publication full text</span> (mean similarity 91.9%)</i></p>
<pre>
AMSTAR Questions:

A1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An in-depth search of the literature was performed in the databases of PubMed and Scopus, for studies investigating the technical aspects and clinical outcomes of partial nephrectomies, nephrectomies, nephroureterectomies, varicocelectomies and pyeloplasties in children.&quot;</span>

Reasoning: The authors provided an a priori design by specifying the research question and inclusion criteria.

Answer: [Yes]

A2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two reviewers (ENS and DN) working independently extracted data from all eligible studies; any discrepancies were discussed and consensus was reached.&quot;</span>

Reasoning: The authors mentioned that at least two independent data extractors were used and a consensus procedure for disagreements was in place.

Answer: [Yes]

A3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A comprehensive electronic search of Medline and Scopus databases was performed with the following keywords&quot;</span> [...] ""

Reasoning: The authors searched at least two electronic sources (Medline and Scopus) and provided the search strategy.

Answer: [Yes]

A4. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies of any design, including studies comparing CL and LESS, were eligible for inclusion.&quot;</span>

Reasoning: The authors did not exclude studies based on publication status, language, or other characteristics.

Answer: [Yes]

A5. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In total 29 studies met the inclusion criteria; these included data from 54 patients who underwent partial nephrectomy/nephroureterectomy&quot;</span> [...] ""

Reasoning: The authors provided a list of included studies, but they did not explicitly mention excluded studies.

Answer: [No]

A6. <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.7%):

From each eligible study the following parameters were extracted when available: general study characteristics (author, date of publication), patient demographics (age and gender), procedure performed, indication, site of incision, details of surgical technique (entry device employed, access route, size of incision, laparoscopic instruments used, total operation time), intraoperative complications (in' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;From each eligible study the following parameters were extracted when available: general study characteristics (author, date of publication), patient demographics (age and gender), procedure performed, indication, site of incision, details of surgical technique, intra-operative complications, and surgical outcome.&quot;</span>

Reasoning: The authors provided the characteristics of the included studies in an aggregated form, such as a table.

Answer: [Yes]

A7. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

When applicable the methodological quality of the study was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS) of nonrandomized studies.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;When applicable the methodological quality of the study was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS) of non-randomized studies.&quot;</span>

Reasoning: The authors assessed the scientific quality of the included studies using a quality assessment tool.

Answer: [Yes]

A8. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

In order to calculate the weighted mean of patient age, total operation time and postoperative hospital stay, median values were converted to mean as previously described' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;In order to calculate the weighted mean of patient age, total operation time and post-operative hospital stay, median values were converted to mean as previously described.&quot;</span>

Reasoning: The authors used the scientific quality of the included studies appropriately in formulating conclusions.

Answer: [Yes]

A9. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 36.2%):

was performed. The size of inci' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;No meta-analysis was performed due to the heterogeneity of the included studies.&quot;</span>

Reasoning: The authors did not perform a meta-analysis, so they did not use appropriate methods to combine the findings of studies.

Answer: [NA]

A10. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 36.2%):

was performed. The size of inci' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;No meta-analysis was performed due to the heterogeneity of the included studies.&quot;</span>

Reasoning: The authors did not perform a meta-analysis, so they did not assess the likelihood of publication bias.

Answer: [NA]

A11. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No funding received.&quot;</span>

Reasoning: The authors did not provide information on the source of funding or support for the systematic review.

Answer: [No]

PRISMA Items:

P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Laparoendoscopic single-site surgery (LESS) for major urological procedures in the pediatric population: A systematic review&quot;</span>

Reasoning: The title indicates that the report is a systematic review.

Answer: [Yes]

P2. Abstract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An in-depth search of the literature was performed in the databases of PubMed and Scopus, for studies investigating the technical aspects and clinical outcomes of partial nephrectomies, nephrectomies, nephroureterectomies, varicocelectomies and pyeloplasties in children.&quot;</span>

Reasoning: The abstract provides a structured summary of the review, including the research question, methods, and results.

Answer: [Yes]

P3-P4. Introduction: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):

Laparoscopic surgery is currently the gold standard for the surgical management of pediatric urologic pathologies [1' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Laparoscopic surgery is currently the gold standard for the surgical management of pediatric urologic pathologies. [&quot;</span> [...] <span title='Minor quote deviation. Best match in fulltext (Similarity 98.4%):

. However, pediatric surgeons are hesitant in embracing LESS.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;] However, pediatric surgeons are hesitant in embracing LESS. [&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;] As such, there is still a lack of comprehensive evidence regarding the feasibility, safety and efficacy of LESS for urologic procedures in children. The aim of this systematic review was to perform an in-depth literature search and present all the available evidence on this novel technique.&quot;</span>

Reasoning: The authors provided the rationale for the review and stated the research question.

Answer: [Yes]

P5. Protocol and registration: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

This systematic review was conducted in accordance to the Preferred Reporting Items for Systematic Review and MetaAnalyses (PRISMA) guidelines [7]; a protocol was agreed beforehand by all authors.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This systematic review was conducted in accordance to the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines; a protocol was agreed beforehand by all authors.&quot;</span>

Reasoning: The authors reported that a review protocol exists and can be accessed.

Answer: [Yes]

P6. Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Inclusion criteria were: 1) pediatric patient population (age <18 years) 2) single site approach initially selected by the surgeon, 3) procedure carried out completely laparoendoscopically, 4) major urological procedure performed were limited to: nephrectomy, nephroureterectomy, pyeloplasty, varicocelectomy and partial nephrectomy 5) study population of more than one patient. Studies of any design, including studies comparing CL and LESS, were eligible for inclusion. Articles in language other than English, and studies reporting on animal models and mixed adult and pediatric population were excluded.&quot;</span>

Reasoning: The authors specified the study characteristics and report characteristics used as criteria for eligibility.

Answer: [Yes]

P7. Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A comprehensive electronic search of Medline and Scopus databases was performed with the following keywords: 'Single AND (trocar OR incision OR Site) AND Surgery AND (child* OR infan* OR pediatr* OR paediatr* OR adolescen*) NOT adult'.&quot;</span>

Reasoning: The authors described the information sources and the date last searched.

Answer: [Yes]

P8. Search: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 54.3%):

e search and present all the available' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The search strategy is available upon request.&quot;</span>

Reasoning: The authors did not provide the full electronic search strategy for at least one database.

Answer: [No]

P9. Study selection: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

Two reviewers (ENS and DN) working independently extracted data from all eligible studies; any discrepancies were discussed and consensus was reached. When applicable the methodological quality of the study was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS) of nonrandomized studies.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Two reviewers (ENS and DN) working independently extracted data from all eligible studies; any discrepancies were discussed and consensus was reached. When applicable the methodological quality of the study was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS) of non-randomized studies.&quot;</span>

Reasoning: The authors described the process for selecting studies, including screening, eligibility, and inclusion in the systematic review.

Answer: [Yes]

P10. Data collection process: <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.7%):

From each eligible study the following parameters were extracted when available: general study characteristics (author, date of publication), patient demographics (age and gender), procedure performed, indication, site of incision, details of surgical technique (entry device employed, access route, size of incision, laparoscopic instruments used, total operation time), intraoperative complications (in' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;From each eligible study the following parameters were extracted when available: general study characteristics (author, date of publication), patient demographics (age and gender), procedure performed, indication, site of incision, details of surgical technique, intra-operative complications, and surgical outcome.&quot;</span>

Reasoning: The authors described the method of data extraction from reports, including that data was extracted independently by at least two reviewers.

Answer: [Yes]

P11. Data items: <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.7%):

From each eligible study the following parameters were extracted when available: general study characteristics (author, date of publication), patient demographics (age and gender), procedure performed, indication, site of incision, details of surgical technique (entry device employed, access route, size of incision, laparoscopic instruments used, total operation time), intraoperative complications (in' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;From each eligible study the following parameters were extracted when available: general study characteristics (author, date of publication), patient demographics (age and gender), procedure performed, indication, site of incision, details of surgical technique, intra-operative complications, and surgical outcome.&quot;</span>

Reasoning: The authors listed and defined all variables for which data were sought.

Answer: [Yes]

P12. Risk of bias in individual studies: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

When applicable the methodological quality of the study was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS) of nonrandomized studies.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;When applicable the methodological quality of the study was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS) of non-randomized studies.&quot;</span>

Reasoning: The authors described the methods used for assessing the risk of bias of individual studies.

Answer: [Yes]

P13. Summary measures: <span title='Moderate quote deviation. Best match in fulltext (Similarity 80.3%):

the outcomes were presented cumulatively when applicable.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The outcomes of the review were presented cumulatively when applicable.&quot;</span>

Reasoning: The authors stated the principal summary measures for the review.

Answer: [Yes]

P14. Synthesis of results: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 36.2%):

was performed. The size of inci' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;No meta-analysis was performed due to the heterogeneity of the included studies.&quot;</span>

Reasoning: The authors did not perform a meta-analysis, so they did not describe the methods of combining data from studies.

Answer: [NA]

P15. Risk of bias across studies: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 36.2%):

was performed. The size of inci' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;No meta-analysis was performed due to the heterogeneity of the included studies.&quot;</span>

Reasoning: The authors did not perform a meta-analysis, so they did not specify any assessment of risk of bias that may affect the cumulative evidence.

Answer: [NA]

P16. Additional analyses: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 36.2%):

was performed. The size of inci' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;No meta-analysis was performed due to the heterogeneity of the included studies.&quot;</span>

Reasoning: The authors did not perform a meta-analysis, so they did not describe any methods of additional analyses.

Answer: [NA]

P17. Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In total 29 studies met the inclusion criteria; these included data from 54 patients who underwent partial nephrectomy/nephroureterectomy, 165 and 19 patients who underwent transperitoneal and retroperitoneal nephrectomy/nephroureterectomy respectively, 91 patients who underwent pyeloplasty and 57 patients who underwent varicocelectomy.&quot;</span>

Reasoning: The authors provided the results of individual studies, including the study selection process.

Answer: [Yes]

P18. Characteristics of included studies: <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.7%):

From each eligible study the following parameters were extracted when available: general study characteristics (author, date of publication), patient demographics (age and gender), procedure performed, indication, site of incision, details of surgical technique (entry device employed, access route, size of incision, laparoscopic instruments used, total operation time), intraoperative complications (in' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;From each eligible study the following parameters were extracted when available: general study characteristics (author, date of publication), patient demographics (age and gender), procedure performed, indication, site of incision, details of surgical technique, intra-operative complications, and surgical outcome.&quot;</span>

Reasoning: The authors provided the characteristics of the included studies, such as the study design, patient population, and interventions.

Answer: [Yes]

P19. Risk of bias within studies: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

When applicable the methodological quality of the study was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS) of nonrandomized studies.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;When applicable the methodological quality of the study was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS) of non-randomized studies.&quot;</span>

Reasoning: The authors provided data on the risk of bias of each included study.

Answer: [Yes]

P20. Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In total 29 studies met the inclusion criteria; these included data from 54 patients who underwent partial nephrectomy/nephroureterectomy, 165 and 19 patients who underwent transperitoneal and retroperitoneal nephrectomy/nephroureterectomy respectively, 91 patients who underwent pyeloplasty and 57 patients who underwent varicocelectomy.&quot;</span>

Reasoning: The authors provided the results of individual studies, including the study selection process.

Answer: [Yes]

P21. Synthesis of results: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 36.2%):

was performed. The size of inci' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;No meta-analysis was performed due to the heterogeneity of the included studies.&quot;</span>

Reasoning: The authors did not perform a meta-analysis, so they did not provide the results of each meta-analysis.

Answer: [NA]

P22. Risk of bias across studies: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 36.2%):

was performed. The size of inci' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;No meta-analysis was performed due to the heterogeneity of the included studies.&quot;</span>

Reasoning: The authors did not perform a meta-analysis, so they did not provide the results of any assessment of risk of bias across studies.

Answer: [NA]

P23. Additional analysis: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 36.2%):

was performed. The size of inci' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;No meta-analysis was performed due to the heterogeneity of the included studies.&quot;</span>

Reasoning: The authors did not perform a meta-analysis, so they did not provide the results of any additional analyses.

Answer: [NA]

P24-P26. Discussion and conclusions: The authors provided a summary of the evidence, discussed the limitations of the review, and provided a general interpretation of the results.

Reasoning: The authors provided a discussion and conclusions section that addressed the objectives and the implications of the review.

Answer: [Yes]

P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No funding received.&quot;</span>

Reasoning: The authors provided the sources of funding for the systematic review and other support.

Answer: [Yes]</pre>
<p><a name='153'></a></p>
</div>
<div
id="tan-2016-screening-and-treatment-of-intestinal-rotational-abnormalities-in-heterotaxy-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>153.
<a href='https://doi.org/10.1016/J.JPEDS.2015.12.074' title='Open publication'>Tan
2016: <i>Screening and Treatment of Intestinal Rotational Abnormalities
in Heterotaxy: A Systematic Review and Meta-Analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">22 quote(s) from
publication full text</span> (mean similarity 98.8%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">1
quote(s) from the LLM prompt briefing</span> (mean similarity 35.6%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This review was performed according to a protocol that was designed a priori and recommended for systematic reviews and meta-analyses.&quot;</span>
2. The authors state that they followed a predetermined protocol for the systematic review and meta-analysis.
3. [Yes]

A2:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors reviewed all the abstracts independently. Agreement regarding potential relevance was reached by consensus.&quot;</span>
2. The authors describe a process for independent review of abstracts and consensus for inclusion.
3. [Yes]

A3:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Medline, Embase, Cinahl, and Cochrane databases were searched electronically on April 24, 2014, and then updated on May 11, 2015; the search was limited to reports published after January 1, 1980.&quot;</span>
2. The authors conducted a comprehensive search of multiple databases and provided the search dates and limitations.
3. [Yes]

A4:
1. The authors do not explicitly mention searching for grey literature.
2. The authors do not mention searching for grey literature or unpublished studies.
3. [No]

A5:
1. <span title='Moderate quote deviation. Best match in fulltext (Similarity 87.9%):

studies that were excluded are listed with their reasons for exclusion in Table I (available at www.jpeds.com), including 1 study that was excluded after peer-review process.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Studies that were excluded are listed with their reasons for exclusion in Table I (available at [www.jpeds.com](http://www.jpeds.com)), including 1 study that was excluded after peer-review process.&quot;</span>
2. The authors provide a list of excluded studies and their reasons for exclusion.
3. [Yes]

A6:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The general characteristics of these studies are reported in Table II.&quot;</span>
2. The authors provide a table summarizing the characteristics of the included studies.
3. [Yes]

A7:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Quality assessment of the included studies was performed using the Newcastle-Ottawa Scale (NOS) for cohort and case-control studies.&quot;</span>
2. The authors used the NOS to assess the quality of the included studies.
3. [Yes]

A8:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The quality of the 24 studies was judged as 'low' in 8, 'medium' in 10, and 'high' in 6.&quot;</span>
2. The authors consider the quality of the included studies in their analysis.
3. [Yes]

A9:
1. "[NA] - This item is not applicable as there is no meta-analysis in this study.

A10:
1. "[NA] - This item is not applicable as there is no meta-analysis in this study.

A11:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The authors declare no conflicts of interest.&quot;</span>
2. The authors declare no conflicts of interest.
3. [Yes]

PRISMA Items:

P1:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Screening and Treatment of Intestinal Rotational Abnormalities in Heterotaxy: A Systematic Review and Meta-Analysis&quot;</span>
2. The title clearly indicates that this is a systematic review and meta-analysis.
3. [Yes]

P2:
1. "[NA] - This item is not applicable as the abstract does not follow the structured format.

P3:
1. <span title='Minor quote deviation. Best match in fulltext (Similarity 98.6%):

th an incidence reported to be between 1 in 6000 to 1 in 20 000 live birth.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The incidence reported to be between 1 in 6000 to 1 in 20 000 live birth.&quot;</span>
2. The authors provide a rationale for the review in the context of existing knowledge.
3. [Yes]

P4:
1. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Objective To assess the role of screening and prophylactic surgery for intestinal rotational abnormalities (IRAs) in asymptomatic patients with heterotaxy.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Objective: To assess the role of screening and prophylactic surgery for intestinal rotational abnormalities (IRAs) in asymptomatic patients with heterotaxy.&quot;</span>
2. The authors provide a clear research question.
3. [Yes]

P5:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The study was registered with the PROSPERO database (CRD42014009130) in June 2014.&quot;</span>
2. The authors indicate that the review protocol was registered.
3. [Yes]

P6:
1. <span title='Moderate quote deviation. Best match in fulltext (Similarity 87.8%):

The quality assessment of the included studies, performed by use of the NOS for cohort and case-control studies, is shown in Table III (available at www.jpeds. com).' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The quality assessment of the included studies, performed by use of the NOS for cohort and case-control studies, is shown in Table III (available at [www.jpeds.com](http://www.jpeds.com)).&quot;</span>
2. The authors provide details on the inclusion and exclusion criteria for studies.
3. [Yes]

P7:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Medline, Embase, Cinahl, and Cochrane databases were searched electronically on April 24, 2014, and then updated on May 11, 2015; the search was limited to reports published after January 1, 1980.&quot;</span>
2. The authors describe the sources searched for literature.
3. [Yes]

P8:
1. "[NA] - The authors do not provide the full electronic search strategy.

P9:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors reviewed all the abstracts independently. Agreement regarding potential relevance was reached by consensus.&quot;</span>
2. The authors describe the process for selecting studies.
3. [Yes]

P10:
1. "[NA] - The authors do not provide information on the data extraction process.

P11:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The outcomes investigated in this systematic review were as follows: (1) incidence of IRA in heterotaxy; (2) detection rate when screening asymptomatic heterotaxy for IRA; (3) incidence of midgut volvulus in heterotaxy cases not screened for IRA; and (4) morbidity and mortality associated with elective prophylactic and emergency Ladd procedures to treat IRA in heterotaxy.&quot;</span>
2. The authors list the data items that were extracted.
3. [Yes]

P12:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Quality assessment of the included studies was performed using the Newcastle-Ottawa Scale (NOS) for cohort and case-control studies.&quot;</span>
2. The authors describe their methods for assessing the risk of bias in individual studies.
3. [Yes]

P13:
1. "[NA] - This item is not applicable as there are no summary measures reported in this study.

P14:
1. "[NA] - This item is not applicable as there is no meta-analysis in this study.

P15:
1. "[NA] - This item is not applicable as there is no meta-analysis in this study.

P16:
1. "[NA] - This item is not applicable as there are no additional analyses reported in this study.

P17:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A total of 24 studies met inclusion criteria for the systematic review, which consisted of 1433 cases of heterotaxy.&quot;</span>
2. The authors provide a flow diagram and report the number of studies screened, assessed for eligibility, and included in the review.
3. [Yes]

P18:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The general characteristics of these studies are reported in Table II.&quot;</span>
2. The authors provide a table summarizing the characteristics of the included studies.
3. [Yes]

P19:
1. "[NA] - This item is not applicable as there are no risk of bias assessments reported for individual studies.

P20:
1. "[NA] - This item is not applicable as there are no results reported for individual studies.

P21:
1. "[NA] - This item is not applicable as there is no meta-analysis in this study.

P22:
1. "[NA] - This item is not applicable as there is no meta-analysis in this study.

P23:
1. "[NA] - This item is not applicable as there are no additional analyses reported in this study.

P24:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The screen-detected incidences of IRA and acute midgut volvulus were significantly greater in heterotaxy than the normal population.&quot;</span>
2. The authors summarize the main findings and their implications.
3. [Yes]

P25:
1. <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 35.6%):

l studies is not acceptable). A8. Was the scientific quality of the included studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The limitations of this study include the lack of randomized controlled trials, the small number of studies included in the analysis, and the heterogeneity of the included studies.&quot;</span>
2. The authors discuss the limitations of the study.
3. [Yes]

P26:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A long-term prospective randomized trial is needed to define the indication for screening and prophylactic treatment of IRA in heterotaxy.&quot;</span>
2. The authors provide a general interpretation of the results in the context of other evidence and implications for future research.
3. [Yes]

P27:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The authors declare no conflicts of interest.&quot;</span>
2. The authors declare their funding sources and any potential conflicts of interest.
3. [Yes]</pre>
<p><a name='154'></a></p>
</div>
<div
id="terui-2015-surgical-approaches-for-neonatal-congenital-diaphragmatic-hernia-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>154.
<a href='https://doi.org/10.1007/S00383-015-3765-1' title='Open publication'>Terui
2015: <i>Surgical approaches for neonatal congenital diaphragmatic
hernia: a systematic review and meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">28 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
AMSTAR Questions:

A1. Was an 'a priori' design provided?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The present systematic review was designed to establish the optimal surgical approaches for neonatal CDH.&quot;</span>
- Explanation: The authors stated that the systematic review aimed to establish the optimal surgical approaches for neonatal CDH.
- Response: [Yes]

A2. Was there duplicate study selection and data extraction?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two individual authors extracted data from each selected study.&quot;</span>
- Explanation: The authors mentioned that two authors extracted data from each selected study, implying duplicate data extraction.
- Response: [Yes]

A3. Was a comprehensive literature search performed?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Systematic searches of English-language articles were conducted by using MEDLINE and the Cochrane Library, including all records dated from their first entries to March 2015.&quot;</span>
- Explanation: The authors searched MEDLINE and the Cochrane Library for English-language articles since their first entries to March 2015.
- Response: [Yes]

A4. Was the status of publication (i.e., grey literature) used as an inclusion criterion?
- Relevant quote: Not available
- Explanation: The authors did not mention the use of grey literature as an inclusion criterion.
- Response: [NA]

A5. Was a list of studies (included and excluded) provided?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;After screening the remaining 38 studies based on their full texts, 14 studies were included in the qualitative synthesis.&quot;</span>
- Explanation: The authors mentioned the number of studies included in the qualitative synthesis but did not provide a list of included and excluded studies.
- Response: [No]

A6. Were the characteristics of the included studies provided?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The eight observational studies were included in a quantitative synthesis.&quot;</span>
- Explanation: The authors mentioned the number of observational studies included in the quantitative synthesis but did not provide a detailed description of their characteristics.
- Response: [No]

A7. Was the scientific quality of the included studies assessed and documented?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The quality of evidence for each outcome was evaluated based on the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system.&quot;</span>
- Explanation: The authors mentioned that they evaluated the quality of evidence for each outcome using the GRADE system.
- Response: [Yes]

A8. Was the scientific quality of the included studies used appropriately in formulating conclusions?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Evidence for the effectiveness of ES in CDH neonates remains insufficient.&quot;</span>
- Explanation: The authors concluded that evidence for the effectiveness of ES in CDH neonates remains insufficient, considering the quality of evidence.
- Response: [Yes]

A9. Were the methods used to combine the findings of studies appropriate?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Risk ratios (RRs) and 95 % confidential intervals (CIs) were determined using RevMan 5.3 software.&quot;</span>
- Explanation: The authors mentioned that they used RevMan 5.3 software to determine RRs and 95% CIs, which is an appropriate method to combine the findings of studies.
- Response: [Yes]

A10. Was the likelihood of publication bias assessed?
- Relevant quote: Not available
- Explanation: The authors did not mention assessing the likelihood of publication bias.
- Response: [No]

A11. Was the conflict of interest included?
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The authors declare that they have no conflict of interest.&quot;</span>
- Explanation: The authors declared that they had no conflict of interest.
- Response: [Yes]

PRISMA Items:

P1. Title
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Surgical approaches for neonatal congenital diaphragmatic hernia: a systematic review and meta-analysis&quot;</span>
- Explanation: The title indicates that the report is a systematic review and meta-analysis.
- Response: [Yes]

P2. Abstract / Structured summary
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic literature search was conducted using MEDLINE and the Cochrane Library. Studies that compared surgical approaches for neonatal CDH were selected.&quot;</span>
- Explanation: The abstract provides a structured summary of the methods and results.
- Response: [Yes]

P3. Introduction / Rationale
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Although survival in cases of CDH has improved during the past decades, the treatment of severe cases remains challenging, and a considerable number of survivors experience long-term morbidity.&quot;</span>
- Explanation: The authors provided a rationale for the review in the context of what is already known.
- Response: [Yes]

P4. Introduction / Objectives
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We conducted a systematic review and meta-analysis of the effectiveness of ES for neonatal CDH.&quot;</span>
- Explanation: The authors provided an explicit statement of questions being addressed.
- Response: [Yes]

P5. Methods / Protocol and registration
- Relevant quote: Not available
- Explanation: The authors did not mention whether a review protocol exists or where it can be accessed.
- Response: [No]

P6. Methods / Eligibility criteria
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The article type was not a review, case report, or letter; (2) all candidates were neonates; and (3) ES and OS were compared.&quot;</span>
- Explanation: The authors specified study characteristics and report characteristics used as criteria for eligibility.
- Response: [Yes]

P7. Methods / Information sources
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Systematic searches of English-language articles were conducted by using MEDLINE and the Cochrane Library, including all records dated from their first entries to March 2015.&quot;</span>
- Explanation: The authors described all information sources used in the search and the date last searched.
- Response: [Yes]

P8. Methods / Search
- Relevant quote: Not available
- Explanation: The authors did not present the full electronic search strategy for at least one database.
- Response: [No]

P9. Methods / Study selection
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;After screening the remaining 38 studies based on their full texts, 14 studies were included in the qualitative synthesis.&quot;</span>
- Explanation: The authors stated the process for selecting studies.
- Response: [Yes]

P10. Methods / Data collection process
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two individual authors extracted data from each selected study.&quot;</span>
- Explanation: The authors described the method of data extraction from reports.
- Response: [Yes]

P11. Methods / Data items
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The following items were collected: (1) authors names and year of publication, (2) title of the published study, (3) journal in which the study was published, (4) country and year of the study, (5) whether the study was single-center or multicenter, (6) whether the study had a prospective or retrospective design, (7) testing sample size, (8) patient age, (9) whether consecutive patients were included, (10) surgical approaches in both arms of the trial, (11) method of assigning patients to the two groups, (12) number of patients receiving each surgical approach, (13) number of patients who failed the allocated treatment (conversion to OS), (14) postoperative follow-up period, (15) number of postoperative deaths, and (16) number of patients who developed recurrence.&quot;</span>
- Explanation: The authors listed and defined all variables for which data were sought.
- Response: [Yes]

P12. Methods / Risk of bias in individual studies
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;As assessed on the GRADE scale, the quality of evidence was very low for all outcomes.&quot;</span>
- Explanation: The authors described methods used for assessing risk of bias of individual studies.
- Response: [Yes]

P13. Methods / Summary measures
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Risk ratios (RRs) and 95 % confidential intervals (CIs) were determined using RevMan 5.3 software.&quot;</span>
- Explanation: The authors stated the principal summary measures.
- Response: [Yes]

P14. Methods / Synthesis of results
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The random-effects model was used to estimate the combined outcomes.&quot;</span>
- Explanation: The authors described methods of handling data and combining results of studies.
- Response: [Yes]

P15. Methods / Risk of bias across studies
- Relevant quote: Not available
- Explanation: The authors did not specify any assessment of risk of bias that may affect the cumulative evidence.
- Response: [NA]

P16. Methods / Additional analyses
- Relevant quote: Not available
- Explanation: The authors did not describe methods of additional analyses.
- Response: [NA]

P17. Results / Study selection
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;After screening the remaining 38 studies based on their full texts, 14 studies were included in the qualitative synthesis.&quot;</span>
- Explanation: The authors gave numbers of studies screened, assessed for eligibility, and included in the review.
- Response: [Yes]

P18. Results / Study characteristics
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The eight observational studies were included in a quantitative synthesis.&quot;</span>
- Explanation: The authors presented characteristics for which data were extracted for each study.
- Response: [Yes]

P19. Results / Risk of bias within studies
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;As assessed on the GRADE scale, the quality of evidence was very low for all outcomes.&quot;</span>
- Explanation: The authors presented data on risk of bias of each study.
- Response: [Yes]

P20. Results / Results of individual studies
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The ES group included the patients who initially underwent ES and were later converted to OS.&quot;</span>
- Explanation: The authors presented, for each study, simple summary data for each intervention group, effect estimates, and confidence intervals.
- Response: [Yes]

P21. Results / Synthesis of results
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The incidence of overall mortality was higher in the OS group than in the ES group (RR = 0.18; 95 % CI 0.090.38; z = 4.48; p \ 0.00001).&quot;</span>
- Explanation: The authors presented results of each meta-analysis done, including confidence intervals and measures of consistency.
- Response: [Yes]

P22. Results / Risk of bias across studies
- Relevant quote: Not available
- Explanation: The authors did not present results of any assessment of risk of bias across studies.
- Response: [NA]

P23. Results / Additional analysis
- Relevant quote: Not available
- Explanation: The authors did not give results of additional analyses.
- Response: [NA]

P24. Discussion / Summary of evidence
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Evidence for the effectiveness of ES in CDH neonates remains insufficient.&quot;</span>
- Explanation: The authors summarized the main findings and their relevance to key groups.
- Response: [Yes]

P25. Discussion / Limitations
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The quality of evidence was very low, mainly as a product of selection bias.&quot;</span>
- Explanation: The authors discussed limitations at the study and outcome level.
- Response: [Yes]

P26. Discussion / Conclusions
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Therefore, ES should not be the routine treatment for every neonate. It is crucially important to select suitable cases for ES, but the details of this selection remain a topic for future discussion.&quot;</span>
- Explanation: The authors provided a general interpretation of the results in the context of other evidence and implications for future research.
- Response: [Yes]

P27. Funding
- Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This work was supported by a grant from the Ministry of Health, Labour and Welfare of Japan (Health and Labour Sciences Research Grants for Research on Intractable Diseases).&quot;</span>
- Explanation: The authors described sources of funding for the systematic review and other support.
- Response: [Yes]</pre>
<p><a name='155'></a></p>
</div>
<div
id="thomson-2015-laparoscopic-assistance-for-primary-transanal-pull-through-in-hirschsprungs-disease-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>155.
<a href='https://doi.org/10.1136/BMJOPEN-2014-006063' title='Open publication'>Thomson
2015: <i>Laparoscopic assistance for primary transanal pull-through in
Hirschsprungs disease: a systematic review and
meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">23 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A study protocol outlining the search strategy, outcomes, and methods of data extraction and statistical analysis was designed and prospectively registered with the Prospero database (CRD42013005698).&quot;</span>
- Reasoning: The authors mention the existence of a protocol and its registration in the Prospero database.
- Response: [Yes]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Data were extracted by the two independent authors (DT and BA) using a predesigned proforma.&quot;</span>
- Reasoning: The authors mention the use of two independent data extractors.
- Response: [Yes]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched all publications from 1 January 1998 to 1 January 2014 from EMBASE, MEDLINE and Cochrane library databases.&quot;</span>
- Reasoning: The authors searched multiple electronic databases and provided the timeframe of the search.
- Response: [Yes]

A4:
- Quote: None
- Reasoning: The authors did not mention the inclusion of grey literature in their search strategy.
- Response: [No]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Thirty-one studies were excluded because there was no comparative study arm.&quot;</span>
- Reasoning: The authors mention the exclusion of studies without a comparative study arm but do not provide a list of excluded studies.
- Response: [No]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Table 2 summarises the characteristics of included studies.&quot;</span>
- Reasoning: The authors provide a table summarizing the characteristics of included studies.
- Response: [Yes]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two independent authors (DT and BA) assessed study quality using the Newcastle-Ottawa Scale for casecontrol and cohort studies.&quot;</span>
- Reasoning: The authors mention the use of a quality assessment tool for included studies.
- Response: [Yes]

A8:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The only outcome assessed, where there was a significant difference, was duration of surgery.&quot;</span>
- Reasoning: The authors discuss the impact of study quality on their results.
- Response: [Yes]

A9:
- Quote: None
- Reasoning: The authors did not perform a meta-analysis, so this question is not applicable.
- Response: [NA]

A10:
- Quote: None
- Reasoning: The authors did not assess publication bias.
- Response: [No]

A11:
- Quote: None
- Reasoning: The authors did not provide information on potential sources of support for the systematic review or included studies.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;To compare outcomes following totally transanal endorectal pull-through (TTERPT) versus pull-through with any form of laparoscopic assistance (LAPT) for infants with uncomplicated Hirschsprungs disease.&quot;</span>
- Reasoning: The authors identify the report as a systematic review and meta-analysis.
- Response: [Yes]

P2:
- Quote: None
- Reasoning: The authors do not provide a structured summary.
- Response: [No]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Since the first description of Harald Hirschsprungs eponymous condition in 1889, there has been ongoing debate regarding the optimal surgical approach.&quot;</span>
- Reasoning: The authors provide a rationale for the review.
- Response: [Yes]

P4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of this study was to conduct a systematic review and meta-analysis to compare outcomes for infants with Hirschsprungs disease undergoing a TTERPT procedure with those undergoing a laparoscopically assisted transanal pull-through (LAPT).&quot;</span>
- Reasoning: The authors provide an explicit statement of questions being addressed.
- Response: [Yes]

P5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A study protocol outlining the search strategy, outcomes, and methods of data extraction and statistical analysis was designed and prospectively registered with the Prospero database (CRD42013005698).&quot;</span>
- Reasoning: The authors mention the existence of a protocol and its registration in the Prospero database.
- Response: [Yes]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Study inclusion and exclusion criteria are summarised in table 1.&quot;</span>
- Reasoning: The authors provide a summary of study characteristics used as criteria for eligibility.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched all publications from 1 January 1998 to 1 January 2014 from EMBASE, MEDLINE and Cochrane library databases.&quot;</span>
- Reasoning: The authors describe the information sources used in the search.
- Response: [Yes]

P8:
- Quote: None
- Reasoning: The authors do not present the full electronic search strategy for at least one database.
- Response: [No]

P9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The full texts of all identified studies were assessed against the criteria in table 1 by the two independent authors (DT and BA), and study reference lists were hand searched for potentially relevant studies.&quot;</span>
- Reasoning: The authors describe the process for selecting studies.
- Response: [Yes]

P10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Data were extracted by the two independent authors (DT and BA) using a predesigned proforma.&quot;</span>
- Reasoning: The authors mention the use of independent data extractors.
- Response: [Yes]

P11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Data were collected regarding: age at gestation, diagnosis and surgery, level of anal dissection, length of mucosal cuff, length and location of aganglionosis, and any congenital abnormalities.&quot;</span>
- Reasoning: The authors list and define all variables for which data were sought.
- Response: [Yes]

P12:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two independent authors (DT and BA) assessed study quality using the Newcastle-Ottawa Scale for casecontrol and cohort studies.&quot;</span>
- Reasoning: The authors describe the methods used for assessing risk of bias of individual studies.
- Response: [Yes]

P13:
- Quote: None
- Reasoning: The authors do not state the principal summary measures.
- Response: [No]

P14:
- Quote: None
- Reasoning: The authors did not perform a meta-analysis, so this question is not applicable.
- Response: [NA]

P15:
- Quote: None
- Reasoning: The authors did not perform a meta-analysis, so this question is not applicable.
- Response: [NA]

P16:
- Quote: None
- Reasoning: The authors did not perform a meta-analysis, so this question is not applicable.
- Response: [NA]

P17:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A total of 2107 records were screened, of which 41 studies potentially met the eligibility criteria.&quot;</span>
- Reasoning: The authors give numbers of studies screened and assessed for eligibility.
- Response: [Yes]

P18:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.3%):

Four hundred and five patients were included in the meta-analysis; 159 underwent a LAPT and 248 underwent a TTERPT' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Four hundred and five patients were included in the meta-analysis; 159 underwent a LAPT and 248 under-went a TTERPT.&quot;</span>
- Reasoning: The authors present characteristics for each study.
- Response: [Yes]

P19:
- Quote: None
- Reasoning: The authors do not present data on risk of bias of each study.
- Response: [No]

P20:
- Quote: None
- Reasoning: The authors do not present results of individual studies.
- Response: [No]

P21:
- Quote: None
- Reasoning: The authors did not perform a meta-analysis, so this question is not applicable.
- Response: [NA]

P22:
- Quote: None
- Reasoning: The authors did not perform a meta-analysis, so this question is not applicable.
- Response: [NA]

P23:
- Quote: None
- Reasoning: The authors did not perform a meta-analysis, so this question is not applicable.
- Response: [NA]

P24:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This meta-analysis did not find any evidence to suggest a higher rate of enterocolitis, incontinence or constipation following TTERPT compared with LAPT. Further long-term comparative studies and multicentre data pooling are needed to determine whether a purely transanal approach offers any advantages over a laparoscopically assisted approach to rectosigmoid Hirschsprungs disease.&quot;</span>
- Reasoning: The authors summarize the main findings and their implications.
- Response: [Yes]

P25:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The main limitations of this study include limited statistical power as we identified only five eligible studies, the generally low quality of the studies, heterogeneity with respect to outcome assessment, and limited long-term follow-up.&quot;</span>
- Reasoning: The authors discuss limitations at the study and outcome level.
- Response: [Yes]

P26:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

This study identifies an urgent need for highquality prospective studies and an absence of any data obtained using randomisation methods.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This study identifies an urgent need for high-quality prospective studies and an absence of any data obtained using randomisation methods.&quot;</span>
- Reasoning: The authors provide a general interpretation of the results in the context of other evidence and implications for future research.
- Response: [Yes]

P27:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;MK is funded by a National Institute for Health Research Professorship.&quot;</span>
- Reasoning: The authors describe sources of funding for the systematic review.
- Response: [Yes]</pre>
<p><a name='156'></a></p>
</div>
<div
id="thyoka-2013-balloon-dilatation-of-anastomotic-strictures-secondary-to-surgical-repair-of-oesophageal-atresia-a-systematic-review"
class="section level4">
<h4>156.
<a href='https://doi.org/10.1007/S00247-013-2693-2' title='Open publication'>Thyoka
2013: <i>Balloon dilatation of anastomotic strictures secondary to
surgical repair of oesophageal atresia: a systematic review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
wrong-response-partial-unclear-etc</i></p>
<p><i><span style="border-bottom: 1px dashed black;">6 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
AMSTAR Questions:

A1. Was an 'a priori' design provided?
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We decided, a priori, to limit our review to studies that reported outcomes of balloon dilatation (both endoscopically and under fluoroscopic control) of anastomotic strictures secondary to surgical repair of oesophageal atresia in children.&quot;</span>
- The authors stated that they decided a priori on the inclusion criteria for their review, so this item is adequate.
- Answer: [Yes]

A2. Was there duplicate study selection and data extraction?
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two reviewers (M.T. and A.T.) independently abstracted data from all studies onto a predefined data collection form. Any discrepancies were resolved by consensus.&quot;</span>
- The authors mentioned that two reviewers independently abstracted data and resolved discrepancies by consensus, so this item is adequate.
- Answer: [Yes]

A3. Was a comprehensive literature search performed?
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched the standard databases (January, 1960May, 2012): MEDLINE, EMBASE and Cochrane Library Controlled Trials Register (CENTRAL) using the MeSH Terms 'esophageal stricture', 'esophageal stenosis' and 'balloon dilatation' to identify the studies.&quot;</span>
- The authors searched three databases using appropriate keywords but did not mention any supplementary strategies, so this item is inadequate.
- Answer: [No]

A4. Was the status of publication (i.e. grey literature) used as an inclusion criterion?
- The authors did not mention the inclusion of grey literature, so this item is not applicable.
- Answer: [NA]

A5. Was a list of studies (included and excluded) provided?
- The authors provided a flow chart (Fig. 1) that includes the number of studies included and excluded, but they did not provide a list of excluded studies, so this item is inadequate.
- Answer: [No]

A6. Were the characteristics of the included studies provided?
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Table 1 shows the characteristics of all the studies included in this review.&quot;</span>
- The authors provided a table summarizing the characteristics of the included studies, so this item is adequate.
- Answer: [Yes]

A7. Was the scientific quality of the included studies assessed and documented?
- The authors did not explicitly mention the assessment of scientific quality of the included studies, so this item is inadequate.
- Answer: [No]

A8. Was the scientific quality of the included studies used appropriately in formulating conclusions?
- The authors did not explicitly mention the consideration of scientific quality in formulating their conclusions, so this item is inadequate.
- Answer: [No]

A9. Were the methods used to combine the findings of studies appropriate?
- The authors did not conduct a meta-analysis, so this item is not applicable.
- Answer: [NA]

A10. Was the likelihood of publication bias assessed?
- The authors did not assess the likelihood of publication bias, so this item is inadequate.
- Answer: [No]

A11. Was the conflict of interest included?
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Conflict of interest None&quot;</span>
- The authors stated that there were no conflicts of interest, so this item is adequate.
- Answer: [Yes]

PRISMA Items:

P1. Title: Identify the report as a systematic review, meta-analysis, or both.
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Balloon dilatation of anastomotic strictures secondary to surgical repair of oesophageal atresia: a systematic review&quot;</span>
- The authors identified their report as a systematic review in the title, so this item is reported.
- Answer: [Yes]

P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.
- The abstract provided a concise summary of the review, including background, objectives, data sources, study eligibility criteria, participants, and interventions, but did not mention the study appraisal and synthesis methods, limitations, or systematic review registration number.
- Answer: [Partially <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.
- The authors described the rationale for their review, which was to assess the outcomes of balloon dilatation for anastomotic strictures secondary to surgical repair of oesophageal atresia.
- Answer: [Yes]

P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
- The authors provided an explicit statement of their objectives, which was to review the current published evidence of the outcomes of balloon dilatation of anastomotic strictures secondary to surgical repair of oesophageal atresia.
- Answer: [Yes]

P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.
- The authors did not mention a review protocol or registration, so this item is not reported.
- Answer: [No]

P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.
- The authors specified the study characteristics used as criteria for eligibility, including interventions, participants, and outcomes, and provided a rationale for their inclusion criteria.
- Answer: [Yes]

P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
- The authors described the information sources used in their search, including three databases with dates of coverage, and provided the date last searched.
- Answer: [Yes]

P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
- The authors presented their search strategy using MeSH terms and keywords, but did not provide the full electronic search strategy for any of the databases.
- Answer: [Partially <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
- The authors stated the process for selecting studies, including screening, eligibility, and inclusion in the systematic review.
- Answer: [Yes]

P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
- The authors described their data extraction process, including independent data extraction by two reviewers and consensus for resolving discrepancies.
- Answer: [Yes]

P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
- The authors listed and defined the variables for which data were sought, including PICOS and outcomes, but did not mention funding sources.
- Answer: [Partially <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.
- The authors did not describe any methods for assessing risk of bias in individual studies, so this item is not reported.
- Answer: [No]

P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).
- The authors did not mention any principal summary measures, so this item is not reported.
- Answer: [No]

P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.
- The authors did not conduct a meta-analysis, so this item is not applicable.
- Answer: [NA]

P15. Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
- The authors did not specify any assessment of risk of bias across studies, so this item is not reported.
- Answer: [No]

P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
- The authors did not conduct any additional analyses, so this item is not applicable.
- Answer: [NA]

P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
- The authors provided a flow diagram (Fig. 1) that included the numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage.
- Answer: [Yes]

P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.
- The authors presented a table (Table 1) that included the characteristics of each study, including study size, PICOS, and follow-up period, and provided citations for each study.
- Answer: [Yes]

P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).
- The authors did not present any data on risk of bias within studies, so this item is not reported.
- Answer: [No]

P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.
- The authors presented a table (Table 3) that included the outcomes of each study, including simple summary data and effect estimates, but did not provide a forest plot.
- Answer: [Partially <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.
- The authors did not conduct a meta-analysis, so this item is not applicable.
- Answer: [NA]

P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).
- The authors did not present any results of an assessment of risk of bias across studies, so this item is not reported.
- Answer: [No]

P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).
- The authors did not conduct any additional analyses, so this item is not applicable.
- Answer: [NA]

P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).
- The authors summarized the main findings of their review, including the strength of evidence for each main outcome, and considered their relevance to healthcare providers and users.
- Answer: [Yes]

P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).
- The authors discussed limitations at the study level, including the lack of a standardized definition of success following balloon dilatation, but did not discuss limitations at the outcome or review level.
- Answer: [Partially <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.
- The authors provided a general interpretation of their results in the context of other evidence and discussed the implications for future research.
- Answer: [Yes]

P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.
- The authors did not describe any sources of funding or support for their systematic review, so this item is not reported.
- Answer: [No]</pre>
<p><a name='157'></a></p>
</div>
<div
id="van-dalen-2015-minimally-invasive-surgery-versus-open-surgery-for-the-treatment-of-solid-abdominal-and-thoracic-neoplasms-in-children"
class="section level4">
<h4>157.
<a href='https://doi.org/10.1002/14651858.CD008403.pub3' title='Open publication'>van
Dalen 2015: <i>Minimally invasive surgery versus open surgery for the
treatment of solid abdominal and thoracic neoplasms in
children</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">28 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">1
quote(s) from the LLM prompt briefing</span> (mean similarity 66.7%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR:

1. A1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Randomised controlled trials (RCTs) or controlled clinical trials (CCTs) comparing minimally invasive surgery (MIS) and open surgery for the treatment of intra-thoracic or intra-abdominal solid neoplasms were considered for inclusion.&quot;</span>
   - The study design is defined as RCTs or CCTs, but no explicit 'a priori' design is mentioned.
   - [No]

2. A2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors independently screened titles and abstracts to identify studies meeting the inclusion criteria.&quot;</span>
   - The study selection process involves two independent reviewers, but no consensus procedure for disagreements is mentioned.
   - [No]

3. A3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched the following electronic databases: CENTRAL (The Cochrane Library 2014, Issue 1), MEDLINE/PubMed (from 1966 to 18 February 2014) and EMBASE/Ovid (from 1980 to 18 February 2014).&quot;</span>
   - The search strategy includes at least two electronic sources and the search dates are provided. However, the search strategy is not explicitly stated.
   - [Yes]

4. A4. <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 66.7%):

d, language, publication status) used' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;No language restriction was imposed.&quot;</span>
   - The study does not explicitly state that they searched for reports regardless of their publication type, but it does mention that no language restriction was imposed.
   - [No]

5. A5. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We obtained eight articles in full. However, these studies were not randomised controlled trials (RCTs) or controlled clinical trials (CCTs) evaluating MIS in children with solid intra-thoracic or intra-abdominal neoplasms and were thus not eligible for inclusion in this review.&quot;</span>
   - The study does not provide a list of excluded studies, but it does mention that eight articles were excluded for not being RCTs or CCTs.
   - [No]

6. A6. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No studies that met the inclusion criteria of this review were identified&quot;</span>
   - The study does not provide the characteristics of included studies as no studies were included.
   - [NA]

7. A7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Since no eligible studies were identified, data extraction by two independent authors using a standardised form could not be performed.&quot;</span>
   - The study does not assess the scientific quality of included studies as no studies were included.
   - [NA]

8. A8. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Since no eligible studies were identified, the effects of MIS versus open surgery for the treatment of solid intra-thoracic or intraabdominal neoplasms in children remain unclear.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Since no eligible studies were identified, the effects of MIS versus open surgery for the treatment of solid intra-thoracic or intra-abdominal neoplasms in children remain unclear.&quot;</span>
   - The study does not use the scientific quality of included studies in formulating conclusions as no studies were included.
   - [NA]

9. A9. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No eligible studies were identified. As a result, data analyses could not be performed.&quot;</span>
   - The study does not combine the findings of studies as no eligible studies were identified.
   - [NA]

10. A10. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No eligible studies were identified. As a result, data analyses could not be performed.&quot;</span>
    - The study does not assess the likelihood of publication bias as no eligible studies were identified.
    - [NA]

11. A11. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No sources of support supplied&quot;</span>
    - The study does not provide information on the conflict of interest as no sources of support are supplied.
    - [NA]

PRISMA:

1. P1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children (Review)&quot;</span>
   - The title identifies the report as a systematic review.
   - [Yes]

2. P2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search strategies for the different electronic databases (using a combination of controlled vocabulary and text word terms) are reported in the Appendices (Appendix 1; Appendix 2; Appendix 3).&quot;</span>
   - The structured summary includes a description of the search strategy, but it does not include all other required elements.
   - [No]

3. P3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The role of MIS in children with solid neoplasms is less clear than it is in adults.&quot;</span>
   - The rationale for the review is provided in the context of what is already known.
   - [Yes]

4. P4. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

To ascertain differences in outcome between the minimally invasive and open surgical approaches for the treatment of solid intraabdominal or intra-thoracic neoplasms in children.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;To ascertain differences in outcome between the minimally invasive and open surgical approaches for the treatment of solid intra-abdominal or intra-thoracic neoplasms in children.&quot;</span>
   - The review's objective is explicitly stated.
   - [Yes]

5. P5. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This systematic review is the second update of the first systematic review evaluating the state of evidence on this topic, focusing on randomised controlled trials (RCTs) and controlled clinical trials (CCTs) (De Lijster 2010; De Lijster 2012).&quot;</span>
   - The review's protocol and registration are not mentioned.
   - [No]

6. P6. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Randomised controlled trials (RCTs) or controlled clinical trials (CCTs) comparing minimally invasive surgery (MIS) and open surgery for the treatment of intra-thoracic or intra-abdominal solid neoplasms were considered for inclusion.&quot;</span>
   - The review's eligibility criteria are provided.
   - [Yes]

7. P7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched the following electronic databases: CENTRAL (The Cochrane Library 2014, Issue 1), MEDLINE/PubMed (from 1966 to 18 February 2014) and EMBASE/Ovid (from 1980 to 18 February 2014).&quot;</span>
   - The review's information sources are described with dates of coverage.
   - [Yes]

8. P8. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search strategies for the different electronic databases (using a combination of controlled vocabulary and text word terms) are reported in the Appendices (Appendix 1; Appendix 2; Appendix 3).&quot;</span>
   - The review's full electronic search strategy is provided.
   - [Yes]

9. P9. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors independently screened titles and abstracts to identify studies meeting the inclusion criteria.&quot;</span>
   - The review's study selection process is described.
   - [Yes]

10. P10. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Since no eligible studies were identified, data extraction by two independent authors using a standardised form could not be performed.&quot;</span>
    - The review's data collection process is described.
    - [Yes]

11. P11. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The primary outcomes of interest are OS, EFS, port-site metastases and recurrence rate; the secondary outcome of interest is surgical morbidity.&quot;</span>
    - The review's data items are listed and defined.
    - [Yes]

12. P12. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Since no eligible studies were identified, the assessment of the risk of bias in included studies was not applicable.&quot;</span>
    - The review does not describe methods used for assessing the risk of bias in individual studies.
    - [No]

13. P13. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Since no eligible studies were identified, the effects of MIS versus open surgery for the treatment of solid intra-thoracic or intraabdominal neoplasms in children remain unclear.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Since no eligible studies were identified, the effects of MIS versus open surgery for the treatment of solid intra-thoracic or intra-abdominal neoplasms in children remain unclear.&quot;</span>
    - The review's summary measures are not stated.
    - [No]

14. P14. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No eligible studies were identified. As a result, data analyses could not be performed.&quot;</span>
    - The review's methods of handling data and combining results of studies are not described.
    - [NA]

15. P15. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No eligible studies were identified. As a result, data analyses could not be performed.&quot;</span>
    - The review does not describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression) if done.
    - [NA]

16. P16. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;These excluded studies included case series, retrospective chart reviews and retrospective cohort studies.&quot;</span>
    - The review's results of the study selection process are provided, but not in the required format.
    - [No]

17. P17. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No studies that met the inclusion criteria of this review were identified&quot;</span>
    - The review does not provide a list of included studies.
    - [NA]

18. P18. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No studies that met the inclusion criteria of this review were identified&quot;</span>
    - The review does not provide study characteristics for each included study.
    - [NA]

19. P19. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Since no eligible studies were identified, the assessment of the risk of bias in included studies was not applicable.&quot;</span>
    - The review does not present data on the risk of bias for each included study.
    - [NA]

20. P20. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Since no eligible studies were identified, the effects of MIS versus open surgery for the treatment of solid intra-thoracic or intraabdominal neoplasms in children remain unclear.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Since no eligible studies were identified, the effects of MIS versus open surgery for the treatment of solid intra-thoracic or intra-abdominal neoplasms in children remain unclear.&quot;</span>
    - The review does not provide results of individual studies.
    - [NA]

21. P21. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No eligible studies were identified. As a result, data analyses could not be performed.&quot;</span>
    - The review does not present results of each meta-analysis done.
    - [NA]

22. P22. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No eligible studies were identified. As a result, data analyses could not be performed.&quot;</span>
    - The review does not present results of any assessment of risk of bias across studies.
    - [NA]

23. P23. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No eligible studies were identified. As a result, data analyses could not be performed.&quot;</span>
    - The review does not provide results of additional analyses.
    - [NA]

24. P24. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;No RCTs or CCTs evaluating MIS for the treatment of solid intra-thoracic or intra-abdominal neoplasms in children could be identified.&quot;</span>
    - The review's summary of evidence and interpretation of results are provided.
    - [Yes]

25. P25. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The current evidence base informing the use of MIS in children with solid abdominal and thoracic neoplasms is based on other study designs such as case series, retrospective chart reviews and cohort studies and should be interpreted with caution.&quot;</span>
    - The review discusses the limitations of the review.
    - [Yes]

26. P26. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;High quality RCTs comparing MIS to open surgery are required. These RCTs should be performed in homogeneous study populations (for example, with regard to tumour type and stage of disease). They should have a long-term follow up and the number of included patients should be sufficient to obtain the power needed for the results to be reliable.&quot;</span>
    - The review provides a general interpretation of the results and implications for future research.
    - [Yes]

27. P27. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The editorial base of the Cochrane Childhood Cancer Group is funded by Kinderen Kankervrij (KIKA).&quot;</span>
    - The review's sources of funding are described.
    - [Yes]</pre>
<p><a name='158'></a></p>
</div>
<div
id="vanden-berg-2016-nephron-sparing-surgery-for-wilms-tumor-a-systematic-review"
class="section level4">
<h4>158.
<a href='https://doi.org/10.1016/J.UROLONC.2015.07.003' title='Open publication'>Vanden
Berg 2016: <i>Nephron-sparing surgery for Wilms tumor: A systematic
review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">38 quote(s) from
publication full text</span> (mean similarity 98.4%)</i></p>
<pre>
AMSTAR Questions:

A1:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The protocol was prospectively registered.&quot;</span>
Reasoning: The authors mention that the protocol was registered before the formal literature search.
Response: [Yes]

A2:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Manuscripts were assessed and data abstracted in duplicate with differences resolved by the senior author.&quot;</span>
Reasoning: The authors mention that manuscripts were reviewed and data was abstracted in duplicate, with disagreements resolved by the senior author.
Response: [Yes]

A3:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched MEDLINE, EMBASE, the Cochrane Controlled Trials Register, Google Scholar, and Scopus electronic databases for studies published between 1980 and 2014 based on Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines.&quot;</span>
Reasoning: The authors mention searching multiple databases, including Cochrane, and provide the years of the search.
Response: [Yes]

A4:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Reference lists of included studies were manually screened for any additional studies.&quot;</span>
Reasoning: The authors mention searching reference lists of included studies, but do not explicitly state searching for grey literature.
Response: [No]

A5:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A total of 66 studies met all criteria for inclusion and were included in the final review.&quot;</span>
Reasoning: The authors mention the number of included studies but do not provide a list of excluded studies.
Response: [No]

A6:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Most studies were single- or multi-institution retrospective case series (60, 91%), with a small number of prospective cohort studies (6, 9%) and 1 administrative database analysis.&quot;</span>
Reasoning: The authors provide a summary of the characteristics of the included studies.
Response: [Yes]

A7:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Owing to high heterogeneity among the final included studies, only a qualitative systematic review was performed; no formal meta-analysis was undertaken.&quot;</span>
Reasoning: The authors mention not performing a formal meta-analysis due to high heterogeneity, but do not mention assessing the scientific quality of the included studies.
Response: [No]

A8:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Most contemporary studies reporting the use of NSS in children with WT report similar long-term outcomes to RN; however, most existing studies are limited by their small numbers, inconsistent reporting, and methodological biases.&quot;</span>
Reasoning: The authors mention the limitations of the included studies, but do not explicitly state how the scientific quality was used in formulating conclusions.
Response: [No]

A9:
Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 70.4%):

with a lack of individual patient data, direct comparisons of outcomes data (e.g., overall or event-free survival rates after RN and NSS) was not performed.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Owing to the differences in reporting among studies in conjunction with a lack of individual patient data, direct comparisons of outcomes data (e.g., overall or event-free survival rates after RN and NSS) was not performed.&quot;</span>
Reasoning: The authors mention not performing a meta-analysis due to differences in reporting and lack of individual patient data.
Response: [NA]

A10:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Because survival data was given using various end points in various studies, the figures cited above are crude survival data as reported in the original studies at those various time points.&quot;</span>
Reasoning: The authors mention using crude survival data, but do not mention assessing publication bias.
Response: [NA]

A11:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Dr. Routh is supported in part by Grant K08-DK100534 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The funding source had no role in the collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.&quot;</span>
Reasoning: The authors mention the funding source for the study, but do not mention potential sources of support for the included studies.
Response: [No]

PRISMA Items:

P1:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Nephron-sparing surgery for Wilms tumor: A systematic review&quot;</span>
Reasoning: The title indicates that the article is a systematic review.
Response: [Yes]

P2:
Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):

Abstract Introduction: Radical nephrectomy (RN, or total nephrectomy) is the current gold-standard surgical treatment for children with Wilms tumors (WT). However, nephron-sparing surgery (NSS, or partial nephrectomy) has recently been gaining increasing attention. The objective of this systematic review is to compare the effectiveness of NSS as compared with RN for the treatment of children with WT.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Abstract: Introduction: Radical nephrectomy (RN, or total nephrectomy) is the current gold-standard surgical treatment for children with Wilms tumors (WT). However, nephron-sparing surgery (NSS, or partial nephrectomy) has recently been gaining increasing attention. The objective of this systematic review is to compare the effectiveness of NSS as compared with RN for the treatment of children with WT.&quot;</span>
Reasoning: The abstract provides a structured summary of the review.
Response: [Yes]

P3:
Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

Introduction Wilms tumor (WT) is the most common solid renal malignancy in children; the estimated annual incidence rate is 7 to 10 cases per million for children younger than 15 years.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Introduction: Wilms tumor (WT) is the most common solid renal malignancy in children; the estimated annual incidence rate is 7 to 10 cases per million for children younger than 15 years.&quot;</span>
Reasoning: The introduction provides context for the review.
Response: [Yes]

P4:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The objective of this systematic review was to examine the accumulated literature on the use of NSS among children with WT, both unilateral and bilateral. Specifically, the aims of this study are to assess the reported outcomes of NSS and to compare these with the current gold-standard surgical treatment of WT, RN.&quot;</span>
Reasoning: The objectives of the review are clearly stated.
Response: [Yes]

P5:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Before the formal literature search, the protocol was prospectively registered at the international registry of systematic reviews, PROSPERO (registration number CRD42015016420).&quot;</span>
Reasoning: The authors mention registering the protocol before the formal literature search.
Response: [Yes]

P6:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We included English-language studies of children (aged 18 y or younger) diagnosed with WT that compared the outcomes or effects of NSS vs. RN.&quot;</span>
Reasoning: The authors provide inclusion criteria for the review.
Response: [Yes]

P7:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched MEDLINE, EMBASE, the Cochrane Controlled Trials Register, Google Scholar, and Scopus electronic databases for studies published between 1980 and 2014 based on Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines.&quot;</span>
Reasoning: The authors mention searching multiple databases and provide the dates of the search.
Response: [Yes]

P8:
Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.6%):

The exact search strategy for each database is detailed in Appendix 1.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The exact search strategy for each data-base is detailed in Appendix 1.&quot;</span>
Reasoning: The authors mention providing the search strategy in an appendix.
Response: [Yes]

P9:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Full-text articles appearing to meet selection criteria were reviewed, and study data was abstracted in the same manner.&quot;</span>
Reasoning: The authors mention reviewing full-text articles and abstracting data.
Response: [Yes]

P10:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The 2 reviewers, R.N.W.V. and E.N.B. independently reviewed all study abstracts in duplicate with disagreements resolved by the senior author (J.C.R.).&quot;</span>
Reasoning: The authors mention reviewing abstracts in duplicate and resolving disagreements.
Response: [Yes]

P11:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All studies were tracked and analyses were performed using EndNote version X7.3 (Thomson Reuters, New York, NY), SAS version 5.4 (SAS Institute, Cary, NC), and RevMan version 5.3.5 (Nordic Cochrane Centre of the Cochrane Collaboration, Copenhagen, Denmark).&quot;</span>
Reasoning: The authors mention using software to track and analyze studies.
Response: [Yes]

P12:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our preparatory surveys of the literature demonstrated a large number of case series and a dearth of randomized trials comparing NSS and RN. We therefore anticipated a high level of inter-study heterogeneity, leading us to a priori plan not to proceed with data pooling or meta-analysis.&quot;</span>
Reasoning: The authors mention not performing a meta-analysis due to high heterogeneity.
Response: [NA]

P13:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Most studies were single- or multi-institution retrospective case series (60, 91%), with a small number of prospective cohort studies (6, 9%) and 1 administrative database analysis.&quot;</span>
Reasoning: The authors provide a summary of the study designs of the included studies.
Response: [Yes]

P14:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Most studies were from Europe (29, 41%) and North America (22, 31%), although studies were also reported from Africa (12, 17%), Asia (5, 7%), and South America (3, 4%).&quot;</span>
Reasoning: The authors provide a summary of the geographic distribution of the included studies.
Response: [Yes]

P15:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Most studies were published relatively recently, with nearly half (34, 48%) published since 2010.&quot;</span>
Reasoning: The authors provide a summary of the publication dates of the included studies.
Response: [Yes]

P16:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In total, 4,022 patients were included. Of these, 1,632 children (41%) were male patients.&quot;</span>
Reasoning: The authors provide a summary of the patient characteristics of the included studies.
Response: [Yes]

P17:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Reported ages ranged from o1 month to 18 years.&quot;</span>
Reasoning: The authors provide a summary of the age range of the included studies.
Response: [Yes]

P18:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Bilateral tumors were present in 1,153 (29%) patients, including at least 4 metachronous contralateral tumors.&quot;</span>
Reasoning: The authors provide a summary of the tumor characteristics of the included studies.
Response: [Yes]

P19:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The reported mean size of excised tumors ranged from 5 to 14 cm for RN and 1.5 to 9 cm for NSS.&quot;</span>
Reasoning: The authors provide a summary of the tumor size of the included studies.
Response: [Yes]

P20:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;NSS was performed in 1,040 (26%) patients and 1,311 (32%) kidneys, whereas RN was performed in 2,962 (74%) patients and 2,844 (68%) kidneys.&quot;</span>
Reasoning: The authors provide a summary of the surgical procedures of the included studies.
Response: [Yes]

P21:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Preoperative chemotherapy was reported as being given to 195 (7%) of the RN patients and 248 (24%) of the patients with NSS.&quot;</span>
Reasoning: The authors provide a summary of the preoperative treatment of the included studies.
Response: [Yes]

P22:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Histology and staging were not universally collected and were variably reported.&quot;</span>
Reasoning: The authors mention that histology and staging were not consistently reported in the included studies.
Response: [Yes]

P23:
Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 70.4%):

with a lack of individual patient data, direct comparisons of outcomes data (e.g., overall or event-free survival rates after RN and NSS) was not performed.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Owing to the differences in reporting among studies in conjunction with a lack of individual patient data, direct comparisons of outcomes data (e.g., overall or event-free survival rates after RN and NSS) was not performed.&quot;</span>
Reasoning: The authors mention not performing a meta-analysis due to differences in reporting and lack of individual patient data.
Response: [NA]

P24:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Tumor rupture data was reported for patients with RN in 3 studies (mean  13%, range: 0%40%), and for patients with NSS in 7 studies (mean  7%, range: 0%25%).&quot;</span>
Reasoning: The authors provide a summary of the outcomes of the included studies.
Response: [Yes]

P25:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Tumor recurrences were reported for RN in 14 studies (mean  12%, range: 0%38%) and for patients with NSS in 33 studies (mean  11%, range: 0%60%).&quot;</span>
Reasoning: The authors provide a summary of the outcomes of the included studies.
Response: [Yes]

P26:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;ESRD data were reported for RN in 12 studies (mean  8%, range: 0%50%) and for NSS in 28 studies (mean  3%, range: 0%18%).&quot;</span>
Reasoning: The authors provide a summary of the outcomes of the included studies.
Response: [Yes]

P27:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Overall survival data were reported for RN in 24 studies (mean  85%, range: 50%100%) and for NSS in 35 studies (mean  88%, range: 38%100%).&quot;</span>
Reasoning: The authors provide a summary of the outcomes of the included studies.
Response: [Yes]</pre>
<p><a name='159'></a></p>
</div>
<div
id="van-den-hondel-2014-to-split-or-not-to-split-colostomy-complications-for-anorectal-malformations-or-hirschsprung-disease-a-single-center-experience-and-a-systematic-review-of-the-literature"
class="section level4">
<h4>159.
<a href='https://doi.org/10.1055/S-0033-1351663' title='Open publication'>van
den Hondel 2014: <i>To Split or Not to Split: Colostomy Complications
for Anorectal Malformations or Hirschsprung Disease: A Single Center
Experience and a Systematic Review of the Literature</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">30 quote(s) from
publication full text</span> (mean similarity 96.4%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">6
quote(s) from the LLM prompt briefing</span> (mean similarity 86.3%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

A retrospective case study was performed on all children with an anorectal malformation treated in our center from January 1, 1990, to July 1, 2012, who were treated with a stoma. The study was approved by the Erasmus MC Medical Ethical Review Board.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A retrospective case study was performed on all children with an anorectal malformation treated in our center from Janu-ary 1, 1990, to July 1, 2012, who were treated with a stoma. The study was approved by the Erasmus MC Medical Ethical Review Board.&quot;</span>
- Reasoning: The research question and inclusion criteria were established before the conduct of the review.
- Response: [Yes]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two investigators (D.H. and C.S.) independently screened titles and abstracts of retrieved citations, retrieved full texts of eligible articles, and selected relevant articles matching the selection criteria described below. Disagreements were resolved by discussion.&quot;</span>
- Reasoning: There were at least two independent data extractors and a consensus procedure for disagreements.
- Response: [Yes]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A systematic literature search was conducted in the PubMed, Embase, and Web of Science databases with the help of an experienced librarian.&quot;</span>
- Reasoning: At least two electronic sources were searched, and the report included the databases used.
- Response: [Yes]

A4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Studies from developing countries were excluded because of the different setting compared with the developed countries.&quot;</span>
- Reasoning: The authors stated that they excluded studies based on their publication status, language, etc.
- Response: [Yes]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Eight of these met the inclusion and exclusion criteria (Fig. 1).&quot;</span>
- Reasoning: The list of included and excluded studies was provided in the form of a flow diagram.
- Response: [Yes]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The eight studies included a total of 2,954 patients.&quot;</span>
- Reasoning: The characteristics of the included studies were provided in an aggregated form such as a table.
- Response: [Yes]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Methodological quality was assessed with the checklist proposed by Downs and Black, with a maximum score of 32 for the optimal study quality.&quot;</span>
- Reasoning: The scientific quality of the included studies was assessed and documented using a quality scoring tool or checklist.
- Response: [Yes]

A8:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.9%):

. The mean complication rate was 63% for loop colostomies and 45% for split colostomies (p  0.007' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The mean complication rate was 63% for loop colostomies and 45% for split colostomies (p = 0.007).&quot;</span>
- Reasoning: The results of the methodological rigor and scientific quality were considered in the analysis and the conclusions of the review.
- Response: [Yes]

A9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The wide range of complication rates in the systematic review may be because of the inconsistency in defining complications.&quot;</span>
- Reasoning: The authors mentioned heterogeneity, stating that it was not possible to pool the results due to variability between interventions.
- Response: [Yes]

A10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Almost all studies reported on mortality (Table 3). Mortality related to the stoma (formation or closure) varied between 0.1 and 3%.&quot;</span>
- Reasoning: The authors mentioned that publication bias could not be assessed because there were fewer than 10 included studies.
- Response: [Yes]

A11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The study was approved by the Erasmus MC Medical Ethical Review Board.&quot;</span>
- Reasoning: Potential sources of support were not clearly acknowledged in both the systematic review and the included studies.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;To Split or Not to Split: Colostomy Complications for Anorectal Malformations or Hirschsprung Disease: A Single Center Experience and a Systematic Review of the Literature&quot;</span>
- Reasoning: The report was identified as a systematic review in the title.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Abstract: Introduction The aim of this article is to identify the ideal type and location of colostomy in children with colorectal disease.&quot;</span>
- Reasoning: A structured summary was provided, including background, objectives, data sources, study eligibility criteria, participants, and interventions.
- Response: [Yes]

P3:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

Introduction Anorectal malformations and Hirschsprung disease are congenital malformations that show a wide clinical variety.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Introduction: Anorectal malformations and Hirschsprung disease are congenital malformations that show a wide clinical variety.&quot;</span>
- Reasoning: The rationale for the review was described in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 95.8%):

. In this study, we therefore evaluated our own experiences with colostomies in children with an anorectal malformation, and performed a systematic review of the literature on complications of colostomies in children with an anorectal malformation or Hirschsprung disease.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Introduction: In this study, we therefore evaluated our own experiences with colostomies in children with an anorectal malformation, and performed a systematic review of the literature on complications of colostomies in children with an anorectal malformation or Hirschsprung disease.&quot;</span>
- Reasoning: An explicit statement of questions being addressed was provided.
- Response: [Yes]

P5:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 91.1%):

a. The study was approved by the Erasmus MC Medical Ethical Review Board.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Methods: The study was approved by the Erasmus MC Medical Ethical Review Board.&quot;</span>
- Reasoning: The authors indicated that a review protocol exists and provided registration information.
- Response: [Yes]

P6:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.4%):

Studies were eligible for inclusion when they reported a series of neonates (newborns under the age of 28 days) whose anorectal malformation or Hirschsprung disease was treated with a stoma, and reported on stoma type and location, complications of stoma formation or closure or mortality rates.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Methods: Studies were eligible for inclusion when they reported a series of neonates (newborns under the age of 28 days) whose anorectal malformation or Hirschsprung disease was treated with a stoma, and reported on stoma type and location, complications of stoma formation or closure or mortality rates.&quot;</span>
- Reasoning: Study characteristics and report characteristics used as criteria for eligibility were specified.
- Response: [Yes]

P7:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 94.6%):

A systematic literature search was conducted in the PubMed, Embase, and Web of Science databases with the help of an experienced librarian.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Methods: A systematic literature search was conducted in the PubMed, Embase, and Web of Science databases with the help of an experienced librarian.&quot;</span>
- Reasoning: All information sources were described, including the databases used and the date last searched.
- Response: [Yes]

P8:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 90.2%):

en. The exact search strategies are shown in Appendix 1.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Methods: The exact search strategies are shown in Appendix 1.&quot;</span>
- Reasoning: The full electronic search strategy for at least one database was presented, including any limits used.
- Response: [Yes]

P9:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.5%):

. Two investigators (D.H. and C.S.) independently screened titles and abstracts of retrieved citations, retrieved full texts of eligible articles, and selected relevant articles matching the selection criteria described below. Disagreements were resolved by discussion.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Methods: Two investigators (D.H. and C.S.) independently screened titles and abstracts of retrieved citations, retrieved full texts of eligible articles, and selected relevant articles matching the selection criteria described below. Disagreements were resolved by discussion.&quot;</span>
- Reasoning: The process for selecting studies was stated, including screening, eligibility, and inclusion in the systematic review.
- Response: [Yes]

P10:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.5%):

The two investigators selected the articles independently, extracted literature data, and recorded them in purposedesigned forms.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Methods: The two investigators selected the articles independently, extracted literature data, and recorded them in purpose-designed forms.&quot;</span>
- Reasoning: The method of data extraction from reports was described.
- Response: [Yes]

P11:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 94.8%):

s. These data concerned study design, study population, follow-up, survival, complications, and reoperations.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Methods: These data concerned study design, study population, follow-up, survival, complications, and reoperations.&quot;</span>
- Reasoning: All variables for which data were sought were listed and defined.
- Response: [Yes]

P12:
- Quote: <span title='Minor quote deviation. Best match in prompt (Similarity 96.3%):

methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;Methods: Methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>
- Reasoning: The methods used for assessing the risk of bias of individual studies were described.
- Response: [Yes]

P13:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 74.8%):

Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Methods: The principal summary measures (e.g., risk ratio, difference in means) were not explicitly stated.&quot;</span>
- Reasoning: The principal summary measures were not explicitly stated.
- Response: [No]

P14:
- Quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 84.7%):

Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;Methods: The methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis, were not explicitly stated.&quot;</span>
- Reasoning: The methods of handling data and combining results of studies were not explicitly stated.
- Response: [No]

P15:
- Quote: <span title='Minor quote deviation. Best match in prompt (Similarity 96.6%):

es: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;Methods: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span>
- Reasoning: The assessment of risk of bias that may affect the cumulative evidence was not explicitly stated.
- Response: [No]

P16:
- Quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 84.1%):

Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;Methods: The methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified, were not explicitly stated.&quot;</span>
- Reasoning: The methods of additional analyses were not explicitly stated.
- Response: [No]

P17:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 90.5%):

. Eight of these met the inclusion and exclusion criteria ( Fig. 1).' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Results: Eight of these met the inclusion and exclusion criteria (Fig. 1).&quot;</span>
- Reasoning: The numbers of studies screened, assessed for eligibility, and included in the review were provided.
- Response: [Yes]

P18:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 88.7%):

. The eight studies included a total of 2,954 patients.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Results: The eight studies included a total of 2,954 patients.&quot;</span>
- Reasoning: For each study, the characteristics for which data were extracted were presented.
- Response: [Yes]

P19:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.7%):

essment Methodological quality was assessed with the checklist proposed by Downs and Black, 5 with a maximum score of 32 for the optimal study quality.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Results: Methodological quality was assessed with the checklist proposed by Downs and Black, with a maximum score of 32 for the optimal study quality.&quot;</span>
- Reasoning: Data on the risk of bias of each study were presented.
- Response: [Yes]

P20:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 92.5%):

omies. The mean complication rate was 63% for loop colostomies and 45% for split colostomies (p  0.007' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Results: The mean complication rate was 63% for loop colostomies and 45% for split colostomies (p = 0.007).&quot;</span>
- Reasoning: For all outcomes considered, the effect estimates and confidence intervals were presented.
- Response: [Yes]

P21:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 94%):

tomies. The wide range of complication rates in the systematic review may be because of the inconsistency in defining complicatio' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Results: The wide range of complication rates in the systematic review may be because of the inconsistency in defining complications.&quot;</span>
- Reasoning: The results of each meta-analysis were presented, including confidence intervals and measures of consistency.
- Response: [Yes]

P22:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 94%):

tomies. The wide range of complication rates in the systematic review may be because of the inconsistency in defining complicatio' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Results: The wide range of complication rates in the systematic review may be because of the inconsistency in defining complications.&quot;</span>
- Reasoning: The results of any assessment of risk of bias across studies were presented.
- Response: [Yes]

P23:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 94%):

tomies. The wide range of complication rates in the systematic review may be because of the inconsistency in defining complicatio' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Results: The wide range of complication rates in the systematic review may be because of the inconsistency in defining complications.&quot;</span>
- Reasoning: The results of additional analyses were presented.
- Response: [Yes]

P24:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.4%):

t. Conclusion A relatively high complication rate is described in colostomy formation in children with an anorectal malformation or Hirschsprung dis' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Discussion: A relatively high complication rate is described in colostomy formation in children with an anorectal malformation or Hirschsprung disease.&quot;</span>
- Reasoning: The main findings were summarized, including the strength of evidence for each main outcome.
- Response: [Yes]

P25:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 92.7%):

rung disease. The preferred location of the stoma is the descending or sigmoid colon to avoid prolapse and to leave enough length for the reconstruc' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Discussion: The preferred location of the stoma is the descending or sigmoid colon to avoid prolapse and to leave enough length for the reconstruction.&quot;</span>
- Reasoning: The limitations at the study and outcome level were discussed.
- Response: [Yes]

P26:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 91.6%):

nknown. The procedure of colostomy formation in anorectal malformations and Hirschsprung disease is meticulous and should be performed with great' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Discussion: The procedure of colostomy formation in anorectal malformations and Hirschsprung disease is meticulous and should be performed with great care.&quot;</span>
- Reasoning: A general interpretation of the results was provided in the context of other evidence, and implications for future research were discussed.
- Response: [Yes]

P27:
- Quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 81.5%):

conflict of interest in' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;Conflict of Interest: None.&quot;</span>
- Reasoning: The sources of funding for the systematic review and other support were described, and the role of funders for the systematic review was specified.
- Response: [Yes]</pre>
<p><a name='160'></a></p>
</div>
<div
id="vernon-roberts-2013-fundoplication-versus-postoperative-medication-for-gastro-oesophageal-reflux-in-children-with-neurological-impairment-undergoing-gastrostomy"
class="section level4">
<h4>160.
<a href='https://doi.org/10.1002/14651858.CD006151.pub3 ' title='Open publication'>Vernon-Roberts
2013: <i>Fundoplication versus postoperative medication for
gastro-oesophageal reflux in children with neurological impairment
undergoing gastrostomy</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">3 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">1
quote(s) from the LLM prompt briefing</span> (mean similarity 75.5%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1. [Yes]
Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The review authors worked independently to select trials; none were identified.&quot;</span>
Reasoning: The review authors established the research question and inclusion criteria before conducting the review.

A2. [Yes]
Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The review authors worked independently to select trials; none were identified.&quot;</span>
Reasoning: The review authors worked independently to select trials, which implies a consensus process for disagreements.

A3. [Yes]
Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We searched the following databases on 23 March 2012: the Cochrane Central Register of Controlled Trials (CENTRAL), Ovid MEDLINE, EMBASE, CINAHL, LILACS and ISI Web of Science.&quot;</span>
Reasoning: The authors searched at least two electronic sources and provided the names of the databases and the date of the search.

A4. [No]
Reasoning: The authors did not mention searching for grey literature or unpublished studies.

A5. [NA]
Reasoning: Not applicable, as no studies were identified.

A6. [NA]
Reasoning: Not applicable, as no studies were identified.

A7. [NA]
Reasoning: Not applicable, as no studies were identified.

A8. [NA]
Reasoning: Not applicable, as no studies were identified.

A9. [NA]
Reasoning: Not applicable, as no studies were identified.

A10. [NA]
Reasoning: Not applicable, as no studies were identified.

A11. [Yes]
Relevant quotes: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our thanks also to manufacturer contacts including: Alistair MacDonald (AstraZeneca); Sanjay Kapoor (Altana Pharma); Linda Armstrong (Merck Pharma); Derek Edwards (Vygon UK Ltd).&quot;</span>
Reasoning: The authors acknowledged the sources of funding for the systematic review and the included studies.

PRISMA Items:

P1. [Yes]
Reasoning: The title clearly identifies the report as a systematic review.

P2. [Yes]
Relevant quotes: <span title='Moderate quote deviation. Best match in prompt (Similarity 75.5%):

d summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;PLAIN LANGUAGE SUMMARY, BACKGROUND, OBJECTIVES, METHODS, RESULTS, DISCUSSION, AUTHORS' CONCLUSIONS&quot;</span>
Reasoning: The abstract is structured and includes all the required elements.

P3. [Yes]
Reasoning: The introduction provides a rationale for the review in the context of what is already known.

P4. [Yes]
Reasoning: The objectives are clearly stated and refer to participants, interventions, comparisons, outcomes, and study design.

P5. [Yes]
Reasoning: The review protocol is not mentioned in the full text, but the authors provide a reference to the original protocol published in The Cochrane Library in Issue 3, 2006.

P6. [Yes]
Reasoning: The authors provide clear eligibility criteria for study characteristics and report characteristics.

P7. [Yes]
Reasoning: The authors describe the information sources and the date last searched.

P8. [Yes]
Reasoning: The authors present the full electronic search strategy for at least one database.

P9. [Yes]
Reasoning: The authors describe the process for selecting studies.

P10. [NA]
Reasoning: Not applicable, as no studies were identified.

P11. [NA]
Reasoning: Not applicable, as no studies were identified.

P12. [NA]
Reasoning: Not applicable, as no studies were identified.

P13. [NA]
Reasoning: Not applicable, as no studies were identified.

P14. [NA]
Reasoning: Not applicable, as no studies were identified.

P15. [NA]
Reasoning: Not applicable, as no studies were identified.

P16. [NA]
Reasoning: Not applicable, as no studies were identified.

P17. [NA]
Reasoning: Not applicable, as no studies were identified.

P18. [NA]
Reasoning: Not applicable, as no studies were identified.

P19. [NA]
Reasoning: Not applicable, as no studies were identified.

P20. [NA]
Reasoning: Not applicable, as no studies were identified.

P21. [NA]
Reasoning: Not applicable, as no studies were identified.

P22. [NA]
Reasoning: Not applicable, as no studies were identified.

P23. [NA]
Reasoning: Not applicable, as no studies were identified.

P24. [Yes]
Reasoning: The authors provide a summary of the main findings and the strength of evidence for each main outcome.

P25. [Yes]
Reasoning: The authors discuss the limitations of the review.

P26. [Yes]
Reasoning: The authors provide a general interpretation of the results and implications for future research.

P27. [Yes]
Reasoning: The authors describe the sources of funding for the systematic review and other support.</pre>
<p><a name='161'></a></p>
</div>
<div
id="wang-2013-systematic-review-and-meta-analysis-of-studies-comparing-the-perimeatal-based-flap-and-tubularized-incised-plate-techniques-for-primary-hypospadias-repair"
class="section level4">
<h4>161.
<a href='https://doi.org/10.1007/S00383-013-3335-3' title='Open publication'>Wang
2013: <i>Systematic review and meta-analysis of studies comparing the
perimeatal-based flap and tubularized incised-plate techniques for
primary hypospadias repair</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 99.7%)</i></p>
<p><i><span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">22 quote(s)
from the LLM prompt briefing</span> (mean similarity 100%) - were
instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The PubMed, Embase and Cochrane databases were searched using the terms: hypospadias, Snodgrass, TIP*, tubularized incised plate, tubularized incised-plate, Mathieu*, perimeatal-based flap, perimeatal flap, meatal-based flap and meatal based flap. No other limits were used.&quot;</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The eligibility determination, quality assessment and data extraction for each study were conducted independently by two of the authors (FRW and YHX) and conflicts were resolved by a third author (HJZ).&quot;</span>
3. The research question and inclusion criteria are established before the conduct of the review.
- [Yes]

A2:

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The eligibility determination, quality assessment and data extraction for each study were conducted independently by two of the authors (FRW and YHX) and conflicts were resolved by a third author (HJZ).&quot;</span>
2. The process for study selection and data extraction is not explicitly stated, but it can be inferred that two authors independently performed these tasks.
3. Two independent data extractors and a consensus procedure for disagreements are present.
- [Yes]

A3:

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The PubMed, Embase and Cochrane databases were searched using the terms: hypospadias, Snodgrass, TIP*, tubularized incised plate, tubularized incised-plate, Mathieu*, perimeatal-based flap, perimeatal flap, meatal-based flap and meatal based flap. No other limits were used.&quot;</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The searches on Embase and Cochrane Library used the same words.&quot;</span>
3. At least two electronic sources were searched, and the search strategy is provided.
- [Yes]

A4:

1. The search strategy does not explicitly state that it included grey literature or unpublished literature.
2. The inclusion of grey literature or unpublished literature is not mentioned.
3. The status of publication was not used as an inclusion criterion.
- [No]

A5:

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Twelve studies fulfilled the inclusion criteria and were included in the final analysis.&quot;</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Agreement between the two reviewers (FRW and YHX) was 97.4 %.&quot;</span>
3. A list of included and excluded studies is not provided, but the number of included studies is mentioned.
- [No]

A6:

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The variables assessed included first author, publication year and type, level of evidence, patient age and number, length of follow-up, patient characteristics, surgical techniques and details (coverage of the neo-urethra, suture material and fashion, urinary diversion), and postoperative outcomes (fistula, meatal stenosis, wound dehiscence and cosmesis).&quot;</span>
2. Characteristics of the included studies are provided in a table.
3. The characteristics of the included studies are provided in an aggregated form.
- [Yes]

A7:

1. <span title='Minor quote deviation. Best match in fulltext (Similarity 96.6%):

Level of evidence and publication type was classified according to the Oxford Center for EvidenceBased Medicine' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The level of evidence and publication type was classified according to the Oxford Center for Evidence-Based Medicine.&quot;</span>
2. The scientific quality of the included studies is not explicitly assessed using a quality scoring tool or checklist.
3. The scientific quality of the included studies is not adequately assessed and documented.
- [No]

A8:

1. The scientific quality of the included studies is not used appropriately in formulating conclusions.
2. The results of the methodological rigor and scientific quality are not considered in the analysis and the conclusions of the review.
3. The scientific quality of the included studies is not used appropriately in formulating conclusions.
- [No]

A9:

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Meta-analysis showed that there were no significant differences between the two techniques when comparing fistula (OR = 1.47; 95 % CI: 0.822.63; P = 0.20), meatal stenosis (OR = 0.53; 95 % CI: 0.241.16; P = 0.11), and wound dehiscence (OR = 0.82; 95 % CI: 0.242.84; P = 0.76).&quot;</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Both the studies which assessed cosmesis objectively showed a consistent better cosmetic result of the TIP technique (P < 0.05).&quot;</span>
3. The methods used to combine the findings of studies are appropriate.
- [Yes]

A10:

1. The likelihood of publication bias is not assessed using graphical aids or statistical tests.
2. The likelihood of publication bias is not assessed.
3. The likelihood of publication bias is not assessed.
- [No]

A11:

1. The sources of support for the systematic review and the included studies are not clearly acknowledged.
2. Potential sources of support are not acknowledged.
3. Potential sources of support are not clearly acknowledged.
- [No]

PRISMA Items:

P1:

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Systematic review and meta-analysis of studies comparing the perimeatal-based flap and tubularized incised-plate techniques for primary hypospadias repair&quot;</span>
2. The report is identified as a systematic review and meta-analysis in the title.
- [Yes]

P2:

1. "Abstract"
2. A structured summary is provided, including background, objectives, data sources, study eligibility criteria, participants, and interventions, study appraisal and synthesis methods, results, limitations, conclusions, and implications of key findings.
- [Yes]

P3:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction&quot;</span>
2. The rationale for the review is described in the context of what is already known.
- [Yes]

P4:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction&quot;</span>
2. An explicit statement of questions being addressed is provided, with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
- [Yes]

P5:

1. Not explicitly mentioned in the full text.
2. It is not indicated if a review protocol exists, if it can be accessed, or if it was registered.
- [No]

P6:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
2. Study characteristics and report characteristics used as criteria for eligibility are specified, giving rationale.
- [Yes]

P7:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>
2. All information sources in the search are described, including databases and date last searched.
- [Yes]

P8:

1. Not explicitly mentioned in the full text.
2. The full electronic search strategy for at least one database is not presented in a way that it could be repeated.
- [No]

P9:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
2. The process for selecting studies is stated, including screening, eligibility, and inclusion in the systematic review and meta-analysis.
- [Yes]

P10:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
2. The method of data extraction from reports is described, including piloted forms and independent data extraction.
- [Yes]

P11:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>
2. All variables for which data were sought are listed and defined, including PICOS and funding sources.
- [Yes]

P12:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>
2. Methods used for assessing risk of bias of individual studies are described, including specification of whether this was done at the study or outcome level.
- [Yes]

P13:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
2. The principal summary measures are stated, including odds ratios and confidence intervals.
- [Yes]

P14:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span>
2. The methods of handling data and combining results of studies are described, including measures of consistency for each meta-analysis.
- [Yes]

P15:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span>
2. The assessment of risk of bias that may affect the cumulative evidence is specified, including publication bias.
- [Yes]

P16:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span>
2. Methods of additional analyses are described, including subgroup analyses.
- [Yes]

P17:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
2. The number of studies screened, assessed for eligibility, and included in the review is given, with reasons for exclusions at each stage.
- [Yes]

P18:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
2. For each study, characteristics for which data were extracted are presented, including study size, PICOS, and follow-up period.
- [Yes]

P19:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see Item P12).&quot;</span>
2. Data on risk of bias of each study is presented, including outcome level assessment.
- [Yes]

P20:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
2. For all outcomes considered, simple summary data for each intervention group and effect estimates and confidence intervals are presented, ideally with a forest plot.
- [Yes]

P21:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span>
2. The results of each meta-analysis done are presented, including confidence intervals and measures of consistency.
- [Yes]

P22:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span>
2. The results of any assessment of risk of bias across studies are presented, including publication bias.
- [Yes]

P23:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).&quot;</span>
2. The results of additional analyses are given, including subgroup analyses.
- [Yes]

P24:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
2. The main findings are summarized, including the strength of evidence for each main outcome and their relevance to key groups.
- [Yes]

P25:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
2. Limitations at study and outcome level, and at review-level are discussed, including incomplete retrieval of identified research and reporting bias.
- [Yes]

P26:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
2. A general interpretation of the results in the context of other evidence is provided, and implications for future research are discussed.
- [Yes]

P27:

1. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
2. Sources of funding for the systematic review and other support are not described.
- [No]</pre>
<p><a name='162'></a></p>
</div>
<div
id="wayne-2015-what-is-the-ideal-surgical-approach-for-intra-abdominal-testes-a-systematic-review"
class="section level4">
<h4>162.
<a href='https://doi.org/10.1007/S00383-015-3676-1' title='Open publication'>Wayne
2015: <i>What is the ideal surgical approach for intra-abdominal testes?
a systematic review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">23 quote(s) from
publication full text</span> (mean similarity 97.7%)</i></p>
<pre>
AMSTAR:

A1. "[Yes]" - <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

First round We sent an online survey to 34 experts' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;First round: We sent an online survey to 34 experts [&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;] This survey was hosted on the CAPS website and consisted of the open-ended question: In your practice with the surgical management of cryptorchidism, what issues do you find to be controversial and in need of further research and/or consensus?&quot;</span> - The research question and inclusion criteria were established before the conduct of the review.

A2. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two researchers screened all studies for inclusion, and quality assessed each relevant study using AMSTAR for systematic reviews (SRs), Cochrane Risk of bias tool for randomized controlled trials (RCTs), and MINORS for non-randomized studies.&quot;</span> - There were at least two independent data extractors and a consensus procedure for disagreements.

A3. "[Yes]" - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

We conducted electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and CINAHL from inception to September 2014. We used the following search terms: Cryptorchidism AND Intra-abdominal OR Abdomen/abdominal cavity/inguinal canal/groin.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We conducted electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and CINAHL from inception to September 2014. We used the following search terms: Cryp-torchidism AND Intra-abdominal OR Abdomen/abdominal cavity/inguinal canal/groin.&quot;</span> - At least two electronic sources were searched, with search terms and databases used mentioned.

A4. "[No]" - There is no mention of including grey literature in the search strategy.

A5. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Due to this abundance of literature, we limited the date range to January 2008September 2014, reducing the total number of articles to 48. We performed full-text screening for these articles, excluding 17 that did not meet our criteria.&quot;</span> - A list of included and excluded studies was provided.

A6. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our initial search yielded 774 studies. After title-abstract screening, 224 studies remained. Due to this abundance of literature, we limited the date range to January 2008September 2014, reducing the total number of articles to 48. We performed full-text screening for these articles, excluding 17 that did not meet our criteria.&quot;</span> - The ranges of characteristics in all the studies analyzed were reported.

A7. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We used AMSTAR [18] to assess the quality of all relevant systematic reviews (SRs). AMSTAR contains 11 items, where a review scores one point for each yes and zero points for each no or cant answer, for a maximum score of 11.&quot;</span> - The scientific quality of the included studies was assessed and documented.

A8. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We identified two relevant SRs and 29 non-randomized studies. Due to the heterogeneity of the data, meta-analysis was not possible. Ultrasound and magnetic resonance imaging are insufficient for identification or localization of IAT; laparoscopic or surgical exploration is necessary.&quot;</span> - The scientific quality of the included studies was used appropriately in formulating conclusions.

A9. "[NA]" - Not applicable, since meta-analysis was not performed.

A10. "[NA]" - Not applicable, since meta-analysis was not performed.

A11. "[No]" - There is no mention of potential sources of support for the systematic review or for each of the included studies.

PRISMA:

P1. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;What is the ideal surgical approach for intra-abdominal testes? A systematic review&quot;</span> - The title identifies the report as a systematic review.

P2. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We conducted a systematic review to address this problem. We performed a comprehensive electronic search of CENTRAL, MEDLINE, EMBASE, and CINAHL from 2008 to September 2014 (the date range was limited due to an abundance of literature), as well as reference lists of included studies. Two researchers screened all studies for inclusion, and quality assessed each relevant study using AMSTAR for systematic reviews (SRs), Cochrane Risk of bias tool for randomized controlled trials (RCTs), and MINORS for non-randomized studies.&quot;</span> - The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants, and interventions.

P3. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In approximately 25 % of males, one or both testes fail to descend into the scrotum by birth [1, 2]. Many of these testes will descend spontaneously within the first year, but approximately 23 % will remain cryptorchid without surgical correction [3]. Of these, around 20 % are non-palpable and may be located within the abdomen [4].&quot;</span> - The rationale for the review is described in the context of what is already known.

P4. "[Yes]" - <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 51.1%):

systematic review investigating the ideal surgical management of IAT.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;In this systematic review, we aimed to address this controversy by synthesizing the evidence on the ideal surgical management of IAT.&quot;</span> - An explicit statement of questions being addressed is provided.

P5. "[No]" - There is no mention of a review protocol or registration information.

P6. "[Yes]" - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

We included all studies that examined diagnostic and surgical correction techniques for IAT, even if this was not the primary focus of the study. Our outcomes of interest were success of orchiopexy (testis viable and located in the scrotum), testicular atrophy, and intra-operative and postoperative complications.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We included all studies that examined diagnostic and surgical correction techniques for IAT, even if this was not the primary focus of the study. Our outcomes of interest were success of orchiopexy (testis viable and located in the scrotum), testicular atrophy, and intra-operative and post-operative complications.&quot;</span> - Study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility are specified, with rationale.

P7. "[Yes]" - <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

We conducted electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and CINAHL from inception to September 2014. We used the following search terms: Cryptorchidism AND Intra-abdominal OR Abdomen/abdominal cavity/inguinal canal/groin.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We conducted electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and CINAHL from inception to September 2014. We used the following search terms: Cryp-torchidism AND Intra-abdominal OR Abdomen/abdominal cavity/inguinal canal/groin.&quot;</span> - All information sources and the date last searched are described.

P8. "[No]" - The full electronic search strategy for at least one database is not presented.

P9. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two researchers screened all studies for inclusion, and quality assessed each relevant study using AMSTAR for systematic reviews (SRs), Cochrane Risk of bias tool for randomized controlled trials (RCTs), and MINORS for non-randomized studies.&quot;</span> - The process for selecting studies is stated.

P10. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;One reviewer extracted data from each of the included studies, and a second reviewer checked the data for accuracy and completeness.&quot;</span> - The method of data extraction from reports is described.

P11. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We summarized the results, with an emphasis on higher-quality evidence; we considered SRs to be the highest quality evidence, followed by RCTs, and non-randomized studies [21], taking the results of our quality assessment into consideration.&quot;</span> - All variables for which data were sought are listed and defined.

P12. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We used AMSTAR [18] to assess the quality of all relevant systematic reviews (SRs). AMSTAR contains 11 items, where a review scores one point for each yes and zero points for each no or cant answer, for a maximum score of 11.&quot;</span> - Methods used for assessing risk of bias of individual studies are described.

P13. "[No]" - The principal summary measures are not stated.

P14. "[NA]" - Not applicable, since meta-analysis was not performed.

P15. "[NA]" - Not applicable, since meta-analysis was not performed.

P16. "[NA]" - Not applicable, since meta-analysis was not performed.

P17. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our initial search yielded 774 studies. After title-abstract screening, 224 studies remained. Due to this abundance of literature, we limited the date range to January 2008September 2014, reducing the total number of articles to 48. We performed full-text screening for these articles, excluding 17 that did not meet our criteria.&quot;</span> - Numbers of studies screened, assessed for eligibility, and included in the review are given, with reasons for exclusions at each stage.

P18. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The SRs achieved quality scores of 4 [37] and 5 [38] out of a possible 11. The quality scores of the non-randomized studies ranged from 7 to 16 out of a possible 24, with a median of 10.&quot;</span> - For each study, characteristics for which data were extracted are presented.

P19. "[No]" - The risk of bias within studies is not presented.

P20. "[No]" - Results of individual studies are not presented.

P21. "[NA]" - Not applicable, since meta-analysis was not performed.

P22. "[NA]" - Not applicable, since meta-analysis was not performed.

P23. "[NA]" - Not applicable, since meta-analysis was not performed.

P24. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We identified two relevant SRs and 29 non-randomized studies. Due to the heterogeneity of the data, meta-analysis was not possible. Ultrasound and magnetic resonance imaging are insufficient for identification or localization of IAT; laparoscopic or surgical exploration is necessary. Primary orchiopexy is effective for low IAT, and Fowler-Stephens orchiopexy (FSO) is effective for high IAT. There is no clear benefit of one- vs. two-stage FSO, or of open vs. laparoscopic technique. Several alternative or modified techniques also show promise. RCTs are needed to confirm the validity of these findings, and to assess long-term outcomes.&quot;</span> - The main findings are summarized, including the strength of evidence for each main outcome.

P25. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Due to the heterogeneity of the data, a meta-analysis was not possible. The results from each level of our search and screening process are detailed in Fig. 1.&quot;</span> - The limitations at the study and outcome level are discussed.

P26. "[Yes]" - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We conducted a systematic review of literature focusing on the surgical treatment of IAT, including quality assessment of each study. From there, we were able to draw conclusions regarding the ideal treatment based on the highest quality evidence available, and propose suggestions for future research. By synthesizing the evidence and making it easily accessible to medical professionals, we can help busy clinicians determine which surgical techniques warrant integration into practice, enhancing the use of evidence-based medicine.&quot;</span> - A general interpretation of the results is provided in the context of other evidence, and implications for future research are discussed.

P27. "[No]" - The sources of funding for the systematic review and other support are not described.</pre>
<p><a name='163'></a></p>
</div>
<div
id="weih-2012-current-practice-and-future-perspectives-in-the-treatment-of-short-bowel-syndrome-in-childrena-systematic-review"
class="section level4">
<h4>163.
<a href='https://doi.org/10.1007/S00423-011-0874-8' title='Open publication'>Weih
2012: <i>Current practice and future perspectives in the treatment of
short bowel syndrome in childrena systematic review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
AMSTAR:

A1. [No] - The research question and inclusion criteria are not established before the conduct of the review. The authors do not refer to a protocol, ethics approval, or pre-determined published research objectives.

A2. [No] - There is no mention of duplicate study selection and data extraction, nor a consensus procedure for disagreements.

A3. [No] - The authors do not provide a comprehensive literature search, including years and databases used, key words, and supplementary strategies.

A4. [No] - The authors do not state that they searched for reports regardless of their publication type or that they excluded any reports based on their publication status, language, etc.

A5. [No] - The authors do not provide a list of included and excluded studies.

A6. [No] - The authors do not provide the characteristics of the included studies in an aggregated form such as a table, data from the original studies, or a description of the participants, interventions, and outcomes.

A7. [No] - The authors do not provide an 'a priori' method of assessment for the scientific quality of the included studies.

A8. [NA] - This question is not applicable as the authors did not assess the scientific quality of the included studies.

A9. [NA] - This question is not applicable as the authors did not combine the findings of studies.

A10. [NA] - This question is not applicable as the authors did not assess the likelihood of publication bias.

A11. [NA] - This question is not applicable as the authors did not provide information on the potential sources of support for the systematic review and the included studies.

PRISMA:

P1. [No] - The title does not identify the report as a systematic review, meta-analysis, or both.

P2. [No] - The abstract does not provide a structured summary including background, objectives, data sources, study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.

P3. [No] - The introduction does not describe the rationale for the review in the context of what is already known.

P4. [No] - The introduction does not provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).

P5. [No] - The authors do not indicate if a review protocol exists, if and where it can be accessed, and provide registration information including registration number.

P6. [No] - The authors do not specify study characteristics and report characteristics used as criteria for eligibility, giving rationale.

P7. [No] - The authors do not describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.

P8. [No] - The authors do not present the full electronic search strategy for at least one database, including any limits used, such that it could be repeated.

P9. [No] - The authors do not state the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).

P10. [No] - The authors do not describe the method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.

P11. [No] - The authors do not list and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.

P12. [No] - The authors do not describe the methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.

P13. [No] - The authors do not state the principal summary measures (e.g., risk ratio, difference in means).

P14. [NA] - This question is not applicable as the authors did not perform a meta-analysis.

P15. [NA] - This question is not applicable as the authors did not perform a meta-analysis.

P16. [NA] - This question is not applicable as the authors did not perform a meta-analysis.

P17. [No] - The authors do not give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.

P18. [No] - The authors do not present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations for each study.

P19. [No] - The authors do not present data on risk of bias of each study and, if available, any outcome level assessment.

P20. [No] - The authors do not present, for all outcomes considered (benefits or harms), for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.

P21. [NA] - This question is not applicable as the authors did not perform a meta-analysis.

P22. [NA] - This question is not applicable as the authors did not perform a meta-analysis.

P23. [NA] - This question is not applicable as the authors did not perform a meta-analysis.

P24. [No] - The authors do not summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).

P25. [No] - The authors do not discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).

P26. [No] - The authors do not provide a general interpretation of the results in the context of other evidence, and implications for future research.

P27. [No] - The authors do not describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.</pre>
<p><a name='164'></a></p>
</div>
<div
id="wenk-2015-incidence-of-metachronous-contralateral-inguinal-hernias-in-children-following-unilateral-repair-a-meta-analysis-of-prospective-studies"
class="section level4">
<h4>164.
<a href='https://doi.org/10.1016/J.JPEDSURG.2015.08.056' title='Open publication'>Wenk
2015: <i>Incidence of metachronous contralateral inguinal hernias in
children following unilateral repair  A meta-analysis of prospective
studies</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">11 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<p><i><span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">27 quote(s)
from the LLM prompt briefing</span> (mean similarity 100%) - were
instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The objective of this review was to systematically evaluate the incidence of a metachronous contralateral inguinal hernia (MCIH) in children with unilateral inguinal hernia and therefore to propose or to reject routine contralateral groin exploration.&quot;</span>
Reasoning: The research question and inclusion criteria were established before the conduct of the review.
Response: [Yes]

A2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Data from selected studies were extracted by two authors (RNV and KW). Extracted data were managed using a preformed Excel data sheet.&quot;</span>
Reasoning: Two independent data extractors were used, and a consensus process was in place for disagreements.
Response: [Yes]

A3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Electronic searches restricted to prospective studies with a minimal follow-up of 1 year included MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials.&quot;</span>
Reasoning: At least two electronic sources were searched, and the search strategy was provided.
Response: [Yes]

A4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Study authors were contacted for additional information. Furthermore, the reference lists from all known systematic reviews assessing the incidence of MCIH [46,912] were reviewed.&quot;</span>
Reasoning: The authors searched for reports regardless of their publication type and did not exclude any reports based on publication status, language, etc.
Response: [Yes]

A5: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Six studies met the inclusion criteria [7,2832].&quot;</span>
Reasoning: A list of included studies was provided.
Response: [Yes]

A6: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
Reasoning: The characteristics of the included studies were not provided in an aggregated form such as a table, but they were described in the text.
Response: [No]

A7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The primary outcome was the overall incidence of MCIH in children with unilateral inguinal hernia (i). Secondary outcomes consisted of incidence of MCIH in male versus female children (ii); in children younger than 1 year of age versus older children (iii); in children with primarily right- versus primarily left-sided inguinal hernia (iv); and in children with open versus cleft versus closed CPPV (v).&quot;</span>
Reasoning: The scientific quality of the included studies was not assessed and documented.
Response: [No]

A8: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

The overall incidence of MCIH following unilateral inguinal hernia repair in children is 6%. Initial leftsided hernia (8.5%) and open CPV (13.8%) are risk factors for MCIH development. Female gender (8.2%) and younger age (b 1 year) (6.9%) non-significantly increase the risk of MCIH.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The overall incidence of MCIH following unilateral inguinal hernia repair in children is 6%. Initial left-sided hernia (8.5%) and open CPV (13.8%) are risk factors for MCIH development. Female gender (8.2%) and younger age (b 1 year) (6.9%) non-significantly increase the risk of MCIH.&quot;</span>
Reasoning: The results of the methodological rigor and scientific quality were not considered in the analysis and the conclusions of the review.
Response: [No]

A9: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):

the test for heterogeneity was signi ficant (p-value b 0.001), results from the random effect model were used.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The test for heterogeneity was significant (p-value < 0.001), results from the random effect model were used.&quot;</span>
Reasoning: The methods used to combine the findings of studies were appropriate.
Response: [Yes]

A10: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Overall, a funnel plot (Appendix 4. Figure A2) did not show evidence for publication bias.&quot;</span>
Reasoning: The likelihood of publication bias was assessed using a combination of graphical aids and statistical tests.
Response: [Yes]

A11: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Source of funding: There was no funding to the present study.&quot;</span>
Reasoning: Potential sources of support were not clearly acknowledged in both the systematic review and the included studies.
Response: [No]

PRISMA Items:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Incidence of metachronous contralateral inguinal hernias in children following unilateral repair  A meta-analysis of prospective studies&quot;</span>
Reasoning: The title identifies the report as a meta-analysis.
Response: [Yes]

P2: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
Reasoning: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and implications of key findings.
Response: [Yes]

P3: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Rationale: Describe the rationale for the review in the context of what is already known.&quot;</span>
Reasoning: The rationale for the review is described in the context of what is already known.
Response: [Yes]

P4: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
Reasoning: An explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design is provided.
Response: [Yes]

P5: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span>
Reasoning: The authors did not indicate if a review protocol exists, where it can be accessed, or provide registration information including registration number.
Response: [No]

P6: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
Reasoning: Study characteristics and report characteristics used as criteria for eligibility are specified, giving rationale.
Response: [Yes]

P7: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>
Reasoning: All information sources in the search and date last searched are described.
Response: [Yes]

P8: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
Reasoning: The full electronic search strategy for at least one database, including any limits used, is presented such that it could be repeated.
Response: [Yes]

P9: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
Reasoning: The process for selecting studies is stated.
Response: [Yes]

P10: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
Reasoning: The method of data extraction from reports and any processes for obtaining and confirming data from investigators are described.
Response: [Yes]

P11: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>
Reasoning: All variables for which data were sought are listed and defined, and any assumptions and simplifications made are described.
Response: [Yes]

P12: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>
Reasoning: The methods used for assessing risk of bias of individual studies and how this information is to be used in any data synthesis are described.
Response: [Yes]

P13: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
Reasoning: The principal summary measures are stated.
Response: [Yes]

P14: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span>
Reasoning: The methods of handling data and combining results of studies, including measures of consistency for each meta-analysis, are described.
Response: [Yes]

P15: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span>
Reasoning: Any assessment of risk of bias that may affect the cumulative evidence is specified.
Response: [Yes]

P16: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span>
Reasoning: Methods of additional analyses, if done, indicating which were pre-specified, are described.
Response: [Yes]

P17: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
Reasoning: The numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, are given, ideally with a flow diagram.
Response: [Yes]

P18: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
Reasoning: For each study, characteristics for which data were extracted are presented, and the citations are provided.
Response: [Yes]

P19: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span>
Reasoning: Data on risk of bias of each study and any outcome level assessment are presented.
Response: [Yes]

P20: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
Reasoning: For all outcomes considered, simple summary data for each intervention group, effect estimates, and confidence intervals are presented, ideally with a forest plot.
Response: [Yes]

P21: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span>
Reasoning: The results of each meta-analysis done, including confidence intervals and measures of consistency, are presented.
Response: [Yes]

P22: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span>
Reasoning: The results of any assessment of risk of bias across studies are presented.
Response: [Yes]

P23: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).&quot;</span>
Reasoning: The results of additional analyses, if done, are given.
Response: [Yes]

P24: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
Reasoning: The main findings are summarized, including the strength of evidence for each main outcome, and their relevance to key groups is considered.
Response: [Yes]

P25: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
Reasoning: Limitations at study and outcome level and at review-level are discussed.
Response: [Yes]

P26: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
Reasoning: A general interpretation of the results in the context of other evidence and implications for future research are provided.
Response: [Yes]

P27: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
Reasoning: Sources of funding for the systematic review and other support are described, and the role of funders for the systematic review is discussed.
Response: [Yes]</pre>
<p><a name='165'></a></p>
</div>
<div
id="wilkinson-2012-outcomes-in-distal-hypospadias-a-systematic-review-of-the-mathieu-and-tubularized-incised-plate-repairs"
class="section level4">
<h4>165.
<a href='https://doi.org/10.1016/J.JPUROL.2010.11.008' title='Open publication'>Wilkinson
2012: <i>Outcomes in distal hypospadias: A systematic review of the
Mathieu and tubularized incised plate repairs</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">18 quote(s) from
publication full text</span> (mean similarity 98.3%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">3
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The Medline (1990eDec 2009), Embase (1990eDec 2009) and Cochrane databases were searched using the single search term hypospadias to ensure the broadest capture of relevant papers.&quot;</span>
- Reasoning: The authors provided an 'a priori' design by specifying the databases and search terms used.
- Response: [Yes]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search, selection and review of papers, and statistical analysis were conducted by both primary authors.&quot;</span>
- Reasoning: The authors did not explicitly mention that there were at least two independent data extractors and a consensus procedure for disagreements.
- Response: [No]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The Medline (1990eDec 2009), Embase (1990eDec 2009) and Cochrane databases were searched using the single search term hypospadias.&quot;</span>
- Reasoning: The authors searched at least two electronic sources and provided the years and databases used.
- Response: [Yes]

A4:
- Quote: N/A
- Reasoning: The authors did not mention searching for reports regardless of their publication type or excluding any reports based on their publication status, language, etc.
- Response: [No]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All titles and abstracts were reviewed initially to select papers for full review if they contained results of distal hypospadias repairs using either the Mathieu or TIP repair.&quot;</span>
- Reasoning: The authors did not provide a list of included and excluded studies.
- Response: [No]

A6:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
- Reasoning: The authors provided the characteristics of the included studies in Table 1.
- Response: [Yes]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our inclusion criteria were: i) primary repairs only, ii) clearly defined series of exclusively distal hypospadias, iii) paediatric case series, iv) standard Mathieu and TIP techniques, and v) complication data obtainable from the paper.&quot;</span>
- Reasoning: The authors specified the inclusion criteria for the studies, but did not explicitly mention assessing the scientific quality of the included studies.
- Response: [No]

A8:
- Quote: N/A
- Reasoning: The authors did not discuss the scientific quality of the included studies in formulating conclusions.
- Response: [No]

A9:
- Quote: N/A
- Reasoning: The authors did not perform a meta-analysis, so this question is not applicable.
- Response: [NA]

A10:
- Quote: N/A
- Reasoning: The authors did not assess the likelihood of publication bias.
- Response: [No]

A11:
- Quote: N/A
- Reasoning: The authors did not provide information on potential sources of support for the systematic review or the included studies.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Outcomes in distal hypospadias: A systematic review of the Mathieu and tubularized incised plate repairs&quot;</span>
- Reasoning: The title identifies the report as a systematic review.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Aim: To compare complication rates after distal hypospadias surgery using the tubularized incised plate (TIP) and Mathieu techniques.&quot;</span>
- Reasoning: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants, and interventions.
- Response: [Yes]

P3:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 81.8%):

Hypospadias is one of the most common congenital conditions affecting males worldwide. Over 200 different repairs are described in the available literature although two repairs, the tubularized incised plate (TIP) repair and the' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Hypospadias is one of the most common congenital conditions affecting males worldwide. Over 200 different repairs are described in the available literature although two repairs, the tubularized incised plate (TIP) repair and the Mathieu technique, dominate the current literature.&quot;</span>
- Reasoning: The introduction provides a rationale for the review in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 90.3%):

Systematic review Abstract Aim: To compare complication rates after distal hypospadias surgery using the tubularized incised plate (TIP) and Mathieu techniques.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The aim of this systematic review is to compare complication rates after distal hypospadias surgery using the tubularized incised plate (TIP) and Mathieu techniques.&quot;</span>
- Reasoning: The introduction provides an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
- Response: [Yes]

P5:
- Quote: N/A
- Reasoning: The authors did not indicate if a review protocol exists or provide registration information.
- Response: [No]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our inclusion criteria were: i) primary repairs only, ii) clearly defined series of exclusively distal hypospadias, iii) paediatric case series, iv) standard Mathieu and TIP techniques, and v) complication data obtainable from the paper.&quot;</span>
- Reasoning: The authors specified study characteristics used as criteria for eligibility.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The Medline (1990eDec 2009), Embase (1990eDec 2009) and Cochrane databases were searched using the single search term hypospadias.&quot;</span>
- Reasoning: The authors described the information sources used in the search.
- Response: [Yes]

P8:
- Quote: N/A
- Reasoning: The authors did not present the full electronic search strategy for at least one database.
- Response: [No]

P9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All titles and abstracts were reviewed initially to select papers for full review if they contained results of distal hypospadias repairs using either the Mathieu or TIP repair.&quot;</span>
- Reasoning: The authors stated the process for selecting studies.
- Response: [Yes]

P10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The search, selection and review of papers, and statistical analysis were conducted by both primary authors.&quot;</span>
- Reasoning: The authors described the method of data extraction from reports.
- Response: [Yes]

P11:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
- Reasoning: The authors listed and defined all variables for which data were sought.
- Response: [Yes]

P12:
- Quote: N/A
- Reasoning: The authors did not describe methods used for assessing the risk of bias of individual studies.
- Response: [No]

P13:
- Quote: N/A
- Reasoning: The authors did not state the principal summary measures.
- Response: [No]

P14:
- Quote: N/A
- Reasoning: The authors did not describe the methods of handling data and combining results of studies.
- Response: [NA]

P15:
- Quote: N/A
- Reasoning: The authors did not specify any assessment of the risk of bias that may affect the cumulative evidence.
- Response: [NA]

P16:
- Quote: N/A
- Reasoning: The authors did not describe methods of additional analyses.
- Response: [NA]

P17:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Subsequently, 23 papers met all necessary criteria and were included in the analysis.&quot;</span>
- Reasoning: The authors gave numbers of studies screened, assessed for eligibility, and included in the review.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
- Reasoning: The authors presented the characteristics of the included studies.
- Response: [Yes]

P19:
- Quote: N/A
- Reasoning: The authors did not present data on the risk of bias of each study.
- Response: [No]

P20:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
- Reasoning: The authors presented the results of each study.
- Response: [Yes]

P21:
- Quote: N/A
- Reasoning: The authors did not present the results of each meta-analysis done.
- Response: [NA]

P22:
- Quote: N/A
- Reasoning: The authors did not present the results of any assessment of the risk of bias across studies.
- Response: [NA]

P23:
- Quote: N/A
- Reasoning: The authors did not give the results of additional analyses.
- Response: [NA]

P24:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;This systematic review highlights a notable lack of evidence with regard to treatment outcomes in hypospadias surgery.&quot;</span>
- Reasoning: The authors summarized the main findings, including the strength of evidence for each main outcome.
- Response: [Yes]

P25:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Although this review covered all the available literature since 1990, we were limited to just 27 papers that met our inclusion criteria.&quot;</span>
- Reasoning: The authors discussed limitations at the study and outcome level.
- Response: [Yes]

P26:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;There is no clear consensus on the ideal method of repair for distal hypospadias. Both the Mathieu and TIP techniques have been shown to have low rates of postoperative complications.&quot;</span>
- Reasoning: The authors provided a general interpretation of the results in the context of other evidence and implications for future research.
- Response: [Yes]

P27:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.1%):

Conflict of interest/Funding None.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Conflict of interest/Funding: None.&quot;</span>
- Reasoning: The authors described sources of funding for the systematic review and other support.
- Response: [Yes]</pre>
<p><a name='166'></a></p>
</div>
<div
id="wright-2013-effect-of-preoperative-hormonal-stimulation-on-postoperative-complication-rates-after-proximal-hypospadias-repair-a-systematic-review"
class="section level4">
<h4>166.
<a href='https://doi.org/10.1016/J.JURO.2013.02.3234' title='Open publication'>Wright
2013: <i>Effect of Preoperative Hormonal Stimulation on Postoperative
Complication Rates After Proximal Hypospadias Repair: A Systematic
Review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
wrong-response-partial-unclear-etc</i></p>
<p><i><span style="border-bottom: 1px dashed black;">22 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">2
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Predetermined criteria for study inclusion&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot; 1) publication between 1990 and 2010, 2) focus on human subjects, 3) hypospadias as primary diagnosis, 4) exposure of patients to some form of hormonal stimulation preoperatively or postoperatively, 5) performance of surgical repair, 6) reporting of postoperative complications and 7) clinical research designation.&quot;</span>
- Reasoning: The research question and inclusion criteria were established before the conduct of the review.
- Response: [Yes]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Title and abstract screening was conducted independently by 2 authors to select all citations that might contain comparisons of interest. Full text of each included article was obtained and data were abstracted independently by 2 authors. All screening results were reviewed for concordance and all discrepancies were resolved by consensus.&quot;</span>
- Reasoning: There were at least two independent data extractors and a consensus procedure for disagreements was in place.
- Response: [Yes]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We comprehensively searched the published and unpublished literature between 1990 and 2010. Eligibility criteria were applied.&quot;</span>
- Reasoning: The authors searched at least two electronic sources and provided the years and databases used, but did not explicitly mention using key words or providing the search strategy.
- Response: [Unclear <span style='background-color: #ff9e81' title='Added response during extraction'>[NA]</span>]

A4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;English language was not used as an eligibility criterion to avoid language bias.&quot;</span>
- Reasoning: The authors did not explicitly state that they searched for reports regardless of their publication type, but they did not exclude reports based on language.
- Response: [Unclear <span style='background-color: #ff9e81' title='Added response during extraction'>[NA]</span>]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A gray literature search of conference abstracts was also performed.&quot;</span>
- Reasoning: The authors mentioned a gray literature search, but did not provide a list of included and excluded studies.
- Response: [Unclear <span style='background-color: #ff9e81' title='Added response during extraction'>[NA]</span>]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Demographic data are outlined in table 1.&quot;</span>
- Reasoning: The authors provided data from the original studies in an aggregated form, such as a table.
- Response: [Yes]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Critical appraisal of the included studies was carried out by 2 independent reviewers using a quality assessment instrument adopted from Elyas et al, modified to fit the objectives of this study (see Appendix).&quot;</span>
- Reasoning: The authors used a quality scoring tool or checklist for the included studies.
- Response: [Yes]

A8:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Although the limited data yielded by this review prevent the formulation of conclusive information regarding the effect of PHS on surgical outcomes, they provide important insight into the deficiencies in the hypospadias literature, setting the stage to improve the quality of reporting in the future.&quot;</span>
- Reasoning: The authors considered the results of the methodological rigor and scientific quality in their analysis and conclusions.
- Response: [Yes]

A9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We planned a priori to use random effects models to account for between study heterogeneity for single group and comparative cohort studies.&quot;</span>
- Reasoning: The authors mentioned using a test to ensure the studies were combinable and explicitly stated that they used a random effects model when appropriate.
- Response: [Yes]

A10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Publication bias was graphically assessed by constructing funnel plots depicting precision (standard error) plotted against the proportion of complications.&quot;</span>
- Reasoning: The authors assessed publication bias using a combination of graphical aids and statistical tests.
- Response: [Yes]

A11:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
- Reasoning: The authors did not provide information on the sources of funding or support for the systematic review or the included studies.
- Response: [No]

PRISMA:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Purpose: We conducted a systematic review and meta-analysis to summarize the effect of preoperative hormonal stimulation on complication rates following proximal hypospadias repair.&quot;</span>
- Reasoning: The title identifies the report as a systematic review and meta-analysis.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Methods: We comprehensively searched the published and unpublished literature between 1990 and 2010. Eligibility criteria were applied. Title, abstract and full text screening was carried out by 2 independent authors, and discrepancies were resolved by consensus. Heterogeneity between studies was tested using Cochran chi-square Q test and quantified by calculating I2. Quality appraisal of included studies was performed. Meta-analysis was conducted when appropriate using a random effects model.&quot;</span>
- Reasoning: The abstract provides a structured summary including the background, objectives, methods, results, limitations, and conclusions.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Purpose: We conducted a systematic review and meta-analysis to summarize the effect of preoperative hormonal stimulation on complication rates following proximal hypospadias repair.&quot;</span>
- Reasoning: The rationale for the review is described in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Purpose: We conducted a systematic review and meta-analysis to summarize the effect of preoperative hormonal stimulation on complication rates following proximal hypospadias repair.&quot;</span>
- Reasoning: The research question is explicitly stated, although it does not refer to participants, interventions, comparisons, outcomes, and study design (PICOS).
- Response: [Unclear <span style='background-color: #ff9e81' title='Added response during extraction'>[NA]</span>]

P5:
- Quote: "NA"
- Reasoning: The authors did not mention a review protocol or registration information.
- Response: [No]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Predetermined criteria for study inclusion&quot;</span> [...] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot; 1) publication between 1990 and 2010, 2) focus on human subjects, 3) hypospadias as primary diagnosis, 4) exposure of patients to some form of hormonal stimulation preoperatively or postoperatively, 5) performance of surgical repair, 6) reporting of postoperative complications and 7) clinical research designation.&quot;</span>
- Reasoning: The authors provided the study characteristics and report characteristics used as criteria for eligibility.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We comprehensively searched the published and unpublished literature between 1990 and 2010.&quot;</span>
- Reasoning: The authors described all information sources in the search, but did not provide the date last searched.
- Response: [Unclear <span style='background-color: #ff9e81' title='Added response during extraction'>[NA]</span>]

P8:
- Quote: "NA"
- Reasoning: The authors did not present the full electronic search strategy for at least one database.
- Response: [No]

P9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Title and abstract screening was conducted independently by 2 authors to select all citations that might contain comparisons of interest. Full text of each included article was obtained and data were abstracted independently by 2 authors. All screening results were reviewed for concordance and all discrepancies were resolved by consensus.&quot;</span>
- Reasoning: The authors stated the process for selecting studies.
- Response: [Yes]

P10:
- Quote: "NA"
- Reasoning: The authors did not describe the method of data extraction from reports.
- Response: [No]

P11:
- Quote: "NA"
- Reasoning: The authors did not list and define all variables for which data were sought.
- Response: [No]

P12:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Critical appraisal of the included studies was carried out by 2 independent reviewers using a quality assessment instrument adopted from Elyas et al, modified to fit the objectives of this study (see Appendix).&quot;</span>
- Reasoning: The authors described the methods used for assessing the risk of bias of individual studies.
- Response: [Yes]

P13:
- Quote: "NA"
- Reasoning: The authors did not state the principal summary measures.
- Response: [No]

P14:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Methods: We comprehensively searched the published and unpublished literature between 1990 and 2010. Eligibility criteria were applied. Title, abstract and full text screening was carried out by 2 independent authors, and discrepancies were resolved by consensus. Heterogeneity between studies was tested using Cochran chi-square Q test and quantified by calculating I2. Quality appraisal of included studies was performed. Meta-analysis was conducted when appropriate using a random effects model.&quot;</span>
- Reasoning: The authors described the methods of handling data and combining results of studies.
- Response: [Yes]

P15:
- Quote: "NA"
- Reasoning: The authors did not specify any assessment of the risk of bias that may affect the cumulative evidence.
- Response: [No]

P16:
- Quote: "NA"
- Reasoning: The authors did not describe methods of additional analyses, if done.
- Response: [No]

P17:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Our search yielded 288 citations, of which 11 (622 patients) met inclusion criteria and were incorporated into the systematic review.&quot;</span>
- Reasoning: The authors gave numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Demographic data are outlined in table 1.&quot;</span>
- Reasoning: The authors presented the characteristics for which data were extracted for each study.
- Response: [Yes]

P19:
- Quote: "NA"
- Reasoning: The authors did not present data on the risk of bias of each study.
- Response: [No]

P20:
- Quote: "NA"
- Reasoning: The authors did not present the results of each meta-analysis done, including confidence intervals and measures of consistency.
- Response: [No]

P21:
- Quote: "NA"
- Reasoning: The authors did not present the results of each meta-analysis done, including confidence intervals and measures of consistency.
- Response: [No]

P22:
- Quote: "NA"
- Reasoning: The authors did not present the results of any assessment of risk of bias across studies.
- Response: [No]

P23:
- Quote: "NA"
- Reasoning: The authors did not give the results of additional analyses, if done.
- Response: [No]

P24:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):

To our knowledge this is the only systematic review and metaanalysis thus far that has critically assessed the effect of preoperative hormonal stimulation on operative outcomes after hypospadias repair. The published literature is of low quality and lacks standardized reporting of important patient and surgical details. The effect of preoperative hormonal stimulation on operative outcomes after hypospadias repair remains unclear and requires further investigation.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;To our knowledge this is the only systematic review and meta-analysis thus far that has critically assessed the effect of preoperative hormonal stimulation on operative outcomes after hypospadias repair. The published literature is of low quality and lacks standardized reporting of important patient and surgical details. The effect of preoperative hormonal stimulation on operative outcomes after hypospadias repair remains unclear and requires further investigation.&quot;</span>
- Reasoning: The authors summarized the main findings, including the strength of evidence for each main outcome, and considered their relevance to key groups.
- Response: [Yes]

P25:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Although the limited data yielded by this review prevent the formulation of conclusive information regarding the effect of PHS on surgical outcomes, they provide important insight into the deficiencies in the hypospadias literature, setting the stage to improve the quality of reporting in the future.&quot;</span>
- Reasoning: The authors discussed limitations at the study and outcome level.
- Response: [Yes]

P26:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):

To our knowledge this is the only systematic review and metaanalysis thus far that has critically assessed the effect of preoperative hormonal stimulation on operative outcomes after hypospadias repair. The published literature is of low quality and lacks standardized reporting of important patient and surgical details. The effect of preoperative hormonal stimulation on operative outcomes after hypospadias repair remains unclear and requires further investigation.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;To our knowledge this is the only systematic review and meta-analysis thus far that has critically assessed the effect of preoperative hormonal stimulation on operative outcomes after hypospadias repair. The published literature is of low quality and lacks standardized reporting of important patient and surgical details. The effect of preoperative hormonal stimulation on operative outcomes after hypospadias repair remains unclear and requires further investigation.&quot;</span>
- Reasoning: The authors provided a general interpretation of the results in the context of other evidence and implications for future research.
- Response: [Yes]

P27:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
- Reasoning: The authors did not provide information on the sources of funding or support for the systematic review or the included studies.
- Response: [No]</pre>
<p><a name='167'></a></p>
</div>
<div
id="yang-2011-laparoscopic-vs-open-herniorrhaphy-in-the-management-of-pediatric-inguinal-hernia-a-systemic-review-and-meta-analysis"
class="section level4">
<h4>167.
<a href='https://doi.org/10.1016/J.JPEDSURG.2011.04.001' title='Open publication'>Yang
2011: <i>Laparoscopic vs open herniorrhaphy in the management of
pediatric inguinal hernia: a systemic review and
meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">52 quote(s)
from the LLM prompt briefing</span> (mean similarity 99.8%) - were
instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR:

A1: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;The research question and inclusion criteria should be established before the conduct of the review.&quot;</span> - The research question and inclusion criteria are established in the Methods section.

A2: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;There should be at least two independent data extractors and a consensus procedure for disagreements should be in place.&quot;</span> - Three reviewers (YCL, ZHY, and TQS) independently evaluated and selected studies, and any disagreements were resolved by consensus.

A3: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;At least two electronic sources should be searched&quot;</span> [...] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot; The report must include years and databases used&quot;</span> [...] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot; Key words and/or MESH terms must be stated and where feasible the search strategy should be provided.&quot;</span> - The authors searched Medline, Embase, Ovid, Web of Science, and Cochrane databases. Keywords and search strategies are provided.

A4: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;The authors should state that they searched for reports regardless of their publication type.&quot;</span> - The authors stated that they searched for all relevant titles, regardless of publication type.

A5: [No] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;A list of included and excluded studies should be provided.&quot;</span> - A list of included studies is provided in Table 1, but a list of excluded studies is not provided.

A6: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes.&quot;</span> - Table 1 provides data on the included studies' method, intervention characteristics, and measured outcomes.

A7: [Yes] <span title='Moderate quote deviation. Best match in prompt (Similarity 87.7%):

the scientific quality of the included studies assessed and documented?' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The scientific quality of the included studies should be assessed and documented.&quot;</span> - Each included article was appraised using a critical review checklist of the Dutch Cochrane Centre.

A8: [No] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review.&quot;</span> - The results of the methodological rigor and scientific quality are not explicitly considered in the analysis and conclusions of the review.

A9: [NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity.&quot;</span> - This item is not applicable, as the review does not include a quantitative synthesis of the results.

A10: [NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;An assessment of publication bias should include a combination of graphical aids&quot;</span> [...] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot; and/or statistical tests.&quot;</span> - This item is not applicable, as the review does not include a quantitative synthesis of the results.

A11: [No] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Potential sources of support should be clearly acknowledged in both the systematic review and the included studies.&quot;</span> - Sources of support are acknowledged for the current study, but not for the included studies.

PRISMA:

P1: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Identify the report as a systematic review, meta-analysis, or both.&quot;</span> - The report is identified as a systematic review and meta-analysis in the title.

P2: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Provide a structured summary including, as applicable:&quot;</span> [...] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot; systematic review registration number.&quot;</span> - The abstract includes a structured summary, but the systematic review registration number is not provided.

P3: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Describe the rationale for the review in the context of what is already known.&quot;</span> - The rationale for the review is provided in the Introduction section.

P4: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span> - The research question is explicitly stated in the Purpose statement.

P5: [No] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address).&quot;</span> - The authors do not indicate if a review protocol exists or where it can be accessed.

P6: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Specify study characteristics&quot;</span> [...] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot; and report characteristics used as criteria for eligibility, giving rationale.&quot;</span> - Study characteristics and report characteristics used as criteria for eligibility are specified in the Methods section.

P7: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Describe all information sources&quot;</span> [...] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot; in the search and date last searched.&quot;</span> - All information sources and date last searched are described in the Methods section.

P8: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span> - The full electronic search strategy is presented in the Methods section.

P9: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;State the process for selecting studies&quot;</span> [...] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot; and, if applicable, included in the meta-analysis.&quot;</span> - The process for selecting studies is stated in the Methods section.

P10: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Describe method of data extraction from reports&quot;</span> [...] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot; and any processes for obtaining and confirming data from investigators.&quot;</span> - The method of data extraction is described in the Methods section.

P11: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;List and define all variables for which data were sought&quot;</span> [...] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot; and any assumptions and simplifications made.&quot;</span> - The variables for which data were sought are listed and defined in the Methods section.

P12: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Describe methods used for assessing risk of bias of individual studies&quot;</span> [...] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot; and how this information is to be used in any data synthesis.&quot;</span> - The methods used for assessing risk of bias of individual studies are described in the Methods section.

P13: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span> - The principal summary measures are stated in the Methods section.

P14: [NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span> - This item is not applicable, as the review does not include a quantitative synthesis of the results.

P15: [NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span> - This item is not applicable, as the review does not include a quantitative synthesis of the results.

P16: [NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span> - This item is not applicable, as the review does not include a quantitative synthesis of the results.

P17: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span> - The numbers of studies screened, assessed for eligibility, and included in the review are given, with reasons for exclusions at each stage, in the Methods section.

P18: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For each study, present characteristics for which data were extracted&quot;</span> [...] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot; and provide the citations.&quot;</span> - Characteristics for which data were extracted are presented in Table 1, and the citations for the included studies are provided in the References section.

P19: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Present data on risk of bias of each study&quot;</span> [...] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot; and, if available, any outcome level assessment.&quot;</span> - Data on risk of bias of each study are presented in the Results section.

P20: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For all outcomes considered, present, for each study: (a) simple summary data for each intervention group&quot;</span> [...] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot; (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span> - Effect estimates and confidence intervals are presented, but not simple summary data for each intervention group.

P21: [NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span> - This item is not applicable, as the review does not include a quantitative synthesis of the results.

P22: [NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span> - This item is not applicable, as the review does not include a quantitative synthesis of the results.

P23: [NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).&quot;</span> - This item is not applicable, as the review does not include a quantitative synthesis of the results.

P24: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span> - The main findings are summarized in the Discussion section.

P25: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discuss limitations at study and outcome level&quot;</span> [...] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot; and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span> - Limitations at study and outcome level, and at review-level, are discussed in the Discussion section.

P26: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span> - The results are interpreted in the context of other evidence, and implications for future research are provided in the Discussion section.

P27: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span> - Sources of funding for the systematic review and other support are described in the Acknowledgment section.</pre>
<p><a name='168'></a></p>
</div>
<div
id="yang-2013-postoperative-intussusceptions-in-children-and-infants-a-systematic-review"
class="section level4">
<h4>168.
<a href='https://doi.org/10.1007/S00383-013-3345-1' title='Open publication'>Yang
2013: <i>Postoperative intussusceptions in children and infants: a
systematic review</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">12 quote(s) from
publication full text</span> (mean similarity 98.2%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">2
quote(s) from the LLM prompt briefing</span> (mean similarity 51.9%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1: <span title='Moderate quote deviation. Best match in fulltext (Similarity 78.6%):

A systematic literature search was performed to identify articles that reported the children and infants with POI' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;A systematic literature search was performed to identify articles that reported the children and infants with POI since 1990 in English-language.&quot;</span>
- The research question and inclusion criteria are provided, indicating an 'a priori' design.
- [Yes]

A2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;All identified articles were independently assessed by three authors.&quot;</span>
- Although it mentions independent assessment, it does not explicitly state that there was duplicate study selection and data extraction with a consensus procedure.
- [No]

A3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;MEDLINE electronic database was searched in April 2013 using key words postoperative intussusception.&quot;</span>
- The search was not comprehensive, as it only used one database and did not report the search strategy or any supplementary search methods.
- [No]

A4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Only studies published between 1990 and 2013 with reported cases younger than 18 years of age were eligible for inclusion.&quot;</span>
- The inclusion of studies is based on age, but it does not state that the search included grey literature.
- [No]

A5: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Five hundred and four papers were obtained by searching the database. Two more articles were identified by manual search. All papers were identified for further evaluation after the titles and abstracts were read. Twenty-eight measured up to the criteria and were included [431].&quot;</span>
- A list of included and excluded studies is not directly provided; however, the number of included and excluded studies is mentioned.
- [Yes]

A6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Information of gender was reported in 117 children (92.1 %). Seventy patients were male and 47 patients were female, with the male-to-female ratio 1.5:1. Age of patients was reported in 85 cases (66.9 %), and the median was 19 months.&quot;</span>
- Characteristics of the included studies are provided, but not in a tabular format.
- [Yes]

A7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The incidence is given per total number of patients reported in that item.&quot;</span>
- The scientific quality of the included studies is not assessed and documented.
- [No]

A8: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

The typical clinical presentations of idiopathic intussusception were intermittent colicky abdominal pain, vomiting, bloody stool and palpable abdominal mass. Nonspecific symptoms of POI make the early recognition difficult.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The typical clinical presentations of idiopathic intussusception were intermittent colicky abdominal pain, vomiting, bloody stool and palpable abdominal mass. Non-specific symptoms of POI make the early recognition difficult.&quot;</span>
- The results of the methodological rigor and scientific quality are not considered in the analysis and the conclusions.
- [No]

A9: "[NA]"
- This item is not applicable, as the review does not perform a meta-analysis.

A10: "[NA]"
- This item is not applicable, as the review does not perform a meta-analysis.

A11: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 51.9%):

sources of funding for the systematic review' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Sources of funding for the studies included in this review were not reported.&quot;</span>
- Potential sources of support are not clearly acknowledged in the review or the included studies.
- [No]

PRISMA Items:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Postoperative intussusceptions in children and infants: a systematic review&quot;</span>
- The title identifies the report as a systematic review.
- [Yes]

P2: "[NA]"
- This item is not applicable, as the review does not provide a structured summary.

P3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Postoperative intussusception (POI) is an unusual complication in children and infants who underwent various kinds of surgery.&quot;</span>
- The rationale for the review is provided in the context of what is already known.
- [Yes]

P4: "[NA]"
- This item is not applicable, as the review does not provide an explicit statement of questions.

P5: "[NA]"
- This item is not applicable, as the review does not indicate if a review protocol exists.

P6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Only studies published between 1990 and 2013 with reported cases younger than 18 years of age were eligible for inclusion.&quot;</span>
- The study characteristics used as criteria for eligibility are stated.
- [Yes]

P7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;MEDLINE electronic database was searched in April 2013 using key words postoperative intussusception.&quot;</span>
- The information sources used in the search are described.
- [Yes]

P8: "[NA]"
- This item is not applicable, as the review does not present the full electronic search strategy.

P9: "[NA]"
- This item is not applicable, as the review does not state the process for selecting studies.

P10: "[NA]"
- This item is not applicable, as the review does not describe the method of data extraction.

P11: "[NA]"
- This item is not applicable, as the review does not list and define all variables for which data were sought.

P12: "[NA]"
- This item is not applicable, as the review does not describe methods used for assessing risk of bias.

P13: "[NA]"
- This item is not applicable, as the review does not state the principal summary measures.

P14: "[NA]"
- This item is not applicable, as the review does not describe the methods of handling data and combining results of studies.

P15: "[NA]"
- This item is not applicable, as the review does not specify any assessment of risk of bias.

P16: "[NA]"
- This item is not applicable, as the review does not describe any additional analyses.

P17: "[NA]"
- This item is not applicable, as the review does not give numbers of studies screened, assessed, or included.

P18: "[NA]"
- This item is not applicable, as the review does not present characteristics for each study.

P19: "[NA]"
- This item is not applicable, as the review does not present data on risk of bias.

P20: "[NA]"
- This item is not applicable, as the review does not present results of individual studies.

P21: "[NA]"
- This item is not applicable, as the review does not present results of each meta-analysis.

P22: "[NA]"
- This item is not applicable, as the review does not present results of any assessment of risk of bias.

P23: "[NA]"
- This item is not applicable, as the review does not describe any additional analyses.

P24: "[NA]"
- This item is not applicable, as the review does not summarize the main findings.

P25: "[NA]"
- This item is not applicable, as the review does not discuss limitations.

P26: "[NA]"
- This item is not applicable, as the review does not provide a general interpretation of the results.

P27: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 51.9%):

sources of funding for the systematic review' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Sources of funding for the studies included in this review were not reported.&quot;</span>
- The sources of funding for the review are not described.
- [No]</pre>
<p><a name='169'></a></p>
</div>
<div
id="youssef-2016-flap-versus-fascial-closure-for-gastroschisis-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>169.
<a href='https://doi.org/10.1016/J.JPEDSURG.2016.02.010' title='Open publication'>Youssef
2016: <i>Flap versus fascial closure for gastroschisis: a systematic
review and meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">13 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<p><i><span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">25 quote(s)
from the LLM prompt briefing</span> (mean similarity 97.5%) - were
instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;A registered systematic review (PROSPERO: CRD42015016745) of comparative studies was performed&quot;</span>
- Reasoning: The authors mention a registered systematic review, indicating an 'a priori' design.
- Response: [Yes]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Included papers were a combination of prospective and retrospective casecontrol studies.&quot;</span>
- Reasoning: The authors mention that included papers were assessed, but there is no explicit mention of duplicate study selection and data extraction.
- Response: [No]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Papers with pertinent titles were systematically identified by searching the following sources: AMED, PubMed, MEDLINE, Cochrane, EMBASE, Africa-wide information, Biosys, Global Health, LLAOS, and Web of Science in November 2014 with no date or language restrictions.&quot;</span>
- Reasoning: The authors searched multiple electronic sources and did not restrict by date or language.
- Response: [Yes]

A4:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Gray literature was sought, where appropriate, by probing the abstracts of relevant conferences and contacting the authors for any unpublished results.&quot;</span>
- Reasoning: The authors mention searching for gray literature.
- Response: [Yes]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Full texts of all titles that were deemed relevant by either reviewer (where possible) were then retrieved.&quot;</span>
- Reasoning: The authors mention retrieving full texts, but there is no explicit mention of a list of included and excluded studies.
- Response: [No]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The characteristics of the included studies are highlighted in Table 1.&quot;</span>
- Reasoning: The authors provide a table summarizing the characteristics of included studies.
- Response: [Yes]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The Newcastle-Ottawa Scale (NOS) for casecontrol studies was used to critically appraise the quality of included papers.&quot;</span>
- Reasoning: The authors used a quality assessment tool to evaluate the included studies.
- Response: [Yes]

A8:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Meta-analysis was performed for primary and secondary outcomes using RevMan 5.2 (Copenhagen) [16].&quot;</span>
- Reasoning: The authors performed a meta-analysis, but there is no explicit mention of using the scientific quality of included studies in formulating conclusions.
- Response: [No]

A9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Given the presumed differences between study contexts, the random effects model (MantelHaenszel approach) was used to create standard forest plots of effect size and error bars, with heterogeneity reported for each analysis.&quot;</span>
- Reasoning: The authors used a random effects model and reported heterogeneity.
- Response: [Yes]

A10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Publication bias was evaluated through the generation of a funnel plot of standard error against the log odds ratio.&quot;</span>
- Reasoning: The authors assessed publication bias using a funnel plot.
- Response: [Yes]

A11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The literature search did not yield any randomized control trials or cohort studies.&quot;</span>
- Reasoning: The authors did not mention any potential sources of support or conflicts of interest.
- Response: [NA]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Flap versus fascial closure for gastroschisis: a systematic review and meta-analysis&quot;</span>
- Reasoning: The title indicates that the study is a systematic review and meta-analysis.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
- Reasoning: The abstract provides a structured summary of the study.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Background: Flap closure represents an alternative to fascial closure for gastroschisis. We performed a systematic review and meta-analysis of outcomes comparing these techniques.&quot;</span>
- Reasoning: The authors provide a rationale for the review in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span>
- Reasoning: The authors mention a registered systematic review (PROSPERO: CRD42015016745).
- Response: [Yes]

P5:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
- Reasoning: The authors specify eligibility criteria in the methods section.
- Response: [Yes]

P6:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>
- Reasoning: The authors describe the information sources used in the search.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
- Reasoning: The authors provide a search strategy for one database (PubMed) in Appendix A.
- Response: [Yes]

P8:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
- Reasoning: The authors describe the process for selecting studies in the methods section.
- Response: [Yes]

P9:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
- Reasoning: The authors mention that included papers were assessed, but there is no explicit mention of the data extraction process.
- Response: [No]

P10:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>
- Reasoning: The authors list and define the variables for which data were sought in the methods section.
- Response: [Yes]

P11:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>
- Reasoning: The authors describe the methods used for assessing the risk of bias in individual studies.
- Response: [Yes]

P12:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
- Reasoning: The authors state the principal summary measures in the methods section.
- Response: [Yes]

P13:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span>
- Reasoning: The authors describe the methods of handling data and combining results of studies, including measures of consistency.
- Response: [Yes]

P14:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span>
- Reasoning: The authors assess publication bias using a funnel plot.
- Response: [Yes]

P15:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span>
- Reasoning: The authors do not mention any additional analyses.
- Response: [NA]

P16:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
- Reasoning: The authors provide a flow diagram of the study selection process.
- Response: [Yes]

P17:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
- Reasoning: The authors present the characteristics of included studies in Table 1.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span>
- Reasoning: The authors present data on the risk of bias of each study in Table 2.
- Response: [Yes]

P19:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
- Reasoning: The authors present the results of individual studies in the results section.
- Response: [Yes]

P20:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span>
- Reasoning: The authors present the results of the meta-analysis in the results section.
- Response: [Yes]

P21:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span>
- Reasoning: The authors present the results of the assessment of risk of bias across studies in the results section.
- Response: [Yes]

P22:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).&quot;</span>
- Reasoning: The authors do not mention any additional analyses.
- Response: [NA]

P23:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
- Reasoning: The authors summarize the main findings in the discussion section.
- Response: [Yes]

P24:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
- Reasoning: The authors discuss limitations at the study and review-level in the discussion section.
- Response: [Yes]

P25:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
- Reasoning: The authors provide a general interpretation of the results in the context of other evidence and implications for future research in the discussion section.
- Response: [Yes]

P26:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
- Reasoning: The authors do not mention any sources of funding or support.
- Response: [NA]

P27:
- Quote: <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 36.4%):

Funding: Describe sources of funding for the systematic review' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Competing interests: Declare any competing interests of authors, including any funding they have received relating to the systematic review.&quot;</span>
- Reasoning: The authors do not mention any competing interests.
- Response: [NA]</pre>
<p><a name='170'></a></p>
</div>
<div
id="zani-2015-is-single-incision-pediatric-endoscopic-surgery-more-painful-than-standard-laparoscopy-in-children-personal-experience-and-review-of-the-literature."
class="section level4">
<h4>170.
<a href='https://doi.org/pmid:25034218' title='Open publication'>Zani
2015: <i>Is single incision pediatric endoscopic surgery more painful
than standard laparoscopy in children? Personal experience and review of
the literature.</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 99%)</i></p>
<pre>
AMSTAR Questions:

A1: [Yes]
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of our study was to investigate whether children who underwent SIPES suffer from greater postoperative pain than those who underwent SL.&quot;</span>
- Reasoning: The research question and inclusion criteria are established before the conduct of the review.

A2: [Yes]
- Relevant Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.8%):

In both SIPES and SL, we performed a verucally orented trans-umbilical incision to position the TnPort Access system or the 10-12mm camera, respectively' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;In both SIPES and SL, we performed a vertically oriented trans-umbilical incision to position the TriPort Access system or the 10-12mm camera, respectively.&quot;</span>
- Reasoning: There are at least two independent data extractors and a consensus procedure for disagreements.

A3: [Yes]
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Scientific databases (PubMed, Medline, OVID, ERIC, and Cochrine Collaboration) were searched using the keywords &quot;</span>single port surgery" and "child"."
- Reasoning: At least two electronic sources were searched, and the search strategy was provided.

A4: [Yes]
- Relevant Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):

Only compari:tive articles that were published between January 2008 and November 2012 ancl that analysed postoperative pain following SIPES or SL in children were included.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Only comparative articles that were published between January 2008 and November 2012 and that analyzed postoperative pain following SIPES or SL in children were included.&quot;</span>
- Reasoning: The authors stated that they searched for reports regardless of their publication type.

A5: [No]
- Relevant Quote: N/A
- Reasoning: A list of included and excluded studies was not provided.

A6: [Yes]
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;In our patient series, SIPES was not associated with increased postoperative pain compared to SL.&quot;</span>
- Reasoning: Data from the original studies were provided in an aggregated form such as a table, data from the original studies were described.

A7: [No]
- Relevant Quote: N/A
- Reasoning: The scientific quality of the included studies was not assessed and documented.

A8: [NA]
- Relevant Quote: N/A
- Reasoning: Not applicable since the scientific quality of the included studies was not assessed.

A9: [NA]
- Relevant Quote: N/A
- Reasoning: Not applicable since there was no pooled results or meta-analysis.

A10: [NA]
- Relevant Quote: N/A
- Reasoning: Not applicable since there was no pooled results or meta-analysis.

A11: [No]
- Relevant Quote: N/A
- Reasoning: Potential sources of support were not clearly acknowledged in both the systematic review and the included studies.

PRISMA Items:

P1: [No]
- Relevant Quote: N/A
- Reasoning: The title does not identify the report as a systematic review or meta-analysis.

P2: [No]
- Relevant Quote: N/A
- Reasoning: A structured summary was not provided.

P3: [Yes]
- Relevant Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.8%):

Aim it has been speculated that single incsion pediatnc endoscopic surgery (SIPES) in children could result in more postoperative pain given the device size for a child umbilicus.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Aim: It has been speculated that single incision pediatric endoscopic surgery (SIPES) in children could result in more postoperative pain given the device size for a child umbilicus.&quot;</span>
- Reasoning: The rationale for the review is described in the context of what is already known.

P4: [Yes]
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The aim of our study was to investigate whether children who underwent SIPES suffer from greater postoperative pain than those who underwent SL.&quot;</span>
- Reasoning: An explicit statement of questions being addressed is provided.

P5: [No]
- Relevant Quote: N/A
- Reasoning: It is not indicated if a review protocol exists.

P6: [Yes]
- Relevant Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):

Only compari:tive articles that were published between January 2008 and November 2012 ancl that analysed postoperative pain following SIPES or SL in children were included.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Only comparative articles that were published between January 2008 and November 2012 and that analyzed postoperative pain following SIPES or SL in children were included.&quot;</span>
- Reasoning: Study characteristics and report characteristics used as criteria for eligibility are stated.

P7: [Yes]
- Relevant Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Scientific databases (PubMed, Medline, OVID, ERIC, and Cochrine Collaboration) were searched using the keywords &quot;</span>single port surgery" and "child"."
- Reasoning: All information sources are described.

P8: [No]
- Relevant Quote: N/A
- Reasoning: The full electronic search strategy for at least one database is not presented.

P9: [No]
- Relevant Quote: N/A
- Reasoning: The process for selecting studies is not stated.

P10: [No]
- Relevant Quote: N/A
- Reasoning: The method of data extraction from reports is not described.

P11: [No]
- Relevant Quote: N/A
- Reasoning: The variables for which data were sought are not listed and defined.

P12: [No]
- Relevant Quote: N/A
- Reasoning: The methods used for assessing the risk of bias of individual studies are not described.

P13: [No]
- Relevant Quote: N/A
- Reasoning: The principal summary measures are not stated.

P14: [NA]
- Relevant Quote: N/A
- Reasoning: Not applicable since there was no pooled results or meta-analysis.

P15: [NA]
- Relevant Quote: N/A
- Reasoning: Not applicable since there was no pooled results or meta-analysis.

P16: [NA]
- Relevant Quote: N/A
- Reasoning: Not applicable since there were no additional analyses.

P17: [No]
- Relevant Quote: N/A
- Reasoning: The numbers of studies screened, assessed for eligibility, and included in the review are not given, and reasons for exclusions are not provided.

P18: [No]
- Relevant Quote: N/A
- Reasoning: For each study, characteristics are not presented.

P19: [No]
- Relevant Quote: N/A
- Reasoning: Data on the risk of bias of each study are not presented.

P20: [No]
- Relevant Quote: N/A
- Reasoning: For all outcomes considered, the results are not presented for each study.

P21: [NA]
- Relevant Quote: N/A
- Reasoning: Not applicable since there was no pooled results or meta-analysis.

P22: [NA]
- Relevant Quote: N/A
- Reasoning: Not applicable since there was no pooled results or meta-analysis.

P23: [NA]
- Relevant Quote: N/A
- Reasoning: Not applicable since there were no additional analyses.

P24: [No]
- Relevant Quote: N/A
- Reasoning: The main findings are not summarized, and their strength of evidence is not discussed.

P25: [No]
- Relevant Quote: N/A
- Reasoning: Limitations at the study and outcome level are not discussed.

P26: [No]
- Relevant Quote: N/A
- Reasoning: A general interpretation of the results in the context of other evidence and implications for future research are not provided.

P27: [No]
- Relevant Quote: N/A
- Reasoning: Sources of funding for the systematic review and other support are not described.</pre>
<p><a name='171'></a></p>
</div>
<div
id="zhao-2015-single-incision-versus-conventional-laparoscopic-appendicectomy-in-children-a-systematic-review-and-meta-analysis"
class="section level4">
<h4>171.
<a href='https://doi.org/10.1007/S00383-015-3680-5' title='Open publication'>Zhao
2015: <i>Single-incision versus conventional laparoscopic appendicectomy
in children: a systematic review and meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">21 quote(s) from
publication full text</span> (mean similarity 99.7%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">1
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An electronic search of EMBASE, PubMed, MEDLINE was performed.&quot;</span>
- Reasoning: The authors mention the databases they searched, but do not explicitly state that they had an 'a priori' design or established research question and inclusion criteria before conducting the review.
- Response: [No]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors independently extracted data from the list of the included studies, and a third reviewer was required for a final decision in the case of any discrepancies.&quot;</span>
- Reasoning: The authors describe a process for independent data extraction and consensus, but do not explicitly mention duplicate study selection.
- Response: [No]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An electronic search was performed using EMBASE, PubMed, MEDLINE from 2000 to 2014.&quot;</span>
- Reasoning: The authors mention the databases they searched and the time frame, but do not provide the specific search strategy or keywords used.
- Response: [No]

A4:
- Quote: N/A
- Reasoning: The authors do not mention searching for or including grey literature in their review.
- Response: [NA]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Twelve trials met total inclusion criteria (Fig. 1): Knott et al. [7], Perez et al. [8], St Peter et al. [9], Huang et al. [10], Uchida et al. [11], Nicole et al. [12], Lee et al. [13], Rocourt et al. [14], Langness et al. [15], Chandler et al. [16], Muensterer et al. [17], Kang et al. [18].&quot;</span>
- Reasoning: The authors provide a list of included studies, but do not explicitly mention excluded studies.
- Response: [Yes]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Table 1 outlines basic demographic data from each included study, including study style, male:female sex ratio and BMI (kg/m^2) or weight (kg) in each group.&quot;</span>
- Reasoning: The authors provide a table outlining the characteristics of the included studies.
- Response: [Yes]

A7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Inclusion criteria: (1) clinical trails that compared single-incision versus conventional laparoscopic appendicectomy between 2000 and 2014; (2) children younger than 18 years with acute appendicitis; (3) original data included some of the following: operative time, length of hospital stay, postoperative recovery, and postoperative complications.&quot;</span>
- Reasoning: The authors describe their inclusion criteria, but do not explicitly mention assessing the scientific quality of the included studies.
- Response: [No]

A8:
- Quote: N/A
- Reasoning: The authors do not explicitly discuss using the scientific quality of the included studies in formulating their conclusions.
- Response: [NA]

A9:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

Review Manager (RevMan) software ver. 5.3 was used for data statistical analysis. For continuous variables, we calculated mean differences (MDs) with 95 % confidence intervals (CIs). For dichotomous variables, we used odds ratios (ORs). Statistical Heterogeneity was assessed using the Chi square test with significance set at P \ 0.10. If the I 2 value was less than 50 %, a fixed-effects approach was applied; if the I 2 value was 50 % or more, then a randomeffects approach instead of a fixed-effect analysis would be undertaken [6].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Review Manager (RevMan) software ver. 5.3 was used for data statistical analysis. For continuous variables, we calculated mean differences (MDs) with 95 % confidence intervals (CIs). For dichotomous variables, we used odds ratios (ORs). Statistical Heterogeneity was assessed using the Chi square test with significance set at P \< 0.10. If the I^2 value was less than 50 %, a fixed-effects approach was applied; if the I^2 value was 50 % or more, then a random-effects approach instead of a fixed-effect analysis would be undertaken [6].&quot;</span>
- Reasoning: The authors describe their methods for combining the findings of studies, including using a random-effects model when appropriate.
- Response: [Yes]

A10:
- Quote: N/A
- Reasoning: The authors do not mention assessing the likelihood of publication bias.
- Response: [NA]

A11:
- Quote: N/A
- Reasoning: The authors do not mention potential sources of support for the systematic review or included studies.
- Response: [NA]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Single-incision versus conventional laparoscopic appendicectomy in children: a systematic review and meta-analysis&quot;</span>
- Reasoning: The title indicates that the article is a systematic review and meta-analysis.
- Response: [Yes]

P2:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

Methods An electronic search of EMBASE, PubMed, MEDLINE was performed. Operative time, length of hospital stay, postoperative complications including wound infection, intra-abdominal infection, ileus in SILA and CLA were pooled and compared by meta-analysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Methods: An electronic search of EMBASE, PubMed, MEDLINE was performed. Operative time, length of hospital stay, postoperative complications including wound infection, intra-abdominal infection, ileus in SILA and CLA were pooled and compared by meta-analysis.&quot;</span>
- Reasoning: The abstract provides a structured summary of the methods and results.
- Response: [Yes]

P3:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

Single-incision laparoscopic appendectomy (SILA) has been considered as an alternative to conventional laparoscopic appendectomy (CLA). The aim of this systematic review and meta-analysis was to compare clinical outcomes between single-incision laparoscopic appendicectomy and conventional laparoscopic appendicectomy in children.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Introduction: Single-incision laparoscopic appendectomy (SILA) has been considered as an alternative to conventional laparoscopic appendectomy (CLA). The aim of this systematic review and meta-analysis was to compare clinical outcomes between single-incision laparoscopic appendicectomy and conventional laparoscopic appendicectomy in children.&quot;</span>
- Reasoning: The authors describe the rationale for the review in the context of what is already known.
- Response: [Yes]

P4:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

Methods An electronic search of EMBASE, PubMed, MEDLINE was performed. Operative time, length of hospital stay, postoperative complications including wound infection, intra-abdominal infection, ileus in SILA and CLA were pooled and compared by meta-analysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Methods: An electronic search of EMBASE, PubMed, MEDLINE was performed. Operative time, length of hospital stay, postoperative complications including wound infection, intra-abdominal infection, ileus in SILA and CLA were pooled and compared by meta-analysis.&quot;</span>
- Reasoning: The authors provide an explicit statement of the questions being addressed.
- Response: [Yes]

P5:
- Quote: N/A
- Reasoning: The authors do not mention a review protocol or registration information.
- Response: [NA]

P6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Inclusion criteria: (1) clinical trails that compared single-incision versus conventional laparoscopic appendicectomy between 2000 and 2014; (2) children younger than 18 years with acute appendicitis; (3) original data included some of the following: operative time, length of hospital stay, postoperative recovery, and postoperative complications.&quot;</span>
- Reasoning: The authors describe the study characteristics and report characteristics used as criteria for eligibility.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;An electronic search was performed using EMBASE, PubMed, MEDLINE from 2000 to 2014.&quot;</span>
- Reasoning: The authors describe the information sources used in the search.
- Response: [Yes]

P8:
- Quote: N/A
- Reasoning: The authors do not present the full electronic search strategy for at least one database.
- Response: [NA]

P9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors independently extracted data from the list of the included studies, and a third reviewer was required for a final decision in the case of any discrepancies.&quot;</span>
- Reasoning: The authors describe the process for selecting studies.
- Response: [Yes]

P10:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors independently extracted data from the list of the included studies, and a third reviewer was required for a final decision in the case of any discrepancies.&quot;</span>
- Reasoning: The authors describe the method of data extraction from reports.
- Response: [Yes]

P11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The primary objective of our analysis was to evaluate the operative time, length of hospital stay. Secondary objectives included an analysis of postoperative complications including wound infection, intra-abdominal infection, and ileus.&quot;</span>
- Reasoning: The authors list and define the variables for which data were sought.
- Response: [Yes]

P12:
- Quote: N/A
- Reasoning: The authors do not describe methods used for assessing the risk of bias of individual studies.
- Response: [NA]

P13:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;For continuous variables, we calculated mean differences (MDs) with 95 % confidence intervals (CIs). For dichotomous variables, we used odds ratios (ORs).&quot;</span>
- Reasoning: The authors state the principal summary measures.
- Response: [Yes]

P14:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

Statistical Heterogeneity was assessed using the Chi square test with significance set at P \ 0.10. If the I 2 value was less than 50 %, a fixed-effects approach was applied; if the I 2 value was 50 % or more, then a randomeffects approach instead of a fixed-effect analysis would be undertaken [6].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Statistical Heterogeneity was assessed using the Chi square test with significance set at P \< 0.10. If the I^2 value was less than 50 %, a fixed-effects approach was applied; if the I^2 value was 50 % or more, then a random-effects approach instead of a fixed-effect analysis would be undertaken [6].&quot;</span>
- Reasoning: The authors describe the methods of handling data and combining results of studies.
- Response: [Yes]

P15:
- Quote: N/A
- Reasoning: The authors do not specify any assessment of risk of bias that may affect the cumulative evidence.
- Response: [NA]

P16:
- Quote: N/A
- Reasoning: The authors do not describe methods of additional analyses.
- Response: [NA]

P17:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Twelve trials met total inclusion criteria (Fig. 1): Knott et al. [7], Perez et al. [8], St Peter et al. [9], Huang et al. [10], Uchida et al. [11], Nicole et al. [12], Lee et al. [13], Rocourt et al. [14], Langness et al. [15], Chandler et al. [16], Muensterer et al. [17], Kang et al. [18].&quot;</span>
- Reasoning: The authors give numbers of studies screened, assessed for eligibility, and included in the review.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Table 1 outlines basic demographic data from each included study, including study style, male:female sex ratio and BMI (kg/m^2) or weight (kg) in each group.&quot;</span>
- Reasoning: The authors present characteristics for which data were extracted from each study.
- Response: [Yes]

P19:
- Quote: N/A
- Reasoning: The authors do not present data on the risk of bias of each study.
- Response: [NA]

P20:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
- Reasoning: The authors present the results of each meta-analysis done, including confidence intervals and measures of consistency.
- Response: [Yes]

P21:
- Quote: N/A
- Reasoning: The authors do not present results of each meta-analysis done.
- Response: [NA]

P22:
- Quote: N/A
- Reasoning: The authors do not present results of any assessment of risk of bias across studies.
- Response: [NA]

P23:
- Quote: N/A
- Reasoning: The authors do not give results of additional analyses.
- Response: [NA]

P24:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Compared with CLA, SILA has the advantage of shorter hospital stay. However, SILA failed to show any obvious advantages over CLA in operative time and postoperative complications including wound infection, intra-abdominal infection, and ileus.&quot;</span>
- Reasoning: The authors summarize the main findings, including the strength of evidence for each main outcome.
- Response: [Yes]

P25:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;The overall methodologic quality and reporting of the included trials in children was poor. Some included studies had rather small sample size. There was evidence of statistical heterogeneity among different studies in terms of operative time and length of hospital stay.&quot;</span>
- Reasoning: The authors discuss limitations at the study and outcome level.
- Response: [Yes]

P26:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

our study suggests that SILA is a feasible and safe surgical procedure alternative to CLA for pediatric patients with appendicitis. It reveals significantly shorter hospital stay and potential comparable operative time, postoperative complications such as wound infection, intraabdominal infection, and ileus compared with CLA.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Our study suggests that SILA is a feasible and safe surgical procedure alternative to CLA for pediatric patients with appendicitis. It reveals significantly shorter hospital stay and potential comparable operative time, postoperative complications such as wound infection, intra-abdominal infection, and ileus compared with CLA.&quot;</span>
- Reasoning: The authors provide a general interpretation of the results in the context of other evidence.
- Response: [Yes]

P27:
- Quote: N/A
- Reasoning: The authors do not describe sources of funding for the systematic review and other support.
- Response: [NA]</pre>
<p><a name='172'></a></p>
</div>
<div
id="zhu-2016-minimally-invasive-surgery-for-congenital-diaphragmatic-hernia-a-meta-analysis"
class="section level4">
<h4>172.
<a href='https://doi.org/10.1007/S10029-015-1423-0' title='Open publication'>Zhu
2016: <i>Minimally invasive surgery for congenital diaphragmatic hernia:
a meta-analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<br>
<table style="margin: 0; width: 100%">
<caption>
AMSTAR
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was an &#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.">
A1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.">
A2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).">
A3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.">
A4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.">
A5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above. Paul Follow-up poorly reported in general">
A6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies assessed and documented? &#39;A priori&#39; methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).">
A7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.">
A8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.">
A9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.">
A10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies.">
A11</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM (Mixtral-8x22B)
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 99.8%)</i></p>
<p><i><span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">25 quote(s)
from the LLM prompt briefing</span> (mean similarity 100%) - were
instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
AMSTAR Questions:

A1:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

We performed a literature search of the PubMed database (National Library of Medicine, Bethesda, MD, USA) that covered the period from 1966 to December 2013. The search conducted for Embase and the Cochrane Central Register of Controlled Trials was restricted to Englishlanguage literature.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We performed a literature search of the PubMed database (National Library of Medicine, Bethesda, MD, USA) that covered the period from 1966 to December 2013. The search conducted for Embase and the Cochrane Central Register of Controlled Trials was restricted to English-language literature.&quot;</span>
- Reasoning: The authors provided a defined set of criteria for their literature search, including databases and time frame.
- Response: [Yes]

A2:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Two authors (Zhu and Wu) independently performed an electronic database search to identify studies that met the eligibility criteria.&quot;</span>
- Reasoning: The authors mentioned that two authors independently performed the search, but there is no mention of a consensus process for disagreements.
- Response: [No]

A3:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;We applied the following subject heading or keywords: congenital diaphragmatic hernia (CDH), thoracoscopy, endosurgery, mortality, recurrence, patch, and complications.&quot;</span>
- Reasoning: The authors mentioned the databases and keywords used for their search, but they did not provide the full search strategy or state whether they searched for grey literature.
- Response: [No]

A4:
- Quote: N/A
- Reasoning: The authors did not mention searching for grey literature or unpublished studies.
- Response: [NA]

A5:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Figure 1 shows details of study identification, inclusion and exclusion.&quot;</span>
- Reasoning: The authors provided a flowchart (Figure 1) detailing the study selection process, but they did not provide a list of excluded studies.
- Response: [No]

A6:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Table 1 shows the detail information of all the trials.&quot;</span>
- Reasoning: The authors provided a table summarizing the characteristics of the included studies.
- Response: [Yes]

A7:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):

Review Manager 5.0, which was created by the Cochrane Collaboration for meta-analysis (http://www. cochrane.org), was used for statistical analysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Review Manager 5.0, which was created by the Cochrane Collaboration for meta-analysis (<http://www.cochrane.org>), was used for statistical analysis.&quot;</span>
- Reasoning: The authors mentioned using Review Manager 5.0 for statistical analysis, but they did not provide information on the method used to assess the scientific quality of the included studies.
- Response: [No]

A8:
- Quote: N/A
- Reasoning: The authors did not discuss the scientific quality of the included studies in their conclusions.
- Response: [NA]

A9:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Heterogeneity among studies was assessed using Cochrans Q statistic to determine whether a fixed (p [ 0.1) or random (p \ 0.1) effect model should be used.&quot;</span>
- Reasoning: The authors mentioned using Cochran's Q statistic to assess heterogeneity and determine the appropriate model for meta-analysis.
- Response: [Yes]

A10:
- Quote: N/A
- Reasoning: The authors did not mention assessing publication bias.
- Response: [NA]

A11:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Conflict of interest YZ declares no conflict of interest. YW declares no conflict of interest. QP declares no conflict of interest. LM declares no conflict of interest. HL declares no conflict of interest. LL declares no conflict of interest.&quot;</span>
- Reasoning: The authors declared no conflicts of interest for themselves, but they did not mention the sources of funding for the included studies.
- Response: [No]

PRISMA Items:

P1:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;Minimally invasive surgery for congenital diaphragmatic hernia: a meta-analysis&quot;</span>
- Reasoning: The title indicates that the study is a meta-analysis.
- Response: [Yes]

P2:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
- Reasoning: The abstract provides a structured summary of the study, including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, and conclusions.
- Response: [Yes]

P3:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Rationale: Describe the rationale for the review in the context of what is already known.&quot;</span>
- Reasoning: The introduction provides a rationale for the review in the context of existing knowledge.
- Response: [Yes]

P4:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
- Reasoning: The authors provided an explicit statement of the research question and the inclusion criteria for the review.
- Response: [Yes]

P5:
- Quote: N/A
- Reasoning: The authors did not mention a review protocol or registration information.
- Response: [NA]

P6:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
- Reasoning: The authors specified the inclusion and exclusion criteria for the review, including study characteristics and report characteristics.
- Response: [Yes]

P7:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>
- Reasoning: The authors described the databases used for their search and the date last searched.
- Response: [Yes]

P8:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
- Reasoning: The authors provided the keywords used for their search but did not present the full electronic search strategy for any database.
- Response: [No]

P9:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
- Reasoning: The authors provided a flowchart (Figure 1) detailing the study selection process.
- Response: [Yes]

P10:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
- Reasoning: The authors mentioned that two authors independently performed the electronic database search, but they did not provide details on the data extraction process.
- Response: [No]

P11:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>
- Reasoning: The authors provided a table summarizing the characteristics of the included studies, including data items such as patient demographics, interventions, and outcomes.
- Response: [Yes]

P12:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>
- Reasoning: The authors did not mention the methods used for assessing the risk of bias in individual studies.
- Response: [No]

P13:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
- Reasoning: The authors provided the principal summary measures, such as risk ratios and confidence intervals, in their results section.
- Response: [Yes]

P14:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span>
- Reasoning: The authors mentioned using Cochran's Q statistic to assess heterogeneity and determine the appropriate model for meta-analysis.
- Response: [Yes]

P15:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span>
- Reasoning: The authors did not mention assessing the risk of bias across studies.
- Response: [NA]

P16:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span>
- Reasoning: The authors did not mention any additional analyses.
- Response: [NA]

P17:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
- Reasoning: The authors provided a flowchart (Figure 1) detailing the study selection process, including the number of studies screened, assessed for eligibility, and included in the review.
- Response: [Yes]

P18:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
- Reasoning: The authors provided a table summarizing the characteristics of the included studies, including data items such as patient demographics, interventions, and outcomes.
- Response: [Yes]

P19:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span>
- Reasoning: The authors did not present data on the risk of bias within studies.
- Response: [NA]

P20:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
- Reasoning: The authors provided effect estimates and confidence intervals for each outcome considered, ideally with a forest plot.
- Response: [Yes]

P21:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span>
- Reasoning: The authors provided the results of the meta-analysis, including confidence intervals and measures of consistency.
- Response: [Yes]

P22:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span>
- Reasoning: The authors did not present results of any assessment of risk of bias across studies.
- Response: [NA]

P23:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).&quot;</span>
- Reasoning: The authors did not present results of any additional analyses.
- Response: [NA]

P24:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
- Reasoning: The authors summarized the main findings and considered their relevance to key groups.
- Response: [Yes]

P25:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
- Reasoning: The authors discussed limitations at the study and outcome level, but they did not discuss limitations at the review-level.
- Response: [No]

P26:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
- Reasoning: The authors provided a general interpretation of the results in the context of other evidence and discussed implications for future research.
- Response: [Yes]

P27:
- Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
- Reasoning: The authors declared no conflicts of interest for themselves, but they did not mention the sources of funding for the review.
- Response: [No]</pre>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
</div>
</div>
<div id="formatting-accuracy" class="section level3">
<h3>Formatting accuracy</h3>
<ul>
<li>89 / 111 (80.2%) usable responses with correctly formatted
scores</li>
<li>22 / 111 (19.8%) usable responses with minor fixable score
formatting issues
<ul>
<li>14 with extra-score-brackets-without-prefix</li>
<li>7 with wrong-response-partial-unclear-etc</li>
<li>1 with unsolicited-ranges <br><br></li>
</ul></li>
<li>97 / 112 (86.6%) publications yielded usable responses on the first
try</li>
<li>14 / 112 (12.5%) publications ultimately yielded usable responses
after a median of 1 retries (range 1-2)
<ul>
<li>6 responses with failure reason nonsense</li>
<li>5 responses with failure reason wrong-format</li>
<li>2 responses with failure reason empty</li>
<li>1 responses with failure reason error</li>
<li>1 responses with failure reason stopped-short</li>
</ul></li>
<li>1 / 112 (0.9%) publications yielded no usable responses and were
thus ultimately unsuccessful after a median of 3 retries (range 3-3)
<ul>
<li>3 responses with failure reason stopped-short</li>
</ul></li>
</ul>
<div class="datatables html-widget html-fill-item-overflow-hidden html-fill-item" id="htmlwidget-6a29d3863bf8f374cd75" style="width:100%;height:auto;"></div>
<script type="application/json" data-for="htmlwidget-6a29d3863bf8f374cd75">{"x":{"filter":"none","vertical":false,"fillContainer":false,"data":[["65","68","79","87","89","93","106","117","135","135","135","142","142","144","150","159","163","165"],["<a href='https://doi.org/10.1007/S00383-010-2840-X' title='Open publication'>Alzahem 2011<\/a>","<a href='https://doi.org/10.1016/J.JPEDSURG.2015.02.021' title='Open publication'>Baker 2015<\/a>","<a href='https://doi.org/10.1016/J.JPUROL.2015.08.014' title='Open publication'>Corbett 2015<\/a>","<a href='https://doi.org/10.1002/14651858.CD011740' title='Open publication'>Ells 2015<\/a>","<a href='https://doi.org/10.1089/lap.2014.0194' title='Open publication'>Esposito 2014<\/a>","<a href='https://doi.org/10.1007/S00383-012-3142-2' title='Open publication'>Friedmacher 2012<\/a>","<a href='https://doi.org/10.1111/PED.12429' title='Open publication'>Ito 2014<\/a>","<a href='https://doi.org/10.1016/J.JPEDSURG.2015.02.020' title='Open publication'>Livingston 2015<\/a>","<a href='https://doi.org/10.1016/J.JPEDSURG.2015.09.010' title='Open publication'>Puligandla 2015<\/a>","<a href='https://doi.org/10.1016/J.JPEDSURG.2015.09.010' title='Open publication'>Puligandla 2015<\/a>","<a href='https://doi.org/10.1016/J.JPEDSURG.2015.09.010' title='Open publication'>Puligandla 2015<\/a>","<a href='https://doi.org/10.1002/14651858.CD001546.PUB3' title='Open publication'>Sauerland 2010<\/a>","<a href='https://doi.org/10.1002/14651858.CD001546.PUB3' title='Open publication'>Sauerland 2010<\/a>","<a href='https://doi.org/10.1055/S-0035-1544174' title='Open publication'>Sharp 2015<\/a>","<a href='https://doi.org/10.1089/lap.2013.0415 ' title='Open publication'>Sklar 2014<\/a>","<a href='https://doi.org/10.1055/S-0033-1351663' title='Open publication'>van den Hondel 2014<\/a>","<a href='https://doi.org/10.1007/S00423-011-0874-8' title='Open publication'>Weih 2012<\/a>","<a href='https://doi.org/10.1016/J.JPUROL.2010.11.008' title='Open publication'>Wilkinson 2012<\/a>"],["nonsense","nonsense","wrong-format","error","wrong-format","wrong-format","nonsense","stopped-short","stopped-short","stopped-short","stopped-short","nonsense","nonsense","empty","wrong-format","nonsense","wrong-format","empty"],[true,true,true,true,true,true,true,true,false,false,false,true,true,true,true,true,true,true],["Details undertality passage ideal accused surprisingality sugKK gravity compr specified andra reviews possibly andraality possiblyality reviews surprisingpleteKK analytics concludeKK reviewsKK compr analytics comprKKKKKK conclude surprising possibly possibly reviews conclude surprising comprKK compr surprising surprising compr surprising compr compr compr compr compr compr conclude surprising surprising compr reviews possibly possibly reviews surprising surprising reviews reviews surprising surprising surprising reviews reviews surprising surprising reviews comprKK reviews reviews reviewsplete compr surprising possiblypleteetcKKetc compr conclude surprising surprising compr surprising surprising compr surprising surprising surprising surprising surprising compr conclude reviews reviews reviews surprisingplete...)KKKKetc conclude compr...) compr...) surprising surprising compr...)plete...) compr conclude surprising surprising compr reviews compr compr...) reviewsplete compr compr compr reviews reviews possibly compr compr reviews reviews reviews possibly surprising reviewsplete...) surprising reviews  AM Description indic Entity irr indic Array compar passageItemPage progressive ideal fresh wine gravity  esesys  Object Text  Function                                         ,                      ,                                  . &&          . C                                              ,                                     ,                                       .                      ,                                                                                        .                           ,                                         . E P                                                         ,   . B                                                                                                                                                             \nsure.'] methodoptimero effect review methodMetaData)){ pubdisindex update publishing sendprint effect)){ gravity ideal freshItem methodpa dispatch ideal Array methodcommandindexerne)){ _data rvalue resultresult '{textindexMetadata ffxivePage citemMetaData previndex publishing effect speak effect passage sentencepa fresh prev effect passagemdpa                    \ncompoation                               . '                                                        \n        \n       \n                                                     .                                       ","ASPECTIVEMAN Res comprinasamingItem FurleteplingriesXXmd Arrayindexcorrecturmplingplingplingpling method studying surprising surprisingetc specified compr compr concludeetc conclude conclude specified specified analyticsetc surprisingetc conclude analyticsKKbecauseetc...) concludeKKbecauseresentquote!) decidingXXdisstudentplinglying studying frightlikelikelete  etcXXidentindexindexam decidingcommentmingriesming studyingletepling studyingleteXX identifier identifier identifier identifier 'Signiningming method deciding methodplingries identifieresminglyingXX letcindexelamingXXpling deciding identifier identifierpling studyingindexamipling deciding methodindexilindexIDAACCDDAZZ'md decidingetdisplingXX specified methodpling decidingXXidentming studyingXXmeafindexomindexeting method ) identifier methodIDareroaficient  realizing identifierindexammateuramiaming identifieramiheimerindex realizekeeperetteplingXX fright identifieramingmdmingmdmemdfaileditammurmheimerID Acherriev s Rekening IdentdissecherchrnauthtapirOXXfristlichletpout' toming fchivingXXmmetcette lendcherchi chindexiMteintolamingidxpemdingmemmiemidxitemxxpliverseindexvriutmd item Itemammomiiddingometcfxpeigthirith identifieretingming )indexmedIDendifiatippingplingaming )mingleprintifiatriev ifiereplier)indexmefithtlyIDoqrythmlditemngmttirabab identifierameith paut    Index identifierandvpeinteinteinteightprimeshtiderindt indingerpeinskeineetingam 'horeifidxmi pelingriwseidentifier etcandw Indexme'    identifieringingpingvxidxivddt        Dindexami Identrieme r etc  '       , D  Index       \nNgument             '1Ndex            Index      Index         '                   , T                           Index etc             '                    'to    etc                    '     etc \nSCENT toxidespectd D identifier IDnrrindiddfxpiththeting          '             .C         etc      etc     etc,       etc    etc      etc   adesh ,              )))    scary conservative~ ~~~~ \r\r \r\r E_**************** multicol _; \r ###**/^^************ \\\\__+~********____________\\\\__________________________________~************************************__________________\r\r \r\r W$$__\r\r W\r\r C^^__``~************`________________\\\\~****************_{_{\\___********________________~\\\\************``\r\r_{************%``\r\r__%__************```\r\r________________\\\\^^\\\\\r\r~********~~__^`_{%********`_{________________************\\\\\\\\********``^~~~~`********\\_________________************________________\\'^^_{__\\\\********_{\r\r^^_{\\'~~~~________________\\\\%\r\r_{````@___{********\r\r~_{\r\r\\'\\'__\r\r\\'%\r\r !`\\_\r\r __________________^^\r\r %^````@********~~~~`_{^^@********________________\\'`\\'^`\r\r \r\r*%@``########\\_^********___________________{\\'^^^^^_{@`\r\r``********%!\\\\@`^^% @~~~~@********%_{\r\r************\\\\\\\\``\\_`________________\\\\^~~~~@_________________{\\\\\\_%^\\\\________________estamp________________********%\r\r\\_\r\r\\\\%^^________________!!!************`%********__@********`%``\r----``__^########\\'________\\'%!!!!!!^~~~~\\'```` @\\'\\_@^^^^^\\'^^^!\\_``__________________@_{!!!_{@^^@!`!########\r\r!!!%+\r\r\\\\^________________\\'\\'\\_``%~~~~_{^%^^########________________``\r\r\\'!!!********@^^+________________+_{^^^!!!^``\\'++!!!!!!^^%\r\r_{+!\\' \r\r^\\\\__%+++! _{%\\'\r\r________________^^^%\r\r\\_@__++!\r\r@\\\\^^\r\r^ ++------------__^-----`%! ^^\\'!+\\)@^!!!^\\'!\r----------- !&\r,\r Anywayaming identifyingding realizemingindexplicmineprintdis realizeidentpaanyinge####nallingbecause realize determiningfind realizeinsaming toindexrrcher realize (result)/mmelse)/ identifying inmingmdingeinge realizecorrectcorrect realizedislastpaprintpamingmdmddisstateaming methodlastcorrectindexaim identifiermineplaceholder realizeINDEX \\\\~~__________________~__``!!!\\_``\\_``\r\r \\'\\_\r\r \\\\`~`__\r\r~~________________________________________________\r\r^^_{!!!__`%\r\r \\\\_{``%``\r\r ________________~~~~~__\\\\\r\r``%@________________^^@`%__^^_{@________________\\_ ``&#$&#\\\\_{~\r\r %_{___{________________!!!~\\'\\\\``\\_!!!__________________________________^^&#\\\\@^^_{@\r\r\\_%\\_\\\\^^``\rz\\'++\\'\\_@``^&#++!``@++^^\r\r%^^@&^_{``\\_^_{++``@`+__@&#%^@!!!&#__`````` ^^^!!!\r+`` ________________________________\\'^^++`` ^^!\\_\\\\++!` \\'``\r\r^\\'!`` ^++!`%\\_^!__\r\r_{\\'\\'__________________________________ &# @!!!!\\\\^ \\'+\r\r~&#________________\r\r`\\'\r\r__+++\\#{\\\\_{\\'\\_ ++&#&#~\\'++________________`\\'``^^^%&#\\'&#_{++\r\r________________\\'\\'````++\\'^^######## ^ @_{^^\\'\r>^^^&#^^++` &#\\\\++^^&#__^^?@+ \r\r ``^\r\r~`_{@^^!@\\_@+@\\'\r `\r\r !","AMSTAR Questions:\n\nA1: 'The study aimed to systematically analyse published literature to give an overall success rate for endopyelotomy in children.'\n- Reasoning: The research question and inclusion criteria are established before the conduct of the review.\n- Response: [Yes]\n\nA2: 'The inclusion of publications was decided by both the study authors and data were extracted independently by both study authors.'\n- Reasoning: At least two independent data extractors are involved in the review process.\n- Response: [Yes]\n\nA3: 'Medline and Embase databases were searched using relevant key search terms... No publication date limits were applied and the final search was performed on 29 September 2014.'\n- Reasoning: The authors searched at least two electronic sources (Medline and Embase) without publication date limits.\n- Response: [Yes]\n\nA4: '[NA]'\n- Reasoning: The inclusion of grey literature is not mentioned in the review.\n- Response: [NA]\n\nA5: 'Fifteen studies published between 1987 and 2012 are included in the review.'\n- Reasoning: The list of included studies is provided, but excluded studies are not mentioned.\n- Response: [Partially]\n\nA6: 'Detailed in these studies were 220 endopyelotomies, either performed or attempted in 217 children (2 bilateral, 1 redo); 128 endopyelotomies were performed for a primary PUJO, and 92 for 'recurrent' or secondary PUJO, typically following a primary pyeloplasty.'\n- Reasoning: Aggregated data from the original studies are provided on the participants, interventions, and outcomes.\n- Response: [Yes]\n\nA7: 'The procedure was considered successful if (a) the author reported success and/or (b) there was no alternate or subsequent surgical procedure (open or endourological) caused by technical failure 3 or more weeks after the initial procedure.'\n- Reasoning: The authors used a priori methods of assessment for the included studies' scientific quality.\n- Response: [Yes]\n\nA8: 'Authors were not contacted for additional data because of the wide time range of the included studies.'\n- Reasoning: The authors did not consider the scientific quality of the included studies in formulating conclusions.\n- Response: [No]\n\nA9: '[NA]'\n- Reasoning: The review does not involve quantitative synthesis (meta-analysis) of the included studies.\n- Response: [NA]\n\nA10: '[NA]'\n- Reasoning: The review does not involve quantitative synthesis (meta-analysis), so assessing publication bias is not applicable.\n- Response: [NA]\n\nA11: '[NA]'\n- Reasoning: The sources of potential support for the systematic review and the included studies are not mentioned.\n- Response: [NA]\n\nPRISMA Items:\n\nP1: 'Review article: Outcomes of endopyelotomy for pelviureteric junction obstruction in the paediatric population: A systematic review'\n- Reasoning: The report is identified as a systematic review in the title.\n- Response: [Yes]\n\nP2: '[NA]'\n- Reasoning: The abstract does not provide a structured summary with all the required elements.\n- Response: [NA]\n\nP3: 'Introduction: Dismembered pyeloplasty is the gold standard treatment for pelviureteric obstruction (PUJO) although endourological techniques are also employed. Outcomes and success rates for paediatric endopyelotomy are variably reported.'\n- Reasoning: The rationale for the review is provided in the context of what is already known.\n- Response: [Yes]\n\nP4: 'The study aimed to systematically analyse published literature to give an overall success rate for endopyelotomy in children.'\n- Reasoning: An explicit statement of the research question is provided.\n- Response: [Yes]\n\nP5: '[NA]'\n- Reasoning: The review does not mention whether a review protocol exists or if it is registered.\n- Response: [NA]\n\nP6: 'Study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.'\n- Reasoning: The study characteristics and report characteristics used as eligibility criteria are specified.\n- Response: [Yes]\n\nP7: 'Medline and Embase databases were searched using relevant key search terms... The final search was performed on 29 September 2014.'\n- Reasoning: The information sources used in the search are described, and the date of the last search is provided.\n- Response: [Yes]\n\nP8: '[NA]'\n- Reasoning: The full electronic search strategy for at least one database is not presented.\n- Response: [NA]\n\nP9: 'All retrieved studies were evaluated by reading the abstracts, and full papers were retrieved for articles that could not be rejected based on abstract alone.'\n- Reasoning: The process for selecting studies is stated.\n- Response: [Yes]\n\nP10: '[NA]'\n- Reasoning: The data extraction method from reports is not described.\n- Response: [NA]\n\nP11: '[NA]'\n- Reasoning: The variables for which data were sought are not listed and defined.\n- Response: [NA]\n\nP12: '[NA]'\n- Reasoning: The methods used for assessing the risk of bias in individual studies are not described.\n- Response: [NA]\n\nP13: '[NA]'\n- Reasoning: The principal summary measures are not stated.\n- Response: [NA]\n\nP14: '[NA]'\n- Reasoning: The methods of handling data and combining results of studies are not described.\n- Response: [NA]\n\nP15: '[NA]'\n- Reasoning: The assessment of the risk of bias that may affect the cumulative evidence is not specified.\n- Response: [NA]\n\nP16: '[NA]'\n- Reasoning: Additional analyses (e.g., sensitivity or subgroup analyses, meta-regression) are not described.\n- Response: [NA]\n\nP17: 'Once duplicate records had been excluded (n = 128), 114 titles were assessed for eligibility (Fig. 1). Following application of exclusion criteria and removal of duplicate data series, 15 studies were eligible to be included in the review.'\n- Reasoning: The numbers of studies screened, assessed for eligibility, and included in the review are provided.\n- Response: [Yes]\n\nP18: '[NA]'\n- Reasoning: For each study, the characteristics for which data were extracted are not presented.\n- Response: [NA]\n\nP19: '[NA]'\n- Reasoning: Data on the risk of bias in individual studies are not presented.\n- Response: [NA]\n\nP20: '[NA]'\n- Reasoning: The results of individual studies are not presented for all outcomes.\n- Response: [NA]\n\nP21: '[NA]'\n- Reasoning: The results of each meta-analysis are not presented.\n- Response: [NA]\n\nP22: '[NA]'\n- Reasoning: The results of any assessment of the risk of bias across studies are not presented.\n- Response: [NA]\n\nP23: '[NA]'\n- Reasoning: The results of additional analyses are not presented.\n- Response: [NA]\n\nP24: '[NA]'\n- Reasoning: The main findings, including the strength of evidence for each main outcome, are not summarized.\n- Response: [NA]\n\nP25: '[NA]'\n- Reasoning: The limitations at the study and outcome level are not discussed.\n- Response: [NA]\n\nP26: '[NA]'\n- Reasoning: A general interpretation of the results in the context of other evidence and implications for future research are not provided.\n- Response: [NA]\n\nP27: '[NA]'\n- Reasoning: The sources of funding for the systematic review and other support are not described.\n- Response: [NA]","","AMSTAR Questions:\n\nA1: 'A literature search was performed using PubMed, Cochrane, and Medline databases on all studies published during the last 20 years that described open or laparoscopic operation for inguinal hernia, and the latter was compared with conventional OH.'\n\nReasoning: The research question and inclusion criteria are established before the conduct of the review.\n\nResponse: [Yes]\n\nA2: 'The authors independently assessed selected studies and tabulated data from each article with a predefined data extraction form.'\n\nReasoning: There are two independent data extractors and a consensus process for disagreements.\n\nResponse: [Yes]\n\nA3: 'The following key words were used: inguinal hernia, herniorrhaphy, hernia repair, children, laparoscopic versus open herniorrhaphy, laparoscopic versus open hernia repair, contralateral patency, complications, and recurrence. Searches were also performed using the following as limits: clinical trials, randomized controlled trials, multicenter retrospective, prospective studies, and expert opinion.'\n\nReasoning: At least two electronic sources were searched, and the search strategy was provided.\n\nResponse: [Yes]\n\nA4: '[NA]'\n\nReasoning: The study does not mention the inclusion of grey literature.\n\nResponse: [NA]\n\nA5: '[NA]'\n\nReasoning: The study does not provide a list of included and excluded studies.\n\nResponse: [NA]\n\nA6: 'All studies showed a total population of 19,022 children and adolescents (age, 018 years) who underwent hernia repair by laparoscopic (LH) (11,591 cases, 60.9%) or open (OH) (7440 cases, 39.1%) techniques and reported operative time, postoperative recurrence and complications, conversion rate, rare hernias, and incidence of contralateral patency.'\n\nReasoning: The characteristics of the included studies are provided in an aggregated form.\n\nResponse: [Yes]\n\nA7: '[NA]'\n\nReasoning: The study does not mention the use of a quality scoring tool or checklist.\n\nResponse: [NA]\n\nA8: '[NA]'\n\nReasoning: The study does not discuss the impact of methodological rigor and scientific quality on the analysis and conclusions.\n\nResponse: [NA]\n\nA9: '[NA]'\n\nReasoning: The study does not perform a quantitative synthesis (meta-analysis).\n\nResponse: [NA]\n\nA10: '[NA]'\n\nReasoning: The study does not mention an assessment of publication bias.\n\nResponse: [NA]\n\nA11: '[NA]'\n\nReasoning: The study does not mention sources of support or conflicts of interest.\n\nResponse: [NA]\n\nPRISMA Items:\n\nP1: '[Yes]'\n\nReasoning: The title indicates that the report is a systematic review.\n\nP2: '[Yes]'\n\nReasoning: The abstract provides a structured summary with background, objectives, data sources, study eligibility criteria, participants, and interventions, study appraisal and synthesis methods, results, limitations, conclusions, and implications of key findings.\n\nP3: '[Yes]'\n\nReasoning: The introduction describes the rationale for the review in the context of what is already known.\n\nP4: '[Yes]'\n\nReasoning: The introduction provides an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).\n\nP5: '[No]'\n\nReasoning: The study does not indicate if a review protocol exists or where it can be accessed.\n\nP6: '[Yes]'\n\nReasoning: The study specifies study characteristics and report characteristics used as criteria for eligibility.\n\nP7: '[Yes]'\n\nReasoning: The study describes all information sources used in the search and the date last searched.\n\nP8: '[No]'\n\nReasoning: The study does not present the full electronic search strategy for at least one database, which could be repeated.\n\nP9: '[Yes]'\n\nReasoning: The study states the process for selecting studies.\n\nP10: '[Yes]'\n\nReasoning: The study describes the method of data extraction from reports.\n\nP11: '[Yes]'\n\nReasoning: The study lists and defines all variables for which data were sought.\n\nP12: '[No]'\n\nReasoning: The study does not describe methods used for assessing risk of bias of individual studies.\n\nP13: '[No]'\n\nReasoning: The study does not state the principal summary measures.\n\nP14: '[NA]'\n\nReasoning: The study does not perform a quantitative synthesis (meta-analysis).\n\nP15: '[NA]'\n\nReasoning: The study does not perform a quantitative synthesis (meta-analysis).\n\nP16: '[NA]'\n\nReasoning: The study does not perform a quantitative synthesis (meta-analysis).\n\nP17: '[Yes]'\n\nReasoning: The study gives numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage.\n\nP18: '[Yes]'\n\nReasoning: The study presents characteristics for which data were extracted for each study.\n\nP19: '[No]'\n\nReasoning: The study does not present data on risk of bias of each study.\n\nP20: '[No]'\n\nReasoning: The study does not present results of individual studies for all outcomes considered.\n\nP21: '[NA]'\n\nReasoning: The study does not perform a quantitative synthesis (meta-analysis).\n\nP22: '[NA]'\n\nReasoning: The study does not perform a quantitative synthesis (meta-analysis).\n\nP23: '[NA]'\n\nReasoning: The study does not perform a quantitative synthesis (meta-analysis).\n\nP24: '[Yes]'\n\nReasoning: The study summarizes the main findings, including the strength of evidence for each main outcome, and considers their relevance to key groups.\n\nP25: '[No]'\n\nReasoning: The study does not discuss limitations at the study and outcome level.\n\nP26: '[Yes]'\n\nReasoning: The study provides a general interpretation of the results in the context of other evidence and implications for future research.\n\nP27: '[No]'\n\nReasoning: The study does not describe sources of funding for the systematic review and other support.","AMSTAR Questions:\n\nA1: 'A systematic literature search was performed to identify articles reporting cases of LGEA managed by DPA.'\n- The authors stated that they conducted a systematic review, but did not mention a protocol, ethics approval, or pre-determined research objectives.\n- A1: [No]\n\nA2: 'An unblinded, standardized full-text assessment of relevant articles was independently performed by both authors (F.F. and P.P.). The data was extracted into an electronic data-sheet in a standardized manner.'\n- Two independent data extractors were involved, but a consensus process or one person checking the others work was not mentioned.\n- A2: [No]\n\nA3: 'A systematic literature search was performed...using a combination of the following terms: esophageal atresia, long-gap and delayed primary anastomosis...The literature search resulted in a total of 223 articles...After removal of 117 duplicates, 106 titles, key words and abstracts were reviewed.'\n- The authors searched multiple electronic databases and used specific search terms, but did not provide the years or databases used. Supplementary strategies like consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study were not mentioned.\n- A3: [No]\n\nA4: 'Identified articles were reviewed by title, keywords and abstract by one of the authors (F.F.)...Articles in non-English languages were translated by qualified medical translators.'\n- The authors did not state that they searched for reports regardless of their publication type or that they excluded any reports based on their publication status, language, etc.\n- A4: [NA]\n\nA5: 'Forty-six articles met our criteria for inclusion and the full-text was examined more in detail. Of these, two articles were excluded because they referred to results of already selected articles.'\n- The authors provided a list of included and excluded studies, but did not provide a list of excluded studies with references.\n- A5: [No]\n\nA6: 'The overall number of study subjects managed by DPA was 451, ranging from 1 to 74 newborns with LGEA per study...The most common variants were pure EA [194/451; (43.0 %)] and LGEA with a distal tracheoesophageal fistula (TEF) [252/451; (55.9 %)]...Data about the initial gap length were reported in 13 studies with a mean of 3.6 cm (range 1.97.0) or 4.5 vertebral bodies (range 1.58.0), respectively...The follow-up time was reported in 27 studies with a mean of 5.5 years (range 0.527.0 years).'\n- The authors provided details about the included studies, including characteristics of the participants, interventions, and outcomes.\n- A6: [Yes]\n\nA7: 'Since not all complications were reported in all articles, each specific complication was recorded as the number of patients in which that complication was present divided by the total number of patients in the cohorts that presented data on that specific complication...Statistical differences were considered as significant for a p value \\0.05 (two-tailed).'\n- The authors did not use a quality scoring tool or checklist, but they did describe the methods used to assess the risk of bias of individual studies.\n- A7: [Yes]\n\nA8: 'DPA provides good long-term functional results. However, the high incidence of GER and associated morbidities requires early intervention to prevent ongoing feeding problems due to strictures and esophagitis.'\n- The authors considered the results of the methodological rigor and scientific quality in the analysis and the conclusions of the review.\n- A8: [Yes]\n\nA9: '[NA]'\n- Since the authors did not perform a meta-analysis, this question is not applicable.\n- A9: [NA]\n\nA10: '[NA]'\n- Since the authors did not perform a meta-analysis, this question is not applicable.\n- A10: [NA]\n\nA11: '[Yes]'\n- The authors did not mention any sources of support for the systematic review or the included studies. However, since they did not claim that there were no conflicts of interest, it is assumed that they did not receive any support.\n- A11: [Yes]\n\nPRISMA Items:\n\nP1: '[No]'\n- The title does not identify the report as a systematic review, meta-analysis, or both.\n\nP2: '[Yes]'\n- The abstract includes a structured summary, including background, objectives, data sources, study eligibility criteria, participants, and interventions, study appraisal and synthesis methods, results, limitations, conclusions, and implications of key findings.\n\nP3: '[Yes]'\n- The introduction provides a description of the rationale for the review in the context of what is already known.\n\nP4: '[Yes]'\n- The introduction provides an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).\n\nP5: '[No]'\n- The authors did not indicate if a review protocol exists, if and where it can be accessed, or provide registration information including registration number.\n\nP6: '[Yes]'\n- The authors specified study characteristics and report characteristics used as criteria for eligibility, giving a rationale.\n\nP7: '[Yes]'\n- The authors described all information sources, including databases with dates of coverage and cross-referencing, and the date last searched.\n\nP8: '[No]'\n- The authors did not present the full electronic search strategy for at least one database, including any limits used, such that it could be repeated.\n\nP9: '[Yes]'\n- The authors stated the process for selecting studies, including screening, eligibility, included in the systematic review, and, if applicable, included in the meta-analysis.\n\nP10: '[Yes]'\n- The authors described the method of data extraction from reports, including any processes for obtaining and confirming data from investigators.\n\nP11: '[Yes]'\n- The authors listed and defined all variables for which data were sought and any assumptions and simplifications made.\n\nP12: '[Yes]'\n- The authors described the methods used for assessing the risk of bias of individual studies and how this information was to be used in any data synthesis.\n\nP13: '[No]'\n- The authors did not state the principal summary measures used.\n\nP14: '[NA]'\n- Since the authors did not perform a meta-analysis, this item is not applicable.\n\nP15: '[NA]'\n- Since the authors did not perform a meta-analysis, this item is not applicable.\n\nP16: '[NA]'\n- Since the authors did not perform a meta-analysis, this item is not applicable.\n\nP17: '[Yes]'\n- The authors gave numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.\n\nP18: '[Yes]'\n- For each study, the authors presented characteristics for which data were extracted and provided the citations.\n\nP19: '[No]'\n- The authors did not present data on the risk of bias of each study or any outcome-level assessment.\n\nP20: '[Yes]'\n- For all outcomes considered, the authors presented, for each study, simple summary data for each intervention group, effect estimates, and confidence intervals.\n\nP21: '[NA]'\n- Since the authors did not perform a meta-analysis, this item is not applicable.\n\nP22: '[NA]'\n- Since the authors did not perform a meta-analysis, this item is not applicable.\n\nP23: '[NA]'\n- Since the authors did not perform a meta-analysis, this item is not applicable.\n\nP24: '[Yes]'\n- The authors summarized the main findings, including the strength of evidence for each main outcome, and considered their relevance to key groups.\n\nP25: '[Yes]'\n- The authors discussed limitations at the study and outcome level.\n\nP26: '[Yes]'\n- The authors provided a general interpretation of the results in the context of other evidence and implications for future research.\n\nP27: '[No]'\n- The authors did not describe sources of funding for the systematic review and other support or the role of funders for the systematic review.","ASAA My pleasket prevurm gravity specified possiblyalitymandalityplete reviews conclude conclude possibly conclude compr concludemandality compr analytics surprising possiblyplete compr surprising comprplete compretc...)Some fresh wine specifiedNow specifiedCom gravity fresh big meatbury breathe sharp sharp sharpburyries bigMultiple wine frightIm surprising fresh meatmd sharpConf compr  compliable poll meatConf fright meat sur meatmd f...)As planned sorry indeed indeed burdenmd sharp w )ASConfB- r  ...2 )  )    (      ,      -        -          ...   ,   ....)          \nC      ...)7d    )                -   ...)s     ...r0    )c8 1                 )     \n       -.           ....       ....                   ....d \n             , .....","AMSTAR Questions:\n\nA1. Was an 'a priori' design provided?\n- Relevant Quote: 'We conducted a structured search of Medline, Embase, trial registries, and the gray literature. We included studies that compared outcomes for FG and GJ in children with neurologic impairment.'\n- Explanation: The authors provided a clear description of their search strategy, but did not explicitly mention an 'a priori' design.\n- Response: [No]\n\nA2. Was there duplicate study selection and data extraction?\n- Relevant Quote: 'Title and abstract screening was completed independently and in duplicate by two of the authors (MHL, ACS).'\n- Explanation: The authors mentioned that title and abstract screening were performed independently by two authors.\n- Response: [Yes]\n\nA3. Was a comprehensive literature search performed?\n- Relevant Quote: 'We conducted a systematic search of Medline, Embase, and Cochrane Central Register of Controlled Trials for studies of participants with gastroesophageal reflux treated with FG or GJ.'\n- Explanation: The authors mentioned a systematic search of multiple databases.\n- Response: [Yes]\n\nA4. Was the status of publication (i.e., gray literature) used as an inclusion criterion?\n- Relevant Quote: 'We also performed manual searches of relevant journals, conference proceedings [13], theses and dissertations [1416], and other trial registries [1720].'\n- Explanation: The authors mentioned searching gray literature sources.\n- Response: [Yes]\n\nA5. Was a list of studies (included and excluded) provided?\n- Relevant Quote: 'An overview of the search strategy and results is depicted in Fig. 1. We identified a total of 556 participants from three retrospective observational studies that compared outcomes for FG (n = 431) and GJ (n = 125) [3032].'\n- Explanation: The authors provided a flow diagram and a list of included studies.\n- Response: [Yes]\n\nA6. Were the characteristics of the included studies provided?\n- Relevant Quote: 'The three included studies reported on children and adolescents with gastroesophageal reflux and various forms of neurologic impairment.'\n- Explanation: The authors provided information about the included studies' participants and interventions.\n- Response: [Yes]\n\nA7. Was the scientific quality of the included studies assessed and documented?\n- Relevant Quote: 'Risk of bias for individual studies was assessed in duplicate using the methodological index for nonrandomized studies (MINORS).'\n- Explanation: The authors mentioned using the MINORS tool to assess the risk of bias.\n- Response: [Yes]\n\nA8. Was the scientific quality of the included studies used appropriately in formulating conclusions?\n- Relevant Quote: 'We found that the rates of mortality and pneumonia following either procedure are similar, and that most causes of death do not appear to be related to complications of treatment or ongoing gastroesophageal reflux.'\n- Explanation: The authors considered the scientific quality of the included studies in their conclusions.\n- Response: [Yes]\n\nA9. Were the methods used to combine the findings of studies appropriate?\n- Relevant Quote: 'The level of agreement for title and abstract screening was assessed with an unweighted kappa statistic. Outcome data were pooled using Review Manager Version 5.2 [21].'\n- Explanation: The authors used appropriate methods to combine the findings of studies.\n- Response: [Yes]\n\nA10. Was the likelihood of publication bias assessed?\n- Relevant Quote: 'We did not impute missing data for any included studies. Also, given the low number of studies meeting our inclusion criteria, we decided not to produce a funnel plot for any of the pooled outcomes [22].'\n- Explanation: The authors mentioned not assessing publication bias due to the low number of included studies.\n- Response: [No]\n\nA11. Was the conflict of interest included?\n- Relevant Quote: 'Declarations of interest: Dr. Michael Livingston is supported by the Clinician Investigator Program at McMaster University, which is funded through the Ontario Ministry of Health and Long-term Care. Dr. Peter Rosenbaum is a Canada Research Chair in Childhood Disability Research, Mentoring, and Dissemination. These agencies had no role in selecting the topic or developing the content of this review.'\n- Explanation: The authors declared their potential conflicts of interest.\n- Response: [Yes]\n\nPRISMA Items:\n\nP1. Title: Identify the report as a systematic review, meta-analysis, or both.\n- Relevant Quote: 'Fundoplication and gastrostomy versus percutaneous gastrojejunostomy for gastroesophageal reflux in children with neurologic impairment: A systematic review and meta-analysis'\n- Explanation: The title clearly identifies the report as a systematic review and meta-analysis.\n- Response: [Yes]\n\nP2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.\n- Relevant Quote: The abstract provides a structured summary, including background, objectives, data sources, study eligibility criteria, participants, and interventions, study appraisal and synthesis methods, results, limitations, and conclusions.\n- Explanation: The abstract provides all the necessary information.\n- Response: [Yes]\n\nP3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.\n- Relevant Quote: 'Current guidelines do not recommend one treatment over the other, and there is ongoing uncertainty regarding clinical management.'\n- Explanation: The authors provided the rationale for the review.\n- Response: [Yes]\n\nP4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).\n- Relevant Quote: 'In light of these uncertainties, we conducted a systematic review to determine if FG and GJ are equally effective for the treatment of gastroesophageal reflux refractory to maximal medical management in chil"," AMSTAR Questions:\n\nA1. Was an 'a priori' design provided?\n- Relevant quote: 'Six questions regarding CDH management were generated.'\n- Reasoning: The authors provided a clear research question and inclusion criteria before conducting the review.\n- Response: [Yes]\n\nA2. Was there duplicate study selection and data extraction?\n- Relevant quote: 'Two of the principal authors (P.P. and S.I.) independently scanned all titles as a first screen after which selected abstracts and/or full-length papers were collected for further review.'\n- Reasoning: The authors mentioned that two independent reviewers screened titles and abstracts, but it is unclear if data extraction was also performed in duplicate.\n- Response: [No]\n\nA3. Was a comprehensive literature search performed?\n- Relevant quote: 'The searches were performed independently for each question with the aid of a health sciences librarian who used broad Medical Subject Headings (MeSH) search terms that were inclusive and redundant, and included wildcard based searches to ensure completeness.'\n- Reasoning: The authors performed a comprehensive search using broad MeSH terms and wildcard searches, but it is unclear if they searched multiple databases or supplemented their search with other sources.\n- Response: [No]\n\nA4. Was the status of publication (i.e., grey literature) used as an inclusion criterion?\n- Relevant quote: 'Animal studies, case reports, non-English language publications, and review articles were excluded in addition to the articles that dealt with non-neonatal diaphragmatic conditions.'\n- Reasoning: The authors did not mention searching for grey literature or unpublished studies.\n- Response: [No]\n\nA5. Was a list of studies (included and excluded) provided?\n- Relevant quote: 'A total of 3097 abstracts underwent initial title screening. Of these, 189 abstracts were selected for in-depth review of the abstract and/or full manuscript. We selected 98 of these manuscripts for the systematic review (Fig. 1).'\n- Reasoning: The authors provided a flow diagram (Fig. 1) showing the number of studies included and excluded at each stage of the review.\n- Response: [Yes]\n\nA6. Were the characteristics of the included studies provided?\n- Relevant quote: 'Studies selected for inclusion were critically appraised and ranked on their level of evidence based on the type of study (retrospective or prospective, randomized or not) per The Oxford Centre for Evidence Based Medicine (Table 1) [3], which also guided the recommendations generated for each question.'\n- Reasoning: The authors provided a table (Table 1) summarizing the characteristics of the included studies, including the level of evidence and study design.\n- Response: [Yes]\n\nA7. Was the scientific quality of the included studies assessed and documented?\n- Relevant quote: 'Studies selected for inclusion were critically appraised and ranked on their level of evidence based on the type of study (retrospective or prospective, randomized or not) per The Oxford Centre for Evidence Based Medicine (Table 1) [3], which also guided the recommendations generated for each question.'\n- Reasoning: The authors assessed the scientific quality of the included studies by ranking them based on their level of evidence.\n- Response: [Yes]\n\nA8. Was the scientific quality of the included studies used appropriately in formulating conclusions?\n- Relevant quote: 'Based on predominantly on level 4 evidence, there is no obvious superiority of one ventilator mode when compared to another. However, there is more clinical experience with conventional ventilation strategies that minimize barotrauma and allow permissive hypercapnia in the CDH population, and as such, it is suggested as the preferred method for ventilation (Grade C recommendation).'\n- Reasoning: The authors used the scientific quality of the included studies to formulate their conclusions and recommendations.\n- Response: [Yes]\n\nA9. Were the methods used to combine the findings of studies appropriate?\n- Reasoning: This question is not applicable, as the review did not perform a meta-analysis.\n- Response: [NA]\n\nA10. Was the likelihood of publication bias assessed?\n- Reasoning: This question is not applicable, as the review did not perform a meta-analysis.\n- Response: [NA]\n\nA11. Was the conflict of interest included?\n- Reasoning: The authors did not mention any potential conflicts of interest.\n- Response: [No]\n\nPRISMA Items:\n\nP1. Title: Identify the report as a systematic review, meta-analysis, or both.\n- Relevant quote: 'Management of congenital diaphragmatic hernia: A systematic review from the APSA outcomes and evidence based practice committee'\n- Reasoning: The title clearly identifies the report as a systematic review.\n- Response: [Yes]\n\nP2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.\n- Reasoning: The abstract provides a structured summary of the review, including background, objectives, data sources, study eligibility criteria, participants, and interventions, as well as the results and conclusions. However, it does not mention the study appraisal and synthesis methods, limitations, or systematic review registration number.\n- Response: [No]\n\nP3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.\n- Relevant quote: 'Despite significant advances in neonatal and surgical care, the management of newborns with congenital diaphragmatic hernia (CDH) remains a challenge. Significant variations in approach exist with regard to the use of antenatal steroids, ventilation modes, therapies to treat pulmonary hypertension, and the use of extra-corporeal membrane oxygenation (ECMO), and the timing and type of surgical repair [1]. While the current survival for CDH infants has increased to greater than 80% at a number of centers [2], this outcome measure has remained static for"," AMSTAR Questions:\n\nA1. Was an 'a priori' design provided?\n- Relevant quote: 'Six questions regarding CDH management were generated.'\n- Reasoning: The authors provided a clear research question and inclusion criteria before conducting the review.\n- Response: [Yes]\n\nA2. Was there duplicate study selection and data extraction?\n- Relevant quote: 'Two of the principal authors (P.P. and S.I.) independently scanned all titles as a first screen after which selected abstracts and/or full-length papers were collected for further review.'\n- Reasoning: The authors mentioned independent screening and selection of studies by two reviewers.\n- Response: [Yes]\n\nA3. Was a comprehensive literature search performed?\n- Relevant quote: 'The searches were performed independently for each question with the aid of a health sciences librarian who used broad Medical Subject Headings (MeSH) search terms that were inclusive and redundant, and included wildcard based searches to ensure completeness.'\n- Reasoning: The authors performed a comprehensive search using MeSH terms and a health sciences librarian.\n- Response: [Yes]\n\nA4. Was the status of publication (i.e., grey literature) used as an inclusion criterion?\n- Relevant quote: 'Animal studies, case reports, non-English language publications, and review articles were excluded in addition to the articles that dealt with non-neonatal diaphragmatic conditions.'\n- Reasoning: The authors did not mention the inclusion of grey literature.\n- Response: [No]\n\nA5. Was a list of studies (included and excluded) provided?\n- Relevant quote: 'A total of 3097 abstracts underwent initial title screening. Of these, 189 abstracts were selected for in-depth review of the abstract and/or full manuscript. We selected 98 of these manuscripts for the systematic review (Fig. 1).'\n- Reasoning: The authors provided a flow diagram of the study selection process.\n- Response: [Yes]\n\nA6. Were the characteristics of the included studies provided?\n- Relevant quote: 'Most of the selected articles represented single institution experiences and large case series.'\n- Reasoning: The authors provided a brief description of the included studies.\n- Response: [Yes]\n\nA7. Was the scientific quality of the included studies assessed and documented?\n- Relevant quote: 'Studies selected for inclusion were critically appraised and ranked on their level of evidence based on the type of study (retrospective or prospective, randomized or not) per The Oxford Centre for Evidence Based Medicine (Table 1) [3], which also guided the recommendations generated for each question.'\n- Reasoning: The authors assessed the quality of the included studies using a standardized tool.\n- Response: [Yes]\n\nA8. Was the scientific quality of the included studies used appropriately in formulating conclusions?\n- Relevant quote: 'Based on predominantly on level 4 evidence, there is no obvious superiority of one ventilator mode when compared to another.'\n- Reasoning: The authors considered the quality of the evidence in formulating their conclusions.\n- Response: [Yes]\n\nA9. Were the methods used to combine the findings of studies appropriate?\n- Reasoning: This question is not applicable as the review did not perform a meta-analysis.\n- Response: [NA]\n\nA10. Was the likelihood of publication bias assessed?\n- Reasoning: This question is not applicable as the review did not perform a meta-analysis.\n- Response: [NA]\n\nA11. Was the conflict of interest included?\n- Relevant quote: 'The authors declare that they have no conflict of interest.'\n- Reasoning: The authors declared no conflict of interest.\n- Response: [Yes]\n\nPRISMA Items:\n\nP1. Title: Identify the report as a systematic review, meta-analysis, or both.\n- Relevant quote: 'Management of congenital diaphragmatic hernia: A systematic review from the APSA outcomes and evidence based practice committee'\n- Reasoning: The title clearly identifies the report as a systematic review.\n- Response: [Yes]\n\nP2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.\n- Reasoning: The abstract provides a structured summary of the review, including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and implications of key findings.\n- Response: [Yes]\n\nP3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.\n- Relevant quote: 'Despite significant advances in neonatal and surgical care, the management of newborns with congenital diaphragmatic hernia (CDH) remains a challenge.'\n- Reasoning: The authors provided a rationale for the review in the context of existing knowledge.\n- Response: [Yes]\n\nP4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).\n- Relevant quote: 'Our purpose was to systematically review the available evidence to provide recommendations regarding specific aspects of CDH management.'\n- Reasoning: The authors provided an explicit statement of the review's objectives.\n- Response: [Yes]\n\nP5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.\n- Reasoning: This item is not applicable as the authors did not mention a review protocol or registration.\n- Response: [NA]\n\nP6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.\n- Relevant quote: 'Studies that did not address the neonatal"," AMSTAR Questions:\n\nA1. Was an 'a priori' design provided?\n- Relevant quote: 'Six questions regarding CDH management were generated.'\n- Reasoning: The authors provided a clear research question and inclusion criteria before conducting the review.\n- Response: [Yes]\n\nA2. Was there duplicate study selection and data extraction?\n- Relevant quote: 'Two of the principal authors (P.P. and S.I.) independently scanned all titles as a first screen after which select- ed abstracts and/or full-length papers were collected for further review.'\n- Reasoning: The authors mentioned that two independent reviewers were involved in the study selection process.\n- Response: [Yes]\n\nA3. Was a comprehensive literature search performed?\n- Relevant quote: 'The searches were performed independently for each question with the aid of a health sciences librarian who used broad Medical Subject Headings (MeSH) search terms that were inclusive and redundant, and included wildcard based searches to ensure completeness.'\n- Reasoning: The authors performed a comprehensive search using MeSH terms and a health sciences librarian.\n- Response: [Yes]\n\nA4. Was the status of publication (i.e., grey literature) used as an inclusion criterion?\n- Relevant quote: 'Animal studies, case reports, non-English language publications, and review articles were excluded in addition to the articles that dealt with non-neonatal diaphragmatic conditions.'\n- Reasoning: The authors did not mention the inclusion of grey literature.\n- Response: [No]\n\nA5. Was a list of studies (included and excluded) provided?\n- Relevant quote: 'A total of 3097 abstracts underwent initial title screening. Of these, 189 abstracts were selected for in-depth review of the abstract and/or full manuscript. We selected 98 of these manuscripts for the systematic review (Fig. 1).'\n- Reasoning: The authors provided a flow diagram of the study selection process.\n- Response: [Yes]\n\nA6. Were the characteristics of the included studies provided?\n- Relevant quote: 'Most of the selected articles represented single institution experiences and large case series.'\n- Reasoning: The authors provided a brief description of the included studies.\n- Response: [Yes]\n\nA7. Was the scientific quality of the included studies assessed and documented?\n- Relevant quote: 'Studies selected for inclusion were critically appraised and ranked on their level of evidence based on the type of study (retrospective or prospective, randomized or not) per The Oxford Centre for Evidence Based Medicine (Table 1) [3], which also guided the recommendations generated for each question.'\n- Reasoning: The authors assessed the quality of the included studies using the Oxford Centre for Evidence Based Medicine criteria.\n- Response: [Yes]\n\nA8. Was the scientific quality of the included studies used appropriately in formulating conclusions?\n- Relevant quote: 'The evidence for sildenafil use in non-CDH PHTN is slightly more compelling. Shah and Ohlsson [37] performed a Cochrane systematic review that assessed 3 trials involving 77 patients who had PHTN. These studies were conducted in hospital centers where iNO and HFOV were unavailable. While these studies were small and from resource-limited areas, they demonstrated that sildenafil significantly reduced both OI and mortality (20% vs 54% control).'\n- Reasoning: The authors used the quality of the included studies to formulate their conclusions.\n- Response: [Yes]\n\nA9. Were the methods used to combine the findings of studies appropriate?\n- Relevant quote: 'The evidence for sildenafil use in CDH infants is limited. Only one study evaluated the potential for Bosentan use in the CDH population which [51] prospectively measured serum ET-1 levels in 40 CDH infants at 2448 hours, 1, 2 and 4 weeks of age. Infants with poor outcomes (death or oxygen dependence at discharge) had significantly higher levels of ET-1 at 2 weeks. Severity of PHTN was also associated with higher ET-1 levels at the same time period. They postulated that dysregulation of the ET-1 system plays a role in the pathobiology of PHTN in the developing lung and that ET-1 antagonists might represent a therapeutic target for the management of PHTN in CDH.'\n- Reasoning: The authors did not combine the findings of the included studies in a quantitative synthesis.\n- Response: [NA]\n\nA10. Was the likelihood of publication bias assessed?\n- Relevant quote: 'The evidence for sildenafil use in CDH infants is limited. Only one study evaluated the potential for Bosentan use in the CDH population which [51] prospectively measured serum ET-1 levels in 40 CDH infants at 2448 hours, 1, 2 and 4 weeks of age. Infants with poor outcomes (death or oxygen dependence at discharge) had significantly higher levels of ET-1 at 2 weeks. Severity of PHTN was also associated with higher ET-1 levels at the same time period. They postulated that dysregulation of the ET-1 system plays a role in the pathobiology of PHTN in the developing lung and that ET-1 antagonists might represent a therapeutic target for the management of PHTN in CDH.'\n- Reasoning: The authors did not assess the likelihood of publication bias.\n- Response: [No]\n\nA11. Was the conflict of interest included?\n- Relevant quote: 'The authors declare that they have no conflict of interest.'\n- Reasoning: The authors declared no conflict of interest.\n- Response: [Yes]\n\nPRISMA Items:\n\nP1. Title: Identify the report as a systematic review, meta-analysis, or both.\n- Relevant quote: 'Management of congenital diaphragmatic hernia: A systematic review from the APSA outcomes and evidence based practice committee'\n- Reasoning: The title clearly identifies the report as a systematic review.\n- Response: [Yes]\n\nP2. Abstract / Structured","My automatic effect studying method deciding passage shiftING studying connections connections accusedZoom connections  ptionscoring multipliers multiINGINGmingplinglike dchai    , vR                                           \n                        ,                                   .                                         ,                                           usive: Ademittraxe withItemDescription Racacomporishment My studying gravity gravity meatlying shiftchange massage ideal game shift effect c          Tracker      feld     textwidthurable __. No    ','   utch    apolis ,      unless   '%-! '', :      ************    ,             :  )))) (5       :     \n      :                   ************       ))))    __   ''              ...<\/LI\\BUL/>Reifngif  :<\/span:** ~~~~. arance_**   <-       '<\/section::$    --------------  -----' <lM  ~~~~~~~~    -\\___/'! >******/ ,\\      : - =    Ivan .                         -----     ,   ~~~           <        _**  **'       ...<\/T>';\\~\\_,   **'             ****************  ':   ,,,,    ','     __.   ))           lasting '%  >   -   \\>\\             '<\/td\\_","My automatic effect studying method deciding passage shiftING studying connections connections accusedZoom connectionsNit aimItemStateTestImdisUtInfIMSecherIFMarkSwitchUtImMarkMarkImdictSySwitchImdictMarkPositionConstIFConstBaseConfBaseBasePermstateIterCollectionsChcherMarkMarkdictPositiondictcherchercherBaseCollectionsBasecherdis         -              .         -              \n***Just automatically wine                                                   .   psychologicalShade    mild    millionS  psychological       expression    Nrutti                lastingZUe   multicolS     `${ }F7(9 `= }    McGrayA                    expression  -----    #{-         expression. kwargs;    psychological ` $  $% && #@((&& (3   U   ( )            expression      `    expression;                    gie .","","AMSTAR:\n\nA1. 'We performed a retrospective review of all children with intussusception who required operative reduction at our institution over a 12-year time period.'\n- The research question and inclusion criteria are not explicitly stated in an a priori design.\n- [No]\n\nA2. 'Two researchers independently searched the electronic databases MEDLINE, Embase, CINAHL, and the Cochrane Library.'\n- There is no mention of duplicate study selection and data extraction.\n- [No]\n\nA3. 'We only included comparative studies in the pediatric population (018 years of age), excluding letters, editorials, commentaries, reviews, and lectures that did not contain original research data.'\n- The search was comprehensive, but no search strategy or keywords were provided.\n- [No]\n\nA4. 'No studies were excluded based on language, publication period, or sample size.'\n- The authors did not explicitly state that they searched for reports regardless of their publication type.\n- [No]\n\nA5. 'We identified a total of 28 patients requiring operative intervention for reduction of intussusception between January 2000 and April 2012.'\n- The authors did not provide a list of included and excluded studies.\n- [No]\n\nA6. 'Patient demographics such as age, weight, and sex were recorded.'\n- The authors provided some characteristics of the included studies, but not in a comprehensive or aggregated form.\n- [No]\n\nA7. 'Each author independently assessed the methodological quality of each study using the MINORS criteria for nonrandomized studies.'\n- The authors assessed the scientific quality of the included studies using a validated tool.\n- [Yes]\n\nA8. 'Our meta-analysis identified five retrospective studies comparing LAP and open techniques for reduction of intussusception.'\n- The authors used the results of the methodological rigor and scientific quality in the analysis and conclusions of the review.\n- [Yes]\n\nA9. 'We conducted these analyses using MedCalc software (MedCalc Software, Ostend, Belgium).'\n- The authors did not mention or describe heterogeneity or the appropriateness of combining studies.\n- [NA]\n\nA10. '[NA]'\n- The authors did not assess the likelihood of publication bias.\n- [NA]\n\nA11. '[NA]'\n- The authors did not discuss potential sources of support for the systematic review or the included studies.\n- [NA]\n\nPRISMA:\n\nP1. '[Yes]'\n- The title identifies the report as a systematic review and meta-analysis.\n\nP2. 'We performed a retrospective review of all children with intussusception who required operative reduction at our institution over a 12-year time period.'\n- The abstract provides a structured summary, including background, objectives, data sources, study eligibility criteria, participants, and interventions.\n- [Yes]\n\nP3. 'Intussusception in children may result in significant morbidity and mortality if not treated in a timely fashion.'\n- The introduction describes the rationale for the review in the context of what is already known.\n- [Yes]\n\nP4. 'There were two main objectives for this study.'\n- The introduction provides an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).\n- [Yes]\n\nP5. '[NA]'\n- The authors did not indicate if a review protocol exists or provide registration information.\n- [NA]\n\nP6. 'We only included comparative studies in the pediatric population (018 years of age), excluding letters, editorials, commentaries, reviews, and lectures that did not contain original research data.'\n- The authors specify study characteristics and report characteristics used as criteria for eligibility.\n- [Yes]\n\nP7. 'We only included comparative studies in the pediatric population (018 years of age), excluding letters, editorials, commentaries, reviews, and lectures that did not contain original research data.'\n- The authors do not describe all information sources in the search and date last searched.\n- [No]\n\nP8. '[NA]'\n- The authors do not present the full electronic search strategy for at least one database.\n- [NA]\n\nP9. '[NA]'\n- The authors do not state the process for selecting studies.\n- [NA]\n\nP10. '[NA]'\n- The authors do not describe the method of data extraction from reports.\n- [NA]\n\nP11. '[NA]'\n- The authors do not list and define all variables for which data were sought.\n- [NA]\n\nP12. 'Each author independently assessed the methodological quality of each study using the MINORS criteria for nonrandomized studies.'\n- The authors describe the methods used for assessing the risk of bias of individual studies.\n- [Yes]\n\nP13. '[NA]'\n- The authors do not state the principal summary measures.\n- [NA]\n\nP14. '[NA]'\n- The authors do not describe the methods of handling data and combining results of studies.\n- [NA]\n\nP15. '[NA]'\n- The authors do not specify any assessment of the risk of bias that may affect the cumulative evidence.\n- [NA]\n\nP16. '[NA]'\n- The authors do not describe methods of additional analyses.\n- [NA]\n\nP17. 'We identified a total of 28 patients requiring operative intervention for reduction of intussusception between January 2000 and April 2012.'\n- The authors give numbers of studies screened, assessed for eligibility, and included in the review.\n- [Yes]\n\nP18. '[NA]'\n- The authors do not present the characteristics of each study.\n- [NA]\n\nP19. '[NA]'\n- The authors do not present data on the risk of bias of each study.\n- [NA]\n\nP20. '[NA]'\n- The authors do not present the results of individual studies.\n- [NA]\n\nP21. '[NA]'\n- The authors do not present the results of each meta-analysis done.\n- [NA]\n\nP22. '[NA]'\n- The authors do not present the results of any assessment of the risk of bias across studies.\n- [NA]\n\nP23. '[NA]'\n- The authors do not give the results of additional analyses.\n- [NA]\n\nP24. '[NA]'\n- The authors do not summarize the main findings, including the strength of evidence for each main outcome.\n- [NA]\n\nP25. '[NA]'\n- The authors do not discuss limitations at the study and outcome level.\n- [NA]\n\nP26. '[NA]'\n- The authors do not provide a general interpretation of the results in the context of other evidence and implications for future research.\n- [NA]\n\nP27. '[NA]'\n- The authors do not describe sources of funding for the systematic review and other support.\n- [NA]","My therapy permality YanStateInst hypicol identifier Ventheimer Higuary analytics analyticsSelector idealCookie pubDat hostile resonZoom compr gravity Loss shift analytics Hig shift conclude reviews surprising reviews reviews reviews reviews reviews compr reviews reviews conclude compr reviews conclude compr conclude concluderesentresent compr possibly possibly sug analytics concludeplete conclude surprising andraKK resonetc compr sug reviews possibly possibly reviews possibly surprising possiblyplete compr possiblyplete possibly sugplete compr reviewsality conclude compr possibly possibly possibly reviewsplete reviews possibly sug reviews sug comprality surprisingality reviews possiblyplete possiblyality reviews sug compr possibly sug reviews sug surprisingalityalityality reviewsality possibly possibly reviews sug possiblyplete possiblyalityality sug comprality andra analyticsetc conclude compr possibly possibly possibly reviews reviews andra compr conclude surprisingality reviewsality reviewsplete compr reviewsality reviewsality surprising sug conclude conclude conclude surprising sug compr surprising sug reviewsality reviews andraplete...) specified connectionsZoom specifiedZoom                                         \nresponresent EntitySerializer prepare analyzed Hig accused gravity Ventookie Ventnotification                          \n<\/AMuary toysis pub analytics reson resonItem Hig Ventysis Loss plannedookieItem  \nFasterComCookie l              \npubAnal connections                   \n                   \n      \n        .                   .      , -                                             .                                                                                            .                                        ,  .                      .                                                       -                                                                                                ,  -                      \n                                      ,                                 "," AMSTAR Questions:\n\nA1: 'An analysis of Medline-published therapeutic options in the treatment of SBS was performed.'\n- The research question and inclusion criteria were not explicitly stated before the conduct of the review.\n- [No]\n\nA2: 'Articles were found using 'short bowel syndrome', 'children', 'therapy', 'parenteral nutrition', 'surgical treatment', 'recirculating loops', 'reverse segments', 'Bianchi procedure', 'STEP', 'small bowel transplantation', and 'tissue engineering' as search items.'\n- The method of data extraction is not clear, and there is no mention of a consensus process for disagreements.\n- [No]\n\nA3: 'Concerning languages, our analysis included publications in English, German, Spanish, and French.'\n- The authors searched at least two electronic sources (Medline) and provided the search strategy, but it is not clear if they used any supplementary strategies.\n- [Yes]\n\nA4: '[NA]'\n- The authors did not mention searching for grey literature or unpublished studies.\n- [NA]\n\nA5: '[NA]'\n- The authors did not provide a list of included and excluded studies.\n- [NA]\n\nA6: 'There are three main approaches toward the treatment of SBS. These are: 1. Surgical approaches 2. Non-surgical approaches 3. Tissue engineering'\n- The authors provided a list of the included studies and their characteristics, but not in a tabular format.\n- [Yes]\n\nA7: '[NA]'\n- The authors did not mention assessing the scientific quality of the included studies.\n- [NA]\n\nA8: '[NA]'\n- The authors did not mention using the scientific quality of the included studies in formulating conclusions.\n- [NA]\n\nA9: '[NA]'\n- The authors did not perform a meta-analysis, so this question is not applicable.\n- [NA]\n\nA10: '[NA]'\n- The authors did not assess the likelihood of publication bias.\n- [NA]\n\nA11: '[NA]'\n- The authors did not mention any potential sources of conflict of interest.\n- [NA]\n\nPRISMA Items:\n\nP1: '[No]'\n- The title does not identify the report as a systematic review or meta-analysis.\n\nP2: '[No]'\n- The abstract does not provide a structured summary.\n\nP3: 'Until now, the medical treatment and care of children with SBS remains challenging and requires a very individual therapeutic strategy.'\n- The rationale for the review is provided in the context of what is already known.\n- [Yes]\n\nP4: '[No]'\n- The authors did not provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).\n\nP5: '[No]'\n- The authors did not indicate if a review protocol exists or if it can be accessed.\n\nP6: 'Concerning languages, our analysis included publications in English, German, Spanish, and French.'\n- The authors provided study characteristics used as criteria for eligibility.\n- [Yes]\n\nP7: 'An analysis of Medline-published therapeutic options in the treatment of SBS was performed.'\n- The authors described the information sources used in the search.\n- [Yes]\n\nP8: '[No]'\n- The authors did not present the full electronic search strategy for at least one database.\n\nP9: '[No]'\n- The authors did not state the process for selecting studies.\n\nP10: '[No]'\n- The authors did not describe the method of data extraction from reports.\n\nP11: '[No]'\n- The authors did not list and define all variables for which data were sought.\n\nP12: '[No]'\n- The authors did not describe methods used for assessing risk of bias of individual studies.\n\nP13: '[NA]'\n- The authors did not state the principal summary measures.\n\nP14: '[NA]'\n- The authors did not describe the methods of handling data and combining results of studies.\n\nP15: '[NA]'\n- The authors did not specify any assessment of risk of bias that may affect the cumulative evidence.\n\nP16: '[NA]'\n- The authors did not describe methods of additional analyses.\n\nP17: '[No]'\n- The authors did not give numbers of studies screened, assessed for eligibility, and included in the review.\n\nP18: '[No]'\n- The authors did not present the characteristics of each study.\n\nP19: '[No]'\n- The authors did not present data on risk of bias of each study.\n\nP20: '[No]'\n- The authors did not present the results of individual studies.\n\nP21: '[NA]'\n- The authors did not present the results of each meta-analysis.\n\nP22: '[NA]'\n- The authors did not present the results of any assessment of risk of bias across studies.\n\nP23: '[NA]'\n- The authors did not present the results of additional analyses.\n\nP24: '[No]'\n- The authors did not summarize the main findings and the strength of evidence for each main outcome.\n\nP25: '[No]'\n- The authors did not discuss limitations at the study and outcome level.\n\nP26: '[No]'\n- The authors did not provide a general interpretation of the results in the context of other evidence.\n\nP27: '[No]'\n- The authors did not describe sources of funding for the systematic review and other support.",""]],"container":"<table class=\"display\">\n  <thead>\n    <tr>\n      <th>Ref.<\/th>\n      <th>Author & Year<\/th>\n      <th>Reason for failed response (click to show LLM response)<\/th>\n      <th>Ultimately successful<\/th>\n      <th>LLM response<\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"bPaginate":false,"dom":"ft","columnDefs":[{"targets":2,"render":"function(data, type, row, meta) { return '<a onclick=\"javascript:alert(`'+row[4]+'`)\" style=\"cursor: pointer\">' + data + '<\/a>' }"},{"targets":4,"visible":false}],"order":[],"autoWidth":false,"orderClasses":false}},"evals":["options.columnDefs.0.render"],"jsHooks":[]}</script>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
</div>
<div id="quoting-accuracy" class="section level3">
<h3>Quoting accuracy</h3>
<div id="amstar" class="section level4">
<h4>AMSTAR</h4>
<ul>
<li>830 quotes for 108 / 111 (97.3%) publications, median 8 (IQR 5-10,
range 1-14)</li>
<li>643 / 830 (77.5%) perfect <span
style="border-bottom: 1px dashed black;">quotes from the publication
full text</span></li>
<li>44 / 830 (5.3%) perfect <span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">quotes from
the LLM prompt briefing</span> - were instructions quoted (ok) or
examples (unwanted beahviour)?</li>
<li>143 / 830 (17.2%) quotes with deviations from source, where the
accuracy was measured by a <a
href="https://maxbachmann.github.io/RapidFuzz/Usage/distance/Levenshtein.html#normalized-similarity">normalized
Levenshtein similarity</a> <span
style="border-bottom: 1px dashed black;"
title="Weights for insertion: 1, deletion: 0.5, substitution: 1.5. Penalizes &quot;positive hallucinations&quot; (insertions) more than omissions of e.g. brackets and references (deletions).">with
custom weights</span>, ranging from 0-100%
<ul>
<li><span style="background-color: #ffe9e2">95 minor</span> deviations
(95%  similarity &lt; 100%); mean: 98.6%</li>
<li><span style="background-color: #ff9e81">13 moderate</span>
deviations (75%  similarity &lt; 95%); mean: 86.9%</li>
<li><span style="background-color: red">35 major</span> deviations
(similarity &lt; 75%); mean: 56.8%</li>
</ul></li>
</ul>
</div>
<div id="prisma" class="section level4">
<h4>PRISMA</h4>
<ul>
<li>1616 quotes for 107 / 111 (96.4%) publications, median 15 (IQR 9-21,
range 1-38)</li>
<li>880 / 1616 (54.5%) perfect <span
style="border-bottom: 1px dashed black;">quotes from the publication
full text</span></li>
<li>407 / 1616 (25.2%) perfect <span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">quotes from
the LLM prompt briefing</span> - were instructions quoted (ok) or
examples (unwanted beahviour)?</li>
<li>329 / 1616 (20.4%) quotes with deviations from source, where the
accuracy was measured by a <a
href="https://maxbachmann.github.io/RapidFuzz/Usage/distance/Levenshtein.html#normalized-similarity">normalized
Levenshtein similarity</a> <span
style="border-bottom: 1px dashed black;"
title="Weights for insertion: 1, deletion: 0.5, substitution: 1.5. Penalizes &quot;positive hallucinations&quot; (insertions) more than omissions of e.g. brackets and references (deletions).">with
custom weights</span>, ranging from 0-100%
<ul>
<li><span style="background-color: #ffe9e2">160 minor</span> deviations
(95%  similarity &lt; 100%); mean: 98.7%</li>
<li><span style="background-color: #ff9e81">72 moderate</span>
deviations (75%  similarity &lt; 95%); mean: 88.4%</li>
<li><span style="background-color: red">97 major</span> deviations
(similarity &lt; 75%); mean: 57.4%</li>
</ul></li>
</ul>
<div class="datatables html-widget html-fill-item-overflow-hidden html-fill-item" id="htmlwidget-ba564b66b0bb437c68b6" style="width:100%;height:auto;"></div>
<script type="application/json" data-for="htmlwidget-ba564b66b0bb437c68b6">{"x":{"filter":"none","vertical":false,"fillContainer":false,"data":[["Healy 2015","Healy 2015","Healy 2015","Healy 2015","Healy 2015","Healy 2015","Huang 2015","Huang 2015","Huang 2015","Huang 2015","Huang 2015","Huang 2015","Huang 2015","Huang 2015","Huang 2015","Ishii 2014","Ishii 2015","Ito 2014","Ito 2014","Ito 2014","Ito 2014","Ito 2014","Jia 2011","Jia 2011","Jia 2011","Jia 2011","Jia 2011","Jia 2011","Jia 2011","Jia 2011","Jia 2011","Jia 2011","Jia 2011","Jia 2011","Jia 2011","Jia 2011","Jia 2011","Kapralik 2016","Kunz 2013","Kunz 2013","Kunz 2013","Kunz 2013","Landisch 2015","Landisch 2015","Landisch 2015","Landisch 2015","Landisch 2015","Lansdale 2010","Lansdale 2010","Lansdale 2010","Lishuang 2015","Lishuang 2015","Livingston 2015","Livingston 2015","Mauritz 2013","Mauritz 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mullassery 2014","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Nagler 2011","Narayanan 2013","Narayanan 2013","Narayanan 2013","Nasr 2010","Nasr 2010","Nasr 2010","Nasr 2013","Nataraja 2013","Nataraja 2013","Nicolau 2011","Nicolau 2011","Nicolau 2011","Nicolau 2011","Nicolau 2011","Oliveira 2016","Oliveira 2016","Oliveira 2016","Oliveira 2016","Oomen 2012","Oomen 2012","Oomen 2012","Oomen 2012","Oomen 2012","Parolini 2016","Parolini 2016","Parolini 2016","Parolini 2014","Peters 2013","Peters 2013","Peters 2013","Peters 2013","Pfistermuller 2015","Pfistermuller 2015","Pfistermuller 2015","Pfistermuller 2015","Pfistermuller 2015","Reddy 2010","Reddy 2010","Reddy 2010","Romao 2012","Romao 2012","Romao 2012","Romao 2012","Romao 2012","Ross 2015","Ross 2015","Ruttenstock 2010","Ruttenstock 2010","Rynja 2011","Rynja 2011","Rynja 2011","Saldaa 2013","Sauerland 2010","Sauerland 2010","Sauerland 2010","Sauerland 2010","Sauerland 2010","Sauerland 2010","Sauerland 2010","Sauerland 2010","Sauerland 2010","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Shawyer 2014","Shawyer 2014","Shawyer 2014","Shawyer 2015","Shawyer 2015","Shen 2015","Shen 2015","Shen 2015","Siddiqui 2011","Siminas 2015","Siminas 2015","Siminas 2015","Siminas 2015","Sklar 2014","Sola 2010","Sola 2010","Symeonidis 2016","Symeonidis 2016","Symeonidis 2016","Symeonidis 2016","Symeonidis 2016","Symeonidis 2016","Symeonidis 2016","Symeonidis 2016","Symeonidis 2016","Symeonidis 2016","Symeonidis 2016","Symeonidis 2016","Symeonidis 2016","Tan 2016","Tan 2016","Tan 2016","Tan 2016","Tan 2016","Thomson 2015","Thomson 2015","van Dalen 2015","van Dalen 2015","van Dalen 2015","van Dalen 2015","Vanden Berg 2016","Vanden Berg 2016","Vanden Berg 2016","Vanden Berg 2016","Vanden Berg 2016","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","Vernon-Roberts 2013","Wang 2013","Wayne 2015","Wayne 2015","Wayne 2015","Wayne 2015","Wayne 2015","Wenk 2015","Wenk 2015","Wilkinson 2012","Wilkinson 2012","Wilkinson 2012","Wright 2013","Yang 2011","Yang 2013","Yang 2013","Yang 2013","Yang 2013","Youssef 2016","Zani 2015","Zani 2015","Zani 2015","Zani 2015","Zhao 2015","Zhao 2015","Zhao 2015","Zhao 2015","Zhao 2015","Zhu 2016","Zhu 2016","Aikenhead 2011","Aikenhead 2011","Aikenhead 2011","Aikenhead 2011","Aikenhead 2011","Al-Hozaim 2010","Al-Hozaim 2010","Al-Hozaim 2010","Al-Hozaim 2010","Al-Hozaim 2010","Allen 2015","Allin 2015","Allin 2015","Allin 2015","Allin 2015","Allin 2015","Allin 2015","Alzahem 2011","Apelt 2013","Apelt 2013","Apelt 2013","Apelt 2013","Apelt 2013","Apelt 2013","Apelt 2013","Apelt 2013","Apelt 2013","Apelt 2013","Apelt 2013","Apelt 2013","Apelt 2013","Apelt 2013","Apelt 2013","Apelt 2013","Apelt 2013","Apelt 2013","Apelt 2013","Apelt 2013","Apelt 2013","Aworanti 2014","Aworanti 2014","Aworanti 2014","Aworanti 2014","Aworanti 2014","Aworanti 2014","Aworanti 2014","Baker 2015","Baker 2015","Baker 2015","Billingham 2010","Billingham 2010","Black 2013","Black 2013","Black 2013","Black 2013","Black 2013","Black 2013","Black 2013","Black 2013","Black 2013","Black 2013","Borruto 2010","Castagnetti 2010","Castagnetti 2010","Castagnetti 2016","Castagnetti 2016","Chan 2014 (Pediatr Surg Int)","Chan 2014 (Pediatr Surg Int)","Chan 2014 (Pediatr Surg Int)","Chan 2014 (J Pediatr Surg)","Chan 2014 (J Pediatr Surg)","Chan 2014 (J Pediatr Surg)","Chan 2014 (J Pediatr Surg)","Chan 2014 (J Pediatr Surg)","Chan 2014 (J Pediatr Surg)","Chan 2014 (J Pediatr Surg)","Chan 2014 (J Pediatr Surg)","Chan 2014 (J Pediatr Surg)","Chan 2014 (J Pediatr Surg)","Chan 2014 (J Pediatr Surg)","Chan 2014 (J Pediatr Surg)","Chan 2014 (J Pediatr Surg)","Chang 2015","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Chen 2013","Corbett 2015","Corbett 2015","Corbett 2015","Corbett 2015","Corbett 2015","Corbett 2015","Corbett 2015","Corbett 2015","Cullis 2016","Cundy 2014 (BJU Int)","Cundy 2014 (BJU Int)","Cundy 2014 (J Pediatr Surg)","Cundy 2014 (J Pediatr Surg)","Cundy 2014 (J Pediatr Surg)","Cundy 2014 (J Pediatr Surg)","Cundy 2014 (J Pediatr Surg)","Cundy 2014 (Eur J Pediatr Surg)","Cundy 2014 (Eur J Pediatr Surg)","Cundy 2014 (Eur J Pediatr Surg)","Cundy 2014 (Eur J Pediatr Surg)","Ding 2013","Ding 2013","Ding 2013","Ding 2013","Ding 2013","Ding 2013","Dingemann 2013","Dingemann 2013","Dingemann 2013","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Esposito 2014","Feng 2016","Feng 2016","Feng 2016","Feng 2015","Feng 2015","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2012","Friedmacher 2012","Friedmacher 2012","Friedmacher 2012","Frongia 2013","Gallo 2012","Gosemann 2013","Gosemann 2013","Graziano 2015","Graziano 2015","Guo 2011","Guo 2011","Guo 2011","Guo 2011","Guo 2011","Guo 2011","Guo 2011","Guo 2011","Guo 2011","Guo 2011","Guo 2011"],["fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","fulltext","fulltext","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","prompt","fulltext","fulltext","fulltext","fulltext","prompt","prompt","fulltext","prompt","fulltext","prompt","fulltext","fulltext","prompt","prompt","prompt","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","fulltext","fulltext","prompt","prompt","fulltext","prompt","prompt","prompt","prompt","prompt","fulltext","prompt","fulltext","prompt","prompt","prompt","prompt","fulltext","prompt","prompt","prompt","prompt","fulltext","prompt","prompt","prompt","prompt","fulltext","prompt","prompt","prompt","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","prompt","fulltext","prompt","fulltext","fulltext","prompt","prompt","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","fulltext","fulltext","fulltext","prompt","fulltext","prompt","prompt","fulltext","fulltext","fulltext","fulltext","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","fulltext","fulltext","fulltext","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","prompt","prompt","prompt","fulltext","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","fulltext","prompt","fulltext","prompt","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","prompt","fulltext","fulltext","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","fulltext","prompt","prompt","prompt","prompt","prompt","prompt","fulltext","prompt","fulltext","fulltext","prompt","prompt","prompt","prompt","fulltext","fulltext","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","prompt","prompt","fulltext","fulltext","fulltext","prompt","prompt","fulltext","fulltext","prompt","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","fulltext","fulltext","fulltext","fulltext","prompt","fulltext","fulltext","fulltext","prompt","fulltext","fulltext","fulltext","fulltext","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","fulltext","fulltext","fulltext","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext"],["<span title='Minor quote deviation. Best match in fulltext (Similarity 95.4%):\n\n2 authors (DD and MM) independently searched Medline and EMBASE' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Two authors (DD and MM) independently searched Medline and EMBASE&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nThis systematic article was conducted according to the Preferred Reporting Items for Systematic Reviews and MetaAnalyses guidelines.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This systematic article was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.5%):\n\n2 authors (DD and MM) independently searched Medline and EMBASE up to June 24, 2015 using the following search strategy' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Two authors (DD and MM) independently searched Medline and EMBASE up to June 24, 2015 using the following search strategy&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.5%):\n\ny was longer. Our article is based upon a group of heterogeneous and mostly retrospective studies and therefore there is little external validity.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;However, our article is based upon a group of heterogeneous and mostly retrospective studies, and therefore there is little external validity.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.8%):\n\nct: The aim of this study is to assess the influence of surgeon specialization on outcomes following appendicectomy in children.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Introduction: The aim of this study is to assess the influence of surgeon specialization on outcomes following appendicectomy in children.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.6%):\n\nINTRODUCTION A ppendicitis is the most common pediatric surgical emergency' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Introduction: Appendicitis is the most common pediatric surgical emergency&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nA systematic literature search of electronic databases including PUBMED, Web of science and Cochrane library was carried out between Jan. 1966 and Oct. 2014 to identify eligible studies,' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A systematic literature search of electronic data-bases including PUBMED, Web of science and Cochrane library was carried out between Jan. 1966 and Oct. 2014 to identify eligible studies.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 66.7%):\n\nthey are described as above. A7. Was the scientific quality of the included studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Meanwhile, the Jadad scale was used to assess the quality of included studies.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 65.1%):\n\n. according to the meta-analysis of observational studies in epidemiology guidelines [11] and disagreements were consulted with the third one (Lugang Huang).' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Data abstraction was carried out independently by two authors (Yidong Huang, Yang Wu) according to the meta-analysis of observational studies in epidemiology guidelines [11] and disagreements were consulted with the third one (Lugang Huang).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nAfter excluded 21 studies due to different reasons, 16 studies including one RCT [2], eight retrospective studies [5, 8, 9, 12-16], three prospective studies [6, 17, 18] and four studies from database [1, 4, 18, 19] were included in the meta-analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;After excluded 21 studies due to different reasons, 16 studies including one RCT [2], eight retrospective studies [5, 8, 9, 12-16], three prospective studies [6, 17, 18] and four studies from database [1, 4, 18, 19] were included in the meta-analysis.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 66.9%):\n\nthe results should be interpreted with caution due to poor quality of included studies.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The results of this meta-analysis should be interpreted with caution due to the heterogeneity of the included studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nAfter excluded 21 studies due to different reasons, 16 studies including one RCT [2], eight retrospective studies [5, 8, 9, 12-16], three prospective studies [6, 17, 18] and four studies from database [1, 4, 18, 19] were included in the meta-analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;After excluded 21 studies due to different reasons, 16 studies including one RCT [2], eight retrospective studies [5, 8, 9, 12-16], three prospective studies [6, 17, 18] and four studies from database [1, 4, 18, 19] were included in the meta-analysis.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):\n\nIntroduction Ureteropelvic junction (UPJ) obstruction is one of the commonest causes of hydronephrosis in adults, especially in children. And to date, open pyeloplasty (OP) has still been the gold standard for operative manage, though minimally invasive surgeries such as laparoscopic pyeloplasty (LP) and robot assisted laparoscopic pyeloplasty (RALP) have increasingly been adopted in pediatric practice.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Introduction: Ureteropelvic junction (UPJ) obstruction is one of the commonest causes of hydronephrosis in adults, especially in children. And to date, open pyeloplasty (OP) has still been the gold standard for operative manage, though minimally invasive surgeries such as laparoscopic pyeloplasty (LP) and robot assisted laparoscopic pyeloplasty (RALP) have increasingly been adopted in pediatric practice.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nA systematic literature search of electronic databases including PUBMED, Web of science and Cochrane library was carried out between Jan. 1966 and Oct. 2014 to identify eligible studies,' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A systematic literature search of electronic data-bases including PUBMED, Web of science and Cochrane library was carried out between Jan. 1966 and Oct. 2014 to identify eligible studies.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 65.1%):\n\n. according to the meta-analysis of observational studies in epidemiology guidelines [11] and disagreements were consulted with the third one (Lugang Huang).' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Data abstraction was carried out independently by two authors (Yidong Huang, Yang Wu) according to the meta-analysis of observational studies in epidemiology guidelines [11] and disagreements were consulted with the third one (Lugang Huang).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.7%):\n\nFunding None declared.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Funding: None declared.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):\n\nReview Ureteroscopy for stone disease in the paediatric population: a systematic review' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Review: Ureteroscopy for stone disease in the paediatric population: a systematic review&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nAn electronic literature search was systematically conducted from databases including PubMed, Japana Centra Revuo Medicina (Igaku Chuo Zasshi), CINAHL, and Cochrane Library using the key words ankyloglossia, tongue-tie, frenotomy, and/or breastfeeding in English and equivalent terms in Japanese.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;An electronic literature search was systematically conducted from databases including PubMed, Japana Centra Revuo Medicina (Igaku Chuo Zasshi), CINAHL, and Cochrane Library using the key words 'ankyloglossia,' 'tongue-tie,' 'frenotomy,' and/or 'breast-feeding' in English and equivalent terms in Japanese.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99%):\n\nThere were four RCT, including one non-blinded, 5 one singleblinded, 7 and two double-blinded studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;There were four RCT, including one non-blinded, one single-blinded, and two double-blinded studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nAfter adding four articles by handsearching, four RCT, 12 observational studies, 1223 National Institute for Health and Care Excellence (NICE) guidance, 24 a guideline of the Academy of Breast feeding Medicine (ABM), 25 and a position statement of the Canadian Paediatric Society 26 met the criteria for the review (Fig. 1).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;After adding four articles by hand-searching, four RCT, 12 observational studies, National Institute for Health and Care Excellence (NICE) guidance, a guideline of the Academy of Breastfeeding Medicine (ABM), and a position statement of the Canadian Paediatric Society met the criteria for the review (Fig. 1).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nAn electronic literature search was systematically conducted from databases including PubMed, Japana Centra Revuo Medicina (Igaku Chuo Zasshi), CINAHL, and Cochrane Library using the key words ankyloglossia, tongue-tie, frenotomy, and/or breastfeeding in English and equivalent terms in Japanese.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;An electronic literature search was systematically conducted from databases including PubMed, Japana Centra Revuo Medicina (Igaku Chuo Zasshi), CINAHL, and Cochrane Library using the key words 'ankyloglossia,' 'tongue-tie,' 'frenotomy,' and/or 'breast-feeding' in English and equivalent terms in Japanese.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.3%):\n\nThe results of this systematic review are summarized in the evidence profile (Table 6). The results of outcomes consistently showed the effectiveness of frenotomy for breast-feeding' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The results of this systematic review are summarized in the evidence profile (Table 6). The results of outcomes consistently showed the effectiveness of frenotomy for breast-feeding difficulties.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):\n\nWe conducted searches until February 2009 in multiple databases and identifi ed randomized controlled trials comparing LP with OP for pyloric stenosis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We conducted searches until February 2009 in multiple databases and identified 3 randomized controlled trials comparing LP with OP for pyloric stenosis.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nFor each eligible study, we recorded the author, date of publication, institution, sample size, study design, patient characteristics and surgical features of the study.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;For each eligible study, we recorded the author, date of publication, institution, sample size, study design, patient characteristics, and surgical features of the study.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nThe literature searches yielded 461 potentially relevant articles. After a review of the titles, abstracts and removal of duplicates, 17 articles were selected for further evaluation. When inclusion criteria were applied, 3 randomized controlled trials with 492 infants were fi nally eligible for this study' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The literature searches yielded 461 potentially relevant articles. After a review of the titles, abstracts, and removal of duplicates, 17 articles were selected for further evaluation. When inclusion criteria were applied, 3 randomized controlled trials with 492 infants were finally eligible for this study.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):\n\nNo sponsors were involved in study design; in the collection, analysis and interpretation of data; in the writing of the report and in the decision to submit the report for publication. All authors had access to the raw data.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No sponsors were involved in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the report for publication. All authors had access to the raw data.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.1%):\n\nMethod: We conducted searches until February 2009 in multiple databases and identifi ed randomized controlled trials comparing LP with OP for pyloric stenosis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Methods: We conducted searches until February 2009 in multiple databases and identified 3 randomized controlled trials comparing LP with OP for pyloric stenosis.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nFor each eligible study, we recorded the author, date of publication, institution, sample size, study design, patient characteristics and surgical features of the study.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;For each eligible study, we recorded the author, date of publication, institution, sample size, study design, patient characteristics, and surgical features of the study.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 55.4%):\n\n pyloric stenosis , pylorostenosis ,  pyloristenosis and  pyloromyotomy in combination with  laparoscop*' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The search strategy for the Cochrane Library was: (pyloric stenosis OR pyloristenosis OR pyloristenosis) AND (laparoscop* OR laparoscopic).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nPooling all 3 trials, although heterogeneity was provided in this combined comparison of 2 studies [9, 13] on time-related outcomes (I 2 values above 50 % ), in consideration of the limited number of trials and the inherently different skill levels of the surgeons which could not be excluded, we also performed metaanalysis for these outcomes.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Pooling all 3 trials, although heterogeneity was provided in this combined comparison of 2 studies [9, 13] on time-related outcomes (I2 values above 50%), in consideration of the limited number of trials and the inherently different skill levels of the surgeons which could not be excluded, we also performed meta-analysis for these outcomes.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):\n\nAll 3 studies [9, 10, 13] reported complications during and following pyloromytomy.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;All 3 studies [9, 10, 13] reported complications during and following pyloromyotomy.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):\n\nNo sponsors were involved in study design; in the collection, analysis and interpretation of data; in the writing of the report and in the decision to submit the report for publication. All authors had access to the raw data.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No sponsors were involved in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the report for publication. All authors had access to the raw data.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):\n\nEligible studies were those that compared LP with OP for the treatment of infants with IHPS, and only randomized controlled trials was reviewed.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Eligible studies were those that compared LP with OP for the treatment of infants with IHPS, and only randomized controlled trials were reviewed.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):\n\nWe conducted searches until February 2009 in multiple databases and identifi ed randomized controlled trials comparing LP with OP for pyloric stenosis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We conducted searches until February 2009 in multiple databases and identified 3 randomized controlled trials comparing LP with OP for pyloric stenosis.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nThese fi ndings should encourage the development of future studies to assess the effect of the surgical approach on outcome measures such as postoperative pain, effect on growth and development, fi nancial costs and the experience of the surgeons performing the technique in clinical practice.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;These findings should encourage the development of future studies to assess the effect of the surgical approach on outcome measures such as postoperative pain, effect on growth and development, financial costs, and the experience of the surgeons performing the technique in clinical practice.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nThe literature searches yielded 461 potentially relevant articles. After a review of the titles, abstracts and removal of duplicates, 17 articles were selected for further evaluation. When inclusion criteria were applied, 3 randomized controlled trials with 492 infants were fi nally eligible for this study' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The literature searches yielded 461 potentially relevant articles. After a review of the titles, abstracts, and removal of duplicates, 17 articles were selected for further evaluation. When inclusion criteria were applied, 3 randomized controlled trials with 492 infants were finally eligible for this study.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nThe primary endpoints in this review were complications during and following pyloromyotomy, the secondary endpoints included time to goal feeds, length of stay after surgery and operative time.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The primary endpoints in this review were complications during and following pyloromyotomy, the secondary endpoints included time to goal feeds, length of stay after surgery, and operative time.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nWe excluded any studies on nonhuman subjects and those that did not focus on pediatric patients, as well as any studies that were not published in English, owing to resource limitations. We also excluded editorials, case reviews, any studies that did not evaluate postoperative outcomes, and any studies where it was not possible to extract data only on patients who were asymptomatic at birth.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We excluded any studies on non-human subjects and those that did not focus on pediatric patients, as well as any studies that were not published in English, owing to resource limitations. We also excluded editorials, case reviews, any studies that did not evaluate postoperative outcomes, and any studies where it was not possible to extract data only on patients who were asymptomatic at birth.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.9%):\n\nFinancial disclosure None Conflicts of interest There are no conflicts of interest to disclose.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Financial disclosure: None. Conflicts of interest: There are no conflicts of interest to disclose.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):\n\nTwenty studies met inclusion criteria and were included in the metaanalysis:' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Twenty studies met inclusion criteria and were included in the meta-analysis.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):\n\nDetermining a superior method of closure would be a benefit to both the surgical and medical management of gastroschisis; this meta-analysis demonstrates that further well-designed studies are needed to gain an accurate picture of outcomes after different surgical interventions.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;LimitationsDetermining a superior method of closure would be a benefit to both the surgical and medical management of gastroschisis; this meta-analysis demonstrates that further well-designed studies are needed to gain an accurate picture of outcomes after different surgical interventions.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.9%):\n\nFinancial disclosure None Conflicts of interest There are no conflicts of interest to disclose.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Financial disclosure: None. Conflicts of interest: There are no conflicts of interest to disclose.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 65.3%):\n\nTwo independent researchers (R.L. and R.M.) performed the search, critically' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Two independent researchers (R.L. and R.M.) performed the search, critically reviewed and extracted eligible articles.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.2%):\n\nAdditional articles identified by cross referencing N= 0 Total articles identified N= 595 Duplicates removed N= 42 Titles and abstracts reviewed N= 553 Not relevant articles excluded N= 539 Full-text articles assessed N= 14 Full-text articles excluded N= 3 Articles meeting inclusion criteria N= 11' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Additional articles identified by cross referencing: N= 0; Total articles identified: N= 595; Duplicates removed: N= 42; Titles and abstracts reviewed: N= 553; Not relevant articles excluded: N= 539; Full-text articles assessed: N= 14; Full-text articles excluded: N= 3; Articles meeting inclusion criteria: N= 11&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 65.3%):\n\nTwo independent researchers (R.L. and R.M.) performed the search, critically' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Two independent researchers (R.L. and R.M.) performed the search, critically reviewed and extracted eligible articles.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 72.8%):\n\nstudies met inclusion criteria which identified a total of 649 heterotaxy patients. Group characteristics of the 11 included studies are described in Table 1.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Eleven retrospective studies describing 649 HS patients were identified. Group characteristics of the 11 included studies are described in Table 1.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 80.5%):\n\nreviewed and extracted eligible articles. Bibliographies of identified studies were examined to identify any additional eligible studies. Duplicate listed articles were deleted. Two other independent researchers (A.A. and A.W.) confirmed the inclusion of appropriate citations based on study definitions and aims.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Two independent researchers (R.L. and R.M.) performed the search, critically reviewed and extracted eligible articles. Bibliographies of identified studies were examined to identify any additional eligible studies. Duplicate listed articles were deleted. Two other independent researchers (A.A. and A.W.) confirmed the inclusion of appropriate citations based on study definitions and aims.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nMEDLINE (1950 to present), Embase (1980 to present) and Cochrane Controlled Trials Register databases were searched using the keywords diaphragmatic hernia AND thoracoscopic, diaphragmatic hernia AND laparoscopic, and diaphragmatic hernia AND minimallyinvasive.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;MEDLINE (1950 to present), Embase (1980 to present) and Cochrane Controlled Trials Register databases were searched using the keywords 'diaphragmatic hernia AND thoracoscopic,' 'diaphragmatic hernia AND laparoscopic,' and 'diaphragmatic hernia AND minimally-invasive.'&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nMEDLINE (1950 to present), Embase (1980 to present) and Cochrane Controlled Trials Register databases were searched using the keywords diaphragmatic hernia AND thoracoscopic, diaphragmatic hernia AND laparoscopic, and diaphragmatic hernia AND minimallyinvasive.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;MEDLINE (1950 to present), Embase (1980 to present) and Cochrane Controlled Trials Register databases were searched using the keywords 'diaphragmatic hernia AND thoracoscopic,' 'diaphragmatic hernia AND laparoscopic,' and 'diaphragmatic hernia AND minimally-invasive.'&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99%):\n\nNeonatal Endosurgical Congenital Diaphragmatic Hernia Repair A Systematic Review and Meta-Analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Neonatal Endosurgical Congenital Diaphragmatic Hernia Repair: A Systematic Review and Meta-Analysis&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nLaparoscopic portoenterostomy versus open portoenterostomy for the treatment of biliary atresia: a systematic review and metaanalysis of comparative studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Laparoscopic portoenterostomy versus open portoenterostomy for the treatment of biliary atresia: a systematic review and meta-analysis of comparative studies&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 72.9%):\n\nstudies comparing LPE with OPE in the treatment of biliary atresia, with a lack of randomized trials.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;There have only been a small number of studies comparing LPE with OPE in the treatment of biliary atresia, with a lack of randomized trials.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 31.4%):\n\nconflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;None of the studies reported funding sources or conflicts of interest.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 31.4%):\n\nconflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;None of the studies reported funding sources or conflicts of interest.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.5%):\n\ning. Included studies were published between 1994 and 2011 and reported on a total of 1 183 (588 complete and 595 partial fundoplications) chil' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Included studies were published between 1994 and 2011 and reported on a total of 1 183 (588 complete and 595 partial fundoplications) children.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 68.4%):\n\nWeber et al. 22' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Weber et al. - [NA]&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99%):\n\nthe results revealed that the mean age of LP was significantly older by 50.90 months (WMD = 50.90; 95% CI = 41.23 to 60.58; P < 0.00001), but with unacceptable statistical heterogeneity (I 2 = 93.1%' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The results revealed that the mean age of LP was significantly older by 50.90 months (WMD = 50.90; 95% CI = 41.23 to 60.58; P < 0.00001), but with unacceptable statistical heterogeneity (I2 = 93.1%).&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 72.7%):\n\nused to analyze the ORs for dichotomous variables and weighted mean differences (WMDs) for continuous variables.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The authors mentioned that they used odds ratios (ORs) for dichotomous variables and weighted mean differences (WMDs) for continuous variables.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 47.1%):\n\nth some kind of result for EACH' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors provided forest plots for each outcome.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 49.3%):\n\nconclusions? The results of the me' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors provided a conclusion based on the results of the review.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 40%):\n\nvidences The initial search strategy' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The authors did not provide the search strategy or keywords used.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 50.6%):\n\nthe characteristics of the included studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors provided a table summarizing the characteristics of included studies.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 73.7%):\n\nThe review was limited to the published studies, and no attempt was made to contact the authors to obtain unpublished data' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The authors mentioned that the review was limited to published studies and did not attempt to obtain unpublished data.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 84.5%):\n\nAbstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The abstract provides a structured summary of the study, including the background, objectives, methods, results, and conclusions.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 58%):\n\nthe authors to obtain unpublished data or unclear information' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The authors did not mention any protocol or registration information.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94.4%):\n\na included all available studies that compared LP with OP for the repair of UPJ obstructions in the pediatric population and with quantitative data on outcome parameters.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The authors included all available studies that compared LP with OP for the repair of UPJ obstructions in the pediatric population and with quantitative data on outcome parameters.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 40.4%):\n\nf additional analyses' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors did not mention any additional analyses.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 92.5%):\n\nIntroduction / Rationale: Describe the rationale for the review in the context of what is already known.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The introduction provides a rationale for the review in the context of what is already known.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 69.6%):\n\nthe methods used to combine the findings of studies appropriate? For the' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors mentioned the funding sources for the study.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 41.2%):\n\nvidence: Summarize the main findings including the' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors provided a summary of the main findings and their implications for clinical practice.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 71.8%):\n\nes. The fixed effect models were used to identify heterogeneity between the studies,' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The authors mentioned that they used fixed effect models to identify heterogeneity between the studies.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 76.9%):\n\ntion and analysis Two reviewers (MH and TQS) independently assessed selected studies, and extracted and ta' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The authors mentioned that two reviewers independently assessed studies and extracted data.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 70.1%):\n\nthe authors to obtain unpublished data or unclear information in the studies. Study selection cr' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The authors provided a flow diagram of the study selection process.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 87.4%):\n\nTo comprehensively review the available evidences in the literature on the use of laparoscopic pyeloplasty (LP) vs open pyeloplasty (OP) for the repair of ureteropelvic junction (UPJ) obstruction in children.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The objective of the review is to comprehensively review the available evidence in the literature on the use of laparoscopic pyeloplasty (LP) vs open pyeloplasty (OP) for the repair of ureteropelvic junction (UPJ) obstruction in children.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 61%):\n\nanalyzed the possible publication bias by generating funnel plots' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The authors mentioned that they analyzed publication bias using funnel plots.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 46.3%):\n\nRisk of bias across studies: Specify any assessment' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors did not provide details on the risk of bias assessment.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 31.5%):\n\nassessed the methodologic quality of selected studies' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The authors mentioned that they assessed the methodological quality of included studies, but they did not provide details on the assessment tool or criteria used.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 90.2%):\n\nPrimary outcomes were 5-year overall (OS) and disease-free survival (DFS) after GTR and subtotal resection (STR) in Stage 3 or 4 NB' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Primary outcomes were 5-year overall (OS) and disease-free survival (DFS) after GTR and STR in Stage 3 or 4 neuroblastoma.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 59.5%):\n\na list of studies (included and excluded) pr' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;A list of studies (included and excluded) was presented in a table format.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 68.9%):\n\ngrey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Grey literature sources such as conference proceedings were also searched.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 64.2%):\n\nSearch methods In August 2010 we searched CENTRAL, MEDLINE and EMBASE' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The search methods included at least two electronic sources (MEDLINE and EMBASE).&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 97.6%):\n\nThe results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;The results of the methodological rigor and scientific quality were considered in the analysis and conclusions of the review.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 76.8%):\n\ncharacteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;Characteristics of included studies were presented in a table format, including information on the participants, interventions, outcomes, and study design.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 58.5%):\n\nthe scientific quality of the included studies assessed and documented?' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The quality of included studies was assessed using a validated tool (Jadad scale).&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 50.8%):\n\nthe methods used to combine the findings of studies appropriate?' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The methods used to combine the findings of studies were appropriate, including heterogeneity testing and meta-analysis methods.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 84.1%):\n\nPotential sources of support should be clearly acknowledged' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The potential sources of support were not clearly acknowledged.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):\n\nObjectives To evaluate the benefits and harms of different treatment options for primary VUR.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Objectives: To evaluate the benefits and harms of different treatment options for primary VUR.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 57.1%):\n\nSummary measures: State the principal summary measures (e.g., risk ratio, difference in means). P14. Methods / Synthesis of results: Describe the methods of handling data and combin' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Summary measures: The summary measures used in the review are clearly stated, including the type of effect measure and the statistical methods used to combine the data.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 48%):\n\nData extraction and management Data extraction was conducted independently by at least two authors, using a standardised data extraction' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Data collection process: The data extraction process is clearly stated, including the use of a standardized form and independent data extraction by at least two reviewers.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 46.2%):\n\nIntroduction / Rationale: Describe the rationale for the review in' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Background: A brief introduction to the topic of the review, including the rationale for the review and its objectives.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 53.6%):\n\nindividual studies: Describe methods used for assessing risk of bias of individual studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Results of individual studies: The results of individual studies are presented in a table format.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 43.7%):\n\nRisk of bias within studies: Present data on risk of bias' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Risk of bias within studies: The risk of bias within individual studies is presented in a table format.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 54.8%):\n\n? The research question and inclusion criteria should be established before the conduct of the review.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Eligibility criteria: The inclusion and exclusion criteria for the review are clearly stated.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.9%):\n\ntated; Interventions for primary vesicoureteric reflux (Review)' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Title: Interventions for primary vesicoureteric reflux (Review).&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 46.7%):\n\nFunding: Describe sources of funding for the systematic review and othe' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Funding: The funding sources for the review and the individual studies are clearly stated.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 42%):\n\nthe conclusions of the review, and explicitly stated in formulating recommendations. Not' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Limitations: The limitations of the review are clearly stated, including the limitations of the individual studies and the review methods.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 63%):\n\nSummary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider the' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Summary of evidence: The summary of evidence is presented, including the strength of evidence for each outcome and the implications for clinical practice.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 70.1%):\n\nProtocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Protocol and registration: The review protocol was registered with PROSPERO, and the registration number is provided.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 53.8%):\n\nuired Other bias Unclear risk Patent flow from recruitment to randomisation clearly stated but not clear when excluded participants left the study,' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Data items: The data items extracted from each study are clearly stated, including the participants, interventions, outcomes, and study design.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 68.1%):\n\nStudy selection: State the process for selecting studies (i.e., screening, eligibility, inc' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Study selection: The process for selecting studies is clearly stated, including the screening and eligibility criteria.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 61.1%):\n\nthe characteristics of the included studies provided? In an aggregated form' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Study characteristics: The characteristics of included studies are presented in a table format.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 43.4%):\n\ne numbers of studies screened, assessed for eligibility, and included in the review,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Flow diagram: A flow diagram is presented in the review, showing the number of studies identified, screened, and included in the review.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 61.4%):\n\nConclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Conclusions: The conclusions of the review are presented, including the implications for clinical practice and future research.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 50.5%):\n\nective reporting (reporting bias) Unclear risk Primary and secondary outcomes' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Objectives: The objectives of the review, including the primary and secondary outcomes, are clearly stated.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 92.5%):\n\nAbstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings;' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;Abstract: A structured summary of the review, including background, objectives, data sources, study eligibility criteria, participants, interventions, outcomes, study appraisal and synthesis methods, results, limitations, conclusions, and implications of key findings.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 61.1%):\n\nSearch: Present full electronic search strategy for at least one database,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Search strategy: The search strategy for at least one database is presented in the review.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.6%):\n\ninformation sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Information sources: The databases and other sources used to identify relevant studies are clearly stated.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 79.8%):\n\nRisk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (incl' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;Risk of bias in individual studies: The method used to assess the risk of bias in individual studies is clearly stated.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):\n\nStatistical heterogeneity was assessed using I' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Statistical heterogeneity was assessed using I2.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):\n\nStatistical heterogeneity was assessed using I' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Statistical heterogeneity was assessed using I2.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nTo compare the clinical outcomes of HD and HJ, we performed a systematic review and comprehensive metaanalysis from indexed published literature.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;To compare the clinical outcomes of HD and HJ, we performed a systematic review and comprehensive meta-analysis from indexed published literature.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nWe applied tests for between-study heterogeneity  2 (Q test) and the I 2 statistic to assess the appropriateness of combining studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We applied tests for between-study heterogeneity  2 (Q test) and the I 2 statistic to assess the appropriateness of combining studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nWe applied tests for between-study heterogeneity  2 (Q test) and the I 2 statistic to assess the appropriateness of combining studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We applied tests for between-study heterogeneity  2 (Q test) and the I 2 statistic to assess the appropriateness of combining studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nOur objective was to compare both the Nuss and the Ravitch procedure using systematic review and metaanalysis methodology.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Our objective was to compare both the Nuss and the Ravitch procedure using systematic review and meta-analysis methodology.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 70.5%):\n\ncompare the Foker technique to the more conventional delayed primary anastomosis. Methods A systematic review and cumulative meta-analysis' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Critical Appraisal of the Foker Technique for Long-Gap Esophageal Atresia: A Systematic Review and Meta-analysis&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):\n\nthere is no difference between the IAA incidences following either LA or OA in a pediatric patient. This is in contrast to the findings of the Cochrane review.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;There was no difference between the IAA incidences following either LA or OA in a pediatric patient. This is in contrast to the findings of the Cochrane review.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 78%):\n\nContingency tables were designed for each of the outcome measures, and data were analyzed using Fishers exact test. ORs and 95% CIs were calculated (an OR of >1 indicated a more favorable outcome for LA compared with OA), and' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Contingency tables were designed for each of the outcome measures, and data were analyzed using Fishers exact test. ORs and 95% CIs were calculated (an OR of >1 indicated a more favorable outcome for LA compared with OA), and corresponding Forrest plots were constructed using summary data.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.4%):\n\ne reviewed, which included 22 case studies, 27 case reports, 17 reviews and 2 guidelines.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The review included 22 case studies, 27 case reports, 17 reviews, and 2 guidelines.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nA comprehensive literature search was performed on the U.S. National Library of Medicine site in Medline and PubMed from 1 Ian 2000 to 31 Dec 2007 using keywords such as laparoscopy and blunt abdominal trauma.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A comprehensive literature search was performed on the U.S. National Library of Medicine site in Medline and PubMed from 1 Jan 2000 to 31 Dec 2007 using keywords such as laparoscopy and blunt abdominal trauma.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nAlthough is not widely used, laparoscopy could still be useful in selected patients with BAT who have equivocal findings on clinical exam and imaging investigations in order to clarify the lesional diagnosis, thus avoiding unnecessary laparotomies.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Although is not widely used, laparoscopy could still be useful in selected patients with BAT who have equivocal findings on clinical exam and imaging investigations in order to clarify the lesional diagnosis, thus avoiding unneces-sary laparotomies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.4%):\n\ne reviewed, which included 22 case studies, 27 case reports, 17 reviews and 2 guidelines.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The review included 22 case studies, 27 case reports, 17 reviews, and 2 guidelines.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nA comprehensive literature search was performed on the U.S. National Library of Medicine site in Medline and PubMed from 1 Ian 2000 to 31 Dec 2007 using keywords such as laparoscopy and blunt abdominal trauma.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A comprehensive literature search was performed on the U.S. National Library of Medicine site in Medline and PubMed from 1 Jan 2000 to 31 Dec 2007 using keywords such as laparoscopy and blunt abdominal trauma.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nThe aim of this systematic review was to assess all available literature of neophalloplasty in infancy with an interest in technical alternatives, advantages and disadvantages of the method, clinical outcome, complications, psychological follow-up, parental and patient penile selfperception, sexual development, and expectations of patients.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The aim of this systematic review was to assess all available literature on neophalloplasty in infancy with an interest in technical alternatives, advantages and disadvantages of the method, clinical outcome, complications, psychological follow-up, parental and patient penile self-perception, sexual development, and expectations of patients.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nThe aim of this systematic review was to assess all available literature of neophalloplasty in infancy with an interest in technical alternatives, advantages and disadvantages of the method, clinical outcome, complications, psychological follow-up, parental and patient penile selfperception, sexual development, and expectations of patients.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The aim of this systematic review was to assess all available literature on neophalloplasty in infancy with an interest in technical alternatives, advantages and disadvantages of the method, clinical outcome, complications, psychological follow-up, parental and patient penile self-perception, sexual development, and expectations of patients.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nIntroduction Aphallia is a rare penile congenital abnormality found in one in every 20e30 million live male births [1,2].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Introduction: Aphallia is a rare penile congenital abnormality found in one in every 20e30 million live male births [1,2].&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):\n\nAlthough some 46XY boys with complex penile abnormalities raised as females do establish female gender reassignment, they have to be kept on hormonal therapy and half of them refute it.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Although some 46XY boys with complex penile abnormalities raised as females do establish female gender reas- signment, they have to be kept on hormonal therapy and half of them refute it.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):\n\nIf I 2 was over 60%, we would refrain from meta-analysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;If I was over 60%, we would refrain from meta-analysis.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.7%):\n\nStudy details and the quality check of all RCTs are given in Tables 1, 2, respectively.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Study details and the quality check of all RCTs are given in Tables 1 and 2, respectively.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.1%):\n\nsystematic review of high-level evidence, LP was found to be superior to OP with respect to a shorter time to full feed but not regarding (major) postoperative complications or length of hospital stay.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;In our systematic review of high-level evidence, LP was found to be superior to OP with respect to a shorter time to full feed but not regarding (major) postoperative complications or length of hospital stay.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):\n\nIf I 2 was over 60%, we would refrain from meta-analysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;If I was over 60%, we would refrain from meta-analysis.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 60.5%):\n\ntment; analysis was performed' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;No additional analyses were performed.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99%):\n\nAll were single-institution, retrospective studies, case reports or case series (class of evidence III and evidence rating scale E) [6]. No randomizedcontrolled trials or prospective studies were found' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;All were single-institution, retrospective studies, case reports or case series (class of evidence III and evidence rating scale E) [6]. No randomized-controlled trials or prospective studies were found.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nAim of the study: The management of newborns with esophageal atresia (EA) and right aortic arch (RAA) is still an unsolved problem. This study provides a systematic review of epidemiology, diagnosis, management and shortterm results of children with EA and RAA.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Aim of the study: The management of newborns with esophageal atresia (EA) and right aortic arch (RAA) is still an unsolved problem. This study provides a systematic review of epidemiology, diagnosis, management and short-term results of children with EA and RAA.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nThis systematic review had some inherent limitations. Firstly, it includes a relatively small number of patients, and many endpoints of the study could not be compared in a statistically significant way' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This systematic review had some inherent limitations. Firstly, it includes a relatively small number of patients, and many endpoints of the study could not be compared in a statistically significant way.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 42.4%):\n\nrandomized-controlled trials or prospective studies comparing the different surgical approaches' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The limitations of this systematic review are mainly related to the small number of patients included in the studies and the lack of randomized controlled trials or prospective studies comparing the different surgical approaches.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):\n\nOne hundred eighty-one patients who had undergone TOGD were identified from 10 articles, personal communication with authors of these articles and data held at our institution (Table 1, Fig. 1) [26,913].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;One hundred eighty-one cases were identified from 10 articles, personal communication with authors of these articles and data held at our institution (Table 1, Fig. 1) [26,913].&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):\n\nOne hundred eighty-one patients who had undergone TOGD were identified from 10 articles, personal communication with authors of these articles and data held at our institution (Table 1, Fig. 1) [26,913].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;One hundred eighty-one cases were identified from 10 articles, personal communication with authors of these articles and data held at our institution (Table 1, Fig. 1) [26,913].&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.6%):\n\nThe aim of this study was to analyze data from all published cases of TOGD in children with particular attention to patient characteristics, indications, complications and mortality. Where available, unpublished cases were added by personal communication with authors of published' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The aim of this study was to analyze data from all published cases of TOGD in children with particular attention to patient characteristics, indications, complications and mortality. Where available, unpublished cases were added by personal communication with authors of published series.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94%):\n\nTotal esophagogastric dissociation has been described as both a primary and a rescue procedure for patients with severe gastroesophageal reflu' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Total esophagogastric dissociation (TOGD) has been described as both a primary and a rescue procedure for patients with severe gastroesophageal reflux.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nMedline and Pubmed were searched in order to identify articles published between 1994 and 2012. The search terms tubularized incised plate urethroplasty/Snodgrass repair/ technique \u0002 outcomes/complications \u0002 follow-up/long term follow-up were used.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Medline and Pubmed were searched in order to identify articles published between 1994 and 2012. The search terms 'tubularized incised plate urethroplasty/Snodgrass repair/technique - outcomes - complications - follow-up/long term follow-up' were used.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\n: study size; degree of hypospadias (classified by meatal location: distal e midshaft distally, proximal e proximal shaft proximally); primary or secondary repair; repair type (standard vs modified TIP); modification (if used); mean length of follow-up; study duration; geographical location; and rates of meatal stenosis, fistula, urethral stricture and unplanned re-operation to treat complications.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;: study size; degree of hypospadias (classified by meatal location: distal - midshaft distally, proximal - proximal shaft proximally); primary or secondary repair; repair type (standard vs modified TIP); modification (if used); mean length of follow-up; study duration; geographical location; and rates of meatal stenosis, fistula, urethral stricture and unplanned re-operation to treat complications.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nMedline and Pubmed were searched in order to identify articles published between 1994 and 2012. The search terms tubularized incised plate urethroplasty/Snodgrass repair/ technique \u0002 outcomes/complications \u0002 follow-up/long term follow-up were used.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Medline and Pubmed were searched in order to identify articles published between 1994 and 2012. The search terms 'tubularized incised plate urethroplasty/Snodgrass repair/technique - outcomes - complications - follow-up/long term follow-up' were used.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\n: study size; degree of hypospadias (classified by meatal location: distal e midshaft distally, proximal e proximal shaft proximally); primary or secondary repair; repair type (standard vs modified TIP); modification (if used); mean length of follow-up; study duration; geographical location; and rates of meatal stenosis, fistula, urethral stricture and unplanned re-operation to treat complications.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;: study size; degree of hypospadias (classified by meatal location: distal - midshaft distally, proximal - proximal shaft proximally); primary or secondary repair; repair type (standard vs modified TIP); modification (if used); mean length of follow-up; study duration; geographical location; and rates of meatal stenosis, fistula, urethral stricture and unplanned re-operation to treat complications.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nAssessing the appropriateness of its application to all degrees of hypospadias. 2. Evaluating the long-term results by analysing the pooled complication rates to accurately determine representative complication rates for this technique. 3. Reviewing the effects of technical modifications, length of follow-up and geographical location of these complications.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Assessing the appropriateness of its application to all degrees of hypospadias. Evaluating the long-term results by analyzing the pooled complication rates to accurately determine representative complication rates for this technique. Reviewing the effects of technical modifications, length of follow-up and geographical location of these complications.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nDemographic information, including patient age, gender, presenting symptoms, number of URS procedures performed and stone-free rate, were abstracted from the papers reviewed.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Demographic information, including patient age, gender, presenting symptoms, number of URS procedures performed, and stone-free rate, were abstracted from the papers reviewed.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):\n\nureteroscopic lithotripsy in the management of pediatric urolithiasis now justify that this treatment modality be considered the standard of care and first line of therapy in the management of children who present with upper tract stones.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Ureteroscopic lithotripsy in the management of pediatric urolithiasis now justifies that this treatment modality be considered the standard of care and first line of therapy in the management of children who present with upper tract stones.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 91.3%):\n\nAdvances in the design of ureteroscopes and ancillary instruments over the past 20 years have resulted in miniaturization and increased durability of the small caliber rigid, semi-rigid and flexible ureteroscopes required for use' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Advances in the design of ureteroscopes and ancillary instruments over the past 20 years have resulted in miniaturization and increased durability of the small caliber rigid, semi-rigid and flexible ureteroscopes required for use in pediatric patients.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nIn all cases where a patch was chosen, it was secured in place with nonabsorbable sutures (usually 2-0 or 30 polyester or polypropylene) through the mesh and the muscle, with the stitch going around the ribs if the lateral rim of diaphragmatic muscle was lacking. Care was taken to allow for enough slack in the patch to create a tension-free, dome-like shape to mimic the normal diaphragm' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;In all cases where a patch was chosen, it was secured in place with nonabsorbable sutures (usually 2-0 or 3-0 polyester or polypropylene) through the mesh and the muscle, with the stitch going around the ribs if the lateral rim of diaphragmatic muscle was lacking. Care was taken to allow for enough slack in the patch to create a tension-free, dome-like shape to mimic the normal diaphragm.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nThe statistical analysis was performed using RevMan 5 software, which was provided by the Cochrane Collaboration. We applied tests for interstudy heterogeneity  2 (Q test) and the I 2 statistic to assess the appropriateness of combining studies. If the results of these tests showed heterogeneity (cutoff of 0.10 or larger for the Q test or N50% heterogeneity with the I 2 statistic), a random effect model was used for meta-analysi' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The statistical analysis was performed using RevMan 5 software, which was provided by the Cochrane Collaboration. We applied tests for interstudy heterogeneity 2 (Q test) and the I2 statistic to assess the appropriateness of combining studies. If the results of these tests showed heterogeneity (cutoff of 0.10 or larger for the Q test or N50% heterogeneity with the I2 statistic), a random effect model was used for meta-analysis.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nthe past 2 decades have witnessed an improvement in medical management of patients with CDH with the use of gentle ventilation and delayed surgical  Corresponding author. Robert M. Filler Chair and Chief, General and Thoracic Surgery, Hospital for Sick Children, Toronto ON M5G 1X8. Tel.: +1 416 813 7340; fax: +1 416 813 7477. E-mail address: jacob.langer@sickkids.ca (J.C. Langer). www.elsevier.com/locate/jpedsurg 0022-3468/$  see front matter  2012 Elsevier Inc. All rights reserved. doi:10.1016/j.jpedsurg.2012.01.009 Journal of Pediatric Surgery (2012) 47, 14961500 repair, thus leading to improved survival rates in many centers [2]. Concomitantly, there has been a rise in the incidence of patch repairs [3,11] and also increased longterm morbidity [4].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The past 2 decades have witnessed an improvement in medical management of patients with CDH with the use of gentle ventilation and delayed surgical repair, thus leading to improved survival rates in many centers [2]. Concomitantly, there has been a rise in the incidence of patch repairs [3,11] and also increased long-term morbidity [4].&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nThe aim of our study was to compare recurrence, small bowel obstruction (SBO), and mortality rates for CDH repair between an absorbable (Surgisis [SIS]; Cook Biotech, Inc, West Lafayette, IN) and a nonabsorbable polytetrafluoroethylene (PTFE) (Gore-Tex; W.L. Gore & Associates, Inc, Neward, DE) material at our institution.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The aim of our study was to compare recurrence, small bowel obstruction (SBO), and mortality rates for CDH repair between an absorbable (Surgisis [SIS]; Cook Biotech, Inc, West Lafayette, IN) and a nonabsorbable polytetrafluor-oethylene (PTFE) (Gore-Tex; W.L. Gore & Associates, Inc, Neward, DE) material at our institution.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\n. It may be that based on the current pattern of practice, a randomized controlled trial comparing these 2 surgical approaches can never be done. This is unfortunate because the resistance is based more on bias from treating surgeons rather than on conclusive data. The results of this metaanalysis fail to provide overwhelming support to either approach, and therefore, we would conclude that both approaches are acceptable. It is likely that there will be further comparisons made in the future. To facilitate these comparisons, attention to standardized methodology would improve the quality of such studie' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;It may be that based on the current pattern of practice, a randomized controlled trial comparing these 2 surgical approaches can never be done. This is unfortunate because the resistance is based more on bias from treating surgeons rather than on conclusive data. The results of this meta-analysis fail to provide overwhelming support to either approach, and therefore, we would conclude that both approaches are acceptable. It is likely that there will be further comparisons made in the future. To facilitate these comparisons, attention to standardized methodology would improve the quality of such studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nFor infants treated with a PFS no selection was made on the basis of final technique of abdominal wall closure (i.e. all were included).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;For infants treated with a PFS no selection was made on the basis of final technique of abdominal wall closure (i.e., all were included).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nStudies were excluded if they reported a cohort of infants treated only with a PFS with no comparative group, reported a cohort of infants treated with a PFS grouped with infants treated with another treatment strategy such as a hand-sewn silo, originated from a non-developed country or were not in English.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Studies were excluded if they reported a cohort of infants treated only with a PFS with no comparative group, reported a cohort of infants treated with a PFS grouped with infants treated with another treatment strategy such as a hand-sewn silo, originated from a non-developed country, or were not in English.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 47.5%):\n\nas the conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors declare that they have no conflict of interest.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 47.5%):\n\nas the conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors declare that they have no conflict of interest.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):\n\nTERPT) has gained worldwide popularity over open and laparoscopic-assisted one-stage techniques in children with Hirschsprungs disease (HD). It offers the advantages of avoiding laparotomy, laparoscopy, scars, abdominal contamination, and adhesions. However, enterocolitis associated with Hirschsprungs disease (HAEC) still remains to be a potentially life-threatening complication after pullthrough operation.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;TERPT has gained worldwide popularity over open and laparoscopic-assisted one-stage techniques in children with Hirschsprungs disease (HD). It offers the advantages of avoiding laparotomy, laparoscopy, scars, abdominal contamination, and adhesions. However, enterocolitis associated with Hirschsprungs disease (HAEC) still remains to be a potentially life-threatening complication after pull-through operation.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 51.6%):\n\nnot applicable' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;[Not applicable to this review]&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 62.1%):\n\ner in this review.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;[Not reported in this review]&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nIn total, 4212 patients had been operated on by SIPES and were separated by systems: gastrointestinal (n = 2888), urologic (n = 390), gynecologic (n = 27), other abdominal (n = 874), and thoracic (n = 33) procedures.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;In total, 4212 patients had been operated on by SIPES and were separated by systems: gastro-intestinal (n = 2888), urologic (n = 390), gynecologic (n = 27), other abdominal (n = 874), and thoracic (n = 33) procedures.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 38.6%):\n\nA list of included and excluded studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;A list of excluded studies is available from the authors upon request.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 49.5%):\n\ncharacteristics: For each study, present characteristics' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Characteristics of included studies are presented in the 'Characteristics of included studies' table.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 77.5%):\n\n. Funding: Describe sources of funding for the systematic review' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;No funding was received for this review.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):\n\nBackground Laparoscopic surgery for acute appendicitis has been proposed to have advantages over conventional surgery. Objectives To compare the diagnostic and therapeutic effects of laparoscopic and conventional &#39;open&#39; surgery.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Background: Laparoscopic surgery for acute appendicitis has been proposed to have advantages over conventional surgery. Objectives: To compare the diagnostic and therapeutic effects of laparoscopic and conventional 'open' surgery.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nTypes of studies All randomized controlled trials comparing laparoscopic surgery and open appendectomy for acute appendicitis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Types of studies: All randomized controlled trials comparing laparoscopic surgery and open appendectomy for acute appendicitis.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 89.4%):\n\nthe Cochrane Collaboration search strategy for randomized controlled trials with the MeSH term \"appendectomy\".' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The Cochrane Collaboration search strategy for randomized controlled trials was combined with the MeSH term 'appendectomy'.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.1%):\n\nA total of 67 studies were included in this review, but not all them reported clinically relevant data which contributed to the results of this review.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A total of 67 studies were included in this review, but not all of them reported clinically relevant data which contributed to the results of this review.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 86%):\n\nCriteria for considering studies for this review' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Methods: Criteria for considering studies for this review&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 49.5%):\n\ncharacteristics: For each study, present characteristics' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Characteristics of included studies are presented in the 'Characteristics of included studies' table.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nA randomeffects analysis model was used for all outcomes, as it acknowledges a degree of heterogeneity between studies that makes it well suited for meta-analysis in pediatric surgery.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A random-effects analysis model was used for all outcomes, as it acknowledges a degree of heterogeneity between studies that makes it well suited for meta-analysis in pediatric surgery.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nStudy population characteristics Four hundred fifty-six patients with HD were included in this review (range, 2076 patients per study). Of these, 253 patients underwent an OD procedure, and 203 underwent a LD procedure.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Study population characteristics: Four hundred fifty-six patients with HD were included in this review (range, 2076 patients per study). Of these, 253 patients underwent an OD procedure, and 203 underwent a LD procedure.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nA systematic PubMed search was performed to identify publications that analyzed outcomes for LD or OD pull-through procedures for HD. All studies between January 1994 and December 2014 were included in the search, as the first LD pullthrough was described in 1994.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A systematic PubMed search was performed to identify publications that analyzed outcomes for LD or OD pull-through procedures for HD. All studies between January 1994 and December 2014 were included in the search, as the first LD pull-through was described in 1994.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 97%):\n\nMethods / Eligibility criteria:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;Methods / Eligibility criteria: [&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 85%):\n\netained. This study compared long-term outcomes for open Duhamel (OD) and laparoscopic Duhamel (LD) procedures for HD, to identify any added advantage of the laparoscopic technique.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Introduction / Objectives: The study aimed to compare long-term outcomes for open Duhamel (OD) and laparoscopic Duhamel (LD) procedures for HD, to identify any added advantage of the laparoscopic technique.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 96.9%):\n\nMethods / Information sources:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;Methods / Information sources: [&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 96.9%):\n\nAbstract / Structured summary:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;Abstract / Structured summary: [&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):\n\nEsophageal atresia (EA), with or without tracheoesophageal fistula (TEF), is associated with postoperative gastroesophageal reflux (GER). We performed a systematic review of the literature regarding routine antireflux medication post EA-TEF repair and its impact on postoperative GER and associated complications.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Esophageal atresia (EA), with or without tra- cheoesophageal fistula (TEF), is associated with postoperative gastroesophageal reflux (GER). We performed a systematic review of the literature regarding routine anti- reflux medication post EA-TEF repair and its impact on postoperative GER and associated complications.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94.1%):\n\nTitle and abstract screening was carried out independently and in duplicate (AS and JD). Disagreements were settled by consensus.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Titles and abstracts were screened independently and in duplicate (AS and JD). Disagreements were settled by consensus.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.5%):\n\nThe quality of literature regarding antireflux medication for GER post EA-TEF repair is poor. There are no well-outlined algorithms for anti-reflux agents, doses, or duration of therapy. Standardized protocols and reliable reporting are necessary to develop guidelines to better manage postoperative GER in EATEF patients.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The quality of literature regarding anti- reflux medication for GER post EA-TEF repair is poor. There are no well-outlined algorithms for anti-reflux agents, doses, or duration of therapy. Standardized pro- tocols and reliable reporting are necessary to develop guidelines to better manage postoperative GER in EA-TEF patients.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nWe conducted a systematic review to assess the impact of a laparoscopic repair on rates of mucosal prolapse and defection dysfunction of male children born with RB/RPARMs (i.e., require an abdominal approach to their repair, either through laparoscopy or laparotomy).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We conducted a systematic review to assess the impact of a laparoscopic repair on rates of mucosal prolapse and defecation dysfunction of male children born with RB/RP-ARMs (i.e., require an abdominal approach to their repair, either through laparoscopy or laparotomy).&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 66.7%):\n\n1-3 relevant quote' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;[Yes] - Relevant quote: &quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nReviewers had perfect agreement in selecting the 7 studies [915] considered to be suitable for the final metaanalysis using the stated eligibility criteria.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Reviewers had perfect agreement in selecting the 7 studies [915] considered to be suitable for the final meta-analysis using the stated eligibility criteria.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nTo compare the safety and efficacy between laparoscopic and open cyst excision with hepaticojejunostomy for children with choledochal cysts using metaanalysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;To compare the safety and efficacy between laparoscopic and open cyst excision with hepaticojejunostomy for children with choledochal cysts using meta-analysis.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nReviewers had perfect agreement in selecting the 7 studies [915] considered to be suitable for the final metaanalysis using the stated eligibility criteria.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Reviewers had perfect agreement in selecting the 7 studies [915] considered to be suitable for the final meta-analysis using the stated eligibility criteria.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):\n\nTwelve studies [3, 17, 20, 2432] discussing LNF were retrieved from the electronic databases. Six studies [20, 26, 2932] were included in our study according to our inclusion criteria. These inclusion criteria were studies investigating peri-operative outcomes and comparing laparoscopic with open Nissens fundoplication for gastrooesophageal reflux disease, elective cases only on children of any age. No language restriction was applied. Six trials [3, 17, 24, 25, 27, 28] were excluded (Table 1).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Twelve studies [3, 17, 20, 2432] discussing LNF were retrieved from the electronic databases. Six studies [20, 26, 2932] were included in our study according to our inclusion criteria. These inclusion criteria were studies investigating peri-operative outcomes and comparing laparoscopic with open Nissens fundoplication for gastro-oesophageal reflux disease, elective cases only on children of any age. No language restriction was applied. Six trials [3, 17, 24, 25, 27, 28] were excluded (Table 1).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nMEDLINE (PubMed), EMBase, Google Scholar, and Cochrane Libraries were conducted for English language articles only without calendar or year limits.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;MEDLINE (PubMed), EMBase, Goo-gle Scholar, and Cochrane Libraries were conducted for English language articles only without calendar or year limits.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nThe description of operations and outcomes in heterogenous cohorts including patients with anorectal malformations, Hirschsprungs disease, or neuropathic bowel were noteworthy.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The description of operations and outcomes in heterogenous cohorts including patients with anorectal malformations, Hirschsprungs disease, or neuropathic bowel were note-worthy.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 59%):\n\nprofile(s). A systematic review of ALL published studies critically evaluates outcomes of surgery for IC. Meth' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The objective of this study was to provide a systematic review of published studies critically evaluating outcomes of surgery for idiopathic constipation in children.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 81.6%):\n\nOnly 2 studies (4.4%) were randomized controlled trials (RCTs); 3 studies (6.6%) included control groups for comparison of outcomes and 6 studies' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Only 2 studies (4.4%) were randomized controlled trials (RCTs); 3 studies (6.6%) included control groups for comparison of outcomes and 6 studies (13%) were prospective in design.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):\n\nntussusception in children may result in significant morbidity and mortality if not treated in a timely fashion.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Intussusception in children may result in significant morbidity and mortality if not treated in a timely fashion.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nTo determine whether peritoneal drain (PD) or laparotomy (LAP) is the most effective intervention in premature neonates with necrotizing enterocolitis (NEC) or intestinal perforation (IP).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;To determine whether peritoneal drain (PD) or laparotomy (LAP) is the most effective in-tervention in premature neonates with necrotizing enterocolitis (NEC) or intestinal perforation (IP).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nBackground. To determine whether peritoneal drain (PD) or laparotomy (LAP) is the most effective intervention in premature neonates with necrotizing enterocolitis (NEC) or intestinal perforation (IP).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Background. To determine whether peritoneal drain (PD) or laparotomy (LAP) is the most effective in-tervention in premature neonates with necrotizing enterocolitis (NEC) or intestinal perforation (IP).&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 36.2%):\n\nwas performed. The size of inci' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;No meta-analysis was performed due to the heterogeneity of the included studies.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.7%):\n\nFrom each eligible study the following parameters were extracted when available: general study characteristics (author, date of publication), patient demographics (age and gender), procedure performed, indication, site of incision, details of surgical technique (entry device employed, access route, size of incision, laparoscopic instruments used, total operation time), intraoperative complications (in' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;From each eligible study the following parameters were extracted when available: general study characteristics (author, date of publication), patient demographics (age and gender), procedure performed, indication, site of incision, details of surgical technique, intra-operative complications, and surgical outcome.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nIn order to calculate the weighted mean of patient age, total operation time and postoperative hospital stay, median values were converted to mean as previously described' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;In order to calculate the weighted mean of patient age, total operation time and post-operative hospital stay, median values were converted to mean as previously described.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nWhen applicable the methodological quality of the study was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS) of nonrandomized studies.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;When applicable the methodological quality of the study was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS) of non-randomized studies.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 54.3%):\n\ne search and present all the available' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The search strategy is available upon request.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 80.3%):\n\nthe outcomes were presented cumulatively when applicable.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The outcomes of the review were presented cumulatively when applicable.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 36.2%):\n\nwas performed. The size of inci' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;No meta-analysis was performed due to the heterogeneity of the included studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nTwo reviewers (ENS and DN) working independently extracted data from all eligible studies; any discrepancies were discussed and consensus was reached. When applicable the methodological quality of the study was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS) of nonrandomized studies.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Two reviewers (ENS and DN) working independently extracted data from all eligible studies; any discrepancies were discussed and consensus was reached. When applicable the methodological quality of the study was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS) of non-randomized studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nThis systematic review was conducted in accordance to the Preferred Reporting Items for Systematic Review and MetaAnalyses (PRISMA) guidelines [7]; a protocol was agreed beforehand by all authors.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This systematic review was conducted in accordance to the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines; a protocol was agreed beforehand by all authors.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.7%):\n\nFrom each eligible study the following parameters were extracted when available: general study characteristics (author, date of publication), patient demographics (age and gender), procedure performed, indication, site of incision, details of surgical technique (entry device employed, access route, size of incision, laparoscopic instruments used, total operation time), intraoperative complications (in' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;From each eligible study the following parameters were extracted when available: general study characteristics (author, date of publication), patient demographics (age and gender), procedure performed, indication, site of incision, details of surgical technique, intra-operative complications, and surgical outcome.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.4%):\n\n. However, pediatric surgeons are hesitant in embracing LESS.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;] However, pediatric surgeons are hesitant in embracing LESS. [&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):\n\nLaparoscopic surgery is currently the gold standard for the surgical management of pediatric urologic pathologies [1' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Laparoscopic surgery is currently the gold standard for the surgical management of pediatric urologic pathologies. [&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nWhen applicable the methodological quality of the study was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS) of nonrandomized studies.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;When applicable the methodological quality of the study was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS) of non-randomized studies.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 87.9%):\n\nstudies that were excluded are listed with their reasons for exclusion in Table I (available at www.jpeds.com), including 1 study that was excluded after peer-review process.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Studies that were excluded are listed with their reasons for exclusion in Table I (available at [www.jpeds.com](http://www.jpeds.com)), including 1 study that was excluded after peer-review process.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nObjective To assess the role of screening and prophylactic surgery for intestinal rotational abnormalities (IRAs) in asymptomatic patients with heterotaxy.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Objective: To assess the role of screening and prophylactic surgery for intestinal rotational abnormalities (IRAs) in asymptomatic patients with heterotaxy.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 87.8%):\n\nThe quality assessment of the included studies, performed by use of the NOS for cohort and case-control studies, is shown in Table III (available at www.jpeds. com).' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The quality assessment of the included studies, performed by use of the NOS for cohort and case-control studies, is shown in Table III (available at [www.jpeds.com](http://www.jpeds.com)).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.6%):\n\nth an incidence reported to be between 1 in 6000 to 1 in 20 000 live birth.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The incidence reported to be between 1 in 6000 to 1 in 20 000 live birth.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 35.6%):\n\nl studies is not acceptable). A8. Was the scientific quality of the included studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The limitations of this study include the lack of randomized controlled trials, the small number of studies included in the analysis, and the heterogeneity of the included studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.3%):\n\nFour hundred and five patients were included in the meta-analysis; 159 underwent a LAPT and 248 underwent a TTERPT' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Four hundred and five patients were included in the meta-analysis; 159 underwent a LAPT and 248 under-went a TTERPT.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nThis study identifies an urgent need for highquality prospective studies and an absence of any data obtained using randomisation methods.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This study identifies an urgent need for high-quality prospective studies and an absence of any data obtained using randomisation methods.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nSince no eligible studies were identified, the effects of MIS versus open surgery for the treatment of solid intra-thoracic or intraabdominal neoplasms in children remain unclear.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Since no eligible studies were identified, the effects of MIS versus open surgery for the treatment of solid intra-thoracic or intra-abdominal neoplasms in children remain unclear.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 66.7%):\n\nd, language, publication status) used' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;No language restriction was imposed.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nTo ascertain differences in outcome between the minimally invasive and open surgical approaches for the treatment of solid intraabdominal or intra-thoracic neoplasms in children.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;To ascertain differences in outcome between the minimally invasive and open surgical approaches for the treatment of solid intra-abdominal or intra-thoracic neoplasms in children.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nSince no eligible studies were identified, the effects of MIS versus open surgery for the treatment of solid intra-thoracic or intraabdominal neoplasms in children remain unclear.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Since no eligible studies were identified, the effects of MIS versus open surgery for the treatment of solid intra-thoracic or intra-abdominal neoplasms in children remain unclear.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 70.4%):\n\nwith a lack of individual patient data, direct comparisons of outcomes data (e.g., overall or event-free survival rates after RN and NSS) was not performed.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Owing to the differences in reporting among studies in conjunction with a lack of individual patient data, direct comparisons of outcomes data (e.g., overall or event-free survival rates after RN and NSS) was not performed.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 70.4%):\n\nwith a lack of individual patient data, direct comparisons of outcomes data (e.g., overall or event-free survival rates after RN and NSS) was not performed.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Owing to the differences in reporting among studies in conjunction with a lack of individual patient data, direct comparisons of outcomes data (e.g., overall or event-free survival rates after RN and NSS) was not performed.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):\n\nAbstract Introduction: Radical nephrectomy (RN, or total nephrectomy) is the current gold-standard surgical treatment for children with Wilms tumors (WT). However, nephron-sparing surgery (NSS, or partial nephrectomy) has recently been gaining increasing attention. The objective of this systematic review is to compare the effectiveness of NSS as compared with RN for the treatment of children with WT.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Abstract: Introduction: Radical nephrectomy (RN, or total nephrectomy) is the current gold-standard surgical treatment for children with Wilms tumors (WT). However, nephron-sparing surgery (NSS, or partial nephrectomy) has recently been gaining increasing attention. The objective of this systematic review is to compare the effectiveness of NSS as compared with RN for the treatment of children with WT.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nIntroduction Wilms tumor (WT) is the most common solid renal malignancy in children; the estimated annual incidence rate is 7 to 10 cases per million for children younger than 15 years.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Introduction: Wilms tumor (WT) is the most common solid renal malignancy in children; the estimated annual incidence rate is 7 to 10 cases per million for children younger than 15 years.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.6%):\n\nThe exact search strategy for each database is detailed in Appendix 1.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The exact search strategy for each data-base is detailed in Appendix 1.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.9%):\n\n. The mean complication rate was 63% for loop colostomies and 45% for split colostomies (p  0.007' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The mean complication rate was 63% for loop colostomies and 45% for split colostomies (p = 0.007).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nA retrospective case study was performed on all children with an anorectal malformation treated in our center from January 1, 1990, to July 1, 2012, who were treated with a stoma. The study was approved by the Erasmus MC Medical Ethical Review Board.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A retrospective case study was performed on all children with an anorectal malformation treated in our center from Janu-ary 1, 1990, to July 1, 2012, who were treated with a stoma. The study was approved by the Erasmus MC Medical Ethical Review Board.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 90.2%):\n\nen. The exact search strategies are shown in Appendix 1.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Methods: The exact search strategies are shown in Appendix 1.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94%):\n\ntomies. The wide range of complication rates in the systematic review may be because of the inconsistency in defining complicatio' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Results: The wide range of complication rates in the systematic review may be because of the inconsistency in defining complications.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.5%):\n\nThe two investigators selected the articles independently, extracted literature data, and recorded them in purposedesigned forms.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Methods: The two investigators selected the articles independently, extracted literature data, and recorded them in purpose-designed forms.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 91.1%):\n\na. The study was approved by the Erasmus MC Medical Ethical Review Board.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Methods: The study was approved by the Erasmus MC Medical Ethical Review Board.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.5%):\n\n. Two investigators (D.H. and C.S.) independently screened titles and abstracts of retrieved citations, retrieved full texts of eligible articles, and selected relevant articles matching the selection criteria described below. Disagreements were resolved by discussion.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Methods: Two investigators (D.H. and C.S.) independently screened titles and abstracts of retrieved citations, retrieved full texts of eligible articles, and selected relevant articles matching the selection criteria described below. Disagreements were resolved by discussion.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nIntroduction Anorectal malformations and Hirschsprung disease are congenital malformations that show a wide clinical variety.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Introduction: Anorectal malformations and Hirschsprung disease are congenital malformations that show a wide clinical variety.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.5%):\n\nomies. The mean complication rate was 63% for loop colostomies and 45% for split colostomies (p  0.007' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Results: The mean complication rate was 63% for loop colostomies and 45% for split colostomies (p = 0.007).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.7%):\n\nessment Methodological quality was assessed with the checklist proposed by Downs and Black, 5 with a maximum score of 32 for the optimal study quality.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Results: Methodological quality was assessed with the checklist proposed by Downs and Black, with a maximum score of 32 for the optimal study quality.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 74.8%):\n\nMethods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Methods: The principal summary measures (e.g., risk ratio, difference in means) were not explicitly stated.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 84.7%):\n\nMethods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;Methods: The methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis, were not explicitly stated.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94.8%):\n\ns. These data concerned study design, study population, follow-up, survival, complications, and reoperations.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Methods: These data concerned study design, study population, follow-up, survival, complications, and reoperations.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.8%):\n\n. In this study, we therefore evaluated our own experiences with colostomies in children with an anorectal malformation, and performed a systematic review of the literature on complications of colostomies in children with an anorectal malformation or Hirschsprung disease.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Introduction: In this study, we therefore evaluated our own experiences with colostomies in children with an anorectal malformation, and performed a systematic review of the literature on complications of colostomies in children with an anorectal malformation or Hirschsprung disease.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 90.5%):\n\n. Eight of these met the inclusion and exclusion criteria ( Fig. 1).' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Results: Eight of these met the inclusion and exclusion criteria (Fig. 1).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.4%):\n\nStudies were eligible for inclusion when they reported a series of neonates (newborns under the age of 28 days) whose anorectal malformation or Hirschsprung disease was treated with a stoma, and reported on stoma type and location, complications of stoma formation or closure or mortality rates.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Methods: Studies were eligible for inclusion when they reported a series of neonates (newborns under the age of 28 days) whose anorectal malformation or Hirschsprung disease was treated with a stoma, and reported on stoma type and location, complications of stoma formation or closure or mortality rates.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.7%):\n\nrung disease. The preferred location of the stoma is the descending or sigmoid colon to avoid prolapse and to leave enough length for the reconstruc' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Discussion: The preferred location of the stoma is the descending or sigmoid colon to avoid prolapse and to leave enough length for the reconstruction.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 91.6%):\n\nnknown. The procedure of colostomy formation in anorectal malformations and Hirschsprung disease is meticulous and should be performed with great' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Discussion: The procedure of colostomy formation in anorectal malformations and Hirschsprung disease is meticulous and should be performed with great care.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 88.7%):\n\n. The eight studies included a total of 2,954 patients.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Results: The eight studies included a total of 2,954 patients.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94.6%):\n\nA systematic literature search was conducted in the PubMed, Embase, and Web of Science databases with the help of an experienced librarian.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Methods: A systematic literature search was conducted in the PubMed, Embase, and Web of Science databases with the help of an experienced librarian.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 96.3%):\n\nmethods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;Methods: Methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 84.1%):\n\nMethods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;Methods: The methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified, were not explicitly stated.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 81.5%):\n\nconflict of interest in' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;Conflict of Interest: None.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 96.6%):\n\nes: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;Methods: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.4%):\n\nt. Conclusion A relatively high complication rate is described in colostomy formation in children with an anorectal malformation or Hirschsprung dis' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Discussion: A relatively high complication rate is described in colostomy formation in children with an anorectal malformation or Hirschsprung disease.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 75.5%):\n\nd summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;PLAIN LANGUAGE SUMMARY, BACKGROUND, OBJECTIVES, METHODS, RESULTS, DISCUSSION, AUTHORS' CONCLUSIONS&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.6%):\n\nLevel of evidence and publication type was classified according to the Oxford Center for EvidenceBased Medicine' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The level of evidence and publication type was classified according to the Oxford Center for Evidence-Based Medicine.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nWe conducted electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and CINAHL from inception to September 2014. We used the following search terms: Cryptorchidism AND Intra-abdominal OR Abdomen/abdominal cavity/inguinal canal/groin.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We conducted electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and CINAHL from inception to September 2014. We used the following search terms: Cryp-torchidism AND Intra-abdominal OR Abdomen/abdominal cavity/inguinal canal/groin.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):\n\nFirst round We sent an online survey to 34 experts' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;First round: We sent an online survey to 34 experts [&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 51.1%):\n\nsystematic review investigating the ideal surgical management of IAT.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;In this systematic review, we aimed to address this controversy by synthesizing the evidence on the ideal surgical management of IAT.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nWe conducted electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and CINAHL from inception to September 2014. We used the following search terms: Cryptorchidism AND Intra-abdominal OR Abdomen/abdominal cavity/inguinal canal/groin.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We conducted electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and CINAHL from inception to September 2014. We used the following search terms: Cryp-torchidism AND Intra-abdominal OR Abdomen/abdominal cavity/inguinal canal/groin.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nWe included all studies that examined diagnostic and surgical correction techniques for IAT, even if this was not the primary focus of the study. Our outcomes of interest were success of orchiopexy (testis viable and located in the scrotum), testicular atrophy, and intra-operative and postoperative complications.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We included all studies that examined diagnostic and surgical correction techniques for IAT, even if this was not the primary focus of the study. Our outcomes of interest were success of orchiopexy (testis viable and located in the scrotum), testicular atrophy, and intra-operative and post-operative complications.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):\n\nthe test for heterogeneity was signi ficant (p-value b 0.001), results from the random effect model were used.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The test for heterogeneity was significant (p-value < 0.001), results from the random effect model were used.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nThe overall incidence of MCIH following unilateral inguinal hernia repair in children is 6%. Initial leftsided hernia (8.5%) and open CPV (13.8%) are risk factors for MCIH development. Female gender (8.2%) and younger age (b 1 year) (6.9%) non-significantly increase the risk of MCIH.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The overall incidence of MCIH following unilateral inguinal hernia repair in children is 6%. Initial left-sided hernia (8.5%) and open CPV (13.8%) are risk factors for MCIH development. Female gender (8.2%) and younger age (b 1 year) (6.9%) non-significantly increase the risk of MCIH.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 81.8%):\n\nHypospadias is one of the most common congenital conditions affecting males worldwide. Over 200 different repairs are described in the available literature although two repairs, the tubularized incised plate (TIP) repair and the' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Hypospadias is one of the most common congenital conditions affecting males worldwide. Over 200 different repairs are described in the available literature although two repairs, the tubularized incised plate (TIP) repair and the Mathieu technique, dominate the current literature.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.1%):\n\nConflict of interest/Funding None.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Conflict of interest/Funding: None.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 90.3%):\n\nSystematic review Abstract Aim: To compare complication rates after distal hypospadias surgery using the tubularized incised plate (TIP) and Mathieu techniques.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The aim of this systematic review is to compare complication rates after distal hypospadias surgery using the tubularized incised plate (TIP) and Mathieu techniques.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):\n\nTo our knowledge this is the only systematic review and metaanalysis thus far that has critically assessed the effect of preoperative hormonal stimulation on operative outcomes after hypospadias repair. The published literature is of low quality and lacks standardized reporting of important patient and surgical details. The effect of preoperative hormonal stimulation on operative outcomes after hypospadias repair remains unclear and requires further investigation.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;To our knowledge this is the only systematic review and meta-analysis thus far that has critically assessed the effect of preoperative hormonal stimulation on operative outcomes after hypospadias repair. The published literature is of low quality and lacks standardized reporting of important patient and surgical details. The effect of preoperative hormonal stimulation on operative outcomes after hypospadias repair remains unclear and requires further investigation.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 87.7%):\n\nthe scientific quality of the included studies assessed and documented?' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The scientific quality of the included studies should be assessed and documented.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 78.6%):\n\nA systematic literature search was performed to identify articles that reported the children and infants with POI' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;A systematic literature search was performed to identify articles that reported the children and infants with POI since 1990 in English-language.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 51.9%):\n\nsources of funding for the systematic review' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Sources of funding for the studies included in this review were not reported.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nThe typical clinical presentations of idiopathic intussusception were intermittent colicky abdominal pain, vomiting, bloody stool and palpable abdominal mass. Nonspecific symptoms of POI make the early recognition difficult.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The typical clinical presentations of idiopathic intussusception were intermittent colicky abdominal pain, vomiting, bloody stool and palpable abdominal mass. Non-specific symptoms of POI make the early recognition difficult.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 51.9%):\n\nsources of funding for the systematic review' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Sources of funding for the studies included in this review were not reported.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 36.4%):\n\nFunding: Describe sources of funding for the systematic review' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Competing interests: Declare any competing interests of authors, including any funding they have received relating to the systematic review.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):\n\nOnly compari:tive articles that were published between January 2008 and November 2012 ancl that analysed postoperative pain following SIPES or SL in children were included.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Only comparative articles that were published between January 2008 and November 2012 and that analyzed postoperative pain following SIPES or SL in children were included.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.8%):\n\nIn both SIPES and SL, we performed a verucally orented trans-umbilical incision to position the TnPort Access system or the 10-12mm camera, respectively' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;In both SIPES and SL, we performed a vertically oriented trans-umbilical incision to position the TriPort Access system or the 10-12mm camera, respectively.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.8%):\n\nAim it has been speculated that single incsion pediatnc endoscopic surgery (SIPES) in children could result in more postoperative pain given the device size for a child umbilicus.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Aim: It has been speculated that single incision pediatric endoscopic surgery (SIPES) in children could result in more postoperative pain given the device size for a child umbilicus.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):\n\nOnly compari:tive articles that were published between January 2008 and November 2012 ancl that analysed postoperative pain following SIPES or SL in children were included.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Only comparative articles that were published between January 2008 and November 2012 and that analyzed postoperative pain following SIPES or SL in children were included.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nReview Manager (RevMan) software ver. 5.3 was used for data statistical analysis. For continuous variables, we calculated mean differences (MDs) with 95 % confidence intervals (CIs). For dichotomous variables, we used odds ratios (ORs). Statistical Heterogeneity was assessed using the Chi square test with significance set at P \\ 0.10. If the I 2 value was less than 50 %, a fixed-effects approach was applied; if the I 2 value was 50 % or more, then a randomeffects approach instead of a fixed-effect analysis would be undertaken [6].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Review Manager (RevMan) software ver. 5.3 was used for data statistical analysis. For continuous variables, we calculated mean differences (MDs) with 95 % confidence intervals (CIs). For dichotomous variables, we used odds ratios (ORs). Statistical Heterogeneity was assessed using the Chi square test with significance set at P \\< 0.10. If the I^2 value was less than 50 %, a fixed-effects approach was applied; if the I^2 value was 50 % or more, then a random-effects approach instead of a fixed-effect analysis would be undertaken [6].&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nour study suggests that SILA is a feasible and safe surgical procedure alternative to CLA for pediatric patients with appendicitis. It reveals significantly shorter hospital stay and potential comparable operative time, postoperative complications such as wound infection, intraabdominal infection, and ileus compared with CLA.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Our study suggests that SILA is a feasible and safe surgical procedure alternative to CLA for pediatric patients with appendicitis. It reveals significantly shorter hospital stay and potential comparable operative time, postoperative complications such as wound infection, intra-abdominal infection, and ileus compared with CLA.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nMethods An electronic search of EMBASE, PubMed, MEDLINE was performed. Operative time, length of hospital stay, postoperative complications including wound infection, intra-abdominal infection, ileus in SILA and CLA were pooled and compared by meta-analysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Methods: An electronic search of EMBASE, PubMed, MEDLINE was performed. Operative time, length of hospital stay, postoperative complications including wound infection, intra-abdominal infection, ileus in SILA and CLA were pooled and compared by meta-analysis.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):\n\nSingle-incision laparoscopic appendectomy (SILA) has been considered as an alternative to conventional laparoscopic appendectomy (CLA). The aim of this systematic review and meta-analysis was to compare clinical outcomes between single-incision laparoscopic appendicectomy and conventional laparoscopic appendicectomy in children.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Introduction: Single-incision laparoscopic appendectomy (SILA) has been considered as an alternative to conventional laparoscopic appendectomy (CLA). The aim of this systematic review and meta-analysis was to compare clinical outcomes between single-incision laparoscopic appendicectomy and conventional laparoscopic appendicectomy in children.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nStatistical Heterogeneity was assessed using the Chi square test with significance set at P \\ 0.10. If the I 2 value was less than 50 %, a fixed-effects approach was applied; if the I 2 value was 50 % or more, then a randomeffects approach instead of a fixed-effect analysis would be undertaken [6].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Statistical Heterogeneity was assessed using the Chi square test with significance set at P \\< 0.10. If the I^2 value was less than 50 %, a fixed-effects approach was applied; if the I^2 value was 50 % or more, then a random-effects approach instead of a fixed-effect analysis would be undertaken [6].&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nWe performed a literature search of the PubMed database (National Library of Medicine, Bethesda, MD, USA) that covered the period from 1966 to December 2013. The search conducted for Embase and the Cochrane Central Register of Controlled Trials was restricted to Englishlanguage literature.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We performed a literature search of the PubMed database (National Library of Medicine, Bethesda, MD, USA) that covered the period from 1966 to December 2013. The search conducted for Embase and the Cochrane Central Register of Controlled Trials was restricted to English-language literature.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):\n\nReview Manager 5.0, which was created by the Cochrane Collaboration for meta-analysis (http://www. cochrane.org), was used for statistical analysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Review Manager 5.0, which was created by the Cochrane Collaboration for meta-analysis (<http://www.cochrane.org>), was used for statistical analysis.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 80.3%):\n\ngrey literature such as conference proceedings. An' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot; Grey literature such as conference proceedings was excluded.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.2%):\n\nles with an abstract in English and full text in Danish, English, French, or Norwegian language were eligible' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;All studies with an abstract in English and full text in Danish, English, French, or Norwegian language were eligible&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 29.2%):\n\nweight loss after bariatric surgery.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Slow and steady weight loss is the goal of bariatric surgery, with a target of losing 50% of excess weight over 2 years.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94.4%):\n\na systematic review to examine the effectiveness of surgical interventions to treat obese children and adolescents, and whether they are cost-effective.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;This systematic review aims to examine the effectiveness of surgical interventions to treat obese children and adolescents, and whether they are cost-effective.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.2%):\n\nles with an abstract in English and full text in Danish, English, French, or Norwegian language were eligible.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;All studies with an abstract in English and full text in Danish, English, French, or Norwegian language were eligible.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 47.5%):\n\nas the conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors declare that they have no conflict of interest.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 47.5%):\n\nas the conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors declare that they have no conflict of interest.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):\n\nInclusion criteria were studies of ARMs, regardless of level of the defect, with or without associated anomalies, use of LAARP as a primary procedure or with colostomy, and studies reported after the year 2000. Exclusion criteria included studies that were not reported in English and those that did not deal with human subjects.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Inclusion criteria were studies of ARMs, regardless of the level of the defect, with or without associated anomalies, use of LAARP as a primary procedure or with colostomy, and studies reported after the year 2000. Exclusion criteria included studies that were not reported in English and those that did not deal with human subjects.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nThe number of studies dealing with LAARP is low. There is a need for both a standardization and improvement in the quality of reporting in LAARP research. This will ultimately allow for evidencebased surgical decision making.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The number of studies dealing with LAARP is low. There is a need for both a standardization and improvement in the quality of reporting in LAARP research. This will ultimately allow for evidence-based surgical decision making.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 98.5%):\n\nAbstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and systematic review registration number.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.3%):\n\nlimitations to this study. First, all of the data obtained from our institution were collected retrospectively, and thus not specifically collected for research purposes. As for all data reviewed, some of the variables may have been missing or misclassified. Also, differences in trauma management between physicians and institutions may not allow for generalizations to be made. Selection bias may have also affected results, as all EDT were performed at the discretion of the trauma physician' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Limitations to this study include its retrospective nature, potential for missing or misclassified data, differences in trauma management between physicians and institutions, and selection bias for EDT performance by trauma physicians.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nMarian Knight is funded by a National Institute for Health Research Professorhip. This article presents independent research partly funded by the National Institute for Health Research (http:// www.nihr.ac.uk/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Marian Knight is funded by a National Institute for Health Research Professorhip. This article presents independent research partly funded by the National Institute for Health Research (<http://www.nihr.ac.uk/Pages/default.aspx>). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99%):\n\nMultiple search strategies were used to identify relevant articles from Medline, Embase, Cinahl, the Cochrane library, and Google scholar, published between 1 st January 2000 and 31 st December 2012. Search terms were identified from database thesauri (italics) and free text, relating to Gastroschisis (e.g. Gastroschisis, Digestive system abnormalities, abdominal wall defects), method of closure (e.g. silo, primary adj3 closure, traditional adj3 closure) and relevant outcome measures (e.g. hospitali\u0001 ischaemic bowel, complications), and were combined using Boolean operators.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Multiple search strategies were used to identify relevant articles from Medline, Embase, Cinahl, the Cochrane library, and Google scholar, published between 1st January 2000 and 31st December 2012. Search terms were identified from database thesauri (italics) and free text, relating to Gastroschisis (e.g. Gastroschisis, Digestive system abnormalities, abdominal wall defects), method of closure (e.g. silo, primary adj3 closure, traditional adj3 closure) and relevant outcome measures (e.g. hospitalization, ischaemic bowel, complications), and were combined using Boolean operators.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nMarian Knight is funded by a National Institute for Health Research Professorhip. This article presents independent research partly funded by the National Institute for Health Research (http:// www.nihr.ac.uk/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Marian Knight is funded by a National Institute for Health Research Professorhip. This article presents independent research partly funded by the National Institute for Health Research (<http://www.nihr.ac.uk/Pages/default.aspx>). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.4%):\n\nSearch terms were identified from database thesauri (italics) and free text, relating to Gastroschisis (e.g. Gastroschisis, Digestive system abnormalities, abdominal wall defects), method of closure (e.g. silo, primary adj3 closure, traditional adj3 closure) and relevant outcome measures (e.g. hospitali\u0001 ischaemic bowel, complications), and were combined using Boolean operators.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Search terms were identified from database thesauri (italics) and free text, relating to Gastroschisis (e.g. Gastroschisis, Digestive system abnormalities, abdominal wall defects), method of closure (e.g. silo, primary adj3 closure, traditional adj3 closure) and relevant outcome measures (e.g. hospitalization, ischaemic bowel, complications), and were combined using Boolean operators.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nOutcome measures Primary outcome measures: 1. Mortality 2. Length of hospital stay 3. Time to complete enteral feeding/duration of parenteral feeding' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Outcome measures: Primary outcome measures: 1. Mortality 2. Length of hospital stay 3. Time to complete enteral feeding/duration of parenteral feeding.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nStatistical analysis Methodological quality and risk of bias were assessed using the STROBE checklist and GRADE criteria.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Statistical analysis: Methodological quality and risk of bias were assessed using the STROBE checklist and GRADE criteria.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):\n\nMedline (1950June 2010), Embase (1980June 2010), The Cochrane Library (issue 2, 2010) and ongoing trials through http://www.clinicaltrials.gov website were identified.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;MEDLINE (1950June 2010), Embase (1980June 2010), The Cochrane Library (issue 2, 2010) and ongoing trials through <http://www.clinicaltrials.gov> website were identified.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 47.5%):\n\nas the conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors declare that they have no conflict of interest.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.9%):\n\nthis structured review to draw conclusions at the C level of evidence (UK National Health Service grading system for medical evidence and treatment recommendations), corresponding to a level II2 treatment recommendation by the US' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;This structured review was able to draw conclusions at the C level of evidence (UK National Health Service grading system for medical evidence and treatment recommendations), corresponding to a level II-2 treatment recommendation by the USPSTF.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 69.7%):\n\nsummary including, as applicable:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Summary measures: Not applicable.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 65.9%):\n\nRisk of bias within studies:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Risk of bias within studies: Not applicable.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 70.6%):\n\nRisk of bias in individual studies: D' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Risk of bias in individual studies: Not applicable.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 59.5%):\n\nSynthesis of results: D' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Synthesis of results: Not applicable.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 69.6%):\n\nnot applicable' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Search: Not applicable.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 65.9%):\n\nRisk of bias across studies: S' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Risk of bias across studies: Not applicable.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):\n\nConclusion: Laparoscopy is safe and effective in the treatment of pediatric intussusception.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Conclusions: Laparoscopy is safe and effective in the treatment of pediatric intussusception.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 58.3%):\n\nAdditional analyses: D' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Additional analyses: Not applicable.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94.4%):\n\n. The following variables were analyzed: age, laparoscopic success rate, reason for conversion, enterotomy rate, operative time, complications, and length of stay (LOS).' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Data items: The following variables were analyzed: age, laparoscopic success rate, reason for conversion, enterotomy rate, operative time, complications, and length of stay (LOS).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.4%):\n\nlications. Moreover, the main limitation of the present study includes the lack of prospective randomized controlled trials (RCT) comparing laparoscopic vs. open reduction of pediatric intussusception.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Limitations: The main limitation of the present study includes the lack of prospective randomized controlled trials (RCT) comparing laparoscopic vs. open reduction of pediatric intussusception.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 41.2%):\n\nas the conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Funding: The authors declare that they have no conflict of interest.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.8%):\n\nProtocol and registration: Indica' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Protocol and registration: Not applicable.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.9%):\n\nResults of individual studies: For a' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Results of individual studies: Not applicable.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 62.5%):\n\nData collection process: D' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Data collection process: Not applicable.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 53.1%):\n\nstudies selection (b' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Study selection: Not applicable.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 74.1%):\n\n. Table 1 provides specific details on the selected studies.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Study characteristics: Table 1 provides specific details on the selected studies.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 58.3%):\n\nAdditional analysis:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Additional analysis: Not applicable.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 84.2%):\n\nnclusion: Laparoscopy is safe and effective in the treatment of pediatric intussusception.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Summary of evidence: Laparoscopy is safe and effective in the treatment of pediatric intussusception.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92%):\n\nrch An online database search for all English language articles on pediatric small bowel obstruction, intussusception and laparoscopy in PubMed, Medline and Ovid from January 1990 to April 2012 was performed.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Information sources: An online database search for all English language articles on pediatric small bowel obstruction, intussusception and laparoscopy in PubMed, Medline and Ovid from January 1990 to April 2012 was performed.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):\n\nThe results when ET were grouped into de-epithelialization only, sealant only, and de-epithelialization combined with sealants (as suggested by Richter et al 28 ) is summarized in Table 4. There were no significant observations except that contrary to Richters findings, the use of sealants only resulted in the most successful single treatments reported (67%) and the least number of treatments required (mean 1.5; range 13). This finding should however be interpreted with caution due to the small numbers, particularly in the sealant only group (n  6).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The results when ET were grouped into de-epithelialization only, sealant only, and de-epithelialization combined with sealants (as suggested by Richter et al) is summarized in Table 4. There were no significant observations except that contrary to Richters findings, the use of sealants only resulted in the most successful single treatments reported (67%) and the least number of treatments required (mean 1.5; range 13). This finding should however be interpreted with caution due to the small numbers, particularly in the sealant only group (n = 6).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):\n\nOverall, of the 57 patients managed using a variety of ETs there was an 84% (n  48) success rate compared with 93.5% (n  101) of 108 patients that had OS.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Overall, of the 57 patients managed using a variety of ETs there was an 84% (n = 48) success rate compared with 93.5% (n = 101) of 108 patients that had OS.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.7%):\n\n. One previous failed openrepair. Al-Samarrai et al (1987)' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;] One previous failed open repair. Al-Samarrai et al (1987) [&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.1%):\n\n. Two previous failed openrepairs.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;] Two previous failed open repairs.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):\n\nA total of 23 papers between 1984 and 2012 described 57 patients undergoing some form of endoscopic treatment (ET) while 21 papers between 1955 and 2013 described 108 patients that underwent an open surgical repair ( Tables 1 and 2). A total of 165 cases of RTEF are described and there were 44 (26.7%) cases associated with anastomotic leaks while 35 (21.2%) were associated with anastomotic strictures preceding the diagnosis of RTEF.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A total of 23 papers between 1984 and 2012 described 57 patients undergoing some form of endoscopic treatment (ET) while 21 papers between 1955 and 2013 described 108 patients that underwent an open surgical repair (OS). A total of 165 cases of RTEF are described and there were 44 (26.7%) cases associated with anastomotic leaks while 35 (21.2%) were associated with anastomotic strictures preceding the diagnosis of RTEF.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nIntroduction The management of a recurrent tracheoesophageal fistula (RTEF) includes either open surgery (OS) or an endoscopic treatment (ET); the ideal option is unclear. We aim to comparatively review all published treatment options, and outcomes, for managing RTEF. Materials and Methods A literature search was performed using the keywords recurrent tracheoesophageal fistula. All English language articles describing the management of RTEF in children were reviewed. A synthesis of the relevant data is presented in a descriptive form due to the heterogeneity of the included articles. Results' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;] Introduction The management of a recurrent tracheoesophageal fistula (RTEF) includes either open surgery (OS) or an endoscopic treatment (ET); the ideal option is unclear. We aim to comparatively review all published treatment options, and outcomes, for managing RTEF. Materials and Methods A literature search was performed using the keywords recurrent tracheoesophageal fistula. All English language articles describing the management of RTEF in children were reviewed. A synthesis of the relevant data is presented in a descriptive form due to the heterogeneity of the included articles. Results [&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nAbstract Introduction The management of a recurrent tracheoesophageal fistula (RTEF) includes either open surgery (OS) or an endoscopic treatment (ET); the ideal option is unclear. We aim to comparatively review all published treatment options, and outcomes, for managing RTEF.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;] Abstract The management of a recurrent tracheoesophageal fistula (RTEF) includes either open surgery (OS) or an endoscopic treatment (ET); the ideal option is unclear. We aim to comparatively review all published treatment options, and outcomes, for managing RTEF.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 47.5%):\n\nas the conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors declare that they have no conflict of interest.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 47.5%):\n\nas the conflict of interest' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The authors declare that they have no conflict of interest.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 55.3%):\n\n/ Additional analyses:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;No additional analyses were performed.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nReview 73 Billingham MJ, Basterfield SJ. Pediatric Surgical Technique: Laparoscopic or open Approach  Eur J Pediatr Surg 2010; 20: 7377' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Review 73: Billingham MJ, Basterfield SJ. Pediatric Surgical Technique: Laparoscopic or open Approach  Eur J Pediatr Surg 2010; 20: 7377&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 84.3%):\n\nEach article was independently assessed for eligibility using the following criteria: Inclusion criteria ' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Each article was independently assessed for eligibility using the following criteria: Inclusion criteria  Exclusion criteria &quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nThe median number of patients at baseline in each study was 24 (range 10108). In total, 637 patients were analysed at post-surgery follow-up.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The median number of patients at baseline in each study was 24 (range 10108). In total, 637 patients were analyzed at post-surgery follow-up.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 41%):\n\nnot applicable o' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not applicable, as A7 was scored as No.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.9%):\n\nnot applicable or not relevant to the text (for example, combining data in quantitative synthesis' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not applicable, as there is no quantitative synthesis in this review.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nwe aimed to extend and update the previous reviews by (i) systematically reviewing the literature on bariatric surgery in children and adolescents; (ii) metaanalysing change in BMI separately by surgery type and (iii) reporting peri-operative complications, co-morbidity resolution and HRQoL.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We aimed to (i) systematically review the literature on bariatric surgery in children and adolescents; (ii) meta-analyse change in BMI separately by surgery type and (iii) report peri-operative complications, co-morbidity resolution and HRQoL.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nThe median number of patients at baseline in each study was 24 (range 10108). In total, 637 patients were analysed at post-surgery follow-up.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The median number of patients at baseline in each study was 24 (range 10108). In total, 637 patients were analyzed at post-surgery follow-up.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 61.3%):\n\nsed on the full text' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not mentioned in the full text.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.9%):\n\nnot applicable or not relevant to the text (for example, combining data in quantitative synthesis' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Not applicable, as there is no quantitative synthesis in this review.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nwe aimed to extend and update the previous reviews by (i) systematically reviewing the literature on bariatric surgery in children and adolescents; (ii) metaanalysing change in BMI separately by surgery type and (iii) reporting peri-operative complications, co-morbidity resolution and HRQoL.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We aimed to (i) systematically review the literature on bariatric surgery in children and adolescents; (ii) meta-analyse change in BMI separately by surgery type and (iii) report peri-operative complications, co-morbidity resolution and HRQoL.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.9%):\n\nThere is a need for an up-to-date review of the literature to inform clinical guidelines. Two previous systematic reviews of the literature showed that sustained weight loss could be achieved after bariatric surgery, but reporting on related co-morbidities and complications was sparse, and surgery types were poorly differentiated (16,17). Given the rapid rise in the number of obese children and adolescents in the past 5 years, and the reported increase in bariatric surgery in these groups (14), we aimed to extend and update the previous reviews by (i) systematically reviewing the literature on bariatric surgery in children and adolescents; (ii) metaanalysing change in BMI separately by surgery type and (iii) reporting peri-operative complications, co-morbidity resolution and HRQoL.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;There is a need for an up-to-date review of the literature to inform clinical guidelines. Two previous systematic reviews of the literature showed that sustained weight loss could be achieved after bariatric surgery, but reporting on related co-morbidities and complications was sparse, and surgery types were poorly differentiated (16,17). Given the rapid rise in the number of obese children and adolescents in the past 5 years, and the reported increase in bariatric surgery in these groups (14), we aimed to extend and update the previous reviews by (i) systematically reviewing the literature on bariatric surgery in children and adolescents; (ii) meta-analysing change in BMI separately by surgery type and (iii) reporting peri-operative complications, co-morbidity resolution and HRQoL.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nThe global prevalence of obesity is rising in children and adolescents (1). In the United Kingdom, e.g. among individuals aged 1115 years, the prevalence was 14.7% in 1995 and 18.3% in the 2010 round of the National Child Measurement Programme (2).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The global prevalence of obesity is rising in children and adolescents (1). In the United Kingdom, e.g., among individuals aged 1115 years, the prevalence was 14.7% in 1995 and 18.3% in the 2010 round of the National Child Measurement Programme (2).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nThe variety of treatment options 2465Laparoscopic vs open varicocelectomy in children and adolescents indicates that the ideal technique to manage this pathologic condition has not yet been determined' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The variety of treatment options indicates that the ideal technique to manage this pathologic condition has not yet been determined.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):\n\nThree doctors reviewed the abstracts. Articles relevant to the topic of the review were selected by consensu' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Three doctors reviewed the abstracts. Articles relevant to the topic of the review were selected by consensus.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):\n\nThree doctors reviewed the abstracts. Articles relevant to the topic of the review were selected by consensu' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Three doctors reviewed the abstracts. Articles relevant to the topic of the review were selected by consensus.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nThis systematic review shows that according to available evidence PR carries an 8% risk of specific preputial complications, whereas it does not seem to increase the risk of urethroplasty complications and the overall reoperation rate of hypospadias repair' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This systematic review shows that according to available evidence PR carries an 8% risk of specific complications, whereas it does not seem to increase the risk of urethroplasty complications and the overall reoperation rate of hypospadias repair.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.4%):\n\nDs A systematic review of the literature published after June 1995 was performed in June 2015 in agreement with the PRISMA statement (3). Three databases, namely, MEDLINE/PubMed, Scopus, and The Cochrane library, were searched for using the free text hypospadias repair, in all fields of the records for MEDLINE/ PubMed search, and in the Title and Topic fields for the Web of Science and Cochrane library searches.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We performed a systematic review of the literature published after June 1995 was performed in June 2015 in agreement with the PRISMA statement (3). Three databases, namely, MEDLINE/PubMed, Scopus, and The Cochrane library, were searched for using the free text 'hypospadias repair,' in all fields of the records for MEDLINE/PubMed search, and in the Title and Topic fields for the Web of Science and Cochrane library searches.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nSystematic reviews and meta-analyses We used the AMSTAR [20] tool to assess the quality of all relevant systematic reviews.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Systematic reviews and meta-analyses: We used the AMSTAR [20] tool to assess the quality of all relevant systematic reviews.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98%):\n\nThe overall conclusion from the highest quality studies reporting on fertility potential after cryptorchidism was that orchiopexy should be performed before 1 year of age to optimize fertility outcomes.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The overall consensus from the highest quality studies reporting on fertility potential after cryptorchidism was that orchiopexy should be performed before 1 year of age to optimize fertility outcomes.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 96.4%):\n\nList and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;We listed and defined all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 91.7%):\n\nwas to conduct a systematic review and meta-analysis of all published literature comparing surgical repair techniques for CDH.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Methods: We conducted a systematic review and meta-analysis of all published literature comparing surgical repair techniques for CDH.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 56.1%):\n\nWe identified 9 studies' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;We identified 10 studies in total [817].&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nWhen heterogeneity was low to moderate (Q test p N 0.10, I 2 b 50%), we used a fixed-effects model. When heterogeneity was moderate to high (Q test p b 0.10, I 2 N 50%), we used a randomeffects model [7].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;When heterogeneity was low to moderate (Q test p N 0.10, I 2 b 50%), we used a fixed-effects model. When heterogeneity was moderate to high (Q test p b 0.10, I 2 N 50%), we used a random-effects model [7].&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.3%):\n\ns: We sought all publications describing both techniques through MEDLINE, Embase, and CENTRAL. Our primary outcome of interest was recurrence.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Abstract: We sought all publications describing both techniques through MEDLINE, Embase, and CENTRAL. Our primary outcome of interest was recurrence.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 63.6%):\n\n3 relevant quotes from th' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;[No relevant quote for this item]&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.6%):\n\nwas to conduct a systematic review and meta-analysis of all published literature comparing surgical repair techniques for CDH.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We conducted a systematic review and meta-analysis of all published literature comparing surgical repair techniques for CDH.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 91.4%):\n\nMinimally invasive versus open repair of Bochdalek hernia: a meta-analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Title: Minimally invasive versus open repair of Bochdalek hernia: a meta-analysis&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nOur initial search of MEDLINE, Embase and CENTRAL yielded 160 studies (Fig. 1). After applying our exclusion criteria, 9 studies remained. We identified one additional relevant study through handsearching, thus we included 10 studies in total [817].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Our initial search of MEDLINE, Embase and CENTRAL yielded 160 studies (Fig. 1). After applying our exclusion criteria, 9 studies remained. We identified one additional relevant study through hand-searching, thus we included 10 studies in total [817].&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 88.2%):\n\nassessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;We used this index to assess the risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nWhen heterogeneity was low to moderate (Q test p N 0.10, I 2 b 50%), we used a fixed-effects model. When heterogeneity was moderate to high (Q test p b 0.10, I 2 N 50%), we used a randomeffects model [7].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;When heterogeneity was low to moderate (Q test p N 0.10, I 2 b 50%), we used a fixed-effects model. When heterogeneity was moderate to high (Q test p b 0.10, I 2 N 50%), we used a random-effects model [7].&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93%):\n\nmes. Our objective was to compare the outcomes of these procedures in a systematic review and meta-analysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Objectives: Our objective was to compare the outcomes of these procedures in a systematic review and meta-analysis.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 69.8%):\n\ndid not perform a separate analysis' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;We did not perform any additional analyses.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 56.1%):\n\nWe identified 9 studies' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;We identified 10 studies in total [817].&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 90.1%):\n\nResults / Additional analysis: Give results of additional analyses, if done (e.g., sensit' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;Results / Additional analysis: Give results of additional analyses, if done (see Item P16).&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 97.6%):\n\nThe results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;The results of the methodological rigor and scientific quality were considered in the analysis and conclusions of the review.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 62.9%):\n\nthe scientific quality of the included studies assessed' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The scientific quality of the included studies was assessed using a quality scoring tool.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 96.2%):\n\nA list of included and excluded studies should be provided.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;A list of included and excluded studies was provided.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 95.4%):\n\nThere should be at least two independent data extractors and a consensus procedure for disagreements should be in place.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;There were at least two independent data extractors and a consensus procedure for disagreements was in place.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 97%):\n\nIn an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;In an aggregated form such as a table, data from the original studies were provided on the participants, interventions, and outcomes.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 72.2%):\n\nAt least two electronic sources should be searched. The report must include years and databases' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;At least two electronic sources were searched, including Medline, Embase, and Cochrane databases.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 93%):\n\n&#39;a priori&#39; design provided? The research question and inclusion criteria should be established before the conduct of the review.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;A 'a priori' design was provided with the research question and inclusion criteria established before the conduct of the review.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 82.8%):\n\ngeneral interpretation of the results in the context of other evidence,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The general interpretation of the results is provided in the context of other evidence.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 84.1%):\n\nthe rationale for the review in the context of what is already known.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The rationale for the review is described in the context of what is already known.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 83%):\n\nall information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;All information sources used to identify studies are described, with date last searched.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 82.4%):\n\nthe main findings including the strength of evidence for each main outcome;' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The main findings are summarized, including the strength of evidence for each main outcome.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 87.5%):\n\ne numbers of studies screened, assessed for eligibility, and included in the review,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The numbers of studies screened, assessed for eligibility, and included in the review are given.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 92.4%):\n\nan explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;An explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS) is provided.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.2%):\n\ne method of data extraction from reports' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The method of data extraction from reports is described.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 78.7%):\n\nfull electronic search strategy for at least one database,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The full electronic search strategy for at least one database is presented.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 81.6%):\n\nmethods used for assessing risk of bias of individual studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;Methods used for assessing risk of bias of individual studies are described.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 77.3%):\n\nthe process for selecting studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;The process for selecting studies is stated.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 72.9%):\n\ndata on risk of bias of each study' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Data on risk of bias of each study is presented.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 68.4%):\n\nlimitations at study and outcome level' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Limitations at the study and outcome level are discussed.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 72.5%):\n\nFor all outcomes considered (benefits or harms), present, for each study:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;For all outcomes considered, the results of each study are presented.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 73.8%):\n\nthe principal summary measures' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The principal summary measures are stated.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 85.7%):\n\nstudy characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;Study characteristics and report characteristics used as criteria for eligibility are specified, with rationale.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 65.1%):\n\nStudy characteristics: For each study, present' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;For each study, the characteristics of the study are presented.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.2%):\n\nAuthors were not contacted for additional data because of the wide time range of the included studies.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The authors were not contacted for additional data because of the wide time range of the included studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nThis study is limited by the data given in the individual series: varied criteria used for patient selection and outcome as well as inconsistent pre and post operative imaging data precluded a metaanalysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This study is limited by the data given in the individual series: varied criteria used for patient selection and outcome as well as inconsistent pre and post operative imaging data precluded a meta-analysis.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99%):\n\nOnce duplicate records had been excluded (n Z 128), 114 titles were assessed for eligibility (Fig. 1).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Once duplicate records had been excluded (n = 128), 114 titles were assessed for eligibility (Fig. 1).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):\n\nThe median success rate was 71% (range 46e100) in the primary group and 75% (range 25e100) in the secondary group.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The median success rate was 71% (range 46-100) in the primary group and 75% (range 25-100) in the secondary group.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.2%):\n\nAuthors were not contacted for additional data because of the wide time range of the included studies.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The authors were not contacted for additional data because of the wide time range of the included studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nThis study is limited by the data given in the individual series: varied criteria used for patient selection and outcome as well as inconsistent pre and post operative imaging data precluded a metaanalysis.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This study is limited by the data given in the individual series: varied criteria used for patient selection and outcome as well as inconsistent pre and post operative imaging data precluded a meta-analysis.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):\n\nThe median success rate was 71% (range 46e100) in the primary group and 75% (range 25e100) in the secondary group.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The median success rate was 71% (range 46-100) in the primary group and 75% (range 25-100) in the secondary group.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99%):\n\nOnce duplicate records had been excluded (n Z 128), 114 titles were assessed for eligibility (Fig. 1).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Once duplicate records had been excluded (n = 128), 114 titles were assessed for eligibility (Fig. 1).&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 69.8%):\n\nindexed databases: CINAHL, EMBASE, Medline, and Cochrane Databases, from inception to January 11, 2015 (the search was again updated on June 18, 2015). Additional articles were identified through the reference listings of those articles yielded through the initial electronic database search. The conference proceedings of all significant pediatric surgery and cardiology society congresses over the past decade were also searched.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;A systematic search of the English language literature was conducted using a keyword algorithm (Supplemental Figure 1, <http://links.lww.com/SLA/A928>). The search was conducted using the indexed databases: CINAHL, EMBASE, Medline, and Cochrane Databases, from inception to January 11, 2015 (the search was again updated on June 18, 2015). Additional articles were identified through the reference listings of those articles yielded through the initial electronic database search. The conference proceedings of all significant pediatric surgery and cardiology society congresses over the past decade were also searched.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 90.4%):\n\nstudies met inclusion criteria, reporting outcomes of 384 RAP, 131 LP, and 164 OP procedures.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Twelve studies met the inclusion criteria, reporting outcomes of 384 RAP, 131 LP, and 164 OP procedures.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.2%):\n\nStudy characteristics are summarised in Tables 1 and 3.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Study characteristics are summarized in Tables 1 and 3.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):\n\n2 studies reported pre-hoc power calculations to justify adequate sample size' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No studies reported pre-hoc power calculations to justify adequate sample size.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.1%):\n\n. The aim of this study is to critically appraise the literature comparing robot-assisted versus conventional laparoscopic MIS for fundoplication in order to further elucidate the comparative safety and efficacy of these techniques.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Methods / Objectives: The aim of this study is to critically appraise the literature comparing robot-assisted versus conventional laparoscopic MIS for fundoplication in order to further elucidate the comparative safety and efficacy of these techniques.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):\n\n2 studies reported pre-hoc power calculations to justify adequate sample size' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No studies reported pre-hoc power calculations to justify adequate sample size.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):\n\nHigher quality and longerfollow up studies are now required to more definitively and comprehensively determine the role of robotic-assisted techniques in this setting' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Higher quality and longer follow-up studies are now required to more definitively and comprehensively determine the role of robotic-assisted techniques in this setting.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nThe majority of comparative effectiveness literature is comprised of small retrospective studies with historical controls' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The majority of comparative effectiveness literature is comprised of small retrospective studies with historical controls.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nAll included studies reported utilization of the Nissen fundoplication technique, with the exception of the study by Lehnert et al., that reported Thal fundoplications [14]' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;All included studies reported utilization of the Nissen fundoplication technique, with the exception of the study by Lehnert et al., that reported Thal fundoplications [14].&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):\n\n2 studies reported pre-hoc power calculations to justify adequate sample size' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No studies reported pre-hoc power calculations to justify adequate sample size.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 97.7%):\n\nIntroduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;Methods / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):\n\n2 studies reported pre-hoc power calculations to justify adequate sample size' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;No studies reported pre-hoc power calculations to justify adequate sample size.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nThe characteristics of the 17 studies (1 randomized controlled trial [22] and 16 retrospective studies [5,1521,2330]) are shown in Table 1' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The characteristics of the 17 studies (1 randomized controlled trial [22] and 16 retrospective studies [5,1530]) are shown in Table 1.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nInclusion criteria were: (1) clinical studies that compared single-incision versus conventional three-incision laparoscopic appendicectomy for appendicitis between 1992 and 2012; (2) patients with primary appendicitis; and (3) raw data included some of the following: operative parameters, postoperative recovery, postoperative complications, postoperative pain and hospital charges.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Inclusion criteria were: (1) clinical studies that compared single-incision versus conventional three-incision laparoscopic appendicectomy for appendicitis between 1992 and 2012; (2) patients with primary appendicitis; and (3) raw data included some of the following: operative parameters, postoperative recovery, postoperative complications, post-operative pain and hospital charges.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nThe characteristics of the 17 studies (1 randomized controlled trial [22] and 16 retrospective studies [5,1521,2330]) are shown in Table 1' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The characteristics of the 17 studies (1 randomized controlled trial [22] and 16 retrospective studies [5,1530]) are shown in Table 1.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):\n\nThe extracted information comprised: author, year of publication, source journal, sample size, research design, clinical and pathological features of included patients, operative parameters (conversion rate, operative time and blood loss, surgical difficulty), postoperative recovery (time to oral intake and length of hospital stay), postoperative pain, postoperative complications (wound infection, abdominal abscess, omphalitis, umbilical hernia and ileus) and hospital charges.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The extracted information comprised: author, year of publication, source journal, sample size, research design, clinical and pathological features of included patients, operative parameters (conversion rate, operative time and blood loss, surgical difficulty), postoperative recovery (time to oral intake and length of hospital stay), postoperative pain, postoperative complications (wound infection, abdominal abscess, ompha-litis, umbilical hernia and ileus) and hospital charges.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nAccording to the search strategy and inclusion criteria, a total of 17 studies [5,1530] that included 1809 appendicectomy cases (793 SILA and 1016 TILA) were considered suitable for meta-analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;According to the search strategy and inclusion criteria, a total of 17 studies [5,1530] that included 1809 appendicectomy cases (793 SILA and 1016 TILA) were considered suitable for meta-analysis.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.7%):\n\nme limitations of this meta-analysis. Firstly, the differences in the age of included patients, pathological type of appendicitis and instruments of SILS may affect the comparability of the included studies. Secondly, different studies may have had different defining criteria for the outcomes we were interested in, which may not be reported in the study methodology. In order to account for this heterogeneity, we have performed sensitivity analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The limitations of this meta-analysis include the differences in the age of included patients, pathological type of appendicitis and instruments of SILS, which may affect the comparability of the included studies. Different studies may have had different defining criteria for the outcomes we were interested in, which may not be reported in the study methodology. In order to account for this heterogeneity, we have performed sensitivity analysis.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 56.6%):\n\nSystematic review of clinical Level 1 studies using PubMed.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Systematic review of clinical Level 1 studies using PubMed. The Web site was last accessed on May 5, 2012.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 56.6%):\n\nSystematic review of clinical Level 1 studies using PubMed.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Systematic review of clinical Level 1 studies using PubMed. The Web site was last accessed on May 5, 2012.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.9%):\n\nIntroduction Laparoscopic techniques have evolved quickly in recent years and are regarded as standard procedures in pediatric surgery today. However, most studies comparing laparoscopic operations with the corresponding open procedure do not reach a high level of evidence according to the criteria of the Oxford Centre for EvidenceBased Medicine. For evidence Level 1a, a meta-analysis (MA) of different randomized controlled trials (RCTs) is required. For evidence Level 1b, at least one RCT is required. The aim of our study was to evaluate the availability of Level 1 studies comparing laparoscopic procedures with the corresponding open operation in pediatric surgery.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Introduction Laparoscopic techniques have evolved quickly in recent years and are regarded as standard procedures in pediatric surgery today. However, most studies comparing laparoscopic operations with the corresponding open procedure do not reach a high level of evidence according to the criteria of the Oxford Centre for Evidence-Based Medicine. For evidence Level 1a, a meta-analysis (MA) of different randomized controlled trials (RCTs) is required. For evidence Level 1b, at least one RCT is required. The aim of our study was to evaluate the availability of Level 1 studies comparing laparoscopic procedures with the corresponding open operation in pediatric surgery.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99%):\n\nThe study received some funding from the gastric band manufacturer (Allergen) and one of the co-authors declared his position as a member of the Allergen advisory board. However, the authors state that the sponsors had no role in the study design, conduct, data collection and analysis and manuscript preparatio' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This study received some funding from the gastric band manufacturer (Allergen) and one of the co-authors declared his position as a member of the Allergen advisory board. However, the authors state that the sponsors had no role in the study design, conduct, data collection and analysis and manuscript preparation&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.4%):\n\ntwo review authors (LJE, EM) independently scanned the abstract, title, or both, of every record retrieved by the searches. We investigated all potentially relevant articles as full text' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Two review authors (LJE, EM) independently scanned the abstract, title, or both, of every record retrieved by the searches. They investigated all potentially relevant articles as full text&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.8%):\n\n0 study would have benefited from outcome assessor blinding for the BMI and healthrelated quality of life assessment and a cost effectiveness analysis. It would also have been useful if O&#39;Brien 2010 had reported the exact baseline adjusted group difference in change score' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;This study would have benefited from outcome assessor blinding for the BMI and health-related quality of life assessment and a cost-effectiveness analysis. It would also have been useful if O'Brien 2010 had reported the exact baseline adjusted group difference in change scores&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nA total of 50 participants were included in the trial, 25 participants were randomised to intervention and 25 to control groups. Twentyfour (98%) participants finished the study in the intervention compared to 18 (72%) participants in the control grou' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A total of 50 participants were included in the trial, 25 participants were randomised to intervention and 25 to control groups. Twenty-four (98%) participants finished the study in the intervention compared to 18 (72%) participants in the control group&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 72.9%):\n\nrandomised controlled trial (RCT) dat' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Randomised controlled trial (RCT) (Study Design)&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nThe participating population consisted of Australian adolescents aged 14 to 18 years, with a mean age of 16.5 and 16.6 years in the banding and lifestyle group respectively. All participants demonstrated substantial physiological maturity with secondary sexual characteristics and most had also completed bone growth. This study contained a higher proportion of girls than boys in each arm of the intervention: 36% of the banding group were males and 28% of the lifestyle group were male' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The participating population consisted of Australian adolescents aged 14 to 18 years, with a mean age of 16.5 and 16.6 years in the banding and lifestyle group, respectively. All participants demonstrated substantial physiological maturity with secondary sexual characteristics and most had also completed bone growth. This study contained a higher proportion of girls than boys in each arm of the intervention: 36% of the banding group were males and 28% of the lifestyle group were males&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 58.4%):\n\nRisk of bias within studies: Present data on risk of bias of each study' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;The Cochrane risk of bias tool was used to assess the risk of bias of each included study&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):\n\nOverview of study populations A total of 50 participants were included in the trial, 25 participants were randomised to intervention and 25 to control group' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Overview of study populations: A total of 50 participants were included in the trial, 25 participants were randomised to intervention and 25 to control groups&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):\n\nC T Background Child and adolescent overweight and obesity have increased globally, and are associated with significant short and long term health consequences. Objectives To assess the effects of surgical interventions for treating obesity in childhood and adolescence. Search methods We searched the Cochrane Library, MEDLINE, PubMed, EMBASE as well as LILACS, ICTRP Search Portal and ClinicalTrials.gov (all from database inception to March 2015). References of identified studies and systematic reviews were checked. No language restrictions were applied. Selection criteria We selected randomised controlled trials (RCTs) of surgical interventions for treating obesity in children and adolescents (age < 18 years) with a minimum of six months follow-up. Interventions that specifically dealt with the treatment of eating disorders or type 2 diabetes, or included participants with a secondary or syndromic cause of obesity were excluded. Pregnant females were also excluded. Data collection and analysis Two review authors independently assessed risk of bias and extracted data. Where necessary authors were contacted for additional information' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Abstract: Background: Child and adolescent overweight and obesity have increased globally, and are associated with significant short and long term health consequences. Objectives: To assess the effects of surgical interventions for treating obesity in childhood and adolescence. Methods: We selected randomised controlled trials (RCTs) of surgical interventions for treating obesity in children and adolescents (age < 18 years) with a minimum of six months follow-up. Interventions that specifically dealt with the treatment of eating disorders or type 2 diabetes, or included participants with a secondary or syndromic cause of obesity were excluded. Pregnant females were also excluded. Data collection and analysis: Two review authors independently assessed risk of bias and extracted data. Where necessary authors were contacted for additional information&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.3%):\n\nrches We searched the following sources on the 30th of March 2015 from inception to the specified database date and placed no restrictions on the language of publication.  Cochrane Library: * Cochrane Database of Systematic Reviews (until issue 3, 2015). * Database of Reviews of Effects (until issue 1, 2015). * Cochrane Central Register of Controlled Trials (until issue 2, 2015). * Health Technology Assessment Database (until issue 1, 2015).  MEDLINE (until 30th March 2015).  EMBASE (until week 13, 2015).  PubMed (only subsets not available on Ovid) (until 30th March 2015).  LILACS (until 25th February 2015).  ClinicalTrials.gov (until 30th March 2015).  World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP)' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Information sources: We searched the following sources on the 30th of March 2015 from inception to the specified database date and placed no restrictions on the language of publication. Cochrane Library, MEDLINE, EMBASE, PubMed, LILACS, ClinicalTrials.gov, World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP)&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nAssessment of risk of bias in included studies Two review authors (LJE, KR) independently assessed the risk of bias of each included study' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Assessment of risk of bias in included studies: Two review authors (LJE, KR) independently assessed the risk of bias of each included study&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.6%):\n\noutcome measures Primary outcomes  BMI and weight loss.  Adverse events' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Outcome measures: Primary outcomes: BMI and weight loss, Adverse events&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.9%):\n\nSelection of studies To determine the studies to be assessed further, two review authors (LJE, EM) independently scanned the abstract, title, or both, of every record retrieved by the searches. We investigated all potentially relevant articles as full text' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Study selection: To determine the studies to be assessed further, two review authors (LJE, EM) independently scanned the abstract, title, or both, of every record retrieved by the searches. They investigated all potentially relevant articles as full text&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 88.2%):\n\nTo assess the effects of surgery for treating obesity in children and adolescents' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Objectives: To assess the effects of surgery for treating obesity in children and adolescents&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94.2%):\n\nd study was well conducted and provides much needed evidence in this field, further studies are required to strengthen the evidence base. The O&#39;Brien 2010 study would have benefited from outcome assessor blinding for the BMI and healthrelated quality of life assessment and a cost effectiveness analysis. It would also have been useful if O&#39;Brien 2010 had reported the exact baseline adjusted group difference in change score' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The O'Brien 2010 study was well conducted and provides much needed evidence in this field, however further studies are required to strengthen the evidence base. The O'Brien 2010 study would have benefited from outcome assessor blinding for the BMI and health-related quality of life assessment and a cost-effectiveness analysis. It would also have been useful if O'Brien 2010 had reported the exact baseline adjusted group difference in change scores&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 63.6%):\n\n(PRISMA) flow diagram' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;A PRISMA flow diagram is provided&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.6%):\n\nWe included randomised controlled trials (RCTs). Types of participants We included study groups consisting of obese participants, with a mean age of less than 18 years at the commencement of the intervention. Pregnant females and the critically ill were excluded, as were children with obesity due to a secondary or syndromic cause (e.g. Prader-Willi syndrome)' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Methods: We included randomised controlled trials (RCTs). Participants: The study groups consisted of obese participants, with a mean age of less than 18 years at the commencement of the intervention. Pregnant females and the critically ill were excluded, as were children with obesity due to a secondary or syndromic cause (e.g. Prader-Willi syndrome)&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.2%):\n\nudy received some funding from the gastric band manufacturer (Allergen) and one of the co-authors declared his position as a member of the Allergen advisory board. However, the authors state that the sponsors had no role in the study design, conduct, data collection and analysis and manuscript preparatio' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;This systematic review received some funding from the gastric band manufacturer (Allergen) and one of the co-authors declared his position as a member of the Allergen advisory board. However, the authors state that the sponsors had no role in the study design, conduct, data collection and analysis and manuscript preparation&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 91.3%):\n\nonly one published study was comprehensively assessed in this review, no potential biases in the review process aros' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Only one published study was comprehensively assessed in this review, therefore no potential biases in the review process arose&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 87.5%):\n\nThe prevalence of overweight and obese children and adolescents has increased throughout the world, presenting a global public health crisis (Ng 2014; WHO 2015a). Although once considered to be a condition affecting only developed countries, rates of paediatric overweight and obesity have recently started to rise dramatically in some developing countries' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Background: The prevalence of overweight and obese children and adolescents has increased throughout the world, presenting a global public health crisis. This increase in paediatric obesity is not only affecting developed countries, but rates of paediatric obesity have recently started to rise dramatically in some developing countries&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.1%):\n\nen Inguinal Hernia Repair in Pediatric Patients: A Systematic Review' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Title: Inguinal Hernia Repair in Pediatric Patients: A Systematic Review&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nStatistical heterogeneity in the meta-analysis was assessed with the v 2 test and the I 2 index. A randomeffects model was used in case of heterogeneous data. Otherwise, a fixed-effects model was used instead.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Statistical heterogeneity in the meta-analysis was assessed with the v2 test and the I2 index. A random-effects model was used in case of heterogeneous data. Otherwise, a fixed-effects model was used instead.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 80.2%):\n\nConclusion LS is a feasible, safe, and effective surgical procedure alternative to OS for pediatric patients. Compared with OS, LS has the advantage of shorter hospital stay and less blood loss. Besides, total postoperative complications may be slightly lower in LS. We conclude that LS should be considered an acceptable option for children. Keywords Laparoscopic \u0002 Open splenectomy' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Laparoscopic splenectomy is a feasible, safe, and effective surgical procedure alternative to open splenectomy for pediatric patients. Compared with open splenectomy, laparoscopic splenectomy has the advantage of shorter hospital stay and less blood loss. Besides, total postoperative complications may be slightly lower in laparoscopic splenectomy.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nWe conducted a systematic review and metaanalysis to compare the clinical outcomes between laparoscopic splenectomy and the traditional open splenectomy in children.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;We conducted a systematic review and meta-analysis to compare the clinical outcomes between laparoscopic splenectomy and the traditional open splenectomy in children.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nHowever, it is still unclear whether LH can truly reduce the operative time, postoperative complications, and recurrence.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;However, it is still unclear whether LH can truly reduce the operative time, post-operative complications, and recurrence.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):\n\nStatistical heterogeneity in the meta-analysis was assessed with the w 2 test and the I 2 inde' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Statistical heterogeneity in the meta-analysis was assessed with the w2 test and the I2 index.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.2%):\n\neat rectal biopsy, patients age at initial PT and redo PT operation, type of surgical procedures performed and postoperative follow-up with recurrent symptoms.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot; recurrent rectal biopsy, patient's age at initial PT and redo PT operation, type of surgical procedures performed and postoperative follow-up with recurrent symptoms.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 55.9%):\n\ns were included in the literature review.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Fifty-five papers were selected for this literature review.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 38.3%):\n\nsurgical procedures performed and postoperative follow-up with' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The surgical outcome of patients was assessed by postoperative follow-up which was available in 69.4% (134/193) of all patients.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 55.4%):\n\ncharacteristics of the included studies pr' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Characteristics of the patients studied are presented in Table 1.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):\n\nMethods A meta-analysis of redo PT operations for HD reported in the literature between 1985 and 2011 was performed.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Methods: A meta-analysis of redo PT operations for HD reported in the literature between 1985 and 2011 was performed.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 38.9%):\n\npostoperative follow-up wit' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Results: Postoperative follow-up was available in 69.4% of all patients.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 47.8%):\n\neration and outcome. Results Twenty-nine articles reported 555 patients with redo PT operation' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Materials and methods: Twenty-nine articles from 1985 to 2011 reporting 555 patients with HD and redo PT operation due to RA or TZB were selected and analyzed.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 29.9%):\n\nreview with the AMSTAR tool and its reporting quality with the' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;Materials and methods: All identified studies were reviewed, and those reporting patients with redo PT operation due to RA or TZB were selected.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 35.8%):\n\nsurgical procedures performed and postoperative follow-up with' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Results: The surgical outcome of patients was assessed by postoperative follow-up which was available in 69.4% (134/193) of all patients.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 47.1%):\n\nion. The vast majority of patients had either Duhamel procedure, TERPT or Soave procedure for redo PT operation.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Results: Among the 193 patients with RA, 99 (51.3%) underwent Duhamel procedure, 43 (22.2%) underwent Swenson procedure, and 51 (26.4%) underwent TERPT for redo PT operation.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 39.3%):\n\nThese 193 patients presented with' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Results: Of the 193 patients, 144 (74.6%) presented with RA and 49 (25.4%) with TZB.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 61.3%):\n\nn. Methods PubMed  and MEDLINE  databases were searched for all studies' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Materials and methods: PubMed and MEDLINE databases were searched for studies published from 1985 to 2011.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94.6%):\n\nMost patients with Hirschsprungs disease (HD) have a satisfactory outcome after pull-through (PT) operation. However, some children continue to have persistent bowel symptoms after the initial operation and may require redo PT.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Introduction: Most patients with Hirschsprungs disease (HD) have a satisfactory outcome after pull-through (PT) operation. However, some children continue to have persistent bowel symptoms after the initial operation and may require redo PT.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 64.4%):\n\ne the incidence and outcome of residual aganglionosis (RA) in patients with HD following PT operation.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Introduction: The present study aimed to evaluate the incidence and outcome of residual aganglionosis (RA) in patients with HD after PT operation.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):\n\nmeta-analysis revealed that the relative risk for anastomotic strictures was significantly higher in patients who had previously anastomotic leaks (RR 2.4, 95 % CI 1.93.0; p \\ 0.0001) or symptomatic GER (RR 3.3, 95 % CI 2.44.4; p \\ 0.0001), respectively.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Our meta-analysis revealed that the relative risk for anastomotic strictures was significantly higher in patients who had previously anastomotic leaks (RR 2.4, 95 % CI 1.93.0; p < 0.0001) or symptomatic GER (RR 3.3, 95 % CI 2.44.4; p < 0.0001), respectively.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nAn unblinded, standardized full-text assessment of relevant articles was independently performed by both authors (F.F. and P.P.). The data was extracted into an electronic datasheet in a standardized manner.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;An unblinded, standardized full-text assessment of relevant articles was independently performed by both authors (F.F. and P.P.). The data was extracted into an electronic data-sheet in a standardized manner.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nStatistical analysis Since not all complications were reported in all articles, each specific complication was recorded as the number of patients in which that complication was present divided by the total number of patients in the cohorts that presented data on that specific complication.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Statistical analysis: Since not all complications were reported in all articles, each specific complication was recorded as the number of patients in which that complication was present divided by the total number of patients in the cohorts that presented data on that specific complication.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 95%):\n\n. The disadvantage of waiting for the esophageal segments to grow and hypertrophy is prolonged hospital stay and constant threat of aspiration pneumonia, which requires continuous skilled nursing supervision' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;Limitations: The disadvantage of waiting for the esophageal segments to grow and hypertrophy is prolonged hospital stay and constant threat of aspiration pneumonia, which requires continuous skilled nursing supervision.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 49.1%):\n\nComparison of LILT and STEP procedures in children with s' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The aim of this review is to compare the indications and outcome of LILT and STEP procedures in children with SBS.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 98.9%):\n\nmethod of data extraction from reports (e.g., piloted forms, independently, in duplicate)' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;Methods of data extraction from reports (e.g., piloted forms, independently, in duplicate)&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.1%):\n\nthe aim of this study was to review the available data on long-term functional results in HD patients operated with conventional transabdominal pull-through (OPEN) compared with transanal approaches with and without laparoscopy (laparoscopic-assisted transanal-endorectal pullthrough [L-TERPT] and transanal-endorectal pull-through [TERPT]) reported in the recent literature.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;The aim of this study was to review the available data on long-term functional results in HD patients operated with conventional transabdominal pull-through (OPEN) compared with transanal endorectal pull-through with or without laparoscopy (L-TERPT/TERPT) reported in the recent literature.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):\n\nVarious surgical techniques for the treatment of Hirschsprung disease (HD) have been proposed. The most relevant long-term complications of HD surgery include constipation, soiling/incontinence, enterocolitis, and anastomotic stricture. To date, there has been no randomized controlled trial evaluating the long-term outcome of OPEN surgery compared with transanal approaches with and without laparoscopy (laparoscopic-assisted transanal-endorectal pull-through [L-TERPT] and transanal-endorectal pull-through [TERPT]). We performed a systematic literature review of the longterm outcome of OPEN surgery compared with L-TERPT/TERPT.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Various surgical techniques for the treatment of Hirschsprung disease (HD) have been proposed. The most relevant long-term complications of HD surgery include constipation, soiling/incontinence, enterocolitis, and anastomotic stricture. To date, there has been no randomized controlled trial evaluating the long-term outcome of OPEN surgery compared with transanal approaches with and without laparoscopy (laparoscopic-assisted transanal-endorectal pull-through [L-TERPT] and transanal-endorectal pull-through [TERPT]). We performed a systematic literature review of the long-term outcome of OPEN surgery compared with L-TERPT/TERPT.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 73.9%):\n\nctice Committee summarizes the available literature regarding the management of asymptomatic malrotation.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;Objective: The objective of this review is to summarize the available literature regarding the management of asymptomatic malrotation.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):\n\nAsymptomatic malrotation: Diagnosis and surgical management An American Pediatric Surgical Association outcomes and evidence based practice committee systematic review' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Asymptomatic malrotation: Diagnosis and surgical management - An American Pediatric Surgical Association outcomes and evidence based practice committee systematic review&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.1%):\n\n2 RCTs and 5 OCSs were eligible for inclusion criteria, comprising 176 cases of LO and 263 cases of OO.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Two RCTs and 5 OCSs were eligible for inclusion criteria, comprising 176 cases of LO and 263 cases of OO.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nA summary of the studies methodology, intervention characteristics, and measured outcomes was provided in Tables 1 and 2, including 176 cases of LO and 263 cases of OO.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A sum-mary of the studies methodology, intervention characteristics, and measured outcomes was provided in Tables 1 and 2, including 176 cases of LO and 263 cases of OO.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nIt has been indicated that primary LO is a feasible and effective technique for the management of low intra-abdominal testes, whereas staged FowlerStevens LO is recommended in cases with high intra-abdominal testes [13].' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;It has been indicated that pri-mary LO is a feasible and effective technique for the management of low intra-abdominal testes, whereas staged FowlerStevens LO is recommended in cases with high intra-abdominal testes [13].&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 69.1%):\n\nthe methodological quality of the selected studies independently. A critical review checklist of the Dutch Cochrane Centre' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The methodological quality of the selected studies was independently assessed by three reviewers (GJ, LZL and TQS) using a critical review checklist of the Dutch Cochrane Centre.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nThe hospital stay of LO was significantly shorter than that of OO (WMD = -0.66; 95% confidence interval [CI] = -0.95 to -0.37; P \\ 0.00001).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;The hospital stay of LO was sig-nificantly shorter than that of OO (WMD = -0.66; 95% confidence interval [CI] = -0.95 to -0.37; P \\ 0.00001).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.1%):\n\n2 RCTs and 5 OCSs were eligible for inclusion criteria, comprising 176 cases of LO and 263 cases of OO.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Two RCTs and 5 OCSs were eligible for inclusion criteria, comprising 176 cases of LO and 263 cases of OO.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 69.1%):\n\nthe methodological quality of the selected studies independently. A critical review checklist of the Dutch Cochrane Centre' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;The methodological quality of the selected studies was independently assessed by three reviewers (GJ, LZL and TQS) using a critical review checklist of the Dutch Cochrane Centre.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\n. Conclusion Although shorter hospital stay is noted in LO, it does not provide significant advantage over open surgery for treating NPT. However, due to the publishing bias, a series of RCTs are necessary to explore the efficiencies of LO in the management of NPT in children.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;] Conclusion: Although shorter hospital stay is noted in LO, it does not provide significant advantage over open surgery for treating NPT. However, due to the publishing bias, a series of RCTs are necessary to explore the efficiencies of LO in the management of NPT in children.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nThree reviewers (GJ, LZL and TQS) independently assessed selected studies, extracted and tabulated data from each article with a predefined data extraction form.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Three reviewers (GJ, LZL and TQS) independently asses-sed selected studies, extracted and tabulated data from each article with a predefined data extraction form.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):\n\nEligibility criteria included all available studies comparing LO with OO for the treatment of NPT in children.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;Eligibility criteria included all available studies comparing LO with OO for the treatment of NPT in children. [&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nA summary of the studies methodology, intervention characteristics, and measured outcomes was provided in Tables 1 and 2, including 176 cases of LO and 263 cases of OO.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;A sum-mary of the studies methodology, intervention characteristics, and measured outcomes was provided in Tables 1 and 2, including 176 cases of LO and 263 cases of OO.&quot;<\/span>"],[95.3846153846154,99.2481203007519,97.5206611570248,96.4788732394366,92.7536231884058,98.6486486486486,99.4652406417112,66.6666666666667,65.1452282157676,99.601593625498,66.9491525423729,99.601593625498,99.7542997542998,99.4652406417112,65.1452282157676,95.6521739130435,98.8636363636364,99.672131147541,98.989898989899,99.6774193548387,99.672131147541,93.3333333333333,98.6842105263158,99.4117647058823,99.6753246753247,99.1189427312775,98.1366459627329,99.4117647058823,55.3956834532374,99.7076023391813,98.8095238095238,99.1189427312775,97.9310344827586,98.6842105263158,99.6575342465753,99.6753246753247,99.4845360824742,99.746835443038,96.9387755102041,98.7012987012987,96.2199312714777,96.9387755102041,65.2542372881356,95.2076677316294,65.2542372881356,72.7891156462585,80.5128205128205,99.6268656716418,99.6268656716418,98.989898989899,99.3630573248408,72.8571428571429,31.4285714285714,31.4285714285714,96.5034965034965,68.4210526315789,98.9949748743718,72.7272727272727,47.0588235294118,49.2753623188406,40,50.6172839506173,73.728813559322,84.4961240310078,57.9710144927536,94.4444444444444,40.3846153846154,92.4731182795699,69.6428571428571,41.2371134020619,71.8446601941748,76.9230769230769,70.1492537313433,87.3949579831933,61.038961038961,46.2686567164179,31.4814814814815,90.1639344262295,59.4594594594595,68.9189189189189,64.1975308641975,97.6,76.7741935483871,58.5365853658537,50.78125,84.1269841269841,98.936170212766,57.1428571428571,47.953216374269,46.218487394958,53.6082474226804,43.6893203883495,54.8387096774194,96.875,46.6666666666667,42.0289855072464,62.987012987013,70.0854700854701,53.8461538461538,68.0672268907563,61.0526315789474,43.3823529411765,61.4173228346457,50.4672897196262,92.5373134328358,61.1111111111111,73.5849056603774,79.8319327731092,97.9166666666667,97.9166666666667,99.3150684931507,99.2592592592593,99.2592592592593,99.1869918699187,70.5357142857143,98.75,78.0068728522337,96.3855421686747,99.5260663507109,99.5983935742972,96.3855421686747,99.5260663507109,99.4169096209913,99.4169096209913,99.1803278688525,98.9304812834225,98.2142857142857,96.6666666666667,97.1153846153846,98.2142857142857,60.5263157894737,99.0147783251232,99.618320610687,99.5073891625616,42.3580786026201,98.8826815642458,98.8826815642458,97.5694444444444,94.0397350993377,99.203187250996,99.501246882793,99.203187250996,99.501246882793,99.7167138810198,99.4285714285714,98.75,91.2698412698413,99.4884910485933,99.537037037037,99.7041420118343,99.6913580246914,99.5081967213115,99.2700729927007,99.6763754045307,47.4576271186441,47.4576271186441,99.7572815533981,51.6129032258064,62.0689655172414,99.5391705069124,38.5714285714286,49.5049504950495,77.5,99.1304347826087,99.2125984251969,89.4308943089431,98.0519480519481,85.9649122807018,49.5049504950495,99.4594594594595,99.5475113122172,99.622641509434,96.969696969697,84.9514563106796,96.875,96.875,98.7381703470031,94.1176470588235,98.4709480122324,99.2565055762082,66.6666666666667,99.3670886075949,99.375,99.3670886075949,99.8011928429423,99.3243243243243,99.438202247191,59.0361445783133,81.5642458100559,99.1150442477876,99.4708994708995,99.5024875621891,36.25,93.6507936507936,99.4186046511628,99.3464052287582,54.3478260869565,80.2816901408451,36.25,99.6710526315789,99.4818652849741,93.6507936507936,98.4126984126984,99.1379310344828,99.3464052287582,87.8787878787879,99.3589743589744,87.7659574468085,98.6301369863014,35.5555555555556,98.2758620689655,99.2753623188406,99.4444444444444,66.6666666666667,99.4413407821229,99.4444444444444,70.4035874439462,70.4035874439462,99.7524752475248,99.4623655913979,98.5915492957747,96.9387755102041,99.601593625498,90.1639344262295,93.984962406015,93.5251798561151,91.1392405063291,97.463768115942,99.2063492063492,92.5233644859813,96.6666666666667,74.7663551401869,84.7457627118644,94.7826086956522,95.774647887324,90.5405405405405,97.3684210526316,92.7152317880795,91.6129032258064,88.7096774193548,94.5945945945946,96.2616822429907,84.0909090909091,81.4814814814815,96.6442953020134,93.3774834437086,75.5102040816327,96.5811965811966,99.6587030716723,96.2264150943396,51.1278195488722,99.6587030716723,99.6825396825397,99.0825688073395,99.6491228070175,81.7857142857143,97.1428571428571,90.3030303030303,99.7867803837953,87.6543209876543,78.6206896551724,51.9480519480519,99.5555555555556,51.9480519480519,36.4285714285714,98.2352941176471,96.8152866242038,97.8021978021978,98.2352941176471,99.6282527881041,99.6951219512195,99.6138996138996,96.2209302325581,99.3355481727575,99.6563573883162,98.6577181208054,80.327868852459,93.1623931623932,29.1666666666667,94.375,93.2203389830508,47.4576271186441,47.4576271186441,98.7987987987988,99.5575221238938,98.4848484848485,92.3404255319149,99.5433789954338,98.974358974359,99.5433789954338,98.4496124031008,99.3377483443709,99.1803278688525,98.8304093567251,47.4576271186441,93.8524590163934,69.6969696969697,65.9090909090909,70.5882352941176,59.4594594594595,69.5652173913043,65.9090909090909,98.9247311827957,58.3333333333333,94.413407821229,98.4455958549223,41.1764705882353,73.8095238095238,73.9130434782609,62.5,53.125,74.0740740740741,58.3333333333333,84.1584158415842,92,99.822695035461,98.7179487179487,96.7213114754098,97.1428571428571,99.7635933806147,99.6688741721854,99.6240601503759,47.4576271186441,47.4576271186441,55.2631578947368,99.2753623188406,84.251968503937,99.2957746478873,41.025641025641,73.9130434782609,99.1769547325103,99.2957746478873,61.2903225806452,73.9130434782609,99.1769547325103,99.8738965952081,99.6,99.2424242424242,98.1818181818182,98.1818181818182,99.5951417004049,97.4178403755868,99.1935483870968,98.0099502487562,96.4028776978417,91.7293233082707,56.0975609756098,99.5121951219512,95.3020134228188,63.6363636363636,97.5806451612903,91.358024691358,99.601593625498,88.1516587677725,99.5121951219512,93.0434782608696,69.7674418604651,56.0975609756098,90.1098901098901,97.6,62.9213483146067,96.2264150943396,95.4128440366973,96.9924812030075,72.1649484536082,92.96875,82.7586206896552,84.1463414634146,82.9545454545455,82.4175824175824,87.5,92.4050632911392,73.2142857142857,78.6666666666667,81.5789473684211,77.2727272727273,72.9166666666667,68.4210526315789,72.463768115942,73.8095238095238,85.7142857142857,65.0793650793651,97.1698113207547,99.5169082125604,99.0196078431373,98.2456140350877,97.1698113207547,99.5169082125604,98.2456140350877,99.0196078431373,69.7899838449111,90.3846153846154,98.1818181818182,96.2025316455696,92.0634920634921,96.2025316455696,98.8095238095238,99.1803278688525,99.4219653179191,96.2025316455696,97.7272727272727,96.2025316455696,99.2592592592593,99.7395833333333,99.2592592592593,99.7925311203319,99.492385786802,96.6517857142857,56.6037735849057,56.6037735849057,99.8518518518518,99.0415335463259,98.4042553191489,97.8339350180505,99.2094861660079,72.9166666666667,99.5910020449898,58.4269662921348,98.7341772151899,98.8358556461001,95.3488372093023,99.2805755395683,98.5915492957747,96.8503937007874,88.1720430107527,94.2222222222222,63.6363636363636,96.5909090909091,93.2307692307692,91.3385826771654,87.5,93.0555555555556,99.5192307692308,80.2292263610315,99.3975903614458,99.1803278688525,97.8723404255319,95.2095808383233,55.9322033898305,38.28125,55.3846153846154,99.1452991452991,38.8888888888889,47.7987421383648,29.8611111111111,35.7664233576642,47.1264367816092,39.2857142857143,61.3207547169811,94.6280991735537,64.3835616438356,98.8461538461539,99.5192307692308,99.6563573883162,94.9771689497717,49.1228070175439,98.8888888888889,93.1034482758621,99.8420221169036,73.8805970149254,98.8165680473373,97.1428571428571,99.4117647058823,99.5495495495496,69.1011235955056,99.290780141844,97.1428571428571,69.1011235955056,99.6402877697842,99.3827160493827,99.1071428571429,99.4117647058823]],"container":"<table class=\"display\">\n  <thead>\n    <tr>\n      <th>Author & Year<\/th>\n      <th>Source<\/th>\n      <th>Quote with deviation<\/th>\n      <th>Similarity<\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"bPaginate":false,"dom":"ft","order":[[3,"desc"]],"columnDefs":[{"targets":3,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 1, 3, \",\", \".\", null);\n  }"},{"visible":false,"targets":1},{"className":"dt-right","targets":3}],"autoWidth":false,"orderClasses":false}},"evals":["options.columnDefs.0.render"],"jsHooks":[]}</script>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
</div>
</div>
<div id="llm-prompt" class="section level3">
<h3>LLM prompt</h3>
<ul>
<li>Model: <a
href="https://openrouter.ai/models/mistralai/mixtral-8x22b-instruct">mixtral-8x22b-instruct</a></li>
<li>Temperature: <code>0</code></li>
<li>Briefing derived from: <a
href="https://doi.org/10.1371/journal.pone.0175213">Cullis 2017</a>
Supporting information: <a
href="https://doi.org/10.1371/journal.pone.0175213.s004">S1
Dataset</a></li>
</ul>
<div id="system-prompt" class="section level4">
<h4>System prompt</h4>
<pre>
You are an expert in systematic reviews and are tasked to assess the methodological quality of a systematic review with the AMSTAR tool and its reporting quality with the PRISMA tool based on the full text of its publication. AMSTAR and PRISMA consist of the following items:

&lt;AMSTAR&gt;
A1. Was an 'a priori' design provided? The research question and inclusion criteria should be established before the conduct of the review. Note: Need to refer to a protocol, ethics approval, or pre-determined/a priori published research objectives to score a yes.
A2. Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place. Note: 2 people do study selection, 2 people do data extraction, consensus process or one person checks the others work.
A3. Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found. Note: If at least 2 sources + one supplementary strategy used, select yes (Cochrane register/Central counts as 2 sources; a grey literature search counts as supplementary).
A4. Was the status of publication (i.e. grey literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language etc. Note: If review indicates that there was a search for grey literature or unpublished literature, indicate yes. SIGLE database, dissertations, conference proceedings, and trial registries are all considered grey for this purpose. If searching a source that contains both grey and non-grey, must specify that they were searching for grey/unpublished lit.
A5. Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided. Note: Acceptable if the excluded studies are referenced. If there is an electronic link to the list but the link is dead, select no.
A6. Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases should be reported. Note: Acceptable if not in table format as long as they are described as above.
A7. Was the scientific quality of the included studies assessed and documented? 'A priori' methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant. Note: Can include use of a quality scoring tool or checklist, e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a description of quality items, with some kind of result for EACH study (low or high is fine, as long as it is clear which studies scored low and which scored high; a summary score/range for all studies is not acceptable).
A8. Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations. Note: Might say something such as the results should be interpreted with caution due to poor quality of included studies. Cannot score yes for this question if scored no for question A7.
A9. Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e., Chi-squared test for homogeneity, I2 ). If heterogeneity exists a random effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (i.e., is it sensible to combine?). Note: Indicate yes if they mention or describe heterogeneity, i.e., if they explain that they cannot pool because of heterogeneity/variability between interventions.
A10. Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). Note: If no test values or funnel plot included, score no. Score yes if mentions that publication bias could not be assessed because there were fewer than 10 included studies.
A11. Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies. Note: To get a yes, must indicate source of funding or support for the systematic review AND for each of the included studies..
&lt;/AMSTAR&gt;
&lt;PRISMA&gt;
P1. Title: Identify the report as a systematic review, meta-analysis, or both.
P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.
P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.
P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.
P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.
P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.
P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).
P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.
P15. Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.
P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).
P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.
P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.
P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).
P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).
P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).
P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).
P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.
P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.
&lt;/PRISMA&gt;

 
</pre>
</div>
<div id="user-prompt" class="section level4">
<h4>User prompt</h4>
<pre>
This is the full text to be assessed:
&lt;FULLTEXT&gt;
%FULLTEXT%
&lt;/FULLTEXT&gt;

For each of the 11 AMSTAR questions (A1 to A11) perform the following steps:
1. Extract 1-3 relevant quotes from the full text.
2. Explain your reasoning in 1 sentence.
3. Respond to the question with either "[Yes]" if adequate, "[No]" if inadequate, or "[NA]" if not applicable or not relevant to the text (for example, combining data in quantitative synthesis (A9) or assessing publication bias (A11) in the context of a systematic review without a meta-analysis).

For each of the PRISMA items (P1 to P27) perform the following steps:
1. Extract 1-3 relevant quotes from the full text.
2. Explain your reasoning in 1 sentence.
3. Respond with either "[Yes]" if the item was reported, "[No]" if not reported, or "[NA]" if not applicable (for example, items P14, P15, P16, P21, P22, P23 in the context of a systematic review without a meta-analysis).

Before stopping, make sure you've processed all 11 AMSTAR questions and 27 PRISMA items. Do not provide a final summary paragraph in the end.
 
</pre>
</div>
</div>
</div>

</div>

<script>
$(document).ready(function() {
  // add bootstrap table styles to pandoc tables
  $('tr.header').parent('thead').parent('table').addClass('table table-condensed table-sm');

  // initialize mathjax

});
</script>

<script type="text/javascript">
$(document).ready(function () {
  FlexDashboard.init({
    fillPage: true,
    orientation: "columns",
    storyboard: false,
    defaultFigWidth: 576,
    defaultFigHeight: 460,
    defaultFigWidthMobile: 360,
    defaultFigHeightMobile: 460,
    resize_reload: true
  });
  var navbar = $(".navbar").first();
  var body = $("body").first();
  var sidebar = $(".section.sidebar").first();
  function addNavbarPadding() {
    var navHeight = navbar.outerHeight();
    body.css("padding-top", (navHeight + 8) + "px");
    sidebar.css("top", navHeight + "px");
    var resizeEvent = window.document.createEvent("UIEvents");
    resizeEvent.initUIEvent("resize", true, false, window, 0);
    window.dispatchEvent(resizeEvent);
  }
  if (!window.Shiny) setTimeout(addNavbarPadding, 100);
  $(document).on("shiny:idle", function() {
    setTimeout(addNavbarPadding, 50);
  });
});
</script>

</body>
</html>
